data_6b3n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6b3n _Structure_validation_residue.Date_analyzed 2017-11-17 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 N-CA-C 110.836 -0.486 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -64.23 103.66 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.397 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.13 132.46 45.08 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.842 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.94 85.69 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.407 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.4 t -141.06 35.13 0.21 Allowed Pre-proline 0 CA--C 1.57 1.712 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 -29.88 6.83 Favored 'Trans proline' 0 C--N 1.387 2.604 0 CA-C-N 121.002 1.394 . . . . 0.0 112.327 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.507 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.0 m-85 -130.87 29.77 4.69 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.336 0.654 . . . . 0.0 111.826 -175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 6' ' ' THR . 11.6 mt -76.6 128.75 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 118.162 0.437 . . . . 0.0 112.025 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -103.83 91.07 3.27 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 86.44 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 0.0 111.518 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.64 -13.5 0.17 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.405 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 10' ' ' LEU . 25.1 m -119.71 158.31 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.202 0.601 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -74.52 -37.81 62.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.079 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -80.61 162.65 24.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.427 0.632 . . . . 0.0 111.285 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 17' ' ' SER . 1.1 tm? -113.43 151.96 30.7 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 35.7 t -57.1 -59.31 5.28 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.673 0.789 . . . . 0.0 110.629 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -174.69 117.43 0.19 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.24 137.56 27.69 Favored Pre-proline 0 N--CA 1.485 1.32 0 CA-C-N 118.402 0.546 . . . . 0.0 110.359 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.87 116.66 3.39 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.272 1.982 . . . . 0.0 110.736 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.499 ' HA ' HD23 ' A' ' 24' ' ' LEU . 27.8 tt0 -65.31 -26.13 67.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.477 0.711 . . . . 0.0 111.129 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.77 -25.94 67.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.871 0.868 . . . . 0.0 111.438 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.53 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 20.5 m -71.28 -47.84 54.5 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.2 mm? -57.33 -33.2 67.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 117.847 0.294 . . . . 0.0 110.627 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.8 m -61.46 -51.09 70.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.458 0.703 . . . . 0.0 111.401 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' THR . 8.2 pt-20 -66.52 -35.73 80.97 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.623 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 23' ' ' THR . 15.5 mm -58.24 -51.52 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.855 0.862 . . . . 0.0 110.091 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.504 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 91.4 mtm180 -59.88 -28.26 67.4 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.98 -42.4 26.81 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.964 0.506 . . . . 0.0 111.553 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 5.4 pt20 -77.7 -23.64 49.43 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.392 0.677 . . . . 0.0 112.448 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 74.1 p -61.49 -28.19 69.12 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.328 0.513 . . . . 0.0 111.352 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.39 -24.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.985 0.914 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -67.19 -19.05 65.5 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.744 0.818 . . . . 0.0 110.316 173.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.24 -22.86 14.83 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.997 0.808 . . . . 0.0 113.25 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 43.7 tt0 -143.98 145.11 32.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.294 0.638 . . . . 0.0 110.366 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.07 106.44 5.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.022 0.929 . . . . 0.0 109.085 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.56 121.9 31.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.683 0.393 . . . . 0.0 110.105 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD11 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -111.92 129.08 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.455 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 33.1 mtm105 -103.29 106.08 16.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 95.4 mt -77.27 68.37 3.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.68 0.82 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.266 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.46 -16.73 22.04 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.021 0.928 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 11.7 mt -81.12 111.27 17.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.7 tpt -84.89 124.76 32.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.98 152.14 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.597 1.159 . . . . 0.0 108.487 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -139.18 99.93 3.88 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.523 0.729 . . . . 0.0 109.757 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 38' ' ' ILE . 11.1 mm -88.46 120.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -161.95 137.76 5.77 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 118.189 0.45 . . . . 0.0 111.189 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 96.7 Cg_endo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 122.563 2.176 . . . . 0.0 111.311 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 9.7 p90 -87.06 114.7 23.9 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.429 0.633 . . . . 0.0 110.202 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.543 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -162.65 -176.57 5.07 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.0 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.7 110.29 2.04 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -125.66 106.47 9.76 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 118.85 19.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.019 0.927 . . . . 0.0 109.684 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.79 91.72 3.53 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.709 . . . . 0.0 109.132 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 125.092 1.357 . . . . 0.0 112.856 -177.172 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 15.1 m120 -56.79 -44.65 82.08 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.358 0.663 . . . . 0.0 111.82 -172.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.32 -35.35 80.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.123 0.569 . . . . 0.0 111.446 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -66.37 -32.96 74.67 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.964 0.505 . . . . 0.0 111.447 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mm -66.19 -45.01 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 76.3 mm-40 -71.61 -54.82 9.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.59 0.756 . . . . 0.0 112.079 -174.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.72 -30.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.35 0.595 . . . . 0.0 109.469 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.62 -57.66 17.8 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.654 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -71.27 -26.78 63.03 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.643 0.722 . . . . 0.0 112.737 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -74.05 -37.0 64.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.357 0.598 . . . . 0.0 110.096 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.93 -24.83 48.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.731 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 1.2 mp -71.54 -46.49 63.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.12 -30.51 71.57 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.608 0.568 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.06 -54.95 34.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.369 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.438 HG22 HD21 ' A' ' 84' ' ' LEU . 56.2 mt -61.24 -32.92 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.332 1.053 . . . . 0.0 112.364 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 49.7 mt-10 -63.1 -39.49 94.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.047 0.539 . . . . 0.0 110.84 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -77.36 -32.9 55.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.917 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -77.63 -26.19 50.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.299 0.64 . . . . 0.0 112.018 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 24' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 C-N-CA 124.086 0.955 . . . . 0.0 109.956 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 93' ' ' GLU . 9.0 t . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.9 p -58.16 -53.46 58.03 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.359 1.063 . . . . 0.0 111.182 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -68.17 -27.88 66.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.094 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HB2' HG21 ' A' ' 90' ' ' THR . 15.0 tp10 -59.91 -33.34 71.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.822 0.849 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.79 -39.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.004 0.922 . . . . 0.0 110.947 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -61.54 -37.28 83.19 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.385 0.674 . . . . 0.0 111.734 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.68 -27.92 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.294 0.638 . . . . 0.0 111.859 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.5 -39.83 85.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.911 0.484 . . . . 0.0 110.031 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -83.22 -34.45 25.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.604 0.761 . . . . 0.0 111.901 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.03 -38.35 57.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.576 0.75 . . . . 0.0 112.38 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.642 0.777 . . . . 0.0 112.557 -176.141 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 CA--C 1.555 1.529 0 CA-C-O 121.373 0.489 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.96 112.89 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.045 0.938 . . . . 0.0 110.465 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.91 134.43 47.24 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.208 0.527 . . . . 0.0 110.275 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 19' ' ' ILE . 4.5 tt -140.42 92.75 2.55 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' HA ' HG13 ' A' ' 9' ' ' ILE . 9.9 t -150.09 55.0 1.67 Allowed Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.66 -31.58 0.43 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.956 1.771 . . . . 0.0 113.099 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HE1' ' HD3' ' A' ' 20' ' ' PRO . 48.4 m-85 -127.86 4.83 6.0 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.439 -171.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 6' ' ' THR . 16.3 mt -54.28 122.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -164.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 mt -98.91 96.4 3.99 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.7 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.18 40.3 0.97 Allowed 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.078 2.518 . . . . 0.0 115.118 -161.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.12 23.23 0.15 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.103 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.36 178.18 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.277 0.631 . . . . 0.0 110.412 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 57.6 p -91.83 -48.96 6.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.748 0.819 . . . . 0.0 111.01 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -79.0 -175.93 4.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.342 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 tp -141.78 169.64 17.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -55.39 -64.44 0.84 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.303 0.641 . . . . 0.0 109.722 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -176.41 105.6 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.167 0.917 . . . . 0.0 108.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.417 HG22 HD22 ' A' ' 5' ' ' LEU . 56.8 mt -63.3 129.47 93.54 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.702 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 14.8 Cg_endo -56.17 120.34 8.12 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.75 2.3 . . . . 0.0 112.038 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.467 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.6 pm0 -60.39 -26.05 66.36 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.453 0.701 . . . . 0.0 111.978 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.41 -36.44 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.762 0.825 . . . . 0.0 110.926 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 27' ' ' ILE . 16.5 m -72.78 -37.51 67.57 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.237 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.0 mm? -64.67 -29.78 70.79 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.6 0.636 . . . . 0.0 110.479 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.1 t -72.48 -35.38 68.19 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.372 0.669 . . . . 0.0 110.289 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 10.6 tp10 -61.33 -50.19 73.95 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.395 0.678 . . . . 0.0 110.229 173.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 23' ' ' THR . 13.9 mm -59.18 -37.17 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.171 0.989 . . . . 0.0 110.522 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.2 tpt180 -60.9 -33.42 73.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.69 -39.05 58.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.445 0.698 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 54.0 mt-30 -73.68 -29.85 62.54 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.25 0.62 . . . . 0.0 110.973 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.5 p -69.81 -27.92 65.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.947 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 28' ' ' ARG . 43.3 mm -67.43 -35.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -67.75 -19.05 65.08 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.17 -21.86 21.62 Favored Glycine 0 C--N 1.346 1.126 0 C-N-CA 123.793 0.711 . . . . 0.0 112.759 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -141.89 119.32 11.58 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 122.974 0.51 . . . . 0.0 110.538 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.95 111.09 21.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -103.12 113.03 26.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.578 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.4 mp -101.23 149.08 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 108.588 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.428 HH21 ' HA ' ' A' ' 42' ' ' GLU . 12.7 mmm-85 -126.03 88.25 2.82 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.187 0.995 . . . . 0.0 109.252 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.1 mt -71.32 77.43 0.74 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 -102.26 0.66 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.829 -166.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HA ' HH21 ' A' ' 39' ' ' ARG . 15.2 pt-20 -100.18 -18.63 16.81 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.811 0.844 . . . . 0.0 111.139 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.0 mt -69.08 110.95 4.76 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.4 ttt -88.8 108.71 19.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.088 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 19.2 t -98.5 154.13 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.641 1.177 . . . . 0.0 108.664 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.3 98.89 3.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.409 0.683 . . . . 0.0 109.8 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 38' ' ' ILE . 37.5 mm -89.63 104.84 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.041 0.936 . . . . 0.0 108.787 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -130.29 128.14 22.64 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.338 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.383 2.369 0 C-N-CA 123.148 2.566 . . . . 0.0 111.922 -178.729 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -86.35 130.25 34.57 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -153.06 179.13 8.98 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.515 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.505 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . -61.89 110.44 3.19 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.23 0.956 . . . . 0.0 113.19 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.2 t -122.43 98.58 5.99 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 121.6 23.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.36 85.8 0.59 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 60' ' ' LEU . 7.4 pt20 . . . . . 0 N--CA 1.478 0.969 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.282 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -57.52 -26.37 61.24 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.744 0.818 . . . . 0.0 111.879 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.22 -54.32 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.495 1.118 . . . . 0.0 110.644 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.57 -25.23 61.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.648 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.03 -39.86 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 50.9 tt0 -65.35 -58.3 6.24 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.445 0.466 . . . . 0.0 110.108 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.8 mt -59.91 -34.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.556 0.743 . . . . 0.0 110.027 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.41 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -64.29 -54.89 26.81 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.37 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.499 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -66.93 -26.98 67.12 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.02 0.91 . . . . 0.0 111.467 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 24.4 mt-30 -64.69 -50.72 65.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.734 0.778 . . . . 0.0 109.44 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' ILE . 10.4 m-85 -69.64 -24.9 63.7 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.773 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -70.52 -42.42 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.404 0.682 . . . . 0.0 111.095 -178.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -68.87 -27.67 66.01 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -72.77 -36.01 67.55 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.279 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 76' ' ' TYR . 38.1 mm -73.59 -43.28 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.234 0.47 . . . . 0.0 110.605 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 12.7 pt-20 -65.5 -38.55 90.05 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.637 0.375 . . . . 0.0 111.489 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -70.39 -26.04 63.52 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.39 0.676 . . . . 0.0 110.555 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m -78.26 -31.87 49.31 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.722 0.809 . . . . 0.0 111.23 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 123.013 0.525 . . . . 0.0 112.178 -178.422 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 81.9 m . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.6 p -56.89 -48.57 77.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.956 0.902 . . . . 0.0 112.194 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' VAL . 42.4 ttp180 -69.0 -27.61 65.84 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 122.219 0.208 . . . . 0.0 111.097 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 1.5 tm-20 -61.69 -24.98 67.12 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 122.993 0.517 . . . . 0.0 110.174 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.17 -34.87 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.056 0.542 . . . . 0.0 111.368 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.0 m -62.97 -30.57 71.68 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 92' ' ' ARG . 26.8 m -65.92 -21.21 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.419 0.688 . . . . 0.0 111.558 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.08 -43.48 87.03 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.628 0.771 . . . . 0.0 110.102 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -79.81 -31.46 40.7 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.918 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -71.66 -44.51 64.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.64 0.776 . . . . 0.0 112.552 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 96' ' ' VAL . 27.5 pt . . . . . 0 CA--C 1.57 1.74 0 C-N-CA 122.971 0.508 . . . . 0.0 111.339 -172.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.548 1.224 0 CA-C-O 121.391 0.496 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.97 116.17 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.761 1.225 . . . . 0.0 108.597 167.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 7.6 p-10 -69.98 142.23 52.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -145.4 89.05 1.9 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.507 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.1 t -147.05 41.46 0.27 Allowed Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.002 0.521 . . . . 0.0 112.377 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 6' ' ' THR . 1.7 Cg_endo -79.6 -39.06 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 121.535 1.49 . . . . 0.0 112.021 -174.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.42 ' HE2' ' HD3' ' A' ' 20' ' ' PRO . 1.1 m-85 -129.43 31.09 4.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.071 0.548 . . . . 0.0 111.03 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.6 mt -63.35 109.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 118.817 0.735 . . . . 0.0 111.258 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.02 98.58 2.04 Favored Pre-proline 0 C--N 1.356 0.879 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.99 -16.79 50.49 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.419 2.079 . . . . 0.0 112.851 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.56 83.17 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.648 0.593 . . . . 0.0 114.356 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 10' ' ' LEU . 33.9 m -129.08 171.1 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 117.248 0.524 . . . . 0.0 111.503 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p -82.73 -34.7 27.13 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.635 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -84.91 177.34 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 122.084 0.945 . . . . 0.0 111.95 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.68 142.03 49.85 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 171.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.1 m -52.76 -48.0 67.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.456 0.702 . . . . 0.0 111.606 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 t70 179.41 119.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.838 1.255 . . . . 0.0 108.015 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.14 134.89 37.83 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 19.8 Cg_endo -58.86 122.65 11.98 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.797 2.331 . . . . 0.0 111.38 170.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.38 -17.9 64.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.153 0.581 . . . . 0.0 111.102 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -56.19 -47.21 78.78 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.222 1.009 . . . . 0.0 110.295 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -65.87 -34.94 79.3 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.043 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.9 mm? -67.65 -32.7 73.58 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.125 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -62.88 -38.61 91.57 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.846 0.458 . . . . 0.0 111.769 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 15.3 pt-20 -73.39 -40.84 64.0 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.261 0.351 . . . . 0.0 110.103 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.67 -36.83 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.004 0.922 . . . . 0.0 110.84 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 21.9 mmm180 -61.73 -45.08 95.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.812 0.845 . . . . 0.0 110.934 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.24 -37.67 83.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.032 0.533 . . . . 0.0 110.935 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 18.0 mm-40 -68.47 -38.38 81.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.842 0.857 . . . . 0.0 111.148 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -69.06 -27.79 65.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 46.6 mm -71.45 -36.61 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -75.17 -12.17 60.24 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.914 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.94 -9.73 60.07 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.594 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -139.23 111.95 7.8 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.214 1.007 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.67 98.99 5.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.811 0.844 . . . . 0.0 109.041 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -99.17 105.96 18.08 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.76 110.25 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.586 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 41.5 mtm105 -88.22 90.23 8.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.629 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 93.5 mt -76.1 70.6 2.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.291 0.637 . . . . 0.0 109.905 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.02 0.55 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.807 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.06 -15.13 32.38 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.177 0.991 . . . . 0.0 111.449 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 22.3 mt -91.3 142.86 27.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.963 0.905 . . . . 0.0 109.765 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.2 tpt -120.24 106.02 11.51 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.426 HG22 HD21 ' A' ' 60' ' ' LEU . 40.4 t -111.42 103.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.114 0.966 . . . . 0.0 109.898 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 t -90.36 98.91 12.05 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -84.74 103.64 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.04 139.36 13.35 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.618 -0.229 . . . . 0.0 110.665 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 C--N 1.378 2.089 0 C-N-CA 122.728 2.285 . . . . 0.0 112.283 175.192 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -88.24 132.77 34.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.926 0.49 . . . . 0.0 110.422 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.9 ptp -160.01 -175.98 5.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.943 1.297 . . . . 0.0 108.628 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.29 110.69 1.89 Allowed Glycine 0 C--N 1.352 1.462 0 O-C-N 123.655 0.597 . . . . 0.0 113.168 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.9 t -128.72 97.73 4.77 Favored 'General case' 0 C--N 1.353 0.717 0 C-N-CA 123.196 0.599 . . . . 0.0 109.872 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.648 ' HG ' ' HA3' ' A' ' 73' ' ' GLY . 3.3 tm? -79.54 113.03 17.36 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -79.49 142.24 36.0 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.174 0.59 . . . . 0.0 112.167 -175.035 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -55.31 -31.92 62.05 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.457 1.103 . . . . 0.0 112.134 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -51.85 67.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.497 1.119 . . . . 0.0 110.216 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.23 -39.46 82.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.04 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 22.6 mm -59.12 -51.71 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.874 0.734 . . . . 0.0 110.65 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 47.5 mt-30 -57.61 -46.72 83.71 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.543 1.152 . . . . 0.0 111.487 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.5 mt -58.13 -41.45 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 124.09 0.869 . . . . 0.0 110.158 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.648 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -60.37 -49.11 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.295 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 70' ' ' ILE . 50.7 mt -57.86 -36.98 73.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.991 0.917 . . . . 0.0 111.323 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 83.6 mm-40 -58.54 -51.39 70.08 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.429 174.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -68.81 -30.43 68.99 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.589 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 73' ' ' GLY . 1.2 mp -66.64 -42.72 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.385 1.074 . . . . 0.0 111.098 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.88 -30.13 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.431 0.457 . . . . 0.0 110.663 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -78.29 -26.75 47.18 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 40' ' ' LEU . 65.2 mt -71.03 -32.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 123.37 0.668 . . . . 0.0 109.638 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.64 -41.31 76.95 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.844 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -71.2 -38.83 72.06 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.638 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -66.83 -33.48 75.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.823 0.849 . . . . 0.0 111.38 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.482 1.159 0 C-N-CA 124.528 1.131 . . . . 0.0 109.777 177.412 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 92' ' ' ARG . 21.8 m . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -66.61 -21.5 66.13 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.918 -0.489 . . . . 0.0 111.245 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' H ' HG23 ' A' ' 90' ' ' THR . 42.3 ttm180 -69.26 -33.5 73.34 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' HG23 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -69.03 -36.83 78.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.47 -20.45 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 120.99 0.424 . . . . 0.0 110.394 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.8 m -78.23 -38.96 41.76 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.406 0.683 . . . . 0.0 111.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 99' ' ' GLU . 30.0 m -76.38 -17.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.723 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.7 mt -51.01 -53.95 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.929 0.491 . . . . 0.0 111.988 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -24.13 30.44 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.803 0.441 . . . . 0.0 111.949 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 34.8 tt0 -77.63 -31.57 52.87 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 112.655 -167.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 CA--C 1.561 1.373 0 C-N-CA 123.341 0.656 . . . . 0.0 112.329 -176.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 CA--C 1.549 1.232 0 CA-C-O 121.321 0.467 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.43 94.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 122.176 0.989 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.24 148.61 49.58 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.547 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.03 102.89 3.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -149.97 38.95 0.18 Allowed Pre-proline 0 CA--C 1.571 1.787 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.69 -26.82 1.9 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 CA-C-N 121.014 1.398 . . . . 0.0 112.507 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 41.8 m-85 -127.97 21.96 6.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.545 0.738 . . . . 0.0 111.225 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.56 126.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.024 0.375 . . . . 0.0 110.507 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.4 90.17 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.34 -16.28 47.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.503 2.135 . . . . 0.0 113.675 -168.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.41 -13.9 82.1 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.585 -0.564 . . . . 0.0 114.082 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.47 173.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 117.737 0.769 . . . . 0.0 110.802 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 p -88.3 9.02 24.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.461 1.104 . . . . 0.0 112.406 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -146.04 177.3 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.375 0.67 . . . . 0.0 111.334 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.49 149.53 45.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 22.7 t -57.45 -64.54 0.86 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.063 0.545 . . . . 0.0 110.868 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -163.34 144.82 9.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.27 130.29 27.45 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.383 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.99 141.31 86.58 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.103 2.535 . . . . 0.0 112.332 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.18 -24.56 67.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.184 0.593 . . . . 0.0 111.647 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.85 -39.86 87.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.03 0.532 . . . . 0.0 110.803 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 27' ' ' ILE . 37.1 m -72.69 -42.88 63.76 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.018 0.527 . . . . 0.0 110.411 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.57 -46.3 90.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.043 0.537 . . . . 0.0 110.775 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -64.85 -33.69 76.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.778 0.831 . . . . 0.0 111.12 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.1 tp10 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.669 0.606 . . . . 0.0 109.697 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 23' ' ' THR . 67.9 mt -54.03 -43.21 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.797 0.839 . . . . 0.0 110.696 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.422 HH11 ' HA ' ' A' ' 28' ' ' ARG . 10.4 mmm180 -66.17 -31.39 72.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -73.28 -44.37 59.34 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.553 0.741 . . . . 0.0 111.11 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.506 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 15.2 mm-40 -77.73 -27.7 50.6 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.184 0.994 . . . . 0.0 112.054 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.6 p -63.51 -25.86 68.45 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.577 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.41 -26.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-O 121.279 0.561 . . . . 0.0 109.771 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -77.56 -26.36 50.84 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.057 168.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.78 4.85 60.21 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.469 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 24.0 tt0 -129.76 116.86 19.37 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -155.62 96.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.426 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.49 113.02 26.01 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.36 112.86 34.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.548 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 52.0 mtp180 -87.46 92.24 9.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD11 HD11 ' A' ' 80' ' ' ILE . 90.5 mt -70.22 75.53 0.52 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.273 0.629 . . . . 0.0 109.709 175.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.45 -99.91 0.37 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -103.62 -7.68 20.56 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.237 1.015 . . . . 0.0 111.657 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 24.3 mt -88.35 109.95 20.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.506 0.722 . . . . 0.0 109.069 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.548 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.5 tpt -84.47 114.44 21.93 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.25 110.68 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.047 0.539 . . . . 0.0 110.561 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.3 m -88.16 113.77 24.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.149 0.58 . . . . 0.0 110.573 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 31.7 mm -104.08 85.03 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -130.55 145.06 55.91 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--N 1.38 2.225 0 C-N-CA 122.455 2.103 . . . . 0.0 111.681 174.002 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -94.44 108.05 20.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.279 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 59.2 mtm -152.78 107.71 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.427 1.491 . . . . 0.0 108.055 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 108.34 0.01 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 m -131.4 96.98 4.13 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 165.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.7 117.75 20.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 0.0 108.977 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 27.7 t-20 -67.65 89.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.761 0.791 . . . . 0.0 109.102 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? . . . . . 0 N--CA 1.477 0.92 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.312 -175.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 119.817 -0.135 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -63.92 -26.69 68.71 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.5 -42.44 71.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.99 -20.66 60.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.416 0.686 . . . . 0.0 111.933 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.54 -50.17 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.88 -57.32 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.097 0.873 . . . . 0.0 110.59 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 43' ' ' LEU . 49.3 mt -61.42 -36.2 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.209 0.603 . . . . 0.0 109.882 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' HD11 ' A' ' 77' ' ' ILE . . . -57.92 -58.0 16.86 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.681 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.44 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -67.09 -27.24 67.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.057 0.543 . . . . 0.0 111.811 -175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -65.04 -43.33 92.73 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.524 0.678 . . . . 0.0 110.198 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.17 -22.62 59.34 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.848 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -67.24 -38.34 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.077 0.551 . . . . 0.0 109.735 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 -34.88 76.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.381 0.673 . . . . 0.0 110.23 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -62.6 -52.7 62.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.695 0.398 . . . . 0.0 110.675 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.62 HD11 HD11 ' A' ' 40' ' ' LEU . 79.5 mt -64.58 -32.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.258 0.623 . . . . 0.0 110.633 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -53.01 -49.67 65.77 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.263 0.625 . . . . 0.0 110.212 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -75.75 -34.82 60.3 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.268 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.5 m -84.06 -31.78 25.18 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.788 0.835 . . . . 0.0 111.901 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 N--CA 1.485 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 109.328 -173.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.8 p -60.61 -39.85 89.68 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.626 171.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -61.42 -41.33 97.0 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.935 0.894 . . . . 0.0 111.971 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.87 -31.66 72.92 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.246 0.341 . . . . 0.0 111.699 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HA ' HD22 ' A' ' 97' ' ' LEU . 7.7 p -90.99 -23.21 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 C-N-CA 122.761 0.424 . . . . 0.0 112.047 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.1 m -65.6 -34.95 79.42 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.982 0.513 . . . . 0.0 110.86 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.25 -20.41 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 94' ' ' VAL . 4.4 mm? -73.06 -48.78 33.0 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.82 0.448 . . . . 0.0 110.488 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -71.19 -24.19 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.736 0.303 . . . . 0.0 110.438 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -69.94 -53.97 15.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.276 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.715 -175.284 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.509 ' HB2' ' HG3' ' A' ' 39' ' ' ARG . 71.8 Cg_endo . . . . . 0 CA--C 1.557 1.656 0 CA-C-O 121.117 0.382 . . . . 0.0 112.644 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.75 99.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.809 0.844 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.4 89.59 0.35 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.312 1.053 . . . . 0.0 111.163 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.43 102.99 15.44 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.479 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.6 t -154.83 53.14 0.82 Allowed Pre-proline 0 CA--C 1.566 1.559 0 C-N-CA 122.833 0.453 . . . . 0.0 112.113 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -82.19 -36.56 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.251 1.967 . . . . 0.0 112.006 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -129.13 17.52 6.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.631 0.772 . . . . 0.0 111.814 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 HG12 HD23 ' A' ' 16' ' ' LEU . 30.0 mt -67.23 123.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 118.577 0.626 . . . . 0.0 111.28 -175.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.486 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -101.29 86.55 0.76 Allowed Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.88 -5.45 17.04 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.381 2.054 . . . . 0.0 113.698 -163.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.81 -11.26 68.35 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.347 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 10' ' ' LEU . 19.7 m -122.07 169.38 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.203 0.601 . . . . 0.0 110.842 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 15.6 m -81.89 -34.99 29.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.351 1.06 . . . . 0.0 111.877 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -88.81 170.82 10.42 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.778 0.799 . . . . 0.0 112.175 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.499 HD23 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -125.83 133.02 52.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 m -55.47 -66.52 0.4 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.823 0.702 . . . . 0.0 110.406 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -146.72 134.18 20.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.59 126.3 37.78 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 169.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.78 121.72 9.55 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.585 2.19 . . . . 0.0 111.683 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.483 ' HA ' HD21 ' A' ' 24' ' ' LEU . 10.1 pt20 -62.1 -23.95 66.83 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.991 0.917 . . . . 0.0 112.059 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.63 -37.09 86.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.71 0.804 . . . . 0.0 110.999 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' ILE . 23.3 m -76.97 -29.83 55.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.468 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.483 HD21 ' HA ' ' A' ' 21' ' ' GLN . 3.6 mm? -61.0 -41.33 96.31 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -54.51 -43.27 71.69 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.935 0.894 . . . . 0.0 112.714 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.9 pt-20 -72.9 -40.72 65.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.234 0.334 . . . . 0.0 110.904 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 23' ' ' THR . 33.7 mm -61.97 -39.98 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.329 0.652 . . . . 0.0 110.084 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.4 mmm180 -60.88 -25.48 66.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.999 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -87.06 -41.86 13.51 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 0.0 112.073 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 45.2 mt-30 -63.92 -31.44 72.62 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.562 0.745 . . . . 0.0 111.982 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -55.63 -33.44 64.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.337 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.45 -37.73 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.245 0.618 . . . . 0.0 110.287 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -61.61 -24.24 66.56 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.787 0.835 . . . . 0.0 111.178 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.67 2.63 67.15 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.231 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 122.53 19.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.821 0.849 . . . . 0.0 110.269 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -164.9 96.33 0.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.611 1.164 . . . . 0.0 108.361 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -105.28 125.32 50.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.96 116.8 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.155 0.982 . . . . 0.0 108.409 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 40.5 mtm105 -86.17 101.34 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.701 HD11 HD13 ' A' ' 80' ' ' ILE . 48.1 mt -76.12 77.67 2.95 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.23 -101.29 0.66 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.284 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -25.93 17.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.143 0.977 . . . . 0.0 111.217 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD13 HG22 ' A' ' 72' ' ' ILE . 61.4 mt -71.77 131.06 42.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.757 0.823 . . . . 0.0 111.143 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.9 tpt -98.14 99.94 11.22 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.48 152.9 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.957 0.903 . . . . 0.0 108.979 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 98.61 4.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.6 0.76 . . . . 0.0 109.52 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 40.7 mm -93.19 84.13 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -129.45 117.14 18.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 C--N 1.383 2.388 0 C-N-CA 122.414 2.076 . . . . 0.0 112.305 -176.588 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.454 ' HB2' HG12 ' A' ' 94' ' ' VAL . 48.3 m-85 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -97.25 126.44 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 121.503 0.668 . . . . 0.0 110.763 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 14.0 ptt? -174.75 -174.38 0.8 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.71 2.004 . . . . 0.0 106.996 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.24 109.24 0.47 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -134.82 122.32 21.9 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.434 1.094 . . . . 0.0 108.203 170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.1 tm? -99.49 124.23 44.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.633 0.773 . . . . 0.0 109.545 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.68 105.75 3.28 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 123.913 0.885 . . . . 0.0 112.072 -178.949 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.493 ' O ' HG12 ' A' ' 70' ' ' ILE . 34.5 t . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.53 -26.02 68.51 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.129 0.572 . . . . 0.0 111.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.23 -48.96 76.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.32 0.648 . . . . 0.0 110.181 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.97 -35.93 81.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.881 0.873 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 66' ' ' SER . 37.5 mm -61.66 -40.27 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.933 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.48 -57.77 10.51 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.909 0.755 . . . . 0.0 112.008 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 43' ' ' LEU . 4.0 mp -66.01 -34.85 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.419 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -58.55 -57.3 20.56 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.175 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -66.95 -30.65 70.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.954 0.501 . . . . 0.0 111.614 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 23.1 mm-40 -60.72 -54.63 42.93 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.531 0.519 . . . . 0.0 110.048 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 80' ' ' ILE . 12.9 m-85 -60.79 -35.91 77.65 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.679 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -62.64 -35.9 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.956 0.902 . . . . 0.0 111.561 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.75 -31.58 66.82 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.457 0.473 . . . . 0.0 110.5 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.78 -32.59 62.07 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.702 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 40' ' ' LEU . 95.5 mt -74.07 -29.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.863 0.865 . . . . 0.0 109.734 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 12.8 tt0 -58.01 -35.7 71.62 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.976 0.911 . . . . 0.0 110.551 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.87 -43.96 43.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.229 0.612 . . . . 0.0 110.692 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -65.93 -25.15 67.01 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.456 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 HD11 HG21 ' A' ' 47' ' ' ILE . 90.9 mt . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.825 1.25 . . . . 0.0 109.546 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 111.423 0.157 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -59.62 -40.39 87.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.943 0.897 . . . . 0.0 110.935 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -39.25 76.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.388 0.675 . . . . 0.0 110.843 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.6 -35.3 78.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 0.0 111.98 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 55' ' ' TYR . 28.0 m -79.39 -28.98 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 118.332 0.515 . . . . 0.0 111.102 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.5 m -68.9 -42.46 76.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.835 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -65.21 -27.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.614 0.571 . . . . 0.0 111.569 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -63.26 -39.7 95.34 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.586 0.707 . . . . 0.0 110.22 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -32.06 32.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.26 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.69 -15.55 56.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.033 0.933 . . . . 0.0 112.482 -167.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.568 1.643 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.523 176.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.556 1.593 0 N-CA-C 113.424 0.509 . . . . 0.0 113.424 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 38' ' ' ILE . 61.9 t -88.62 94.14 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.967 0.907 . . . . 0.0 109.442 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.73 99.31 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.169 0.988 . . . . 0.0 110.259 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.541 HD13 HG22 ' A' ' 23' ' ' THR . 56.1 tp -117.83 98.73 6.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.728 . . . . 0.0 109.208 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 t -158.33 60.3 1.77 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.649 0.78 . . . . 0.0 110.97 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.7 -36.03 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.536 2.158 . . . . 0.0 112.286 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.43 -4.78 5.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.611 0.764 . . . . 0.0 111.552 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -48.07 124.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -161.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.1 mt -107.74 90.22 6.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.34 -19.41 38.18 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.458 2.105 . . . . 0.0 112.589 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.63 -2.41 80.55 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.983 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.92 173.43 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.51 0.655 . . . . 0.0 110.349 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 m -91.5 -13.39 32.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.269 1.027 . . . . 0.0 111.877 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -114.65 -172.86 2.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.838 . . . . 0.0 110.482 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.555 HD23 HG12 ' A' ' 19' ' ' ILE . 16.0 tp -143.33 139.71 30.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -50.03 -41.99 48.57 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.76 1.224 . . . . 0.0 112.183 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -166.47 147.66 6.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.597 0.759 . . . . 0.0 110.029 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.555 HG12 HD23 ' A' ' 16' ' ' LEU . 69.1 mt -121.24 130.47 24.81 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 168.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.99 116.63 2.9 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.964 2.442 . . . . 0.0 111.63 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HA ' HD21 ' A' ' 24' ' ' LEU . 25.6 mp0 -63.75 -27.24 69.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.619 1.168 . . . . 0.0 110.384 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.15 -36.13 83.28 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.077 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.541 HG22 HD13 ' A' ' 5' ' ' LEU . 48.3 m -66.77 -36.28 82.06 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.671 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 83' ' ' THR . 3.8 mm? -63.27 -42.75 99.16 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.156 0.435 . . . . 0.0 110.292 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.3 t -61.21 -39.47 90.38 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.563 0.745 . . . . 0.0 110.849 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 38.3 tt0 -65.62 -45.12 84.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.608 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 23' ' ' THR . 96.4 mt -60.3 -41.83 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.245 1.018 . . . . 0.0 110.184 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.448 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 20.4 mtp180 -63.52 -25.47 68.27 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.459 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.39 -34.88 25.45 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.613 0.765 . . . . 0.0 111.548 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 5.4 mm100 -73.21 -31.32 64.1 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.423 0.63 . . . . 0.0 110.239 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -68.27 -19.02 64.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.193 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.24 -33.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -70.47 -31.15 68.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.211 0.605 . . . . 0.0 110.11 168.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.5 3.09 50.39 Favored Glycine 0 N--CA 1.468 0.81 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.258 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.97 107.59 7.41 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.905 0.882 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 30' ' ' GLN . . . -136.64 95.85 3.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -101.56 98.11 8.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG23 HD21 ' A' ' 40' ' ' LEU . 1.9 mp -94.22 117.79 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -172.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 -89.59 104.65 17.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.556 HD21 HG23 ' A' ' 38' ' ' ILE . 3.9 mm? -76.68 74.88 3.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.35 -104.31 1.26 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.62 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.85 -20.55 23.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.123 0.969 . . . . 0.0 110.572 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 43.7 mt -78.13 146.52 35.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.471 0.708 . . . . 0.0 110.543 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.5 tpt -116.72 121.21 40.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.85 123.99 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.341 1.057 . . . . 0.0 109.435 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 59' ' ' SER . 66.9 m -98.58 97.68 8.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.212 0.605 . . . . 0.0 110.416 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -85.16 100.7 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.88 141.55 41.5 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.385 2.456 0 C-N-CA 123.166 2.578 . . . . 0.0 112.445 -177.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.359 0.6 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.448 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 38.5 p90 -84.67 125.75 32.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 111.162 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.706 ' HE1' ' HA ' ' A' ' 91' ' ' SER . 23.8 ptt? -177.62 112.95 0.08 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.581 1.152 . . . . 0.0 109.002 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 43.29 103.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.182 1.372 . . . . 0.0 116.254 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' SER . 32.4 m -136.72 98.91 3.9 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.168 -0.607 . . . . 0.0 109.639 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.9 126.4 27.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.58 0.752 . . . . 0.0 109.35 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.93 93.11 6.44 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--N 1.35 0.592 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -176.257 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -62.7 -23.36 67.11 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.615 0.766 . . . . 0.0 112.228 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -48.51 73.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.708 0.803 . . . . 0.0 109.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.2 -26.36 62.92 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.147 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.66 -43.85 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.481 0.712 . . . . 0.0 109.859 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 26.9 tt0 -59.75 -58.94 6.39 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.204 1.001 . . . . 0.0 111.591 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.26 -29.75 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' O ' HD11 ' A' ' 77' ' ' ILE . . . -55.94 -57.66 17.93 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.592 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.74 -26.26 66.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.976 0.51 . . . . 0.0 111.802 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 16.1 mm-40 -65.3 -41.55 93.96 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.577 172.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.466 ' O ' HG12 ' A' ' 80' ' ' ILE . 11.7 m-85 -77.98 -23.09 48.53 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.737 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -65.52 -47.77 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.563 0.619 . . . . 0.0 110.086 175.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -71.6 -28.49 63.85 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.949 0.781 . . . . 0.0 110.912 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -68.08 -50.32 55.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.197 0.311 . . . . 0.0 110.173 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 76' ' ' TYR . 45.8 mm -61.53 -39.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.755 0.822 . . . . 0.0 109.757 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 43.4 tt0 -57.74 -42.69 84.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.101 0.96 . . . . 0.0 111.174 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -71.8 -27.51 62.98 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.559 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.464 HG22 ' HG ' ' A' ' 24' ' ' LEU . 10.5 m -97.13 -23.41 16.23 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.767 0.827 . . . . 0.0 112.091 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 57' ' ' MET . 41.9 tp . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 124.175 0.99 . . . . 0.0 111.094 -170.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.706 ' HA ' ' HE1' ' A' ' 57' ' ' MET . 78.1 p -63.04 -52.47 62.72 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.02 0.928 . . . . 0.0 112.071 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -57.74 -34.02 69.09 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.497 0.719 . . . . 0.0 112.189 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -33.08 72.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.941 0.897 . . . . 0.0 112.359 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.37 -36.21 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.992 0.517 . . . . 0.0 110.024 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -64.07 -39.61 94.46 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.552 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.01 -32.83 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 0.0 111.086 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.67 -35.61 79.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.213 0.605 . . . . 0.0 110.432 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -82.19 -25.47 34.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.087 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.14 -41.22 22.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.953 0.901 . . . . 0.0 111.42 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.288 0.635 . . . . 0.0 111.068 -178.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.549 1.257 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 99.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.17 0.986 . . . . 0.0 109.127 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.55 110.42 3.66 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.2 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.81 113.3 15.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.333 1.053 . . . . 0.0 110.154 -168.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -154.75 40.65 0.14 Allowed Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.66 -31.97 0.98 Allowed 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 121.844 1.696 . . . . 0.0 112.998 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -128.09 21.99 6.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.665 0.786 . . . . 0.0 111.21 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.67 128.24 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 120.905 0.383 . . . . 0.0 110.07 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.1 mm? -98.55 95.65 3.19 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.4 95.92 0.95 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.975 2.45 . . . . 0.0 110.674 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.61 -35.2 0.75 Allowed Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.999 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 10' ' ' LEU . 20.5 m -93.56 175.74 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.438 0.637 . . . . 0.0 111.535 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.7 p -85.03 -32.36 22.94 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.03 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -102.71 172.34 6.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.877 0.846 . . . . 0.0 112.91 -167.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.83 47.04 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.0 p -64.66 -62.76 1.38 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.591 0.757 . . . . 0.0 110.215 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -166.82 126.87 1.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.766 0.826 . . . . 0.0 109.137 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.0 mt -88.44 137.02 30.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.0 Cg_endo -55.22 129.62 36.23 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.513 2.142 . . . . 0.0 111.251 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -23.68 62.9 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.593 0.757 . . . . 0.0 112.822 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.0 pt-20 -63.52 -32.51 73.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.095 0.958 . . . . 0.0 111.326 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 m -70.9 -46.71 62.07 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.551 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.09 -27.46 68.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.55 0.159 . . . . 0.0 111.055 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -73.12 -44.2 60.57 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 111.045 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 -28.77 62.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.451 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.43 -42.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.641 0.776 . . . . 0.0 109.324 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 tpt85 -64.21 -24.66 67.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.542 0.737 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -75.66 -54.68 6.59 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.915 0.886 . . . . 0.0 111.002 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -68.27 -25.02 64.96 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.36 0.664 . . . . 0.0 112.553 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 47' ' ' ILE . 37.8 p -64.98 -33.42 76.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.414 0.285 . . . . 0.0 111.186 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.15 -32.57 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.849 0.46 . . . . 0.0 110.187 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -71.01 -26.56 63.18 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.083 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.23 11.94 57.97 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.958 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -138.34 105.96 5.59 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 47' ' ' ILE . . . -147.09 126.29 12.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.957 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -130.06 137.93 50.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.595 0.758 . . . . 0.0 108.963 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.49 112.17 30.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 21.2 mtm105 -87.52 95.46 10.04 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -80.77 69.51 7.33 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.559 0.695 . . . . 0.0 109.505 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -103.53 1.31 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.079 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.38 -19.14 21.6 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.966 0.906 . . . . 0.0 110.375 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -76.85 109.67 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.48 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 14.1 tpt -87.75 111.8 21.73 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -110.16 153.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 59' ' ' SER . 61.1 m -137.77 139.47 40.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.482 1.113 . . . . 0.0 108.337 172.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 28.3 mm -123.62 100.76 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -129.77 129.21 23.06 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.373 1.82 0 C-N-CA 122.366 2.044 . . . . 0.0 111.533 170.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.533 0.206 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -123.94 118.21 26.54 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.718 0.807 . . . . 0.0 110.041 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -167.51 107.24 0.57 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.885 0.874 . . . . 0.0 108.938 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.5 106.98 0.01 OUTLIER Glycine 0 CA--C 1.54 1.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 115.006 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 46' ' ' SER . 47.1 t -133.58 97.77 4.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.69 107.79 4.7 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.502 0.721 . . . . 0.0 109.464 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.1 96.93 1.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 123.884 0.874 . . . . 0.0 111.984 -176.522 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 70' ' ' ILE . 23.0 t . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.42 -40.13 64.9 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.229 1.011 . . . . 0.0 112.791 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -67.22 -40.75 86.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.542 0.737 . . . . 0.0 111.198 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -68.16 -29.6 68.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.486 0.714 . . . . 0.0 111.012 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 66' ' ' SER . 43.3 mm -65.51 -46.11 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.167 0.587 . . . . 0.0 109.963 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -58.09 -55.29 36.91 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.068 0.855 . . . . 0.0 110.879 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.0 mt -60.8 -38.77 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 O-C-N 123.689 0.618 . . . . 0.0 110.06 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -59.52 -57.33 20.16 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.066 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 pp -64.96 -26.35 68.26 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.851 0.46 . . . . 0.0 111.634 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -64.56 -48.51 74.76 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.573 0.545 . . . . 0.0 110.379 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.488 ' O ' HG12 ' A' ' 80' ' ' ILE . 26.1 m-85 -67.35 -29.12 68.58 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.279 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.493 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.3 -44.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.817 0.847 . . . . 0.0 111.158 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.74 -20.92 61.1 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.89 0.376 . . . . 0.0 111.026 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -81.9 -27.04 33.63 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.8 mm -69.89 -35.71 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.896 0.478 . . . . 0.0 110.683 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.5 -30.98 71.43 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 110.564 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -75.89 -32.82 59.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.697 0.799 . . . . 0.0 110.913 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.8 m -78.75 -38.39 38.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.482 0.713 . . . . 0.0 110.375 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 125.055 1.342 . . . . 0.0 108.634 171.103 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 19.6 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 p -49.03 -50.72 34.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.697 1.199 . . . . 0.0 112.291 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -63.69 -28.5 69.94 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 123.996 0.918 . . . . 0.0 112.431 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.435 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 43.5 mt-10 -59.51 -39.02 82.51 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.546 0.612 . . . . 0.0 112.544 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 122.8 0.44 . . . . 0.0 111.319 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -69.9 -27.61 64.94 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.092 0.557 . . . . 0.0 111.469 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.9 p -66.69 -22.85 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.439 0.695 . . . . 0.0 110.951 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.24 -35.15 76.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.183 0.516 . . . . 0.0 110.681 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -82.41 -31.29 29.66 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.836 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.96 -58.3 3.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.458 0.703 . . . . 0.0 111.39 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 96' ' ' VAL . 31.2 pt . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.528 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 CA--C 1.55 1.308 0 CA-C-O 121.07 0.363 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG11 HG13 ' A' ' 38' ' ' ILE . 5.7 p -80.23 94.37 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 121.793 0.806 . . . . 0.0 109.643 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.2 123.69 19.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.135 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.569 HD12 HG23 ' A' ' 23' ' ' THR . 58.9 tp -131.01 106.41 8.38 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.565 0.746 . . . . 0.0 109.681 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -150.07 71.0 9.38 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 121.498 0.666 . . . . 0.0 110.329 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.87 -40.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.827 2.352 . . . . 0.0 113.318 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 66.3 m-85 -129.18 20.45 5.81 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.092 0.957 . . . . 0.0 111.122 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.535 HG12 HD23 ' A' ' 16' ' ' LEU . 19.6 mt -72.5 129.83 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.557 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -107.34 87.45 3.27 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.48 -4.46 13.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.66 2.24 . . . . 0.0 114.284 -163.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.89 -8.59 72.53 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.218 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.9 m -126.52 175.99 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.594 0.758 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -88.22 -28.76 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.306 1.042 . . . . 0.0 112.4 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -91.95 166.38 12.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.417 0.627 . . . . 0.0 112.002 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -112.39 149.3 32.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.925 1.29 . . . . 0.0 107.708 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 55.0 m -67.58 -58.94 3.82 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -171.91 149.73 2.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.034 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.01 134.68 22.47 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.86 126.54 22.82 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.7 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.104 0.962 . . . . 0.0 110.994 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.35 -44.35 95.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.242 1.017 . . . . 0.0 110.782 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.569 HG23 HD12 ' A' ' 5' ' ' LEU . 13.7 m -72.19 -34.52 68.48 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.793 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.81 -40.94 97.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.786 0.266 . . . . 0.0 111.115 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 m -66.81 -36.83 83.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.489 0.716 . . . . 0.0 110.345 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.7 tp10 -60.4 -45.38 93.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.227 1.011 . . . . 0.0 110.294 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.455 ' O ' HG21 ' A' ' 31' ' ' THR . 97.5 mt -60.9 -48.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.447 1.099 . . . . 0.0 110.701 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.72 -24.73 64.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.515 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 8.8 p30 -85.13 -35.66 21.6 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.599 0.636 . . . . 0.0 111.879 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 3.8 pt20 -75.68 -23.39 56.2 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.148 0.579 . . . . 0.0 111.812 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 27' ' ' ILE . 35.0 p -56.82 -25.45 55.97 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.9 -19.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.246 1.018 . . . . 0.0 110.858 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 30' ' ' GLN . 2.9 mpt_? -75.16 -8.49 56.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.376 1.07 . . . . 0.0 111.159 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.43 -22.85 37.8 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 123.44 0.543 . . . . 0.0 112.927 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.1 134.64 33.17 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 108.865 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 47' ' ' ILE . . . -145.3 97.63 3.03 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -100.09 122.87 43.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.046 0.538 . . . . 0.0 110.716 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.455 HG13 HG11 ' A' ' 3' ' ' VAL . 2.6 mp -109.31 113.43 44.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.701 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 71.3 mtt180 -85.0 92.1 8.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.62 76.7 1.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.242 0.544 . . . . 0.0 109.893 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -102.13 0.75 Allowed Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.423 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.01 -18.18 20.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 110.979 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt -84.52 113.58 21.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.167 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.701 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.4 tpt -85.1 111.64 19.94 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.85 148.46 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 t -134.02 110.12 9.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.193 0.52 . . . . 0.0 109.668 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 56' ' ' PHE . 31.9 mm -87.44 107.11 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -154.29 128.45 4.61 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 118.709 0.686 . . . . 0.0 111.176 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HG3' ' HD1' ' A' ' 56' ' ' PHE . 31.3 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.256 2.637 . . . . 0.0 113.546 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.009 0.433 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 47' ' ' ILE . 35.9 p90 -101.42 116.46 32.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.357 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.693 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 55.6 mtm -145.37 -176.03 4.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.725 0.81 . . . . 0.0 109.535 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 81' ' ' GLU . . . -54.37 113.52 3.46 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.324 1.015 . . . . 0.0 114.467 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -129.51 113.0 14.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 112.76 16.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.317 0.647 . . . . 0.0 109.834 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.85 115.59 18.64 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.894 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 . . . . . 0 CA--C 1.549 0.932 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.074 179.511 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.814 -0.136 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -59.5 -33.53 71.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.331 1.052 . . . . 0.0 112.895 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.5 p-10 -71.44 -42.35 68.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -34.95 78.99 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.868 0.867 . . . . 0.0 111.714 175.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.5 mm -58.01 -43.2 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.363 0.665 . . . . 0.0 109.461 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.24 -56.75 12.47 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.922 0.763 . . . . 0.0 110.95 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 68' ' ' ASP . 7.4 mm -57.08 -38.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.526 0.679 . . . . 0.0 109.352 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.25 -58.05 14.26 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.426 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.89 -22.93 66.55 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.669 0.735 . . . . 0.0 111.891 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 25.1 mm-40 -70.86 -46.45 62.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.632 0.773 . . . . 0.0 110.145 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 80' ' ' ILE . 13.8 m-85 -69.84 -27.2 64.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.201 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -61.98 -51.42 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.625 0.77 . . . . 0.0 109.893 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 75' ' ' GLN . 12.5 pt-20 -64.42 -34.66 78.69 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.475 0.484 . . . . 0.0 110.411 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.95 -31.5 66.38 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.873 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 76' ' ' TYR . 28.5 mm -69.77 -43.7 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.693 ' HG2' ' HB3' ' A' ' 57' ' ' MET . 44.9 mt-10 -60.75 -36.99 80.32 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.604 0.761 . . . . 0.0 111.377 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -73.28 -39.3 65.48 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.929 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -74.42 -22.93 58.9 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.672 0.789 . . . . 0.0 111.202 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.225 1.01 . . . . 0.0 110.08 -176.126 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 26.0 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.6 m -64.02 -47.1 81.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -62.17 -26.22 68.22 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.2 tp10 -57.34 -47.65 81.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.063 0.945 . . . . 0.0 111.306 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.11 -27.2 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.412 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 m -64.96 -45.24 86.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.156 0.582 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.31 -28.1 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 111.195 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.74 -38.56 76.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -80.51 -26.97 37.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.768 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.721 0.808 . . . . 0.0 111.372 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.293 174.082 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.553 1.435 0 CA-C-O 121.991 0.746 . . . . 0.0 112.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.37 116.32 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.473 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.84 137.42 43.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.907 0.483 . . . . 0.0 110.455 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.407 HD22 HG23 ' A' ' 19' ' ' ILE . 5.4 tt -145.11 94.11 2.48 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.421 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -147.81 47.4 0.54 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 6' ' ' THR . 67.9 Cg_endo -85.18 -30.69 0.46 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 121.88 1.72 . . . . 0.0 113.642 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.47 18.82 6.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.961 0.505 . . . . 0.0 111.542 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 16' ' ' LEU . 20.6 mt -70.63 135.97 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.691 0.396 . . . . 0.0 111.307 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.574 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -117.31 85.59 19.94 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.7 22.12 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.017 2.478 . . . . 0.0 114.081 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.57 -39.2 90.88 Favored Glycine 0 C--N 1.346 1.127 0 O-C-N 123.425 0.453 . . . . 0.0 113.862 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 10' ' ' LEU . 22.3 m -108.71 178.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.972 0.509 . . . . 0.0 111.666 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.5 p -91.29 -24.89 19.7 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.256 1.023 . . . . 0.0 112.026 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -94.15 162.08 14.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.306 0.574 . . . . 0.0 111.589 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD23 HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -103.66 142.82 33.66 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 10' ' ' LEU . 23.6 t -74.59 -48.8 24.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.879 0.471 . . . . 0.0 110.026 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.19 142.56 10.13 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.407 HG23 HD22 ' A' ' 5' ' ' LEU . 76.0 mt -121.43 121.74 28.33 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 163.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.8 127.22 20.87 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.742 2.295 . . . . 0.0 111.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.58 -16.81 62.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 111.182 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.76 -38.26 88.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.056 0.542 . . . . 0.0 110.35 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 17.9 m -74.66 -35.63 62.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.9 0.48 . . . . 0.0 109.836 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.19 -25.1 65.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.772 0.429 . . . . 0.0 111.138 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -68.8 -40.74 79.43 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.652 0.781 . . . . 0.0 110.962 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 23' ' ' THR . 12.8 pt-20 -71.66 -30.7 66.01 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 23' ' ' THR . 12.0 mm -65.29 -43.07 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 121.427 0.632 . . . . 0.0 109.57 172.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -62.04 -31.08 71.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.959 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.37 -41.14 14.74 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 3.6 pt20 -70.58 -24.03 62.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -53.64 -36.31 61.93 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.014 0.526 . . . . 0.0 111.244 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.08 -36.45 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.621 0.768 . . . . 0.0 110.311 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.84 -16.62 63.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.595 0.758 . . . . 0.0 110.627 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.16 -19.17 25.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.41 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -138.2 131.03 29.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -143.28 101.57 3.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.313 1.045 . . . . 0.0 108.439 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.67 115.41 29.82 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.435 HG23 HD12 ' A' ' 40' ' ' LEU . 3.0 mp -107.66 126.61 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.519 0.728 . . . . 0.0 109.747 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -91.6 96.98 10.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.151 0.58 . . . . 0.0 110.243 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 HG23 ' A' ' 38' ' ' ILE . 8.1 mp -81.76 71.85 8.8 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 169.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.34 -102.88 1.07 Allowed Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 -19.03 18.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.611 0.764 . . . . 0.0 110.445 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD13 ' HA2' ' A' ' 73' ' ' GLY . 17.6 mt -74.64 108.76 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.2 tpt -93.13 113.63 25.93 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.78 151.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.798 0.839 . . . . 0.0 109.521 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 m -133.66 98.11 4.11 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.27 0.628 . . . . 0.0 109.921 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 49.5 mm -83.21 93.02 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.72 0.808 . . . . 0.0 109.0 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -127.04 126.39 24.32 Favored Pre-proline 0 N--CA 1.483 1.209 0 O-C-N 121.929 -0.482 . . . . 0.0 110.853 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.41 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 45.0 Cg_endo . . . . . 0 C--N 1.383 2.365 0 C-N-CA 124.18 3.253 . . . . 0.0 112.831 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 25.0 p90 -86.43 113.19 22.17 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.771 0.796 . . . . 0.0 111.373 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.1 -178.23 3.52 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.643 1.177 . . . . 0.0 108.2 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.42 ' HA3' HG13 ' A' ' 77' ' ' ILE . . . -67.57 110.77 3.64 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.541 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.3 t -100.84 96.67 7.45 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.535 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.0 tm? -82.23 109.49 16.56 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -64.06 92.9 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.826 -178.003 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.62 0.248 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 37.55 -79.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.535 2.334 . . . . 0.0 116.32 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.1 p-10 -79.97 -42.76 23.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.12 0.568 . . . . 0.0 110.222 -170.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -67.8 -35.4 78.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.088 0.47 . . . . 0.0 110.066 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 27.1 mm -55.94 -48.47 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.456 0.702 . . . . 0.0 110.876 169.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -59.9 -52.02 67.22 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.665 0.603 . . . . 0.0 111.044 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ASP . 33.8 mt -57.87 -39.24 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.263 0.625 . . . . 0.0 109.702 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -62.99 -59.08 9.6 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.161 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.1 pp -68.13 -23.11 64.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.449 0.625 . . . . 0.0 112.261 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -73.98 -37.08 64.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.073 0.549 . . . . 0.0 110.978 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -72.54 -31.19 65.1 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.409 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -67.46 -39.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.707 0.803 . . . . 0.0 110.64 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -22.46 57.69 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.773 0.32 . . . . 0.0 110.511 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.41 -40.43 57.83 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.417 0.687 . . . . 0.0 110.167 168.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.539 HG23 HD23 ' A' ' 84' ' ' LEU . 42.8 mt -73.98 -33.68 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 0.0 111.528 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -64.05 -33.05 74.86 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 120.928 0.394 . . . . 0.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -76.73 -37.1 56.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.008 0.923 . . . . 0.0 111.134 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -71.78 -42.78 66.74 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.037 0.535 . . . . 0.0 111.108 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.539 HD23 HG23 ' A' ' 80' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 110.964 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -60.25 -49.46 77.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 0.0 110.364 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -50.67 -33.95 24.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.093 1.357 . . . . 0.0 112.399 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -61.26 -42.4 98.57 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.297 0.639 . . . . 0.0 111.19 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.84 -20.83 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 122.621 0.368 . . . . 0.0 111.442 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 96.1 m -75.37 -30.74 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.131 0.572 . . . . 0.0 111.759 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.38 -18.37 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 118.19 0.45 . . . . 0.0 112.136 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.86 -42.11 73.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.727 0.411 . . . . 0.0 110.116 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -81.84 -29.27 32.62 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.751 0.421 . . . . 0.0 110.884 177.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -71.45 -27.03 62.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.899 0.88 . . . . 0.0 111.609 -168.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.561 1.396 0 C-N-CA 123.166 0.586 . . . . 0.0 110.618 173.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.715 0 N-CA-C 113.209 0.427 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -69.46 127.78 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.42 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.91 140.81 42.32 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -146.02 87.97 1.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 12.8 t -147.04 37.12 0.18 Allowed Pre-proline 0 CA--C 1.571 1.779 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.3 Cg_endo -79.69 -32.47 1.56 Allowed 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 121.609 1.54 . . . . 0.0 111.758 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 59.5 m-85 -129.23 24.89 5.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.882 0.873 . . . . 0.0 111.529 -173.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 6' ' ' THR . 17.7 mt -67.79 123.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.989 0.423 . . . . 0.0 110.524 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HB2' HG22 ' A' ' 13' ' ' VAL . 62.8 mt -107.32 91.61 7.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 86.47 1.58 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.513 2.142 . . . . 0.0 110.866 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.53 -37.44 0.27 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.598 -173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 10' ' ' LEU . 11.5 m -93.36 167.88 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.993 0.517 . . . . 0.0 110.392 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 45.3 m -78.82 -37.22 41.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.425 0.69 . . . . 0.0 111.499 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -91.85 177.85 6.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.44 0.696 . . . . 0.0 112.272 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 140.6 49.46 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 22.8 m -52.55 -58.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.303 0.641 . . . . 0.0 111.059 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -172.24 135.53 0.77 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.608 1.163 . . . . 0.0 108.018 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 83' ' ' THR . 65.3 mt -105.91 127.86 27.55 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.08 130.35 31.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.849 2.366 . . . . 0.0 112.517 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.53 -14.91 62.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.117 0.567 . . . . 0.0 111.409 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.97 -43.32 93.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.642 0.777 . . . . 0.0 110.252 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 m -65.82 -42.21 90.9 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.063 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 9.4 mp -58.6 -39.11 79.5 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.849 0.46 . . . . 0.0 110.52 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -39.16 69.49 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.711 0.804 . . . . 0.0 111.818 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -72.08 -27.11 62.45 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' HA ' HE21 ' A' ' 30' ' ' GLN . 83.9 mt -68.53 -42.65 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 122.734 0.414 . . . . 0.0 109.997 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 20.1 mmt180 -63.5 -25.17 68.13 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.389 0.675 . . . . 0.0 110.883 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -76.42 -52.73 9.29 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.446 0.698 . . . . 0.0 110.696 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.425 HE21 ' HA ' ' A' ' 27' ' ' ILE . 25.7 pt20 -70.03 -27.57 64.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.855 0.462 . . . . 0.0 111.813 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.508 ' HB ' ' HG3' ' A' ' 49' ' ' PRO . 8.3 p -61.91 -24.11 66.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.052 0.541 . . . . 0.0 112.272 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.51 -23.35 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 122.944 0.498 . . . . 0.0 110.924 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.13 0.87 26.38 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.718 0.807 . . . . 0.0 111.029 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.23 -17.84 54.11 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.432 0.539 . . . . 0.0 112.698 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.37 131.48 30.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.914 0.885 . . . . 0.0 110.213 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.566 ' HB1' ' HB ' ' A' ' 47' ' ' ILE . . . -126.78 133.36 50.84 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.155 0.982 . . . . 0.0 108.935 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -112.03 115.82 29.54 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.75 144.38 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.467 1.107 . . . . 0.0 108.24 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -128.54 88.59 2.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.917 . . . . 0.0 110.392 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 76' ' ' TYR . 88.4 mt -76.68 80.16 3.32 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.75 -104.04 1.16 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -99.04 -11.78 21.17 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.525 0.73 . . . . 0.0 110.966 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD11 ' HA2' ' A' ' 73' ' ' GLY . 52.9 mt -83.3 132.0 35.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.296 1.038 . . . . 0.0 110.236 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.05 128.65 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.48 120.76 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.051 0.94 . . . . 0.0 109.603 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.6 m -100.84 110.32 22.38 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.774 0.83 . . . . 0.0 110.403 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.566 ' HB ' ' HB1' ' A' ' 36' ' ' ALA . 22.8 mm -101.84 115.08 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -133.59 103.49 12.27 Favored Pre-proline 0 N--CA 1.493 1.685 0 C-N-CA 122.754 0.422 . . . . 0.0 111.963 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 52.5 Cg_endo . . . . . 0 C--N 1.378 2.12 0 C-N-CA 123.185 2.59 . . . . 0.0 113.65 167.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.242 0.688 0 CA-C-O 121.363 0.601 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 47' ' ' ILE . 8.1 p90 -88.68 116.88 27.25 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.709 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 21.3 ptt? -172.89 -175.73 1.3 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.437 1.095 . . . . 0.0 109.379 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.8 110.29 0.22 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 124.397 1.061 . . . . 0.0 115.618 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.0 t -134.49 101.4 4.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.882 0.873 . . . . 0.0 108.79 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.71 111.72 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.843 0.857 . . . . 0.0 109.717 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.54 103.05 3.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.19 0.996 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 -174.159 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 110.92 -0.03 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -57.9 -31.55 66.86 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.227 1.011 . . . . 0.0 113.363 -171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.3 p-10 -65.15 -44.28 89.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.44 -19.37 59.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 0.0 111.804 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 -44.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 35.2 tt0 -66.84 -55.81 13.16 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.804 0.69 . . . . 0.0 110.281 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 68' ' ' ASP . 28.8 mt -56.81 -37.02 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 123.725 0.81 . . . . 0.0 109.928 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -60.88 -56.86 21.77 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.901 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.2 pp -65.18 -27.23 68.56 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.203 0.501 . . . . 0.0 111.945 -174.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 22.5 mm-40 -66.5 -47.0 74.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 0.0 110.332 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' A' ' 40' ' ' LEU . 12.4 m-85 -73.55 -27.11 61.16 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.362 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.5 -43.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.737 0.815 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.36 -21.35 62.04 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.61 0.569 . . . . 0.0 110.947 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -78.05 -40.42 38.78 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.242 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.4 mm -65.68 -29.59 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 123.219 0.608 . . . . 0.0 110.825 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.633 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.2 pt-20 -70.46 -39.5 74.27 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -24.5 42.97 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 19' ' ' ILE . 99.6 m -73.11 -55.68 6.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.611 0.765 . . . . 0.0 110.404 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 124.927 1.291 . . . . 0.0 108.367 178.596 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -63.47 -50.23 70.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.366 0.667 . . . . 0.0 111.45 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -62.07 -40.2 95.02 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.528 0.331 . . . . 0.0 110.227 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 14.5 tp10 -66.6 -34.06 77.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.004 0.522 . . . . 0.0 111.149 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.433 HG11 ' HE3' ' A' ' 57' ' ' MET . 1.4 p -80.3 -23.01 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.4 m -77.65 -34.66 53.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.954 0.902 . . . . 0.0 110.78 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.87 -25.82 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 23.9 tp -67.79 -42.03 82.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.517 1.127 . . . . 0.0 111.039 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -79.66 -21.67 44.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.592 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.99 -40.96 68.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.099 0.56 . . . . 0.0 111.583 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 CA--C 1.568 1.657 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.516 -174.489 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.542 0.9 0 N-CA-C 110.5 -0.615 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.59 107.23 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.165 0.986 . . . . 0.0 111.879 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.4 136.09 37.58 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD22 HD11 ' A' ' 19' ' ' ILE . 61.3 tp -136.27 95.51 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.61 1.164 . . . . 0.0 108.079 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.423 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.3 t -144.54 31.05 0.1 Allowed Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.83 -29.71 8.25 Favored 'Trans proline' 0 C--N 1.391 2.811 0 CA-C-N 121.565 1.595 . . . . 0.0 112.949 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -129.44 26.27 5.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.602 0.761 . . . . 0.0 111.484 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 6' ' ' THR . 21.8 mt -71.76 135.4 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 173.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -109.9 90.19 8.98 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.43 90.91 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.913 2.409 . . . . 0.0 109.77 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.72 -43.06 0.28 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.667 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 10' ' ' LEU . 34.2 m -99.69 -175.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 110.968 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -105.68 6.01 31.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.106 0.962 . . . . 0.0 112.755 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -126.91 165.76 18.77 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.435 0.636 . . . . 0.0 111.715 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.42 143.82 34.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' HD22 ' A' ' 10' ' ' LEU . 28.9 t -63.71 -60.68 3.0 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.545 0.738 . . . . 0.0 109.834 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.4 138.6 0.71 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.537 1.135 . . . . 0.0 108.548 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 83' ' ' THR . 76.4 mt -104.52 137.18 19.15 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 123.096 0.558 . . . . 0.0 109.616 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.5 Cg_endo -57.19 133.11 55.38 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.872 2.381 . . . . 0.0 111.94 170.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.369 1.068 . . . . 0.0 112.128 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.4 pt-20 -60.0 -31.85 70.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 0.0 111.557 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 HD11 ' A' ' 5' ' ' LEU . 6.3 m -67.89 -50.32 56.97 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.8 -27.06 69.05 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.729 0.412 . . . . 0.0 110.659 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -69.92 -47.33 62.87 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.046 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.8 -32.38 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.191 0.197 . . . . 0.0 110.979 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.2 mt -62.72 -44.58 99.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.547 0.739 . . . . 0.0 109.333 171.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -60.0 -27.85 67.22 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.558 0.743 . . . . 0.0 111.606 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.09 -46.23 15.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.538 0.735 . . . . 0.0 111.621 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -75.29 -25.89 58.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.994 0.518 . . . . 0.0 111.867 -175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -62.12 -28.67 69.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.552 0.341 . . . . 0.0 111.281 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.75 -30.54 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.987 0.515 . . . . 0.0 110.527 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -70.87 -13.06 61.89 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.419 0.688 . . . . 0.0 110.452 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.07 -21.88 21.83 Favored Glycine 0 C--N 1.348 1.207 0 C-N-CA 124.2 0.905 . . . . 0.0 112.919 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HA ' ' HG2' ' A' ' 48' ' ' ARG . 34.6 tt0 -140.32 128.46 22.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.996 0.518 . . . . 0.0 110.979 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.13 130.39 53.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.89 0.876 . . . . 0.0 108.72 169.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -120.99 99.44 6.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.36 0.664 . . . . 0.0 109.328 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.15 123.09 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.877 0.871 . . . . 0.0 109.077 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 15.0 mtm180 -99.2 92.74 5.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 94.6 mt -74.45 75.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 -103.72 1.21 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.19 -10.56 19.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.515 0.726 . . . . 0.0 110.71 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.9 mt -81.2 108.41 14.82 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.413 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 13.2 tpt -86.26 124.4 32.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.02 126.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.795 0.838 . . . . 0.0 109.651 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -107.57 99.76 9.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.596 0.758 . . . . 0.0 110.569 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.407 HG23 ' HB2' ' A' ' 56' ' ' PHE . 18.3 mm -86.68 90.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 46.4 mtp180 -125.99 124.43 24.68 Favored Pre-proline 0 N--CA 1.484 1.255 0 O-C-N 121.914 -0.491 . . . . 0.0 111.986 -171.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.412 2.075 . . . . 0.0 111.066 165.491 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.012 0.434 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HB2' HG23 ' A' ' 47' ' ' ILE . 29.4 p90 -87.99 114.21 24.39 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.262 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.491 ' HE2' HG13 ' A' ' 94' ' ' VAL . 37.7 mtm -139.66 -174.84 4.01 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.493 1.117 . . . . 0.0 108.081 174.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.12 110.39 1.51 Allowed Glycine 0 C--N 1.351 1.399 0 O-C-N 123.497 0.498 . . . . 0.0 112.755 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 t -133.82 115.95 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.6 115.1 18.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.353 0.661 . . . . 0.0 109.26 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.93 96.6 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.418 1.087 . . . . 0.0 109.31 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.487 1.4 0 C-N-CA 124.269 1.028 . . . . 0.0 112.825 -169.322 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 118.971 -0.537 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -91.4 -53.45 4.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.061 0.846 . . . . 0.0 112.68 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -57.04 -46.4 82.45 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.524 0.73 . . . . 0.0 112.232 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.21 -40.74 74.52 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.149 0.98 . . . . 0.0 112.707 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.2 mm -64.65 -46.29 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 122.47 0.308 . . . . 0.0 110.592 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 97.9 mt-30 -62.48 -57.4 11.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.035 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.81 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.864 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -52.05 55.06 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.852 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.59 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -66.87 -26.85 67.1 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.487 0.643 . . . . 0.0 111.437 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 13.9 mm-40 -60.76 -50.82 71.94 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.119 0.962 . . . . 0.0 110.24 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.483 ' O ' HG12 ' A' ' 80' ' ' ILE . 49.3 m-85 -72.46 -25.11 61.32 Favored 'General case' 0 C--O 1.202 -1.424 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.583 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.23 -45.7 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.619 0.768 . . . . 0.0 110.924 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.74 -22.37 61.62 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -73.69 -47.17 41.62 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.668 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -66.53 -35.79 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 124.337 1.055 . . . . 0.0 111.349 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.8 pt-20 -56.79 -43.39 80.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.288 0.367 . . . . 0.0 110.705 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -78.0 -32.73 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.763 0.825 . . . . 0.0 111.879 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.54 HG21 HD12 ' A' ' 19' ' ' ILE . 21.9 m -69.58 -37.02 76.8 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.049 0.54 . . . . 0.0 110.803 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 t -60.05 -34.36 73.31 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -65.68 -42.48 91.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.499 0.59 . . . . 0.0 110.77 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -27.13 69.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.798 -173.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.491 HG13 ' HE2' ' A' ' 57' ' ' MET . 14.9 p -90.04 -35.91 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.161 0.505 . . . . 0.0 110.748 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.8 m -75.77 -27.88 58.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 100' ' ' ILE . 8.1 p -67.4 -20.69 26.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.201 0.6 . . . . 0.0 110.43 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 0.0 111.1 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -32.67 71.1 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.487 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.44 -35.11 58.69 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.596 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 96' ' ' VAL . 15.1 pt . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.546 1.076 0 N-CA-C 113.054 0.367 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -103.64 139.47 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -89.65 141.16 28.86 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.504 HD23 HG23 ' A' ' 19' ' ' ILE . 38.5 tp -145.71 110.46 5.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -149.93 53.51 1.3 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 123.415 0.686 . . . . 0.0 111.2 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.99 -27.64 0.65 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.282 1.988 . . . . 0.0 113.443 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.86 4.55 6.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.99 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.84 116.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -165.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -104.6 90.95 3.7 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 172.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.5 -23.17 58.01 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.205 1.937 . . . . 0.0 113.925 -167.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.25 72.61 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.133 0.413 . . . . 0.0 114.133 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 10' ' ' LEU . 22.9 m -104.82 158.66 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.907 0.483 . . . . 0.0 111.324 -174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -73.28 -20.28 60.86 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.465 1.106 . . . . 0.0 112.905 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -105.89 174.6 5.81 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.374 0.67 . . . . 0.0 111.525 -175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -123.03 147.57 46.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.455 ' OG ' HD22 ' A' ' 10' ' ' LEU . 12.8 m -53.09 -49.27 66.78 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.939 0.774 . . . . 0.0 110.098 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -176.2 166.9 2.9 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.021 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.504 HG23 HD23 ' A' ' 5' ' ' LEU . 83.0 mt -121.35 129.94 25.03 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 167.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 124.17 15.29 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.638 2.225 . . . . 0.0 111.897 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 24' ' ' LEU . 27.3 mp0 -71.08 -15.0 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.645 0.778 . . . . 0.0 111.577 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.47 -46.19 84.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.567 0.747 . . . . 0.0 110.102 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.442 HG21 HD11 ' A' ' 5' ' ' LEU . 17.6 m -69.47 -37.41 77.27 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.248 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.503 HD13 HG21 ' A' ' 83' ' ' THR . 95.8 mt -61.32 -37.23 82.5 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.564 0.54 . . . . 0.0 111.217 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -69.88 -30.86 68.41 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.727 0.642 . . . . 0.0 110.775 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.1 tp10 -66.6 -38.5 87.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.842 0.457 . . . . 0.0 109.917 172.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 23' ' ' THR . 18.0 mm -63.37 -44.64 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.952 0.501 . . . . 0.0 109.912 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 11.6 mmm180 -64.44 -29.34 70.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.975 0.91 . . . . 0.0 110.807 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.62 -48.13 34.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.798 0.839 . . . . 0.0 110.987 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 4.1 pt20 -76.96 -26.11 53.58 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.115 0.566 . . . . 0.0 112.207 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -61.01 -23.77 65.66 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.13 0.423 . . . . 0.0 111.68 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.89 -31.62 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 122.663 0.385 . . . . 0.0 110.137 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -73.44 -13.57 61.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.018 0.927 . . . . 0.0 111.144 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.39 -18.61 22.92 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-O 119.585 -0.564 . . . . 0.0 113.839 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.83 154.56 48.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.757 0.778 . . . . 0.0 112.105 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB3' ' HG3' ' A' ' 30' ' ' GLN . . . -153.15 138.96 17.98 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.708 1.203 . . . . 0.0 107.781 168.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' NE2' ' HE2' ' A' ' 44' ' ' MET . 52.2 mt-30 -140.26 129.33 23.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 109.651 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.81 112.61 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -82.5 94.32 7.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 76.5 mt -76.31 65.2 2.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.236 0.615 . . . . 0.0 110.426 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.08 -99.96 0.26 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -71.67 -43.19 66.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.23 1.012 . . . . 0.0 110.984 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.56 160.87 25.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.729 0.812 . . . . 0.0 110.231 -174.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.415 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 26.4 ttt -140.47 129.41 23.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.862 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.78 153.8 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.007 1.323 . . . . 0.0 108.564 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -132.55 98.59 4.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.698 0.799 . . . . 0.0 109.777 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.422 HG22 ' HB2' ' A' ' 56' ' ' PHE . 30.2 mm -89.32 84.19 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -116.38 125.47 28.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 121.976 -0.452 . . . . 0.0 110.467 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 92.5 Cg_endo . . . . . 0 C--N 1.378 2.126 0 C-N-CA 123.308 2.672 . . . . 0.0 112.427 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' HB2' HG22 ' A' ' 47' ' ' ILE . 31.1 p90 -87.67 116.46 25.82 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.487 0.661 . . . . 0.0 111.42 -172.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.8 ptp -148.11 -176.09 5.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.997 1.319 . . . . 0.0 108.925 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.97 119.23 8.44 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 -172.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -135.33 118.13 16.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.932 . . . . 0.0 109.17 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.24 128.64 35.15 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.312 0.645 . . . . 0.0 109.316 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.3 78.32 1.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.447 0.699 . . . . 0.0 109.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 122.968 0.507 . . . . 0.0 111.804 -173.453 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 70' ' ' ILE . 30.7 t . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -37.19 74.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.05 -41.13 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -68.46 -17.33 64.17 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 66' ' ' SER . 47.3 mm -59.32 -43.63 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.919 0.487 . . . . 0.0 109.947 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -50.92 69.14 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.161 0.584 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mp -63.71 -34.54 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.508 0.671 . . . . 0.0 109.832 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.44 -55.13 24.98 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.811 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.4 pp -67.12 -33.2 74.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.067 0.547 . . . . 0.0 111.685 -169.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -70.76 -36.46 73.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.791 0.436 . . . . 0.0 110.187 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -71.79 -25.9 62.2 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.729 172.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.58 -38.03 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.517 0.727 . . . . 0.0 109.985 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 73.4 mt-10 -68.05 -33.11 73.96 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.896 0.747 . . . . 0.0 110.533 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -66.37 -52.31 48.19 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.337 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.46 HD13 HD12 ' A' ' 40' ' ' LEU . 75.2 mt -64.35 -29.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.3 -38.38 83.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.272 1.029 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -77.66 -47.05 20.18 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.834 0.854 . . . . 0.0 111.187 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.503 HG21 HD13 ' A' ' 24' ' ' LEU . 31.5 m -78.47 -54.61 5.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.302 1.041 . . . . 0.0 112.782 -164.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 122.915 0.486 . . . . 0.0 110.686 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.686 0.279 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.7 t -61.75 -46.45 89.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.791 0.836 . . . . 0.0 112.268 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.26 -43.31 92.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.702 0.626 . . . . 0.0 110.604 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.51 -29.31 70.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.877 0.871 . . . . 0.0 113.219 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.1 -33.55 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 118.341 0.518 . . . . 0.0 110.771 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.5 m -66.49 -39.61 88.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.495 0.718 . . . . 0.0 110.978 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.1 -27.83 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.309 0.644 . . . . 0.0 111.48 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.76 -38.75 73.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.073 0.549 . . . . 0.0 110.882 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -79.93 -24.89 40.75 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.321 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.51 -49.17 64.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.274 1.03 . . . . 0.0 110.914 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.563 1.457 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.026 -177.072 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 CA--C 1.551 1.368 0 N-CA-C 114.502 0.924 . . . . 0.0 114.502 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 121.44 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.878 0.871 . . . . 0.0 109.058 168.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 4.8 p-10 -81.7 96.41 7.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.667 . . . . 0.0 109.665 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.77 106.62 15.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.108 0.963 . . . . 0.0 109.108 -172.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.2 t -153.98 57.71 1.94 Allowed Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 123.295 0.638 . . . . 0.0 111.819 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -89.25 -34.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.322 2.014 . . . . 0.0 113.282 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 55.7 m-85 -127.85 22.07 6.33 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.481 0.713 . . . . 0.0 110.499 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.51 117.49 12.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-O 121.251 0.548 . . . . 0.0 110.285 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.438 ' HB2' HG23 ' A' ' 13' ' ' VAL . 65.5 mt -106.97 99.22 25.0 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.4 -20.99 66.79 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.739 2.292 . . . . 0.0 112.85 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.27 -3.3 81.78 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.891 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 10' ' ' LEU . 27.1 m -132.57 170.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.623 0.769 . . . . 0.0 109.889 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.6 p -89.31 -0.52 57.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.092 0.957 . . . . 0.0 112.455 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.434 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 40.1 p90 -129.01 159.01 37.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.646 0.736 . . . . 0.0 112.111 -173.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.04 142.54 47.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.873 166.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 34.3 t -67.04 -33.06 74.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 168.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -167.61 152.94 7.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.996 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -125.94 133.08 24.57 Favored Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.88 126.8 23.72 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.263 1.976 . . . . 0.0 111.061 168.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -65.31 -17.49 64.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 110.868 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.28 -43.88 83.51 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.944 0.898 . . . . 0.0 110.139 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.431 ' O ' HG13 ' A' ' 27' ' ' ILE . 25.7 m -65.46 -48.63 72.02 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.035 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.08 -39.56 78.85 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.299 0.5 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -66.48 -43.45 85.36 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.073 0.549 . . . . 0.0 111.72 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.1 pt-20 -74.92 -27.5 60.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 119.442 -0.313 . . . . 0.0 111.062 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.616 ' HA ' HE21 ' A' ' 30' ' ' GLN . 95.4 mt -58.96 -39.9 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.328 0.651 . . . . 0.0 109.692 172.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' O ' HG12 ' A' ' 32' ' ' ILE . 17.9 mmt180 -62.02 -25.2 67.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.576 0.751 . . . . 0.0 111.893 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.445 ' N ' HD21 ' A' ' 29' ' ' ASN . 0.8 OUTLIER -80.22 -36.12 35.23 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.889 0.476 . . . . 0.0 109.908 176.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.616 HE21 ' HA ' ' A' ' 27' ' ' ILE . 30.1 mt-30 -73.68 -30.54 62.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.275 0.63 . . . . 0.0 111.036 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.8 p -67.93 -32.24 72.56 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.74 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.3 mm -74.93 -28.54 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.555 0.742 . . . . 0.0 110.595 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -64.74 -33.34 75.74 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.65 39.98 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.253 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.02 106.2 5.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.203 0.601 . . . . 0.0 110.755 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . . . -117.11 122.05 43.02 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' ' 44' ' ' MET . 44.9 mt-30 -131.46 107.42 8.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.103 0.478 . . . . 0.0 109.919 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 47' ' ' ILE . 1.7 mp -98.41 110.29 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.549 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 61.4 mtt-85 -82.07 88.16 6.44 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.0 mt -78.62 78.54 5.07 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 -102.22 0.45 Allowed Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.981 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.95 -40.85 19.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.037 0.935 . . . . 0.0 109.751 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.82 110.65 14.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.68 1.192 . . . . 0.0 110.531 -166.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.454 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.1 tpt -82.28 105.51 13.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.47 155.39 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.677 0.791 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -140.25 127.73 21.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.841 0.857 . . . . 0.0 108.7 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.422 HG12 HD12 ' A' ' 38' ' ' ILE . 16.0 mm -113.09 92.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -134.57 127.76 18.77 Favored Pre-proline 0 N--CA 1.484 1.234 0 O-C-N 122.235 -0.291 . . . . 0.0 110.499 -174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 59.1 Cg_endo . . . . . 0 C--N 1.385 2.491 0 C-N-CA 123.136 2.557 . . . . 0.0 112.242 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 . . . . . 0 C--O 1.242 0.699 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 27.6 p90 -102.42 139.76 37.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 0.0 110.737 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -159.94 -174.97 4.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 125.063 1.345 . . . . 0.0 108.2 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.29 115.54 6.32 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 123.338 0.399 . . . . 0.0 112.806 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 t -126.0 135.05 51.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.299 1.04 . . . . 0.0 108.395 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.0 tm? -101.82 112.14 24.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.902 0.481 . . . . 0.0 110.555 -171.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -73.64 97.02 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.873 1.269 . . . . 0.0 112.034 -177.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -53.72 -45.7 70.57 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.423 0.689 . . . . 0.0 111.337 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.55 -45.21 80.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.885 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -57.77 -24.94 59.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.596 0.759 . . . . 0.0 112.626 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.6 mm -62.89 -46.72 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 122.781 0.432 . . . . 0.0 110.064 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -64.14 -54.82 27.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.718 0.807 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.33 -33.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.943 0.497 . . . . 0.0 109.922 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.02 -58.19 13.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.011 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.36 -28.67 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.851 0.461 . . . . 0.0 111.909 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -63.09 -54.25 40.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.468 ' O ' HG12 ' A' ' 80' ' ' ILE . 17.4 m-85 -61.13 -37.81 84.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.075 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -60.09 -43.43 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.669 0.788 . . . . 0.0 112.19 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.32 -29.39 61.58 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.177 0.298 . . . . 0.0 110.811 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.434 ' ND1' ' HB3' ' A' ' 15' ' ' PHE . 58.9 m-70 -77.62 -27.38 51.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 76' ' ' TYR . 37.6 mm -71.91 -40.35 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.52 -45.04 77.16 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 124.224 1.009 . . . . 0.0 109.948 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -50.46 -43.38 55.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 111.884 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -81.77 -33.63 30.82 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.921 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 0.0 110.522 -168.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.246 0.919 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.3 p -55.23 -39.7 70.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.614 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -63.07 -34.51 77.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.505 0.503 . . . . 0.0 111.359 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.2 mp0 -62.09 -50.58 71.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.675 0.39 . . . . 0.0 111.951 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.99 -30.02 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 118.16 0.436 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.0 m -69.42 -46.19 67.4 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 124.238 1.015 . . . . 0.0 111.174 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 100' ' ' ILE . 34.0 m -75.22 -25.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.431 0.457 . . . . 0.0 111.084 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 93' ' ' GLU . 7.7 mp -68.05 -40.68 82.78 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.627 0.771 . . . . 0.0 110.078 170.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -78.29 -24.26 46.83 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.94 0.896 . . . . 0.0 110.255 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.03 -49.45 44.8 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.135 0.974 . . . . 0.0 109.918 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 96' ' ' VAL . 28.9 pt . . . . . 0 CA--C 1.569 1.681 0 O-C-N 123.47 0.481 . . . . 0.0 110.508 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 CA--C 1.55 1.299 0 CA-C-O 121.089 0.37 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.57 99.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-O 121.931 0.872 . . . . 0.0 110.401 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.62 124.58 24.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.073 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 19' ' ' ILE . 4.0 tt -133.78 94.2 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -152.52 60.38 3.38 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 121.512 0.673 . . . . 0.0 111.689 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.13 -34.59 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.146 1.897 . . . . 0.0 113.129 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.37 0.43 11.11 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.479 0.712 . . . . 0.0 112.143 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.5 mt -59.68 123.37 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -165.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.16 92.22 5.29 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 113.828 -1.533 . . . . 0.0 107.51 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.38 88.49 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.893 2.395 . . . . 0.0 110.761 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.25 -36.5 0.3 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.255 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -83.61 165.51 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 49.6 m -85.7 -20.09 29.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 111.848 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -113.56 -173.3 2.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 0.0 110.302 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.683 HD23 HG12 ' A' ' 19' ' ' ILE . 8.1 tp -133.38 133.26 42.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 m -51.55 -55.4 19.32 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.313 1.008 . . . . 0.0 111.106 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -141.6 144.45 34.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.858 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.683 HG12 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -127.8 127.58 23.95 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.76 117.33 4.04 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.815 2.343 . . . . 0.0 112.415 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -61.3 -23.05 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.242 1.017 . . . . 0.0 111.727 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.08 -47.74 82.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.295 1.038 . . . . 0.0 110.502 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.0 m -67.36 -36.81 82.14 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 27' ' ' ILE . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.47 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 m -62.39 -42.12 99.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.832 0.453 . . . . 0.0 110.112 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.8 tp10 -60.16 -56.96 15.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 109.894 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.567 HD12 HD13 ' A' ' 24' ' ' LEU . 74.4 mt -54.85 -46.88 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.131 1.372 . . . . 0.0 111.331 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -72.58 -28.14 62.62 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.624 -171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.09 -42.28 16.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.646 0.378 . . . . 0.0 111.948 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.509 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 5.1 pt20 -69.31 -23.62 63.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.079 0.552 . . . . 0.0 111.711 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -62.39 -25.98 68.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.47 -34.41 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.122 0.486 . . . . 0.0 109.769 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -73.19 -14.49 61.36 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.274 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 12.23 67.16 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 123.719 0.676 . . . . 0.0 113.047 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -138.35 107.34 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.293 0.637 . . . . 0.0 111.024 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 30' ' ' GLN . . . -146.67 134.48 21.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.883 0.873 . . . . 0.0 108.685 173.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.537 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 1.9 pm0 -155.67 122.27 5.26 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.48 141.97 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.132 1.373 . . . . 0.0 109.245 -174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -108.07 97.68 7.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 HD13 HG22 ' A' ' 45' ' ' VAL . 96.4 mt -77.9 69.14 4.09 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.56 0.695 . . . . 0.0 109.843 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.03 2.04 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.693 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HG3' HD22 ' A' ' 69' ' ' ASN . 11.7 pt-20 -91.74 -21.88 20.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.293 0.637 . . . . 0.0 110.627 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD13 ' HA2' ' A' ' 73' ' ' GLY . 34.6 mt -74.71 108.18 7.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.537 ' HE3' ' HB2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -88.96 131.82 34.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 40' ' ' LEU . 59.3 t -132.14 135.49 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.693 0.797 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 t -116.75 126.54 53.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.378 0.671 . . . . 0.0 109.774 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.21 84.35 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -116.49 108.14 45.78 Favored Pre-proline 0 N--CA 1.481 1.121 0 O-C-N 121.932 -0.48 . . . . 0.0 110.394 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 C--N 1.374 1.885 0 C-N-CA 122.516 2.144 . . . . 0.0 111.585 170.171 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -87.49 113.33 23.09 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-O 121.908 0.861 . . . . 0.0 109.898 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.44 ' HE1' HG21 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -161.03 -175.23 4.79 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.721 176.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 109.38 1.97 Allowed Glycine 0 CA--C 1.534 1.246 0 O-C-N 123.651 0.594 . . . . 0.0 113.608 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 t -102.92 97.82 7.89 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -73.66 109.18 6.97 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 36.2 t30 -64.28 109.95 2.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.813 0.845 . . . . 0.0 109.451 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 124.066 0.946 . . . . 0.0 112.096 -178.79 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' HG12 ' A' ' 70' ' ' ILE . 48.5 t . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -54.13 -33.54 58.07 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.61 -36.56 73.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.457 0.703 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.44 HD22 ' HG3' ' A' ' 42' ' ' GLU . 63.0 t30 -76.81 -35.96 57.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.221 0.608 . . . . 0.0 111.635 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 66' ' ' SER . 29.9 mm -50.42 -37.53 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.939 0.896 . . . . 0.0 110.553 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 56.1 tp60 -53.16 -53.18 54.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.177 0.991 . . . . 0.0 111.557 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.2 mp -61.26 -38.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.456 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.87 -57.06 21.33 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.307 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.69 -26.08 67.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.283 0.633 . . . . 0.0 111.42 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.589 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 84.3 mm-40 -70.63 -40.63 72.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.166 0.587 . . . . 0.0 110.651 173.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.473 ' O ' HG12 ' A' ' 80' ' ' ILE . 9.2 m-85 -71.73 -27.38 62.96 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.2 mp -68.21 -46.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.026 0.93 . . . . 0.0 110.493 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.79 -28.31 63.52 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 0.0 109.865 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.16 -42.31 80.25 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.481 0.712 . . . . 0.0 110.961 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 76' ' ' TYR . 34.8 mm -67.72 -34.95 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.484 0.713 . . . . 0.0 109.913 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -64.94 -37.97 89.42 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.455 0.472 . . . . 0.0 111.036 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.28 -25.56 60.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.689 0.396 . . . . 0.0 111.501 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -78.44 -46.05 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.976 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 123.28 0.632 . . . . 0.0 110.802 -176.873 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -60.18 -34.22 73.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.53 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -53.66 -34.86 60.08 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.884 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -51.6 68.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.512 1.125 . . . . 0.0 112.092 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 HG21 ' HE1' ' A' ' 57' ' ' MET . 34.6 m -77.86 -22.51 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.635 0.652 . . . . 0.0 111.215 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.7 m -67.64 -38.83 84.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.54 0.736 . . . . 0.0 111.13 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -76.49 -33.01 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.665 0.386 . . . . 0.0 110.868 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.47 -29.54 59.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 0.0 111.98 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -81.71 -29.18 33.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.829 0.452 . . . . 0.0 110.274 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.32 -38.86 71.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.619 0.768 . . . . 0.0 110.831 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.776 177.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 CA--C 1.55 1.324 0 CA-C-O 121.216 0.423 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.42 99.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.138 0.971 . . . . 0.0 110.68 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 8.2 p-10 -71.07 139.32 50.35 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.024 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.485 HD11 HG23 ' A' ' 23' ' ' THR . 45.2 tp -146.81 117.86 7.74 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.714 1.205 . . . . 0.0 108.833 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -154.13 52.59 0.8 Allowed Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.72 -31.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.929 1.753 . . . . 0.0 113.622 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.7 m-85 -131.29 17.21 4.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.707 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HA ' HD23 ' A' ' 16' ' ' LEU . 28.9 mt -68.05 121.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -96.64 92.44 1.1 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.39 82.05 2.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.725 2.283 . . . . 0.0 111.298 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.97 -37.85 0.26 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.092 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 10' ' ' LEU . 6.4 m -82.71 159.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.889 0.476 . . . . 0.0 110.513 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -83.77 -0.21 50.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.318 0.647 . . . . 0.0 112.701 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -131.15 -174.04 3.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.815 0.846 . . . . 0.0 111.354 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 17' ' ' SER . 1.5 tm? -139.1 147.34 41.84 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 16' ' ' LEU . 25.3 t -63.62 -77.52 0.05 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.43 0.692 . . . . 0.0 111.011 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -145.44 94.63 2.54 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.802 0.441 . . . . 0.0 110.621 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.32 132.91 68.83 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 122.25 11.24 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.637 2.225 . . . . 0.0 111.927 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HA ' HD23 ' A' ' 24' ' ' LEU . 13.5 pt20 -64.63 -22.78 67.06 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.027 0.931 . . . . 0.0 111.212 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -60.91 -39.28 88.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.16 0.984 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.485 HG23 HD11 ' A' ' 5' ' ' LEU . 33.0 m -71.51 -37.15 71.24 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.16 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.3 mm? -63.44 -37.0 85.61 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.684 0.675 . . . . 0.0 110.789 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -63.91 -35.0 79.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.046 0.539 . . . . 0.0 110.519 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 10.5 tp10 -70.37 -36.72 74.31 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.764 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.49 HG23 HD13 ' A' ' 38' ' ' ILE . 11.9 mm -63.36 -42.32 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 32' ' ' ILE . 67.6 mtt180 -65.32 -25.29 67.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.451 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -71.78 -43.97 64.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.675 0.39 . . . . 0.0 111.101 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.23 0.612 . . . . 0.0 110.429 -177.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.0 p -67.18 -18.67 65.36 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.338 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 28' ' ' ARG . 44.4 mm -66.67 -28.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -71.57 -15.79 62.29 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.382 0.673 . . . . 0.0 110.446 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.79 -22.19 19.57 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 123.547 0.594 . . . . 0.0 113.238 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 154.64 45.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.563 0.745 . . . . 0.0 110.043 173.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.9 147.0 34.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.074 . . . . 0.0 108.607 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -129.03 117.02 20.21 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 27' ' ' ILE . 1.6 mp -107.5 115.37 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 92.0 mtt180 -88.25 88.51 7.66 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 58.8 mt -71.47 77.49 0.78 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 -99.91 0.53 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -169.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -110.71 -4.37 15.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.308 1.043 . . . . 0.0 111.618 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.0 mt -83.46 111.26 18.89 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.516 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.6 tpt -87.54 103.95 16.03 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.163 0.506 . . . . 0.0 110.409 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.99 152.28 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.081 0.952 . . . . 0.0 109.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.2 109.44 6.47 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.688 0.795 . . . . 0.0 109.704 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 56' ' ' PHE . 34.6 mm -97.34 110.21 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.853 0.861 . . . . 0.0 109.163 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -128.05 116.74 20.46 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 122.744 0.417 . . . . 0.0 110.831 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 71.0 Cg_endo . . . . . 0 C--N 1.371 1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 113.057 166.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 p90 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.559 ' HB2' HG22 ' A' ' 47' ' ' ILE . 50.2 p90 -86.76 129.0 35.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.087 0.47 . . . . 0.0 110.385 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -158.5 -176.4 5.87 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.389 1.075 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.35 114.02 3.9 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.811 0.695 . . . . 0.0 114.552 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.7 t -134.01 120.44 20.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.6 tp -89.04 144.15 26.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.457 . . . . 0.0 111.961 -174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -96.52 81.64 3.26 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.468 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 N--CA 1.484 1.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.436 175.199 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.97 -34.44 74.76 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.203 0.601 . . . . 0.0 112.269 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.034 0.533 . . . . 0.0 109.736 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.47 -23.84 67.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.582 0.753 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.5 mt -72.87 -42.73 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 122.971 0.508 . . . . 0.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -65.27 -58.32 6.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.4 -26.66 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.354 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.6 24.22 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.269 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.06 -34.47 78.14 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.705 0.752 . . . . 0.0 112.167 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -73.05 -34.49 66.31 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.974 0.416 . . . . 0.0 110.808 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.483 ' O ' HG12 ' A' ' 80' ' ' ILE . 5.0 m-85 -69.9 -29.83 67.11 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.818 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.71 -45.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.296 0.638 . . . . 0.0 110.892 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.79 -26.98 64.53 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.559 0.537 . . . . 0.0 110.251 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.88 -43.96 82.12 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.46 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.5 mm -66.37 -29.23 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 110.983 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 51.8 mt-10 -64.36 -44.04 92.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.09 0.471 . . . . 0.0 110.232 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -66.35 -31.45 72.24 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.803 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -78.88 -35.59 43.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.504 0.722 . . . . 0.0 111.466 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.4 mt . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.818 0.847 . . . . 0.0 112.172 -177.584 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.596 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 15.4 m . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 t -54.86 -37.96 66.88 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.712 0.633 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -68.06 -38.87 82.94 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.596 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 47.6 mt-10 -61.18 -45.0 96.41 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.852 0.461 . . . . 0.0 111.564 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.57 -24.79 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.807 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.0 m -72.87 -52.05 16.33 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.05 0.54 . . . . 0.0 111.437 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.01 -27.44 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.736 0.815 . . . . 0.0 112.418 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.36 -48.32 80.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.877 0.871 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -83.04 -24.76 32.65 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.085 0.554 . . . . 0.0 111.272 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -75.68 -36.93 59.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.106 0.962 . . . . 0.0 111.325 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 CA--C 1.567 1.621 0 C-N-CA 122.731 0.412 . . . . 0.0 111.614 -178.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 23.6 Cg_exo . . . . . 0 CA--C 1.542 0.902 0 N-CA-C 114.189 0.804 . . . . 0.0 114.189 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 38' ' ' ILE . 17.1 t -76.7 93.95 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.927 0.891 . . . . 0.0 108.713 169.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.48 102.2 1.1 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.5 100.3 7.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.564 0.746 . . . . 0.0 109.272 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.538 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.9 t -151.0 47.32 0.43 Allowed Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 123.263 0.625 . . . . 0.0 111.704 170.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 6' ' ' THR . 5.9 Cg_exo -80.75 -45.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.751 2.3 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 5.4 m-85 -126.89 20.5 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.962 0.905 . . . . 0.0 110.617 -170.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' HG ' ' A' ' 16' ' ' LEU . 26.9 mt -65.77 131.24 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 117.893 0.315 . . . . 0.0 110.701 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -110.93 88.5 8.23 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.63 -2.62 12.12 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.464 2.109 . . . . 0.0 112.959 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.94 -21.56 57.17 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 123.17 0.414 . . . . 0.0 113.488 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.97 166.06 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 117.371 0.586 . . . . 0.0 111.05 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 t -67.93 -23.72 65.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.37 1.068 . . . . 0.0 112.27 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -112.32 175.53 5.39 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.818 0.818 . . . . 0.0 111.672 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 9' ' ' ILE . 3.1 tt -109.67 152.1 26.03 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 48.6 m -55.66 -55.45 32.01 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.45 0.568 . . . . 0.0 111.185 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -167.97 128.75 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.37 1.068 . . . . 0.0 108.273 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.3 mt -98.94 119.85 59.97 Favored Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 42.8 Cg_endo -67.51 142.61 59.86 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.26 1.974 . . . . 0.0 111.411 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.6 -27.01 67.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.69 0.796 . . . . 0.0 111.495 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 13.4 pt-20 -68.14 -31.45 71.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.628 0.771 . . . . 0.0 112.148 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.9 m -68.19 -52.21 36.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 95.5 mt -57.73 -42.52 84.03 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.27 0.981 . . . . 0.0 111.539 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.5 p -66.01 -33.55 76.06 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 124.049 0.843 . . . . 0.0 111.39 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 35.0 tt0 -70.22 -43.44 70.64 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 174.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.74 -35.86 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.5 0.72 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.8 mmt85 -63.97 -37.82 88.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.69 -40.46 84.38 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.089 0.556 . . . . 0.0 109.831 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 71.2 mm-40 -71.66 -33.95 69.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.523 0.729 . . . . 0.0 111.25 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.452 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 34.5 p -66.31 -26.23 67.21 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.719 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.5 mm -70.1 -27.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 120.604 0.24 . . . . 0.0 110.494 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -73.53 -14.57 61.23 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.396 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.81 15.64 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 123.849 0.738 . . . . 0.0 113.415 171.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.57 126.76 18.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.418 0.687 . . . . 0.0 109.734 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . . . -110.01 102.14 10.9 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.486 1.115 . . . . 0.0 108.643 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 13.7 mp0 -82.43 120.27 25.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 3' ' ' VAL . 2.4 mp -118.76 127.44 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -98.38 95.31 7.26 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 90.5 mt -79.1 70.46 5.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.046 174.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -103.37 0.92 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.735 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.48 -18.3 28.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.615 0.766 . . . . 0.0 110.959 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 12.4 mt -86.07 109.18 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.61 0.764 . . . . 0.0 109.459 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.1 tpt -86.61 101.83 13.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.46 152.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.191 0.997 . . . . 0.0 109.003 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 59' ' ' SER . 64.0 m -141.35 102.83 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.503 0.721 . . . . 0.0 109.621 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.589 HG21 ' HB2' ' A' ' 56' ' ' PHE . 22.1 mm -84.03 110.62 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.363 1.465 . . . . 0.0 110.874 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.63 131.14 23.53 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 41.8 Cg_endo . . . . . 0 C--N 1.376 2.003 0 C-N-CA 122.927 2.418 . . . . 0.0 111.392 168.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 p90 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.589 ' HB2' HG21 ' A' ' 47' ' ' ILE . 9.7 p90 -85.63 121.92 29.0 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 122.005 0.907 . . . . 0.0 111.388 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.6 ptp -146.37 -179.18 6.57 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 121.16 22.43 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.439 0.462 . . . . 0.0 112.485 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' SER . 42.8 t -130.5 97.8 4.49 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 172.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -76.09 120.7 21.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.985 0.914 . . . . 0.0 109.204 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.57 100.76 0.91 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -161.636 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.02 -15.89 37.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.19 -57.57 6.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.58 0.752 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.08 -35.29 80.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.381 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mm -56.65 -46.72 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.565 0.746 . . . . 0.0 110.908 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.9 -53.02 36.32 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.477 0.486 . . . . 0.0 110.851 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.521 HG22 HD13 ' A' ' 43' ' ' LEU . 49.5 mt -54.77 -41.88 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 123.827 0.705 . . . . 0.0 109.562 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.5 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -58.72 -58.07 16.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.629 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -65.75 -26.22 67.63 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.106 0.453 . . . . 0.0 111.919 -172.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.83 -46.58 84.43 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.601 0.761 . . . . 0.0 110.457 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.449 ' O ' HG12 ' A' ' 80' ' ' ILE . 48.9 m-85 -70.82 -33.22 70.47 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.433 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.03 -43.98 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.989 0.916 . . . . 0.0 111.194 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.47 -25.47 60.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.778 0.431 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.22 -42.17 72.65 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.774 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -67.22 -40.81 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.988 0.915 . . . . 0.0 111.65 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.4 -36.08 79.3 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.188 0.305 . . . . 0.0 111.226 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -71.31 -44.2 65.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.439 0.696 . . . . 0.0 110.097 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -61.8 -38.77 89.33 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.592 1.157 . . . . 0.0 112.234 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.057 0.543 . . . . 0.0 111.818 -176.728 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.537 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 58.2 m . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -59.4 -51.42 70.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.878 0.471 . . . . 0.0 111.674 -172.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -63.2 -19.5 64.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 0.0 112.612 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG2' ' HB ' ' A' ' 90' ' ' THR . 10.3 mm-40 -59.21 -52.72 64.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.253 0.621 . . . . 0.0 111.559 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.3 m -90.44 -27.37 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 122.992 0.517 . . . . 0.0 112.026 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -72.63 -33.28 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.811 0.444 . . . . 0.0 111.527 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.3 p -59.81 -27.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.722 0.409 . . . . 0.0 111.013 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 mp -54.25 -51.45 64.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.501 1.12 . . . . 0.0 111.239 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -81.67 -27.11 34.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 0.0 111.101 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.84 -27.91 36.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.769 0.828 . . . . 0.0 112.359 -166.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 96' ' ' VAL . 9.1 pt . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 119.139 -0.457 . . . . 0.0 110.503 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.549 1.244 0 CA-C-O 120.9 0.292 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.3 128.76 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.061 0.544 . . . . 0.0 110.048 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.91 129.53 37.83 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.2 100.72 4.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.524 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.4 t -152.79 38.24 0.12 Allowed Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -79.79 -18.48 10.38 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 121.621 1.547 . . . . 0.0 111.978 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.33 -9.07 5.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.051 -171.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 6' ' ' THR . 29.2 mt -47.9 116.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -164.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 17' ' ' SER . 44.8 mt -98.93 98.33 6.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.17 1.388 . . . . 0.0 108.438 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.85 42.12 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.686 2.257 . . . . 0.0 112.588 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.23 -6.17 0.57 Allowed Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.819 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.2 163.8 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.766 0.827 . . . . 0.0 110.254 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -77.56 -38.56 48.24 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.992 0.917 . . . . 0.0 111.621 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -82.29 -175.22 5.57 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.067 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 19' ' ' ILE . 12.1 tp -137.99 136.49 36.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.062 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.486 ' HB2' HD11 ' A' ' 10' ' ' LEU . 22.0 t -58.63 -33.72 70.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.886 0.874 . . . . 0.0 111.813 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -162.4 148.04 12.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 108.599 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.64 HG12 HD22 ' A' ' 16' ' ' LEU . 64.6 mt -127.43 124.58 23.65 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 166.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.42 113.44 1.79 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.075 1.85 . . . . 0.0 110.555 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HA ' HD23 ' A' ' 24' ' ' LEU . 24.0 tm0? -64.91 -22.73 67.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.835 0.854 . . . . 0.0 110.727 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.72 -38.32 69.61 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.223 0.609 . . . . 0.0 111.101 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.403 ' O ' HG12 ' A' ' 27' ' ' ILE . 26.3 m -71.91 -36.64 70.05 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.676 0.79 . . . . 0.0 110.751 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 21' ' ' GLN . 4.1 mm? -63.59 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.833 0.453 . . . . 0.0 110.517 173.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -68.66 -33.21 73.6 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.508 0.723 . . . . 0.0 110.864 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 12.6 tp10 -65.64 -45.9 81.25 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.731 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 23' ' ' THR . 32.9 mm -60.49 -39.78 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 55.9 mmm-85 -61.88 -38.46 88.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.378 0.671 . . . . 0.0 110.966 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 33.7 t30 -62.05 -41.31 98.0 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.814 0.846 . . . . 0.0 110.871 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 61.7 mt-30 -79.51 -32.08 42.32 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.008 0.923 . . . . 0.0 112.415 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.1 -38.82 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.202 0.525 . . . . 0.0 110.024 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -72.17 -12.39 61.16 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.901 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -8.62 58.21 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.475 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -140.12 124.54 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.242 0.521 . . . . 0.0 111.041 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -145.56 143.39 29.9 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.232 1.013 . . . . 0.0 108.585 168.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -137.27 153.9 50.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.43 129.58 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -96.91 87.49 4.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 78.7 mt -70.79 74.89 0.61 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.422 0.689 . . . . 0.0 109.253 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.42 -101.47 0.76 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -100.77 -16.77 17.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.516 0.726 . . . . 0.0 111.282 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.6 mt -74.97 110.53 9.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.309 0.644 . . . . 0.0 109.361 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.1 tpt -85.57 129.23 34.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.67 117.33 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.648 0.779 . . . . 0.0 109.803 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.5 m -86.87 111.98 21.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.341 0.656 . . . . 0.0 110.227 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 mm -119.19 88.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -154.44 139.12 11.61 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.92 -0.488 . . . . 0.0 111.574 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.379 2.162 0 C-N-CA 122.849 2.366 . . . . 0.0 111.907 176.528 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HE1' HD22 ' A' ' 97' ' ' LEU . 11.5 m-85 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 121.265 0.555 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.033 0.92 . . . . 0.0 108.928 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.637 ' HA ' HD21 ' A' ' 84' ' ' LEU . 14.7 ptp -158.17 172.4 18.46 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.658 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 110.15 1.56 Allowed Glycine 0 C--N 1.352 1.458 0 O-C-N 123.978 0.799 . . . . 0.0 113.199 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -134.35 119.07 18.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.712 0.805 . . . . 0.0 109.491 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.85 124.93 34.66 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.033 0.933 . . . . 0.0 109.525 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.69 107.1 16.71 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.521 0.729 . . . . 0.0 109.104 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.083 0.953 . . . . 0.0 112.235 -174.584 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 70' ' ' ILE . 46.1 m . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -61.18 -42.08 97.93 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.97 0.908 . . . . 0.0 112.641 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.74 -37.21 86.83 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.222 0.534 . . . . 0.0 109.978 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.4 -22.91 58.94 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.684 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 66' ' ' SER . 46.0 mm -65.79 -43.86 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -69.6 -45.92 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.269 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -66.82 -34.32 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 123.727 0.642 . . . . 0.0 109.481 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.32 -57.26 17.55 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.724 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.7 pp -67.96 -33.52 74.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.98 0.512 . . . . 0.0 111.854 -171.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.84 -38.33 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.059 0.456 . . . . 0.0 110.038 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' O ' HG12 ' A' ' 80' ' ' ILE . 6.2 m-85 -69.47 -29.86 67.62 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.816 173.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -68.56 -35.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 110.591 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 49.9 mt-10 -70.27 -32.6 70.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.886 0.741 . . . . 0.0 110.345 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.422 ' HD1' HD13 ' A' ' 19' ' ' ILE . 36.0 t-80 -74.21 -41.59 61.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.997 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.8 mm -63.02 -37.61 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.698 0.799 . . . . 0.0 109.111 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.79 -48.5 81.06 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 123.797 0.686 . . . . 0.0 109.743 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -34.4 77.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.415 0.447 . . . . 0.0 111.308 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -79.26 -24.21 43.12 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 111.823 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 57' ' ' MET . 19.5 tp . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.704 . . . . 0.0 111.884 -171.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 93' ' ' GLU . 14.8 t . . . . . 0 C--O 1.245 0.817 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -54.28 -35.98 63.17 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.033 0.933 . . . . 0.0 111.995 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -66.83 -41.28 87.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.049 0.539 . . . . 0.0 111.219 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.63 ' HG2' HG22 ' A' ' 90' ' ' THR . 22.7 mm-40 -71.56 -22.15 61.79 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -170.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.02 -27.85 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 118.072 0.396 . . . . 0.0 111.19 168.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.4 m -79.35 -28.38 42.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.096 0.558 . . . . 0.0 112.136 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.77 -17.81 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.288 0.635 . . . . 0.0 112.266 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD22 ' HE1' ' A' ' 55' ' ' TYR . 3.8 mm? -66.41 -35.09 79.43 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.295 0.638 . . . . 0.0 110.099 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.64 -31.14 28.91 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.236 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.11 -38.54 78.95 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.563 0.745 . . . . 0.0 112.187 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 123.365 0.666 . . . . 0.0 111.856 -175.612 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 CA--C 1.552 1.398 0 N-CA-C 114.45 0.904 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.81 92.63 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.845 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.21 113.77 4.23 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 7' ' ' PRO . 3.9 tt -125.71 95.12 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.495 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.2 t -154.46 52.92 0.81 Allowed Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.465 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 6' ' ' THR . 3.2 Cg_exo -80.59 -38.53 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.374 2.049 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.29 17.25 6.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.526 0.73 . . . . 0.0 111.866 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.439 ' HA ' HD23 ' A' ' 16' ' ' LEU . 22.7 mt -64.15 133.49 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.3 mm? -102.2 101.7 20.65 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.62 1.168 . . . . 0.0 107.911 176.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 6.8 Cg_exo -72.33 92.84 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.567 2.844 . . . . 0.0 111.458 -169.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -38.58 1.65 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.729 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.92 142.37 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 122.852 0.461 . . . . 0.0 110.023 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 p -74.12 -23.7 59.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 111.681 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -109.54 177.34 4.77 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.256 0.622 . . . . 0.0 111.619 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.55 149.31 47.11 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.995 -177.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -61.01 -57.92 10.58 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.606 0.762 . . . . 0.0 110.023 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -171.62 133.91 0.81 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.123 0.89 . . . . 0.0 109.307 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 83' ' ' THR . 58.6 mt -103.61 136.48 19.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.62 112.69 1.08 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.691 2.26 . . . . 0.0 111.644 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.507 ' HA ' HD22 ' A' ' 24' ' ' LEU . 93.1 mt-30 -63.89 -24.99 67.95 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.526 0.731 . . . . 0.0 111.699 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.3 -35.06 76.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.376 0.67 . . . . 0.0 110.957 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.8 m -74.23 -27.44 60.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.171 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 21' ' ' GLN . 3.7 mm? -72.27 -34.09 67.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -62.95 -38.92 93.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.353 0.661 . . . . 0.0 111.571 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 11.3 pt-20 -71.08 -34.84 71.54 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.278 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.436 HD11 HD11 ' A' ' 24' ' ' LEU . 78.4 mt -63.05 -36.89 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.077 0.551 . . . . 0.0 110.206 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 32' ' ' ILE . 10.9 mmm180 -57.87 -38.4 75.65 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 110.284 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -68.61 -43.78 75.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.851 0.86 . . . . 0.0 111.375 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.5 mm-40 -65.44 -37.19 86.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.948 0.499 . . . . 0.0 110.644 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -69.57 -22.84 63.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.452 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.1 mm -69.13 -36.16 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' A' ' 35' ' ' GLU . 39.9 ttp-105 -66.35 -34.46 78.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 169.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.05 5.4 47.01 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.637 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB3' ' HE ' ' A' ' 33' ' ' ARG . 1.9 tm-20 -133.93 107.83 8.05 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . . . -134.56 95.54 3.39 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -98.27 104.77 16.83 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.64 128.22 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.306 0.643 . . . . 0.0 109.838 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -105.46 98.47 8.16 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.641 0.376 . . . . 0.0 109.987 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 97.3 mt -77.33 64.95 2.8 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.681 0.792 . . . . 0.0 110.093 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.54 -110.0 3.06 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.238 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 -20.82 37.69 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.389 0.675 . . . . 0.0 110.903 175.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -81.56 110.98 17.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.08 130.35 35.03 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.08 145.54 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.087 0.955 . . . . 0.0 108.992 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -135.96 97.69 3.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.83 0.452 . . . . 0.0 110.507 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 36' ' ' ALA . 5.7 mm -72.3 102.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.887 0.875 . . . . 0.0 109.0 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -129.25 123.15 21.44 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 C--N 1.378 2.095 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 176.54 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.42 ' HB2' HG23 ' A' ' 47' ' ' ILE . 21.5 p90 -87.77 114.0 23.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.745 0.783 . . . . 0.0 108.937 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtm -130.06 -174.74 3.41 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.708 1.203 . . . . 0.0 108.268 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.65 137.93 49.78 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.878 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -133.66 98.82 4.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.754 0.822 . . . . 0.0 108.847 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.54 104.21 3.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.221 0.609 . . . . 0.0 109.679 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.15 109.65 3.64 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.245 0.842 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.53 -168.35 0.2 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.15 0.58 . . . . 0.0 111.257 165.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.64 -18.46 20.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.164 0.986 . . . . 0.0 112.759 169.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.12 -40.78 77.78 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.782 0.433 . . . . 0.0 110.869 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.3 mm -56.12 -49.28 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.998 0.519 . . . . 0.0 111.131 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.24 -54.82 40.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.737 0.815 . . . . 0.0 111.429 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.04 -37.87 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.929 0.892 . . . . 0.0 110.103 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -63.2 -59.71 8.59 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.581 177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -67.42 -27.92 67.46 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -172.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -67.26 -41.65 85.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.119 0.567 . . . . 0.0 110.189 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -73.47 -25.52 60.51 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.991 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -63.86 -43.27 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.4 -34.36 65.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.117 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.08 -39.73 93.62 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.814 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' LEU . 68.2 mt -66.33 -34.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.591 0.756 . . . . 0.0 110.24 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.65 -47.07 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.046 0.539 . . . . 0.0 110.106 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -76.47 -30.44 57.29 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.491 1.116 . . . . 0.0 112.722 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.445 HG21 HD12 ' A' ' 19' ' ' ILE . 31.3 m -86.65 -28.56 23.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.871 0.469 . . . . 0.0 111.659 -173.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 124.216 1.006 . . . . 0.0 109.888 -177.031 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 37.9 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.3 t -65.02 -45.55 85.03 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.385 0.428 . . . . 0.0 110.33 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.336 0.654 . . . . 0.0 111.492 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 4.7 tm-20 -58.68 -51.47 69.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 109.982 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.66 -23.52 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.249 0.62 . . . . 0.0 112.254 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 m -66.5 -48.53 69.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.593 0.357 . . . . 0.0 110.466 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.7 m -69.41 -24.41 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.269 0.628 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 89.6 mt -66.26 -47.35 73.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.99 0.424 . . . . 0.0 110.08 171.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -80.41 -24.14 39.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.682 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -75.65 -46.8 29.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.692 0.797 . . . . 0.0 111.841 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.952 -172.095 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.545 1.051 0 CA-C-O 121.269 0.445 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.61 99.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.75 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.11 146.21 53.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.9 tp -146.25 93.5 2.32 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.913 -1.144 . . . . 0.0 107.913 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -139.02 33.7 0.21 Allowed Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.42 -33.57 0.96 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 CA-C-N 121.173 1.455 . . . . 0.0 112.731 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 39.9 m-85 -129.34 22.1 5.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.527 0.731 . . . . 0.0 111.651 -174.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -64.25 123.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' OG ' ' A' ' 17' ' ' SER . 25.3 mt -111.7 85.76 6.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.55 -12.8 34.08 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.407 2.071 . . . . 0.0 113.083 -167.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.83 -12.81 79.2 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.767 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -126.92 178.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 117.826 0.813 . . . . 0.0 111.128 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 p -84.13 -42.94 15.5 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.184 0.994 . . . . 0.0 111.983 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -81.97 -177.95 6.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.471 0.653 . . . . 0.0 112.207 -173.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -134.63 148.42 50.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.277 1.031 . . . . 0.0 108.336 -173.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.553 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 49.3 m -84.86 63.94 8.33 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.543 0.687 . . . . 0.0 111.223 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.5 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.197 1.399 . . . . 0.0 112.094 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 65.6 mt -68.85 136.32 89.95 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.213 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 17.2 Cg_endo -58.22 117.57 4.3 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.871 1.714 . . . . 0.0 110.504 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.436 ' HA ' HD21 ' A' ' 24' ' ' LEU . 5.0 pt20 -62.35 -18.24 60.98 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.665 0.786 . . . . 0.0 111.365 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.8 -46.55 77.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.787 1.235 . . . . 0.0 110.48 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.1 m -60.89 -47.34 86.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.274 0.629 . . . . 0.0 110.933 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.8 mm? -58.58 -42.36 87.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.668 0.605 . . . . 0.0 110.741 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -63.09 -32.62 74.04 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.913 0.758 . . . . 0.0 111.44 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.8 tp10 -71.66 -45.46 61.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.233 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.25 -35.6 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.935 0.894 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.533 ' O ' HG12 ' A' ' 32' ' ' ILE . 22.5 mmm180 -56.77 -42.67 79.81 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.786 0.834 . . . . 0.0 110.608 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -72.97 -40.52 65.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.666 0.786 . . . . 0.0 111.488 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 24.5 mm-40 -64.47 -40.62 96.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.491 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.9 p -69.96 -24.85 63.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.225 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.9 mm -68.46 -32.78 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 172.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.09 -12.33 58.28 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.981 0.419 . . . . 0.0 110.409 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.42 -16.94 29.04 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 114.491 0.557 . . . . 0.0 114.491 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -134.9 116.8 15.16 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.35 0.575 . . . . 0.0 111.223 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.59 138.09 54.69 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.71 105.03 5.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.419 HD11 HG12 ' A' ' 47' ' ' ILE . 2.8 mp -101.81 114.81 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.713 0.805 . . . . 0.0 109.636 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 42.7 mtm180 -87.08 93.56 9.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 86.4 mt -75.89 71.54 2.71 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.119 0.485 . . . . 0.0 109.815 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.33 -101.99 0.56 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.594 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -99.61 -15.02 18.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.783 0.833 . . . . 0.0 111.251 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 18.3 mt -83.5 109.77 17.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.451 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.7 tpt -86.51 117.88 25.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.31 149.97 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 59' ' ' SER . 57.1 m -137.17 134.44 36.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.844 0.858 . . . . 0.0 108.902 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.49 HG23 HD21 ' A' ' 84' ' ' LEU . 31.9 mm -112.85 104.03 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -127.91 107.6 20.22 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.102 0.561 . . . . 0.0 109.54 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--N 1.377 2.053 0 C-N-CA 122.606 2.204 . . . . 0.0 111.738 173.344 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' HG13 ' A' ' 94' ' ' VAL . 88.8 m-85 . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.402 ' HB2' HG22 ' A' ' 47' ' ' ILE . 27.0 p90 -88.1 110.2 20.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.784 0.433 . . . . 0.0 110.648 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -170.26 108.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.551 0.74 . . . . 0.0 109.852 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.21 106.18 0.01 OUTLIER Glycine 0 CA--C 1.541 1.69 0 O-C-N 124.532 1.145 . . . . 0.0 115.765 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 46' ' ' SER . 28.7 t -134.98 99.78 4.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.81 113.92 12.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 109.428 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -68.7 109.08 3.64 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.757 0.661 . . . . 0.0 109.474 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 124.244 1.018 . . . . 0.0 112.004 -176.432 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 70' ' ' ILE . 33.0 t . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 119.54 -0.266 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.35 -32.66 71.48 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 111.617 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.8 -38.92 73.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.35 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -69.2 -28.02 66.01 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.52 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 66' ' ' SER . 33.6 mm -64.63 -45.25 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 tt0 -61.86 -57.1 13.11 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.07 0.856 . . . . 0.0 111.281 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.27 -37.75 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 77' ' ' ILE . . . -59.46 -52.6 52.17 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.115 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.99 -24.81 65.18 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.295 0.547 . . . . 0.0 111.537 -174.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 80.0 mm-40 -59.69 -50.74 72.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.497 0.665 . . . . 0.0 109.327 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -68.84 -26.66 65.27 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.993 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.91 -37.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.11 -38.76 75.69 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.856 0.863 . . . . 0.0 111.987 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -76.89 -48.12 19.22 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.029 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.65 -29.85 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.349 0.66 . . . . 0.0 110.646 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -47.14 -66.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.401 1.08 . . . . 0.0 111.161 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -71.0 -24.43 62.38 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.083 -173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.0 m -72.72 -23.43 60.85 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.113 0.565 . . . . 0.0 111.448 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 47' ' ' ILE . 34.2 tp . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 93' ' ' GLU . 5.3 t . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.849 0.357 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.7 p -59.85 -36.55 77.07 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 0.0 110.632 172.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -62.38 -33.31 74.5 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.636 0.774 . . . . 0.0 111.339 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 90' ' ' THR . 7.1 tp10 -65.9 -48.7 70.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.072 0.549 . . . . 0.0 110.031 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 55' ' ' TYR . 15.7 m -73.66 -24.12 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 100.0 m -65.45 -46.46 79.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.866 0.466 . . . . 0.0 110.495 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 100' ' ' ILE . 25.0 m -75.24 -23.65 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.323 0.249 . . . . 0.0 111.393 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 93' ' ' GLU . 5.4 mp -62.47 -47.85 82.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.681 0.792 . . . . 0.0 110.261 169.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -74.0 -23.16 59.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -76.62 -35.93 57.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.134 0.974 . . . . 0.0 110.463 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 96' ' ' VAL . 38.4 pt . . . . . 0 CA--C 1.568 1.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.352 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 CA--C 1.546 1.089 0 CA-C-O 121.171 0.405 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.21 103.7 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 0.0 109.172 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -70.35 136.46 49.73 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.17 0.51 . . . . 0.0 110.168 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 23' ' ' THR . 48.2 tp -136.29 100.59 4.43 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.547 1.139 . . . . 0.0 108.283 -175.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.405 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -143.31 42.17 0.39 Allowed Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 6' ' ' THR . 97.1 Cg_endo -82.34 -34.85 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 121.546 1.497 . . . . 0.0 112.803 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -129.66 25.11 5.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.053 0.941 . . . . 0.0 110.848 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.81 121.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 13' ' ' VAL . 26.7 mt -111.07 91.56 13.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -16.99 47.46 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.736 2.291 . . . . 0.0 113.502 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.84 -27.78 64.11 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.46 0.475 . . . . 0.0 113.142 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 10' ' ' LEU . 16.3 m -112.19 170.37 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 0.0 110.77 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -90.37 -23.62 21.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.243 1.017 . . . . 0.0 112.18 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -95.57 168.01 10.95 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.372 0.606 . . . . 0.0 111.682 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.67 143.61 39.19 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -57.22 -64.84 0.75 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.43 0.692 . . . . 0.0 111.081 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -170.89 123.3 0.61 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.04 135.1 32.09 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.879 0.471 . . . . 0.0 109.859 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.79 123.13 12.66 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.86 2.374 . . . . 0.0 111.566 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.77 -22.79 67.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.154 0.581 . . . . 0.0 110.938 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.52 -34.89 74.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.804 0.841 . . . . 0.0 111.08 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.417 HG21 HD12 ' A' ' 5' ' ' LEU . 31.3 m -65.26 -48.4 73.38 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 83' ' ' THR . 8.6 mp -61.92 -30.48 70.93 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.286 0.634 . . . . 0.0 111.64 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -68.86 -52.36 30.55 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.866 0.866 . . . . 0.0 110.279 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.6 pt-20 -65.09 -42.84 93.68 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.227 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.8 -31.63 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.583 0.753 . . . . 0.0 111.031 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 14.0 tpt180 -61.56 -34.8 76.21 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.697 0.399 . . . . 0.0 110.439 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -73.22 -43.08 61.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.805 0.842 . . . . 0.0 110.882 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.6 mm100 -61.69 -44.1 97.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.984 0.914 . . . . 0.0 111.812 -176.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 47' ' ' ILE . 68.1 p -60.47 -38.67 85.0 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.595 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.4 mm -58.71 -37.74 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.005 0.522 . . . . 0.0 110.974 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.3 -7.66 59.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.256 1.022 . . . . 0.0 111.429 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.37 63.72 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.717 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 26.1 tt0 -137.63 105.82 5.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.168 0.587 . . . . 0.0 109.651 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 47' ' ' ILE . . . -155.29 106.69 2.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.686 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 92.4 mt-30 -121.37 116.58 25.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.779 0.832 . . . . 0.0 109.12 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.38 116.63 49.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mtm105 -87.9 99.19 11.94 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.44 78.43 4.9 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.48 -100.95 0.52 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.73 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.87 -29.51 32.42 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.749 0.82 . . . . 0.0 110.728 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.24 160.44 15.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 111.129 -167.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.686 ' SD ' ' HB3' ' A' ' 37' ' ' GLN . 48.9 tpp -120.3 140.74 50.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.019 0.928 . . . . 0.0 108.903 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.28 110.12 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.779 0.832 . . . . 0.0 109.549 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -90.96 95.75 10.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 120.988 0.423 . . . . 0.0 110.219 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 56' ' ' PHE . 19.0 mm -88.36 84.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -135.26 126.28 17.33 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--N 1.378 2.087 0 C-N-CA 122.878 2.385 . . . . 0.0 111.474 -179.103 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.462 ' HB2' HG21 ' A' ' 47' ' ' ILE . 54.1 p90 -87.6 115.86 25.33 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.45 ' SD ' HG11 ' A' ' 94' ' ' VAL . 7.2 ptm -169.67 -178.17 2.93 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.97 110.23 1.42 Allowed Glycine 0 CA--C 1.537 1.436 0 O-C-N 123.796 0.685 . . . . 0.0 114.071 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 t -127.84 100.47 5.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.453 0.701 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.2 tm? -84.52 112.82 20.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.58 HD22 ' HB3' ' A' ' 44' ' ' MET . 2.4 p-10 -83.78 133.1 34.79 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 C-N-CA 124.534 1.134 . . . . 0.0 112.874 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 70' ' ' ILE . 42.1 t . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -52.33 -43.23 64.46 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.216 1.007 . . . . 0.0 112.789 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.44 -40.82 96.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.702 . . . . 0.0 110.975 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -66.18 -39.39 89.68 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.425 0.69 . . . . 0.0 110.673 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 66' ' ' SER . 50.0 mm -59.93 -43.68 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.573 0.749 . . . . 0.0 109.935 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.85 -51.74 65.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.894 0.746 . . . . 0.0 111.042 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.4 mt -53.18 -41.62 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.826 0.85 . . . . 0.0 110.192 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.31 -58.93 8.49 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.964 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.8 pp -64.72 -22.98 67.11 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.988 0.515 . . . . 0.0 112.17 -172.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -73.98 -47.76 35.03 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.111 0.564 . . . . 0.0 110.86 173.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -66.28 -26.79 67.5 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -70.44 -47.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.787 0.835 . . . . 0.0 109.929 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -24.89 60.25 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.687 0.617 . . . . 0.0 110.604 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -70.68 -49.25 49.23 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.375 0.67 . . . . 0.0 110.471 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.42 -35.4 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.564 0.745 . . . . 0.0 110.6 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 57' ' ' MET . 37.2 tt0 -59.14 -43.56 92.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.586 1.154 . . . . 0.0 110.667 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.4 -39.82 94.59 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.202 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.441 HG22 HD21 ' A' ' 24' ' ' LEU . 17.9 m -72.03 -29.16 63.9 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 123.879 0.872 . . . . 0.0 111.771 179.794 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 92' ' ' ARG . 25.4 m . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 t -57.19 -39.47 75.44 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.022 0.529 . . . . 0.0 110.361 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.8 ttp180 -67.55 -28.99 68.26 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.635 0.774 . . . . 0.0 111.795 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -47.09 83.32 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.068 0.547 . . . . 0.0 109.565 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG11 ' SD ' ' A' ' 57' ' ' MET . 10.6 p -80.7 -23.25 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.954 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' HA ' ' A' ' 92' ' ' ARG . 3.6 m -64.73 -46.51 81.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.505 0.722 . . . . 0.0 111.204 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.6 -33.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.4 -43.37 77.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.727 . . . . 0.0 111.753 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.1 -25.87 52.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.885 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -23.65 38.21 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.639 0.775 . . . . 0.0 112.6 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.005 178.062 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 1.2 pmm? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.2 Cg_endo -79.01 90.61 1.26 Allowed 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.575 2.183 . . . . 0.0 110.836 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 2.4 p -64.23 103.66 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.397 177.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.13 132.46 45.08 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.842 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.94 85.69 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.407 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.4 t -141.06 35.13 0.21 Allowed Pre-proline 0 CA--C 1.57 1.712 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 -29.88 6.83 Favored 'Trans proline' 0 C--N 1.387 2.604 0 CA-C-N 121.002 1.394 . . . . 0.0 112.327 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.507 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.0 m-85 -130.87 29.77 4.69 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.336 0.654 . . . . 0.0 111.826 -175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.407 HG13 ' HA ' ' A' ' 6' ' ' THR . 11.6 mt -76.6 128.75 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 118.162 0.437 . . . . 0.0 112.025 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.494 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -103.83 91.07 3.27 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 86.44 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 0.0 111.518 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.64 -13.5 0.17 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.405 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 10' ' ' LEU . 25.1 m -119.71 158.31 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.202 0.601 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -74.52 -37.81 62.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.079 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -80.61 162.65 24.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.427 0.632 . . . . 0.0 111.285 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 17' ' ' SER . 1.1 tm? -113.43 151.96 30.7 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 35.7 t -57.1 -59.31 5.28 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.673 0.789 . . . . 0.0 110.629 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -174.69 117.43 0.19 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.24 137.56 27.69 Favored Pre-proline 0 N--CA 1.485 1.32 0 CA-C-N 118.402 0.546 . . . . 0.0 110.359 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.87 116.66 3.39 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.272 1.982 . . . . 0.0 110.736 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.499 ' HA ' HD23 ' A' ' 24' ' ' LEU . 27.8 tt0 -65.31 -26.13 67.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.477 0.711 . . . . 0.0 111.129 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.77 -25.94 67.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.871 0.868 . . . . 0.0 111.438 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.53 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 20.5 m -71.28 -47.84 54.5 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.2 mm? -57.33 -33.2 67.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 117.847 0.294 . . . . 0.0 110.627 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.8 m -61.46 -51.09 70.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.458 0.703 . . . . 0.0 111.401 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' THR . 8.2 pt-20 -66.52 -35.73 80.97 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.623 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 23' ' ' THR . 15.5 mm -58.24 -51.52 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.855 0.862 . . . . 0.0 110.091 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.504 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 91.4 mtm180 -59.88 -28.26 67.4 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.98 -42.4 26.81 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.964 0.506 . . . . 0.0 111.553 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 5.4 pt20 -77.7 -23.64 49.43 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.392 0.677 . . . . 0.0 112.448 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 74.1 p -61.49 -28.19 69.12 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.328 0.513 . . . . 0.0 111.352 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.39 -24.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.985 0.914 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -67.19 -19.05 65.5 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.744 0.818 . . . . 0.0 110.316 173.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.24 -22.86 14.83 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.997 0.808 . . . . 0.0 113.25 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 43.7 tt0 -143.98 145.11 32.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.294 0.638 . . . . 0.0 110.366 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.07 106.44 5.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.022 0.929 . . . . 0.0 109.085 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.56 121.9 31.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.683 0.393 . . . . 0.0 110.105 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD11 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -111.92 129.08 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.455 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 33.1 mtm105 -103.29 106.08 16.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 95.4 mt -77.27 68.37 3.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.68 0.82 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.266 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.46 -16.73 22.04 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.021 0.928 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 11.7 mt -81.12 111.27 17.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.7 tpt -84.89 124.76 32.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.98 152.14 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.597 1.159 . . . . 0.0 108.487 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -139.18 99.93 3.88 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.523 0.729 . . . . 0.0 109.757 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HD11 ' A' ' 38' ' ' ILE . 11.1 mm -88.46 120.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.478 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -161.95 137.76 5.77 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 118.189 0.45 . . . . 0.0 111.189 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 96.7 Cg_endo -80.44 87.38 1.52 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.563 2.176 . . . . 0.0 111.311 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.541 ' HG3' HG22 ' A' ' 52' ' ' VAL . 15.7 tpt -71.15 102.45 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.854 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.27 75.93 4.79 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.673 0.789 . . . . 0.0 110.944 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 50' ' ' MET . 15.9 m -144.98 -43.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.824 1.649 . . . . 0.0 107.642 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 98' ' ' ARG . 4.4 t30 179.51 104.41 0.03 OUTLIER 'General case' 0 C--N 1.354 0.786 0 C-N-CA 126.188 1.795 . . . . 0.0 106.987 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.26 134.09 3.22 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 122.871 0.107 . . . . 0.0 112.886 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -87.06 173.13 9.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.871 0.868 . . . . 0.0 110.157 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 9.7 p90 -87.06 114.7 23.9 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.429 0.633 . . . . 0.0 110.202 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.543 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -162.65 -176.57 5.07 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.0 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.7 110.29 2.04 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -125.66 106.47 9.76 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 118.85 19.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.019 0.927 . . . . 0.0 109.684 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.79 91.72 3.53 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.709 . . . . 0.0 109.132 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -71.62 -11.47 60.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.092 1.357 . . . . 0.0 112.856 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.86 118.49 7.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.521 0.728 . . . . 0.0 110.909 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 -4.3 85.76 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.573 0.545 . . . . 0.0 114.282 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.48 175.96 10.09 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.813 0.816 . . . . 0.0 112.685 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -113.84 171.03 7.83 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.686 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 15.1 m120 -56.79 -44.65 82.08 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.358 0.663 . . . . 0.0 111.82 -172.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.32 -35.35 80.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.123 0.569 . . . . 0.0 111.446 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -66.37 -32.96 74.67 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.964 0.505 . . . . 0.0 111.447 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mm -66.19 -45.01 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 76.3 mm-40 -71.61 -54.82 9.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.59 0.756 . . . . 0.0 112.079 -174.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.72 -30.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.35 0.595 . . . . 0.0 109.469 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.62 -57.66 17.8 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.654 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -71.27 -26.78 63.03 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.643 0.722 . . . . 0.0 112.737 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -74.05 -37.0 64.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.357 0.598 . . . . 0.0 110.096 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.93 -24.83 48.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.731 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 1.2 mp -71.54 -46.49 63.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.12 -30.51 71.57 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.608 0.568 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.06 -54.95 34.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.369 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.438 HG22 HD21 ' A' ' 84' ' ' LEU . 56.2 mt -61.24 -32.92 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.332 1.053 . . . . 0.0 112.364 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 49.7 mt-10 -63.1 -39.49 94.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.047 0.539 . . . . 0.0 110.84 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -77.36 -32.9 55.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.917 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -77.63 -26.19 50.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.299 0.64 . . . . 0.0 112.018 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD22 HD13 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -75.94 -28.56 58.01 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.086 0.955 . . . . 0.0 109.956 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -138.02 87.83 2.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.12 0.968 . . . . 0.0 108.725 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -60.82 107.32 0.69 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.507 0.723 . . . . 0.0 112.386 -169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 10.56 76.96 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 114.222 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.9 t -80.45 -66.9 0.82 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.297 0.639 . . . . 0.0 110.479 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.9 162.24 40.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.034 0.534 . . . . 0.0 111.131 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 93' ' ' GLU . 9.0 t -102.81 179.11 4.37 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.9 p -58.16 -53.46 58.03 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.359 1.063 . . . . 0.0 111.182 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -68.17 -27.88 66.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.094 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HB2' HG21 ' A' ' 90' ' ' THR . 15.0 tp10 -59.91 -33.34 71.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.822 0.849 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.79 -39.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.004 0.922 . . . . 0.0 110.947 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -61.54 -37.28 83.19 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.385 0.674 . . . . 0.0 111.734 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.68 -27.92 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.294 0.638 . . . . 0.0 111.859 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.5 -39.83 85.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.911 0.484 . . . . 0.0 110.031 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.534 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 3.3 tpm_? -83.22 -34.45 25.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.604 0.761 . . . . 0.0 111.901 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.03 -38.35 57.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.576 0.75 . . . . 0.0 112.38 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.642 0.777 . . . . 0.0 112.557 -176.141 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.6 116.3 2.57 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.634 2.223 . . . . 0.0 112.856 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.96 112.89 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.045 0.938 . . . . 0.0 110.465 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.91 134.43 47.24 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.208 0.527 . . . . 0.0 110.275 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 19' ' ' ILE . 4.5 tt -140.42 92.75 2.55 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.406 ' HA ' HG13 ' A' ' 9' ' ' ILE . 9.9 t -150.09 55.0 1.67 Allowed Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.66 -31.58 0.43 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.956 1.771 . . . . 0.0 113.099 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HE1' ' HD3' ' A' ' 20' ' ' PRO . 48.4 m-85 -127.86 4.83 6.0 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.439 -171.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 6' ' ' THR . 16.3 mt -54.28 122.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -164.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 mt -98.91 96.4 3.99 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.7 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.18 40.3 0.97 Allowed 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.078 2.518 . . . . 0.0 115.118 -161.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.12 23.23 0.15 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.103 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.36 178.18 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.277 0.631 . . . . 0.0 110.412 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 57.6 p -91.83 -48.96 6.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.748 0.819 . . . . 0.0 111.01 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -79.0 -175.93 4.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.342 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 15.7 tp -141.78 169.64 17.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -55.39 -64.44 0.84 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.303 0.641 . . . . 0.0 109.722 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -176.41 105.6 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.167 0.917 . . . . 0.0 108.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.417 HG22 HD22 ' A' ' 5' ' ' LEU . 56.8 mt -63.3 129.47 93.54 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.702 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.445 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 14.8 Cg_endo -56.17 120.34 8.12 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.75 2.3 . . . . 0.0 112.038 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.467 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.6 pm0 -60.39 -26.05 66.36 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.453 0.701 . . . . 0.0 111.978 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.41 -36.44 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.762 0.825 . . . . 0.0 110.926 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 27' ' ' ILE . 16.5 m -72.78 -37.51 67.57 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.237 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.0 mm? -64.67 -29.78 70.79 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.6 0.636 . . . . 0.0 110.479 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.1 t -72.48 -35.38 68.19 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.372 0.669 . . . . 0.0 110.289 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 10.6 tp10 -61.33 -50.19 73.95 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.395 0.678 . . . . 0.0 110.229 173.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 23' ' ' THR . 13.9 mm -59.18 -37.17 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.171 0.989 . . . . 0.0 110.522 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.2 tpt180 -60.9 -33.42 73.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.69 -39.05 58.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.445 0.698 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 54.0 mt-30 -73.68 -29.85 62.54 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.25 0.62 . . . . 0.0 110.973 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.5 p -69.81 -27.92 65.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.947 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 28' ' ' ARG . 43.3 mm -67.43 -35.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -67.75 -19.05 65.08 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.17 -21.86 21.62 Favored Glycine 0 C--N 1.346 1.126 0 C-N-CA 123.793 0.711 . . . . 0.0 112.759 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -141.89 119.32 11.58 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 122.974 0.51 . . . . 0.0 110.538 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.95 111.09 21.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -103.12 113.03 26.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.578 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.4 mp -101.23 149.08 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 108.588 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.428 HH21 ' HA ' ' A' ' 42' ' ' GLU . 12.7 mmm-85 -126.03 88.25 2.82 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.187 0.995 . . . . 0.0 109.252 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.1 mt -71.32 77.43 0.74 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 -102.26 0.66 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.829 -166.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HA ' HH21 ' A' ' 39' ' ' ARG . 15.2 pt-20 -100.18 -18.63 16.81 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.811 0.844 . . . . 0.0 111.139 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.0 mt -69.08 110.95 4.76 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.4 ttt -88.8 108.71 19.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.088 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 19.2 t -98.5 154.13 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.641 1.177 . . . . 0.0 108.664 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.3 98.89 3.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.409 0.683 . . . . 0.0 109.8 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 38' ' ' ILE . 37.5 mm -89.63 104.84 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.041 0.936 . . . . 0.0 108.787 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -130.29 128.14 22.64 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.338 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.6 110.76 1.71 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.148 2.566 . . . . 0.0 111.922 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.3 tpt -71.45 105.12 3.45 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.309 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -63.06 -52.92 60.86 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 0.0 112.275 -168.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.87 81.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 71.19 145.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.156 1.382 . . . . 0.0 111.761 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.7 -143.16 15.67 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.454 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 179.39 5.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.057 0.943 . . . . 0.0 110.224 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -86.35 130.25 34.57 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -153.06 179.13 8.98 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.515 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.505 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . -61.89 110.44 3.19 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.23 0.956 . . . . 0.0 113.19 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.2 t -122.43 98.58 5.99 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 121.6 23.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.36 85.8 0.59 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.407 ' HB3' HD11 ' A' ' 60' ' ' LEU . 7.4 pt20 -103.67 20.35 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.282 -172.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.81 94.62 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 0.0 109.85 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 68.59 16.32 69.6 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.173 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -73.63 157.42 36.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.096 0.959 . . . . 0.0 110.416 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -60.73 132.92 55.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.549 0.34 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -57.52 -26.37 61.24 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.744 0.818 . . . . 0.0 111.879 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.22 -54.32 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.495 1.118 . . . . 0.0 110.644 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.57 -25.23 61.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.648 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.03 -39.86 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 50.9 tt0 -65.35 -58.3 6.24 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.445 0.466 . . . . 0.0 110.108 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.8 mt -59.91 -34.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.556 0.743 . . . . 0.0 110.027 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.41 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -64.29 -54.89 26.81 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.37 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.499 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -66.93 -26.98 67.12 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.02 0.91 . . . . 0.0 111.467 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 24.4 mt-30 -64.69 -50.72 65.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.734 0.778 . . . . 0.0 109.44 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' ILE . 10.4 m-85 -69.64 -24.9 63.7 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.773 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -70.52 -42.42 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.404 0.682 . . . . 0.0 111.095 -178.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -68.87 -27.67 66.01 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.072 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -72.77 -36.01 67.55 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.279 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 76' ' ' TYR . 38.1 mm -73.59 -43.28 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.234 0.47 . . . . 0.0 110.605 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.505 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 12.7 pt-20 -65.5 -38.55 90.05 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.637 0.375 . . . . 0.0 111.489 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -70.39 -26.04 63.52 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.39 0.676 . . . . 0.0 110.555 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m -78.26 -31.87 49.31 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.722 0.809 . . . . 0.0 111.23 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.2 -22.63 22.68 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.013 0.525 . . . . 0.0 112.178 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -85.98 92.81 8.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.088 0.555 . . . . 0.0 110.109 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -119.82 14.29 12.48 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.513 0.725 . . . . 0.0 110.393 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.35 -177.27 44.55 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.741 -0.209 . . . . 0.0 112.595 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -82.88 66.83 8.7 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.85 0.833 . . . . 0.0 108.967 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.58 146.19 19.41 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.016 -169.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 81.9 m -122.91 147.69 46.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.353 1.061 . . . . 0.0 109.051 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.6 p -56.89 -48.57 77.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.956 0.902 . . . . 0.0 112.194 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.427 ' O ' HG13 ' A' ' 96' ' ' VAL . 42.4 ttp180 -69.0 -27.61 65.84 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 122.219 0.208 . . . . 0.0 111.097 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 1.5 tm-20 -61.69 -24.98 67.12 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 122.993 0.517 . . . . 0.0 110.174 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.17 -34.87 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.056 0.542 . . . . 0.0 111.368 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.0 m -62.97 -30.57 71.68 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 92' ' ' ARG . 26.8 m -65.92 -21.21 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.419 0.688 . . . . 0.0 111.558 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.08 -43.48 87.03 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.628 0.771 . . . . 0.0 110.102 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -79.81 -31.46 40.7 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.918 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -71.66 -44.51 64.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.64 0.776 . . . . 0.0 112.552 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 96' ' ' VAL . 27.5 pt . . . . . 0 CA--C 1.57 1.74 0 C-N-CA 122.971 0.508 . . . . 0.0 111.339 -172.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.54 155.63 24.56 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.118 1.879 . . . . 0.0 112.559 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.97 116.17 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.761 1.225 . . . . 0.0 108.597 167.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 7.6 p-10 -69.98 142.23 52.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -145.4 89.05 1.9 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.507 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.1 t -147.05 41.46 0.27 Allowed Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.002 0.521 . . . . 0.0 112.377 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 6' ' ' THR . 1.7 Cg_endo -79.6 -39.06 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 121.535 1.49 . . . . 0.0 112.021 -174.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.42 ' HE2' ' HD3' ' A' ' 20' ' ' PRO . 1.1 m-85 -129.43 31.09 4.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.071 0.548 . . . . 0.0 111.03 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.6 mt -63.35 109.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 118.817 0.735 . . . . 0.0 111.258 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.02 98.58 2.04 Favored Pre-proline 0 C--N 1.356 0.879 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.99 -16.79 50.49 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.419 2.079 . . . . 0.0 112.851 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.56 83.17 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.648 0.593 . . . . 0.0 114.356 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 10' ' ' LEU . 33.9 m -129.08 171.1 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 117.248 0.524 . . . . 0.0 111.503 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p -82.73 -34.7 27.13 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.635 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -84.91 177.34 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 122.084 0.945 . . . . 0.0 111.95 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.68 142.03 49.85 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 171.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.1 m -52.76 -48.0 67.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.456 0.702 . . . . 0.0 111.606 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 t70 179.41 119.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.838 1.255 . . . . 0.0 108.015 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.14 134.89 37.83 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 19.8 Cg_endo -58.86 122.65 11.98 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.797 2.331 . . . . 0.0 111.38 170.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.38 -17.9 64.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.153 0.581 . . . . 0.0 111.102 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -56.19 -47.21 78.78 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.222 1.009 . . . . 0.0 110.295 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -65.87 -34.94 79.3 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.043 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.9 mm? -67.65 -32.7 73.58 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.125 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -62.88 -38.61 91.57 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.846 0.458 . . . . 0.0 111.769 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 15.3 pt-20 -73.39 -40.84 64.0 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.261 0.351 . . . . 0.0 110.103 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.67 -36.83 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.004 0.922 . . . . 0.0 110.84 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 21.9 mmm180 -61.73 -45.08 95.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.812 0.845 . . . . 0.0 110.934 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.24 -37.67 83.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.032 0.533 . . . . 0.0 110.935 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 18.0 mm-40 -68.47 -38.38 81.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.842 0.857 . . . . 0.0 111.148 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -69.06 -27.79 65.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 46.6 mm -71.45 -36.61 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -75.17 -12.17 60.24 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.914 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.94 -9.73 60.07 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.594 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -139.23 111.95 7.8 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.214 1.007 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -125.67 98.99 5.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.811 0.844 . . . . 0.0 109.041 169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -99.17 105.96 18.08 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.76 110.25 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.586 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 41.5 mtm105 -88.22 90.23 8.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.629 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 93.5 mt -76.1 70.6 2.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.291 0.637 . . . . 0.0 109.905 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.02 0.55 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.807 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.06 -15.13 32.38 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.177 0.991 . . . . 0.0 111.449 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 22.3 mt -91.3 142.86 27.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.963 0.905 . . . . 0.0 109.765 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.2 tpt -120.24 106.02 11.51 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG22 HD21 ' A' ' 60' ' ' LEU . 40.4 t -111.42 103.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.114 0.966 . . . . 0.0 109.898 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 t -90.36 98.91 12.05 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -84.74 103.64 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.04 139.36 13.35 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.618 -0.229 . . . . 0.0 110.665 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.44 153.26 23.78 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.728 2.285 . . . . 0.0 112.283 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.456 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 56.9 ttm -98.41 137.84 36.51 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.383 0.673 . . . . 0.0 110.188 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.92 -41.94 92.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.5 1.12 . . . . 0.0 112.432 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -87.57 46.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.571 0.748 . . . . 0.0 111.098 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t30 65.83 99.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.528 1.531 . . . . 0.0 110.892 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -161.67 124.6 1.33 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -81.73 147.16 29.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.232 0.613 . . . . 0.0 110.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -88.24 132.77 34.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.926 0.49 . . . . 0.0 110.422 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.9 ptp -160.01 -175.98 5.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.943 1.297 . . . . 0.0 108.628 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.29 110.69 1.89 Allowed Glycine 0 C--N 1.352 1.462 0 O-C-N 123.655 0.597 . . . . 0.0 113.168 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.9 t -128.72 97.73 4.77 Favored 'General case' 0 C--N 1.353 0.717 0 C-N-CA 123.196 0.599 . . . . 0.0 109.872 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.648 ' HG ' ' HA3' ' A' ' 73' ' ' GLY . 3.3 tm? -79.54 113.03 17.36 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -79.49 142.24 36.0 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -107.49 1.7 23.65 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.174 0.59 . . . . 0.0 112.167 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.31 107.87 6.74 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.68 12.84 58.93 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.535 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -117.0 162.62 17.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.863 0.865 . . . . 0.0 110.497 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m -100.82 161.72 13.4 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.051 0.94 . . . . 0.0 109.637 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -55.31 -31.92 62.05 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.457 1.103 . . . . 0.0 112.134 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -51.85 67.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.497 1.119 . . . . 0.0 110.216 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.23 -39.46 82.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.04 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 22.6 mm -59.12 -51.71 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.874 0.734 . . . . 0.0 110.65 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.471 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 47.5 mt-30 -57.61 -46.72 83.71 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.543 1.152 . . . . 0.0 111.487 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.5 mt -58.13 -41.45 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 124.09 0.869 . . . . 0.0 110.158 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.648 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -60.37 -49.11 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.295 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 70' ' ' ILE . 50.7 mt -57.86 -36.98 73.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.991 0.917 . . . . 0.0 111.323 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 83.6 mm-40 -58.54 -51.39 70.08 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.429 174.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -68.81 -30.43 68.99 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.589 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 73' ' ' GLY . 1.2 mp -66.64 -42.72 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.385 1.074 . . . . 0.0 111.098 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.88 -30.13 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.431 0.457 . . . . 0.0 110.663 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -78.29 -26.75 47.18 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.528 HD11 HD11 ' A' ' 40' ' ' LEU . 65.2 mt -71.03 -32.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 123.37 0.668 . . . . 0.0 109.638 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.64 -41.31 76.95 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.844 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -71.2 -38.83 72.06 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.638 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -66.83 -33.48 75.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.823 0.849 . . . . 0.0 111.38 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.14 46.09 0.93 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.528 1.131 . . . . 0.0 109.777 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -54.68 115.65 2.27 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.22 1.008 . . . . 0.0 111.721 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -99.03 176.99 5.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.094 0.958 . . . . 0.0 109.542 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.57 -165.56 4.71 Favored Glycine 0 C--N 1.353 1.5 0 C-N-CA 122.883 0.277 . . . . 0.0 112.627 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 m -60.54 94.49 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.515 0.726 . . . . 0.0 112.796 -170.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 pp -156.27 177.72 11.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.449 1.1 . . . . 0.0 109.75 169.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 92' ' ' ARG . 21.8 m -135.16 156.02 49.71 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -66.61 -21.5 66.13 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.918 -0.489 . . . . 0.0 111.245 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' H ' HG23 ' A' ' 90' ' ' THR . 42.3 ttm180 -69.26 -33.5 73.34 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' HA ' HG23 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -69.03 -36.83 78.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.47 -20.45 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 120.99 0.424 . . . . 0.0 110.394 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.8 m -78.23 -38.96 41.76 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.406 0.683 . . . . 0.0 111.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 99' ' ' GLU . 30.0 m -76.38 -17.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.723 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 93.7 mt -51.01 -53.95 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.929 0.491 . . . . 0.0 111.988 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -24.13 30.44 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.803 0.441 . . . . 0.0 111.949 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.534 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 34.8 tt0 -77.63 -31.57 52.87 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 112.655 -167.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 CA--C 1.561 1.373 0 C-N-CA 123.341 0.656 . . . . 0.0 112.329 -176.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.6 80.25 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.563 2.175 . . . . 0.0 111.941 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.43 94.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 122.176 0.989 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.24 148.61 49.58 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.547 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.03 102.89 3.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -149.97 38.95 0.18 Allowed Pre-proline 0 CA--C 1.571 1.787 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.69 -26.82 1.9 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 CA-C-N 121.014 1.398 . . . . 0.0 112.507 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 41.8 m-85 -127.97 21.96 6.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.545 0.738 . . . . 0.0 111.225 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.56 126.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.024 0.375 . . . . 0.0 110.507 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.4 90.17 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.34 -16.28 47.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.503 2.135 . . . . 0.0 113.675 -168.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.41 -13.9 82.1 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.585 -0.564 . . . . 0.0 114.082 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.47 173.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 117.737 0.769 . . . . 0.0 110.802 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 p -88.3 9.02 24.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.461 1.104 . . . . 0.0 112.406 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -146.04 177.3 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.375 0.67 . . . . 0.0 111.334 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.49 149.53 45.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 22.7 t -57.45 -64.54 0.86 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.063 0.545 . . . . 0.0 110.868 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -163.34 144.82 9.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.27 130.29 27.45 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.383 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.99 141.31 86.58 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.103 2.535 . . . . 0.0 112.332 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.18 -24.56 67.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.184 0.593 . . . . 0.0 111.647 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.85 -39.86 87.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.03 0.532 . . . . 0.0 110.803 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 27' ' ' ILE . 37.1 m -72.69 -42.88 63.76 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.018 0.527 . . . . 0.0 110.411 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.57 -46.3 90.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.043 0.537 . . . . 0.0 110.775 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -64.85 -33.69 76.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.778 0.831 . . . . 0.0 111.12 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.1 tp10 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.669 0.606 . . . . 0.0 109.697 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 23' ' ' THR . 67.9 mt -54.03 -43.21 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.797 0.839 . . . . 0.0 110.696 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.422 HH11 ' HA ' ' A' ' 28' ' ' ARG . 10.4 mmm180 -66.17 -31.39 72.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -73.28 -44.37 59.34 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.553 0.741 . . . . 0.0 111.11 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.506 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 15.2 mm-40 -77.73 -27.7 50.6 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.184 0.994 . . . . 0.0 112.054 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.6 p -63.51 -25.86 68.45 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.577 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.41 -26.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-O 121.279 0.561 . . . . 0.0 109.771 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -77.56 -26.36 50.84 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.057 168.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.78 4.85 60.21 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.469 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 24.0 tt0 -129.76 116.86 19.37 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -155.62 96.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.426 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.49 113.02 26.01 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.36 112.86 34.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.548 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 52.0 mtp180 -87.46 92.24 9.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD11 HD11 ' A' ' 80' ' ' ILE . 90.5 mt -70.22 75.53 0.52 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.273 0.629 . . . . 0.0 109.709 175.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.45 -99.91 0.37 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -103.62 -7.68 20.56 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.237 1.015 . . . . 0.0 111.657 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 24.3 mt -88.35 109.95 20.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.506 0.722 . . . . 0.0 109.069 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.548 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.5 tpt -84.47 114.44 21.93 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.25 110.68 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.047 0.539 . . . . 0.0 110.561 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.3 m -88.16 113.77 24.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.149 0.58 . . . . 0.0 110.573 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 31.7 mm -104.08 85.03 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -130.55 145.06 55.91 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.88 154.77 64.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.455 2.103 . . . . 0.0 111.681 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.732 ' HB2' ' HA3' ' A' ' 54' ' ' GLY . 22.4 mmt -101.61 -172.08 2.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.92 -60.34 2.58 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.1 0.56 . . . . 0.0 110.432 -174.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.71 145.0 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.342 0.657 . . . . 0.0 109.588 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.67 21.63 12.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.578 1.151 . . . . 0.0 111.489 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.732 ' HA3' ' HB2' ' A' ' 50' ' ' MET . . . -113.4 79.1 0.26 Allowed Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.299 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.43 142.4 57.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.678 0.791 . . . . 0.0 109.232 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -94.44 108.05 20.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.279 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.501 ' SD ' ' HB3' ' A' ' 85' ' ' ASN . 59.2 mtm -152.78 107.71 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.427 1.491 . . . . 0.0 108.055 174.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 108.34 0.01 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 m -131.4 96.98 4.13 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 165.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.7 117.75 20.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 0.0 108.977 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 27.7 t-20 -67.65 89.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.761 0.791 . . . . 0.0 109.102 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -86.5 -8.3 57.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.312 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -65.02 100.82 0.45 Allowed 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.742 0.651 . . . . 0.0 110.596 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.99 9.66 86.64 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.602 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 tp -81.95 143.52 31.57 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.268 0.627 . . . . 0.0 109.349 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -72.18 150.19 43.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.308 0.643 . . . . 0.0 110.855 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -63.92 -26.69 68.71 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.5 -42.44 71.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.99 -20.66 60.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.416 0.686 . . . . 0.0 111.933 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.54 -50.17 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.88 -57.32 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.097 0.873 . . . . 0.0 110.59 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 43' ' ' LEU . 49.3 mt -61.42 -36.2 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.209 0.603 . . . . 0.0 109.882 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' HD11 ' A' ' 77' ' ' ILE . . . -57.92 -58.0 16.86 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.681 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.44 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -67.09 -27.24 67.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.057 0.543 . . . . 0.0 111.811 -175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -65.04 -43.33 92.73 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.524 0.678 . . . . 0.0 110.198 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.17 -22.62 59.34 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.848 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -67.24 -38.34 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.077 0.551 . . . . 0.0 109.735 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 -34.88 76.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.381 0.673 . . . . 0.0 110.23 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -62.6 -52.7 62.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.695 0.398 . . . . 0.0 110.675 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.62 HD11 HD11 ' A' ' 40' ' ' LEU . 79.5 mt -64.58 -32.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.258 0.623 . . . . 0.0 110.633 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -53.01 -49.67 65.77 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.263 0.625 . . . . 0.0 110.212 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -75.75 -34.82 60.3 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.268 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.5 m -84.06 -31.78 25.18 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.788 0.835 . . . . 0.0 111.901 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.13 -41.93 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 109.328 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 57' ' ' MET . 23.8 t-20 -128.12 156.42 42.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.563 0.745 . . . . 0.0 109.469 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -142.25 19.08 2.08 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.175 0.59 . . . . 0.0 111.014 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.89 -174.95 34.57 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.469 0.557 . . . . 0.0 114.26 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 p -77.61 4.26 11.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.563 0.745 . . . . 0.0 112.974 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.48 139.13 43.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.259 0.624 . . . . 0.0 110.446 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.3 p -81.68 -179.21 7.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.094 0.958 . . . . 0.0 111.406 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.8 p -60.61 -39.85 89.68 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.626 171.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -61.42 -41.33 97.0 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.935 0.894 . . . . 0.0 111.971 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.87 -31.66 72.92 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.246 0.341 . . . . 0.0 111.699 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HA ' HD22 ' A' ' 97' ' ' LEU . 7.7 p -90.99 -23.21 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 C-N-CA 122.761 0.424 . . . . 0.0 112.047 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.1 m -65.6 -34.95 79.42 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.982 0.513 . . . . 0.0 110.86 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.25 -20.41 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' A' ' 94' ' ' VAL . 4.4 mm? -73.06 -48.78 33.0 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.82 0.448 . . . . 0.0 110.488 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -71.19 -24.19 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.736 0.303 . . . . 0.0 110.438 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -69.94 -53.97 15.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.276 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.715 -175.284 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 tpp . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.509 ' HB2' ' HG3' ' A' ' 39' ' ' ARG . 71.8 Cg_endo -73.23 112.22 3.47 Favored 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 121.157 1.449 . . . . 0.0 112.644 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.75 99.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.809 0.844 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.4 89.59 0.35 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.312 1.053 . . . . 0.0 111.163 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.43 102.99 15.44 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.479 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.6 t -154.83 53.14 0.82 Allowed Pre-proline 0 CA--C 1.566 1.559 0 C-N-CA 122.833 0.453 . . . . 0.0 112.113 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -82.19 -36.56 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.251 1.967 . . . . 0.0 112.006 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -129.13 17.52 6.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.631 0.772 . . . . 0.0 111.814 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 HG12 HD23 ' A' ' 16' ' ' LEU . 30.0 mt -67.23 123.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 118.577 0.626 . . . . 0.0 111.28 -175.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.486 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -101.29 86.55 0.76 Allowed Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.88 -5.45 17.04 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.381 2.054 . . . . 0.0 113.698 -163.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.81 -11.26 68.35 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.347 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 10' ' ' LEU . 19.7 m -122.07 169.38 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.203 0.601 . . . . 0.0 110.842 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 15.6 m -81.89 -34.99 29.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.351 1.06 . . . . 0.0 111.877 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -88.81 170.82 10.42 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.778 0.799 . . . . 0.0 112.175 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.499 HD23 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -125.83 133.02 52.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 m -55.47 -66.52 0.4 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.823 0.702 . . . . 0.0 110.406 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -146.72 134.18 20.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.59 126.3 37.78 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 169.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.78 121.72 9.55 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.585 2.19 . . . . 0.0 111.683 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.483 ' HA ' HD21 ' A' ' 24' ' ' LEU . 10.1 pt20 -62.1 -23.95 66.83 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.991 0.917 . . . . 0.0 112.059 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.63 -37.09 86.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.71 0.804 . . . . 0.0 110.999 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' ILE . 23.3 m -76.97 -29.83 55.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.468 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.483 HD21 ' HA ' ' A' ' 21' ' ' GLN . 3.6 mm? -61.0 -41.33 96.31 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -54.51 -43.27 71.69 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.935 0.894 . . . . 0.0 112.714 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.9 pt-20 -72.9 -40.72 65.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.234 0.334 . . . . 0.0 110.904 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 23' ' ' THR . 33.7 mm -61.97 -39.98 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.329 0.652 . . . . 0.0 110.084 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.4 mmm180 -60.88 -25.48 66.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.999 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -87.06 -41.86 13.51 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 0.0 112.073 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 45.2 mt-30 -63.92 -31.44 72.62 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.562 0.745 . . . . 0.0 111.982 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -55.63 -33.44 64.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.337 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.45 -37.73 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.245 0.618 . . . . 0.0 110.287 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -61.61 -24.24 66.56 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.787 0.835 . . . . 0.0 111.178 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.67 2.63 67.15 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.231 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 122.53 19.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.821 0.849 . . . . 0.0 110.269 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -164.9 96.33 0.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.611 1.164 . . . . 0.0 108.361 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -105.28 125.32 50.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.96 116.8 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.155 0.982 . . . . 0.0 108.409 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 40.5 mtm105 -86.17 101.34 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.701 HD11 HD13 ' A' ' 80' ' ' ILE . 48.1 mt -76.12 77.67 2.95 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.23 -101.29 0.66 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.284 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -25.93 17.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.143 0.977 . . . . 0.0 111.217 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD13 HG22 ' A' ' 72' ' ' ILE . 61.4 mt -71.77 131.06 42.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.757 0.823 . . . . 0.0 111.143 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.9 tpt -98.14 99.94 11.22 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.48 152.9 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.957 0.903 . . . . 0.0 108.979 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 98.61 4.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.6 0.76 . . . . 0.0 109.52 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.44 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 40.7 mm -93.19 84.13 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -129.45 117.14 18.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.05 -55.0 0.87 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.414 2.076 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.4 tpt 68.33 141.06 0.04 OUTLIER 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.613 1.196 . . . . 0.0 110.702 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -78.26 167.81 20.8 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.067 -0.396 . . . . 0.0 110.726 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t 67.48 76.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 124.649 1.18 . . . . 0.0 110.009 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.6 t30 68.64 16.67 9.01 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 112.987 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.59 137.08 13.52 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 122.217 -0.302 . . . . 0.0 112.926 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.454 ' HB2' HG12 ' A' ' 94' ' ' VAL . 48.3 m-85 -126.25 146.52 49.96 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.302 1.041 . . . . 0.0 109.564 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -97.25 126.44 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 121.503 0.668 . . . . 0.0 110.763 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 14.0 ptt? -174.75 -174.38 0.8 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.71 2.004 . . . . 0.0 106.996 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.24 109.24 0.47 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -134.82 122.32 21.9 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.434 1.094 . . . . 0.0 108.203 170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.1 tm? -99.49 124.23 44.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.633 0.773 . . . . 0.0 109.545 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.68 105.75 3.28 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -88.04 -8.73 55.13 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.913 0.885 . . . . 0.0 112.072 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.64 115.76 5.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.478 0.711 . . . . 0.0 111.21 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.95 -5.19 83.38 Favored Glycine 0 C--N 1.351 1.392 0 O-C-N 123.793 0.683 . . . . 0.0 113.843 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -89.03 169.26 11.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 122.018 0.913 . . . . 0.0 111.93 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.493 ' O ' HG12 ' A' ' 70' ' ' ILE . 34.5 t -101.75 158.88 15.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.422 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.53 -26.02 68.51 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.129 0.572 . . . . 0.0 111.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.23 -48.96 76.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.32 0.648 . . . . 0.0 110.181 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.97 -35.93 81.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.881 0.873 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 66' ' ' SER . 37.5 mm -61.66 -40.27 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.933 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.48 -57.77 10.51 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.909 0.755 . . . . 0.0 112.008 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 43' ' ' LEU . 4.0 mp -66.01 -34.85 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.419 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -58.55 -57.3 20.56 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.175 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -66.95 -30.65 70.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.954 0.501 . . . . 0.0 111.614 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 23.1 mm-40 -60.72 -54.63 42.93 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.531 0.519 . . . . 0.0 110.048 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 80' ' ' ILE . 12.9 m-85 -60.79 -35.91 77.65 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.679 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -62.64 -35.9 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.956 0.902 . . . . 0.0 111.561 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.75 -31.58 66.82 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.457 0.473 . . . . 0.0 110.5 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.78 -32.59 62.07 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.702 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 40' ' ' LEU . 95.5 mt -74.07 -29.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.863 0.865 . . . . 0.0 109.734 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 12.8 tt0 -58.01 -35.7 71.62 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.976 0.911 . . . . 0.0 110.551 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.87 -43.96 43.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.229 0.612 . . . . 0.0 110.692 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -65.93 -25.15 67.01 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.456 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 HD11 HG21 ' A' ' 47' ' ' ILE . 90.9 mt -129.98 43.86 3.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.825 1.25 . . . . 0.0 109.546 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -68.29 97.08 0.7 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.717 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -137.46 108.41 6.71 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.699 0.8 . . . . 0.0 108.98 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.77 -134.88 7.69 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.984 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -163.47 41.2 0.1 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.1 164.36 38.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.673 0.389 . . . . 0.0 111.959 -171.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.7 m -82.49 161.87 22.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.487 1.115 . . . . 0.0 111.423 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -59.62 -40.39 87.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.943 0.897 . . . . 0.0 110.935 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -39.25 76.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.388 0.675 . . . . 0.0 110.843 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.6 -35.3 78.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 0.0 111.98 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 55' ' ' TYR . 28.0 m -79.39 -28.98 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 118.332 0.515 . . . . 0.0 111.102 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.5 m -68.9 -42.46 76.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.835 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -65.21 -27.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.614 0.571 . . . . 0.0 111.569 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -63.26 -39.7 95.34 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.586 0.707 . . . . 0.0 110.22 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -32.06 32.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.26 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.69 -15.55 56.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.033 0.933 . . . . 0.0 112.482 -167.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.568 1.643 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.523 176.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 CA--C 1.55 0.975 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.31 138.19 8.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.27 2.647 . . . . 0.0 113.424 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 38' ' ' ILE . 61.9 t -88.62 94.14 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.967 0.907 . . . . 0.0 109.442 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.73 99.31 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.169 0.988 . . . . 0.0 110.259 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.541 HD13 HG22 ' A' ' 23' ' ' THR . 56.1 tp -117.83 98.73 6.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.728 . . . . 0.0 109.208 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 t -158.33 60.3 1.77 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.649 0.78 . . . . 0.0 110.97 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.7 -36.03 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.536 2.158 . . . . 0.0 112.286 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.43 -4.78 5.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.611 0.764 . . . . 0.0 111.552 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -48.07 124.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -161.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.1 mt -107.74 90.22 6.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.34 -19.41 38.18 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.458 2.105 . . . . 0.0 112.589 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.63 -2.41 80.55 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.983 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.92 173.43 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.51 0.655 . . . . 0.0 110.349 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 m -91.5 -13.39 32.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.269 1.027 . . . . 0.0 111.877 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -114.65 -172.86 2.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.838 . . . . 0.0 110.482 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.555 HD23 HG12 ' A' ' 19' ' ' ILE . 16.0 tp -143.33 139.71 30.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -50.03 -41.99 48.57 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.76 1.224 . . . . 0.0 112.183 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -166.47 147.66 6.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.597 0.759 . . . . 0.0 110.029 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.555 HG12 HD23 ' A' ' 16' ' ' LEU . 69.1 mt -121.24 130.47 24.81 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 168.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.99 116.63 2.9 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.964 2.442 . . . . 0.0 111.63 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HA ' HD21 ' A' ' 24' ' ' LEU . 25.6 mp0 -63.75 -27.24 69.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.619 1.168 . . . . 0.0 110.384 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.15 -36.13 83.28 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.077 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.541 HG22 HD13 ' A' ' 5' ' ' LEU . 48.3 m -66.77 -36.28 82.06 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.671 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 83' ' ' THR . 3.8 mm? -63.27 -42.75 99.16 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.156 0.435 . . . . 0.0 110.292 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.3 t -61.21 -39.47 90.38 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.563 0.745 . . . . 0.0 110.849 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 38.3 tt0 -65.62 -45.12 84.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.608 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 23' ' ' THR . 96.4 mt -60.3 -41.83 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.245 1.018 . . . . 0.0 110.184 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.448 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 20.4 mtp180 -63.52 -25.47 68.27 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.459 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.39 -34.88 25.45 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.613 0.765 . . . . 0.0 111.548 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 5.4 mm100 -73.21 -31.32 64.1 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.423 0.63 . . . . 0.0 110.239 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -68.27 -19.02 64.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.193 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.24 -33.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -70.47 -31.15 68.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.211 0.605 . . . . 0.0 110.11 168.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.5 3.09 50.39 Favored Glycine 0 N--CA 1.468 0.81 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.258 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.97 107.59 7.41 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.905 0.882 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 30' ' ' GLN . . . -136.64 95.85 3.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -101.56 98.11 8.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.556 HG23 HD21 ' A' ' 40' ' ' LEU . 1.9 mp -94.22 117.79 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -172.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 -89.59 104.65 17.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD21 HG23 ' A' ' 38' ' ' ILE . 3.9 mm? -76.68 74.88 3.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.35 -104.31 1.26 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.62 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.85 -20.55 23.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.123 0.969 . . . . 0.0 110.572 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 43.7 mt -78.13 146.52 35.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.471 0.708 . . . . 0.0 110.543 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.5 tpt -116.72 121.21 40.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.85 123.99 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.341 1.057 . . . . 0.0 109.435 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 59' ' ' SER . 66.9 m -98.58 97.68 8.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.212 0.605 . . . . 0.0 110.416 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -85.16 100.7 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.88 141.55 41.5 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.03 -26.05 66.1 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.166 2.578 . . . . 0.0 112.445 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.5 mtt 76.43 -21.99 0.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.843 1.657 . . . . 0.0 112.748 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.22 99.85 0.02 OUTLIER 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.227 1.411 . . . . 0.0 109.646 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.6 t 71.5 155.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 124.998 1.319 . . . . 0.0 109.363 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.35 72.29 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.883 1.273 . . . . 0.0 109.392 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.34 -127.25 17.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.932 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -163.83 -178.78 5.9 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.794 0.838 . . . . 0.0 111.046 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.448 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 38.5 p90 -84.67 125.75 32.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 111.162 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.706 ' HE1' ' HA ' ' A' ' 91' ' ' SER . 23.8 ptt? -177.62 112.95 0.08 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.581 1.152 . . . . 0.0 109.002 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 43.29 103.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.182 1.372 . . . . 0.0 116.254 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' SER . 32.4 m -136.72 98.91 3.9 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.168 -0.607 . . . . 0.0 109.639 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.9 126.4 27.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.58 0.752 . . . . 0.0 109.35 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.93 93.11 6.44 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -82.58 -56.0 4.13 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p30 41.72 33.72 0.35 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.506 1.522 . . . . 0.0 113.508 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.14 45.27 2.23 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.53 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' A' ' 69' ' ' ASN . 14.4 tp -91.11 156.46 17.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.236 1.014 . . . . 0.0 110.225 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -67.85 144.54 55.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.107 0.563 . . . . 0.0 110.623 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -62.7 -23.36 67.11 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.615 0.766 . . . . 0.0 112.228 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -48.51 73.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.708 0.803 . . . . 0.0 109.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.481 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 1.4 m-20 -71.2 -26.36 62.92 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.147 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.66 -43.85 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.481 0.712 . . . . 0.0 109.859 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 26.9 tt0 -59.75 -58.94 6.39 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.204 1.001 . . . . 0.0 111.591 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.26 -29.75 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' O ' HD11 ' A' ' 77' ' ' ILE . . . -55.94 -57.66 17.93 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.592 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.574 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.74 -26.26 66.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.976 0.51 . . . . 0.0 111.802 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 16.1 mm-40 -65.3 -41.55 93.96 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.577 172.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.466 ' O ' HG12 ' A' ' 80' ' ' ILE . 11.7 m-85 -77.98 -23.09 48.53 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.737 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -65.52 -47.77 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.563 0.619 . . . . 0.0 110.086 175.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -71.6 -28.49 63.85 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.949 0.781 . . . . 0.0 110.912 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -68.08 -50.32 55.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.197 0.311 . . . . 0.0 110.173 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 76' ' ' TYR . 45.8 mm -61.53 -39.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.755 0.822 . . . . 0.0 109.757 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 43.4 tt0 -57.74 -42.69 84.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.101 0.96 . . . . 0.0 111.174 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -71.8 -27.51 62.98 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.559 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.464 HG22 ' HG ' ' A' ' 24' ' ' LEU . 10.5 m -97.13 -23.41 16.23 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.767 0.827 . . . . 0.0 112.091 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 57' ' ' MET . 41.9 tp -109.94 -5.82 15.37 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.175 0.99 . . . . 0.0 111.094 -170.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 85' ' ' ASN . 0.1 OUTLIER -49.85 138.31 15.14 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.674 0.79 . . . . 0.0 112.246 176.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -79.0 -33.23 45.17 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.453 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.67 172.2 45.24 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m 70.18 -61.1 0.47 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.209 1.404 . . . . 0.0 110.849 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.89 138.74 38.26 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.7 m -92.6 153.52 18.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.355 0.662 . . . . 0.0 109.902 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.706 ' HA ' ' HE1' ' A' ' 57' ' ' MET . 78.1 p -63.04 -52.47 62.72 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.02 0.928 . . . . 0.0 112.071 -172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -57.74 -34.02 69.09 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.497 0.719 . . . . 0.0 112.189 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -33.08 72.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.941 0.897 . . . . 0.0 112.359 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.37 -36.21 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.992 0.517 . . . . 0.0 110.024 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -64.07 -39.61 94.46 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.552 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.01 -32.83 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 0.0 111.086 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.67 -35.61 79.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.213 0.605 . . . . 0.0 110.432 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -82.19 -25.47 34.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.087 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.14 -41.22 22.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.953 0.901 . . . . 0.0 111.42 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.288 0.635 . . . . 0.0 111.068 -178.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 pmm? . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -87.91 100.72 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.904 2.403 . . . . 0.0 113.815 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 99.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.17 0.986 . . . . 0.0 109.127 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.55 110.42 3.66 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.2 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.81 113.3 15.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.333 1.053 . . . . 0.0 110.154 -168.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -154.75 40.65 0.14 Allowed Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.66 -31.97 0.98 Allowed 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 121.844 1.696 . . . . 0.0 112.998 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -128.09 21.99 6.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.665 0.786 . . . . 0.0 111.21 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.67 128.24 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 120.905 0.383 . . . . 0.0 110.07 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.461 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.1 mm? -98.55 95.65 3.19 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.4 95.92 0.95 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.975 2.45 . . . . 0.0 110.674 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.61 -35.2 0.75 Allowed Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.999 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 10' ' ' LEU . 20.5 m -93.56 175.74 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.438 0.637 . . . . 0.0 111.535 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.7 p -85.03 -32.36 22.94 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.03 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -102.71 172.34 6.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.877 0.846 . . . . 0.0 112.91 -167.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.83 47.04 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.0 p -64.66 -62.76 1.38 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.591 0.757 . . . . 0.0 110.215 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -166.82 126.87 1.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.766 0.826 . . . . 0.0 109.137 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.0 mt -88.44 137.02 30.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.0 Cg_endo -55.22 129.62 36.23 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.513 2.142 . . . . 0.0 111.251 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -23.68 62.9 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.593 0.757 . . . . 0.0 112.822 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.474 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.0 pt-20 -63.52 -32.51 73.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.095 0.958 . . . . 0.0 111.326 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 m -70.9 -46.71 62.07 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.551 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.09 -27.46 68.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.55 0.159 . . . . 0.0 111.055 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -73.12 -44.2 60.57 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 111.045 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 -28.77 62.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.451 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.43 -42.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.641 0.776 . . . . 0.0 109.324 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 tpt85 -64.21 -24.66 67.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.542 0.737 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -75.66 -54.68 6.59 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.915 0.886 . . . . 0.0 111.002 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -68.27 -25.02 64.96 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.36 0.664 . . . . 0.0 112.553 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.413 HG21 ' O ' ' A' ' 47' ' ' ILE . 37.8 p -64.98 -33.42 76.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.414 0.285 . . . . 0.0 111.186 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.15 -32.57 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.849 0.46 . . . . 0.0 110.187 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -71.01 -26.56 63.18 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.083 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.23 11.94 57.97 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.958 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -138.34 105.96 5.59 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 47' ' ' ILE . . . -147.09 126.29 12.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.957 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -130.06 137.93 50.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.595 0.758 . . . . 0.0 108.963 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.49 112.17 30.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 21.2 mtm105 -87.52 95.46 10.04 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -80.77 69.51 7.33 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.559 0.695 . . . . 0.0 109.505 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -103.53 1.31 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.079 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.38 -19.14 21.6 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.966 0.906 . . . . 0.0 110.375 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -76.85 109.67 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.48 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 14.1 tpt -87.75 111.8 21.73 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -110.16 153.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 59' ' ' SER . 61.1 m -137.77 139.47 40.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.482 1.113 . . . . 0.0 108.337 172.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.46 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 28.3 mm -123.62 100.76 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -129.77 129.21 23.06 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.02 151.65 45.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.366 2.044 . . . . 0.0 111.533 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.49 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 12.6 tpt -89.19 149.89 22.92 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 171.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -56.94 -35.75 69.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.735 1.214 . . . . 0.0 112.372 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 p -163.62 149.3 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.627 0.771 . . . . 0.0 109.605 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.14 30.33 19.79 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.262 1.025 . . . . 0.0 111.59 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -164.49 146.73 11.69 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.121 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -123.64 -178.34 4.0 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.925 1.29 . . . . 0.0 111.099 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -123.94 118.21 26.54 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.718 0.807 . . . . 0.0 110.041 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -167.51 107.24 0.57 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.885 0.874 . . . . 0.0 108.938 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.5 106.98 0.01 OUTLIER Glycine 0 CA--C 1.54 1.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 115.006 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 46' ' ' SER . 47.1 t -133.58 97.77 4.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.69 107.79 4.7 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.502 0.721 . . . . 0.0 109.464 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.1 96.93 1.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -74.27 -6.87 50.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.884 0.874 . . . . 0.0 111.984 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.19 115.36 6.78 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.414 0.685 . . . . 0.0 110.05 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.78 -6.79 67.5 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.248 0.452 . . . . 0.0 113.197 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.68 163.2 12.74 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 111.419 -178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 70' ' ' ILE . 23.0 t -115.1 172.23 7.19 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.984 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.42 -40.13 64.9 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.229 1.011 . . . . 0.0 112.791 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -67.22 -40.75 86.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.542 0.737 . . . . 0.0 111.198 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -68.16 -29.6 68.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.486 0.714 . . . . 0.0 111.012 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 66' ' ' SER . 43.3 mm -65.51 -46.11 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.167 0.587 . . . . 0.0 109.963 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -58.09 -55.29 36.91 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.068 0.855 . . . . 0.0 110.879 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.0 mt -60.8 -38.77 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 O-C-N 123.689 0.618 . . . . 0.0 110.06 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -59.52 -57.33 20.16 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.066 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.493 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 pp -64.96 -26.35 68.26 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.851 0.46 . . . . 0.0 111.634 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -64.56 -48.51 74.76 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.573 0.545 . . . . 0.0 110.379 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.488 ' O ' HG12 ' A' ' 80' ' ' ILE . 26.1 m-85 -67.35 -29.12 68.58 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.279 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.493 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.3 -44.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.817 0.847 . . . . 0.0 111.158 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.74 -20.92 61.1 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.89 0.376 . . . . 0.0 111.026 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -81.9 -27.04 33.63 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.8 mm -69.89 -35.71 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.896 0.478 . . . . 0.0 110.683 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.5 -30.98 71.43 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 110.564 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -75.89 -32.82 59.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.697 0.799 . . . . 0.0 110.913 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.8 m -78.75 -38.39 38.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.482 0.713 . . . . 0.0 110.375 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.95 47.42 1.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.055 1.342 . . . . 0.0 108.634 171.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -54.34 107.95 0.33 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.975 0.91 . . . . 0.0 111.73 -171.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -75.87 178.79 5.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.446 1.099 . . . . 0.0 111.851 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.97 -125.66 3.25 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.641 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -74.29 104.52 5.09 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.833 0.853 . . . . 0.0 109.826 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tt -162.0 139.32 8.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 19.6 m -111.32 147.48 35.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.837 0.855 . . . . 0.0 109.242 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 p -49.03 -50.72 34.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.697 1.199 . . . . 0.0 112.291 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -63.69 -28.5 69.94 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 123.996 0.918 . . . . 0.0 112.431 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.435 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 43.5 mt-10 -59.51 -39.02 82.51 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.546 0.612 . . . . 0.0 112.544 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 122.8 0.44 . . . . 0.0 111.319 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -69.9 -27.61 64.94 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.092 0.557 . . . . 0.0 111.469 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.9 p -66.69 -22.85 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.439 0.695 . . . . 0.0 110.951 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.24 -35.15 76.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.183 0.516 . . . . 0.0 110.681 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -82.41 -31.29 29.66 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.836 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.96 -58.3 3.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.458 0.703 . . . . 0.0 111.39 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 96' ' ' VAL . 31.2 pt . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.528 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.28 106.62 1.91 Allowed 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.426 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG11 HG13 ' A' ' 38' ' ' ILE . 5.7 p -80.23 94.37 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 121.793 0.806 . . . . 0.0 109.643 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.2 123.69 19.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.135 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.569 HD12 HG23 ' A' ' 23' ' ' THR . 58.9 tp -131.01 106.41 8.38 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.565 0.746 . . . . 0.0 109.681 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -150.07 71.0 9.38 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 121.498 0.666 . . . . 0.0 110.329 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.87 -40.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.827 2.352 . . . . 0.0 113.318 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 66.3 m-85 -129.18 20.45 5.81 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.092 0.957 . . . . 0.0 111.122 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.535 HG12 HD23 ' A' ' 16' ' ' LEU . 19.6 mt -72.5 129.83 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.557 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -107.34 87.45 3.27 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.48 -4.46 13.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.66 2.24 . . . . 0.0 114.284 -163.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.89 -8.59 72.53 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.218 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.9 m -126.52 175.99 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.594 0.758 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -88.22 -28.76 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.306 1.042 . . . . 0.0 112.4 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -91.95 166.38 12.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.417 0.627 . . . . 0.0 112.002 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -112.39 149.3 32.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.925 1.29 . . . . 0.0 107.708 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.516 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 55.0 m -67.58 -58.94 3.82 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -171.91 149.73 2.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.034 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.01 134.68 22.47 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.86 126.54 22.82 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.7 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.104 0.962 . . . . 0.0 110.994 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.35 -44.35 95.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.242 1.017 . . . . 0.0 110.782 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.569 HG23 HD12 ' A' ' 5' ' ' LEU . 13.7 m -72.19 -34.52 68.48 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.793 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.81 -40.94 97.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.786 0.266 . . . . 0.0 111.115 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 m -66.81 -36.83 83.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.489 0.716 . . . . 0.0 110.345 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.7 tp10 -60.4 -45.38 93.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.227 1.011 . . . . 0.0 110.294 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.455 ' O ' HG21 ' A' ' 31' ' ' THR . 97.5 mt -60.9 -48.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.447 1.099 . . . . 0.0 110.701 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.72 -24.73 64.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.515 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 8.8 p30 -85.13 -35.66 21.6 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.599 0.636 . . . . 0.0 111.879 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 3.8 pt20 -75.68 -23.39 56.2 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.148 0.579 . . . . 0.0 111.812 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 27' ' ' ILE . 35.0 p -56.82 -25.45 55.97 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.9 -19.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.246 1.018 . . . . 0.0 110.858 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 30' ' ' GLN . 2.9 mpt_? -75.16 -8.49 56.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.376 1.07 . . . . 0.0 111.159 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.43 -22.85 37.8 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 123.44 0.543 . . . . 0.0 112.927 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.1 134.64 33.17 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 108.865 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 47' ' ' ILE . . . -145.3 97.63 3.03 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -100.09 122.87 43.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.046 0.538 . . . . 0.0 110.716 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.455 HG13 HG11 ' A' ' 3' ' ' VAL . 2.6 mp -109.31 113.43 44.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.701 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 71.3 mtt180 -85.0 92.1 8.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.62 76.7 1.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.242 0.544 . . . . 0.0 109.893 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -102.13 0.75 Allowed Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.423 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.01 -18.18 20.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 110.979 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt -84.52 113.58 21.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.167 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.701 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.4 tpt -85.1 111.64 19.94 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.85 148.46 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 t -134.02 110.12 9.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.193 0.52 . . . . 0.0 109.668 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 56' ' ' PHE . 31.9 mm -87.44 107.11 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.481 ' HG3' ' HB3' ' A' ' 51' ' ' GLN . 14.2 ptm180 -154.29 128.45 4.61 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 118.709 0.686 . . . . 0.0 111.176 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.521 ' HG3' ' HD1' ' A' ' 56' ' ' PHE . 31.3 Cg_exo -59.5 -49.04 11.38 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.256 2.637 . . . . 0.0 113.546 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.8 tpt -86.12 64.6 8.66 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.712 0.768 . . . . 0.0 110.673 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.481 ' HB3' ' HG3' ' A' ' 48' ' ' ARG . 5.8 tp-100 -176.67 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.065 1.346 . . . . 0.0 107.871 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -70.27 -35.39 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.971 175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 97' ' ' LEU . 56.2 t30 73.54 143.61 0.07 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.198 1.799 . . . . 0.0 110.966 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.79 -75.75 2.33 Favored Glycine 0 C--N 1.343 0.922 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -134.03 177.34 7.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.299 1.04 . . . . 0.0 110.327 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 47' ' ' ILE . 35.9 p90 -101.42 116.46 32.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.357 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.693 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 55.6 mtm -145.37 -176.03 4.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.725 0.81 . . . . 0.0 109.535 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.447 ' H ' ' HG2' ' A' ' 81' ' ' GLU . . . -54.37 113.52 3.46 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.324 1.015 . . . . 0.0 114.467 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -129.51 113.0 14.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 65' ' ' LEU . 3.2 tm? -79.22 112.76 16.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.317 0.647 . . . . 0.0 109.834 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.85 115.59 18.64 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.894 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 10.2 pt20 -79.47 -64.96 1.07 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.074 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t70 59.86 19.05 7.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.8 0.81 . . . . 0.0 110.811 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.1 43.56 4.67 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 60' ' ' LEU . 21.2 tp -80.46 146.14 31.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.922 0.889 . . . . 0.0 110.431 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m -65.09 148.8 51.0 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.714 . . . . 0.0 111.285 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -59.5 -33.53 71.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.331 1.052 . . . . 0.0 112.895 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.5 p-10 -71.44 -42.35 68.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -34.95 78.99 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.868 0.867 . . . . 0.0 111.714 175.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.5 mm -58.01 -43.2 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.363 0.665 . . . . 0.0 109.461 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.24 -56.75 12.47 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.922 0.763 . . . . 0.0 110.95 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 68' ' ' ASP . 7.4 mm -57.08 -38.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.526 0.679 . . . . 0.0 109.352 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.25 -58.05 14.26 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.426 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.89 -22.93 66.55 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.669 0.735 . . . . 0.0 111.891 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 25.1 mm-40 -70.86 -46.45 62.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.632 0.773 . . . . 0.0 110.145 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 80' ' ' ILE . 13.8 m-85 -69.84 -27.2 64.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.201 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -61.98 -51.42 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.625 0.77 . . . . 0.0 109.893 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 75' ' ' GLN . 12.5 pt-20 -64.42 -34.66 78.69 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.475 0.484 . . . . 0.0 110.411 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.95 -31.5 66.38 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.873 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 76' ' ' TYR . 28.5 mm -69.77 -43.7 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.693 ' HG2' ' HB3' ' A' ' 57' ' ' MET . 44.9 mt-10 -60.75 -36.99 80.32 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.604 0.761 . . . . 0.0 111.377 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -73.28 -39.3 65.48 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.929 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -74.42 -22.93 58.9 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.672 0.789 . . . . 0.0 111.202 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -109.43 10.0 25.42 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.225 1.01 . . . . 0.0 110.08 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.14 125.76 24.91 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.991 0.916 . . . . 0.0 109.858 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.38 -29.0 62.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.563 0.745 . . . . 0.0 111.503 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.72 -75.2 0.03 OUTLIER Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -136.77 19.69 3.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.12 0.968 . . . . 0.0 109.905 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.59 140.48 58.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.005 1.322 . . . . 0.0 112.452 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 26.0 m -102.15 149.21 24.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.238 1.015 . . . . 0.0 109.545 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.6 m -64.02 -47.1 81.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -62.17 -26.22 68.22 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.2 tp10 -57.34 -47.65 81.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.063 0.945 . . . . 0.0 111.306 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.11 -27.2 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.412 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 m -64.96 -45.24 86.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.156 0.582 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.31 -28.1 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 111.195 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.404 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . 75.0 mt -69.74 -38.56 76.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -80.51 -26.97 37.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.768 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.721 0.808 . . . . 0.0 111.372 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.293 174.082 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.97 91.79 0.44 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.572 2.181 . . . . 0.0 112.742 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.37 116.32 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.473 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.84 137.42 43.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.907 0.483 . . . . 0.0 110.455 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD22 HG23 ' A' ' 19' ' ' ILE . 5.4 tt -145.11 94.11 2.48 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.421 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -147.81 47.4 0.54 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 6' ' ' THR . 67.9 Cg_endo -85.18 -30.69 0.46 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 121.88 1.72 . . . . 0.0 113.642 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.47 18.82 6.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.961 0.505 . . . . 0.0 111.542 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 16' ' ' LEU . 20.6 mt -70.63 135.97 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.691 0.396 . . . . 0.0 111.307 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.574 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -117.31 85.59 19.94 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.7 22.12 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.017 2.478 . . . . 0.0 114.081 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.57 -39.2 90.88 Favored Glycine 0 C--N 1.346 1.127 0 O-C-N 123.425 0.453 . . . . 0.0 113.862 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 10' ' ' LEU . 22.3 m -108.71 178.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.972 0.509 . . . . 0.0 111.666 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.5 p -91.29 -24.89 19.7 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.256 1.023 . . . . 0.0 112.026 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -94.15 162.08 14.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.306 0.574 . . . . 0.0 111.589 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD23 HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -103.66 142.82 33.66 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HB2' HD22 ' A' ' 10' ' ' LEU . 23.6 t -74.59 -48.8 24.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.879 0.471 . . . . 0.0 110.026 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.19 142.56 10.13 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.407 HG23 HD22 ' A' ' 5' ' ' LEU . 76.0 mt -121.43 121.74 28.33 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 163.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.8 127.22 20.87 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.742 2.295 . . . . 0.0 111.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.58 -16.81 62.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 111.182 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.76 -38.26 88.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.056 0.542 . . . . 0.0 110.35 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.5 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 17.9 m -74.66 -35.63 62.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.9 0.48 . . . . 0.0 109.836 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.19 -25.1 65.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.772 0.429 . . . . 0.0 111.138 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -68.8 -40.74 79.43 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.652 0.781 . . . . 0.0 110.962 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 23' ' ' THR . 12.8 pt-20 -71.66 -30.7 66.01 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 23' ' ' THR . 12.0 mm -65.29 -43.07 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 121.427 0.632 . . . . 0.0 109.57 172.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -62.04 -31.08 71.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.959 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.37 -41.14 14.74 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 3.6 pt20 -70.58 -24.03 62.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -53.64 -36.31 61.93 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.014 0.526 . . . . 0.0 111.244 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.08 -36.45 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.621 0.768 . . . . 0.0 110.311 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.84 -16.62 63.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.595 0.758 . . . . 0.0 110.627 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.16 -19.17 25.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.41 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -138.2 131.03 29.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 47' ' ' ILE . . . -143.28 101.57 3.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.313 1.045 . . . . 0.0 108.439 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.67 115.41 29.82 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.435 HG23 HD12 ' A' ' 40' ' ' LEU . 3.0 mp -107.66 126.61 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.519 0.728 . . . . 0.0 109.747 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -91.6 96.98 10.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.151 0.58 . . . . 0.0 110.243 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 HG23 ' A' ' 38' ' ' ILE . 8.1 mp -81.76 71.85 8.8 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 169.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.34 -102.88 1.07 Allowed Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 -19.03 18.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.611 0.764 . . . . 0.0 110.445 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' A' ' 65' ' ' LEU . 17.6 mt -74.64 108.76 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.2 tpt -93.13 113.63 25.93 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.78 151.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.798 0.839 . . . . 0.0 109.521 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 m -133.66 98.11 4.11 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.27 0.628 . . . . 0.0 109.921 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.514 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 49.5 mm -83.21 93.02 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.72 0.808 . . . . 0.0 109.0 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -127.04 126.39 24.32 Favored Pre-proline 0 N--CA 1.483 1.209 0 O-C-N 121.929 -0.482 . . . . 0.0 110.853 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.41 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 45.0 Cg_endo -78.79 -145.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.18 3.253 . . . . 0.0 112.831 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.404 ' H ' ' HB2' ' A' ' 49' ' ' PRO . 41.4 tpp 80.73 162.05 0.16 Allowed 'General case' 0 C--N 1.371 1.505 0 C-N-CA 124.834 1.253 . . . . 0.0 110.352 175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.57 -20.82 0.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.964 1.306 . . . . 0.0 114.371 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.85 112.67 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 C-N-CA 123.859 0.864 . . . . 0.0 110.217 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.53 18.63 9.63 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.592 1.157 . . . . 0.0 112.888 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 -76.89 2.05 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.138 0.399 . . . . 0.0 113.583 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -131.45 178.09 6.99 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 0.0 110.652 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 25.0 p90 -86.43 113.19 22.17 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.771 0.796 . . . . 0.0 111.373 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.1 -178.23 3.52 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.643 1.177 . . . . 0.0 108.2 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.42 ' HA3' HG13 ' A' ' 77' ' ' ILE . . . -67.57 110.77 3.64 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.541 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.3 t -100.84 96.67 7.45 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.535 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.0 tm? -82.23 109.49 16.56 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -64.06 92.9 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.32 -17.88 57.93 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.826 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.23 101.8 4.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.14 -32.71 3.88 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.494 HD12 ' HA ' ' A' ' 43' ' ' LEU . 69.5 mt -90.99 162.46 14.71 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.445 0.698 . . . . 0.0 110.554 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -148.07 145.82 28.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.121 0.568 . . . . 0.0 111.21 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 37.55 -79.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.535 2.334 . . . . 0.0 116.32 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.1 p-10 -79.97 -42.76 23.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.12 0.568 . . . . 0.0 110.222 -170.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -67.8 -35.4 78.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.088 0.47 . . . . 0.0 110.066 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 27.1 mm -55.94 -48.47 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.456 0.702 . . . . 0.0 110.876 169.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -59.9 -52.02 67.22 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.665 0.603 . . . . 0.0 111.044 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ASP . 33.8 mt -57.87 -39.24 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.263 0.625 . . . . 0.0 109.702 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -62.99 -59.08 9.6 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.161 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.1 pp -68.13 -23.11 64.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.449 0.625 . . . . 0.0 112.261 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -73.98 -37.08 64.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.073 0.549 . . . . 0.0 110.978 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -72.54 -31.19 65.1 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.409 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.549 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -67.46 -39.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.707 0.803 . . . . 0.0 110.64 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -22.46 57.69 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.773 0.32 . . . . 0.0 110.511 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.41 -40.43 57.83 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.417 0.687 . . . . 0.0 110.167 168.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.539 HG23 HD23 ' A' ' 84' ' ' LEU . 42.8 mt -73.98 -33.68 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 0.0 111.528 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -64.05 -33.05 74.86 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 120.928 0.394 . . . . 0.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -76.73 -37.1 56.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.008 0.923 . . . . 0.0 111.134 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -71.78 -42.78 66.74 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.037 0.535 . . . . 0.0 111.108 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.539 HD23 HG23 ' A' ' 80' ' ' ILE . 3.9 mm? -100.55 21.69 12.93 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 110.964 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.53 146.31 49.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.705 0.802 . . . . 0.0 109.117 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -64.82 -33.39 75.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.946 0.499 . . . . 0.0 111.091 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.7 -44.14 0.6 Allowed Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.674 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.6 m -148.06 73.92 1.28 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.205 1.002 . . . . 0.0 108.731 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.52 140.23 27.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.367 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -91.35 144.31 25.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.565 0.746 . . . . 0.0 109.009 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -60.25 -49.46 77.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 0.0 110.364 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -50.67 -33.95 24.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.093 1.357 . . . . 0.0 112.399 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -61.26 -42.4 98.57 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.297 0.639 . . . . 0.0 111.19 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.84 -20.83 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 122.621 0.368 . . . . 0.0 111.442 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 96.1 m -75.37 -30.74 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.131 0.572 . . . . 0.0 111.759 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.38 -18.37 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 118.19 0.45 . . . . 0.0 112.136 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.86 -42.11 73.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.727 0.411 . . . . 0.0 110.116 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -81.84 -29.27 32.62 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.751 0.421 . . . . 0.0 110.884 177.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -71.45 -27.03 62.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.899 0.88 . . . . 0.0 111.609 -168.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.561 1.396 0 C-N-CA 123.166 0.586 . . . . 0.0 110.618 173.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 tmm? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.43 102.56 1.57 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.644 2.229 . . . . 0.0 113.209 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -69.46 127.78 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.42 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.91 140.81 42.32 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -146.02 87.97 1.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.555 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 12.8 t -147.04 37.12 0.18 Allowed Pre-proline 0 CA--C 1.571 1.779 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.3 Cg_endo -79.69 -32.47 1.56 Allowed 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 121.609 1.54 . . . . 0.0 111.758 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 59.5 m-85 -129.23 24.89 5.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.882 0.873 . . . . 0.0 111.529 -173.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 6' ' ' THR . 17.7 mt -67.79 123.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.989 0.423 . . . . 0.0 110.524 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HB2' HG22 ' A' ' 13' ' ' VAL . 62.8 mt -107.32 91.61 7.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 86.47 1.58 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.513 2.142 . . . . 0.0 110.866 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.53 -37.44 0.27 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.598 -173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 10' ' ' LEU . 11.5 m -93.36 167.88 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.993 0.517 . . . . 0.0 110.392 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 45.3 m -78.82 -37.22 41.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.425 0.69 . . . . 0.0 111.499 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -91.85 177.85 6.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.44 0.696 . . . . 0.0 112.272 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 140.6 49.46 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 22.8 m -52.55 -58.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.303 0.641 . . . . 0.0 111.059 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -172.24 135.53 0.77 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.608 1.163 . . . . 0.0 108.018 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 83' ' ' THR . 65.3 mt -105.91 127.86 27.55 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.08 130.35 31.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.849 2.366 . . . . 0.0 112.517 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.53 -14.91 62.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.117 0.567 . . . . 0.0 111.409 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.97 -43.32 93.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.642 0.777 . . . . 0.0 110.252 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 m -65.82 -42.21 90.9 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.063 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 9.4 mp -58.6 -39.11 79.5 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.849 0.46 . . . . 0.0 110.52 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -39.16 69.49 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.711 0.804 . . . . 0.0 111.818 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -72.08 -27.11 62.45 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' HA ' HE21 ' A' ' 30' ' ' GLN . 83.9 mt -68.53 -42.65 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 122.734 0.414 . . . . 0.0 109.997 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 20.1 mmt180 -63.5 -25.17 68.13 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.389 0.675 . . . . 0.0 110.883 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -76.42 -52.73 9.29 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.446 0.698 . . . . 0.0 110.696 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.425 HE21 ' HA ' ' A' ' 27' ' ' ILE . 25.7 pt20 -70.03 -27.57 64.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.855 0.462 . . . . 0.0 111.813 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.508 ' HB ' ' HG3' ' A' ' 49' ' ' PRO . 8.3 p -61.91 -24.11 66.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.052 0.541 . . . . 0.0 112.272 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.51 -23.35 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 122.944 0.498 . . . . 0.0 110.924 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.13 0.87 26.38 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.718 0.807 . . . . 0.0 111.029 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.23 -17.84 54.11 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.432 0.539 . . . . 0.0 112.698 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.37 131.48 30.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.914 0.885 . . . . 0.0 110.213 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.566 ' HB1' ' HB ' ' A' ' 47' ' ' ILE . . . -126.78 133.36 50.84 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.155 0.982 . . . . 0.0 108.935 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -112.03 115.82 29.54 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.75 144.38 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.467 1.107 . . . . 0.0 108.24 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -128.54 88.59 2.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.917 . . . . 0.0 110.392 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 76' ' ' TYR . 88.4 mt -76.68 80.16 3.32 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.75 -104.04 1.16 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -99.04 -11.78 21.17 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.525 0.73 . . . . 0.0 110.966 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD11 ' HA2' ' A' ' 73' ' ' GLY . 52.9 mt -83.3 132.0 35.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.296 1.038 . . . . 0.0 110.236 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.05 128.65 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.48 120.76 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.051 0.94 . . . . 0.0 109.603 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.6 m -100.84 110.32 22.38 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.774 0.83 . . . . 0.0 110.403 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.566 ' HB ' ' HB1' ' A' ' 36' ' ' ALA . 22.8 mm -101.84 115.08 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -133.59 103.49 12.27 Favored Pre-proline 0 N--CA 1.493 1.685 0 C-N-CA 122.754 0.422 . . . . 0.0 111.963 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 52.5 Cg_endo -91.57 145.83 3.27 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.185 2.59 . . . . 0.0 113.65 167.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.6 ttm 169.12 -54.19 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.415 1.886 . . . . 0.0 106.36 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -178.82 -24.73 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.397 -1.728 . . . . 0.0 107.758 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.42 137.02 20.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.359 1.063 . . . . 0.0 110.319 169.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.561 ' HA ' ' HB3' ' A' ' 98' ' ' ARG . 17.2 m120 64.09 14.73 8.76 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' HA3' HD21 ' A' ' 97' ' ' LEU . . . 65.89 -98.15 0.34 Allowed Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -169.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.7 160.41 14.39 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 110.742 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 47' ' ' ILE . 8.1 p90 -88.68 116.88 27.25 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.709 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 21.3 ptt? -172.89 -175.73 1.3 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.437 1.095 . . . . 0.0 109.379 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.8 110.29 0.22 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 124.397 1.061 . . . . 0.0 115.618 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.0 t -134.49 101.4 4.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.882 0.873 . . . . 0.0 108.79 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.71 111.72 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.843 0.857 . . . . 0.0 109.717 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.54 103.05 3.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.19 0.996 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 8.6 pt20 -98.99 -71.18 0.7 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 4.9 m-20 56.2 26.26 10.13 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.546 1.139 . . . . 0.0 113.323 172.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.51 12.38 6.19 Favored Glycine 0 N--CA 1.477 1.413 0 C-N-CA 123.308 0.48 . . . . 0.0 113.265 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.68 153.61 39.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.882 0.873 . . . . 0.0 111.669 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.2 p -66.93 139.94 57.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.267 1.027 . . . . 0.0 110.92 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -57.9 -31.55 66.86 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.227 1.011 . . . . 0.0 113.363 -171.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.3 p-10 -65.15 -44.28 89.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.44 -19.37 59.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 0.0 111.804 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 -44.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 35.2 tt0 -66.84 -55.81 13.16 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.804 0.69 . . . . 0.0 110.281 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 68' ' ' ASP . 28.8 mt -56.81 -37.02 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 123.725 0.81 . . . . 0.0 109.928 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.445 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -60.88 -56.86 21.77 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.901 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.2 pp -65.18 -27.23 68.56 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.203 0.501 . . . . 0.0 111.945 -174.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 22.5 mm-40 -66.5 -47.0 74.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 0.0 110.332 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.487 ' HB3' HD11 ' A' ' 40' ' ' LEU . 12.4 m-85 -73.55 -27.11 61.16 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.362 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.5 -43.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.737 0.815 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.36 -21.35 62.04 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.61 0.569 . . . . 0.0 110.947 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -78.05 -40.42 38.78 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.242 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.4 mm -65.68 -29.59 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 123.219 0.608 . . . . 0.0 110.825 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.633 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.2 pt-20 -70.46 -39.5 74.27 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -24.5 42.97 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.469 HG22 HD13 ' A' ' 19' ' ' ILE . 99.6 m -73.11 -55.68 6.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.611 0.765 . . . . 0.0 110.404 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.62 47.65 1.25 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.927 1.291 . . . . 0.0 108.367 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -59.06 130.3 46.35 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.78 -166.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -80.9 -147.78 0.06 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 125.779 1.632 . . . . 0.0 110.061 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.85 -102.1 0.02 OUTLIER Glycine 0 C--N 1.354 1.544 0 N-CA-C 112.311 -0.316 . . . . 0.0 112.311 167.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -154.79 104.69 2.53 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.96 0.904 . . . . 0.0 109.782 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 HD23 ' HB ' ' A' ' 94' ' ' VAL . 4.0 tt -152.98 139.46 18.65 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.2 m -70.55 149.38 47.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.365 1.066 . . . . 0.0 111.493 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -63.47 -50.23 70.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.366 0.667 . . . . 0.0 111.45 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -62.07 -40.2 95.02 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.528 0.331 . . . . 0.0 110.227 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 14.5 tp10 -66.6 -34.06 77.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.004 0.522 . . . . 0.0 111.149 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.472 ' HB ' HD23 ' A' ' 89' ' ' LEU . 1.4 p -80.3 -23.01 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.4 m -77.65 -34.66 53.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.954 0.902 . . . . 0.0 110.78 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.87 -25.82 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.471 HD21 ' HA3' ' A' ' 54' ' ' GLY . 23.9 tp -67.79 -42.03 82.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.517 1.127 . . . . 0.0 111.039 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.561 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 13.3 ptp180 -79.66 -21.67 44.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.592 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.99 -40.96 68.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.099 0.56 . . . . 0.0 111.583 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 CA--C 1.568 1.657 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.516 -174.489 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 23.8 mmt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.3 Cg_exo -75.11 99.74 1.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.538 2.158 . . . . 0.0 110.5 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.59 107.23 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.165 0.986 . . . . 0.0 111.879 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.4 136.09 37.58 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD22 HD11 ' A' ' 19' ' ' ILE . 61.3 tp -136.27 95.51 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.61 1.164 . . . . 0.0 108.079 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.423 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.3 t -144.54 31.05 0.1 Allowed Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.83 -29.71 8.25 Favored 'Trans proline' 0 C--N 1.391 2.811 0 CA-C-N 121.565 1.595 . . . . 0.0 112.949 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -129.44 26.27 5.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.602 0.761 . . . . 0.0 111.484 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 6' ' ' THR . 21.8 mt -71.76 135.4 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 173.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -109.9 90.19 8.98 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.43 90.91 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.913 2.409 . . . . 0.0 109.77 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.72 -43.06 0.28 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.667 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 10' ' ' LEU . 34.2 m -99.69 -175.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 110.968 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -105.68 6.01 31.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.106 0.962 . . . . 0.0 112.755 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -126.91 165.76 18.77 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.435 0.636 . . . . 0.0 111.715 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.42 143.82 34.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' HD22 ' A' ' 10' ' ' LEU . 28.9 t -63.71 -60.68 3.0 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.545 0.738 . . . . 0.0 109.834 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.4 138.6 0.71 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.537 1.135 . . . . 0.0 108.548 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 83' ' ' THR . 76.4 mt -104.52 137.18 19.15 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 123.096 0.558 . . . . 0.0 109.616 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.428 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.5 Cg_endo -57.19 133.11 55.38 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.872 2.381 . . . . 0.0 111.94 170.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.369 1.068 . . . . 0.0 112.128 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.4 pt-20 -60.0 -31.85 70.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 0.0 111.557 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 HD11 ' A' ' 5' ' ' LEU . 6.3 m -67.89 -50.32 56.97 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -62.8 -27.06 69.05 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.729 0.412 . . . . 0.0 110.659 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -69.92 -47.33 62.87 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.046 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.8 -32.38 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.191 0.197 . . . . 0.0 110.979 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.2 mt -62.72 -44.58 99.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.547 0.739 . . . . 0.0 109.333 171.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -60.0 -27.85 67.22 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.558 0.743 . . . . 0.0 111.606 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.09 -46.23 15.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.538 0.735 . . . . 0.0 111.621 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -75.29 -25.89 58.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.994 0.518 . . . . 0.0 111.867 -175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -62.12 -28.67 69.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.552 0.341 . . . . 0.0 111.281 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.75 -30.54 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.987 0.515 . . . . 0.0 110.527 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -70.87 -13.06 61.89 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.419 0.688 . . . . 0.0 110.452 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.07 -21.88 21.83 Favored Glycine 0 C--N 1.348 1.207 0 C-N-CA 124.2 0.905 . . . . 0.0 112.919 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.583 ' HA ' ' HG2' ' A' ' 48' ' ' ARG . 34.6 tt0 -140.32 128.46 22.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.996 0.518 . . . . 0.0 110.979 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.13 130.39 53.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.89 0.876 . . . . 0.0 108.72 169.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -120.99 99.44 6.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.36 0.664 . . . . 0.0 109.328 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.15 123.09 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.877 0.871 . . . . 0.0 109.077 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 15.0 mtm180 -99.2 92.74 5.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 94.6 mt -74.45 75.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 -103.72 1.21 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.19 -10.56 19.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.515 0.726 . . . . 0.0 110.71 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.9 mt -81.2 108.41 14.82 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.413 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 13.2 tpt -86.26 124.4 32.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.02 126.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.795 0.838 . . . . 0.0 109.651 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -107.57 99.76 9.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.596 0.758 . . . . 0.0 110.569 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.407 HG23 ' HB2' ' A' ' 56' ' ' PHE . 18.3 mm -86.68 90.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.583 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 46.4 mtp180 -125.99 124.43 24.68 Favored Pre-proline 0 N--CA 1.484 1.255 0 O-C-N 121.914 -0.491 . . . . 0.0 111.986 -171.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.27 -35.83 1.15 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.412 2.075 . . . . 0.0 111.066 165.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.4 82.21 6.48 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 176.38 178.9 0.2 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.7 1.6 . . . . 0.0 107.253 -174.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.7 m -61.81 168.3 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.454 0.701 . . . . 0.0 111.219 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 94' ' ' VAL . 28.6 m-80 73.95 158.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.289 1.436 . . . . 0.0 110.283 -169.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.57 -40.04 59.91 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 114.027 0.371 . . . . 0.0 114.027 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -130.91 168.69 16.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.861 0.865 . . . . 0.0 110.81 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HB2' HG23 ' A' ' 47' ' ' ILE . 29.4 p90 -87.99 114.21 24.39 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.262 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.491 ' HE2' HG13 ' A' ' 94' ' ' VAL . 37.7 mtm -139.66 -174.84 4.01 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.493 1.117 . . . . 0.0 108.081 174.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.12 110.39 1.51 Allowed Glycine 0 C--N 1.351 1.399 0 O-C-N 123.497 0.498 . . . . 0.0 112.755 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 t -133.82 115.95 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.6 115.1 18.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.353 0.661 . . . . 0.0 109.26 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.93 96.6 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.418 1.087 . . . . 0.0 109.31 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HA ' HD13 ' A' ' 65' ' ' LEU . 11.3 pt20 -93.41 12.79 23.66 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.269 1.028 . . . . 0.0 112.825 -169.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.52 106.75 1.21 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.133 0.973 . . . . 0.0 111.76 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.78 22.24 78.14 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.507 -0.769 . . . . 0.0 114.062 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.655 ' HB3' ' ND2' ' A' ' 69' ' ' ASN . 14.2 mt -88.33 174.59 8.08 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.34 0.656 . . . . 0.0 112.337 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 m -105.4 -151.08 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.658 1.183 . . . . 0.0 109.644 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -91.4 -53.45 4.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.061 0.846 . . . . 0.0 112.68 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -57.04 -46.4 82.45 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.524 0.73 . . . . 0.0 112.232 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.655 ' ND2' ' HB3' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.21 -40.74 74.52 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.149 0.98 . . . . 0.0 112.707 175.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.2 mm -64.65 -46.29 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 122.47 0.308 . . . . 0.0 110.592 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 97.9 mt-30 -62.48 -57.4 11.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.035 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.81 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.864 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -52.05 55.06 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.852 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.59 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -66.87 -26.85 67.1 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.487 0.643 . . . . 0.0 111.437 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 13.9 mm-40 -60.76 -50.82 71.94 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.119 0.962 . . . . 0.0 110.24 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.483 ' O ' HG12 ' A' ' 80' ' ' ILE . 49.3 m-85 -72.46 -25.11 61.32 Favored 'General case' 0 C--O 1.202 -1.424 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.583 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.23 -45.7 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.619 0.768 . . . . 0.0 110.924 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.74 -22.37 61.62 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -73.69 -47.17 41.62 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.668 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -66.53 -35.79 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 124.337 1.055 . . . . 0.0 111.349 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.8 pt-20 -56.79 -43.39 80.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.288 0.367 . . . . 0.0 110.705 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -78.0 -32.73 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.763 0.825 . . . . 0.0 111.879 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.54 HG21 HD12 ' A' ' 19' ' ' ILE . 21.9 m -69.58 -37.02 76.8 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.049 0.54 . . . . 0.0 110.803 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.9 -51.22 12.95 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -154.59 103.76 2.49 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.665 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -74.03 165.05 25.83 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.02 176.98 38.42 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.867 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 62.2 p -73.33 -11.76 60.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.961 0.904 . . . . 0.0 111.264 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 HD21 ' HB ' ' A' ' 94' ' ' VAL . 8.9 tt -65.34 138.34 58.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.38 0.672 . . . . 0.0 109.416 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -117.15 152.69 34.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.127 0.971 . . . . 0.0 109.706 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 t -60.05 -34.36 73.31 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -65.68 -42.48 91.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.499 0.59 . . . . 0.0 110.77 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -27.13 69.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.798 -173.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.53 ' HB ' HD21 ' A' ' 89' ' ' LEU . 14.9 p -90.04 -35.91 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.161 0.505 . . . . 0.0 110.748 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.8 m -75.77 -27.88 58.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 100' ' ' ILE . 8.1 p -67.4 -20.69 26.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.201 0.6 . . . . 0.0 110.43 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 0.0 111.1 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -32.67 71.1 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.487 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.44 -35.11 58.69 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.596 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 96' ' ' VAL . 15.1 pt . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -86.13 147.23 9.02 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.692 2.261 . . . . 0.0 113.054 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -103.64 139.47 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -89.65 141.16 28.86 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD23 HG23 ' A' ' 19' ' ' ILE . 38.5 tp -145.71 110.46 5.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -149.93 53.51 1.3 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 123.415 0.686 . . . . 0.0 111.2 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.99 -27.64 0.65 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.282 1.988 . . . . 0.0 113.443 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.86 4.55 6.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.99 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.84 116.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -165.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -104.6 90.95 3.7 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 172.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.5 -23.17 58.01 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.205 1.937 . . . . 0.0 113.925 -167.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.25 72.61 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.133 0.413 . . . . 0.0 114.133 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 10' ' ' LEU . 22.9 m -104.82 158.66 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.907 0.483 . . . . 0.0 111.324 -174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -73.28 -20.28 60.86 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.465 1.106 . . . . 0.0 112.905 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -105.89 174.6 5.81 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.374 0.67 . . . . 0.0 111.525 -175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -123.03 147.57 46.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.455 ' OG ' HD22 ' A' ' 10' ' ' LEU . 12.8 m -53.09 -49.27 66.78 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.939 0.774 . . . . 0.0 110.098 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -176.2 166.9 2.9 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.021 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.504 HG23 HD23 ' A' ' 5' ' ' LEU . 83.0 mt -121.35 129.94 25.03 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 167.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 124.17 15.29 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.638 2.225 . . . . 0.0 111.897 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 24' ' ' LEU . 27.3 mp0 -71.08 -15.0 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.645 0.778 . . . . 0.0 111.577 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.47 -46.19 84.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.567 0.747 . . . . 0.0 110.102 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.442 HG21 HD11 ' A' ' 5' ' ' LEU . 17.6 m -69.47 -37.41 77.27 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.248 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.503 HD13 HG21 ' A' ' 83' ' ' THR . 95.8 mt -61.32 -37.23 82.5 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.564 0.54 . . . . 0.0 111.217 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -69.88 -30.86 68.41 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.727 0.642 . . . . 0.0 110.775 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.1 tp10 -66.6 -38.5 87.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.842 0.457 . . . . 0.0 109.917 172.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 23' ' ' THR . 18.0 mm -63.37 -44.64 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.952 0.501 . . . . 0.0 109.912 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 11.6 mmm180 -64.44 -29.34 70.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.975 0.91 . . . . 0.0 110.807 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.62 -48.13 34.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.798 0.839 . . . . 0.0 110.987 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 4.1 pt20 -76.96 -26.11 53.58 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.115 0.566 . . . . 0.0 112.207 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -61.01 -23.77 65.66 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.13 0.423 . . . . 0.0 111.68 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.89 -31.62 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 122.663 0.385 . . . . 0.0 110.137 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -73.44 -13.57 61.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.018 0.927 . . . . 0.0 111.144 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.39 -18.61 22.92 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-O 119.585 -0.564 . . . . 0.0 113.839 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.83 154.56 48.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.757 0.778 . . . . 0.0 112.105 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB3' ' HG3' ' A' ' 30' ' ' GLN . . . -153.15 138.96 17.98 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.708 1.203 . . . . 0.0 107.781 168.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' NE2' ' HE2' ' A' ' 44' ' ' MET . 52.2 mt-30 -140.26 129.33 23.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 109.651 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.81 112.61 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -82.5 94.32 7.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 76.5 mt -76.31 65.2 2.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.236 0.615 . . . . 0.0 110.426 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.08 -99.96 0.26 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -71.67 -43.19 66.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.23 1.012 . . . . 0.0 110.984 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.56 160.87 25.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.729 0.812 . . . . 0.0 110.231 -174.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.415 ' HE2' ' NE2' ' A' ' 37' ' ' GLN . 26.4 ttt -140.47 129.41 23.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.862 176.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.78 153.8 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.007 1.323 . . . . 0.0 108.564 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -132.55 98.59 4.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.698 0.799 . . . . 0.0 109.777 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.422 HG22 ' HB2' ' A' ' 56' ' ' PHE . 30.2 mm -89.32 84.19 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -116.38 125.47 28.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 121.976 -0.452 . . . . 0.0 110.467 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 92.5 Cg_endo -78.41 1.91 8.58 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.308 2.672 . . . . 0.0 112.427 169.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.1 ttp -74.36 73.2 1.85 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.999 0.905 . . . . 0.0 109.392 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -171.96 119.97 0.44 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.148 1.379 . . . . 0.0 107.428 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.93 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 93.6 m-20 62.31 18.82 10.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.267 1.027 . . . . 0.0 111.702 -170.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.62 100.93 0.67 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.843 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -74.79 152.75 38.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.767 0.827 . . . . 0.0 109.581 170.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' HB2' HG22 ' A' ' 47' ' ' ILE . 31.1 p90 -87.67 116.46 25.82 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.487 0.661 . . . . 0.0 111.42 -172.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.8 ptp -148.11 -176.09 5.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.997 1.319 . . . . 0.0 108.925 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.97 119.23 8.44 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 -172.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -135.33 118.13 16.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.932 . . . . 0.0 109.17 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.24 128.64 35.15 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.312 0.645 . . . . 0.0 109.316 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.3 78.32 1.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.447 0.699 . . . . 0.0 109.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -73.45 -23.92 60.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.968 0.507 . . . . 0.0 111.804 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.02 102.1 4.72 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.747 0.819 . . . . 0.0 109.482 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.76 3.43 55.02 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.517 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 161.03 14.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.83 0.852 . . . . 0.0 109.166 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 70' ' ' ILE . 30.7 t -85.99 146.52 26.63 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.897 0.479 . . . . 0.0 110.2 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -37.19 74.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.05 -41.13 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -68.46 -17.33 64.17 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 66' ' ' SER . 47.3 mm -59.32 -43.63 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.919 0.487 . . . . 0.0 109.947 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -50.92 69.14 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.161 0.584 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mp -63.71 -34.54 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.508 0.671 . . . . 0.0 109.832 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.44 -55.13 24.98 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.811 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.4 pp -67.12 -33.2 74.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.067 0.547 . . . . 0.0 111.685 -169.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -70.76 -36.46 73.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.791 0.436 . . . . 0.0 110.187 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -71.79 -25.9 62.2 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.729 172.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.58 -38.03 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.517 0.727 . . . . 0.0 109.985 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 73.4 mt-10 -68.05 -33.11 73.96 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.896 0.747 . . . . 0.0 110.533 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -66.37 -52.31 48.19 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.337 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.46 HD13 HD12 ' A' ' 40' ' ' LEU . 75.2 mt -64.35 -29.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.3 -38.38 83.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.272 1.029 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -77.66 -47.05 20.18 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.834 0.854 . . . . 0.0 111.187 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.503 HG21 HD13 ' A' ' 24' ' ' LEU . 31.5 m -78.47 -54.61 5.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.302 1.041 . . . . 0.0 112.782 -164.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.98 -41.96 81.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.915 0.486 . . . . 0.0 110.686 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.09 81.87 0.69 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.615 0.722 . . . . 0.0 110.903 -172.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -84.69 127.07 33.91 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.23 -2.58 3.56 Favored Glycine 0 N--CA 1.47 0.964 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.589 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t 62.9 21.12 12.66 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.734 1.214 . . . . 0.0 111.943 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.443 HD11 ' HB ' ' A' ' 94' ' ' VAL . 3.2 tm? -73.94 135.68 43.24 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p -97.2 142.92 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.281 0.632 . . . . 0.0 110.44 -175.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.7 t -61.75 -46.45 89.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.791 0.836 . . . . 0.0 112.268 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.26 -43.31 92.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.702 0.626 . . . . 0.0 110.604 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.51 -29.31 70.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.877 0.871 . . . . 0.0 113.219 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' A' ' 89' ' ' LEU . 8.1 p -89.1 -33.55 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 118.341 0.518 . . . . 0.0 110.771 174.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.5 m -66.49 -39.61 88.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.495 0.718 . . . . 0.0 110.978 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.1 -27.83 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.309 0.644 . . . . 0.0 111.48 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 53' ' ' ASN . 97.1 mt -70.76 -38.75 73.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.073 0.549 . . . . 0.0 110.882 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -79.93 -24.89 40.75 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.321 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.51 -49.17 64.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.274 1.03 . . . . 0.0 110.914 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.563 1.457 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.026 -177.072 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.555 ' SD ' ' HG3' ' A' ' 33' ' ' ARG . 20.2 ptm . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -100.11 161.36 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.382 2.721 . . . . 0.0 114.502 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 121.44 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.878 0.871 . . . . 0.0 109.058 168.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 4.8 p-10 -81.7 96.41 7.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.667 . . . . 0.0 109.665 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.77 106.62 15.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.108 0.963 . . . . 0.0 109.108 -172.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.2 t -153.98 57.71 1.94 Allowed Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 123.295 0.638 . . . . 0.0 111.819 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -89.25 -34.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.322 2.014 . . . . 0.0 113.282 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 55.7 m-85 -127.85 22.07 6.33 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.481 0.713 . . . . 0.0 110.499 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.51 117.49 12.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-O 121.251 0.548 . . . . 0.0 110.285 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.438 ' HB2' HG23 ' A' ' 13' ' ' VAL . 65.5 mt -106.97 99.22 25.0 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.4 -20.99 66.79 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.739 2.292 . . . . 0.0 112.85 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.27 -3.3 81.78 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.891 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.438 HG23 ' HB2' ' A' ' 10' ' ' LEU . 27.1 m -132.57 170.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.623 0.769 . . . . 0.0 109.889 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.6 p -89.31 -0.52 57.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.092 0.957 . . . . 0.0 112.455 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.434 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 40.1 p90 -129.01 159.01 37.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.646 0.736 . . . . 0.0 112.111 -173.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.04 142.54 47.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.873 166.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 34.3 t -67.04 -33.06 74.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 168.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -167.61 152.94 7.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.996 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -125.94 133.08 24.57 Favored Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.88 126.8 23.72 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.263 1.976 . . . . 0.0 111.061 168.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -65.31 -17.49 64.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 110.868 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.28 -43.88 83.51 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.944 0.898 . . . . 0.0 110.139 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.431 ' O ' HG13 ' A' ' 27' ' ' ILE . 25.7 m -65.46 -48.63 72.02 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.035 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.08 -39.56 78.85 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.299 0.5 . . . . 0.0 111.209 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -66.48 -43.45 85.36 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.073 0.549 . . . . 0.0 111.72 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.1 pt-20 -74.92 -27.5 60.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 119.442 -0.313 . . . . 0.0 111.062 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.616 ' HA ' HE21 ' A' ' 30' ' ' GLN . 95.4 mt -58.96 -39.9 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.328 0.651 . . . . 0.0 109.692 172.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' O ' HG12 ' A' ' 32' ' ' ILE . 17.9 mmt180 -62.02 -25.2 67.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.576 0.751 . . . . 0.0 111.893 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.445 HD21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -80.22 -36.12 35.23 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.889 0.476 . . . . 0.0 109.908 176.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.616 HE21 ' HA ' ' A' ' 27' ' ' ILE . 30.1 mt-30 -73.68 -30.54 62.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.275 0.63 . . . . 0.0 111.036 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.8 p -67.93 -32.24 72.56 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.74 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.3 mm -74.93 -28.54 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.555 0.742 . . . . 0.0 110.595 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 26.9 mmt180 -64.74 -33.34 75.74 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 168.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.65 39.98 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.253 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.02 106.2 5.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.203 0.601 . . . . 0.0 110.755 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . . . -117.11 122.05 43.02 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' ' 44' ' ' MET . 44.9 mt-30 -131.46 107.42 8.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.103 0.478 . . . . 0.0 109.919 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 47' ' ' ILE . 1.7 mp -98.41 110.29 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.549 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 61.4 mtt-85 -82.07 88.16 6.44 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.0 mt -78.62 78.54 5.07 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 -102.22 0.45 Allowed Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.981 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.95 -40.85 19.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.037 0.935 . . . . 0.0 109.751 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.82 110.65 14.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.68 1.192 . . . . 0.0 110.531 -166.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.454 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.1 tpt -82.28 105.51 13.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.47 155.39 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.677 0.791 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -140.25 127.73 21.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.841 0.857 . . . . 0.0 108.7 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.422 HG12 HD12 ' A' ' 38' ' ' ILE . 16.0 mm -113.09 92.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -134.57 127.76 18.77 Favored Pre-proline 0 N--CA 1.484 1.234 0 O-C-N 122.235 -0.291 . . . . 0.0 110.499 -174.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 59.1 Cg_endo -71.32 125.9 11.77 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.136 2.557 . . . . 0.0 112.242 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.416 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 54.4 ttm -81.45 85.53 6.46 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.704 0.802 . . . . 0.0 110.78 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 47.72 -88.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 126.219 1.808 . . . . 0.0 114.351 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.98 133.28 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.069 0.948 . . . . 0.0 108.737 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 52.23 17.59 0.74 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 126.532 1.933 . . . . 0.0 113.574 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -114.21 94.54 0.69 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -73.08 169.1 17.71 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.48 0.712 . . . . 0.0 109.403 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.407 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 27.6 p90 -102.42 139.76 37.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 0.0 110.737 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -159.94 -174.97 4.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 125.063 1.345 . . . . 0.0 108.2 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.29 115.54 6.32 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 123.338 0.399 . . . . 0.0 112.806 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 t -126.0 135.05 51.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.299 1.04 . . . . 0.0 108.395 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.0 tm? -101.82 112.14 24.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.902 0.481 . . . . 0.0 110.555 -171.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -73.64 97.02 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.9 pt20 -82.32 -13.77 56.39 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.873 1.269 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.6 103.59 4.26 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.434 0.694 . . . . 0.0 110.296 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.61 -9.63 23.86 Favored Glycine 0 N--CA 1.472 1.047 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.702 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 62' ' ' GLN . 36.3 mt -77.55 179.27 6.64 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.646 0.736 . . . . 0.0 111.916 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.4 t -104.81 166.95 10.04 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.268 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -53.72 -45.7 70.57 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.423 0.689 . . . . 0.0 111.337 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.55 -45.21 80.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.885 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -57.77 -24.94 59.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.596 0.759 . . . . 0.0 112.626 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.6 mm -62.89 -46.72 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 122.781 0.432 . . . . 0.0 110.064 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -64.14 -54.82 27.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.718 0.807 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.33 -33.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.943 0.497 . . . . 0.0 109.922 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.02 -58.19 13.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.011 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.36 -28.67 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.851 0.461 . . . . 0.0 111.909 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -63.09 -54.25 40.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.468 ' O ' HG12 ' A' ' 80' ' ' ILE . 17.4 m-85 -61.13 -37.81 84.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.075 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -60.09 -43.43 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.669 0.788 . . . . 0.0 112.19 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.32 -29.39 61.58 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.177 0.298 . . . . 0.0 110.811 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.434 ' ND1' ' HB3' ' A' ' 15' ' ' PHE . 58.9 m-70 -77.62 -27.38 51.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 76' ' ' TYR . 37.6 mm -71.91 -40.35 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -55.52 -45.04 77.16 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 124.224 1.009 . . . . 0.0 109.948 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -50.46 -43.38 55.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 111.884 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -81.77 -33.63 30.82 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.921 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.38 -23.69 19.99 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 0.0 110.522 -168.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 7.8 t-20 -83.35 -174.55 5.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.538 0.735 . . . . 0.0 110.122 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 73.36 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.299 1.44 . . . . 0.0 111.493 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.26 -100.89 0.15 Allowed Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -69.19 -18.07 63.87 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.641 0.776 . . . . 0.0 111.671 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.51 173.65 14.88 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.38 1.072 . . . . 0.0 109.593 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -86.35 159.68 19.32 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.119 0.568 . . . . 0.0 109.664 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.3 p -55.23 -39.7 70.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.614 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -63.07 -34.51 77.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.505 0.503 . . . . 0.0 111.359 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.2 mp0 -62.09 -50.58 71.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.675 0.39 . . . . 0.0 111.951 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.99 -30.02 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 118.16 0.436 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.0 m -69.42 -46.19 67.4 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 124.238 1.015 . . . . 0.0 111.174 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.452 ' O ' HG12 ' A' ' 100' ' ' ILE . 34.0 m -75.22 -25.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.431 0.457 . . . . 0.0 111.084 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 93' ' ' GLU . 7.7 mp -68.05 -40.68 82.78 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.627 0.771 . . . . 0.0 110.078 170.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -78.29 -24.26 46.83 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.94 0.896 . . . . 0.0 110.255 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.03 -49.45 44.8 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.135 0.974 . . . . 0.0 109.918 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 96' ' ' VAL . 28.9 pt . . . . . 0 CA--C 1.569 1.681 0 O-C-N 123.47 0.481 . . . . 0.0 110.508 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' H ' ' HD3' ' A' ' 2' ' ' PRO . 27.2 ttt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.892 0.377 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.52 ' HD3' ' H ' ' A' ' 1' ' ' MET . 86.8 Cg_endo -92.87 100.45 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.093 2.528 . . . . 0.0 111.558 176.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.57 99.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-O 121.931 0.872 . . . . 0.0 110.401 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.62 124.58 24.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.073 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 19' ' ' ILE . 4.0 tt -133.78 94.2 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -152.52 60.38 3.38 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 121.512 0.673 . . . . 0.0 111.689 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.13 -34.59 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.146 1.897 . . . . 0.0 113.129 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.37 0.43 11.11 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.479 0.712 . . . . 0.0 112.143 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.5 mt -59.68 123.37 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -165.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.16 92.22 5.29 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 113.828 -1.533 . . . . 0.0 107.51 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.38 88.49 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.893 2.395 . . . . 0.0 110.761 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.25 -36.5 0.3 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.255 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -83.61 165.51 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.589 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 49.6 m -85.7 -20.09 29.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 111.848 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -113.56 -173.3 2.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 0.0 110.302 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.683 HD23 HG12 ' A' ' 19' ' ' ILE . 8.1 tp -133.38 133.26 42.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 m -51.55 -55.4 19.32 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.313 1.008 . . . . 0.0 111.106 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -141.6 144.45 34.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.858 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.683 HG12 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -127.8 127.58 23.95 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.76 117.33 4.04 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.815 2.343 . . . . 0.0 112.415 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -61.3 -23.05 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.242 1.017 . . . . 0.0 111.727 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.08 -47.74 82.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.295 1.038 . . . . 0.0 110.502 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.0 m -67.36 -36.81 82.14 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.567 HD13 HD12 ' A' ' 27' ' ' ILE . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.47 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 m -62.39 -42.12 99.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.832 0.453 . . . . 0.0 110.112 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.8 tp10 -60.16 -56.96 15.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 109.894 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.567 HD12 HD13 ' A' ' 24' ' ' LEU . 74.4 mt -54.85 -46.88 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.131 1.372 . . . . 0.0 111.331 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -72.58 -28.14 62.62 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.624 -171.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.09 -42.28 16.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.646 0.378 . . . . 0.0 111.948 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.509 ' HG3' ' HB3' ' A' ' 36' ' ' ALA . 5.1 pt20 -69.31 -23.62 63.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.079 0.552 . . . . 0.0 111.711 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -62.39 -25.98 68.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.47 -34.41 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.122 0.486 . . . . 0.0 109.769 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -73.19 -14.49 61.36 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.274 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 12.23 67.16 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 123.719 0.676 . . . . 0.0 113.047 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -138.35 107.34 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.293 0.637 . . . . 0.0 111.024 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HB3' ' HG3' ' A' ' 30' ' ' GLN . . . -146.67 134.48 21.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.883 0.873 . . . . 0.0 108.685 173.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.537 ' HB2' ' HE3' ' A' ' 44' ' ' MET . 1.9 pm0 -155.67 122.27 5.26 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.48 141.97 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.132 1.373 . . . . 0.0 109.245 -174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -108.07 97.68 7.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 HD13 HG22 ' A' ' 45' ' ' VAL . 96.4 mt -77.9 69.14 4.09 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.56 0.695 . . . . 0.0 109.843 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.03 2.04 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.693 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HG3' HD22 ' A' ' 69' ' ' ASN . 11.7 pt-20 -91.74 -21.88 20.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.293 0.637 . . . . 0.0 110.627 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD13 ' HA2' ' A' ' 73' ' ' GLY . 34.6 mt -74.71 108.18 7.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.537 ' HE3' ' HB2' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -88.96 131.82 34.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 40' ' ' LEU . 59.3 t -132.14 135.49 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.693 0.797 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 t -116.75 126.54 53.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.378 0.671 . . . . 0.0 109.774 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.21 84.35 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -116.49 108.14 45.78 Favored Pre-proline 0 N--CA 1.481 1.121 0 O-C-N 121.932 -0.48 . . . . 0.0 110.394 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.14 137.69 26.67 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.516 2.144 . . . . 0.0 111.585 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.65 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 51.4 ttm -130.86 115.22 16.28 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -66.32 -28.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.194 0.597 . . . . 0.0 111.811 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.15 60.7 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 59.73 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.543 1.537 . . . . 0.0 112.097 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.65 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -176.1 96.13 0.1 Allowed Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -72.97 126.04 29.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 0.0 109.788 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -87.49 113.33 23.09 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-O 121.908 0.861 . . . . 0.0 109.898 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.561 ' HG2' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -161.03 -175.23 4.79 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.721 176.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 109.38 1.97 Allowed Glycine 0 CA--C 1.534 1.246 0 O-C-N 123.651 0.594 . . . . 0.0 113.608 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 t -102.92 97.82 7.89 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -73.66 109.18 6.97 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 36.2 t30 -64.28 109.95 2.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.813 0.845 . . . . 0.0 109.451 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -76.94 -19.42 57.4 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.066 0.946 . . . . 0.0 112.096 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 134.75 48.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.082 0.553 . . . . 0.0 110.317 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.6 -22.53 23.9 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.333 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD22 ' ND2' ' A' ' 69' ' ' ASN . 17.2 mt -91.03 -172.14 3.23 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.039 0.535 . . . . 0.0 110.944 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.418 ' O ' HG12 ' A' ' 70' ' ' ILE . 48.5 t -138.08 162.08 35.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 107.979 170.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -54.13 -33.54 58.07 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.61 -36.56 73.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.457 0.703 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.568 ' ND2' HD22 ' A' ' 65' ' ' LEU . 63.0 t30 -76.81 -35.96 57.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.221 0.608 . . . . 0.0 111.635 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 66' ' ' SER . 29.9 mm -50.42 -37.53 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.939 0.896 . . . . 0.0 110.553 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 56.1 tp60 -53.16 -53.18 54.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.177 0.991 . . . . 0.0 111.557 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 69' ' ' ASN . 4.2 mp -61.26 -38.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.456 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.87 -57.06 21.33 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.307 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.69 -26.08 67.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.283 0.633 . . . . 0.0 111.42 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.589 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 84.3 mm-40 -70.63 -40.63 72.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.166 0.587 . . . . 0.0 110.651 173.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.473 ' O ' HG12 ' A' ' 80' ' ' ILE . 9.2 m-85 -71.73 -27.38 62.96 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.2 mp -68.21 -46.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.026 0.93 . . . . 0.0 110.493 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.79 -28.31 63.52 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 0.0 109.865 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.16 -42.31 80.25 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.481 0.712 . . . . 0.0 110.961 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 76' ' ' TYR . 34.8 mm -67.72 -34.95 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.484 0.713 . . . . 0.0 109.913 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -64.94 -37.97 89.42 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.455 0.472 . . . . 0.0 111.036 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.28 -25.56 60.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.689 0.396 . . . . 0.0 111.501 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -78.44 -46.05 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.976 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.0 -52.95 5.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.28 0.632 . . . . 0.0 110.802 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.13 168.73 10.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.414 0.686 . . . . 0.0 109.778 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -66.1 -67.37 0.45 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.238 0.615 . . . . 0.0 110.692 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.41 -108.51 3.18 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.6 p -166.23 141.09 4.5 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 122.915 0.486 . . . . 0.0 111.661 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 57' ' ' MET . 0.0 OUTLIER -89.08 147.78 24.05 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 163.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p -70.82 141.41 51.34 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -60.18 -34.22 73.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.53 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -53.66 -34.86 60.08 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.884 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -51.6 68.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.512 1.125 . . . . 0.0 112.092 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG12 HD21 ' A' ' 89' ' ' LEU . 34.6 m -77.86 -22.51 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.635 0.652 . . . . 0.0 111.215 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.7 m -67.64 -38.83 84.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.54 0.736 . . . . 0.0 111.13 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -76.49 -33.01 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.665 0.386 . . . . 0.0 110.868 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.47 -29.54 59.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 0.0 111.98 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -81.71 -29.18 33.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.829 0.452 . . . . 0.0 110.274 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.32 -38.86 71.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.619 0.768 . . . . 0.0 110.831 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.776 177.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.35 104.71 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.523 2.149 . . . . 0.0 111.717 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.42 99.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.138 0.971 . . . . 0.0 110.68 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 8.2 p-10 -71.07 139.32 50.35 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.024 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.485 HD11 HG23 ' A' ' 23' ' ' THR . 45.2 tp -146.81 117.86 7.74 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.714 1.205 . . . . 0.0 108.833 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -154.13 52.59 0.8 Allowed Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.72 -31.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.929 1.753 . . . . 0.0 113.622 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.7 m-85 -131.29 17.21 4.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.707 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' HA ' HD23 ' A' ' 16' ' ' LEU . 28.9 mt -68.05 121.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.523 ' HB2' HG21 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -96.64 92.44 1.1 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.39 82.05 2.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.725 2.283 . . . . 0.0 111.298 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.97 -37.85 0.26 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.092 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 10' ' ' LEU . 6.4 m -82.71 159.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.889 0.476 . . . . 0.0 110.513 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -83.77 -0.21 50.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.318 0.647 . . . . 0.0 112.701 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -131.15 -174.04 3.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.815 0.846 . . . . 0.0 111.354 -171.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 17' ' ' SER . 1.5 tm? -139.1 147.34 41.84 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 16' ' ' LEU . 25.3 t -63.62 -77.52 0.05 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.43 0.692 . . . . 0.0 111.011 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -145.44 94.63 2.54 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.802 0.441 . . . . 0.0 110.621 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.32 132.91 68.83 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 122.25 11.24 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.637 2.225 . . . . 0.0 111.927 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.456 ' HA ' HD23 ' A' ' 24' ' ' LEU . 13.5 pt20 -64.63 -22.78 67.06 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.027 0.931 . . . . 0.0 111.212 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -60.91 -39.28 88.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.16 0.984 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.485 HG23 HD11 ' A' ' 5' ' ' LEU . 33.0 m -71.51 -37.15 71.24 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.16 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.3 mm? -63.44 -37.0 85.61 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.684 0.675 . . . . 0.0 110.789 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -63.91 -35.0 79.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.046 0.539 . . . . 0.0 110.519 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 10.5 tp10 -70.37 -36.72 74.31 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.764 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG23 HD13 ' A' ' 38' ' ' ILE . 11.9 mm -63.36 -42.32 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 32' ' ' ILE . 67.6 mtt180 -65.32 -25.29 67.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.451 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -71.78 -43.97 64.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.675 0.39 . . . . 0.0 111.101 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.23 0.612 . . . . 0.0 110.429 -177.008 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.0 p -67.18 -18.67 65.36 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.338 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 28' ' ' ARG . 44.4 mm -66.67 -28.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -71.57 -15.79 62.29 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.382 0.673 . . . . 0.0 110.446 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.79 -22.19 19.57 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 123.547 0.594 . . . . 0.0 113.238 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 154.64 45.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.563 0.745 . . . . 0.0 110.043 173.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.9 147.0 34.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.074 . . . . 0.0 108.607 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -129.03 117.02 20.21 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 27' ' ' ILE . 1.6 mp -107.5 115.37 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.516 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 92.0 mtt180 -88.25 88.51 7.66 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 58.8 mt -71.47 77.49 0.78 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 -99.91 0.53 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -169.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -110.71 -4.37 15.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.308 1.043 . . . . 0.0 111.618 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.0 mt -83.46 111.26 18.89 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.516 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.6 tpt -87.54 103.95 16.03 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.163 0.506 . . . . 0.0 110.409 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.99 152.28 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.081 0.952 . . . . 0.0 109.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.2 109.44 6.47 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.688 0.795 . . . . 0.0 109.704 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 56' ' ' PHE . 34.6 mm -97.34 110.21 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.853 0.861 . . . . 0.0 109.163 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -128.05 116.74 20.46 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 122.744 0.417 . . . . 0.0 110.831 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 71.0 Cg_endo -84.17 -0.4 9.51 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 113.057 166.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.0 tpp -73.26 -45.84 53.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.108 0.563 . . . . 0.0 111.438 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -155.52 150.54 26.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.716 -173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t 68.88 110.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.048 1.339 . . . . 0.0 110.183 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 76.2 137.27 0.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.258 1.423 . . . . 0.0 110.629 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.31 -35.96 91.73 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.218 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -122.62 169.49 10.98 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' HB2' HG22 ' A' ' 47' ' ' ILE . 50.2 p90 -86.76 129.0 35.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.087 0.47 . . . . 0.0 110.385 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.562 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -158.5 -176.4 5.87 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.389 1.075 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.35 114.02 3.9 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.811 0.695 . . . . 0.0 114.552 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.7 t -134.01 120.44 20.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.6 tp -89.04 144.15 26.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.457 . . . . 0.0 111.961 -174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -96.52 81.64 3.26 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.468 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -78.19 -14.09 59.59 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.436 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.19 106.79 0.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.431 1.092 . . . . 0.0 110.827 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.85 20.45 77.93 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.547 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -97.55 155.22 17.06 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.748 0.819 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 m -66.73 139.81 57.84 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.97 -34.44 74.76 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.203 0.601 . . . . 0.0 112.269 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.034 0.533 . . . . 0.0 109.736 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.47 -23.84 67.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.582 0.753 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.5 mt -72.87 -42.73 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 122.971 0.508 . . . . 0.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -65.27 -58.32 6.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.4 -26.66 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.354 -178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.6 24.22 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.269 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.06 -34.47 78.14 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.705 0.752 . . . . 0.0 112.167 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -73.05 -34.49 66.31 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.974 0.416 . . . . 0.0 110.808 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.483 ' O ' HG12 ' A' ' 80' ' ' ILE . 5.0 m-85 -69.9 -29.83 67.11 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.818 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.71 -45.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.296 0.638 . . . . 0.0 110.892 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.79 -26.98 64.53 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.559 0.537 . . . . 0.0 110.251 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.88 -43.96 82.12 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.46 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.5 mm -66.37 -29.23 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 110.983 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 51.8 mt-10 -64.36 -44.04 92.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.09 0.471 . . . . 0.0 110.232 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -66.35 -31.45 72.24 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.803 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -78.88 -35.59 43.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.504 0.722 . . . . 0.0 111.466 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.4 mt -99.46 7.72 45.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.818 0.847 . . . . 0.0 112.172 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.46 118.77 7.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -94.15 8.92 39.89 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.12 -148.69 20.61 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 121.775 -0.25 . . . . 0.0 113.055 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -63.21 93.67 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 111.241 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -144.01 137.42 27.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.596 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 15.4 m -103.58 145.59 29.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 t -54.86 -37.96 66.88 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.712 0.633 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -68.06 -38.87 82.94 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.596 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 47.6 mt-10 -61.18 -45.0 96.41 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.852 0.461 . . . . 0.0 111.564 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.57 -24.79 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.807 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.0 m -72.87 -52.05 16.33 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.05 0.54 . . . . 0.0 111.437 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.01 -27.44 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.736 0.815 . . . . 0.0 112.418 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.36 -48.32 80.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.877 0.871 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -83.04 -24.76 32.65 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.085 0.554 . . . . 0.0 111.272 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -75.68 -36.93 59.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.106 0.962 . . . . 0.0 111.325 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 CA--C 1.567 1.621 0 C-N-CA 122.731 0.412 . . . . 0.0 111.614 -178.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 CA--C 1.544 0.742 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 23.6 Cg_exo -63.64 119.35 6.38 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.268 2.646 . . . . 0.0 114.189 -170.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 38' ' ' ILE . 17.1 t -76.7 93.95 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.927 0.891 . . . . 0.0 108.713 169.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.48 102.2 1.1 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.5 100.3 7.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.564 0.746 . . . . 0.0 109.272 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.538 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.9 t -151.0 47.32 0.43 Allowed Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 123.263 0.625 . . . . 0.0 111.704 170.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 6' ' ' THR . 5.9 Cg_exo -80.75 -45.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.751 2.3 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 5.4 m-85 -126.89 20.5 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.962 0.905 . . . . 0.0 110.617 -170.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' HA ' ' HG ' ' A' ' 16' ' ' LEU . 26.9 mt -65.77 131.24 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 117.893 0.315 . . . . 0.0 110.701 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -110.93 88.5 8.23 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.63 -2.62 12.12 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.464 2.109 . . . . 0.0 112.959 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.94 -21.56 57.17 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 123.17 0.414 . . . . 0.0 113.488 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.97 166.06 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 117.371 0.586 . . . . 0.0 111.05 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 t -67.93 -23.72 65.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.37 1.068 . . . . 0.0 112.27 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -112.32 175.53 5.39 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.818 0.818 . . . . 0.0 111.672 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 9' ' ' ILE . 3.1 tt -109.67 152.1 26.03 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 48.6 m -55.66 -55.45 32.01 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.45 0.568 . . . . 0.0 111.185 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -167.97 128.75 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.37 1.068 . . . . 0.0 108.273 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.3 mt -98.94 119.85 59.97 Favored Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 42.8 Cg_endo -67.51 142.61 59.86 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.26 1.974 . . . . 0.0 111.411 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.6 -27.01 67.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.69 0.796 . . . . 0.0 111.495 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 13.4 pt-20 -68.14 -31.45 71.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.628 0.771 . . . . 0.0 112.148 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.9 m -68.19 -52.21 36.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 95.5 mt -57.73 -42.52 84.03 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.27 0.981 . . . . 0.0 111.539 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.5 p -66.01 -33.55 76.06 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 124.049 0.843 . . . . 0.0 111.39 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 35.0 tt0 -70.22 -43.44 70.64 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 174.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.74 -35.86 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.5 0.72 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.8 mmt85 -63.97 -37.82 88.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.69 -40.46 84.38 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.089 0.556 . . . . 0.0 109.831 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 71.2 mm-40 -71.66 -33.95 69.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.523 0.729 . . . . 0.0 111.25 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.452 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 34.5 p -66.31 -26.23 67.21 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.719 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.5 mm -70.1 -27.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 120.604 0.24 . . . . 0.0 110.494 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -73.53 -14.57 61.23 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.396 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.81 15.64 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 123.849 0.738 . . . . 0.0 113.415 171.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.57 126.76 18.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.418 0.687 . . . . 0.0 109.734 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HB2' ' HB ' ' A' ' 47' ' ' ILE . . . -110.01 102.14 10.9 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.486 1.115 . . . . 0.0 108.643 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 13.7 mp0 -82.43 120.27 25.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.545 HG13 ' HB ' ' A' ' 3' ' ' VAL . 2.4 mp -118.76 127.44 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -98.38 95.31 7.26 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 90.5 mt -79.1 70.46 5.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.046 174.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -103.37 0.92 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.735 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.48 -18.3 28.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.615 0.766 . . . . 0.0 110.959 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 12.4 mt -86.07 109.18 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.61 0.764 . . . . 0.0 109.459 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.1 tpt -86.61 101.83 13.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.46 152.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.191 0.997 . . . . 0.0 109.003 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 59' ' ' SER . 64.0 m -141.35 102.83 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.503 0.721 . . . . 0.0 109.621 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.589 HG21 ' HB2' ' A' ' 56' ' ' PHE . 22.1 mm -84.03 110.62 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.363 1.465 . . . . 0.0 110.874 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.63 131.14 23.53 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 41.8 Cg_endo -64.28 -32.7 61.57 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.927 2.418 . . . . 0.0 111.392 168.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.9 tpp 67.54 147.78 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.174 1.39 . . . . 0.0 111.377 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.26 178.54 8.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.879 0.472 . . . . 0.0 109.979 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.282 15.0 p 54.34 -70.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 126.624 1.97 . . . . 0.0 114.19 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -152.0 152.55 32.59 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.339 0.656 . . . . 0.0 109.658 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.14 -178.81 20.86 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -153.92 178.65 9.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.654 0.782 . . . . 0.0 109.786 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.589 ' HB2' HG21 ' A' ' 47' ' ' ILE . 9.7 p90 -85.63 121.92 29.0 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 122.005 0.907 . . . . 0.0 111.388 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.6 ptp -146.37 -179.18 6.57 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 121.16 22.43 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.439 0.462 . . . . 0.0 112.485 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' SER . 42.8 t -130.5 97.8 4.49 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 172.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -76.09 120.7 21.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.985 0.914 . . . . 0.0 109.204 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.57 100.76 0.91 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.528 ' HA ' HD21 ' A' ' 65' ' ' LEU . 10.1 pt20 -112.1 6.12 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -161.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.5 120.56 22.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.864 0.466 . . . . 0.0 111.016 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.47 18.57 75.65 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 113.673 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 62' ' ' GLN . 10.9 mp -92.4 -176.31 4.28 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.884 0.85 . . . . 0.0 111.62 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.8 t -119.76 151.19 39.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.356 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.02 -15.89 37.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.19 -57.57 6.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.58 0.752 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.08 -35.29 80.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.381 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mm -56.65 -46.72 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.565 0.746 . . . . 0.0 110.908 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.9 -53.02 36.32 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.477 0.486 . . . . 0.0 110.851 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.521 HG22 HD13 ' A' ' 43' ' ' LEU . 49.5 mt -54.77 -41.88 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 123.827 0.705 . . . . 0.0 109.562 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.5 ' HA2' HD11 ' A' ' 43' ' ' LEU . . . -58.72 -58.07 16.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.629 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -65.75 -26.22 67.63 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.106 0.453 . . . . 0.0 111.919 -172.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.83 -46.58 84.43 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.601 0.761 . . . . 0.0 110.457 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.449 ' O ' HG12 ' A' ' 80' ' ' ILE . 48.9 m-85 -70.82 -33.22 70.47 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.433 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.03 -43.98 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.989 0.916 . . . . 0.0 111.194 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.47 -25.47 60.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.778 0.431 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.22 -42.17 72.65 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.774 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -67.22 -40.81 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.988 0.915 . . . . 0.0 111.65 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.4 -36.08 79.3 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.188 0.305 . . . . 0.0 111.226 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -71.31 -44.2 65.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.439 0.696 . . . . 0.0 110.097 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -61.8 -38.77 89.33 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.592 1.157 . . . . 0.0 112.234 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.94 -46.18 9.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.057 0.543 . . . . 0.0 111.818 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -145.96 93.45 2.34 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.256 0.55 . . . . 0.0 110.653 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -80.56 98.21 7.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.6 157.64 25.8 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.211 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 m -83.92 69.21 10.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.547 0.739 . . . . 0.0 109.792 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -76.15 153.18 36.4 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.489 -176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.537 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 58.2 m -85.3 144.17 28.25 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -59.4 -51.42 70.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.878 0.471 . . . . 0.0 111.674 -172.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -63.2 -19.5 64.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 0.0 112.612 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.537 ' HG2' ' HB ' ' A' ' 90' ' ' THR . 10.3 mm-40 -59.21 -52.72 64.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.253 0.621 . . . . 0.0 111.559 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.3 m -90.44 -27.37 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 122.992 0.517 . . . . 0.0 112.026 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -72.63 -33.28 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.811 0.444 . . . . 0.0 111.527 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.3 p -59.81 -27.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.722 0.409 . . . . 0.0 111.013 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 mp -54.25 -51.45 64.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.501 1.12 . . . . 0.0 111.239 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -81.67 -27.11 34.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 0.0 111.101 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.84 -27.91 36.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.769 0.828 . . . . 0.0 112.359 -166.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 96' ' ' VAL . 9.1 pt . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 119.139 -0.457 . . . . 0.0 110.503 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.17 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.391 2.787 0 CA-C-N 121.21 1.468 . . . . 0.0 112.454 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.3 128.76 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.061 0.544 . . . . 0.0 110.048 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.91 129.53 37.83 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.2 100.72 4.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.524 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.4 t -152.79 38.24 0.12 Allowed Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -79.79 -18.48 10.38 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 121.621 1.547 . . . . 0.0 111.978 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.33 -9.07 5.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.051 -171.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 6' ' ' THR . 29.2 mt -47.9 116.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -164.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 17' ' ' SER . 44.8 mt -98.93 98.33 6.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.17 1.388 . . . . 0.0 108.438 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.85 42.12 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.686 2.257 . . . . 0.0 112.588 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.23 -6.17 0.57 Allowed Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.819 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.2 163.8 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.766 0.827 . . . . 0.0 110.254 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -77.56 -38.56 48.24 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.992 0.917 . . . . 0.0 111.621 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -82.29 -175.22 5.57 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.067 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.64 HD22 HG12 ' A' ' 19' ' ' ILE . 12.1 tp -137.99 136.49 36.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.062 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.486 ' HB2' HD11 ' A' ' 10' ' ' LEU . 22.0 t -58.63 -33.72 70.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.886 0.874 . . . . 0.0 111.813 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -162.4 148.04 12.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 108.599 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.64 HG12 HD22 ' A' ' 16' ' ' LEU . 64.6 mt -127.43 124.58 23.65 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 166.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.42 113.44 1.79 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.075 1.85 . . . . 0.0 110.555 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HA ' HD23 ' A' ' 24' ' ' LEU . 24.0 tm0? -64.91 -22.73 67.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.835 0.854 . . . . 0.0 110.727 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.72 -38.32 69.61 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.223 0.609 . . . . 0.0 111.101 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.403 ' O ' HG12 ' A' ' 27' ' ' ILE . 26.3 m -71.91 -36.64 70.05 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.676 0.79 . . . . 0.0 110.751 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 21' ' ' GLN . 4.1 mm? -63.59 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.833 0.453 . . . . 0.0 110.517 173.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -68.66 -33.21 73.6 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.508 0.723 . . . . 0.0 110.864 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 12.6 tp10 -65.64 -45.9 81.25 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.731 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 23' ' ' THR . 32.9 mm -60.49 -39.78 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.424 ' NH2' ' HB2' ' A' ' 88' ' ' SER . 55.9 mmm-85 -61.88 -38.46 88.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.378 0.671 . . . . 0.0 110.966 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 33.7 t30 -62.05 -41.31 98.0 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.814 0.846 . . . . 0.0 110.871 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.49 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 61.7 mt-30 -79.51 -32.08 42.32 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.008 0.923 . . . . 0.0 112.415 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.1 -38.82 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.202 0.525 . . . . 0.0 110.024 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -72.17 -12.39 61.16 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.901 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -8.62 58.21 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.475 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -140.12 124.54 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.242 0.521 . . . . 0.0 111.041 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -145.56 143.39 29.9 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.232 1.013 . . . . 0.0 108.585 168.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -137.27 153.9 50.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.43 129.58 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -96.91 87.49 4.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 78.7 mt -70.79 74.89 0.61 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.422 0.689 . . . . 0.0 109.253 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.42 -101.47 0.76 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -100.77 -16.77 17.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.516 0.726 . . . . 0.0 111.282 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.6 mt -74.97 110.53 9.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.309 0.644 . . . . 0.0 109.361 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.1 tpt -85.57 129.23 34.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.67 117.33 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.648 0.779 . . . . 0.0 109.803 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.5 m -86.87 111.98 21.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.341 0.656 . . . . 0.0 110.227 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 mm -119.19 88.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -154.44 139.12 11.61 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.92 -0.488 . . . . 0.0 111.574 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.33 102.58 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.849 2.366 . . . . 0.0 111.907 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -81.29 150.34 28.56 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.729 1.212 . . . . 0.0 110.783 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.75 175.32 2.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.863 0.465 . . . . 0.0 111.992 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m 65.14 -58.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 127.524 2.33 . . . . 0.0 111.862 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -173.54 150.41 1.78 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 107.795 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.0 87.41 1.19 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.485 ' HE1' HD22 ' A' ' 97' ' ' LEU . 11.5 m-85 -77.5 -176.4 4.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.265 1.026 . . . . 0.0 111.28 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.033 0.92 . . . . 0.0 108.928 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.637 ' HA ' HD21 ' A' ' 84' ' ' LEU . 14.7 ptp -158.17 172.4 18.46 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.658 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 110.15 1.56 Allowed Glycine 0 C--N 1.352 1.458 0 O-C-N 123.978 0.799 . . . . 0.0 113.199 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -134.35 119.07 18.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.712 0.805 . . . . 0.0 109.491 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.85 124.93 34.66 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.033 0.933 . . . . 0.0 109.525 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.69 107.1 16.71 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.521 0.729 . . . . 0.0 109.104 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -83.88 -14.92 49.9 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.083 0.953 . . . . 0.0 112.235 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.26 113.35 3.53 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.505 0.722 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.0 0.74 85.33 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.964 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.39 161.98 14.17 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.597 0.759 . . . . 0.0 110.815 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 70' ' ' ILE . 46.1 m -97.52 163.73 12.73 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.18 0.592 . . . . 0.0 110.379 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -61.18 -42.08 97.93 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.97 0.908 . . . . 0.0 112.641 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.74 -37.21 86.83 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.222 0.534 . . . . 0.0 109.978 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.4 -22.91 58.94 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.684 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 66' ' ' SER . 46.0 mm -65.79 -43.86 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -69.6 -45.92 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.269 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -66.82 -34.32 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 123.727 0.642 . . . . 0.0 109.481 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.32 -57.26 17.55 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.724 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.7 pp -67.96 -33.52 74.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.98 0.512 . . . . 0.0 111.854 -171.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.84 -38.33 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.059 0.456 . . . . 0.0 110.038 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.459 ' O ' HG12 ' A' ' 80' ' ' ILE . 6.2 m-85 -69.47 -29.86 67.62 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.816 173.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -68.56 -35.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 110.591 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 49.9 mt-10 -70.27 -32.6 70.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.886 0.741 . . . . 0.0 110.345 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.422 ' HD1' HD13 ' A' ' 19' ' ' ILE . 36.0 t-80 -74.21 -41.59 61.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.997 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.8 mm -63.02 -37.61 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.698 0.799 . . . . 0.0 109.111 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.79 -48.5 81.06 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 123.797 0.686 . . . . 0.0 109.743 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -34.4 77.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.415 0.447 . . . . 0.0 111.308 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -79.26 -24.21 43.12 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 111.823 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 57' ' ' MET . 19.5 tp -110.15 -20.19 12.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.704 . . . . 0.0 111.884 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.495 ' OD1' ' HA ' ' A' ' 90' ' ' THR . 64.2 t30 -72.11 150.07 44.2 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.095 0.558 . . . . 0.0 109.836 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.9 t60 76.81 -9.96 1.42 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.812 1.245 . . . . 0.0 110.71 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.31 86.52 1.56 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.424 ' HB2' ' NH2' ' A' ' 28' ' ' ARG . 32.3 t 79.94 -42.13 0.24 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.185 1.794 . . . . 0.0 111.693 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.23 162.18 26.8 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.226 0.61 . . . . 0.0 110.523 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.63 HG22 ' HG2' ' A' ' 93' ' ' GLU . 14.8 t -140.68 -175.96 4.48 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.129 0.972 . . . . 0.0 109.175 174.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -54.28 -35.98 63.17 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.033 0.933 . . . . 0.0 111.995 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -66.83 -41.28 87.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.049 0.539 . . . . 0.0 111.219 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.63 ' HG2' HG22 ' A' ' 90' ' ' THR . 22.7 mm-40 -71.56 -22.15 61.79 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -170.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.02 -27.85 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 118.072 0.396 . . . . 0.0 111.19 168.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.4 m -79.35 -28.38 42.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.096 0.558 . . . . 0.0 112.136 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.77 -17.81 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.288 0.635 . . . . 0.0 112.266 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD22 ' HE1' ' A' ' 55' ' ' TYR . 3.8 mm? -66.41 -35.09 79.43 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.295 0.638 . . . . 0.0 110.099 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.64 -31.14 28.91 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.236 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.11 -38.54 78.95 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.563 0.745 . . . . 0.0 112.187 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 123.365 0.666 . . . . 0.0 111.856 -175.612 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.5 141.35 60.84 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.993 2.462 . . . . 0.0 114.45 -173.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.81 92.63 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.845 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.21 113.77 4.23 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 7' ' ' PRO . 3.9 tt -125.71 95.12 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.495 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.2 t -154.46 52.92 0.81 Allowed Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.465 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 6' ' ' THR . 3.2 Cg_exo -80.59 -38.53 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.374 2.049 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.29 17.25 6.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.526 0.73 . . . . 0.0 111.866 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.439 ' HA ' HD23 ' A' ' 16' ' ' LEU . 22.7 mt -64.15 133.49 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 1.3 mm? -102.2 101.7 20.65 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.62 1.168 . . . . 0.0 107.911 176.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 10' ' ' LEU . 6.8 Cg_exo -72.33 92.84 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.567 2.844 . . . . 0.0 111.458 -169.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -38.58 1.65 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.729 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.92 142.37 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 122.852 0.461 . . . . 0.0 110.023 -175.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 p -74.12 -23.7 59.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 111.681 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -109.54 177.34 4.77 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.256 0.622 . . . . 0.0 111.619 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.55 149.31 47.11 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.995 -177.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -61.01 -57.92 10.58 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.606 0.762 . . . . 0.0 110.023 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -171.62 133.91 0.81 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.123 0.89 . . . . 0.0 109.307 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 83' ' ' THR . 58.6 mt -103.61 136.48 19.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.62 112.69 1.08 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.691 2.26 . . . . 0.0 111.644 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.507 ' HA ' HD22 ' A' ' 24' ' ' LEU . 93.1 mt-30 -63.89 -24.99 67.95 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.526 0.731 . . . . 0.0 111.699 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.3 -35.06 76.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.376 0.67 . . . . 0.0 110.957 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.426 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.8 m -74.23 -27.44 60.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.171 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.507 HD22 ' HA ' ' A' ' 21' ' ' GLN . 3.7 mm? -72.27 -34.09 67.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -62.95 -38.92 93.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.353 0.661 . . . . 0.0 111.571 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 11.3 pt-20 -71.08 -34.84 71.54 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.278 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.436 HD11 HD11 ' A' ' 24' ' ' LEU . 78.4 mt -63.05 -36.89 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.077 0.551 . . . . 0.0 110.206 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 32' ' ' ILE . 10.9 mmm180 -57.87 -38.4 75.65 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 110.284 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -68.61 -43.78 75.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.851 0.86 . . . . 0.0 111.375 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.5 mm-40 -65.44 -37.19 86.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.948 0.499 . . . . 0.0 110.644 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -69.57 -22.84 63.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.452 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.1 mm -69.13 -36.16 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.468 ' HE ' ' HB3' ' A' ' 35' ' ' GLU . 39.9 ttp-105 -66.35 -34.46 78.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 169.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.05 5.4 47.01 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.637 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HB3' ' HE ' ' A' ' 33' ' ' ARG . 1.9 tm-20 -133.93 107.83 8.05 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 30' ' ' GLN . . . -134.56 95.54 3.39 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -98.27 104.77 16.83 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.9 mp -104.64 128.22 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.306 0.643 . . . . 0.0 109.838 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -105.46 98.47 8.16 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.641 0.376 . . . . 0.0 109.987 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 97.3 mt -77.33 64.95 2.8 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.681 0.792 . . . . 0.0 110.093 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.54 -110.0 3.06 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.238 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 -20.82 37.69 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.389 0.675 . . . . 0.0 110.903 175.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -81.56 110.98 17.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.08 130.35 35.03 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.08 145.54 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.087 0.955 . . . . 0.0 108.992 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -135.96 97.69 3.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.83 0.452 . . . . 0.0 110.507 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 36' ' ' ALA . 5.7 mm -72.3 102.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.887 0.875 . . . . 0.0 109.0 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -129.25 123.15 21.44 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.25 151.63 80.65 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -78.25 132.44 37.53 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -58.8 -34.6 71.67 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.754 0.659 . . . . 0.0 112.263 -171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.33 115.67 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.012 0.925 . . . . 0.0 109.187 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.29 80.26 0.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.73 1.212 . . . . 0.0 112.522 171.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.03 130.9 1.31 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.375 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.19 147.7 42.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.112 0.965 . . . . 0.0 111.249 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.42 ' HB2' HG23 ' A' ' 47' ' ' ILE . 21.5 p90 -87.77 114.0 23.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.745 0.783 . . . . 0.0 108.937 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtm -130.06 -174.74 3.41 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.708 1.203 . . . . 0.0 108.268 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.65 137.93 49.78 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.878 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -133.66 98.82 4.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.754 0.822 . . . . 0.0 108.847 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.54 104.21 3.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.221 0.609 . . . . 0.0 109.679 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.15 109.65 3.64 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 49.6 tt0 -83.94 -75.77 0.32 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 35.7 43.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.627 1.571 . . . . 0.0 114.105 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.84 -19.78 4.65 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.811 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 62' ' ' GLN . 4.1 mp -63.31 148.91 46.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.188 0.994 . . . . 0.0 110.654 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 m -149.61 -168.15 3.03 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.986 1.315 . . . . 0.0 108.005 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.53 -168.35 0.2 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.15 0.58 . . . . 0.0 111.257 165.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.64 -18.46 20.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.164 0.986 . . . . 0.0 112.759 169.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.12 -40.78 77.78 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.782 0.433 . . . . 0.0 110.869 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.3 mm -56.12 -49.28 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.998 0.519 . . . . 0.0 111.131 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.24 -54.82 40.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.737 0.815 . . . . 0.0 111.429 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.04 -37.87 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.929 0.892 . . . . 0.0 110.103 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -63.2 -59.71 8.59 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.581 177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -67.42 -27.92 67.46 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -172.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -67.26 -41.65 85.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.119 0.567 . . . . 0.0 110.189 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -73.47 -25.52 60.51 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.991 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -63.86 -43.27 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.4 -34.36 65.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.117 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.08 -39.73 93.62 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.814 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' LEU . 68.2 mt -66.33 -34.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.591 0.756 . . . . 0.0 110.24 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.65 -47.07 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.046 0.539 . . . . 0.0 110.106 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -76.47 -30.44 57.29 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.491 1.116 . . . . 0.0 112.722 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.445 HG21 HD12 ' A' ' 19' ' ' ILE . 31.3 m -86.65 -28.56 23.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.871 0.469 . . . . 0.0 111.659 -173.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -87.98 -38.58 15.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.216 1.006 . . . . 0.0 109.888 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -139.64 148.7 42.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.636 -1.166 . . . . 0.0 107.915 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -65.8 -34.86 79.14 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 119.045 0.839 . . . . 0.0 110.15 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.63 0.46 Allowed Glycine 0 C--N 1.348 1.241 0 CA-C-N 114.42 -1.263 . . . . 0.0 114.706 165.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 m 67.03 20.99 10.34 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.213 1.405 . . . . 0.0 111.756 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.46 165.71 24.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.082 0.553 . . . . 0.0 110.011 173.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 37.9 m -79.76 140.3 36.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.3 t -65.02 -45.55 85.03 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.385 0.428 . . . . 0.0 110.33 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.336 0.654 . . . . 0.0 111.492 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 4.7 tm-20 -58.68 -51.47 69.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 109.982 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.66 -23.52 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.249 0.62 . . . . 0.0 112.254 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 m -66.5 -48.53 69.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.593 0.357 . . . . 0.0 110.466 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.7 m -69.41 -24.41 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.269 0.628 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 89.6 mt -66.26 -47.35 73.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.99 0.424 . . . . 0.0 110.08 171.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -80.41 -24.14 39.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.682 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -75.65 -46.8 29.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.692 0.797 . . . . 0.0 111.841 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.952 -172.095 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.45 92.65 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.237 1.958 . . . . 0.0 111.077 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.61 99.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.75 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.11 146.21 53.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 58.9 tp -146.25 93.5 2.32 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.913 -1.144 . . . . 0.0 107.913 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -139.02 33.7 0.21 Allowed Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.42 -33.57 0.96 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 CA-C-N 121.173 1.455 . . . . 0.0 112.731 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.553 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 39.9 m-85 -129.34 22.1 5.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.527 0.731 . . . . 0.0 111.651 -174.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -64.25 123.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD11 ' OG ' ' A' ' 17' ' ' SER . 25.3 mt -111.7 85.76 6.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.55 -12.8 34.08 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.407 2.071 . . . . 0.0 113.083 -167.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.83 -12.81 79.2 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.767 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -126.92 178.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 117.826 0.813 . . . . 0.0 111.128 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 p -84.13 -42.94 15.5 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.184 0.994 . . . . 0.0 111.983 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -81.97 -177.95 6.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.471 0.653 . . . . 0.0 112.207 -173.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD13 ' N ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -134.63 148.42 50.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.277 1.031 . . . . 0.0 108.336 -173.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.553 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 49.3 m -84.86 63.94 8.33 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.543 0.687 . . . . 0.0 111.223 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.5 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.197 1.399 . . . . 0.0 112.094 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 65.6 mt -68.85 136.32 89.95 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.213 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 17.2 Cg_endo -58.22 117.57 4.3 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.871 1.714 . . . . 0.0 110.504 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.436 ' HA ' HD21 ' A' ' 24' ' ' LEU . 5.0 pt20 -62.35 -18.24 60.98 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.665 0.786 . . . . 0.0 111.365 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.8 -46.55 77.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.787 1.235 . . . . 0.0 110.48 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.1 m -60.89 -47.34 86.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.274 0.629 . . . . 0.0 110.933 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.8 mm? -58.58 -42.36 87.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.668 0.605 . . . . 0.0 110.741 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -63.09 -32.62 74.04 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.913 0.758 . . . . 0.0 111.44 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.8 tp10 -71.66 -45.46 61.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.233 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.25 -35.6 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.935 0.894 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' O ' HG12 ' A' ' 32' ' ' ILE . 22.5 mmm180 -56.77 -42.67 79.81 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.786 0.834 . . . . 0.0 110.608 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -72.97 -40.52 65.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.666 0.786 . . . . 0.0 111.488 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 24.5 mm-40 -64.47 -40.62 96.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.491 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.9 p -69.96 -24.85 63.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.225 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.9 mm -68.46 -32.78 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 172.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.09 -12.33 58.28 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.981 0.419 . . . . 0.0 110.409 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.42 -16.94 29.04 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 114.491 0.557 . . . . 0.0 114.491 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -134.9 116.8 15.16 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.35 0.575 . . . . 0.0 111.223 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.59 138.09 54.69 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.71 105.03 5.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.419 HD11 HG12 ' A' ' 47' ' ' ILE . 2.8 mp -101.81 114.81 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.713 0.805 . . . . 0.0 109.636 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 42.7 mtm180 -87.08 93.56 9.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 86.4 mt -75.89 71.54 2.71 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.119 0.485 . . . . 0.0 109.815 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.33 -101.99 0.56 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.594 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -99.61 -15.02 18.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.783 0.833 . . . . 0.0 111.251 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 18.3 mt -83.5 109.77 17.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.451 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.7 tpt -86.51 117.88 25.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.31 149.97 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 59' ' ' SER . 57.1 m -137.17 134.44 36.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.844 0.858 . . . . 0.0 108.902 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.49 HG23 HD21 ' A' ' 84' ' ' LEU . 31.9 mm -112.85 104.03 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -127.91 107.6 20.22 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.102 0.561 . . . . 0.0 109.54 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.22 142.84 38.47 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.606 2.204 . . . . 0.0 111.738 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 mmt -128.1 154.68 45.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.151 0.98 . . . . 0.0 109.087 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -67.93 171.83 6.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.528 168.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.253 9.6 p 46.59 75.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.015 1.326 . . . . 0.0 113.284 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 63.6 21.08 12.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.062 1.345 . . . . 0.0 113.689 170.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.68 76.1 1.25 Allowed Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HB2' HG13 ' A' ' 94' ' ' VAL . 88.8 m-85 -74.55 136.11 42.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.264 0.625 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.402 ' HB2' HG22 ' A' ' 47' ' ' ILE . 27.0 p90 -88.1 110.2 20.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.784 0.433 . . . . 0.0 110.648 -175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.4 ptt? -170.26 108.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.551 0.74 . . . . 0.0 109.852 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.21 106.18 0.01 OUTLIER Glycine 0 CA--C 1.541 1.69 0 O-C-N 124.532 1.145 . . . . 0.0 115.765 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 46' ' ' SER . 28.7 t -134.98 99.78 4.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.81 113.92 12.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 109.428 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -68.7 109.08 3.64 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.757 0.661 . . . . 0.0 109.474 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.15 7.5 46.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.244 1.018 . . . . 0.0 112.004 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.61 95.35 0.48 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.067 0.547 . . . . 0.0 110.548 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.69 9.92 86.57 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.784 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 HD23 HD11 ' A' ' 70' ' ' ILE . 12.8 tp -84.96 143.77 28.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.321 0.649 . . . . 0.0 110.56 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 70' ' ' ILE . 33.0 t -64.05 148.74 49.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.761 0.824 . . . . 0.0 111.674 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.35 -32.66 71.48 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 111.617 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.8 -38.92 73.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.35 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -69.2 -28.02 66.01 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.52 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.472 HD11 HD23 ' A' ' 65' ' ' LEU . 33.6 mm -64.63 -45.25 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.528 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 tt0 -61.86 -57.1 13.11 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.07 0.856 . . . . 0.0 111.281 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.27 -37.75 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 77' ' ' ILE . . . -59.46 -52.6 52.17 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.115 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.578 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.99 -24.81 65.18 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.295 0.547 . . . . 0.0 111.537 -174.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 80.0 mm-40 -59.69 -50.74 72.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.497 0.665 . . . . 0.0 109.327 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -68.84 -26.66 65.27 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.993 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.578 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.91 -37.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.11 -38.76 75.69 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.856 0.863 . . . . 0.0 111.987 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -76.89 -48.12 19.22 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.029 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.65 -29.85 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.349 0.66 . . . . 0.0 110.646 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -47.14 -66.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.401 1.08 . . . . 0.0 111.161 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -71.0 -24.43 62.38 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.083 -173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.0 m -72.72 -23.43 60.85 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.113 0.565 . . . . 0.0 111.448 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 47' ' ' ILE . 34.2 tp -113.3 -56.46 2.4 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -171.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.31 136.92 13.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.773 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -167.85 -47.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.609 0.764 . . . . 0.0 109.698 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.72 -86.06 0.12 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.388 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -145.1 22.57 1.55 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.1 163.57 33.88 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.293 0.637 . . . . 0.0 111.185 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 93' ' ' GLU . 5.3 t -93.41 166.89 12.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.801 0.841 . . . . 0.0 110.954 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.7 p -59.85 -36.55 77.07 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 0.0 110.632 172.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -62.38 -33.31 74.5 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.636 0.774 . . . . 0.0 111.339 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.503 ' H ' HG22 ' A' ' 90' ' ' THR . 7.1 tp10 -65.9 -48.7 70.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.072 0.549 . . . . 0.0 110.031 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' A' ' 55' ' ' TYR . 15.7 m -73.66 -24.12 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 100.0 m -65.45 -46.46 79.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.866 0.466 . . . . 0.0 110.495 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 100' ' ' ILE . 25.0 m -75.24 -23.65 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.323 0.249 . . . . 0.0 111.393 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 93' ' ' GLU . 5.4 mp -62.47 -47.85 82.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.681 0.792 . . . . 0.0 110.261 169.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -74.0 -23.16 59.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -76.62 -35.93 57.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.134 0.974 . . . . 0.0 110.463 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 96' ' ' VAL . 38.4 pt . . . . . 0 CA--C 1.568 1.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.352 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.26 122.76 4.76 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.471 2.114 . . . . 0.0 111.137 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.21 103.7 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 0.0 109.172 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -70.35 136.46 49.73 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.17 0.51 . . . . 0.0 110.168 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 23' ' ' THR . 48.2 tp -136.29 100.59 4.43 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.547 1.139 . . . . 0.0 108.283 -175.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.405 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -143.31 42.17 0.39 Allowed Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 6' ' ' THR . 97.1 Cg_endo -82.34 -34.85 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 121.546 1.497 . . . . 0.0 112.803 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -129.66 25.11 5.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.053 0.941 . . . . 0.0 110.848 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.81 121.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.473 ' HB2' HG21 ' A' ' 13' ' ' VAL . 26.7 mt -111.07 91.56 13.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -16.99 47.46 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.736 2.291 . . . . 0.0 113.502 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.84 -27.78 64.11 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.46 0.475 . . . . 0.0 113.142 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' A' ' 10' ' ' LEU . 16.3 m -112.19 170.37 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 0.0 110.77 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -90.37 -23.62 21.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.243 1.017 . . . . 0.0 112.18 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -95.57 168.01 10.95 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.372 0.606 . . . . 0.0 111.682 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.67 143.61 39.19 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -57.22 -64.84 0.75 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.43 0.692 . . . . 0.0 111.081 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -170.89 123.3 0.61 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.04 135.1 32.09 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.879 0.471 . . . . 0.0 109.859 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.79 123.13 12.66 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.86 2.374 . . . . 0.0 111.566 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.77 -22.79 67.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.154 0.581 . . . . 0.0 110.938 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.52 -34.89 74.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.804 0.841 . . . . 0.0 111.08 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.417 HG21 HD12 ' A' ' 5' ' ' LEU . 31.3 m -65.26 -48.4 73.38 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 83' ' ' THR . 8.6 mp -61.92 -30.48 70.93 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.286 0.634 . . . . 0.0 111.64 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -68.86 -52.36 30.55 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.866 0.866 . . . . 0.0 110.279 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.6 pt-20 -65.09 -42.84 93.68 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.227 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.0 mm -63.8 -31.63 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.583 0.753 . . . . 0.0 111.031 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 14.0 tpt180 -61.56 -34.8 76.21 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.697 0.399 . . . . 0.0 110.439 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -73.22 -43.08 61.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.805 0.842 . . . . 0.0 110.882 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.6 mm100 -61.69 -44.1 97.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.984 0.914 . . . . 0.0 111.812 -176.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 47' ' ' ILE . 68.1 p -60.47 -38.67 85.0 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.595 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.4 mm -58.71 -37.74 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.005 0.522 . . . . 0.0 110.974 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.3 -7.66 59.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.256 1.022 . . . . 0.0 111.429 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.37 63.72 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.717 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 26.1 tt0 -137.63 105.82 5.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.168 0.587 . . . . 0.0 109.651 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 47' ' ' ILE . . . -155.29 106.69 2.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.686 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 92.4 mt-30 -121.37 116.58 25.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.779 0.832 . . . . 0.0 109.12 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.38 116.63 49.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mtm105 -87.9 99.19 11.94 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.44 78.43 4.9 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.48 -100.95 0.52 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.73 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.87 -29.51 32.42 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.749 0.82 . . . . 0.0 110.728 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.24 160.44 15.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 111.129 -167.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.686 ' SD ' ' HB3' ' A' ' 37' ' ' GLN . 48.9 tpp -120.3 140.74 50.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.019 0.928 . . . . 0.0 108.903 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.28 110.12 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.779 0.832 . . . . 0.0 109.549 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -90.96 95.75 10.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 120.988 0.423 . . . . 0.0 110.219 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 56' ' ' PHE . 19.0 mm -88.36 84.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -135.26 126.28 17.33 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.24 85.95 1.74 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.878 2.385 . . . . 0.0 111.474 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.403 ' HG3' HG13 ' A' ' 52' ' ' VAL . 16.0 tpt -68.96 94.95 0.67 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -72.03 85.53 1.01 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG13 ' HG3' ' A' ' 50' ' ' MET . 12.2 p -165.0 44.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.415 ' HB3' HD22 ' A' ' 97' ' ' LEU . 24.8 m-80 68.3 65.06 0.34 Allowed 'General case' 0 C--N 1.36 1.039 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.161 -166.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.5 138.67 5.56 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.799 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.89 166.77 11.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.309 1.044 . . . . 0.0 110.626 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.462 ' HB2' HG21 ' A' ' 47' ' ' ILE . 54.1 p90 -87.6 115.86 25.33 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.524 ' HE2' HD12 ' A' ' 89' ' ' LEU . 7.2 ptm -169.67 -178.17 2.93 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.97 110.23 1.42 Allowed Glycine 0 CA--C 1.537 1.436 0 O-C-N 123.796 0.685 . . . . 0.0 114.071 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 t -127.84 100.47 5.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.453 0.701 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.2 tm? -84.52 112.82 20.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.58 HD22 ' HB3' ' A' ' 44' ' ' MET . 2.4 p-10 -83.78 133.1 34.79 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.33 -1.25 42.15 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.534 1.134 . . . . 0.0 112.874 -168.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.26 107.92 2.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.92 -17.11 58.67 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.184 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.99 162.22 21.52 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.711 0.767 . . . . 0.0 111.786 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 70' ' ' ILE . 42.1 t -113.18 167.63 10.38 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.121 1.369 . . . . 0.0 108.756 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -52.33 -43.23 64.46 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.216 1.007 . . . . 0.0 112.789 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.44 -40.82 96.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.702 . . . . 0.0 110.975 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -66.18 -39.39 89.68 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.425 0.69 . . . . 0.0 110.673 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 66' ' ' SER . 50.0 mm -59.93 -43.68 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.573 0.749 . . . . 0.0 109.935 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.85 -51.74 65.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.894 0.746 . . . . 0.0 111.042 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.4 mt -53.18 -41.62 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.826 0.85 . . . . 0.0 110.192 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.31 -58.93 8.49 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.964 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.8 pp -64.72 -22.98 67.11 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.988 0.515 . . . . 0.0 112.17 -172.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -73.98 -47.76 35.03 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.111 0.564 . . . . 0.0 110.86 173.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -66.28 -26.79 67.5 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -70.44 -47.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.787 0.835 . . . . 0.0 109.929 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -24.89 60.25 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.687 0.617 . . . . 0.0 110.604 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -70.68 -49.25 49.23 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.375 0.67 . . . . 0.0 110.471 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.42 -35.4 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.564 0.745 . . . . 0.0 110.6 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 57' ' ' MET . 37.2 tt0 -59.14 -43.56 92.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.586 1.154 . . . . 0.0 110.667 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.4 -39.82 94.59 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.202 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.441 HG22 HD21 ' A' ' 24' ' ' LEU . 17.9 m -72.03 -29.16 63.9 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.99 -6.84 56.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.879 0.872 . . . . 0.0 111.771 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -69.22 87.93 0.43 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.624 0.726 . . . . 0.0 110.003 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -102.99 128.83 49.65 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.42 1.088 . . . . 0.0 108.384 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.07 -115.37 4.01 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -140.83 115.28 9.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 110.327 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD12 ' HE2' ' A' ' 57' ' ' MET . 0.5 OUTLIER -159.21 139.29 11.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.426 HG21 ' H ' ' A' ' 92' ' ' ARG . 25.4 m -112.89 149.48 33.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 t -57.19 -39.47 75.44 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.022 0.529 . . . . 0.0 110.361 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.532 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.8 ttp180 -67.55 -28.99 68.26 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.635 0.774 . . . . 0.0 111.795 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -47.09 83.32 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.068 0.547 . . . . 0.0 109.565 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.45 HG11 ' SD ' ' A' ' 57' ' ' MET . 10.6 p -80.7 -23.25 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.954 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' HA ' ' A' ' 92' ' ' ARG . 3.6 m -64.73 -46.51 81.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.505 0.722 . . . . 0.0 111.204 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.6 -33.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 HD22 ' HB3' ' A' ' 53' ' ' ASN . 86.2 mt -68.4 -43.37 77.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.727 . . . . 0.0 111.753 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.1 -25.87 52.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.885 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -23.65 38.21 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.639 0.775 . . . . 0.0 112.6 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.005 178.062 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 N-CA-C 110.836 -0.486 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.23 103.66 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.397 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.13 132.46 45.08 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.842 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.94 85.69 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.406 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.4 t -141.06 35.13 0.21 Allowed Pre-proline 0 CA--C 1.57 1.712 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 -29.88 6.83 Favored 'Trans proline' 0 C--N 1.387 2.604 0 CA-C-N 121.002 1.394 . . . . 0.0 112.327 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.0 m-85 -130.87 29.77 4.69 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.336 0.654 . . . . 0.0 111.826 -175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 6' ' ' THR . 11.6 mt -76.6 128.75 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 118.162 0.437 . . . . 0.0 112.025 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -103.83 91.07 3.27 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 86.44 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 0.0 111.518 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.64 -13.5 0.17 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.405 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 10' ' ' LEU . 25.1 m -119.71 158.31 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.202 0.601 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -74.52 -37.81 62.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.079 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -80.61 162.65 24.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.427 0.632 . . . . 0.0 111.285 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 17' ' ' SER . 1.1 tm? -113.43 151.96 30.7 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 35.7 t -57.1 -59.31 5.28 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.673 0.789 . . . . 0.0 110.629 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -174.69 117.43 0.19 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.24 137.56 27.69 Favored Pre-proline 0 N--CA 1.485 1.32 0 CA-C-N 118.402 0.546 . . . . 0.0 110.359 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.87 116.66 3.39 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.272 1.982 . . . . 0.0 110.736 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.504 ' HA ' HD23 ' A' ' 24' ' ' LEU . 27.8 tt0 -65.31 -26.13 67.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.477 0.711 . . . . 0.0 111.129 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.77 -25.94 67.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.871 0.868 . . . . 0.0 111.438 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 20.5 m -71.28 -47.84 54.5 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.2 mm? -57.33 -33.2 67.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 117.847 0.294 . . . . 0.0 110.627 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.8 m -61.46 -51.09 70.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.458 0.703 . . . . 0.0 111.401 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 23' ' ' THR . 8.2 pt-20 -66.52 -35.73 80.97 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.623 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 15.5 mm -58.24 -51.52 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.855 0.862 . . . . 0.0 110.091 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 91.4 mtm180 -59.88 -28.26 67.4 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.98 -42.4 26.81 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.964 0.506 . . . . 0.0 111.553 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 5.4 pt20 -77.7 -23.64 49.43 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.392 0.677 . . . . 0.0 112.448 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 74.1 p -61.49 -28.19 69.12 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.328 0.513 . . . . 0.0 111.352 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.39 -24.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.985 0.914 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -67.19 -19.05 65.5 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.744 0.818 . . . . 0.0 110.316 173.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.24 -22.86 14.83 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.997 0.808 . . . . 0.0 113.25 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 43.7 tt0 -143.98 145.11 32.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.294 0.638 . . . . 0.0 110.366 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.07 106.44 5.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.022 0.929 . . . . 0.0 109.085 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.56 121.9 31.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.683 0.393 . . . . 0.0 110.105 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -111.92 129.08 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 33.1 mtm105 -103.29 106.08 16.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 95.4 mt -77.27 68.37 3.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.68 0.82 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.266 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.46 -16.73 22.04 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.021 0.928 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 11.7 mt -81.12 111.27 17.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.7 tpt -84.89 124.76 32.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.98 152.14 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.597 1.159 . . . . 0.0 108.487 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -139.18 99.93 3.88 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.523 0.729 . . . . 0.0 109.757 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.507 HG12 HD13 ' A' ' 38' ' ' ILE . 11.1 mm -88.46 120.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -161.95 137.76 5.77 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 118.189 0.45 . . . . 0.0 111.189 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 96.7 Cg_endo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 122.563 2.176 . . . . 0.0 111.311 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 9.7 p90 -87.06 114.7 23.9 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.429 0.633 . . . . 0.0 110.202 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.582 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -162.65 -176.57 5.07 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.0 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.7 110.29 2.04 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -125.66 106.47 9.76 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 118.85 19.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.019 0.927 . . . . 0.0 109.684 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.79 91.72 3.53 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.709 . . . . 0.0 109.132 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 125.092 1.357 . . . . 0.0 112.856 -177.172 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 15.1 m120 -56.79 -44.65 82.08 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.358 0.663 . . . . 0.0 111.82 -172.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.32 -35.35 80.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.123 0.569 . . . . 0.0 111.446 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -66.37 -32.96 74.67 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.964 0.505 . . . . 0.0 111.447 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mm -66.19 -45.01 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 76.3 mm-40 -71.61 -54.82 9.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.59 0.756 . . . . 0.0 112.079 -174.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.72 -30.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.35 0.595 . . . . 0.0 109.469 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.62 -57.66 17.8 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.654 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -71.27 -26.78 63.03 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.643 0.722 . . . . 0.0 112.737 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -74.05 -37.0 64.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.357 0.598 . . . . 0.0 110.096 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.93 -24.83 48.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.731 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 1.2 mp -71.54 -46.49 63.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.12 -30.51 71.57 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.608 0.568 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.06 -54.95 34.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.369 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.45 HG23 HD23 ' A' ' 84' ' ' LEU . 56.2 mt -61.24 -32.92 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.332 1.053 . . . . 0.0 112.364 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 49.7 mt-10 -63.1 -39.49 94.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.047 0.539 . . . . 0.0 110.84 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -77.36 -32.9 55.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.917 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -77.63 -26.19 50.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.299 0.64 . . . . 0.0 112.018 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD22 HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 C-N-CA 124.086 0.955 . . . . 0.0 109.956 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 93' ' ' GLU . 9.0 t . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.9 p -58.16 -53.46 58.03 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.359 1.063 . . . . 0.0 111.182 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -68.17 -27.88 66.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.094 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 90' ' ' THR . 15.0 tp10 -59.91 -33.34 71.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.822 0.849 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.79 -39.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.004 0.922 . . . . 0.0 110.947 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -61.54 -37.28 83.19 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.385 0.674 . . . . 0.0 111.734 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.68 -27.92 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.294 0.638 . . . . 0.0 111.859 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.5 -39.83 85.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.911 0.484 . . . . 0.0 110.031 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -83.22 -34.45 25.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.604 0.761 . . . . 0.0 111.901 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.03 -38.35 57.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.576 0.75 . . . . 0.0 112.38 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.642 0.777 . . . . 0.0 112.557 -176.141 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 CA--C 1.555 1.529 0 CA-C-O 121.373 0.489 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.96 112.89 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.045 0.938 . . . . 0.0 110.465 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.91 134.43 47.24 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.208 0.527 . . . . 0.0 110.275 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD21 HG23 ' A' ' 19' ' ' ILE . 4.5 tt -140.42 92.75 2.55 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -150.09 55.0 1.67 Allowed Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.66 -31.58 0.43 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.956 1.771 . . . . 0.0 113.099 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.439 ' HE1' ' HD3' ' A' ' 20' ' ' PRO . 48.4 m-85 -127.86 4.83 6.0 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.439 -171.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.28 122.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 mt -98.91 96.4 3.99 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.7 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.18 40.3 0.97 Allowed 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.078 2.518 . . . . 0.0 115.118 -161.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.12 23.23 0.15 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.103 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.36 178.18 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.277 0.631 . . . . 0.0 110.412 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 57.6 p -91.83 -48.96 6.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.748 0.819 . . . . 0.0 111.01 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -79.0 -175.93 4.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.342 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 19' ' ' ILE . 15.7 tp -141.78 169.64 17.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -55.39 -64.44 0.84 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.303 0.641 . . . . 0.0 109.722 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -176.41 105.6 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.167 0.917 . . . . 0.0 108.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.431 HG12 HD23 ' A' ' 16' ' ' LEU . 56.8 mt -63.3 129.47 93.54 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.702 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 14.8 Cg_endo -56.17 120.34 8.12 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.75 2.3 . . . . 0.0 112.038 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.6 pm0 -60.39 -26.05 66.36 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.453 0.701 . . . . 0.0 111.978 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.41 -36.44 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.762 0.825 . . . . 0.0 110.926 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' ILE . 16.5 m -72.78 -37.51 67.57 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.237 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.0 mm? -64.67 -29.78 70.79 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.6 0.636 . . . . 0.0 110.479 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.1 t -72.48 -35.38 68.19 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.372 0.669 . . . . 0.0 110.289 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 10.6 tp10 -61.33 -50.19 73.95 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.395 0.678 . . . . 0.0 110.229 173.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 23' ' ' THR . 13.9 mm -59.18 -37.17 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.171 0.989 . . . . 0.0 110.522 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.2 tpt180 -60.9 -33.42 73.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.69 -39.05 58.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.445 0.698 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 54.0 mt-30 -73.68 -29.85 62.54 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.25 0.62 . . . . 0.0 110.973 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.5 p -69.81 -27.92 65.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.947 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ARG . 43.3 mm -67.43 -35.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -67.75 -19.05 65.08 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.17 -21.86 21.62 Favored Glycine 0 C--N 1.346 1.126 0 C-N-CA 123.793 0.711 . . . . 0.0 112.759 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -141.89 119.32 11.58 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 122.974 0.51 . . . . 0.0 110.538 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.95 111.09 21.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -103.12 113.03 26.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.4 mp -101.23 149.08 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 108.588 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 42' ' ' GLU . 12.7 mmm-85 -126.03 88.25 2.82 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.187 0.995 . . . . 0.0 109.252 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.1 mt -71.32 77.43 0.74 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 -102.26 0.66 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.829 -166.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HA ' HH21 ' A' ' 39' ' ' ARG . 15.2 pt-20 -100.18 -18.63 16.81 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.811 0.844 . . . . 0.0 111.139 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.0 mt -69.08 110.95 4.76 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.4 ttt -88.8 108.71 19.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.088 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 19.2 t -98.5 154.13 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.641 1.177 . . . . 0.0 108.664 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.3 98.89 3.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.409 0.683 . . . . 0.0 109.8 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 38' ' ' ILE . 37.5 mm -89.63 104.84 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.041 0.936 . . . . 0.0 108.787 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -130.29 128.14 22.64 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.338 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.383 2.369 0 C-N-CA 123.148 2.566 . . . . 0.0 111.922 -178.729 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -86.35 130.25 34.57 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -153.06 179.13 8.98 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.515 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . -61.89 110.44 3.19 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.23 0.956 . . . . 0.0 113.19 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.2 t -122.43 98.58 5.99 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 121.6 23.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.36 85.8 0.59 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.478 0.969 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.282 -172.043 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -57.52 -26.37 61.24 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.744 0.818 . . . . 0.0 111.879 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.22 -54.32 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.495 1.118 . . . . 0.0 110.644 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.57 -25.23 61.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.648 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.03 -39.86 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 50.9 tt0 -65.35 -58.3 6.24 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.445 0.466 . . . . 0.0 110.108 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 43' ' ' LEU . 59.8 mt -59.91 -34.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.556 0.743 . . . . 0.0 110.027 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.29 -54.89 26.81 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.37 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -66.93 -26.98 67.12 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.02 0.91 . . . . 0.0 111.467 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 98.4 mt-30 -64.69 -50.72 65.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.734 0.778 . . . . 0.0 109.44 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 80' ' ' ILE . 10.4 m-85 -69.64 -24.9 63.7 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.773 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -70.52 -42.42 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.404 0.682 . . . . 0.0 111.095 -178.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -68.87 -27.67 66.01 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -72.77 -36.01 67.55 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.279 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 76' ' ' TYR . 38.1 mm -73.59 -43.28 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.234 0.47 . . . . 0.0 110.605 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.544 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 12.7 pt-20 -65.5 -38.55 90.05 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.637 0.375 . . . . 0.0 111.489 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -70.39 -26.04 63.52 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.39 0.676 . . . . 0.0 110.555 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m -78.26 -31.87 49.31 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.722 0.809 . . . . 0.0 111.23 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 123.013 0.525 . . . . 0.0 112.178 -178.422 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 81.9 m . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.6 p -56.89 -48.57 77.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.956 0.902 . . . . 0.0 112.194 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' VAL . 42.4 ttp180 -69.0 -27.61 65.84 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 122.219 0.208 . . . . 0.0 111.097 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 1.5 tm-20 -61.69 -24.98 67.12 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 122.993 0.517 . . . . 0.0 110.174 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.17 -34.87 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.056 0.542 . . . . 0.0 111.368 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.0 m -62.97 -30.57 71.68 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 92' ' ' ARG . 26.8 m -65.92 -21.21 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.419 0.688 . . . . 0.0 111.558 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.08 -43.48 87.03 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.628 0.771 . . . . 0.0 110.102 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -79.81 -31.46 40.7 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.918 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -71.66 -44.51 64.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.64 0.776 . . . . 0.0 112.552 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 96' ' ' VAL . 27.5 pt . . . . . 0 CA--C 1.57 1.74 0 C-N-CA 122.971 0.508 . . . . 0.0 111.339 -172.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.548 1.224 0 CA-C-O 121.391 0.496 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.97 116.17 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.761 1.225 . . . . 0.0 108.597 167.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 7.6 p-10 -69.98 142.23 52.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -145.4 89.05 1.9 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.1 t -147.05 41.46 0.27 Allowed Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.002 0.521 . . . . 0.0 112.377 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 6' ' ' THR . 1.7 Cg_endo -79.6 -39.06 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 121.535 1.49 . . . . 0.0 112.021 -174.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.463 ' HE2' ' HD3' ' A' ' 20' ' ' PRO . 1.1 m-85 -129.43 31.09 4.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.071 0.548 . . . . 0.0 111.03 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.6 mt -63.35 109.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 118.817 0.735 . . . . 0.0 111.258 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.02 98.58 2.04 Favored Pre-proline 0 C--N 1.356 0.879 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.99 -16.79 50.49 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.419 2.079 . . . . 0.0 112.851 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.56 83.17 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.648 0.593 . . . . 0.0 114.356 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 10' ' ' LEU . 33.9 m -129.08 171.1 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 117.248 0.524 . . . . 0.0 111.503 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p -82.73 -34.7 27.13 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.635 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -84.91 177.34 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 122.084 0.945 . . . . 0.0 111.95 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.68 142.03 49.85 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 171.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.1 m -52.76 -48.0 67.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.456 0.702 . . . . 0.0 111.606 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 t70 179.41 119.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.838 1.255 . . . . 0.0 108.015 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.14 134.89 37.83 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 19.8 Cg_endo -58.86 122.65 11.98 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.797 2.331 . . . . 0.0 111.38 170.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.38 -17.9 64.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.153 0.581 . . . . 0.0 111.102 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -56.19 -47.21 78.78 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.222 1.009 . . . . 0.0 110.295 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -65.87 -34.94 79.3 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.043 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.9 mm? -67.65 -32.7 73.58 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.125 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -62.88 -38.61 91.57 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.846 0.458 . . . . 0.0 111.769 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 15.3 pt-20 -73.39 -40.84 64.0 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.261 0.351 . . . . 0.0 110.103 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 24' ' ' LEU . 97.1 mt -55.67 -36.83 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.004 0.922 . . . . 0.0 110.84 176.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 32' ' ' ILE . 21.9 mmm180 -61.73 -45.08 95.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.812 0.845 . . . . 0.0 110.934 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.24 -37.67 83.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.032 0.533 . . . . 0.0 110.935 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 18.0 mm-40 -68.47 -38.38 81.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.842 0.857 . . . . 0.0 111.148 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -69.06 -27.79 65.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 28' ' ' ARG . 46.6 mm -71.45 -36.61 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -75.17 -12.17 60.24 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.914 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.94 -9.73 60.07 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.594 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -139.23 111.95 7.8 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.214 1.007 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -125.67 98.99 5.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.811 0.844 . . . . 0.0 109.041 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -99.17 105.96 18.08 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.76 110.25 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.594 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 41.5 mtm105 -88.22 90.23 8.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.629 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 93.5 mt -76.1 70.6 2.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.291 0.637 . . . . 0.0 109.905 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.02 0.55 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.807 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.06 -15.13 32.38 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.177 0.991 . . . . 0.0 111.449 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 22.3 mt -91.3 142.86 27.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.963 0.905 . . . . 0.0 109.765 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.594 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.2 tpt -120.24 106.02 11.51 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.42 103.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.114 0.966 . . . . 0.0 109.898 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 t -90.36 98.91 12.05 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -84.74 103.64 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.04 139.36 13.35 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.618 -0.229 . . . . 0.0 110.665 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 C--N 1.378 2.089 0 C-N-CA 122.728 2.285 . . . . 0.0 112.283 175.192 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -88.24 132.77 34.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.926 0.49 . . . . 0.0 110.422 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.9 ptp -160.01 -175.98 5.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.943 1.297 . . . . 0.0 108.628 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.29 110.69 1.89 Allowed Glycine 0 C--N 1.352 1.462 0 O-C-N 123.655 0.597 . . . . 0.0 113.168 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.9 t -128.72 97.73 4.77 Favored 'General case' 0 C--N 1.353 0.717 0 C-N-CA 123.196 0.599 . . . . 0.0 109.872 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.658 ' HG ' ' HA3' ' A' ' 73' ' ' GLY . 3.3 tm? -79.54 113.03 17.36 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -79.49 142.24 36.0 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.174 0.59 . . . . 0.0 112.167 -175.035 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -55.31 -31.92 62.05 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.457 1.103 . . . . 0.0 112.134 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -51.85 67.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.497 1.119 . . . . 0.0 110.216 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.23 -39.46 82.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.04 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 22.6 mm -59.12 -51.71 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.874 0.734 . . . . 0.0 110.65 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 47.5 mt-30 -57.61 -46.72 83.71 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.543 1.152 . . . . 0.0 111.487 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 43' ' ' LEU . 59.5 mt -58.13 -41.45 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 124.09 0.869 . . . . 0.0 110.158 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.658 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -60.37 -49.11 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.295 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 70' ' ' ILE . 50.7 mt -57.86 -36.98 73.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.991 0.917 . . . . 0.0 111.323 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 83.6 mm-40 -58.54 -51.39 70.08 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.429 174.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -68.81 -30.43 68.99 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.589 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 73' ' ' GLY . 1.2 mp -66.64 -42.72 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.385 1.074 . . . . 0.0 111.098 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.88 -30.13 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.431 0.457 . . . . 0.0 110.663 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -78.29 -26.75 47.18 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 40' ' ' LEU . 65.2 mt -71.03 -32.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 123.37 0.668 . . . . 0.0 109.638 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.64 -41.31 76.95 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.844 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -71.2 -38.83 72.06 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.638 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -66.83 -33.48 75.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.823 0.849 . . . . 0.0 111.38 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.482 1.159 0 C-N-CA 124.528 1.131 . . . . 0.0 109.777 177.412 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 92' ' ' ARG . 21.8 m . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -66.61 -21.5 66.13 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.918 -0.489 . . . . 0.0 111.245 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 90' ' ' THR . 42.3 ttm180 -69.26 -33.5 73.34 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -69.03 -36.83 78.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.47 -20.45 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 120.99 0.424 . . . . 0.0 110.394 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.8 m -78.23 -38.96 41.76 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.406 0.683 . . . . 0.0 111.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 99' ' ' GLU . 30.0 m -76.38 -17.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.723 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 93.7 mt -51.01 -53.95 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.929 0.491 . . . . 0.0 111.988 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -84.11 -24.13 30.44 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.803 0.441 . . . . 0.0 111.949 176.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 34.8 tt0 -77.63 -31.57 52.87 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 112.655 -167.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 CA--C 1.561 1.373 0 C-N-CA 123.341 0.656 . . . . 0.0 112.329 -176.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 CA--C 1.549 1.232 0 CA-C-O 121.321 0.467 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.43 94.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 122.176 0.989 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.24 148.61 49.58 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.547 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.03 102.89 3.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -149.97 38.95 0.18 Allowed Pre-proline 0 CA--C 1.571 1.787 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.69 -26.82 1.9 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 CA-C-N 121.014 1.398 . . . . 0.0 112.507 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.546 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 41.8 m-85 -127.97 21.96 6.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.545 0.738 . . . . 0.0 111.225 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.56 126.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.024 0.375 . . . . 0.0 110.507 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.4 90.17 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.34 -16.28 47.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.503 2.135 . . . . 0.0 113.675 -168.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.41 -13.9 82.1 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.585 -0.564 . . . . 0.0 114.082 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.47 173.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 117.737 0.769 . . . . 0.0 110.802 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 p -88.3 9.02 24.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.461 1.104 . . . . 0.0 112.406 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -146.04 177.3 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.375 0.67 . . . . 0.0 111.334 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.49 149.53 45.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 22.7 t -57.45 -64.54 0.86 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.063 0.545 . . . . 0.0 110.868 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -163.34 144.82 9.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.27 130.29 27.45 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.383 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.99 141.31 86.58 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.103 2.535 . . . . 0.0 112.332 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.18 -24.56 67.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.184 0.593 . . . . 0.0 111.647 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.85 -39.86 87.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.03 0.532 . . . . 0.0 110.803 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 27' ' ' ILE . 37.1 m -72.69 -42.88 63.76 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.018 0.527 . . . . 0.0 110.411 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.57 -46.3 90.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.043 0.537 . . . . 0.0 110.775 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -64.85 -33.69 76.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.778 0.831 . . . . 0.0 111.12 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.1 tp10 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.669 0.606 . . . . 0.0 109.697 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 23' ' ' THR . 67.9 mt -54.03 -43.21 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.797 0.839 . . . . 0.0 110.696 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 28' ' ' ARG . 10.4 mmm180 -66.17 -31.39 72.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -73.28 -44.37 59.34 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.553 0.741 . . . . 0.0 111.11 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 15.2 mm-40 -77.73 -27.7 50.6 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.184 0.994 . . . . 0.0 112.054 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.6 p -63.51 -25.86 68.45 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.577 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.41 -26.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-O 121.279 0.561 . . . . 0.0 109.771 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -77.56 -26.36 50.84 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.057 168.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.78 4.85 60.21 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.469 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 24.0 tt0 -129.76 116.86 19.37 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.62 96.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.426 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.49 113.02 26.01 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.36 112.86 34.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 52.0 mtp180 -87.46 92.24 9.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 80' ' ' ILE . 90.5 mt -70.22 75.53 0.52 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.273 0.629 . . . . 0.0 109.709 175.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.45 -99.91 0.37 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -103.62 -7.68 20.56 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.237 1.015 . . . . 0.0 111.657 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 24.3 mt -88.35 109.95 20.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.506 0.722 . . . . 0.0 109.069 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.553 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.5 tpt -84.47 114.44 21.93 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.25 110.68 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.047 0.539 . . . . 0.0 110.561 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.3 m -88.16 113.77 24.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.149 0.58 . . . . 0.0 110.573 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 31.7 mm -104.08 85.03 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 36' ' ' ALA . 24.6 mtm180 -130.55 145.06 55.91 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--N 1.38 2.225 0 C-N-CA 122.455 2.103 . . . . 0.0 111.681 174.002 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -94.44 108.05 20.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.279 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 59.2 mtm -152.78 107.71 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.427 1.491 . . . . 0.0 108.055 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 108.34 0.01 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 m -131.4 96.98 4.13 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 165.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.7 117.75 20.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 0.0 108.977 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 27.7 t-20 -67.65 89.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.761 0.791 . . . . 0.0 109.102 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? . . . . . 0 N--CA 1.477 0.92 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.312 -175.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 119.817 -0.135 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -63.92 -26.69 68.71 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.5 -42.44 71.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.99 -20.66 60.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.416 0.686 . . . . 0.0 111.933 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.54 -50.17 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.88 -57.32 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.097 0.873 . . . . 0.0 110.59 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 43' ' ' LEU . 49.3 mt -61.42 -36.2 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.209 0.603 . . . . 0.0 109.882 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -57.92 -58.0 16.86 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.681 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -67.09 -27.24 67.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.057 0.543 . . . . 0.0 111.811 -175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -65.04 -43.33 92.73 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.524 0.678 . . . . 0.0 110.198 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.17 -22.62 59.34 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.848 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -67.24 -38.34 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.077 0.551 . . . . 0.0 109.735 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 -34.88 76.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.381 0.673 . . . . 0.0 110.23 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -62.6 -52.7 62.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.695 0.398 . . . . 0.0 110.675 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 40' ' ' LEU . 79.5 mt -64.58 -32.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.258 0.623 . . . . 0.0 110.633 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -53.01 -49.67 65.77 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.263 0.625 . . . . 0.0 110.212 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -75.75 -34.82 60.3 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.268 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.5 m -84.06 -31.78 25.18 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.788 0.835 . . . . 0.0 111.901 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 N--CA 1.485 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 109.328 -173.954 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.8 p -60.61 -39.85 89.68 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.626 171.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -61.42 -41.33 97.0 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.935 0.894 . . . . 0.0 111.971 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.87 -31.66 72.92 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.246 0.341 . . . . 0.0 111.699 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.414 ' HA ' HD23 ' A' ' 97' ' ' LEU . 7.7 p -90.99 -23.21 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 C-N-CA 122.761 0.424 . . . . 0.0 112.047 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.1 m -65.6 -34.95 79.42 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.982 0.513 . . . . 0.0 110.86 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.25 -20.41 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 94' ' ' VAL . 4.4 mm? -73.06 -48.78 33.0 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.82 0.448 . . . . 0.0 110.488 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -71.19 -24.19 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.736 0.303 . . . . 0.0 110.438 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -69.94 -53.97 15.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.276 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.715 -175.284 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.519 ' HB2' ' HG3' ' A' ' 39' ' ' ARG . 71.8 Cg_endo . . . . . 0 CA--C 1.557 1.656 0 CA-C-O 121.117 0.382 . . . . 0.0 112.644 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.75 99.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.809 0.844 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.4 89.59 0.35 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.312 1.053 . . . . 0.0 111.163 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.43 102.99 15.44 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.6 t -154.83 53.14 0.82 Allowed Pre-proline 0 CA--C 1.566 1.559 0 C-N-CA 122.833 0.453 . . . . 0.0 112.113 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -82.19 -36.56 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.251 1.967 . . . . 0.0 112.006 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -129.13 17.52 6.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.631 0.772 . . . . 0.0 111.814 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 HD21 ' A' ' 16' ' ' LEU . 30.0 mt -67.23 123.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 118.577 0.626 . . . . 0.0 111.28 -175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -101.29 86.55 0.76 Allowed Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.88 -5.45 17.04 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.381 2.054 . . . . 0.0 113.698 -163.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.81 -11.26 68.35 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.347 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 10' ' ' LEU . 19.7 m -122.07 169.38 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.203 0.601 . . . . 0.0 110.842 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 15.6 m -81.89 -34.99 29.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.351 1.06 . . . . 0.0 111.877 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -88.81 170.82 10.42 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.778 0.799 . . . . 0.0 112.175 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.527 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -125.83 133.02 52.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 m -55.47 -66.52 0.4 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.823 0.702 . . . . 0.0 110.406 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -146.72 134.18 20.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.59 126.3 37.78 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 169.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.78 121.72 9.55 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.585 2.19 . . . . 0.0 111.683 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 10.1 pt20 -62.1 -23.95 66.83 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.991 0.917 . . . . 0.0 112.059 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.63 -37.09 86.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.71 0.804 . . . . 0.0 110.999 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' ILE . 23.3 m -76.97 -29.83 55.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.468 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.6 mm? -61.0 -41.33 96.31 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -54.51 -43.27 71.69 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.935 0.894 . . . . 0.0 112.714 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.9 pt-20 -72.9 -40.72 65.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.234 0.334 . . . . 0.0 110.904 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 33.7 mm -61.97 -39.98 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.329 0.652 . . . . 0.0 110.084 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.4 mmm180 -60.88 -25.48 66.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.999 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -87.06 -41.86 13.51 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 0.0 112.073 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 45.2 mt-30 -63.92 -31.44 72.62 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.562 0.745 . . . . 0.0 111.982 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -55.63 -33.44 64.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.337 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.45 -37.73 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.245 0.618 . . . . 0.0 110.287 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -61.61 -24.24 66.56 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.787 0.835 . . . . 0.0 111.178 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.67 2.63 67.15 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.231 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 122.53 19.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.821 0.849 . . . . 0.0 110.269 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -164.9 96.33 0.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.611 1.164 . . . . 0.0 108.361 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -105.28 125.32 50.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.96 116.8 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.155 0.982 . . . . 0.0 108.409 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 40.5 mtm105 -86.17 101.34 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.734 HD11 HD11 ' A' ' 80' ' ' ILE . 48.1 mt -76.12 77.67 2.95 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.23 -101.29 0.66 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.284 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -25.93 17.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.143 0.977 . . . . 0.0 111.217 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 72' ' ' ILE . 61.4 mt -71.77 131.06 42.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.757 0.823 . . . . 0.0 111.143 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.9 tpt -98.14 99.94 11.22 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.48 152.9 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.957 0.903 . . . . 0.0 108.979 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 98.61 4.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.6 0.76 . . . . 0.0 109.52 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 84' ' ' LEU . 40.7 mm -93.19 84.13 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -129.45 117.14 18.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 C--N 1.383 2.388 0 C-N-CA 122.414 2.076 . . . . 0.0 112.305 -176.588 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.448 ' HB2' HG11 ' A' ' 94' ' ' VAL . 48.3 m-85 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -97.25 126.44 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 121.503 0.668 . . . . 0.0 110.763 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 14.0 ptt? -174.75 -174.38 0.8 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.71 2.004 . . . . 0.0 106.996 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.24 109.24 0.47 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -134.82 122.32 21.9 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.434 1.094 . . . . 0.0 108.203 170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.1 tm? -99.49 124.23 44.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.633 0.773 . . . . 0.0 109.545 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.68 105.75 3.28 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 123.913 0.885 . . . . 0.0 112.072 -178.949 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 70' ' ' ILE . 34.5 t . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.53 -26.02 68.51 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.129 0.572 . . . . 0.0 111.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.23 -48.96 76.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.32 0.648 . . . . 0.0 110.181 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.97 -35.93 81.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.881 0.873 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 66' ' ' SER . 37.5 mm -61.66 -40.27 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.933 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.48 -57.77 10.51 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.909 0.755 . . . . 0.0 112.008 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.0 mp -66.01 -34.85 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.55 -57.3 20.56 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.175 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 70' ' ' ILE . 3.7 pp -66.95 -30.65 70.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.954 0.501 . . . . 0.0 111.614 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 23.1 mm-40 -60.72 -54.63 42.93 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.531 0.519 . . . . 0.0 110.048 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' ILE . 12.9 m-85 -60.79 -35.91 77.65 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.679 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -62.64 -35.9 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.956 0.902 . . . . 0.0 111.561 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.75 -31.58 66.82 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.457 0.473 . . . . 0.0 110.5 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.78 -32.59 62.07 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.702 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 40' ' ' LEU . 95.5 mt -74.07 -29.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.863 0.865 . . . . 0.0 109.734 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 12.8 tt0 -58.01 -35.7 71.62 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.976 0.911 . . . . 0.0 110.551 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.87 -43.96 43.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.229 0.612 . . . . 0.0 110.692 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -65.93 -25.15 67.01 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.456 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 90.9 mt . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.825 1.25 . . . . 0.0 109.546 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 111.423 0.157 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -59.62 -40.39 87.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.943 0.897 . . . . 0.0 110.935 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -39.25 76.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.388 0.675 . . . . 0.0 110.843 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.6 -35.3 78.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 0.0 111.98 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 55' ' ' TYR . 28.0 m -79.39 -28.98 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 118.332 0.515 . . . . 0.0 111.102 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.5 m -68.9 -42.46 76.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.835 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -65.21 -27.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.614 0.571 . . . . 0.0 111.569 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -63.26 -39.7 95.34 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.586 0.707 . . . . 0.0 110.22 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -32.06 32.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.26 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.69 -15.55 56.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.033 0.933 . . . . 0.0 112.482 -167.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.568 1.643 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.523 176.255 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.556 1.593 0 N-CA-C 113.424 0.509 . . . . 0.0 113.424 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 38' ' ' ILE . 61.9 t -88.62 94.14 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.967 0.907 . . . . 0.0 109.442 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.73 99.31 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.169 0.988 . . . . 0.0 110.259 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 23' ' ' THR . 56.1 tp -117.83 98.73 6.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.728 . . . . 0.0 109.208 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 t -158.33 60.3 1.77 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.649 0.78 . . . . 0.0 110.97 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.7 -36.03 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.536 2.158 . . . . 0.0 112.286 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.43 -4.78 5.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.611 0.764 . . . . 0.0 111.552 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -48.07 124.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -161.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.1 mt -107.74 90.22 6.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.34 -19.41 38.18 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.458 2.105 . . . . 0.0 112.589 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.63 -2.41 80.55 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.983 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.92 173.43 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.51 0.655 . . . . 0.0 110.349 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 m -91.5 -13.39 32.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.269 1.027 . . . . 0.0 111.877 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -114.65 -172.86 2.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.838 . . . . 0.0 110.482 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 19' ' ' ILE . 16.0 tp -143.33 139.71 30.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -50.03 -41.99 48.57 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.76 1.224 . . . . 0.0 112.183 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -166.47 147.66 6.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.597 0.759 . . . . 0.0 110.029 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 16' ' ' LEU . 69.1 mt -121.24 130.47 24.81 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 168.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.99 116.63 2.9 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.964 2.442 . . . . 0.0 111.63 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HA ' HD23 ' A' ' 24' ' ' LEU . 25.6 mp0 -63.75 -27.24 69.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.619 1.168 . . . . 0.0 110.384 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.15 -36.13 83.28 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.077 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.555 HG21 HD13 ' A' ' 5' ' ' LEU . 48.3 m -66.77 -36.28 82.06 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.671 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 83' ' ' THR . 3.8 mm? -63.27 -42.75 99.16 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.156 0.435 . . . . 0.0 110.292 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.3 t -61.21 -39.47 90.38 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.563 0.745 . . . . 0.0 110.849 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 38.3 tt0 -65.62 -45.12 84.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.608 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 23' ' ' THR . 96.4 mt -60.3 -41.83 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.245 1.018 . . . . 0.0 110.184 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 20.4 mtp180 -63.52 -25.47 68.27 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.459 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.39 -34.88 25.45 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.613 0.765 . . . . 0.0 111.548 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 5.4 mm100 -73.21 -31.32 64.1 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.423 0.63 . . . . 0.0 110.239 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -68.27 -19.02 64.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.193 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.24 -33.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -70.47 -31.15 68.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.211 0.605 . . . . 0.0 110.11 168.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.5 3.09 50.39 Favored Glycine 0 N--CA 1.468 0.81 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.258 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.97 107.59 7.41 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.905 0.882 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -136.64 95.85 3.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -101.56 98.11 8.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG22 HD22 ' A' ' 40' ' ' LEU . 1.9 mp -94.22 117.79 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -172.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 -89.59 104.65 17.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 38' ' ' ILE . 3.9 mm? -76.68 74.88 3.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.35 -104.31 1.26 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.62 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.85 -20.55 23.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.123 0.969 . . . . 0.0 110.572 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 43.7 mt -78.13 146.52 35.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.471 0.708 . . . . 0.0 110.543 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.5 tpt -116.72 121.21 40.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.85 123.99 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.341 1.057 . . . . 0.0 109.435 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' SER . 66.9 m -98.58 97.68 8.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.212 0.605 . . . . 0.0 110.416 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -85.16 100.7 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.88 141.55 41.5 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.385 2.456 0 C-N-CA 123.166 2.578 . . . . 0.0 112.445 -177.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.359 0.6 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 38.5 p90 -84.67 125.75 32.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 111.162 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 23.8 ptt? -177.62 112.95 0.08 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.581 1.152 . . . . 0.0 109.002 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 43.29 103.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.182 1.372 . . . . 0.0 116.254 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 32.4 m -136.72 98.91 3.9 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.168 -0.607 . . . . 0.0 109.639 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.9 126.4 27.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.58 0.752 . . . . 0.0 109.35 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.93 93.11 6.44 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--N 1.35 0.592 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -176.257 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -62.7 -23.36 67.11 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.615 0.766 . . . . 0.0 112.228 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -48.51 73.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.708 0.803 . . . . 0.0 109.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.2 -26.36 62.92 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.147 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.66 -43.85 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.481 0.712 . . . . 0.0 109.859 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 26.9 tt0 -59.75 -58.94 6.39 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.204 1.001 . . . . 0.0 111.591 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.26 -29.75 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -55.94 -57.66 17.93 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.592 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.74 -26.26 66.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.976 0.51 . . . . 0.0 111.802 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 16.1 mm-40 -65.3 -41.55 93.96 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.577 172.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 80' ' ' ILE . 11.7 m-85 -77.98 -23.09 48.53 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.737 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -65.52 -47.77 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.563 0.619 . . . . 0.0 110.086 175.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -71.6 -28.49 63.85 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.949 0.781 . . . . 0.0 110.912 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -68.08 -50.32 55.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.197 0.311 . . . . 0.0 110.173 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 76' ' ' TYR . 45.8 mm -61.53 -39.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.755 0.822 . . . . 0.0 109.757 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 43.4 tt0 -57.74 -42.69 84.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.101 0.96 . . . . 0.0 111.174 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -71.8 -27.51 62.98 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.559 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.475 HG22 ' HG ' ' A' ' 24' ' ' LEU . 10.5 m -97.13 -23.41 16.23 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.767 0.827 . . . . 0.0 112.091 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 57' ' ' MET . 41.9 tp . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 124.175 0.99 . . . . 0.0 111.094 -170.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -63.04 -52.47 62.72 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.02 0.928 . . . . 0.0 112.071 -172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -57.74 -34.02 69.09 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.497 0.719 . . . . 0.0 112.189 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -33.08 72.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.941 0.897 . . . . 0.0 112.359 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.37 -36.21 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.992 0.517 . . . . 0.0 110.024 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -64.07 -39.61 94.46 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.552 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.01 -32.83 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 0.0 111.086 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.67 -35.61 79.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.213 0.605 . . . . 0.0 110.432 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -82.19 -25.47 34.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.087 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.14 -41.22 22.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.953 0.901 . . . . 0.0 111.42 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.288 0.635 . . . . 0.0 111.068 -178.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.549 1.257 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 99.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.17 0.986 . . . . 0.0 109.127 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.55 110.42 3.66 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.2 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.81 113.3 15.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.333 1.053 . . . . 0.0 110.154 -168.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -154.75 40.65 0.14 Allowed Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.66 -31.97 0.98 Allowed 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 121.844 1.696 . . . . 0.0 112.998 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -128.09 21.99 6.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.665 0.786 . . . . 0.0 111.21 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.67 128.24 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 120.905 0.383 . . . . 0.0 110.07 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.1 mm? -98.55 95.65 3.19 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.4 95.92 0.95 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.975 2.45 . . . . 0.0 110.674 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.61 -35.2 0.75 Allowed Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.999 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.5 m -93.56 175.74 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.438 0.637 . . . . 0.0 111.535 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.7 p -85.03 -32.36 22.94 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.03 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -102.71 172.34 6.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.877 0.846 . . . . 0.0 112.91 -167.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.83 47.04 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.0 p -64.66 -62.76 1.38 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.591 0.757 . . . . 0.0 110.215 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -166.82 126.87 1.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.766 0.826 . . . . 0.0 109.137 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.0 mt -88.44 137.02 30.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.0 Cg_endo -55.22 129.62 36.23 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.513 2.142 . . . . 0.0 111.251 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -23.68 62.9 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.593 0.757 . . . . 0.0 112.822 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.0 pt-20 -63.52 -32.51 73.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.095 0.958 . . . . 0.0 111.326 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 m -70.9 -46.71 62.07 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.551 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.09 -27.46 68.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.55 0.159 . . . . 0.0 111.055 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -73.12 -44.2 60.57 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 111.045 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 -28.77 62.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.451 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.43 -42.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.641 0.776 . . . . 0.0 109.324 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 tpt85 -64.21 -24.66 67.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.542 0.737 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -75.66 -54.68 6.59 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.915 0.886 . . . . 0.0 111.002 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.7 pt20 -68.27 -25.02 64.96 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.36 0.664 . . . . 0.0 112.553 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 37.8 p -64.98 -33.42 76.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.414 0.285 . . . . 0.0 111.186 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.15 -32.57 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.849 0.46 . . . . 0.0 110.187 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -71.01 -26.56 63.18 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.083 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.23 11.94 57.97 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.958 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -138.34 105.96 5.59 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -147.09 126.29 12.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.957 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -130.06 137.93 50.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.595 0.758 . . . . 0.0 108.963 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.49 112.17 30.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 21.2 mtm105 -87.52 95.46 10.04 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -80.77 69.51 7.33 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.559 0.695 . . . . 0.0 109.505 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -103.53 1.31 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.079 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.38 -19.14 21.6 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.966 0.906 . . . . 0.0 110.375 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -76.85 109.67 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.48 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 14.1 tpt -87.75 111.8 21.73 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -110.16 153.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 59' ' ' SER . 61.1 m -137.77 139.47 40.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.482 1.113 . . . . 0.0 108.337 172.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 28.3 mm -123.62 100.76 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.5 mtt85 -129.77 129.21 23.06 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.55 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.373 1.82 0 C-N-CA 122.366 2.044 . . . . 0.0 111.533 170.831 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.533 0.206 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -123.94 118.21 26.54 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.718 0.807 . . . . 0.0 110.041 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -167.51 107.24 0.57 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.885 0.874 . . . . 0.0 108.938 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' HA3' HG23 ' A' ' 77' ' ' ILE . . . 55.5 106.98 0.01 OUTLIER Glycine 0 CA--C 1.54 1.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 115.006 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' SER . 47.1 t -133.58 97.77 4.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.69 107.79 4.7 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.502 0.721 . . . . 0.0 109.464 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.1 96.93 1.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 123.884 0.874 . . . . 0.0 111.984 -176.522 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 70' ' ' ILE . 23.0 t . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.42 -40.13 64.9 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.229 1.011 . . . . 0.0 112.791 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -67.22 -40.75 86.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.542 0.737 . . . . 0.0 111.198 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -68.16 -29.6 68.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.486 0.714 . . . . 0.0 111.012 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' SER . 43.3 mm -65.51 -46.11 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.167 0.587 . . . . 0.0 109.963 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -58.09 -55.29 36.91 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.068 0.855 . . . . 0.0 110.879 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 43' ' ' LEU . 34.0 mt -60.8 -38.77 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 O-C-N 123.689 0.618 . . . . 0.0 110.06 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.452 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -59.52 -57.33 20.16 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.066 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 pp -64.96 -26.35 68.26 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.851 0.46 . . . . 0.0 111.634 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.56 -48.51 74.76 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.573 0.545 . . . . 0.0 110.379 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' HG12 ' A' ' 80' ' ' ILE . 26.1 m-85 -67.35 -29.12 68.58 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.279 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.3 -44.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.817 0.847 . . . . 0.0 111.158 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.74 -20.92 61.1 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.89 0.376 . . . . 0.0 111.026 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -81.9 -27.04 33.63 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.8 mm -69.89 -35.71 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.896 0.478 . . . . 0.0 110.683 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.5 -30.98 71.43 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 110.564 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -75.89 -32.82 59.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.697 0.799 . . . . 0.0 110.913 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.8 m -78.75 -38.39 38.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.482 0.713 . . . . 0.0 110.375 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 125.055 1.342 . . . . 0.0 108.634 171.103 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 19.6 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 p -49.03 -50.72 34.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.697 1.199 . . . . 0.0 112.291 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -63.69 -28.5 69.94 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 123.996 0.918 . . . . 0.0 112.431 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 43.5 mt-10 -59.51 -39.02 82.51 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.546 0.612 . . . . 0.0 112.544 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 122.8 0.44 . . . . 0.0 111.319 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -69.9 -27.61 64.94 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.092 0.557 . . . . 0.0 111.469 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.9 p -66.69 -22.85 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.439 0.695 . . . . 0.0 110.951 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.24 -35.15 76.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.183 0.516 . . . . 0.0 110.681 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -82.41 -31.29 29.66 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.836 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.96 -58.3 3.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.458 0.703 . . . . 0.0 111.39 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 96' ' ' VAL . 31.2 pt . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.528 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 CA--C 1.55 1.308 0 CA-C-O 121.07 0.363 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 38' ' ' ILE . 5.7 p -80.23 94.37 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 121.793 0.806 . . . . 0.0 109.643 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 9.4 p-10 -64.2 123.69 19.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.135 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -131.01 106.41 8.38 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.565 0.746 . . . . 0.0 109.681 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -150.07 71.0 9.38 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 121.498 0.666 . . . . 0.0 110.329 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.87 -40.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.827 2.352 . . . . 0.0 113.318 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 66.3 m-85 -129.18 20.45 5.81 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.092 0.957 . . . . 0.0 111.122 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.584 HG12 HD21 ' A' ' 16' ' ' LEU . 19.6 mt -72.5 129.83 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -107.34 87.45 3.27 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.48 -4.46 13.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.66 2.24 . . . . 0.0 114.284 -163.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.89 -8.59 72.53 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.218 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.9 m -126.52 175.99 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.594 0.758 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -88.22 -28.76 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.306 1.042 . . . . 0.0 112.4 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -91.95 166.38 12.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.417 0.627 . . . . 0.0 112.002 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.584 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -112.39 149.3 32.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.925 1.29 . . . . 0.0 107.708 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 55.0 m -67.58 -58.94 3.82 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -171.91 149.73 2.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.034 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.01 134.68 22.47 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.86 126.54 22.82 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.7 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.104 0.962 . . . . 0.0 110.994 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.35 -44.35 95.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.242 1.017 . . . . 0.0 110.782 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.646 HG21 HD13 ' A' ' 5' ' ' LEU . 13.7 m -72.19 -34.52 68.48 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.793 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.81 -40.94 97.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.786 0.266 . . . . 0.0 111.115 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 m -66.81 -36.83 83.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.489 0.716 . . . . 0.0 110.345 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 11.7 tp10 -60.4 -45.38 93.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.227 1.011 . . . . 0.0 110.294 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' THR . 97.5 mt -60.9 -48.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.447 1.099 . . . . 0.0 110.701 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.72 -24.73 64.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.515 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -85.13 -35.66 21.6 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.599 0.636 . . . . 0.0 111.879 176.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 3.8 pt20 -75.68 -23.39 56.2 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.148 0.579 . . . . 0.0 111.812 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' ILE . 35.0 p -56.82 -25.45 55.97 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.9 -19.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.246 1.018 . . . . 0.0 110.858 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 30' ' ' GLN . 2.9 mpt_? -75.16 -8.49 56.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.376 1.07 . . . . 0.0 111.159 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.43 -22.85 37.8 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 123.44 0.543 . . . . 0.0 112.927 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.1 134.64 33.17 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 108.865 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -145.3 97.63 3.03 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -100.09 122.87 43.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.046 0.538 . . . . 0.0 110.716 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.456 HG13 HG13 ' A' ' 3' ' ' VAL . 2.6 mp -109.31 113.43 44.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 71.3 mtt180 -85.0 92.1 8.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.62 76.7 1.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.242 0.544 . . . . 0.0 109.893 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -102.13 0.75 Allowed Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.423 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.01 -18.18 20.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 110.979 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt -84.52 113.58 21.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.167 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.722 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.4 tpt -85.1 111.64 19.94 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.85 148.46 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 t -134.02 110.12 9.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.193 0.52 . . . . 0.0 109.668 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 56' ' ' PHE . 31.9 mm -87.44 107.11 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.2 ptm180 -154.29 128.45 4.61 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 118.709 0.686 . . . . 0.0 111.176 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HD1' ' A' ' 56' ' ' PHE . 31.3 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.256 2.637 . . . . 0.0 113.546 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.009 0.433 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' ILE . 35.9 p90 -101.42 116.46 32.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.357 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.705 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 55.6 mtm -145.37 -176.03 4.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.725 0.81 . . . . 0.0 109.535 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' HG2' ' A' ' 81' ' ' GLU . . . -54.37 113.52 3.46 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.324 1.015 . . . . 0.0 114.467 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -129.51 113.0 14.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 112.76 16.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.317 0.647 . . . . 0.0 109.834 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.85 115.59 18.64 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.894 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 . . . . . 0 CA--C 1.549 0.932 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.074 179.511 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.814 -0.136 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -59.5 -33.53 71.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.331 1.052 . . . . 0.0 112.895 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.5 p-10 -71.44 -42.35 68.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -63.67 -34.95 78.99 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.868 0.867 . . . . 0.0 111.714 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.5 mm -58.01 -43.2 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.363 0.665 . . . . 0.0 109.461 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.24 -56.75 12.47 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.922 0.763 . . . . 0.0 110.95 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' ASP . 7.4 mm -57.08 -38.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.526 0.679 . . . . 0.0 109.352 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.25 -58.05 14.26 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.426 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.89 -22.93 66.55 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.669 0.735 . . . . 0.0 111.891 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 16.0 mm100 -70.86 -46.45 62.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.632 0.773 . . . . 0.0 110.145 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' ILE . 13.8 m-85 -69.84 -27.2 64.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.201 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -61.98 -51.42 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.625 0.77 . . . . 0.0 109.893 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 75' ' ' GLN . 12.5 pt-20 -64.42 -34.66 78.69 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.475 0.484 . . . . 0.0 110.411 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.95 -31.5 66.38 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.873 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 76' ' ' TYR . 28.5 mm -69.77 -43.7 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.705 ' HG2' ' HB3' ' A' ' 57' ' ' MET . 44.9 mt-10 -60.75 -36.99 80.32 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.604 0.761 . . . . 0.0 111.377 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -73.28 -39.3 65.48 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.929 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -74.42 -22.93 58.9 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.672 0.789 . . . . 0.0 111.202 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.225 1.01 . . . . 0.0 110.08 -176.126 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 26.0 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.6 m -64.02 -47.1 81.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -62.17 -26.22 68.22 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.2 tp10 -57.34 -47.65 81.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.063 0.945 . . . . 0.0 111.306 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.11 -27.2 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.412 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 m -64.96 -45.24 86.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.156 0.582 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.31 -28.1 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 111.195 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.74 -38.56 76.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -80.51 -26.97 37.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.768 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.721 0.808 . . . . 0.0 111.372 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.293 174.082 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 56.2 Cg_endo . . . . . 0 CA--C 1.553 1.435 0 CA-C-O 121.991 0.746 . . . . 0.0 112.742 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.37 116.32 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.473 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.84 137.42 43.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.907 0.483 . . . . 0.0 110.455 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 19' ' ' ILE . 5.4 tt -145.11 94.11 2.48 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -147.81 47.4 0.54 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 6' ' ' THR . 67.9 Cg_endo -85.18 -30.69 0.46 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 121.88 1.72 . . . . 0.0 113.642 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.47 18.82 6.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.961 0.505 . . . . 0.0 111.542 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 16' ' ' LEU . 20.6 mt -70.63 135.97 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.691 0.396 . . . . 0.0 111.307 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.584 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -117.31 85.59 19.94 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.7 22.12 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.017 2.478 . . . . 0.0 114.081 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.57 -39.2 90.88 Favored Glycine 0 C--N 1.346 1.127 0 O-C-N 123.425 0.453 . . . . 0.0 113.862 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.3 m -108.71 178.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.972 0.509 . . . . 0.0 111.666 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.5 p -91.29 -24.89 19.7 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.256 1.023 . . . . 0.0 112.026 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -94.15 162.08 14.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.306 0.574 . . . . 0.0 111.589 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -103.66 142.82 33.66 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.307 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 10' ' ' LEU . 23.6 t -74.59 -48.8 24.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.879 0.471 . . . . 0.0 110.026 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.19 142.56 10.13 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.47 HG23 HD21 ' A' ' 5' ' ' LEU . 76.0 mt -121.43 121.74 28.33 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 163.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.8 127.22 20.87 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.742 2.295 . . . . 0.0 111.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.58 -16.81 62.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 111.182 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.76 -38.26 88.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.056 0.542 . . . . 0.0 110.35 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 17.9 m -74.66 -35.63 62.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.9 0.48 . . . . 0.0 109.836 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.19 -25.1 65.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.772 0.429 . . . . 0.0 111.138 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -68.8 -40.74 79.43 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.652 0.781 . . . . 0.0 110.962 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 23' ' ' THR . 12.8 pt-20 -71.66 -30.7 66.01 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 23' ' ' THR . 12.0 mm -65.29 -43.07 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 121.427 0.632 . . . . 0.0 109.57 172.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -62.04 -31.08 71.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.959 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.37 -41.14 14.74 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 3.6 pt20 -70.58 -24.03 62.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -53.64 -36.31 61.93 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.014 0.526 . . . . 0.0 111.244 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.08 -36.45 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.621 0.768 . . . . 0.0 110.311 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.84 -16.62 63.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.595 0.758 . . . . 0.0 110.627 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.16 -19.17 25.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.41 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -138.2 131.03 29.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -143.28 101.57 3.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.313 1.045 . . . . 0.0 108.439 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 42.1 mt-30 -109.67 115.41 29.82 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 40' ' ' LEU . 3.0 mp -107.66 126.61 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.519 0.728 . . . . 0.0 109.747 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -91.6 96.98 10.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.151 0.58 . . . . 0.0 110.243 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 38' ' ' ILE . 8.1 mp -81.76 71.85 8.8 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 169.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.34 -102.88 1.07 Allowed Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 -19.03 18.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.611 0.764 . . . . 0.0 110.445 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' A' ' 73' ' ' GLY . 17.6 mt -74.64 108.76 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.2 tpt -93.13 113.63 25.93 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.78 151.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.798 0.839 . . . . 0.0 109.521 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 m -133.66 98.11 4.11 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.27 0.628 . . . . 0.0 109.921 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 49.5 mm -83.21 93.02 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.72 0.808 . . . . 0.0 109.0 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -127.04 126.39 24.32 Favored Pre-proline 0 N--CA 1.483 1.209 0 O-C-N 121.929 -0.482 . . . . 0.0 110.853 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 45.0 Cg_endo . . . . . 0 C--N 1.383 2.365 0 C-N-CA 124.18 3.253 . . . . 0.0 112.831 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 25.0 p90 -86.43 113.19 22.17 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.771 0.796 . . . . 0.0 111.373 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.1 -178.23 3.52 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.643 1.177 . . . . 0.0 108.2 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 77' ' ' ILE . . . -67.57 110.77 3.64 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.541 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.3 t -100.84 96.67 7.45 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.0 tm? -82.23 109.49 16.56 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -64.06 92.9 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.826 -178.003 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.62 0.248 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 37.55 -79.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.535 2.334 . . . . 0.0 116.32 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.1 p-10 -79.97 -42.76 23.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.12 0.568 . . . . 0.0 110.222 -170.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -67.8 -35.4 78.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.088 0.47 . . . . 0.0 110.066 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -55.94 -48.47 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.456 0.702 . . . . 0.0 110.876 169.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -59.9 -52.02 67.22 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.665 0.603 . . . . 0.0 111.044 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ASP . 33.8 mt -57.87 -39.24 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.263 0.625 . . . . 0.0 109.702 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -62.99 -59.08 9.6 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.161 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.1 pp -68.13 -23.11 64.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.449 0.625 . . . . 0.0 112.261 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -73.98 -37.08 64.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.073 0.549 . . . . 0.0 110.978 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -72.54 -31.19 65.1 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.409 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -67.46 -39.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.707 0.803 . . . . 0.0 110.64 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -22.46 57.69 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.773 0.32 . . . . 0.0 110.511 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.41 -40.43 57.83 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.417 0.687 . . . . 0.0 110.167 168.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.57 HG23 HD23 ' A' ' 84' ' ' LEU . 42.8 mt -73.98 -33.68 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 0.0 111.528 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -64.05 -33.05 74.86 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 120.928 0.394 . . . . 0.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -76.73 -37.1 56.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.008 0.923 . . . . 0.0 111.134 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -71.78 -42.78 66.74 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.037 0.535 . . . . 0.0 111.108 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.57 HD23 HG23 ' A' ' 80' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 110.964 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -60.25 -49.46 77.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 0.0 110.364 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -50.67 -33.95 24.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.093 1.357 . . . . 0.0 112.399 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -61.26 -42.4 98.57 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.297 0.639 . . . . 0.0 111.19 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.84 -20.83 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 122.621 0.368 . . . . 0.0 111.442 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 96.1 m -75.37 -30.74 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.131 0.572 . . . . 0.0 111.759 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.38 -18.37 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 118.19 0.45 . . . . 0.0 112.136 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.86 -42.11 73.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.727 0.411 . . . . 0.0 110.116 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -81.84 -29.27 32.62 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.751 0.421 . . . . 0.0 110.884 177.024 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -71.45 -27.03 62.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.899 0.88 . . . . 0.0 111.609 -168.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.561 1.396 0 C-N-CA 123.166 0.586 . . . . 0.0 110.618 173.132 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.715 0 N-CA-C 113.209 0.427 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -69.46 127.78 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.42 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.91 140.81 42.32 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -146.02 87.97 1.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 12.8 t -147.04 37.12 0.18 Allowed Pre-proline 0 CA--C 1.571 1.779 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.3 Cg_endo -79.69 -32.47 1.56 Allowed 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 121.609 1.54 . . . . 0.0 111.758 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 59.5 m-85 -129.23 24.89 5.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.882 0.873 . . . . 0.0 111.529 -173.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 6' ' ' THR . 17.7 mt -67.79 123.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.989 0.423 . . . . 0.0 110.524 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 13' ' ' VAL . 62.8 mt -107.32 91.61 7.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 86.47 1.58 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.513 2.142 . . . . 0.0 110.866 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.53 -37.44 0.27 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.598 -173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' LEU . 11.5 m -93.36 167.88 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.993 0.517 . . . . 0.0 110.392 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 45.3 m -78.82 -37.22 41.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.425 0.69 . . . . 0.0 111.499 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -91.85 177.85 6.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.44 0.696 . . . . 0.0 112.272 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 140.6 49.46 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 22.8 m -52.55 -58.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.303 0.641 . . . . 0.0 111.059 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -172.24 135.53 0.77 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.608 1.163 . . . . 0.0 108.018 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 83' ' ' THR . 65.3 mt -105.91 127.86 27.55 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.08 130.35 31.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.849 2.366 . . . . 0.0 112.517 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.53 -14.91 62.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.117 0.567 . . . . 0.0 111.409 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.97 -43.32 93.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.642 0.777 . . . . 0.0 110.252 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 m -65.82 -42.21 90.9 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.063 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 9.4 mp -58.6 -39.11 79.5 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.849 0.46 . . . . 0.0 110.52 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -39.16 69.49 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.711 0.804 . . . . 0.0 111.818 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -72.08 -27.11 62.45 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.53 -42.65 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 122.734 0.414 . . . . 0.0 109.997 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 20.1 mmt180 -63.5 -25.17 68.13 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.389 0.675 . . . . 0.0 110.883 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -76.42 -52.73 9.29 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.446 0.698 . . . . 0.0 110.696 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -70.03 -27.57 64.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.855 0.462 . . . . 0.0 111.813 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' HG3' ' A' ' 49' ' ' PRO . 8.3 p -61.91 -24.11 66.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.052 0.541 . . . . 0.0 112.272 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.51 -23.35 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 122.944 0.498 . . . . 0.0 110.924 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.13 0.87 26.38 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.718 0.807 . . . . 0.0 111.029 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.23 -17.84 54.11 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.432 0.539 . . . . 0.0 112.698 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.37 131.48 30.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.914 0.885 . . . . 0.0 110.213 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -126.78 133.36 50.84 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.155 0.982 . . . . 0.0 108.935 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -112.03 115.82 29.54 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.75 144.38 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.467 1.107 . . . . 0.0 108.24 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -128.54 88.59 2.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.917 . . . . 0.0 110.392 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 76' ' ' TYR . 88.4 mt -76.68 80.16 3.32 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.75 -104.04 1.16 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -99.04 -11.78 21.17 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.525 0.73 . . . . 0.0 110.966 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD13 ' HA2' ' A' ' 73' ' ' GLY . 52.9 mt -83.3 132.0 35.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.296 1.038 . . . . 0.0 110.236 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.05 128.65 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.48 120.76 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.051 0.94 . . . . 0.0 109.603 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.6 m -100.84 110.32 22.38 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.774 0.83 . . . . 0.0 110.403 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 22.8 mm -101.84 115.08 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -133.59 103.49 12.27 Favored Pre-proline 0 N--CA 1.493 1.685 0 C-N-CA 122.754 0.422 . . . . 0.0 111.963 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 52.5 Cg_endo . . . . . 0 C--N 1.378 2.12 0 C-N-CA 123.185 2.59 . . . . 0.0 113.65 167.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.242 0.688 0 CA-C-O 121.363 0.601 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 47' ' ' ILE . 8.1 p90 -88.68 116.88 27.25 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.709 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.644 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 21.3 ptt? -172.89 -175.73 1.3 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.437 1.095 . . . . 0.0 109.379 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.8 110.29 0.22 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 124.397 1.061 . . . . 0.0 115.618 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.0 t -134.49 101.4 4.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.882 0.873 . . . . 0.0 108.79 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.71 111.72 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.843 0.857 . . . . 0.0 109.717 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.54 103.05 3.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.19 0.996 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 -174.159 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 110.92 -0.03 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -57.9 -31.55 66.86 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.227 1.011 . . . . 0.0 113.363 -171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.3 p-10 -65.15 -44.28 89.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.44 -19.37 59.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 0.0 111.804 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 -44.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 35.2 tt0 -66.84 -55.81 13.16 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.804 0.69 . . . . 0.0 110.281 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 68' ' ' ASP . 28.8 mt -56.81 -37.02 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 123.725 0.81 . . . . 0.0 109.928 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -60.88 -56.86 21.77 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.901 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.18 -27.23 68.56 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.203 0.501 . . . . 0.0 111.945 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 22.5 mm-40 -66.5 -47.0 74.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 0.0 110.332 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 12.4 m-85 -73.55 -27.11 61.16 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.362 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.5 -43.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.737 0.815 . . . . 0.0 110.456 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.36 -21.35 62.04 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.61 0.569 . . . . 0.0 110.947 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -78.05 -40.42 38.78 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.242 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.4 mm -65.68 -29.59 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 123.219 0.608 . . . . 0.0 110.825 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.2 pt-20 -70.46 -39.5 74.27 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -24.5 42.97 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 19' ' ' ILE . 99.6 m -73.11 -55.68 6.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.611 0.765 . . . . 0.0 110.404 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 124.927 1.291 . . . . 0.0 108.367 178.596 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -63.47 -50.23 70.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.366 0.667 . . . . 0.0 111.45 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -62.07 -40.2 95.02 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.528 0.331 . . . . 0.0 110.227 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 14.5 tp10 -66.6 -34.06 77.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.004 0.522 . . . . 0.0 111.149 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.3 -23.01 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.4 m -77.65 -34.66 53.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.954 0.902 . . . . 0.0 110.78 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.87 -25.82 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 23.9 tp -67.79 -42.03 82.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.517 1.127 . . . . 0.0 111.039 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -79.66 -21.67 44.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.592 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.99 -40.96 68.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.099 0.56 . . . . 0.0 111.583 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 CA--C 1.568 1.657 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.516 -174.489 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.542 0.9 0 N-CA-C 110.5 -0.615 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.59 107.23 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.165 0.986 . . . . 0.0 111.879 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.4 136.09 37.58 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD21 HD13 ' A' ' 19' ' ' ILE . 61.3 tp -136.27 95.51 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.61 1.164 . . . . 0.0 108.079 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.423 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.3 t -144.54 31.05 0.1 Allowed Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.83 -29.71 8.25 Favored 'Trans proline' 0 C--N 1.391 2.811 0 CA-C-N 121.565 1.595 . . . . 0.0 112.949 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 59.1 m-85 -129.44 26.27 5.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.602 0.761 . . . . 0.0 111.484 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 6' ' ' THR . 21.8 mt -71.76 135.4 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 173.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -109.9 90.19 8.98 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.43 90.91 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.913 2.409 . . . . 0.0 109.77 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.72 -43.06 0.28 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.667 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 10' ' ' LEU . 34.2 m -99.69 -175.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 110.968 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -105.68 6.01 31.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.106 0.962 . . . . 0.0 112.755 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -126.91 165.76 18.77 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.435 0.636 . . . . 0.0 111.715 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.42 143.82 34.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' HD21 ' A' ' 10' ' ' LEU . 28.9 t -63.71 -60.68 3.0 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.545 0.738 . . . . 0.0 109.834 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.4 138.6 0.71 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.537 1.135 . . . . 0.0 108.548 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 83' ' ' THR . 76.4 mt -104.52 137.18 19.15 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 123.096 0.558 . . . . 0.0 109.616 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.5 Cg_endo -57.19 133.11 55.38 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.872 2.381 . . . . 0.0 111.94 170.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.369 1.068 . . . . 0.0 112.128 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.4 pt-20 -60.0 -31.85 70.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 0.0 111.557 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.488 HG21 HD13 ' A' ' 5' ' ' LEU . 6.3 m -67.89 -50.32 56.97 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD22 ' H ' ' A' ' 24' ' ' LEU . 2.5 mm? -62.8 -27.06 69.05 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.729 0.412 . . . . 0.0 110.659 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -69.92 -47.33 62.87 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.046 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.8 -32.38 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.191 0.197 . . . . 0.0 110.979 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.2 mt -62.72 -44.58 99.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.547 0.739 . . . . 0.0 109.333 171.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.441 HH12 HD11 ' A' ' 32' ' ' ILE . 46.8 tpt85 -60.0 -27.85 67.22 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.558 0.743 . . . . 0.0 111.606 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.09 -46.23 15.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.538 0.735 . . . . 0.0 111.621 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -75.29 -25.89 58.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.994 0.518 . . . . 0.0 111.867 -175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -62.12 -28.67 69.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.552 0.341 . . . . 0.0 111.281 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.441 HD11 HH12 ' A' ' 28' ' ' ARG . 49.2 mm -65.75 -30.54 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.987 0.515 . . . . 0.0 110.527 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -70.87 -13.06 61.89 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.419 0.688 . . . . 0.0 110.452 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.07 -21.88 21.83 Favored Glycine 0 C--N 1.348 1.207 0 C-N-CA 124.2 0.905 . . . . 0.0 112.919 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 48' ' ' ARG . 34.6 tt0 -140.32 128.46 22.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.996 0.518 . . . . 0.0 110.979 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.13 130.39 53.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.89 0.876 . . . . 0.0 108.72 169.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -120.99 99.44 6.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.36 0.664 . . . . 0.0 109.328 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.15 123.09 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.877 0.871 . . . . 0.0 109.077 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 15.0 mtm180 -99.2 92.74 5.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 94.6 mt -74.45 75.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 -103.72 1.21 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.19 -10.56 19.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.515 0.726 . . . . 0.0 110.71 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.9 mt -81.2 108.41 14.82 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 13.2 tpt -86.26 124.4 32.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.02 126.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.795 0.838 . . . . 0.0 109.651 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -107.57 99.76 9.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.596 0.758 . . . . 0.0 110.569 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 56' ' ' PHE . 18.3 mm -86.68 90.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 46.4 mtp180 -125.99 124.43 24.68 Favored Pre-proline 0 N--CA 1.484 1.255 0 O-C-N 121.914 -0.491 . . . . 0.0 111.986 -171.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.412 2.075 . . . . 0.0 111.066 165.491 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.012 0.434 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB2' HG22 ' A' ' 47' ' ' ILE . 29.4 p90 -87.99 114.21 24.39 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.262 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 37.7 mtm -139.66 -174.84 4.01 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.493 1.117 . . . . 0.0 108.081 174.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.12 110.39 1.51 Allowed Glycine 0 C--N 1.351 1.399 0 O-C-N 123.497 0.498 . . . . 0.0 112.755 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 t -133.82 115.95 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.6 115.1 18.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.353 0.661 . . . . 0.0 109.26 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.93 96.6 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.418 1.087 . . . . 0.0 109.31 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.487 1.4 0 C-N-CA 124.269 1.028 . . . . 0.0 112.825 -169.322 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 118.971 -0.537 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -91.4 -53.45 4.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.061 0.846 . . . . 0.0 112.68 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -57.04 -46.4 82.45 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.524 0.73 . . . . 0.0 112.232 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.21 -40.74 74.52 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.149 0.98 . . . . 0.0 112.707 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.2 mm -64.65 -46.29 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 122.47 0.308 . . . . 0.0 110.592 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 97.9 mt-30 -62.48 -57.4 11.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.035 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.81 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.864 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -52.05 55.06 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.852 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -66.87 -26.85 67.1 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.487 0.643 . . . . 0.0 111.437 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 13.9 mm-40 -60.76 -50.82 71.94 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.119 0.962 . . . . 0.0 110.24 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.51 ' O ' HG12 ' A' ' 80' ' ' ILE . 49.3 m-85 -72.46 -25.11 61.32 Favored 'General case' 0 C--O 1.202 -1.424 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.583 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.23 -45.7 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.619 0.768 . . . . 0.0 110.924 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.74 -22.37 61.62 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -73.69 -47.17 41.62 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.668 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -66.53 -35.79 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 124.337 1.055 . . . . 0.0 111.349 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.425 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.8 pt-20 -56.79 -43.39 80.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.288 0.367 . . . . 0.0 110.705 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -78.0 -32.73 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.763 0.825 . . . . 0.0 111.879 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.572 HG21 HD12 ' A' ' 19' ' ' ILE . 21.9 m -69.58 -37.02 76.8 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.049 0.54 . . . . 0.0 110.803 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 t -60.05 -34.36 73.31 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -65.68 -42.48 91.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.499 0.59 . . . . 0.0 110.77 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -27.13 69.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.798 -173.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.04 -35.91 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.161 0.505 . . . . 0.0 110.748 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.8 m -75.77 -27.88 58.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 100' ' ' ILE . 8.1 p -67.4 -20.69 26.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.201 0.6 . . . . 0.0 110.43 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 0.0 111.1 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -32.67 71.1 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.487 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.44 -35.11 58.69 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.596 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 96' ' ' VAL . 15.1 pt . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.546 1.076 0 N-CA-C 113.054 0.367 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -103.64 139.47 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -89.65 141.16 28.86 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 19' ' ' ILE . 38.5 tp -145.71 110.46 5.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -149.93 53.51 1.3 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 123.415 0.686 . . . . 0.0 111.2 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.99 -27.64 0.65 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.282 1.988 . . . . 0.0 113.443 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.86 4.55 6.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.99 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.84 116.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -165.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.564 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -104.6 90.95 3.7 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 172.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.5 -23.17 58.01 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.205 1.937 . . . . 0.0 113.925 -167.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.25 72.61 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.133 0.413 . . . . 0.0 114.133 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.9 m -104.82 158.66 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.907 0.483 . . . . 0.0 111.324 -174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -73.28 -20.28 60.86 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.465 1.106 . . . . 0.0 112.905 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -105.89 174.6 5.81 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.374 0.67 . . . . 0.0 111.525 -175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -123.03 147.57 46.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.476 ' OG ' HD21 ' A' ' 10' ' ' LEU . 12.8 m -53.09 -49.27 66.78 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.939 0.774 . . . . 0.0 110.098 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -176.2 166.9 2.9 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.021 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.521 HG23 HD21 ' A' ' 5' ' ' LEU . 83.0 mt -121.35 129.94 25.03 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 167.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 124.17 15.29 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.638 2.225 . . . . 0.0 111.897 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 24' ' ' LEU . 27.3 mp0 -71.08 -15.0 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.645 0.778 . . . . 0.0 111.577 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.47 -46.19 84.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.567 0.747 . . . . 0.0 110.102 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 5' ' ' LEU . 17.6 m -69.47 -37.41 77.27 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.248 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 83' ' ' THR . 95.8 mt -61.32 -37.23 82.5 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.564 0.54 . . . . 0.0 111.217 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -69.88 -30.86 68.41 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.727 0.642 . . . . 0.0 110.775 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.1 tp10 -66.6 -38.5 87.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.842 0.457 . . . . 0.0 109.917 172.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 23' ' ' THR . 18.0 mm -63.37 -44.64 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.952 0.501 . . . . 0.0 109.912 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 11.6 mmm180 -64.44 -29.34 70.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.975 0.91 . . . . 0.0 110.807 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.62 -48.13 34.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.798 0.839 . . . . 0.0 110.987 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.1 pt20 -76.96 -26.11 53.58 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.115 0.566 . . . . 0.0 112.207 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -61.01 -23.77 65.66 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.13 0.423 . . . . 0.0 111.68 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.89 -31.62 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 122.663 0.385 . . . . 0.0 110.137 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -73.44 -13.57 61.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.018 0.927 . . . . 0.0 111.144 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.39 -18.61 22.92 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-O 119.585 -0.564 . . . . 0.0 113.839 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.83 154.56 48.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.757 0.778 . . . . 0.0 112.105 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.466 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -153.15 138.96 17.98 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.708 1.203 . . . . 0.0 107.781 168.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -140.26 129.33 23.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 109.651 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.81 112.61 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -82.5 94.32 7.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 76.5 mt -76.31 65.2 2.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.236 0.615 . . . . 0.0 110.426 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.08 -99.96 0.26 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -71.67 -43.19 66.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.23 1.012 . . . . 0.0 110.984 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.56 160.87 25.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.729 0.812 . . . . 0.0 110.231 -174.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.4 ttt -140.47 129.41 23.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.862 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.78 153.8 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.007 1.323 . . . . 0.0 108.564 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -132.55 98.59 4.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.698 0.799 . . . . 0.0 109.777 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 56' ' ' PHE . 30.2 mm -89.32 84.19 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -116.38 125.47 28.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 121.976 -0.452 . . . . 0.0 110.467 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 92.5 Cg_endo . . . . . 0 C--N 1.378 2.126 0 C-N-CA 123.308 2.672 . . . . 0.0 112.427 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 31.1 p90 -87.67 116.46 25.82 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.487 0.661 . . . . 0.0 111.42 -172.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.8 ptp -148.11 -176.09 5.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.997 1.319 . . . . 0.0 108.925 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.97 119.23 8.44 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 -172.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -135.33 118.13 16.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.932 . . . . 0.0 109.17 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.24 128.64 35.15 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.312 0.645 . . . . 0.0 109.316 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.3 78.32 1.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.447 0.699 . . . . 0.0 109.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 122.968 0.507 . . . . 0.0 111.804 -173.453 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 70' ' ' ILE . 30.7 t . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -58.46 -37.19 74.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 -170.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.05 -41.13 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -68.46 -17.33 64.17 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 66' ' ' SER . 47.3 mm -59.32 -43.63 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.919 0.487 . . . . 0.0 109.947 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -50.92 69.14 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.161 0.584 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -63.71 -34.54 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.508 0.671 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.44 -55.13 24.98 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.811 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.4 pp -67.12 -33.2 74.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.067 0.547 . . . . 0.0 111.685 -169.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -70.76 -36.46 73.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.791 0.436 . . . . 0.0 110.187 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -71.79 -25.9 62.2 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.729 172.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.58 -38.03 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.517 0.727 . . . . 0.0 109.985 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 73.4 mt-10 -68.05 -33.11 73.96 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.896 0.747 . . . . 0.0 110.533 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -66.37 -52.31 48.19 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.337 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 40' ' ' LEU . 75.2 mt -64.35 -29.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.3 -38.38 83.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.272 1.029 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -77.66 -47.05 20.18 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.834 0.854 . . . . 0.0 111.187 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 24' ' ' LEU . 31.5 m -78.47 -54.61 5.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.302 1.041 . . . . 0.0 112.782 -164.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 122.915 0.486 . . . . 0.0 110.686 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.686 0.279 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.7 t -61.75 -46.45 89.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.791 0.836 . . . . 0.0 112.268 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.26 -43.31 92.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.702 0.626 . . . . 0.0 110.604 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.51 -29.31 70.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.877 0.871 . . . . 0.0 113.219 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.1 -33.55 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 118.341 0.518 . . . . 0.0 110.771 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.5 m -66.49 -39.61 88.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.495 0.718 . . . . 0.0 110.978 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.1 -27.83 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.309 0.644 . . . . 0.0 111.48 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.76 -38.75 73.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.073 0.549 . . . . 0.0 110.882 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -79.93 -24.89 40.75 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.321 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.51 -49.17 64.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.274 1.03 . . . . 0.0 110.914 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.563 1.457 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.026 -177.072 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 CA--C 1.551 1.368 0 N-CA-C 114.502 0.924 . . . . 0.0 114.502 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 121.44 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.878 0.871 . . . . 0.0 109.058 168.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 4.8 p-10 -81.7 96.41 7.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.667 . . . . 0.0 109.665 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.404 ' HG ' HG21 ' A' ' 23' ' ' THR . 3.2 tm? -110.77 106.62 15.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.108 0.963 . . . . 0.0 109.108 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.2 t -153.98 57.71 1.94 Allowed Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 123.295 0.638 . . . . 0.0 111.819 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -89.25 -34.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.322 2.014 . . . . 0.0 113.282 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 55.7 m-85 -127.85 22.07 6.33 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.481 0.713 . . . . 0.0 110.499 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.51 117.49 12.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-O 121.251 0.548 . . . . 0.0 110.285 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 13' ' ' VAL . 65.5 mt -106.97 99.22 25.0 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.4 -20.99 66.79 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.739 2.292 . . . . 0.0 112.85 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.27 -3.3 81.78 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.891 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 10' ' ' LEU . 27.1 m -132.57 170.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.623 0.769 . . . . 0.0 109.889 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.6 p -89.31 -0.52 57.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.092 0.957 . . . . 0.0 112.455 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.444 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 40.1 p90 -129.01 159.01 37.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.646 0.736 . . . . 0.0 112.111 -173.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.04 142.54 47.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.873 166.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 34.3 t -67.04 -33.06 74.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 168.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -167.61 152.94 7.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.996 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -125.94 133.08 24.57 Favored Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.88 126.8 23.72 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.263 1.976 . . . . 0.0 111.061 168.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -65.31 -17.49 64.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 110.868 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.28 -43.88 83.51 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.944 0.898 . . . . 0.0 110.139 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 27' ' ' ILE . 25.7 m -65.46 -48.63 72.02 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.035 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.4 mm? -58.08 -39.56 78.85 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.299 0.5 . . . . 0.0 111.209 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -66.48 -43.45 85.36 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.073 0.549 . . . . 0.0 111.72 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.1 pt-20 -74.92 -27.5 60.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 119.442 -0.313 . . . . 0.0 111.062 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 23' ' ' THR . 95.4 mt -58.96 -39.9 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.328 0.651 . . . . 0.0 109.692 172.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' O ' HG12 ' A' ' 32' ' ' ILE . 17.9 mmt180 -62.02 -25.2 67.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.576 0.751 . . . . 0.0 111.893 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -80.22 -36.12 35.23 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.889 0.476 . . . . 0.0 109.908 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 29.3 mt-30 -73.68 -30.54 62.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.275 0.63 . . . . 0.0 111.036 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.8 p -67.93 -32.24 72.56 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.74 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.3 mm -74.93 -28.54 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.555 0.742 . . . . 0.0 110.595 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -64.74 -33.34 75.74 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.65 39.98 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.253 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.02 106.2 5.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.203 0.601 . . . . 0.0 110.755 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -117.11 122.05 43.02 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -131.46 107.42 8.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.103 0.478 . . . . 0.0 109.919 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 47' ' ' ILE . 1.7 mp -98.41 110.29 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 61.4 mtt-85 -82.07 88.16 6.44 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.0 mt -78.62 78.54 5.07 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 -102.22 0.45 Allowed Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.981 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.95 -40.85 19.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.037 0.935 . . . . 0.0 109.751 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.82 110.65 14.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.68 1.192 . . . . 0.0 110.531 -166.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.462 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.1 tpt -82.28 105.51 13.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.47 155.39 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.677 0.791 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -140.25 127.73 21.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.841 0.857 . . . . 0.0 108.7 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 38' ' ' ILE . 16.0 mm -113.09 92.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -134.57 127.76 18.77 Favored Pre-proline 0 N--CA 1.484 1.234 0 O-C-N 122.235 -0.291 . . . . 0.0 110.499 -174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 59.1 Cg_endo . . . . . 0 C--N 1.385 2.491 0 C-N-CA 123.136 2.557 . . . . 0.0 112.242 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 . . . . . 0 C--O 1.242 0.699 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 27.6 p90 -102.42 139.76 37.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 0.0 110.737 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -159.94 -174.97 4.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 125.063 1.345 . . . . 0.0 108.2 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.29 115.54 6.32 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 123.338 0.399 . . . . 0.0 112.806 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 t -126.0 135.05 51.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.299 1.04 . . . . 0.0 108.395 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.0 tm? -101.82 112.14 24.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.902 0.481 . . . . 0.0 110.555 -171.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -73.64 97.02 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.873 1.269 . . . . 0.0 112.034 -177.851 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -53.72 -45.7 70.57 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.423 0.689 . . . . 0.0 111.337 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.55 -45.21 80.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.885 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -57.77 -24.94 59.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.596 0.759 . . . . 0.0 112.626 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.6 mm -62.89 -46.72 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 122.781 0.432 . . . . 0.0 110.064 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -64.14 -54.82 27.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.718 0.807 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.33 -33.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.943 0.497 . . . . 0.0 109.922 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.02 -58.19 13.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.011 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.36 -28.67 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.851 0.461 . . . . 0.0 111.909 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -63.09 -54.25 40.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.49 ' O ' HG12 ' A' ' 80' ' ' ILE . 17.4 m-85 -61.13 -37.81 84.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.075 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -60.09 -43.43 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.669 0.788 . . . . 0.0 112.19 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.32 -29.39 61.58 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.177 0.298 . . . . 0.0 110.811 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.444 ' ND1' ' HB3' ' A' ' 15' ' ' PHE . 58.9 m-70 -77.62 -27.38 51.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 76' ' ' TYR . 37.6 mm -71.91 -40.35 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.52 -45.04 77.16 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 124.224 1.009 . . . . 0.0 109.948 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -50.46 -43.38 55.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 111.884 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -81.77 -33.63 30.82 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.921 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 0.0 110.522 -168.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.246 0.919 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.3 p -55.23 -39.7 70.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.614 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -63.07 -34.51 77.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.505 0.503 . . . . 0.0 111.359 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HD13 ' A' ' 97' ' ' LEU . 1.2 mp0 -62.09 -50.58 71.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.675 0.39 . . . . 0.0 111.951 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.99 -30.02 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 118.16 0.436 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.0 m -69.42 -46.19 67.4 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 124.238 1.015 . . . . 0.0 111.174 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 100' ' ' ILE . 34.0 m -75.22 -25.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.431 0.457 . . . . 0.0 111.084 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 93' ' ' GLU . 7.7 mp -68.05 -40.68 82.78 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.627 0.771 . . . . 0.0 110.078 170.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -78.29 -24.26 46.83 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.94 0.896 . . . . 0.0 110.255 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.03 -49.45 44.8 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.135 0.974 . . . . 0.0 109.918 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' VAL . 28.9 pt . . . . . 0 CA--C 1.569 1.681 0 O-C-N 123.47 0.481 . . . . 0.0 110.508 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 CA--C 1.55 1.299 0 CA-C-O 121.089 0.37 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.57 99.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-O 121.931 0.872 . . . . 0.0 110.401 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.62 124.58 24.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.073 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 19' ' ' ILE . 4.0 tt -133.78 94.2 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -152.52 60.38 3.38 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 121.512 0.673 . . . . 0.0 111.689 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.13 -34.59 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.146 1.897 . . . . 0.0 113.129 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.37 0.43 11.11 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.479 0.712 . . . . 0.0 112.143 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.5 mt -59.68 123.37 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -165.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.16 92.22 5.29 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 113.828 -1.533 . . . . 0.0 107.51 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.38 88.49 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.893 2.395 . . . . 0.0 110.761 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.25 -36.5 0.3 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.255 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -83.61 165.51 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 49.6 m -85.7 -20.09 29.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 111.848 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -113.56 -173.3 2.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 0.0 110.302 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.701 HD23 HG12 ' A' ' 19' ' ' ILE . 8.1 tp -133.38 133.26 42.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 m -51.55 -55.4 19.32 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.313 1.008 . . . . 0.0 111.106 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -141.6 144.45 34.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.858 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.701 HG12 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -127.8 127.58 23.95 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.76 117.33 4.04 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.815 2.343 . . . . 0.0 112.415 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -61.3 -23.05 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.242 1.017 . . . . 0.0 111.727 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.08 -47.74 82.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.295 1.038 . . . . 0.0 110.502 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.0 m -67.36 -36.81 82.14 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 27' ' ' ILE . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.47 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 m -62.39 -42.12 99.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.832 0.453 . . . . 0.0 110.112 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.8 tp10 -60.16 -56.96 15.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 109.894 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 24' ' ' LEU . 74.4 mt -54.85 -46.88 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.131 1.372 . . . . 0.0 111.331 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -72.58 -28.14 62.62 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.624 -171.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.09 -42.28 16.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.646 0.378 . . . . 0.0 111.948 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 5.1 pt20 -69.31 -23.62 63.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.079 0.552 . . . . 0.0 111.711 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -62.39 -25.98 68.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.47 -34.41 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.122 0.486 . . . . 0.0 109.769 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -73.19 -14.49 61.36 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.274 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 12.23 67.16 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 123.719 0.676 . . . . 0.0 113.047 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -138.35 107.34 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.293 0.637 . . . . 0.0 111.024 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -146.67 134.48 21.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.883 0.873 . . . . 0.0 108.685 173.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.67 122.27 5.26 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.48 141.97 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.132 1.373 . . . . 0.0 109.245 -174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -108.07 97.68 7.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 HG21 ' A' ' 45' ' ' VAL . 96.4 mt -77.9 69.14 4.09 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.56 0.695 . . . . 0.0 109.843 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.03 2.04 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.693 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -91.74 -21.88 20.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.293 0.637 . . . . 0.0 110.627 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' A' ' 73' ' ' GLY . 34.6 mt -74.71 108.18 7.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -88.96 131.82 34.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 40' ' ' LEU . 59.3 t -132.14 135.49 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.693 0.797 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 t -116.75 126.54 53.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.378 0.671 . . . . 0.0 109.774 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.21 84.35 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -116.49 108.14 45.78 Favored Pre-proline 0 N--CA 1.481 1.121 0 O-C-N 121.932 -0.48 . . . . 0.0 110.394 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 C--N 1.374 1.885 0 C-N-CA 122.516 2.144 . . . . 0.0 111.585 170.171 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -87.49 113.33 23.09 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-O 121.908 0.861 . . . . 0.0 109.898 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.03 -175.23 4.79 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.721 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 109.38 1.97 Allowed Glycine 0 CA--C 1.534 1.246 0 O-C-N 123.651 0.594 . . . . 0.0 113.608 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 t -102.92 97.82 7.89 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -73.66 109.18 6.97 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 36.2 t30 -64.28 109.95 2.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.813 0.845 . . . . 0.0 109.451 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 62' ' ' GLN . 4.2 pp0? . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 124.066 0.946 . . . . 0.0 112.096 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' HG12 ' A' ' 70' ' ' ILE . 48.5 t . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -54.13 -33.54 58.07 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.61 -36.56 73.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.457 0.703 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -76.81 -35.96 57.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.221 0.608 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 66' ' ' SER . 29.9 mm -50.42 -37.53 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.939 0.896 . . . . 0.0 110.553 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 7.7 tp-100 -53.16 -53.18 54.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.177 0.991 . . . . 0.0 111.557 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -61.26 -38.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.87 -57.06 21.33 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.307 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.69 -26.08 67.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.283 0.633 . . . . 0.0 111.42 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 84.3 mm-40 -70.63 -40.63 72.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.166 0.587 . . . . 0.0 110.651 173.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 9.2 m-85 -71.73 -27.38 62.96 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.2 mp -68.21 -46.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.026 0.93 . . . . 0.0 110.493 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.79 -28.31 63.52 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 0.0 109.865 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.16 -42.31 80.25 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.481 0.712 . . . . 0.0 110.961 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 34.8 mm -67.72 -34.95 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.484 0.713 . . . . 0.0 109.913 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -64.94 -37.97 89.42 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.455 0.472 . . . . 0.0 111.036 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.28 -25.56 60.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.689 0.396 . . . . 0.0 111.501 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -78.44 -46.05 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.976 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 123.28 0.632 . . . . 0.0 110.802 -176.873 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -60.18 -34.22 73.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.53 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -53.66 -34.86 60.08 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.884 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -51.6 68.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.512 1.125 . . . . 0.0 112.092 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.86 -22.51 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.635 0.652 . . . . 0.0 111.215 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.7 m -67.64 -38.83 84.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.54 0.736 . . . . 0.0 111.13 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -76.49 -33.01 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.665 0.386 . . . . 0.0 110.868 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.47 -29.54 59.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 0.0 111.98 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -81.71 -29.18 33.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.829 0.452 . . . . 0.0 110.274 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.32 -38.86 71.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.619 0.768 . . . . 0.0 110.831 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.776 177.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 CA--C 1.55 1.324 0 CA-C-O 121.216 0.423 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.42 99.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.138 0.971 . . . . 0.0 110.68 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 8.2 p-10 -71.07 139.32 50.35 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.024 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 23' ' ' THR . 45.2 tp -146.81 117.86 7.74 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.714 1.205 . . . . 0.0 108.833 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -154.13 52.59 0.8 Allowed Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.72 -31.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.929 1.753 . . . . 0.0 113.622 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.472 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.7 m-85 -131.29 17.21 4.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.707 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' HD21 ' A' ' 16' ' ' LEU . 28.9 mt -68.05 121.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -96.64 92.44 1.1 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.39 82.05 2.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.725 2.283 . . . . 0.0 111.298 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.97 -37.85 0.26 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.092 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 10' ' ' LEU . 6.4 m -82.71 159.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.889 0.476 . . . . 0.0 110.513 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -83.77 -0.21 50.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.318 0.647 . . . . 0.0 112.701 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' H ' HG23 ' A' ' 13' ' ' VAL . 40.3 p90 -131.15 -174.04 3.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.815 0.846 . . . . 0.0 111.354 -171.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 17' ' ' SER . 1.5 tm? -139.1 147.34 41.84 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.515 ' N ' HD13 ' A' ' 16' ' ' LEU . 25.3 t -63.62 -77.52 0.05 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.43 0.692 . . . . 0.0 111.011 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -145.44 94.63 2.54 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.802 0.441 . . . . 0.0 110.621 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.32 132.91 68.83 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 122.25 11.24 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.637 2.225 . . . . 0.0 111.927 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.462 ' HA ' HD23 ' A' ' 24' ' ' LEU . 13.5 pt20 -64.63 -22.78 67.06 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.027 0.931 . . . . 0.0 111.212 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -60.91 -39.28 88.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.16 0.984 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 5' ' ' LEU . 33.0 m -71.51 -37.15 71.24 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.16 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.3 mm? -63.44 -37.0 85.61 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.684 0.675 . . . . 0.0 110.789 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -63.91 -35.0 79.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.046 0.539 . . . . 0.0 110.519 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 10.5 tp10 -70.37 -36.72 74.31 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.764 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 38' ' ' ILE . 11.9 mm -63.36 -42.32 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 67.6 mtt180 -65.32 -25.29 67.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.451 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -71.78 -43.97 64.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.675 0.39 . . . . 0.0 111.101 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.7 mm-40 -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.23 0.612 . . . . 0.0 110.429 -177.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.0 p -67.18 -18.67 65.36 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.338 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 44.4 mm -66.67 -28.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -71.57 -15.79 62.29 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.382 0.673 . . . . 0.0 110.446 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.79 -22.19 19.57 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 123.547 0.594 . . . . 0.0 113.238 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 154.64 45.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.563 0.745 . . . . 0.0 110.043 173.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.9 147.0 34.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.074 . . . . 0.0 108.607 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -129.03 117.02 20.21 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 47' ' ' ILE . 1.6 mp -107.5 115.37 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 92.0 mtt180 -88.25 88.51 7.66 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 58.8 mt -71.47 77.49 0.78 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 -99.91 0.53 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -169.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -110.71 -4.37 15.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.308 1.043 . . . . 0.0 111.618 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 72' ' ' ILE . 13.0 mt -83.46 111.26 18.89 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.537 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.6 tpt -87.54 103.95 16.03 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.163 0.506 . . . . 0.0 110.409 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.99 152.28 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.081 0.952 . . . . 0.0 109.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.2 109.44 6.47 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.688 0.795 . . . . 0.0 109.704 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.58 HG22 ' HB2' ' A' ' 56' ' ' PHE . 34.6 mm -97.34 110.21 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.853 0.861 . . . . 0.0 109.163 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -128.05 116.74 20.46 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 122.744 0.417 . . . . 0.0 110.831 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 71.0 Cg_endo . . . . . 0 C--N 1.371 1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 113.057 166.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 p90 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 47' ' ' ILE . 50.2 p90 -86.76 129.0 35.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.087 0.47 . . . . 0.0 110.385 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.586 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -158.5 -176.4 5.87 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.389 1.075 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.35 114.02 3.9 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.811 0.695 . . . . 0.0 114.552 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.7 t -134.01 120.44 20.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.6 tp -89.04 144.15 26.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.457 . . . . 0.0 111.961 -174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -96.52 81.64 3.26 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.468 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 N--CA 1.484 1.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.436 175.199 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.97 -34.44 74.76 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.203 0.601 . . . . 0.0 112.269 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.034 0.533 . . . . 0.0 109.736 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.47 -23.84 67.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.582 0.753 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.5 mt -72.87 -42.73 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 122.971 0.508 . . . . 0.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -65.27 -58.32 6.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 43' ' ' LEU . 3.2 mp -68.4 -26.66 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.354 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.6 24.22 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.269 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.06 -34.47 78.14 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.705 0.752 . . . . 0.0 112.167 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 72' ' ' ILE . 13.1 pt20 -73.05 -34.49 66.31 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.974 0.416 . . . . 0.0 110.808 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 80' ' ' ILE . 5.0 m-85 -69.9 -29.83 67.11 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.818 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.71 -45.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.296 0.638 . . . . 0.0 110.892 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.79 -26.98 64.53 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.559 0.537 . . . . 0.0 110.251 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.88 -43.96 82.12 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.46 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.5 mm -66.37 -29.23 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 110.983 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 51.8 mt-10 -64.36 -44.04 92.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.09 0.471 . . . . 0.0 110.232 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -66.35 -31.45 72.24 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.803 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -78.88 -35.59 43.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.504 0.722 . . . . 0.0 111.466 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.4 mt . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.818 0.847 . . . . 0.0 112.172 -177.584 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 15.4 m . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 t -54.86 -37.96 66.88 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.712 0.633 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -68.06 -38.87 82.94 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.58 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 47.6 mt-10 -61.18 -45.0 96.41 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.852 0.461 . . . . 0.0 111.564 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.57 -24.79 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.807 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.0 m -72.87 -52.05 16.33 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.05 0.54 . . . . 0.0 111.437 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.01 -27.44 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.736 0.815 . . . . 0.0 112.418 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.36 -48.32 80.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.877 0.871 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -83.04 -24.76 32.65 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.085 0.554 . . . . 0.0 111.272 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -75.68 -36.93 59.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.106 0.962 . . . . 0.0 111.325 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 CA--C 1.567 1.621 0 C-N-CA 122.731 0.412 . . . . 0.0 111.614 -178.05 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 23.6 Cg_exo . . . . . 0 CA--C 1.542 0.902 0 N-CA-C 114.189 0.804 . . . . 0.0 114.189 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 38' ' ' ILE . 17.1 t -76.7 93.95 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.927 0.891 . . . . 0.0 108.713 169.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.48 102.2 1.1 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.5 100.3 7.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.564 0.746 . . . . 0.0 109.272 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.9 t -151.0 47.32 0.43 Allowed Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 123.263 0.625 . . . . 0.0 111.704 170.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 6' ' ' THR . 5.9 Cg_exo -80.75 -45.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.751 2.3 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 5.4 m-85 -126.89 20.5 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.962 0.905 . . . . 0.0 110.617 -170.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 16' ' ' LEU . 26.9 mt -65.77 131.24 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 117.893 0.315 . . . . 0.0 110.701 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -110.93 88.5 8.23 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.63 -2.62 12.12 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.464 2.109 . . . . 0.0 112.959 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.94 -21.56 57.17 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 123.17 0.414 . . . . 0.0 113.488 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.97 166.06 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 117.371 0.586 . . . . 0.0 111.05 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 t -67.93 -23.72 65.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.37 1.068 . . . . 0.0 112.27 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -112.32 175.53 5.39 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.818 0.818 . . . . 0.0 111.672 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 9' ' ' ILE . 3.1 tt -109.67 152.1 26.03 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 48.6 m -55.66 -55.45 32.01 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.45 0.568 . . . . 0.0 111.185 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -167.97 128.75 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.37 1.068 . . . . 0.0 108.273 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.3 mt -98.94 119.85 59.97 Favored Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 42.8 Cg_endo -67.51 142.61 59.86 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.26 1.974 . . . . 0.0 111.411 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.6 -27.01 67.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.69 0.796 . . . . 0.0 111.495 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 13.4 pt-20 -68.14 -31.45 71.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.628 0.771 . . . . 0.0 112.148 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.9 m -68.19 -52.21 36.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.528 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 95.5 mt -57.73 -42.52 84.03 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.27 0.981 . . . . 0.0 111.539 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.5 p -66.01 -33.55 76.06 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 124.049 0.843 . . . . 0.0 111.39 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 35.0 tt0 -70.22 -43.44 70.64 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 174.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.74 -35.86 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.5 0.72 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.8 mmt85 -63.97 -37.82 88.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.69 -40.46 84.38 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.089 0.556 . . . . 0.0 109.831 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 71.2 mm-40 -71.66 -33.95 69.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.523 0.729 . . . . 0.0 111.25 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 34.5 p -66.31 -26.23 67.21 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.719 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.5 mm -70.1 -27.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 120.604 0.24 . . . . 0.0 110.494 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -73.53 -14.57 61.23 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.396 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.81 15.64 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 123.849 0.738 . . . . 0.0 113.415 171.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.57 126.76 18.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.418 0.687 . . . . 0.0 109.734 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -110.01 102.14 10.9 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.486 1.115 . . . . 0.0 108.643 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 13.7 mp0 -82.43 120.27 25.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 3' ' ' VAL . 2.4 mp -118.76 127.44 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -98.38 95.31 7.26 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 90.5 mt -79.1 70.46 5.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.046 174.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -103.37 0.92 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.735 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.48 -18.3 28.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.615 0.766 . . . . 0.0 110.959 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 72' ' ' ILE . 12.4 mt -86.07 109.18 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.61 0.764 . . . . 0.0 109.459 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.1 tpt -86.61 101.83 13.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.46 152.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.191 0.997 . . . . 0.0 109.003 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 59' ' ' SER . 64.0 m -141.35 102.83 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.503 0.721 . . . . 0.0 109.621 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.611 HG22 ' HB2' ' A' ' 56' ' ' PHE . 22.1 mm -84.03 110.62 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.363 1.465 . . . . 0.0 110.874 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.63 131.14 23.53 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 41.8 Cg_endo . . . . . 0 C--N 1.376 2.003 0 C-N-CA 122.927 2.418 . . . . 0.0 111.392 168.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 p90 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 47' ' ' ILE . 9.7 p90 -85.63 121.92 29.0 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 122.005 0.907 . . . . 0.0 111.388 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.6 ptp -146.37 -179.18 6.57 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 121.16 22.43 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.439 0.462 . . . . 0.0 112.485 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 46' ' ' SER . 42.8 t -130.5 97.8 4.49 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 172.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -76.09 120.7 21.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.985 0.914 . . . . 0.0 109.204 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.57 100.76 0.91 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -161.636 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.02 -15.89 37.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.19 -57.57 6.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.58 0.752 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.08 -35.29 80.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.381 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mm -56.65 -46.72 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.565 0.746 . . . . 0.0 110.908 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.9 -53.02 36.32 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.477 0.486 . . . . 0.0 110.851 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 43' ' ' LEU . 49.5 mt -54.77 -41.88 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 123.827 0.705 . . . . 0.0 109.562 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.72 -58.07 16.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.629 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -65.75 -26.22 67.63 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.106 0.453 . . . . 0.0 111.919 -172.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.83 -46.58 84.43 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.601 0.761 . . . . 0.0 110.457 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 80' ' ' ILE . 48.9 m-85 -70.82 -33.22 70.47 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.433 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.03 -43.98 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.989 0.916 . . . . 0.0 111.194 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.47 -25.47 60.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.778 0.431 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.22 -42.17 72.65 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.774 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -67.22 -40.81 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.988 0.915 . . . . 0.0 111.65 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.4 -36.08 79.3 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.188 0.305 . . . . 0.0 111.226 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -71.31 -44.2 65.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.439 0.696 . . . . 0.0 110.097 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -61.8 -38.77 89.33 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.592 1.157 . . . . 0.0 112.234 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.057 0.543 . . . . 0.0 111.818 -176.728 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.593 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 58.2 m . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -59.4 -51.42 70.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.878 0.471 . . . . 0.0 111.674 -172.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -63.2 -19.5 64.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 0.0 112.612 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.593 ' HG2' ' HB ' ' A' ' 90' ' ' THR . 10.3 mm-40 -59.21 -52.72 64.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.253 0.621 . . . . 0.0 111.559 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.3 m -90.44 -27.37 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 122.992 0.517 . . . . 0.0 112.026 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -72.63 -33.28 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.811 0.444 . . . . 0.0 111.527 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.3 p -59.81 -27.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.722 0.409 . . . . 0.0 111.013 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 mp -54.25 -51.45 64.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.501 1.12 . . . . 0.0 111.239 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -81.67 -27.11 34.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 0.0 111.101 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.84 -27.91 36.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.769 0.828 . . . . 0.0 112.359 -166.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 96' ' ' VAL . 9.1 pt . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 119.139 -0.457 . . . . 0.0 110.503 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.549 1.244 0 CA-C-O 120.9 0.292 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.429 HG22 HD11 ' A' ' 27' ' ' ILE . 30.7 m -93.3 128.76 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.061 0.544 . . . . 0.0 110.048 175.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.91 129.53 37.83 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.2 100.72 4.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.4 t -152.79 38.24 0.12 Allowed Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -79.79 -18.48 10.38 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 121.621 1.547 . . . . 0.0 111.978 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.33 -9.07 5.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.051 -171.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.451 HG13 ' HA ' ' A' ' 6' ' ' THR . 29.2 mt -47.9 116.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -164.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 17' ' ' SER . 44.8 mt -98.93 98.33 6.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.17 1.388 . . . . 0.0 108.438 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.85 42.12 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.686 2.257 . . . . 0.0 112.588 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.23 -6.17 0.57 Allowed Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.819 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.2 163.8 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.766 0.827 . . . . 0.0 110.254 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -77.56 -38.56 48.24 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.992 0.917 . . . . 0.0 111.621 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -82.29 -175.22 5.57 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.067 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 19' ' ' ILE . 12.1 tp -137.99 136.49 36.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.062 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' LEU . 22.0 t -58.63 -33.72 70.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.886 0.874 . . . . 0.0 111.813 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -162.4 148.04 12.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 108.599 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.661 HG12 HD23 ' A' ' 16' ' ' LEU . 64.6 mt -127.43 124.58 23.65 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 166.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.42 113.44 1.79 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.075 1.85 . . . . 0.0 110.555 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.46 ' HA ' HD23 ' A' ' 24' ' ' LEU . 24.0 tm0? -64.91 -22.73 67.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.835 0.854 . . . . 0.0 110.727 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.72 -38.32 69.61 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.223 0.609 . . . . 0.0 111.101 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 27' ' ' ILE . 26.3 m -71.91 -36.64 70.05 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.676 0.79 . . . . 0.0 110.751 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 21' ' ' GLN . 4.1 mm? -63.59 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.833 0.453 . . . . 0.0 110.517 173.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -68.66 -33.21 73.6 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.508 0.723 . . . . 0.0 110.864 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 12.6 tp10 -65.64 -45.9 81.25 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.731 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 3' ' ' VAL . 32.9 mm -60.49 -39.78 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 55.9 mmm-85 -61.88 -38.46 88.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.378 0.671 . . . . 0.0 110.966 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 33.7 t30 -62.05 -41.31 98.0 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.814 0.846 . . . . 0.0 110.871 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 61.7 mt-30 -79.51 -32.08 42.32 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.008 0.923 . . . . 0.0 112.415 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 27' ' ' ILE . 42.5 p -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.1 -38.82 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.202 0.525 . . . . 0.0 110.024 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -72.17 -12.39 61.16 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.901 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -8.62 58.21 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.475 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -140.12 124.54 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.242 0.521 . . . . 0.0 111.041 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -145.56 143.39 29.9 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.232 1.013 . . . . 0.0 108.585 168.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -137.27 153.9 50.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.43 129.58 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -96.91 87.49 4.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 78.7 mt -70.79 74.89 0.61 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.422 0.689 . . . . 0.0 109.253 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.42 -101.47 0.76 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -100.77 -16.77 17.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.516 0.726 . . . . 0.0 111.282 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.6 mt -74.97 110.53 9.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.309 0.644 . . . . 0.0 109.361 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.1 tpt -85.57 129.23 34.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.67 117.33 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.648 0.779 . . . . 0.0 109.803 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.5 m -86.87 111.98 21.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.341 0.656 . . . . 0.0 110.227 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 mm -119.19 88.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -154.44 139.12 11.61 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.92 -0.488 . . . . 0.0 111.574 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.379 2.162 0 C-N-CA 122.849 2.366 . . . . 0.0 111.907 176.528 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HE1' HD21 ' A' ' 97' ' ' LEU . 11.5 m-85 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 121.265 0.555 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.033 0.92 . . . . 0.0 108.928 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.625 ' HA ' HD23 ' A' ' 84' ' ' LEU . 14.7 ptp -158.17 172.4 18.46 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.658 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 110.15 1.56 Allowed Glycine 0 C--N 1.352 1.458 0 O-C-N 123.978 0.799 . . . . 0.0 113.199 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -134.35 119.07 18.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.712 0.805 . . . . 0.0 109.491 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.85 124.93 34.66 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.033 0.933 . . . . 0.0 109.525 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -84.69 107.1 16.71 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.521 0.729 . . . . 0.0 109.104 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.083 0.953 . . . . 0.0 112.235 -174.584 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 70' ' ' ILE . 46.1 m . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -61.18 -42.08 97.93 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.97 0.908 . . . . 0.0 112.641 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.74 -37.21 86.83 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.222 0.534 . . . . 0.0 109.978 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.4 -22.91 58.94 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.684 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 66' ' ' SER . 46.0 mm -65.79 -43.86 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -69.6 -45.92 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.269 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -66.82 -34.32 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 123.727 0.642 . . . . 0.0 109.481 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.32 -57.26 17.55 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.724 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.7 pp -67.96 -33.52 74.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.98 0.512 . . . . 0.0 111.854 -171.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.84 -38.33 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.059 0.456 . . . . 0.0 110.038 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 80' ' ' ILE . 6.2 m-85 -69.47 -29.86 67.62 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.816 173.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -68.56 -35.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 110.591 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 49.9 mt-10 -70.27 -32.6 70.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.886 0.741 . . . . 0.0 110.345 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -74.21 -41.59 61.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.997 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.8 mm -63.02 -37.61 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.698 0.799 . . . . 0.0 109.111 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.79 -48.5 81.06 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 123.797 0.686 . . . . 0.0 109.743 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -34.4 77.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.415 0.447 . . . . 0.0 111.308 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -79.26 -24.21 43.12 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 111.823 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 57' ' ' MET . 19.5 tp . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.704 . . . . 0.0 111.884 -171.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 93' ' ' GLU . 14.8 t . . . . . 0 C--O 1.245 0.817 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -54.28 -35.98 63.17 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.033 0.933 . . . . 0.0 111.995 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' H ' HG23 ' A' ' 90' ' ' THR . 57.8 ttt180 -66.83 -41.28 87.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.049 0.539 . . . . 0.0 111.219 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.634 ' HG2' HG22 ' A' ' 90' ' ' THR . 22.7 mm-40 -71.56 -22.15 61.79 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -170.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.02 -27.85 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 118.072 0.396 . . . . 0.0 111.19 168.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.4 m -79.35 -28.38 42.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.096 0.558 . . . . 0.0 112.136 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.77 -17.81 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.288 0.635 . . . . 0.0 112.266 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' HE1' ' A' ' 55' ' ' TYR . 3.8 mm? -66.41 -35.09 79.43 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.295 0.638 . . . . 0.0 110.099 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.64 -31.14 28.91 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.236 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.11 -38.54 78.95 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.563 0.745 . . . . 0.0 112.187 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 123.365 0.666 . . . . 0.0 111.856 -175.612 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 CA--C 1.552 1.398 0 N-CA-C 114.45 0.904 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.81 92.63 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.845 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.21 113.77 4.23 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.466 HD23 ' HD3' ' A' ' 7' ' ' PRO . 3.9 tt -125.71 95.12 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.496 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.2 t -154.46 52.92 0.81 Allowed Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.465 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 6' ' ' THR . 3.2 Cg_exo -80.59 -38.53 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.374 2.049 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.29 17.25 6.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.526 0.73 . . . . 0.0 111.866 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.463 ' HA ' HD21 ' A' ' 16' ' ' LEU . 22.7 mt -64.15 133.49 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.2 101.7 20.65 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.62 1.168 . . . . 0.0 107.911 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.33 92.84 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.567 2.844 . . . . 0.0 111.458 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -38.58 1.65 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.729 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 15' ' ' PHE . 7.3 t -80.92 142.37 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 122.852 0.461 . . . . 0.0 110.023 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 p -74.12 -23.7 59.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 111.681 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.402 ' H ' HG12 ' A' ' 13' ' ' VAL . 17.9 p90 -109.54 177.34 4.77 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.256 0.622 . . . . 0.0 111.619 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.55 149.31 47.11 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.995 -177.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -61.01 -57.92 10.58 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.606 0.762 . . . . 0.0 110.023 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -171.62 133.91 0.81 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.123 0.89 . . . . 0.0 109.307 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 83' ' ' THR . 58.6 mt -103.61 136.48 19.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.62 112.69 1.08 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.691 2.26 . . . . 0.0 111.644 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.513 ' HA ' HD23 ' A' ' 24' ' ' LEU . 93.1 mt-30 -63.89 -24.99 67.95 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.526 0.731 . . . . 0.0 111.699 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.3 -35.06 76.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.376 0.67 . . . . 0.0 110.957 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.8 m -74.23 -27.44 60.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.171 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.7 mm? -72.27 -34.09 67.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -62.95 -38.92 93.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.353 0.661 . . . . 0.0 111.571 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 11.3 pt-20 -71.08 -34.84 71.54 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.278 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD12 HD13 ' A' ' 24' ' ' LEU . 78.4 mt -63.05 -36.89 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.077 0.551 . . . . 0.0 110.206 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' ILE . 10.9 mmm180 -57.87 -38.4 75.65 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 110.284 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -68.61 -43.78 75.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.851 0.86 . . . . 0.0 111.375 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.5 mm-40 -65.44 -37.19 86.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.948 0.499 . . . . 0.0 110.644 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -69.57 -22.84 63.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.452 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.1 mm -69.13 -36.16 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HE ' ' HB3' ' A' ' 35' ' ' GLU . 39.9 ttp-105 -66.35 -34.46 78.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 169.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.05 5.4 47.01 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.637 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' HB3' ' HE ' ' A' ' 33' ' ' ARG . 1.9 tm-20 -133.93 107.83 8.05 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -134.56 95.54 3.39 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -98.27 104.77 16.83 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -104.64 128.22 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.306 0.643 . . . . 0.0 109.838 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -105.46 98.47 8.16 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.641 0.376 . . . . 0.0 109.987 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 97.3 mt -77.33 64.95 2.8 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.681 0.792 . . . . 0.0 110.093 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.54 -110.0 3.06 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.238 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 -20.82 37.69 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.389 0.675 . . . . 0.0 110.903 175.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -81.56 110.98 17.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.08 130.35 35.03 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.08 145.54 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.087 0.955 . . . . 0.0 108.992 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -135.96 97.69 3.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.83 0.452 . . . . 0.0 110.507 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 5.7 mm -72.3 102.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.887 0.875 . . . . 0.0 109.0 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -129.25 123.15 21.44 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 55.2 Cg_endo . . . . . 0 C--N 1.378 2.095 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HB2' HG22 ' A' ' 47' ' ' ILE . 21.5 p90 -87.77 114.0 23.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.745 0.783 . . . . 0.0 108.937 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtm -130.06 -174.74 3.41 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.708 1.203 . . . . 0.0 108.268 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.65 137.93 49.78 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.878 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -133.66 98.82 4.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.754 0.822 . . . . 0.0 108.847 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.54 104.21 3.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.221 0.609 . . . . 0.0 109.679 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.15 109.65 3.64 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.245 0.842 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.53 -168.35 0.2 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.15 0.58 . . . . 0.0 111.257 165.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.64 -18.46 20.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.164 0.986 . . . . 0.0 112.759 169.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.12 -40.78 77.78 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.782 0.433 . . . . 0.0 110.869 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.3 mm -56.12 -49.28 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.998 0.519 . . . . 0.0 111.131 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.24 -54.82 40.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.737 0.815 . . . . 0.0 111.429 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.04 -37.87 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.929 0.892 . . . . 0.0 110.103 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -63.2 -59.71 8.59 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.581 177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -67.42 -27.92 67.46 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -172.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -67.26 -41.65 85.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.119 0.567 . . . . 0.0 110.189 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -73.47 -25.52 60.51 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.991 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -63.86 -43.27 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.4 -34.36 65.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.117 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.08 -39.73 93.62 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.814 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.531 HD11 HD11 ' A' ' 40' ' ' LEU . 68.2 mt -66.33 -34.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.591 0.756 . . . . 0.0 110.24 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.65 -47.07 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.046 0.539 . . . . 0.0 110.106 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -76.47 -30.44 57.29 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.491 1.116 . . . . 0.0 112.722 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 19' ' ' ILE . 31.3 m -86.65 -28.56 23.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.871 0.469 . . . . 0.0 111.659 -173.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 124.216 1.006 . . . . 0.0 109.888 -177.031 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 37.9 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.3 t -65.02 -45.55 85.03 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.385 0.428 . . . . 0.0 110.33 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.336 0.654 . . . . 0.0 111.492 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 4.7 tm-20 -58.68 -51.47 69.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 109.982 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.66 -23.52 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.249 0.62 . . . . 0.0 112.254 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 m -66.5 -48.53 69.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.593 0.357 . . . . 0.0 110.466 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.7 m -69.41 -24.41 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.269 0.628 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 89.6 mt -66.26 -47.35 73.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.99 0.424 . . . . 0.0 110.08 171.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -80.41 -24.14 39.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.682 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -75.65 -46.8 29.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.692 0.797 . . . . 0.0 111.841 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.952 -172.095 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.545 1.051 0 CA-C-O 121.269 0.445 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.61 99.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.75 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.11 146.21 53.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -146.25 93.5 2.32 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.913 -1.144 . . . . 0.0 107.913 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -139.02 33.7 0.21 Allowed Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.42 -33.57 0.96 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 CA-C-N 121.173 1.455 . . . . 0.0 112.731 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 39.9 m-85 -129.34 22.1 5.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.527 0.731 . . . . 0.0 111.651 -174.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -64.25 123.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' A' ' 17' ' ' SER . 25.3 mt -111.7 85.76 6.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.55 -12.8 34.08 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.407 2.071 . . . . 0.0 113.083 -167.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.83 -12.81 79.2 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.767 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -126.92 178.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 117.826 0.813 . . . . 0.0 111.128 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 p -84.13 -42.94 15.5 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.184 0.994 . . . . 0.0 111.983 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -81.97 -177.95 6.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.471 0.653 . . . . 0.0 112.207 -173.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -134.63 148.42 50.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.277 1.031 . . . . 0.0 108.336 -173.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 49.3 m -84.86 63.94 8.33 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.543 0.687 . . . . 0.0 111.223 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.5 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.197 1.399 . . . . 0.0 112.094 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 65.6 mt -68.85 136.32 89.95 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.213 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 17.2 Cg_endo -58.22 117.57 4.3 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.871 1.714 . . . . 0.0 110.504 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.442 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.0 pt20 -62.35 -18.24 60.98 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.665 0.786 . . . . 0.0 111.365 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.8 -46.55 77.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.787 1.235 . . . . 0.0 110.48 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.409 HG21 HD13 ' A' ' 5' ' ' LEU . 18.1 m -60.89 -47.34 86.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.274 0.629 . . . . 0.0 110.933 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.8 mm? -58.58 -42.36 87.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.668 0.605 . . . . 0.0 110.741 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -63.09 -32.62 74.04 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.913 0.758 . . . . 0.0 111.44 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.8 tp10 -71.66 -45.46 61.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.233 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.25 -35.6 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.935 0.894 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' O ' HG12 ' A' ' 32' ' ' ILE . 22.5 mmm180 -56.77 -42.67 79.81 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.786 0.834 . . . . 0.0 110.608 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -72.97 -40.52 65.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.666 0.786 . . . . 0.0 111.488 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 24.5 mm-40 -64.47 -40.62 96.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.491 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.9 p -69.96 -24.85 63.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.225 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.9 mm -68.46 -32.78 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 172.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.09 -12.33 58.28 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.981 0.419 . . . . 0.0 110.409 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.42 -16.94 29.04 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 114.491 0.557 . . . . 0.0 114.491 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -134.9 116.8 15.16 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.35 0.575 . . . . 0.0 111.223 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.59 138.09 54.69 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.71 105.03 5.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 47' ' ' ILE . 2.8 mp -101.81 114.81 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.713 0.805 . . . . 0.0 109.636 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 42.7 mtm180 -87.08 93.56 9.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 86.4 mt -75.89 71.54 2.71 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.119 0.485 . . . . 0.0 109.815 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.33 -101.99 0.56 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.594 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -99.61 -15.02 18.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.783 0.833 . . . . 0.0 111.251 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 18.3 mt -83.5 109.77 17.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.466 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.7 tpt -86.51 117.88 25.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.31 149.97 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 59' ' ' SER . 57.1 m -137.17 134.44 36.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.844 0.858 . . . . 0.0 108.902 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 84' ' ' LEU . 31.9 mm -112.85 104.03 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -127.91 107.6 20.22 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.102 0.561 . . . . 0.0 109.54 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--N 1.377 2.053 0 C-N-CA 122.606 2.204 . . . . 0.0 111.738 173.344 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' HG11 ' A' ' 94' ' ' VAL . 88.8 m-85 . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -88.1 110.2 20.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.784 0.433 . . . . 0.0 110.648 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 8.4 ptt? -170.26 108.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.551 0.74 . . . . 0.0 109.852 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.21 106.18 0.01 OUTLIER Glycine 0 CA--C 1.541 1.69 0 O-C-N 124.532 1.145 . . . . 0.0 115.765 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' SER . 28.7 t -134.98 99.78 4.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.81 113.92 12.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 109.428 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -68.7 109.08 3.64 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.757 0.661 . . . . 0.0 109.474 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 124.244 1.018 . . . . 0.0 112.004 -176.432 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 70' ' ' ILE . 33.0 t . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 119.54 -0.266 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.35 -32.66 71.48 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 111.617 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.8 -38.92 73.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.35 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -69.2 -28.02 66.01 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.52 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 66' ' ' SER . 33.6 mm -64.63 -45.25 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 tt0 -61.86 -57.1 13.11 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.07 0.856 . . . . 0.0 111.281 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.27 -37.75 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.46 -52.6 52.17 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.115 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.99 -24.81 65.18 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.295 0.547 . . . . 0.0 111.537 -174.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 80.0 mm-40 -59.69 -50.74 72.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.497 0.665 . . . . 0.0 109.327 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -68.84 -26.66 65.27 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.993 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.91 -37.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.11 -38.76 75.69 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.856 0.863 . . . . 0.0 111.987 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -76.89 -48.12 19.22 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.029 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.65 -29.85 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.349 0.66 . . . . 0.0 110.646 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 4.6 tt0 -47.14 -66.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.401 1.08 . . . . 0.0 111.161 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -71.0 -24.43 62.38 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.083 -173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.0 m -72.72 -23.43 60.85 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.113 0.565 . . . . 0.0 111.448 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 47' ' ' ILE . 34.2 tp . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 93' ' ' GLU . 5.3 t . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.849 0.357 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.7 p -59.85 -36.55 77.07 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 0.0 110.632 172.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -62.38 -33.31 74.5 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.636 0.774 . . . . 0.0 111.339 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.569 ' H ' HG23 ' A' ' 90' ' ' THR . 7.1 tp10 -65.9 -48.7 70.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.072 0.549 . . . . 0.0 110.031 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 55' ' ' TYR . 15.7 m -73.66 -24.12 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 100.0 m -65.45 -46.46 79.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.866 0.466 . . . . 0.0 110.495 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 100' ' ' ILE . 25.0 m -75.24 -23.65 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.323 0.249 . . . . 0.0 111.393 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 93' ' ' GLU . 5.4 mp -62.47 -47.85 82.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.681 0.792 . . . . 0.0 110.261 169.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -74.0 -23.16 59.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -76.62 -35.93 57.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.134 0.974 . . . . 0.0 110.463 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 96' ' ' VAL . 38.4 pt . . . . . 0 CA--C 1.568 1.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.352 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 CA--C 1.546 1.089 0 CA-C-O 121.171 0.405 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.21 103.7 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 0.0 109.172 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -70.35 136.46 49.73 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.17 0.51 . . . . 0.0 110.168 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 23' ' ' THR . 48.2 tp -136.29 100.59 4.43 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.547 1.139 . . . . 0.0 108.283 -175.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.412 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -143.31 42.17 0.39 Allowed Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 6' ' ' THR . 97.1 Cg_endo -82.34 -34.85 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 121.546 1.497 . . . . 0.0 112.803 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -129.66 25.11 5.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.053 0.941 . . . . 0.0 110.848 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.81 121.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' A' ' 13' ' ' VAL . 26.7 mt -111.07 91.56 13.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -16.99 47.46 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.736 2.291 . . . . 0.0 113.502 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.84 -27.78 64.11 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.46 0.475 . . . . 0.0 113.142 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 10' ' ' LEU . 16.3 m -112.19 170.37 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 0.0 110.77 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -90.37 -23.62 21.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.243 1.017 . . . . 0.0 112.18 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -95.57 168.01 10.95 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.372 0.606 . . . . 0.0 111.682 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.67 143.61 39.19 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -57.22 -64.84 0.75 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.43 0.692 . . . . 0.0 111.081 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -170.89 123.3 0.61 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.04 135.1 32.09 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.879 0.471 . . . . 0.0 109.859 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.79 123.13 12.66 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.86 2.374 . . . . 0.0 111.566 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.77 -22.79 67.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.154 0.581 . . . . 0.0 110.938 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.52 -34.89 74.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.804 0.841 . . . . 0.0 111.08 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 5' ' ' LEU . 31.3 m -65.26 -48.4 73.38 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 83' ' ' THR . 8.6 mp -61.92 -30.48 70.93 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.286 0.634 . . . . 0.0 111.64 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -68.86 -52.36 30.55 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.866 0.866 . . . . 0.0 110.279 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.6 pt-20 -65.09 -42.84 93.68 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.227 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 31' ' ' THR . 35.0 mm -63.8 -31.63 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.583 0.753 . . . . 0.0 111.031 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 32' ' ' ILE . 14.0 tpt180 -61.56 -34.8 76.21 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.697 0.399 . . . . 0.0 110.439 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -73.22 -43.08 61.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.805 0.842 . . . . 0.0 110.882 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.6 mm100 -61.69 -44.1 97.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.984 0.914 . . . . 0.0 111.812 -176.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 68.1 p -60.47 -38.67 85.0 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.595 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.4 mm -58.71 -37.74 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.005 0.522 . . . . 0.0 110.974 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.3 -7.66 59.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.256 1.022 . . . . 0.0 111.429 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.37 63.72 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.717 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 26.1 tt0 -137.63 105.82 5.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.168 0.587 . . . . 0.0 109.651 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.29 106.69 2.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.693 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 92.4 mt-30 -121.37 116.58 25.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.779 0.832 . . . . 0.0 109.12 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.38 116.63 49.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mtm105 -87.9 99.19 11.94 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.44 78.43 4.9 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.48 -100.95 0.52 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.73 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.87 -29.51 32.42 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.749 0.82 . . . . 0.0 110.728 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.24 160.44 15.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 111.129 -167.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.693 ' SD ' ' HB3' ' A' ' 37' ' ' GLN . 48.9 tpp -120.3 140.74 50.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.019 0.928 . . . . 0.0 108.903 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.28 110.12 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.779 0.832 . . . . 0.0 109.549 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -90.96 95.75 10.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 120.988 0.423 . . . . 0.0 110.219 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 56' ' ' PHE . 19.0 mm -88.36 84.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -135.26 126.28 17.33 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--N 1.378 2.087 0 C-N-CA 122.878 2.385 . . . . 0.0 111.474 -179.103 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.469 ' HB2' HG22 ' A' ' 47' ' ' ILE . 54.1 p90 -87.6 115.86 25.33 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.451 ' SD ' HG11 ' A' ' 94' ' ' VAL . 7.2 ptm -169.67 -178.17 2.93 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.97 110.23 1.42 Allowed Glycine 0 CA--C 1.537 1.436 0 O-C-N 123.796 0.685 . . . . 0.0 114.071 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 t -127.84 100.47 5.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.453 0.701 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.52 112.82 20.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.608 HD21 ' HB3' ' A' ' 44' ' ' MET . 2.4 p-10 -83.78 133.1 34.79 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 C-N-CA 124.534 1.134 . . . . 0.0 112.874 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 70' ' ' ILE . 42.1 t . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -52.33 -43.23 64.46 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.216 1.007 . . . . 0.0 112.789 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.44 -40.82 96.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.702 . . . . 0.0 110.975 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -66.18 -39.39 89.68 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.425 0.69 . . . . 0.0 110.673 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 66' ' ' SER . 50.0 mm -59.93 -43.68 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.573 0.749 . . . . 0.0 109.935 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.85 -51.74 65.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.894 0.746 . . . . 0.0 111.042 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.4 mt -53.18 -41.62 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.826 0.85 . . . . 0.0 110.192 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.31 -58.93 8.49 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.964 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.8 pp -64.72 -22.98 67.11 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.988 0.515 . . . . 0.0 112.17 -172.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -73.98 -47.76 35.03 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.111 0.564 . . . . 0.0 110.86 173.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -66.28 -26.79 67.5 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -70.44 -47.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.787 0.835 . . . . 0.0 109.929 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -24.89 60.25 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.687 0.617 . . . . 0.0 110.604 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -70.68 -49.25 49.23 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.375 0.67 . . . . 0.0 110.471 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.42 -35.4 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.564 0.745 . . . . 0.0 110.6 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 57' ' ' MET . 37.2 tt0 -59.14 -43.56 92.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.586 1.154 . . . . 0.0 110.667 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.4 -39.82 94.59 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.202 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 24' ' ' LEU . 17.9 m -72.03 -29.16 63.9 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 123.879 0.872 . . . . 0.0 111.771 179.794 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 92' ' ' ARG . 25.4 m . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 t -57.19 -39.47 75.44 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.022 0.529 . . . . 0.0 110.361 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.8 ttp180 -67.55 -28.99 68.26 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.635 0.774 . . . . 0.0 111.795 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -47.09 83.32 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.068 0.547 . . . . 0.0 109.565 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.451 HG11 ' SD ' ' A' ' 57' ' ' MET . 10.6 p -80.7 -23.25 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.954 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 92' ' ' ARG . 3.6 m -64.73 -46.51 81.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.505 0.722 . . . . 0.0 111.204 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.6 -33.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.4 -43.37 77.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.727 . . . . 0.0 111.753 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.1 -25.87 52.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.885 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -23.65 38.21 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.639 0.775 . . . . 0.0 112.6 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.005 178.062 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 1.2 pmm? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.2 Cg_endo -79.01 90.61 1.26 Allowed 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.575 2.183 . . . . 0.0 110.836 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.23 103.66 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.397 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.13 132.46 45.08 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.842 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.94 85.69 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.406 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.4 t -141.06 35.13 0.21 Allowed Pre-proline 0 CA--C 1.57 1.712 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 -29.88 6.83 Favored 'Trans proline' 0 C--N 1.387 2.604 0 CA-C-N 121.002 1.394 . . . . 0.0 112.327 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.0 m-85 -130.87 29.77 4.69 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.336 0.654 . . . . 0.0 111.826 -175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 6' ' ' THR . 11.6 mt -76.6 128.75 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 118.162 0.437 . . . . 0.0 112.025 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -103.83 91.07 3.27 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 86.44 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 0.0 111.518 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.64 -13.5 0.17 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.405 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 10' ' ' LEU . 25.1 m -119.71 158.31 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.202 0.601 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -74.52 -37.81 62.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.079 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -80.61 162.65 24.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.427 0.632 . . . . 0.0 111.285 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 17' ' ' SER . 1.1 tm? -113.43 151.96 30.7 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 35.7 t -57.1 -59.31 5.28 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.673 0.789 . . . . 0.0 110.629 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -174.69 117.43 0.19 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.24 137.56 27.69 Favored Pre-proline 0 N--CA 1.485 1.32 0 CA-C-N 118.402 0.546 . . . . 0.0 110.359 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.87 116.66 3.39 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.272 1.982 . . . . 0.0 110.736 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.504 ' HA ' HD23 ' A' ' 24' ' ' LEU . 27.8 tt0 -65.31 -26.13 67.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.477 0.711 . . . . 0.0 111.129 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.77 -25.94 67.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.871 0.868 . . . . 0.0 111.438 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 20.5 m -71.28 -47.84 54.5 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.2 mm? -57.33 -33.2 67.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 117.847 0.294 . . . . 0.0 110.627 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.8 m -61.46 -51.09 70.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.458 0.703 . . . . 0.0 111.401 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 23' ' ' THR . 8.2 pt-20 -66.52 -35.73 80.97 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.623 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 15.5 mm -58.24 -51.52 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.855 0.862 . . . . 0.0 110.091 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 91.4 mtm180 -59.88 -28.26 67.4 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.98 -42.4 26.81 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.964 0.506 . . . . 0.0 111.553 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 5.4 pt20 -77.7 -23.64 49.43 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.392 0.677 . . . . 0.0 112.448 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 74.1 p -61.49 -28.19 69.12 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.328 0.513 . . . . 0.0 111.352 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.39 -24.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.985 0.914 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -67.19 -19.05 65.5 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.744 0.818 . . . . 0.0 110.316 173.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.24 -22.86 14.83 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.997 0.808 . . . . 0.0 113.25 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 43.7 tt0 -143.98 145.11 32.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.294 0.638 . . . . 0.0 110.366 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.07 106.44 5.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.022 0.929 . . . . 0.0 109.085 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.56 121.9 31.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.683 0.393 . . . . 0.0 110.105 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -111.92 129.08 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 33.1 mtm105 -103.29 106.08 16.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 95.4 mt -77.27 68.37 3.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.68 0.82 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.266 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.46 -16.73 22.04 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.021 0.928 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 11.7 mt -81.12 111.27 17.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.7 tpt -84.89 124.76 32.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.98 152.14 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.597 1.159 . . . . 0.0 108.487 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -139.18 99.93 3.88 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.523 0.729 . . . . 0.0 109.757 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.507 HG12 HD13 ' A' ' 38' ' ' ILE . 11.1 mm -88.46 120.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -161.95 137.76 5.77 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 118.189 0.45 . . . . 0.0 111.189 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 96.7 Cg_endo -80.44 87.38 1.52 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.563 2.176 . . . . 0.0 111.311 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.55 ' HG3' HG22 ' A' ' 52' ' ' VAL . 15.7 tpt -71.15 102.45 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.854 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.27 75.93 4.79 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.673 0.789 . . . . 0.0 110.944 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 50' ' ' MET . 15.9 m -144.98 -43.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.824 1.649 . . . . 0.0 107.642 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' ' 98' ' ' ARG . 4.4 t30 179.51 104.41 0.03 OUTLIER 'General case' 0 C--N 1.354 0.786 0 C-N-CA 126.188 1.795 . . . . 0.0 106.987 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.26 134.09 3.22 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 122.871 0.107 . . . . 0.0 112.886 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -87.06 173.13 9.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.871 0.868 . . . . 0.0 110.157 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 9.7 p90 -87.06 114.7 23.9 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.429 0.633 . . . . 0.0 110.202 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.582 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -162.65 -176.57 5.07 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.0 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.7 110.29 2.04 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -125.66 106.47 9.76 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 118.85 19.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.019 0.927 . . . . 0.0 109.684 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -76.79 91.72 3.53 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.709 . . . . 0.0 109.132 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -71.62 -11.47 60.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.092 1.357 . . . . 0.0 112.856 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.86 118.49 7.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.521 0.728 . . . . 0.0 110.909 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 -4.3 85.76 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.573 0.545 . . . . 0.0 114.282 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.48 175.96 10.09 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.813 0.816 . . . . 0.0 112.685 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -113.84 171.03 7.83 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.686 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 15.1 m120 -56.79 -44.65 82.08 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.358 0.663 . . . . 0.0 111.82 -172.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.32 -35.35 80.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.123 0.569 . . . . 0.0 111.446 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -66.37 -32.96 74.67 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.964 0.505 . . . . 0.0 111.447 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mm -66.19 -45.01 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 76.3 mm-40 -71.61 -54.82 9.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.59 0.756 . . . . 0.0 112.079 -174.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.72 -30.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.35 0.595 . . . . 0.0 109.469 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.62 -57.66 17.8 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.654 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -71.27 -26.78 63.03 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.643 0.722 . . . . 0.0 112.737 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -74.05 -37.0 64.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.357 0.598 . . . . 0.0 110.096 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.93 -24.83 48.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.731 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 1.2 mp -71.54 -46.49 63.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.12 -30.51 71.57 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.608 0.568 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.06 -54.95 34.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.369 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.45 HG23 HD23 ' A' ' 84' ' ' LEU . 56.2 mt -61.24 -32.92 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.332 1.053 . . . . 0.0 112.364 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 49.7 mt-10 -63.1 -39.49 94.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.047 0.539 . . . . 0.0 110.84 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -77.36 -32.9 55.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.917 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -77.63 -26.19 50.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.299 0.64 . . . . 0.0 112.018 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD22 HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -75.94 -28.56 58.01 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.086 0.955 . . . . 0.0 109.956 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -138.02 87.83 2.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.12 0.968 . . . . 0.0 108.725 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -60.82 107.32 0.69 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.507 0.723 . . . . 0.0 112.386 -169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 10.56 76.96 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 114.222 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.9 t -80.45 -66.9 0.82 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.297 0.639 . . . . 0.0 110.479 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.9 162.24 40.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.034 0.534 . . . . 0.0 111.131 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 93' ' ' GLU . 9.0 t -102.81 179.11 4.37 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.9 p -58.16 -53.46 58.03 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.359 1.063 . . . . 0.0 111.182 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -68.17 -27.88 66.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.094 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 90' ' ' THR . 15.0 tp10 -59.91 -33.34 71.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.822 0.849 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.79 -39.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.004 0.922 . . . . 0.0 110.947 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -61.54 -37.28 83.19 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.385 0.674 . . . . 0.0 111.734 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.68 -27.92 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.294 0.638 . . . . 0.0 111.859 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.5 -39.83 85.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.911 0.484 . . . . 0.0 110.031 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.536 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 3.3 tpm_? -83.22 -34.45 25.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.604 0.761 . . . . 0.0 111.901 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.03 -38.35 57.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.576 0.75 . . . . 0.0 112.38 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.642 0.777 . . . . 0.0 112.557 -176.141 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.6 116.3 2.57 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.634 2.223 . . . . 0.0 112.856 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.96 112.89 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.045 0.938 . . . . 0.0 110.465 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.91 134.43 47.24 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.208 0.527 . . . . 0.0 110.275 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD21 HG23 ' A' ' 19' ' ' ILE . 4.5 tt -140.42 92.75 2.55 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -150.09 55.0 1.67 Allowed Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.66 -31.58 0.43 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.956 1.771 . . . . 0.0 113.099 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.439 ' HE1' ' HD3' ' A' ' 20' ' ' PRO . 48.4 m-85 -127.86 4.83 6.0 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.439 -171.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.28 122.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 mt -98.91 96.4 3.99 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.7 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.18 40.3 0.97 Allowed 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.078 2.518 . . . . 0.0 115.118 -161.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.12 23.23 0.15 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.103 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.36 178.18 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.277 0.631 . . . . 0.0 110.412 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 57.6 p -91.83 -48.96 6.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.748 0.819 . . . . 0.0 111.01 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -79.0 -175.93 4.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.342 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 19' ' ' ILE . 15.7 tp -141.78 169.64 17.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -55.39 -64.44 0.84 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.303 0.641 . . . . 0.0 109.722 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -176.41 105.6 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.167 0.917 . . . . 0.0 108.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.431 HG12 HD23 ' A' ' 16' ' ' LEU . 56.8 mt -63.3 129.47 93.54 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.702 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 14.8 Cg_endo -56.17 120.34 8.12 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.75 2.3 . . . . 0.0 112.038 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.6 pm0 -60.39 -26.05 66.36 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.453 0.701 . . . . 0.0 111.978 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.41 -36.44 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.762 0.825 . . . . 0.0 110.926 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' ILE . 16.5 m -72.78 -37.51 67.57 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.237 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.0 mm? -64.67 -29.78 70.79 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.6 0.636 . . . . 0.0 110.479 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.1 t -72.48 -35.38 68.19 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.372 0.669 . . . . 0.0 110.289 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 10.6 tp10 -61.33 -50.19 73.95 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.395 0.678 . . . . 0.0 110.229 173.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 23' ' ' THR . 13.9 mm -59.18 -37.17 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.171 0.989 . . . . 0.0 110.522 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.2 tpt180 -60.9 -33.42 73.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.69 -39.05 58.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.445 0.698 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 54.0 mt-30 -73.68 -29.85 62.54 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.25 0.62 . . . . 0.0 110.973 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.5 p -69.81 -27.92 65.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.947 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ARG . 43.3 mm -67.43 -35.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -67.75 -19.05 65.08 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.17 -21.86 21.62 Favored Glycine 0 C--N 1.346 1.126 0 C-N-CA 123.793 0.711 . . . . 0.0 112.759 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -141.89 119.32 11.58 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 122.974 0.51 . . . . 0.0 110.538 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.95 111.09 21.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -103.12 113.03 26.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.4 mp -101.23 149.08 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 108.588 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 42' ' ' GLU . 12.7 mmm-85 -126.03 88.25 2.82 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.187 0.995 . . . . 0.0 109.252 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.1 mt -71.32 77.43 0.74 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 -102.26 0.66 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.829 -166.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HA ' HH21 ' A' ' 39' ' ' ARG . 15.2 pt-20 -100.18 -18.63 16.81 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.811 0.844 . . . . 0.0 111.139 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.0 mt -69.08 110.95 4.76 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.4 ttt -88.8 108.71 19.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.088 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 19.2 t -98.5 154.13 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.641 1.177 . . . . 0.0 108.664 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.3 98.89 3.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.409 0.683 . . . . 0.0 109.8 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 38' ' ' ILE . 37.5 mm -89.63 104.84 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.041 0.936 . . . . 0.0 108.787 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -130.29 128.14 22.64 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.338 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.6 110.76 1.71 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.148 2.566 . . . . 0.0 111.922 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.3 tpt -71.45 105.12 3.45 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.309 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -63.06 -52.92 60.86 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 0.0 112.275 -168.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.87 81.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 71.19 145.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.156 1.382 . . . . 0.0 111.761 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.7 -143.16 15.67 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.454 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 179.39 5.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.057 0.943 . . . . 0.0 110.224 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -86.35 130.25 34.57 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -153.06 179.13 8.98 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.515 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . -61.89 110.44 3.19 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.23 0.956 . . . . 0.0 113.19 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.2 t -122.43 98.58 5.99 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 121.6 23.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.36 85.8 0.59 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -103.67 20.35 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.282 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.81 94.62 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 0.0 109.85 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 68.59 16.32 69.6 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.173 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -73.63 157.42 36.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.096 0.959 . . . . 0.0 110.416 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -60.73 132.92 55.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.549 0.34 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -57.52 -26.37 61.24 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.744 0.818 . . . . 0.0 111.879 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.22 -54.32 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.495 1.118 . . . . 0.0 110.644 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.57 -25.23 61.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.648 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.03 -39.86 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 50.9 tt0 -65.35 -58.3 6.24 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.445 0.466 . . . . 0.0 110.108 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 43' ' ' LEU . 59.8 mt -59.91 -34.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.556 0.743 . . . . 0.0 110.027 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.29 -54.89 26.81 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.37 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -66.93 -26.98 67.12 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.02 0.91 . . . . 0.0 111.467 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 98.4 mt-30 -64.69 -50.72 65.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.734 0.778 . . . . 0.0 109.44 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 80' ' ' ILE . 10.4 m-85 -69.64 -24.9 63.7 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.773 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -70.52 -42.42 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.404 0.682 . . . . 0.0 111.095 -178.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -68.87 -27.67 66.01 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -72.77 -36.01 67.55 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.279 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 76' ' ' TYR . 38.1 mm -73.59 -43.28 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.234 0.47 . . . . 0.0 110.605 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.544 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 12.7 pt-20 -65.5 -38.55 90.05 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.637 0.375 . . . . 0.0 111.489 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -70.39 -26.04 63.52 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.39 0.676 . . . . 0.0 110.555 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m -78.26 -31.87 49.31 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.722 0.809 . . . . 0.0 111.23 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.2 -22.63 22.68 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.013 0.525 . . . . 0.0 112.178 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -85.98 92.81 8.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.088 0.555 . . . . 0.0 110.109 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -119.82 14.29 12.48 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.513 0.725 . . . . 0.0 110.393 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.35 -177.27 44.55 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.741 -0.209 . . . . 0.0 112.595 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -82.88 66.83 8.7 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.85 0.833 . . . . 0.0 108.967 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.58 146.19 19.41 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.016 -169.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 81.9 m -122.91 147.69 46.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.353 1.061 . . . . 0.0 109.051 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.6 p -56.89 -48.57 77.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.956 0.902 . . . . 0.0 112.194 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' VAL . 42.4 ttp180 -69.0 -27.61 65.84 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 122.219 0.208 . . . . 0.0 111.097 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 1.5 tm-20 -61.69 -24.98 67.12 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 122.993 0.517 . . . . 0.0 110.174 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.17 -34.87 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.056 0.542 . . . . 0.0 111.368 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.0 m -62.97 -30.57 71.68 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 92' ' ' ARG . 26.8 m -65.92 -21.21 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.419 0.688 . . . . 0.0 111.558 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.08 -43.48 87.03 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.628 0.771 . . . . 0.0 110.102 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -79.81 -31.46 40.7 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.918 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -71.66 -44.51 64.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.64 0.776 . . . . 0.0 112.552 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 96' ' ' VAL . 27.5 pt . . . . . 0 CA--C 1.57 1.74 0 C-N-CA 122.971 0.508 . . . . 0.0 111.339 -172.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.54 155.63 24.56 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.118 1.879 . . . . 0.0 112.559 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.97 116.17 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.761 1.225 . . . . 0.0 108.597 167.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 7.6 p-10 -69.98 142.23 52.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -145.4 89.05 1.9 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.1 t -147.05 41.46 0.27 Allowed Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.002 0.521 . . . . 0.0 112.377 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 6' ' ' THR . 1.7 Cg_endo -79.6 -39.06 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 121.535 1.49 . . . . 0.0 112.021 -174.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' HE2' ' HD3' ' A' ' 20' ' ' PRO . 1.1 m-85 -129.43 31.09 4.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.071 0.548 . . . . 0.0 111.03 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.6 mt -63.35 109.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 118.817 0.735 . . . . 0.0 111.258 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.02 98.58 2.04 Favored Pre-proline 0 C--N 1.356 0.879 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.99 -16.79 50.49 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.419 2.079 . . . . 0.0 112.851 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.56 83.17 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.648 0.593 . . . . 0.0 114.356 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 10' ' ' LEU . 33.9 m -129.08 171.1 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 117.248 0.524 . . . . 0.0 111.503 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p -82.73 -34.7 27.13 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.635 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -84.91 177.34 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 122.084 0.945 . . . . 0.0 111.95 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.68 142.03 49.85 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 171.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.1 m -52.76 -48.0 67.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.456 0.702 . . . . 0.0 111.606 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 t70 179.41 119.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.838 1.255 . . . . 0.0 108.015 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.14 134.89 37.83 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 19.8 Cg_endo -58.86 122.65 11.98 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.797 2.331 . . . . 0.0 111.38 170.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.38 -17.9 64.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.153 0.581 . . . . 0.0 111.102 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -56.19 -47.21 78.78 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.222 1.009 . . . . 0.0 110.295 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -65.87 -34.94 79.3 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.043 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.9 mm? -67.65 -32.7 73.58 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.125 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -62.88 -38.61 91.57 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.846 0.458 . . . . 0.0 111.769 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 15.3 pt-20 -73.39 -40.84 64.0 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.261 0.351 . . . . 0.0 110.103 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 24' ' ' LEU . 97.1 mt -55.67 -36.83 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.004 0.922 . . . . 0.0 110.84 176.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 32' ' ' ILE . 21.9 mmm180 -61.73 -45.08 95.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.812 0.845 . . . . 0.0 110.934 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.24 -37.67 83.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.032 0.533 . . . . 0.0 110.935 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 18.0 mm-40 -68.47 -38.38 81.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.842 0.857 . . . . 0.0 111.148 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -69.06 -27.79 65.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 28' ' ' ARG . 46.6 mm -71.45 -36.61 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -75.17 -12.17 60.24 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.914 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.94 -9.73 60.07 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.594 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -139.23 111.95 7.8 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.214 1.007 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -125.67 98.99 5.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.811 0.844 . . . . 0.0 109.041 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -99.17 105.96 18.08 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.76 110.25 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.594 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 41.5 mtm105 -88.22 90.23 8.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.629 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 93.5 mt -76.1 70.6 2.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.291 0.637 . . . . 0.0 109.905 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.02 0.55 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.807 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.06 -15.13 32.38 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.177 0.991 . . . . 0.0 111.449 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 22.3 mt -91.3 142.86 27.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.963 0.905 . . . . 0.0 109.765 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.594 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.2 tpt -120.24 106.02 11.51 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.42 103.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.114 0.966 . . . . 0.0 109.898 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 t -90.36 98.91 12.05 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -84.74 103.64 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.04 139.36 13.35 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.618 -0.229 . . . . 0.0 110.665 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.44 153.26 23.78 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.728 2.285 . . . . 0.0 112.283 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.457 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 56.9 ttm -98.41 137.84 36.51 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.383 0.673 . . . . 0.0 110.188 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.92 -41.94 92.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.5 1.12 . . . . 0.0 112.432 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -87.57 46.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.571 0.748 . . . . 0.0 111.098 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t30 65.83 99.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.528 1.531 . . . . 0.0 110.892 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -161.67 124.6 1.33 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -81.73 147.16 29.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.232 0.613 . . . . 0.0 110.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -88.24 132.77 34.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.926 0.49 . . . . 0.0 110.422 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.9 ptp -160.01 -175.98 5.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.943 1.297 . . . . 0.0 108.628 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.29 110.69 1.89 Allowed Glycine 0 C--N 1.352 1.462 0 O-C-N 123.655 0.597 . . . . 0.0 113.168 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.9 t -128.72 97.73 4.77 Favored 'General case' 0 C--N 1.353 0.717 0 C-N-CA 123.196 0.599 . . . . 0.0 109.872 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.658 ' HG ' ' HA3' ' A' ' 73' ' ' GLY . 3.3 tm? -79.54 113.03 17.36 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -79.49 142.24 36.0 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -107.49 1.7 23.65 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.174 0.59 . . . . 0.0 112.167 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.31 107.87 6.74 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.68 12.84 58.93 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.535 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -117.0 162.62 17.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.863 0.865 . . . . 0.0 110.497 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m -100.82 161.72 13.4 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.051 0.94 . . . . 0.0 109.637 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -55.31 -31.92 62.05 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.457 1.103 . . . . 0.0 112.134 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -51.85 67.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.497 1.119 . . . . 0.0 110.216 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.23 -39.46 82.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.04 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 22.6 mm -59.12 -51.71 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.874 0.734 . . . . 0.0 110.65 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 47.5 mt-30 -57.61 -46.72 83.71 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.543 1.152 . . . . 0.0 111.487 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 43' ' ' LEU . 59.5 mt -58.13 -41.45 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 124.09 0.869 . . . . 0.0 110.158 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.658 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -60.37 -49.11 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.295 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 70' ' ' ILE . 50.7 mt -57.86 -36.98 73.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.991 0.917 . . . . 0.0 111.323 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 83.6 mm-40 -58.54 -51.39 70.08 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.429 174.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -68.81 -30.43 68.99 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.589 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 73' ' ' GLY . 1.2 mp -66.64 -42.72 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.385 1.074 . . . . 0.0 111.098 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.88 -30.13 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.431 0.457 . . . . 0.0 110.663 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -78.29 -26.75 47.18 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 40' ' ' LEU . 65.2 mt -71.03 -32.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 123.37 0.668 . . . . 0.0 109.638 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.64 -41.31 76.95 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.844 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -71.2 -38.83 72.06 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.638 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -66.83 -33.48 75.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.823 0.849 . . . . 0.0 111.38 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.14 46.09 0.93 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.528 1.131 . . . . 0.0 109.777 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -54.68 115.65 2.27 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.22 1.008 . . . . 0.0 111.721 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -99.03 176.99 5.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.094 0.958 . . . . 0.0 109.542 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.57 -165.56 4.71 Favored Glycine 0 C--N 1.353 1.5 0 C-N-CA 122.883 0.277 . . . . 0.0 112.627 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 m -60.54 94.49 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.515 0.726 . . . . 0.0 112.796 -170.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 93' ' ' GLU . 2.7 pp -156.27 177.72 11.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.449 1.1 . . . . 0.0 109.75 169.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 92' ' ' ARG . 21.8 m -135.16 156.02 49.71 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -66.61 -21.5 66.13 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.918 -0.489 . . . . 0.0 111.245 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 90' ' ' THR . 42.3 ttm180 -69.26 -33.5 73.34 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -69.03 -36.83 78.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.47 -20.45 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 120.99 0.424 . . . . 0.0 110.394 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.8 m -78.23 -38.96 41.76 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.406 0.683 . . . . 0.0 111.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 99' ' ' GLU . 30.0 m -76.38 -17.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.723 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 93.7 mt -51.01 -53.95 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.929 0.491 . . . . 0.0 111.988 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -84.11 -24.13 30.44 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.803 0.441 . . . . 0.0 111.949 176.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 34.8 tt0 -77.63 -31.57 52.87 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 112.655 -167.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 CA--C 1.561 1.373 0 C-N-CA 123.341 0.656 . . . . 0.0 112.329 -176.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.6 80.25 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.563 2.175 . . . . 0.0 111.941 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.43 94.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 122.176 0.989 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.24 148.61 49.58 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.547 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.03 102.89 3.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -149.97 38.95 0.18 Allowed Pre-proline 0 CA--C 1.571 1.787 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.69 -26.82 1.9 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 CA-C-N 121.014 1.398 . . . . 0.0 112.507 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.546 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 41.8 m-85 -127.97 21.96 6.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.545 0.738 . . . . 0.0 111.225 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.56 126.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.024 0.375 . . . . 0.0 110.507 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.4 90.17 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.34 -16.28 47.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.503 2.135 . . . . 0.0 113.675 -168.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.41 -13.9 82.1 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.585 -0.564 . . . . 0.0 114.082 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.47 173.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 117.737 0.769 . . . . 0.0 110.802 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 p -88.3 9.02 24.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.461 1.104 . . . . 0.0 112.406 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -146.04 177.3 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.375 0.67 . . . . 0.0 111.334 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.49 149.53 45.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 22.7 t -57.45 -64.54 0.86 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.063 0.545 . . . . 0.0 110.868 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -163.34 144.82 9.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.27 130.29 27.45 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.383 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.99 141.31 86.58 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.103 2.535 . . . . 0.0 112.332 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.18 -24.56 67.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.184 0.593 . . . . 0.0 111.647 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.85 -39.86 87.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.03 0.532 . . . . 0.0 110.803 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 27' ' ' ILE . 37.1 m -72.69 -42.88 63.76 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.018 0.527 . . . . 0.0 110.411 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.57 -46.3 90.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.043 0.537 . . . . 0.0 110.775 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -64.85 -33.69 76.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.778 0.831 . . . . 0.0 111.12 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.1 tp10 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.669 0.606 . . . . 0.0 109.697 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 23' ' ' THR . 67.9 mt -54.03 -43.21 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.797 0.839 . . . . 0.0 110.696 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 28' ' ' ARG . 10.4 mmm180 -66.17 -31.39 72.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -73.28 -44.37 59.34 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.553 0.741 . . . . 0.0 111.11 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 15.2 mm-40 -77.73 -27.7 50.6 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.184 0.994 . . . . 0.0 112.054 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.6 p -63.51 -25.86 68.45 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.577 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.41 -26.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-O 121.279 0.561 . . . . 0.0 109.771 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -77.56 -26.36 50.84 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.057 168.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.78 4.85 60.21 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.469 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 24.0 tt0 -129.76 116.86 19.37 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.62 96.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.426 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.49 113.02 26.01 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.36 112.86 34.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 52.0 mtp180 -87.46 92.24 9.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 80' ' ' ILE . 90.5 mt -70.22 75.53 0.52 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.273 0.629 . . . . 0.0 109.709 175.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.45 -99.91 0.37 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -103.62 -7.68 20.56 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.237 1.015 . . . . 0.0 111.657 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 24.3 mt -88.35 109.95 20.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.506 0.722 . . . . 0.0 109.069 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.553 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.5 tpt -84.47 114.44 21.93 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.25 110.68 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.047 0.539 . . . . 0.0 110.561 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.3 m -88.16 113.77 24.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.149 0.58 . . . . 0.0 110.573 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 31.7 mm -104.08 85.03 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 36' ' ' ALA . 24.6 mtm180 -130.55 145.06 55.91 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.88 154.77 64.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.455 2.103 . . . . 0.0 111.681 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.742 ' HB2' ' HA3' ' A' ' 54' ' ' GLY . 22.4 mmt -101.61 -172.08 2.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.92 -60.34 2.58 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.1 0.56 . . . . 0.0 110.432 -174.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.71 145.0 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.342 0.657 . . . . 0.0 109.588 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.67 21.63 12.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.578 1.151 . . . . 0.0 111.489 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.742 ' HA3' ' HB2' ' A' ' 50' ' ' MET . . . -113.4 79.1 0.26 Allowed Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.299 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.43 142.4 57.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.678 0.791 . . . . 0.0 109.232 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -94.44 108.05 20.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.279 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.5 ' SD ' ' HB3' ' A' ' 85' ' ' ASN . 59.2 mtm -152.78 107.71 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.427 1.491 . . . . 0.0 108.055 174.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 108.34 0.01 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 m -131.4 96.98 4.13 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 165.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.7 117.75 20.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 0.0 108.977 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 27.7 t-20 -67.65 89.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.761 0.791 . . . . 0.0 109.102 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -86.5 -8.3 57.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.312 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -65.02 100.82 0.45 Allowed 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.742 0.651 . . . . 0.0 110.596 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.99 9.66 86.64 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.602 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 tp -81.95 143.52 31.57 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.268 0.627 . . . . 0.0 109.349 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -72.18 150.19 43.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.308 0.643 . . . . 0.0 110.855 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -63.92 -26.69 68.71 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.5 -42.44 71.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.99 -20.66 60.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.416 0.686 . . . . 0.0 111.933 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.54 -50.17 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.88 -57.32 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.097 0.873 . . . . 0.0 110.59 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 43' ' ' LEU . 49.3 mt -61.42 -36.2 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.209 0.603 . . . . 0.0 109.882 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -57.92 -58.0 16.86 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.681 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -67.09 -27.24 67.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.057 0.543 . . . . 0.0 111.811 -175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -65.04 -43.33 92.73 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.524 0.678 . . . . 0.0 110.198 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.17 -22.62 59.34 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.848 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -67.24 -38.34 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.077 0.551 . . . . 0.0 109.735 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 -34.88 76.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.381 0.673 . . . . 0.0 110.23 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -62.6 -52.7 62.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.695 0.398 . . . . 0.0 110.675 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 40' ' ' LEU . 79.5 mt -64.58 -32.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.258 0.623 . . . . 0.0 110.633 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -53.01 -49.67 65.77 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.263 0.625 . . . . 0.0 110.212 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -75.75 -34.82 60.3 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.268 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.5 m -84.06 -31.78 25.18 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.788 0.835 . . . . 0.0 111.901 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.13 -41.93 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 109.328 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.5 ' HB3' ' SD ' ' A' ' 57' ' ' MET . 23.8 t-20 -128.12 156.42 42.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.563 0.745 . . . . 0.0 109.469 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -142.25 19.08 2.08 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.175 0.59 . . . . 0.0 111.014 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.89 -174.95 34.57 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.469 0.557 . . . . 0.0 114.26 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 p -77.61 4.26 11.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.563 0.745 . . . . 0.0 112.974 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.48 139.13 43.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.259 0.624 . . . . 0.0 110.446 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.3 p -81.68 -179.21 7.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.094 0.958 . . . . 0.0 111.406 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.8 p -60.61 -39.85 89.68 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.626 171.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -61.42 -41.33 97.0 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.935 0.894 . . . . 0.0 111.971 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.87 -31.66 72.92 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.246 0.341 . . . . 0.0 111.699 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.414 ' HA ' HD23 ' A' ' 97' ' ' LEU . 7.7 p -90.99 -23.21 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 C-N-CA 122.761 0.424 . . . . 0.0 112.047 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.1 m -65.6 -34.95 79.42 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.982 0.513 . . . . 0.0 110.86 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.25 -20.41 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 94' ' ' VAL . 4.4 mm? -73.06 -48.78 33.0 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.82 0.448 . . . . 0.0 110.488 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -71.19 -24.19 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.736 0.303 . . . . 0.0 110.438 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -69.94 -53.97 15.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.276 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.715 -175.284 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 tpp . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.519 ' HB2' ' HG3' ' A' ' 39' ' ' ARG . 71.8 Cg_endo -73.23 112.22 3.47 Favored 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 121.157 1.449 . . . . 0.0 112.644 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.75 99.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.809 0.844 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.4 89.59 0.35 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.312 1.053 . . . . 0.0 111.163 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.43 102.99 15.44 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.6 t -154.83 53.14 0.82 Allowed Pre-proline 0 CA--C 1.566 1.559 0 C-N-CA 122.833 0.453 . . . . 0.0 112.113 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -82.19 -36.56 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.251 1.967 . . . . 0.0 112.006 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -129.13 17.52 6.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.631 0.772 . . . . 0.0 111.814 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 HD21 ' A' ' 16' ' ' LEU . 30.0 mt -67.23 123.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 118.577 0.626 . . . . 0.0 111.28 -175.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -101.29 86.55 0.76 Allowed Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.88 -5.45 17.04 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.381 2.054 . . . . 0.0 113.698 -163.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.81 -11.26 68.35 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.347 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 10' ' ' LEU . 19.7 m -122.07 169.38 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.203 0.601 . . . . 0.0 110.842 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 15.6 m -81.89 -34.99 29.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.351 1.06 . . . . 0.0 111.877 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -88.81 170.82 10.42 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.778 0.799 . . . . 0.0 112.175 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.527 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -125.83 133.02 52.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 m -55.47 -66.52 0.4 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.823 0.702 . . . . 0.0 110.406 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -146.72 134.18 20.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.59 126.3 37.78 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 169.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.78 121.72 9.55 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.585 2.19 . . . . 0.0 111.683 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 10.1 pt20 -62.1 -23.95 66.83 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.991 0.917 . . . . 0.0 112.059 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.63 -37.09 86.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.71 0.804 . . . . 0.0 110.999 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' ILE . 23.3 m -76.97 -29.83 55.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.468 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.6 mm? -61.0 -41.33 96.31 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -54.51 -43.27 71.69 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.935 0.894 . . . . 0.0 112.714 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.9 pt-20 -72.9 -40.72 65.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.234 0.334 . . . . 0.0 110.904 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 33.7 mm -61.97 -39.98 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.329 0.652 . . . . 0.0 110.084 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.4 mmm180 -60.88 -25.48 66.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.999 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -87.06 -41.86 13.51 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 0.0 112.073 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 45.2 mt-30 -63.92 -31.44 72.62 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.562 0.745 . . . . 0.0 111.982 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -55.63 -33.44 64.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.337 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.45 -37.73 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.245 0.618 . . . . 0.0 110.287 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -61.61 -24.24 66.56 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.787 0.835 . . . . 0.0 111.178 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.67 2.63 67.15 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.231 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 122.53 19.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.821 0.849 . . . . 0.0 110.269 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -164.9 96.33 0.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.611 1.164 . . . . 0.0 108.361 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -105.28 125.32 50.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.96 116.8 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.155 0.982 . . . . 0.0 108.409 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 40.5 mtm105 -86.17 101.34 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.734 HD11 HD11 ' A' ' 80' ' ' ILE . 48.1 mt -76.12 77.67 2.95 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.23 -101.29 0.66 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.284 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -25.93 17.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.143 0.977 . . . . 0.0 111.217 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 72' ' ' ILE . 61.4 mt -71.77 131.06 42.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.757 0.823 . . . . 0.0 111.143 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.9 tpt -98.14 99.94 11.22 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.48 152.9 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.957 0.903 . . . . 0.0 108.979 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 98.61 4.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.6 0.76 . . . . 0.0 109.52 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 84' ' ' LEU . 40.7 mm -93.19 84.13 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -129.45 117.14 18.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.05 -55.0 0.87 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.414 2.076 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.4 tpt 68.33 141.06 0.04 OUTLIER 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.613 1.196 . . . . 0.0 110.702 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -78.26 167.81 20.8 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.067 -0.396 . . . . 0.0 110.726 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t 67.48 76.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 124.649 1.18 . . . . 0.0 110.009 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.6 t30 68.64 16.67 9.01 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 112.987 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.59 137.08 13.52 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 122.217 -0.302 . . . . 0.0 112.926 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.448 ' HB2' HG11 ' A' ' 94' ' ' VAL . 48.3 m-85 -126.25 146.52 49.96 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.302 1.041 . . . . 0.0 109.564 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -97.25 126.44 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 121.503 0.668 . . . . 0.0 110.763 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 14.0 ptt? -174.75 -174.38 0.8 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.71 2.004 . . . . 0.0 106.996 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.24 109.24 0.47 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -134.82 122.32 21.9 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.434 1.094 . . . . 0.0 108.203 170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.1 tm? -99.49 124.23 44.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.633 0.773 . . . . 0.0 109.545 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.68 105.75 3.28 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -88.04 -8.73 55.13 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.913 0.885 . . . . 0.0 112.072 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.64 115.76 5.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.478 0.711 . . . . 0.0 111.21 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.95 -5.19 83.38 Favored Glycine 0 C--N 1.351 1.392 0 O-C-N 123.793 0.683 . . . . 0.0 113.843 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -89.03 169.26 11.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 122.018 0.913 . . . . 0.0 111.93 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 70' ' ' ILE . 34.5 t -101.75 158.88 15.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.422 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.53 -26.02 68.51 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.129 0.572 . . . . 0.0 111.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.23 -48.96 76.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.32 0.648 . . . . 0.0 110.181 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.97 -35.93 81.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.881 0.873 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 66' ' ' SER . 37.5 mm -61.66 -40.27 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.933 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.48 -57.77 10.51 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.909 0.755 . . . . 0.0 112.008 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.0 mp -66.01 -34.85 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.55 -57.3 20.56 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.175 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 70' ' ' ILE . 3.7 pp -66.95 -30.65 70.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.954 0.501 . . . . 0.0 111.614 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 23.1 mm-40 -60.72 -54.63 42.93 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.531 0.519 . . . . 0.0 110.048 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' ILE . 12.9 m-85 -60.79 -35.91 77.65 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.679 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -62.64 -35.9 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.956 0.902 . . . . 0.0 111.561 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.75 -31.58 66.82 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.457 0.473 . . . . 0.0 110.5 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.78 -32.59 62.07 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.702 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 40' ' ' LEU . 95.5 mt -74.07 -29.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.863 0.865 . . . . 0.0 109.734 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 12.8 tt0 -58.01 -35.7 71.62 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.976 0.911 . . . . 0.0 110.551 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.87 -43.96 43.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.229 0.612 . . . . 0.0 110.692 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -65.93 -25.15 67.01 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.456 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 90.9 mt -129.98 43.86 3.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.825 1.25 . . . . 0.0 109.546 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -68.29 97.08 0.7 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.717 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -137.46 108.41 6.71 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.699 0.8 . . . . 0.0 108.98 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.77 -134.88 7.69 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.984 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -163.47 41.2 0.1 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.1 164.36 38.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.673 0.389 . . . . 0.0 111.959 -171.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.7 m -82.49 161.87 22.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.487 1.115 . . . . 0.0 111.423 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -59.62 -40.39 87.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.943 0.897 . . . . 0.0 110.935 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -39.25 76.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.388 0.675 . . . . 0.0 110.843 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.6 -35.3 78.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 0.0 111.98 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 55' ' ' TYR . 28.0 m -79.39 -28.98 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 118.332 0.515 . . . . 0.0 111.102 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.5 m -68.9 -42.46 76.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.835 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -65.21 -27.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.614 0.571 . . . . 0.0 111.569 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -63.26 -39.7 95.34 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.586 0.707 . . . . 0.0 110.22 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -32.06 32.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.26 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.69 -15.55 56.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.033 0.933 . . . . 0.0 112.482 -167.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.568 1.643 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.523 176.255 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 CA--C 1.55 0.975 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.31 138.19 8.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.27 2.647 . . . . 0.0 113.424 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 38' ' ' ILE . 61.9 t -88.62 94.14 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.967 0.907 . . . . 0.0 109.442 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.73 99.31 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.169 0.988 . . . . 0.0 110.259 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 23' ' ' THR . 56.1 tp -117.83 98.73 6.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.728 . . . . 0.0 109.208 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 t -158.33 60.3 1.77 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.649 0.78 . . . . 0.0 110.97 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.7 -36.03 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.536 2.158 . . . . 0.0 112.286 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.43 -4.78 5.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.611 0.764 . . . . 0.0 111.552 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -48.07 124.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -161.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.1 mt -107.74 90.22 6.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.34 -19.41 38.18 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.458 2.105 . . . . 0.0 112.589 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.63 -2.41 80.55 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.983 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.92 173.43 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.51 0.655 . . . . 0.0 110.349 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 m -91.5 -13.39 32.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.269 1.027 . . . . 0.0 111.877 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -114.65 -172.86 2.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.838 . . . . 0.0 110.482 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 19' ' ' ILE . 16.0 tp -143.33 139.71 30.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -50.03 -41.99 48.57 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.76 1.224 . . . . 0.0 112.183 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -166.47 147.66 6.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.597 0.759 . . . . 0.0 110.029 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 16' ' ' LEU . 69.1 mt -121.24 130.47 24.81 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 168.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.99 116.63 2.9 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.964 2.442 . . . . 0.0 111.63 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HA ' HD23 ' A' ' 24' ' ' LEU . 25.6 mp0 -63.75 -27.24 69.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.619 1.168 . . . . 0.0 110.384 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.15 -36.13 83.28 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.077 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.555 HG21 HD13 ' A' ' 5' ' ' LEU . 48.3 m -66.77 -36.28 82.06 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.671 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 83' ' ' THR . 3.8 mm? -63.27 -42.75 99.16 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.156 0.435 . . . . 0.0 110.292 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.3 t -61.21 -39.47 90.38 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.563 0.745 . . . . 0.0 110.849 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 38.3 tt0 -65.62 -45.12 84.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.608 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 23' ' ' THR . 96.4 mt -60.3 -41.83 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.245 1.018 . . . . 0.0 110.184 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 20.4 mtp180 -63.52 -25.47 68.27 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.459 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.39 -34.88 25.45 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.613 0.765 . . . . 0.0 111.548 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 5.4 mm100 -73.21 -31.32 64.1 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.423 0.63 . . . . 0.0 110.239 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -68.27 -19.02 64.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.193 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.24 -33.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -70.47 -31.15 68.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.211 0.605 . . . . 0.0 110.11 168.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.5 3.09 50.39 Favored Glycine 0 N--CA 1.468 0.81 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.258 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.97 107.59 7.41 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.905 0.882 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -136.64 95.85 3.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -101.56 98.11 8.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.556 HG22 HD22 ' A' ' 40' ' ' LEU . 1.9 mp -94.22 117.79 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -172.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 -89.59 104.65 17.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 38' ' ' ILE . 3.9 mm? -76.68 74.88 3.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.35 -104.31 1.26 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.62 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.85 -20.55 23.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.123 0.969 . . . . 0.0 110.572 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 43.7 mt -78.13 146.52 35.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.471 0.708 . . . . 0.0 110.543 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.5 tpt -116.72 121.21 40.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.85 123.99 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.341 1.057 . . . . 0.0 109.435 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' SER . 66.9 m -98.58 97.68 8.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.212 0.605 . . . . 0.0 110.416 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -85.16 100.7 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.88 141.55 41.5 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.03 -26.05 66.1 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.166 2.578 . . . . 0.0 112.445 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.5 mtt 76.43 -21.99 0.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.843 1.657 . . . . 0.0 112.748 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? 60.22 99.85 0.02 OUTLIER 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.227 1.411 . . . . 0.0 109.646 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.6 t 71.5 155.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 124.998 1.319 . . . . 0.0 109.363 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.35 72.29 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.883 1.273 . . . . 0.0 109.392 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.34 -127.25 17.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.932 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -163.83 -178.78 5.9 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.794 0.838 . . . . 0.0 111.046 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 38.5 p90 -84.67 125.75 32.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 111.162 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 23.8 ptt? -177.62 112.95 0.08 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.581 1.152 . . . . 0.0 109.002 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 43.29 103.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.182 1.372 . . . . 0.0 116.254 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 32.4 m -136.72 98.91 3.9 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.168 -0.607 . . . . 0.0 109.639 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.9 126.4 27.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.58 0.752 . . . . 0.0 109.35 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.93 93.11 6.44 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -82.58 -56.0 4.13 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p30 41.72 33.72 0.35 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.506 1.522 . . . . 0.0 113.508 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.14 45.27 2.23 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.53 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 69' ' ' ASN . 14.4 tp -91.11 156.46 17.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.236 1.014 . . . . 0.0 110.225 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -67.85 144.54 55.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.107 0.563 . . . . 0.0 110.623 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -62.7 -23.36 67.11 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.615 0.766 . . . . 0.0 112.228 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -48.51 73.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.708 0.803 . . . . 0.0 109.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.496 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 1.4 m-20 -71.2 -26.36 62.92 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.147 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.66 -43.85 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.481 0.712 . . . . 0.0 109.859 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 26.9 tt0 -59.75 -58.94 6.39 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.204 1.001 . . . . 0.0 111.591 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.26 -29.75 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -55.94 -57.66 17.93 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.592 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.74 -26.26 66.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.976 0.51 . . . . 0.0 111.802 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 16.1 mm-40 -65.3 -41.55 93.96 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.577 172.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 80' ' ' ILE . 11.7 m-85 -77.98 -23.09 48.53 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.737 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -65.52 -47.77 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.563 0.619 . . . . 0.0 110.086 175.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -71.6 -28.49 63.85 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.949 0.781 . . . . 0.0 110.912 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -68.08 -50.32 55.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.197 0.311 . . . . 0.0 110.173 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 76' ' ' TYR . 45.8 mm -61.53 -39.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.755 0.822 . . . . 0.0 109.757 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 43.4 tt0 -57.74 -42.69 84.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.101 0.96 . . . . 0.0 111.174 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -71.8 -27.51 62.98 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.559 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.475 HG22 ' HG ' ' A' ' 24' ' ' LEU . 10.5 m -97.13 -23.41 16.23 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.767 0.827 . . . . 0.0 112.091 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 57' ' ' MET . 41.9 tp -109.94 -5.82 15.37 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.175 0.99 . . . . 0.0 111.094 -170.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -49.85 138.31 15.14 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.674 0.79 . . . . 0.0 112.246 176.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -79.0 -33.23 45.17 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.453 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.67 172.2 45.24 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m 70.18 -61.1 0.47 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.209 1.404 . . . . 0.0 110.849 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.89 138.74 38.26 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.7 m -92.6 153.52 18.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.355 0.662 . . . . 0.0 109.902 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -63.04 -52.47 62.72 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.02 0.928 . . . . 0.0 112.071 -172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -57.74 -34.02 69.09 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.497 0.719 . . . . 0.0 112.189 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -33.08 72.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.941 0.897 . . . . 0.0 112.359 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.37 -36.21 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.992 0.517 . . . . 0.0 110.024 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -64.07 -39.61 94.46 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.552 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.01 -32.83 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 0.0 111.086 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.67 -35.61 79.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.213 0.605 . . . . 0.0 110.432 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -82.19 -25.47 34.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.087 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.14 -41.22 22.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.953 0.901 . . . . 0.0 111.42 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.288 0.635 . . . . 0.0 111.068 -178.736 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -87.91 100.72 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.904 2.403 . . . . 0.0 113.815 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 99.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.17 0.986 . . . . 0.0 109.127 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.55 110.42 3.66 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.2 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.81 113.3 15.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.333 1.053 . . . . 0.0 110.154 -168.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -154.75 40.65 0.14 Allowed Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.66 -31.97 0.98 Allowed 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 121.844 1.696 . . . . 0.0 112.998 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -128.09 21.99 6.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.665 0.786 . . . . 0.0 111.21 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.67 128.24 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 120.905 0.383 . . . . 0.0 110.07 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.1 mm? -98.55 95.65 3.19 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.4 95.92 0.95 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.975 2.45 . . . . 0.0 110.674 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.61 -35.2 0.75 Allowed Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.999 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.5 m -93.56 175.74 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.438 0.637 . . . . 0.0 111.535 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.7 p -85.03 -32.36 22.94 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.03 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -102.71 172.34 6.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.877 0.846 . . . . 0.0 112.91 -167.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.83 47.04 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.0 p -64.66 -62.76 1.38 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.591 0.757 . . . . 0.0 110.215 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -166.82 126.87 1.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.766 0.826 . . . . 0.0 109.137 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.0 mt -88.44 137.02 30.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.0 Cg_endo -55.22 129.62 36.23 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.513 2.142 . . . . 0.0 111.251 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -23.68 62.9 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.593 0.757 . . . . 0.0 112.822 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.0 pt-20 -63.52 -32.51 73.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.095 0.958 . . . . 0.0 111.326 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 m -70.9 -46.71 62.07 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.551 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.09 -27.46 68.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.55 0.159 . . . . 0.0 111.055 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -73.12 -44.2 60.57 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 111.045 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 -28.77 62.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.451 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.43 -42.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.641 0.776 . . . . 0.0 109.324 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 tpt85 -64.21 -24.66 67.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.542 0.737 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -75.66 -54.68 6.59 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.915 0.886 . . . . 0.0 111.002 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.7 pt20 -68.27 -25.02 64.96 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.36 0.664 . . . . 0.0 112.553 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 37.8 p -64.98 -33.42 76.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.414 0.285 . . . . 0.0 111.186 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.15 -32.57 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.849 0.46 . . . . 0.0 110.187 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -71.01 -26.56 63.18 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.083 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.23 11.94 57.97 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.958 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -138.34 105.96 5.59 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -147.09 126.29 12.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.957 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.448 HE21 ' NH2' ' A' ' 48' ' ' ARG . 26.9 mp0 -130.06 137.93 50.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.595 0.758 . . . . 0.0 108.963 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.49 112.17 30.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 21.2 mtm105 -87.52 95.46 10.04 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -80.77 69.51 7.33 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.559 0.695 . . . . 0.0 109.505 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -103.53 1.31 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.079 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.38 -19.14 21.6 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.966 0.906 . . . . 0.0 110.375 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -76.85 109.67 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.48 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 14.1 tpt -87.75 111.8 21.73 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -110.16 153.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 59' ' ' SER . 61.1 m -137.77 139.47 40.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.482 1.113 . . . . 0.0 108.337 172.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 28.3 mm -123.62 100.76 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' NH2' HE21 ' A' ' 37' ' ' GLN . 67.5 mtt85 -129.77 129.21 23.06 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.02 151.65 45.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.366 2.044 . . . . 0.0 111.533 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.484 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 12.6 tpt -89.19 149.89 22.92 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 171.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -56.94 -35.75 69.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.735 1.214 . . . . 0.0 112.372 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 p -163.62 149.3 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.627 0.771 . . . . 0.0 109.605 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.14 30.33 19.79 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.262 1.025 . . . . 0.0 111.59 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -164.49 146.73 11.69 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.121 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -123.64 -178.34 4.0 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.925 1.29 . . . . 0.0 111.099 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -123.94 118.21 26.54 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.718 0.807 . . . . 0.0 110.041 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -167.51 107.24 0.57 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.885 0.874 . . . . 0.0 108.938 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' HA3' HG23 ' A' ' 77' ' ' ILE . . . 55.5 106.98 0.01 OUTLIER Glycine 0 CA--C 1.54 1.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 115.006 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' SER . 47.1 t -133.58 97.77 4.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.69 107.79 4.7 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.502 0.721 . . . . 0.0 109.464 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.1 96.93 1.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -74.27 -6.87 50.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.884 0.874 . . . . 0.0 111.984 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.19 115.36 6.78 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.414 0.685 . . . . 0.0 110.05 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.78 -6.79 67.5 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.248 0.452 . . . . 0.0 113.197 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD11 ' H ' ' A' ' 44' ' ' MET . 10.9 mp -98.68 163.2 12.74 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 111.419 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 70' ' ' ILE . 23.0 t -115.1 172.23 7.19 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.984 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.42 -40.13 64.9 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.229 1.011 . . . . 0.0 112.791 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -67.22 -40.75 86.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.542 0.737 . . . . 0.0 111.198 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -68.16 -29.6 68.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.486 0.714 . . . . 0.0 111.012 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' SER . 43.3 mm -65.51 -46.11 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.167 0.587 . . . . 0.0 109.963 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -58.09 -55.29 36.91 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.068 0.855 . . . . 0.0 110.879 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 43' ' ' LEU . 34.0 mt -60.8 -38.77 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 O-C-N 123.689 0.618 . . . . 0.0 110.06 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.452 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -59.52 -57.33 20.16 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.066 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 pp -64.96 -26.35 68.26 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.851 0.46 . . . . 0.0 111.634 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -64.56 -48.51 74.76 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.573 0.545 . . . . 0.0 110.379 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' HG12 ' A' ' 80' ' ' ILE . 26.1 m-85 -67.35 -29.12 68.58 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.279 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.3 -44.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.817 0.847 . . . . 0.0 111.158 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.74 -20.92 61.1 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.89 0.376 . . . . 0.0 111.026 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -81.9 -27.04 33.63 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.8 mm -69.89 -35.71 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.896 0.478 . . . . 0.0 110.683 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.5 -30.98 71.43 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 110.564 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -75.89 -32.82 59.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.697 0.799 . . . . 0.0 110.913 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.8 m -78.75 -38.39 38.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.482 0.713 . . . . 0.0 110.375 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.95 47.42 1.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.055 1.342 . . . . 0.0 108.634 171.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -54.34 107.95 0.33 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.975 0.91 . . . . 0.0 111.73 -171.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -75.87 178.79 5.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.446 1.099 . . . . 0.0 111.851 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.97 -125.66 3.25 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.641 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -74.29 104.52 5.09 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.833 0.853 . . . . 0.0 109.826 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tt -162.0 139.32 8.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 19.6 m -111.32 147.48 35.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.837 0.855 . . . . 0.0 109.242 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 p -49.03 -50.72 34.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.697 1.199 . . . . 0.0 112.291 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -63.69 -28.5 69.94 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 123.996 0.918 . . . . 0.0 112.431 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 43.5 mt-10 -59.51 -39.02 82.51 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.546 0.612 . . . . 0.0 112.544 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 122.8 0.44 . . . . 0.0 111.319 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -69.9 -27.61 64.94 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.092 0.557 . . . . 0.0 111.469 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.9 p -66.69 -22.85 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.439 0.695 . . . . 0.0 110.951 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.24 -35.15 76.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.183 0.516 . . . . 0.0 110.681 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -82.41 -31.29 29.66 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.836 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.96 -58.3 3.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.458 0.703 . . . . 0.0 111.39 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 96' ' ' VAL . 31.2 pt . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.528 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.28 106.62 1.91 Allowed 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.426 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 38' ' ' ILE . 5.7 p -80.23 94.37 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 121.793 0.806 . . . . 0.0 109.643 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 9.4 p-10 -64.2 123.69 19.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.135 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -131.01 106.41 8.38 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.565 0.746 . . . . 0.0 109.681 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -150.07 71.0 9.38 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 121.498 0.666 . . . . 0.0 110.329 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.87 -40.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.827 2.352 . . . . 0.0 113.318 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 66.3 m-85 -129.18 20.45 5.81 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.092 0.957 . . . . 0.0 111.122 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.584 HG12 HD21 ' A' ' 16' ' ' LEU . 19.6 mt -72.5 129.83 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -107.34 87.45 3.27 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.48 -4.46 13.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.66 2.24 . . . . 0.0 114.284 -163.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.89 -8.59 72.53 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.218 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.9 m -126.52 175.99 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.594 0.758 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -88.22 -28.76 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.306 1.042 . . . . 0.0 112.4 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -91.95 166.38 12.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.417 0.627 . . . . 0.0 112.002 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.584 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -112.39 149.3 32.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.925 1.29 . . . . 0.0 107.708 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 55.0 m -67.58 -58.94 3.82 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -171.91 149.73 2.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.034 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.01 134.68 22.47 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.86 126.54 22.82 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.7 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.104 0.962 . . . . 0.0 110.994 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.35 -44.35 95.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.242 1.017 . . . . 0.0 110.782 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.646 HG21 HD13 ' A' ' 5' ' ' LEU . 13.7 m -72.19 -34.52 68.48 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.793 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.81 -40.94 97.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.786 0.266 . . . . 0.0 111.115 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 m -66.81 -36.83 83.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.489 0.716 . . . . 0.0 110.345 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.423 ' HA ' ' OD1' ' A' ' 29' ' ' ASN . 11.7 tp10 -60.4 -45.38 93.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.227 1.011 . . . . 0.0 110.294 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' THR . 97.5 mt -60.9 -48.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.447 1.099 . . . . 0.0 110.701 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.72 -24.73 64.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.515 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' OD1' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -85.13 -35.66 21.6 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.599 0.636 . . . . 0.0 111.879 176.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 3.8 pt20 -75.68 -23.39 56.2 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.148 0.579 . . . . 0.0 111.812 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' ILE . 35.0 p -56.82 -25.45 55.97 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.9 -19.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.246 1.018 . . . . 0.0 110.858 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 30' ' ' GLN . 2.9 mpt_? -75.16 -8.49 56.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.376 1.07 . . . . 0.0 111.159 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.43 -22.85 37.8 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 123.44 0.543 . . . . 0.0 112.927 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.1 134.64 33.17 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 108.865 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -145.3 97.63 3.03 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -100.09 122.87 43.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.046 0.538 . . . . 0.0 110.716 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.456 HG13 HG13 ' A' ' 3' ' ' VAL . 2.6 mp -109.31 113.43 44.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 71.3 mtt180 -85.0 92.1 8.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.62 76.7 1.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.242 0.544 . . . . 0.0 109.893 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -102.13 0.75 Allowed Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.423 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.01 -18.18 20.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 110.979 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt -84.52 113.58 21.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.167 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.722 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.4 tpt -85.1 111.64 19.94 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.85 148.46 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 t -134.02 110.12 9.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.193 0.52 . . . . 0.0 109.668 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 56' ' ' PHE . 31.9 mm -87.44 107.11 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 51' ' ' GLN . 14.2 ptm180 -154.29 128.45 4.61 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 118.709 0.686 . . . . 0.0 111.176 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HD1' ' A' ' 56' ' ' PHE . 31.3 Cg_exo -59.5 -49.04 11.38 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.256 2.637 . . . . 0.0 113.546 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.8 tpt -86.12 64.6 8.66 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.712 0.768 . . . . 0.0 110.673 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.503 ' HB3' ' HG3' ' A' ' 48' ' ' ARG . 5.8 tp-100 -176.67 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.065 1.346 . . . . 0.0 107.871 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -70.27 -35.39 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.971 175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 97' ' ' LEU . 56.2 t30 73.54 143.61 0.07 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.198 1.799 . . . . 0.0 110.966 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.79 -75.75 2.33 Favored Glycine 0 C--N 1.343 0.922 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -134.03 177.34 7.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.299 1.04 . . . . 0.0 110.327 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' ILE . 35.9 p90 -101.42 116.46 32.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.357 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.705 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 55.6 mtm -145.37 -176.03 4.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.725 0.81 . . . . 0.0 109.535 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' HG2' ' A' ' 81' ' ' GLU . . . -54.37 113.52 3.46 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.324 1.015 . . . . 0.0 114.467 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -129.51 113.0 14.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.482 HD11 HD23 ' A' ' 65' ' ' LEU . 3.2 tm? -79.22 112.76 16.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.317 0.647 . . . . 0.0 109.834 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.85 115.59 18.64 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.894 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 10.2 pt20 -79.47 -64.96 1.07 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.074 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t70 59.86 19.05 7.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.8 0.81 . . . . 0.0 110.811 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.1 43.56 4.67 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD11 ' A' ' 60' ' ' LEU . 21.2 tp -80.46 146.14 31.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.922 0.889 . . . . 0.0 110.431 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m -65.09 148.8 51.0 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.714 . . . . 0.0 111.285 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -59.5 -33.53 71.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.331 1.052 . . . . 0.0 112.895 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.5 p-10 -71.44 -42.35 68.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -34.95 78.99 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.868 0.867 . . . . 0.0 111.714 175.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.5 mm -58.01 -43.2 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.363 0.665 . . . . 0.0 109.461 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.24 -56.75 12.47 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.922 0.763 . . . . 0.0 110.95 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' ASP . 7.4 mm -57.08 -38.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.526 0.679 . . . . 0.0 109.352 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.25 -58.05 14.26 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.426 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.89 -22.93 66.55 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.669 0.735 . . . . 0.0 111.891 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 16.0 mm100 -70.86 -46.45 62.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.632 0.773 . . . . 0.0 110.145 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' ILE . 13.8 m-85 -69.84 -27.2 64.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.201 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -61.98 -51.42 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.625 0.77 . . . . 0.0 109.893 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 75' ' ' GLN . 12.5 pt-20 -64.42 -34.66 78.69 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.475 0.484 . . . . 0.0 110.411 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.95 -31.5 66.38 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.873 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 76' ' ' TYR . 28.5 mm -69.77 -43.7 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.705 ' HG2' ' HB3' ' A' ' 57' ' ' MET . 44.9 mt-10 -60.75 -36.99 80.32 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.604 0.761 . . . . 0.0 111.377 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -73.28 -39.3 65.48 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.929 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -74.42 -22.93 58.9 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.672 0.789 . . . . 0.0 111.202 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -109.43 10.0 25.42 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.225 1.01 . . . . 0.0 110.08 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.14 125.76 24.91 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.991 0.916 . . . . 0.0 109.858 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.38 -29.0 62.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.563 0.745 . . . . 0.0 111.503 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.72 -75.2 0.03 OUTLIER Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -136.77 19.69 3.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.12 0.968 . . . . 0.0 109.905 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.59 140.48 58.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.005 1.322 . . . . 0.0 112.452 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 26.0 m -102.15 149.21 24.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.238 1.015 . . . . 0.0 109.545 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.6 m -64.02 -47.1 81.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -62.17 -26.22 68.22 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.2 tp10 -57.34 -47.65 81.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.063 0.945 . . . . 0.0 111.306 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.11 -27.2 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.412 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 m -64.96 -45.24 86.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.156 0.582 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.31 -28.1 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 111.195 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . 75.0 mt -69.74 -38.56 76.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -80.51 -26.97 37.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.768 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.721 0.808 . . . . 0.0 111.372 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.293 174.082 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 56.2 Cg_endo -68.97 91.79 0.44 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.572 2.181 . . . . 0.0 112.742 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.37 116.32 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.473 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.84 137.42 43.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.907 0.483 . . . . 0.0 110.455 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 19' ' ' ILE . 5.4 tt -145.11 94.11 2.48 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -147.81 47.4 0.54 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 6' ' ' THR . 67.9 Cg_endo -85.18 -30.69 0.46 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 121.88 1.72 . . . . 0.0 113.642 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.47 18.82 6.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.961 0.505 . . . . 0.0 111.542 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 16' ' ' LEU . 20.6 mt -70.63 135.97 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.691 0.396 . . . . 0.0 111.307 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.584 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -117.31 85.59 19.94 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.7 22.12 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.017 2.478 . . . . 0.0 114.081 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.57 -39.2 90.88 Favored Glycine 0 C--N 1.346 1.127 0 O-C-N 123.425 0.453 . . . . 0.0 113.862 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.3 m -108.71 178.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.972 0.509 . . . . 0.0 111.666 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.5 p -91.29 -24.89 19.7 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.256 1.023 . . . . 0.0 112.026 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -94.15 162.08 14.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.306 0.574 . . . . 0.0 111.589 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -103.66 142.82 33.66 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 10' ' ' LEU . 23.6 t -74.59 -48.8 24.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.879 0.471 . . . . 0.0 110.026 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.19 142.56 10.13 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.47 HG23 HD21 ' A' ' 5' ' ' LEU . 76.0 mt -121.43 121.74 28.33 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 163.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.8 127.22 20.87 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.742 2.295 . . . . 0.0 111.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.58 -16.81 62.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 111.182 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.76 -38.26 88.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.056 0.542 . . . . 0.0 110.35 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 17.9 m -74.66 -35.63 62.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.9 0.48 . . . . 0.0 109.836 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.19 -25.1 65.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.772 0.429 . . . . 0.0 111.138 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -68.8 -40.74 79.43 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.652 0.781 . . . . 0.0 110.962 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 23' ' ' THR . 12.8 pt-20 -71.66 -30.7 66.01 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 23' ' ' THR . 12.0 mm -65.29 -43.07 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 121.427 0.632 . . . . 0.0 109.57 172.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -62.04 -31.08 71.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.959 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.37 -41.14 14.74 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 3.6 pt20 -70.58 -24.03 62.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -53.64 -36.31 61.93 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.014 0.526 . . . . 0.0 111.244 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.08 -36.45 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.621 0.768 . . . . 0.0 110.311 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.84 -16.62 63.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.595 0.758 . . . . 0.0 110.627 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.16 -19.17 25.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.41 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -138.2 131.03 29.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -143.28 101.57 3.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.313 1.045 . . . . 0.0 108.439 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 42.1 mt-30 -109.67 115.41 29.82 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 40' ' ' LEU . 3.0 mp -107.66 126.61 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.519 0.728 . . . . 0.0 109.747 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -91.6 96.98 10.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.151 0.58 . . . . 0.0 110.243 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 38' ' ' ILE . 8.1 mp -81.76 71.85 8.8 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 169.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.34 -102.88 1.07 Allowed Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 -19.03 18.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.611 0.764 . . . . 0.0 110.445 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HA ' HD11 ' A' ' 65' ' ' LEU . 17.6 mt -74.64 108.76 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.2 tpt -93.13 113.63 25.93 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.78 151.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.798 0.839 . . . . 0.0 109.521 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 m -133.66 98.11 4.11 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.27 0.628 . . . . 0.0 109.921 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 49.5 mm -83.21 93.02 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.72 0.808 . . . . 0.0 109.0 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -127.04 126.39 24.32 Favored Pre-proline 0 N--CA 1.483 1.209 0 O-C-N 121.929 -0.482 . . . . 0.0 110.853 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 45.0 Cg_endo -78.79 -145.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.18 3.253 . . . . 0.0 112.831 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.4 tpp 80.73 162.05 0.16 Allowed 'General case' 0 C--N 1.371 1.505 0 C-N-CA 124.834 1.253 . . . . 0.0 110.352 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.57 -20.82 0.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.964 1.306 . . . . 0.0 114.371 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.85 112.67 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 C-N-CA 123.859 0.864 . . . . 0.0 110.217 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.53 18.63 9.63 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.592 1.157 . . . . 0.0 112.888 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 -76.89 2.05 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.138 0.399 . . . . 0.0 113.583 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -131.45 178.09 6.99 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 0.0 110.652 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 25.0 p90 -86.43 113.19 22.17 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.771 0.796 . . . . 0.0 111.373 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.1 -178.23 3.52 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.643 1.177 . . . . 0.0 108.2 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 77' ' ' ILE . . . -67.57 110.77 3.64 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.541 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.3 t -100.84 96.67 7.45 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.0 tm? -82.23 109.49 16.56 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -64.06 92.9 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.32 -17.88 57.93 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.826 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.23 101.8 4.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.14 -32.71 3.88 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 43' ' ' LEU . 69.5 mt -90.99 162.46 14.71 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.445 0.698 . . . . 0.0 110.554 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -148.07 145.82 28.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.121 0.568 . . . . 0.0 111.21 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 37.55 -79.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.535 2.334 . . . . 0.0 116.32 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.1 p-10 -79.97 -42.76 23.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.12 0.568 . . . . 0.0 110.222 -170.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -67.8 -35.4 78.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.088 0.47 . . . . 0.0 110.066 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -55.94 -48.47 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.456 0.702 . . . . 0.0 110.876 169.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -59.9 -52.02 67.22 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.665 0.603 . . . . 0.0 111.044 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ASP . 33.8 mt -57.87 -39.24 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.263 0.625 . . . . 0.0 109.702 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -62.99 -59.08 9.6 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.161 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.1 pp -68.13 -23.11 64.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.449 0.625 . . . . 0.0 112.261 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -73.98 -37.08 64.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.073 0.549 . . . . 0.0 110.978 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -72.54 -31.19 65.1 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.409 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -67.46 -39.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.707 0.803 . . . . 0.0 110.64 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -22.46 57.69 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.773 0.32 . . . . 0.0 110.511 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.41 -40.43 57.83 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.417 0.687 . . . . 0.0 110.167 168.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.57 HG23 HD23 ' A' ' 84' ' ' LEU . 42.8 mt -73.98 -33.68 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 0.0 111.528 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -64.05 -33.05 74.86 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 120.928 0.394 . . . . 0.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -76.73 -37.1 56.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.008 0.923 . . . . 0.0 111.134 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -71.78 -42.78 66.74 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.037 0.535 . . . . 0.0 111.108 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.57 HD23 HG23 ' A' ' 80' ' ' ILE . 3.9 mm? -100.55 21.69 12.93 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 110.964 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.53 146.31 49.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.705 0.802 . . . . 0.0 109.117 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -64.82 -33.39 75.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.946 0.499 . . . . 0.0 111.091 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.7 -44.14 0.6 Allowed Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.674 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.6 m -148.06 73.92 1.28 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.205 1.002 . . . . 0.0 108.731 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.52 140.23 27.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.367 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -91.35 144.31 25.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.565 0.746 . . . . 0.0 109.009 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -60.25 -49.46 77.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 0.0 110.364 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -50.67 -33.95 24.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.093 1.357 . . . . 0.0 112.399 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -61.26 -42.4 98.57 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.297 0.639 . . . . 0.0 111.19 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.84 -20.83 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 122.621 0.368 . . . . 0.0 111.442 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 96.1 m -75.37 -30.74 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.131 0.572 . . . . 0.0 111.759 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.38 -18.37 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 118.19 0.45 . . . . 0.0 112.136 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.86 -42.11 73.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.727 0.411 . . . . 0.0 110.116 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -81.84 -29.27 32.62 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.751 0.421 . . . . 0.0 110.884 177.024 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -71.45 -27.03 62.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.899 0.88 . . . . 0.0 111.609 -168.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.561 1.396 0 C-N-CA 123.166 0.586 . . . . 0.0 110.618 173.132 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 tmm? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.43 102.56 1.57 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.644 2.229 . . . . 0.0 113.209 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -69.46 127.78 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.42 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.91 140.81 42.32 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -146.02 87.97 1.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 12.8 t -147.04 37.12 0.18 Allowed Pre-proline 0 CA--C 1.571 1.779 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.3 Cg_endo -79.69 -32.47 1.56 Allowed 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 121.609 1.54 . . . . 0.0 111.758 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 59.5 m-85 -129.23 24.89 5.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.882 0.873 . . . . 0.0 111.529 -173.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 6' ' ' THR . 17.7 mt -67.79 123.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.989 0.423 . . . . 0.0 110.524 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 13' ' ' VAL . 62.8 mt -107.32 91.61 7.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 86.47 1.58 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.513 2.142 . . . . 0.0 110.866 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.53 -37.44 0.27 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.598 -173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' LEU . 11.5 m -93.36 167.88 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.993 0.517 . . . . 0.0 110.392 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 45.3 m -78.82 -37.22 41.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.425 0.69 . . . . 0.0 111.499 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -91.85 177.85 6.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.44 0.696 . . . . 0.0 112.272 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 140.6 49.46 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 22.8 m -52.55 -58.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.303 0.641 . . . . 0.0 111.059 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -172.24 135.53 0.77 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.608 1.163 . . . . 0.0 108.018 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 83' ' ' THR . 65.3 mt -105.91 127.86 27.55 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.08 130.35 31.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.849 2.366 . . . . 0.0 112.517 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.53 -14.91 62.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.117 0.567 . . . . 0.0 111.409 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.97 -43.32 93.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.642 0.777 . . . . 0.0 110.252 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 m -65.82 -42.21 90.9 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.063 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 9.4 mp -58.6 -39.11 79.5 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.849 0.46 . . . . 0.0 110.52 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -39.16 69.49 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.711 0.804 . . . . 0.0 111.818 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -72.08 -27.11 62.45 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 83.9 mt -68.53 -42.65 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 122.734 0.414 . . . . 0.0 109.997 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 20.1 mmt180 -63.5 -25.17 68.13 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.389 0.675 . . . . 0.0 110.883 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -76.42 -52.73 9.29 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.446 0.698 . . . . 0.0 110.696 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -70.03 -27.57 64.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.855 0.462 . . . . 0.0 111.813 -176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' HG3' ' A' ' 49' ' ' PRO . 8.3 p -61.91 -24.11 66.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.052 0.541 . . . . 0.0 112.272 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.51 -23.35 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 122.944 0.498 . . . . 0.0 110.924 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.13 0.87 26.38 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.718 0.807 . . . . 0.0 111.029 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.23 -17.84 54.11 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.432 0.539 . . . . 0.0 112.698 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.37 131.48 30.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.914 0.885 . . . . 0.0 110.213 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -126.78 133.36 50.84 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.155 0.982 . . . . 0.0 108.935 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -112.03 115.82 29.54 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.75 144.38 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.467 1.107 . . . . 0.0 108.24 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -128.54 88.59 2.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.917 . . . . 0.0 110.392 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 76' ' ' TYR . 88.4 mt -76.68 80.16 3.32 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.75 -104.04 1.16 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -99.04 -11.78 21.17 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.525 0.73 . . . . 0.0 110.966 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD13 ' HA2' ' A' ' 73' ' ' GLY . 52.9 mt -83.3 132.0 35.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.296 1.038 . . . . 0.0 110.236 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.05 128.65 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.48 120.76 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.051 0.94 . . . . 0.0 109.603 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.6 m -100.84 110.32 22.38 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.774 0.83 . . . . 0.0 110.403 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 22.8 mm -101.84 115.08 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -133.59 103.49 12.27 Favored Pre-proline 0 N--CA 1.493 1.685 0 C-N-CA 122.754 0.422 . . . . 0.0 111.963 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 52.5 Cg_endo -91.57 145.83 3.27 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.185 2.59 . . . . 0.0 113.65 167.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.6 ttm 169.12 -54.19 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.415 1.886 . . . . 0.0 106.36 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -178.82 -24.73 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.397 -1.728 . . . . 0.0 107.758 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.42 137.02 20.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.359 1.063 . . . . 0.0 110.319 169.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 98' ' ' ARG . 17.2 m120 64.09 14.73 8.76 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.487 ' HA3' HD23 ' A' ' 97' ' ' LEU . . . 65.89 -98.15 0.34 Allowed Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -169.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.7 160.41 14.39 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 110.742 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 47' ' ' ILE . 8.1 p90 -88.68 116.88 27.25 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.709 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.644 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 21.3 ptt? -172.89 -175.73 1.3 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.437 1.095 . . . . 0.0 109.379 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.8 110.29 0.22 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 124.397 1.061 . . . . 0.0 115.618 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.0 t -134.49 101.4 4.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.882 0.873 . . . . 0.0 108.79 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.71 111.72 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.843 0.857 . . . . 0.0 109.717 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.54 103.05 3.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.19 0.996 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 8.6 pt20 -98.99 -71.18 0.7 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 4.9 m-20 56.2 26.26 10.13 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.546 1.139 . . . . 0.0 113.323 172.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.51 12.38 6.19 Favored Glycine 0 N--CA 1.477 1.413 0 C-N-CA 123.308 0.48 . . . . 0.0 113.265 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.68 153.61 39.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.882 0.873 . . . . 0.0 111.669 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.2 p -66.93 139.94 57.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.267 1.027 . . . . 0.0 110.92 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -57.9 -31.55 66.86 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.227 1.011 . . . . 0.0 113.363 -171.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.3 p-10 -65.15 -44.28 89.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -75.44 -19.37 59.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 0.0 111.804 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 -44.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 35.2 tt0 -66.84 -55.81 13.16 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.804 0.69 . . . . 0.0 110.281 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 68' ' ' ASP . 28.8 mt -56.81 -37.02 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 123.725 0.81 . . . . 0.0 109.928 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -60.88 -56.86 21.77 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.901 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.18 -27.23 68.56 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.203 0.501 . . . . 0.0 111.945 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 22.5 mm-40 -66.5 -47.0 74.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 0.0 110.332 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 12.4 m-85 -73.55 -27.11 61.16 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.362 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.5 -43.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.737 0.815 . . . . 0.0 110.456 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.36 -21.35 62.04 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.61 0.569 . . . . 0.0 110.947 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -78.05 -40.42 38.78 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.242 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.4 mm -65.68 -29.59 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 123.219 0.608 . . . . 0.0 110.825 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.2 pt-20 -70.46 -39.5 74.27 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -24.5 42.97 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 19' ' ' ILE . 99.6 m -73.11 -55.68 6.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.611 0.765 . . . . 0.0 110.404 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.62 47.65 1.25 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.927 1.291 . . . . 0.0 108.367 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -59.06 130.3 46.35 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.78 -166.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -80.9 -147.78 0.06 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 125.779 1.632 . . . . 0.0 110.061 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.85 -102.1 0.02 OUTLIER Glycine 0 C--N 1.354 1.544 0 N-CA-C 112.311 -0.316 . . . . 0.0 112.311 167.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -154.79 104.69 2.53 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.96 0.904 . . . . 0.0 109.782 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' A' ' 94' ' ' VAL . 4.0 tt -152.98 139.46 18.65 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.414 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.2 m -70.55 149.38 47.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.365 1.066 . . . . 0.0 111.493 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -63.47 -50.23 70.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.366 0.667 . . . . 0.0 111.45 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -62.07 -40.2 95.02 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.528 0.331 . . . . 0.0 110.227 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 14.5 tp10 -66.6 -34.06 77.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.004 0.522 . . . . 0.0 111.149 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.478 ' HB ' HD22 ' A' ' 89' ' ' LEU . 1.4 p -80.3 -23.01 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.4 m -77.65 -34.66 53.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.954 0.902 . . . . 0.0 110.78 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.87 -25.82 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 HD23 ' HA3' ' A' ' 54' ' ' GLY . 23.9 tp -67.79 -42.03 82.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.517 1.127 . . . . 0.0 111.039 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 13.3 ptp180 -79.66 -21.67 44.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.592 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.99 -40.96 68.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.099 0.56 . . . . 0.0 111.583 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 CA--C 1.568 1.657 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.516 -174.489 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 23.8 mmt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.3 Cg_exo -75.11 99.74 1.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.538 2.158 . . . . 0.0 110.5 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.59 107.23 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.165 0.986 . . . . 0.0 111.879 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.4 136.09 37.58 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD21 HD13 ' A' ' 19' ' ' ILE . 61.3 tp -136.27 95.51 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.61 1.164 . . . . 0.0 108.079 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.423 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.3 t -144.54 31.05 0.1 Allowed Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.83 -29.71 8.25 Favored 'Trans proline' 0 C--N 1.391 2.811 0 CA-C-N 121.565 1.595 . . . . 0.0 112.949 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 59.1 m-85 -129.44 26.27 5.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.602 0.761 . . . . 0.0 111.484 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 6' ' ' THR . 21.8 mt -71.76 135.4 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 173.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -109.9 90.19 8.98 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.43 90.91 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.913 2.409 . . . . 0.0 109.77 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.72 -43.06 0.28 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.667 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 10' ' ' LEU . 34.2 m -99.69 -175.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 110.968 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -105.68 6.01 31.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.106 0.962 . . . . 0.0 112.755 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -126.91 165.76 18.77 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.435 0.636 . . . . 0.0 111.715 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.42 143.82 34.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' HD21 ' A' ' 10' ' ' LEU . 28.9 t -63.71 -60.68 3.0 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.545 0.738 . . . . 0.0 109.834 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.4 138.6 0.71 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.537 1.135 . . . . 0.0 108.548 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 83' ' ' THR . 76.4 mt -104.52 137.18 19.15 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 123.096 0.558 . . . . 0.0 109.616 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.5 Cg_endo -57.19 133.11 55.38 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.872 2.381 . . . . 0.0 111.94 170.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.369 1.068 . . . . 0.0 112.128 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.4 pt-20 -60.0 -31.85 70.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 0.0 111.557 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.488 HG21 HD13 ' A' ' 5' ' ' LEU . 6.3 m -67.89 -50.32 56.97 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD22 ' H ' ' A' ' 24' ' ' LEU . 2.5 mm? -62.8 -27.06 69.05 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.729 0.412 . . . . 0.0 110.659 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -69.92 -47.33 62.87 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.046 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.8 -32.38 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.191 0.197 . . . . 0.0 110.979 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.2 mt -62.72 -44.58 99.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.547 0.739 . . . . 0.0 109.333 171.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 HH12 HD11 ' A' ' 32' ' ' ILE . 46.8 tpt85 -60.0 -27.85 67.22 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.558 0.743 . . . . 0.0 111.606 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.09 -46.23 15.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.538 0.735 . . . . 0.0 111.621 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -75.29 -25.89 58.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.994 0.518 . . . . 0.0 111.867 -175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -62.12 -28.67 69.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.552 0.341 . . . . 0.0 111.281 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.441 HD11 HH12 ' A' ' 28' ' ' ARG . 49.2 mm -65.75 -30.54 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.987 0.515 . . . . 0.0 110.527 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -70.87 -13.06 61.89 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.419 0.688 . . . . 0.0 110.452 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.07 -21.88 21.83 Favored Glycine 0 C--N 1.348 1.207 0 C-N-CA 124.2 0.905 . . . . 0.0 112.919 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 48' ' ' ARG . 34.6 tt0 -140.32 128.46 22.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.996 0.518 . . . . 0.0 110.979 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.13 130.39 53.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.89 0.876 . . . . 0.0 108.72 169.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -120.99 99.44 6.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.36 0.664 . . . . 0.0 109.328 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.15 123.09 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.877 0.871 . . . . 0.0 109.077 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 15.0 mtm180 -99.2 92.74 5.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 94.6 mt -74.45 75.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 -103.72 1.21 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.19 -10.56 19.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.515 0.726 . . . . 0.0 110.71 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.9 mt -81.2 108.41 14.82 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 13.2 tpt -86.26 124.4 32.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.02 126.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.795 0.838 . . . . 0.0 109.651 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -107.57 99.76 9.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.596 0.758 . . . . 0.0 110.569 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 56' ' ' PHE . 18.3 mm -86.68 90.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 46.4 mtp180 -125.99 124.43 24.68 Favored Pre-proline 0 N--CA 1.484 1.255 0 O-C-N 121.914 -0.491 . . . . 0.0 111.986 -171.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.27 -35.83 1.15 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.412 2.075 . . . . 0.0 111.066 165.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.4 82.21 6.48 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 176.38 178.9 0.2 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.7 1.6 . . . . 0.0 107.253 -174.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.7 m -61.81 168.3 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.454 0.701 . . . . 0.0 111.219 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 94' ' ' VAL . 28.6 m-80 73.95 158.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.289 1.436 . . . . 0.0 110.283 -169.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.57 -40.04 59.91 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 114.027 0.371 . . . . 0.0 114.027 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -130.91 168.69 16.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.861 0.865 . . . . 0.0 110.81 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB2' HG22 ' A' ' 47' ' ' ILE . 29.4 p90 -87.99 114.21 24.39 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.262 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 37.7 mtm -139.66 -174.84 4.01 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.493 1.117 . . . . 0.0 108.081 174.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.12 110.39 1.51 Allowed Glycine 0 C--N 1.351 1.399 0 O-C-N 123.497 0.498 . . . . 0.0 112.755 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 t -133.82 115.95 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.6 115.1 18.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.353 0.661 . . . . 0.0 109.26 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.93 96.6 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.418 1.087 . . . . 0.0 109.31 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.525 ' HA ' HD12 ' A' ' 65' ' ' LEU . 11.3 pt20 -93.41 12.79 23.66 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.269 1.028 . . . . 0.0 112.825 -169.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.52 106.75 1.21 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.133 0.973 . . . . 0.0 111.76 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.78 22.24 78.14 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.507 -0.769 . . . . 0.0 114.062 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.659 ' HB3' ' ND2' ' A' ' 69' ' ' ASN . 14.2 mt -88.33 174.59 8.08 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.34 0.656 . . . . 0.0 112.337 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 m -105.4 -151.08 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.658 1.183 . . . . 0.0 109.644 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -91.4 -53.45 4.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.061 0.846 . . . . 0.0 112.68 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -57.04 -46.4 82.45 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.524 0.73 . . . . 0.0 112.232 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.659 ' ND2' ' HB3' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.21 -40.74 74.52 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.149 0.98 . . . . 0.0 112.707 175.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.2 mm -64.65 -46.29 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 122.47 0.308 . . . . 0.0 110.592 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 97.9 mt-30 -62.48 -57.4 11.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.035 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.81 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.864 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -52.05 55.06 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.852 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -66.87 -26.85 67.1 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.487 0.643 . . . . 0.0 111.437 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 13.9 mm-40 -60.76 -50.82 71.94 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.119 0.962 . . . . 0.0 110.24 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.51 ' O ' HG12 ' A' ' 80' ' ' ILE . 49.3 m-85 -72.46 -25.11 61.32 Favored 'General case' 0 C--O 1.202 -1.424 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.583 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.23 -45.7 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.619 0.768 . . . . 0.0 110.924 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.74 -22.37 61.62 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -73.69 -47.17 41.62 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.668 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -66.53 -35.79 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 124.337 1.055 . . . . 0.0 111.349 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.8 pt-20 -56.79 -43.39 80.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.288 0.367 . . . . 0.0 110.705 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -78.0 -32.73 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.763 0.825 . . . . 0.0 111.879 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.572 HG21 HD12 ' A' ' 19' ' ' ILE . 21.9 m -69.58 -37.02 76.8 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.049 0.54 . . . . 0.0 110.803 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.9 -51.22 12.95 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -154.59 103.76 2.49 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.665 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -74.03 165.05 25.83 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.02 176.98 38.42 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.867 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 62.2 p -73.33 -11.76 60.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.961 0.904 . . . . 0.0 111.264 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.539 HD21 ' HB ' ' A' ' 94' ' ' VAL . 8.9 tt -65.34 138.34 58.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.38 0.672 . . . . 0.0 109.416 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -117.15 152.69 34.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.127 0.971 . . . . 0.0 109.706 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 t -60.05 -34.36 73.31 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -65.68 -42.48 91.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.499 0.59 . . . . 0.0 110.77 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -27.13 69.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.798 -173.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' HB ' HD21 ' A' ' 89' ' ' LEU . 14.9 p -90.04 -35.91 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.161 0.505 . . . . 0.0 110.748 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.8 m -75.77 -27.88 58.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 100' ' ' ILE . 8.1 p -67.4 -20.69 26.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.201 0.6 . . . . 0.0 110.43 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 0.0 111.1 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -32.67 71.1 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.487 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.44 -35.11 58.69 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.596 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 96' ' ' VAL . 15.1 pt . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -86.13 147.23 9.02 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.692 2.261 . . . . 0.0 113.054 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -103.64 139.47 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -89.65 141.16 28.86 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 19' ' ' ILE . 38.5 tp -145.71 110.46 5.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -149.93 53.51 1.3 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 123.415 0.686 . . . . 0.0 111.2 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.99 -27.64 0.65 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.282 1.988 . . . . 0.0 113.443 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.86 4.55 6.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.99 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.84 116.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -165.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -104.6 90.95 3.7 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 172.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.5 -23.17 58.01 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.205 1.937 . . . . 0.0 113.925 -167.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.25 72.61 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.133 0.413 . . . . 0.0 114.133 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.9 m -104.82 158.66 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.907 0.483 . . . . 0.0 111.324 -174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -73.28 -20.28 60.86 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.465 1.106 . . . . 0.0 112.905 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -105.89 174.6 5.81 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.374 0.67 . . . . 0.0 111.525 -175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -123.03 147.57 46.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.476 ' OG ' HD21 ' A' ' 10' ' ' LEU . 12.8 m -53.09 -49.27 66.78 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.939 0.774 . . . . 0.0 110.098 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -176.2 166.9 2.9 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.021 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.521 HG23 HD21 ' A' ' 5' ' ' LEU . 83.0 mt -121.35 129.94 25.03 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 167.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 124.17 15.29 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.638 2.225 . . . . 0.0 111.897 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 24' ' ' LEU . 27.3 mp0 -71.08 -15.0 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.645 0.778 . . . . 0.0 111.577 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.47 -46.19 84.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.567 0.747 . . . . 0.0 110.102 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 5' ' ' LEU . 17.6 m -69.47 -37.41 77.27 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.248 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 83' ' ' THR . 95.8 mt -61.32 -37.23 82.5 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.564 0.54 . . . . 0.0 111.217 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -69.88 -30.86 68.41 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.727 0.642 . . . . 0.0 110.775 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.1 tp10 -66.6 -38.5 87.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.842 0.457 . . . . 0.0 109.917 172.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 23' ' ' THR . 18.0 mm -63.37 -44.64 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.952 0.501 . . . . 0.0 109.912 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 11.6 mmm180 -64.44 -29.34 70.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.975 0.91 . . . . 0.0 110.807 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.62 -48.13 34.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.798 0.839 . . . . 0.0 110.987 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.1 pt20 -76.96 -26.11 53.58 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.115 0.566 . . . . 0.0 112.207 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -61.01 -23.77 65.66 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.13 0.423 . . . . 0.0 111.68 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.89 -31.62 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 122.663 0.385 . . . . 0.0 110.137 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -73.44 -13.57 61.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.018 0.927 . . . . 0.0 111.144 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.39 -18.61 22.92 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-O 119.585 -0.564 . . . . 0.0 113.839 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.83 154.56 48.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.757 0.778 . . . . 0.0 112.105 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.466 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -153.15 138.96 17.98 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.708 1.203 . . . . 0.0 107.781 168.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -140.26 129.33 23.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 109.651 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.81 112.61 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -82.5 94.32 7.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 76.5 mt -76.31 65.2 2.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.236 0.615 . . . . 0.0 110.426 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.08 -99.96 0.26 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -71.67 -43.19 66.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.23 1.012 . . . . 0.0 110.984 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.56 160.87 25.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.729 0.812 . . . . 0.0 110.231 -174.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.4 ttt -140.47 129.41 23.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.862 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.78 153.8 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.007 1.323 . . . . 0.0 108.564 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -132.55 98.59 4.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.698 0.799 . . . . 0.0 109.777 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 56' ' ' PHE . 30.2 mm -89.32 84.19 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -116.38 125.47 28.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 121.976 -0.452 . . . . 0.0 110.467 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 92.5 Cg_endo -78.41 1.91 8.58 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.308 2.672 . . . . 0.0 112.427 169.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.1 ttp -74.36 73.2 1.85 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.999 0.905 . . . . 0.0 109.392 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -171.96 119.97 0.44 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.148 1.379 . . . . 0.0 107.428 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.93 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 93.6 m-20 62.31 18.82 10.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.267 1.027 . . . . 0.0 111.702 -170.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.62 100.93 0.67 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.843 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -74.79 152.75 38.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.767 0.827 . . . . 0.0 109.581 170.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 31.1 p90 -87.67 116.46 25.82 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.487 0.661 . . . . 0.0 111.42 -172.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.8 ptp -148.11 -176.09 5.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.997 1.319 . . . . 0.0 108.925 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.97 119.23 8.44 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 -172.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -135.33 118.13 16.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.932 . . . . 0.0 109.17 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.24 128.64 35.15 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.312 0.645 . . . . 0.0 109.316 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.3 78.32 1.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.447 0.699 . . . . 0.0 109.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -73.45 -23.92 60.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.968 0.507 . . . . 0.0 111.804 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.02 102.1 4.72 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.747 0.819 . . . . 0.0 109.482 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.76 3.43 55.02 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.517 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 161.03 14.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.83 0.852 . . . . 0.0 109.166 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 70' ' ' ILE . 30.7 t -85.99 146.52 26.63 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.897 0.479 . . . . 0.0 110.2 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -58.46 -37.19 74.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 -170.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.05 -41.13 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -68.46 -17.33 64.17 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 66' ' ' SER . 47.3 mm -59.32 -43.63 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.919 0.487 . . . . 0.0 109.947 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -50.92 69.14 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.161 0.584 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -63.71 -34.54 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.508 0.671 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.44 -55.13 24.98 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.811 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.4 pp -67.12 -33.2 74.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.067 0.547 . . . . 0.0 111.685 -169.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -70.76 -36.46 73.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.791 0.436 . . . . 0.0 110.187 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -71.79 -25.9 62.2 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.729 172.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.58 -38.03 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.517 0.727 . . . . 0.0 109.985 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 73.4 mt-10 -68.05 -33.11 73.96 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.896 0.747 . . . . 0.0 110.533 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -66.37 -52.31 48.19 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.337 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 40' ' ' LEU . 75.2 mt -64.35 -29.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.3 -38.38 83.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.272 1.029 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -77.66 -47.05 20.18 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.834 0.854 . . . . 0.0 111.187 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 24' ' ' LEU . 31.5 m -78.47 -54.61 5.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.302 1.041 . . . . 0.0 112.782 -164.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.98 -41.96 81.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.915 0.486 . . . . 0.0 110.686 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.09 81.87 0.69 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.615 0.722 . . . . 0.0 110.903 -172.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -84.69 127.07 33.91 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.23 -2.58 3.56 Favored Glycine 0 N--CA 1.47 0.964 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.589 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t 62.9 21.12 12.66 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.734 1.214 . . . . 0.0 111.943 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD11 ' HB ' ' A' ' 94' ' ' VAL . 3.2 tm? -73.94 135.68 43.24 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p -97.2 142.92 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.281 0.632 . . . . 0.0 110.44 -175.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.7 t -61.75 -46.45 89.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.791 0.836 . . . . 0.0 112.268 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.26 -43.31 92.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.702 0.626 . . . . 0.0 110.604 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.51 -29.31 70.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.877 0.871 . . . . 0.0 113.219 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' A' ' 89' ' ' LEU . 8.1 p -89.1 -33.55 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 118.341 0.518 . . . . 0.0 110.771 174.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.5 m -66.49 -39.61 88.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.495 0.718 . . . . 0.0 110.978 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.1 -27.83 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.309 0.644 . . . . 0.0 111.48 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 53' ' ' ASN . 97.1 mt -70.76 -38.75 73.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.073 0.549 . . . . 0.0 110.882 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -79.93 -24.89 40.75 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.321 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.51 -49.17 64.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.274 1.03 . . . . 0.0 110.914 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.563 1.457 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.026 -177.072 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.564 ' SD ' ' HG3' ' A' ' 33' ' ' ARG . 20.2 ptm . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -100.11 161.36 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.382 2.721 . . . . 0.0 114.502 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 121.44 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.878 0.871 . . . . 0.0 109.058 168.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 4.8 p-10 -81.7 96.41 7.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.667 . . . . 0.0 109.665 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' HG ' HG21 ' A' ' 23' ' ' THR . 3.2 tm? -110.77 106.62 15.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.108 0.963 . . . . 0.0 109.108 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.2 t -153.98 57.71 1.94 Allowed Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 123.295 0.638 . . . . 0.0 111.819 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -89.25 -34.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.322 2.014 . . . . 0.0 113.282 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 55.7 m-85 -127.85 22.07 6.33 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.481 0.713 . . . . 0.0 110.499 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.51 117.49 12.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-O 121.251 0.548 . . . . 0.0 110.285 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 13' ' ' VAL . 65.5 mt -106.97 99.22 25.0 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.4 -20.99 66.79 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.739 2.292 . . . . 0.0 112.85 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.27 -3.3 81.78 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.891 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 10' ' ' LEU . 27.1 m -132.57 170.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.623 0.769 . . . . 0.0 109.889 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.6 p -89.31 -0.52 57.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.092 0.957 . . . . 0.0 112.455 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.444 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 40.1 p90 -129.01 159.01 37.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.646 0.736 . . . . 0.0 112.111 -173.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.04 142.54 47.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.873 166.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 34.3 t -67.04 -33.06 74.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 168.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -167.61 152.94 7.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.996 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -125.94 133.08 24.57 Favored Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.88 126.8 23.72 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.263 1.976 . . . . 0.0 111.061 168.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -65.31 -17.49 64.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 110.868 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.28 -43.88 83.51 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.944 0.898 . . . . 0.0 110.139 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 27' ' ' ILE . 25.7 m -65.46 -48.63 72.02 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.035 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.4 mm? -58.08 -39.56 78.85 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.299 0.5 . . . . 0.0 111.209 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -66.48 -43.45 85.36 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.073 0.549 . . . . 0.0 111.72 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.1 pt-20 -74.92 -27.5 60.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 119.442 -0.313 . . . . 0.0 111.062 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 23' ' ' THR . 95.4 mt -58.96 -39.9 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.328 0.651 . . . . 0.0 109.692 172.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' O ' HG12 ' A' ' 32' ' ' ILE . 17.9 mmt180 -62.02 -25.2 67.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.576 0.751 . . . . 0.0 111.893 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -80.22 -36.12 35.23 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.889 0.476 . . . . 0.0 109.908 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 29.3 mt-30 -73.68 -30.54 62.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.275 0.63 . . . . 0.0 111.036 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.8 p -67.93 -32.24 72.56 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.74 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.3 mm -74.93 -28.54 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.555 0.742 . . . . 0.0 110.595 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 26.9 mmt180 -64.74 -33.34 75.74 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 168.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.65 39.98 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.253 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.02 106.2 5.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.203 0.601 . . . . 0.0 110.755 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -117.11 122.05 43.02 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -131.46 107.42 8.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.103 0.478 . . . . 0.0 109.919 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 47' ' ' ILE . 1.7 mp -98.41 110.29 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 61.4 mtt-85 -82.07 88.16 6.44 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.0 mt -78.62 78.54 5.07 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 -102.22 0.45 Allowed Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.981 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.95 -40.85 19.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.037 0.935 . . . . 0.0 109.751 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.82 110.65 14.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.68 1.192 . . . . 0.0 110.531 -166.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.462 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.1 tpt -82.28 105.51 13.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.47 155.39 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.677 0.791 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -140.25 127.73 21.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.841 0.857 . . . . 0.0 108.7 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 38' ' ' ILE . 16.0 mm -113.09 92.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -134.57 127.76 18.77 Favored Pre-proline 0 N--CA 1.484 1.234 0 O-C-N 122.235 -0.291 . . . . 0.0 110.499 -174.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 59.1 Cg_endo -71.32 125.9 11.77 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.136 2.557 . . . . 0.0 112.242 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.431 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 54.4 ttm -81.45 85.53 6.46 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.704 0.802 . . . . 0.0 110.78 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 47.72 -88.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 126.219 1.808 . . . . 0.0 114.351 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.98 133.28 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.069 0.948 . . . . 0.0 108.737 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 52.23 17.59 0.74 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 126.532 1.933 . . . . 0.0 113.574 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -114.21 94.54 0.69 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -73.08 169.1 17.71 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.48 0.712 . . . . 0.0 109.403 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 27.6 p90 -102.42 139.76 37.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 0.0 110.737 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -159.94 -174.97 4.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 125.063 1.345 . . . . 0.0 108.2 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.29 115.54 6.32 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 123.338 0.399 . . . . 0.0 112.806 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 t -126.0 135.05 51.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.299 1.04 . . . . 0.0 108.395 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.0 tm? -101.82 112.14 24.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.902 0.481 . . . . 0.0 110.555 -171.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -73.64 97.02 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.9 pt20 -82.32 -13.77 56.39 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.873 1.269 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.6 103.59 4.26 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.434 0.694 . . . . 0.0 110.296 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.61 -9.63 23.86 Favored Glycine 0 N--CA 1.472 1.047 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.702 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 62' ' ' GLN . 36.3 mt -77.55 179.27 6.64 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.646 0.736 . . . . 0.0 111.916 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.4 t -104.81 166.95 10.04 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.268 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -53.72 -45.7 70.57 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.423 0.689 . . . . 0.0 111.337 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.55 -45.21 80.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.885 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' HB3' HD22 ' A' ' 65' ' ' LEU . 14.1 m120 -57.77 -24.94 59.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.596 0.759 . . . . 0.0 112.626 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.6 mm -62.89 -46.72 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 122.781 0.432 . . . . 0.0 110.064 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -64.14 -54.82 27.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.718 0.807 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.33 -33.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.943 0.497 . . . . 0.0 109.922 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.02 -58.19 13.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.011 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.36 -28.67 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.851 0.461 . . . . 0.0 111.909 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -63.09 -54.25 40.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.49 ' O ' HG12 ' A' ' 80' ' ' ILE . 17.4 m-85 -61.13 -37.81 84.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.075 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -60.09 -43.43 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.669 0.788 . . . . 0.0 112.19 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.32 -29.39 61.58 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.177 0.298 . . . . 0.0 110.811 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.444 ' ND1' ' HB3' ' A' ' 15' ' ' PHE . 58.9 m-70 -77.62 -27.38 51.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 76' ' ' TYR . 37.6 mm -71.91 -40.35 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -55.52 -45.04 77.16 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 124.224 1.009 . . . . 0.0 109.948 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -50.46 -43.38 55.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 111.884 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -81.77 -33.63 30.82 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.921 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.38 -23.69 19.99 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 0.0 110.522 -168.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 7.8 t-20 -83.35 -174.55 5.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.538 0.735 . . . . 0.0 110.122 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 73.36 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.299 1.44 . . . . 0.0 111.493 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.26 -100.89 0.15 Allowed Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -69.19 -18.07 63.87 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.641 0.776 . . . . 0.0 111.671 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.51 173.65 14.88 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.38 1.072 . . . . 0.0 109.593 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -86.35 159.68 19.32 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.119 0.568 . . . . 0.0 109.664 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.3 p -55.23 -39.7 70.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.614 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -63.07 -34.51 77.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.505 0.503 . . . . 0.0 111.359 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HD13 ' A' ' 97' ' ' LEU . 1.2 mp0 -62.09 -50.58 71.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.675 0.39 . . . . 0.0 111.951 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.99 -30.02 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 118.16 0.436 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.0 m -69.42 -46.19 67.4 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 124.238 1.015 . . . . 0.0 111.174 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 100' ' ' ILE . 34.0 m -75.22 -25.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.431 0.457 . . . . 0.0 111.084 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 93' ' ' GLU . 7.7 mp -68.05 -40.68 82.78 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.627 0.771 . . . . 0.0 110.078 170.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -78.29 -24.26 46.83 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.94 0.896 . . . . 0.0 110.255 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.03 -49.45 44.8 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.135 0.974 . . . . 0.0 109.918 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' VAL . 28.9 pt . . . . . 0 CA--C 1.569 1.681 0 O-C-N 123.47 0.481 . . . . 0.0 110.508 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.892 0.377 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -92.87 100.45 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.093 2.528 . . . . 0.0 111.558 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.57 99.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-O 121.931 0.872 . . . . 0.0 110.401 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.62 124.58 24.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.073 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 19' ' ' ILE . 4.0 tt -133.78 94.2 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -152.52 60.38 3.38 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 121.512 0.673 . . . . 0.0 111.689 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.13 -34.59 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.146 1.897 . . . . 0.0 113.129 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.37 0.43 11.11 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.479 0.712 . . . . 0.0 112.143 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.5 mt -59.68 123.37 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -165.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.16 92.22 5.29 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 113.828 -1.533 . . . . 0.0 107.51 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.38 88.49 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.893 2.395 . . . . 0.0 110.761 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.25 -36.5 0.3 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.255 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -83.61 165.51 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 49.6 m -85.7 -20.09 29.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 111.848 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -113.56 -173.3 2.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 0.0 110.302 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.701 HD23 HG12 ' A' ' 19' ' ' ILE . 8.1 tp -133.38 133.26 42.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 m -51.55 -55.4 19.32 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.313 1.008 . . . . 0.0 111.106 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -141.6 144.45 34.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.858 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.701 HG12 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -127.8 127.58 23.95 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.76 117.33 4.04 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.815 2.343 . . . . 0.0 112.415 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -61.3 -23.05 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.242 1.017 . . . . 0.0 111.727 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.08 -47.74 82.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.295 1.038 . . . . 0.0 110.502 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.0 m -67.36 -36.81 82.14 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 27' ' ' ILE . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.47 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 m -62.39 -42.12 99.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.832 0.453 . . . . 0.0 110.112 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.8 tp10 -60.16 -56.96 15.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 109.894 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 24' ' ' LEU . 74.4 mt -54.85 -46.88 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.131 1.372 . . . . 0.0 111.331 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -72.58 -28.14 62.62 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.624 -171.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.09 -42.28 16.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.646 0.378 . . . . 0.0 111.948 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 5.1 pt20 -69.31 -23.62 63.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.079 0.552 . . . . 0.0 111.711 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -62.39 -25.98 68.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.47 -34.41 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.122 0.486 . . . . 0.0 109.769 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -73.19 -14.49 61.36 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.274 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 12.23 67.16 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 123.719 0.676 . . . . 0.0 113.047 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -138.35 107.34 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.293 0.637 . . . . 0.0 111.024 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -146.67 134.48 21.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.883 0.873 . . . . 0.0 108.685 173.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.67 122.27 5.26 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.48 141.97 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.132 1.373 . . . . 0.0 109.245 -174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -108.07 97.68 7.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 HG21 ' A' ' 45' ' ' VAL . 96.4 mt -77.9 69.14 4.09 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.56 0.695 . . . . 0.0 109.843 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.03 2.04 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.693 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -91.74 -21.88 20.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.293 0.637 . . . . 0.0 110.627 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' A' ' 73' ' ' GLY . 34.6 mt -74.71 108.18 7.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -88.96 131.82 34.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 40' ' ' LEU . 59.3 t -132.14 135.49 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.693 0.797 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 t -116.75 126.54 53.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.378 0.671 . . . . 0.0 109.774 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.21 84.35 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -116.49 108.14 45.78 Favored Pre-proline 0 N--CA 1.481 1.121 0 O-C-N 121.932 -0.48 . . . . 0.0 110.394 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.14 137.69 26.67 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.516 2.144 . . . . 0.0 111.585 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.655 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 51.4 ttm -130.86 115.22 16.28 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -66.32 -28.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.194 0.597 . . . . 0.0 111.811 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.15 60.7 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 59.73 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.543 1.537 . . . . 0.0 112.097 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.655 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -176.1 96.13 0.1 Allowed Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -72.97 126.04 29.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 0.0 109.788 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -87.49 113.33 23.09 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-O 121.908 0.861 . . . . 0.0 109.898 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.606 ' HG2' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -161.03 -175.23 4.79 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.721 176.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 109.38 1.97 Allowed Glycine 0 CA--C 1.534 1.246 0 O-C-N 123.651 0.594 . . . . 0.0 113.608 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 t -102.92 97.82 7.89 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -73.66 109.18 6.97 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 36.2 t30 -64.28 109.95 2.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.813 0.845 . . . . 0.0 109.451 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 62' ' ' GLN . 4.2 pp0? -76.94 -19.42 57.4 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.066 0.946 . . . . 0.0 112.096 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 134.75 48.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.082 0.553 . . . . 0.0 110.317 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.6 -22.53 23.9 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.333 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.433 HD22 ' OD1' ' A' ' 69' ' ' ASN . 17.2 mt -91.03 -172.14 3.23 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.039 0.535 . . . . 0.0 110.944 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' HG12 ' A' ' 70' ' ' ILE . 48.5 t -138.08 162.08 35.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 107.979 170.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -54.13 -33.54 58.07 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.61 -36.56 73.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.457 0.703 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.433 ' OD1' HD22 ' A' ' 65' ' ' LEU . 2.5 t-20 -76.81 -35.96 57.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.221 0.608 . . . . 0.0 111.635 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 66' ' ' SER . 29.9 mm -50.42 -37.53 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.939 0.896 . . . . 0.0 110.553 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 7.7 tp-100 -53.16 -53.18 54.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.177 0.991 . . . . 0.0 111.557 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -61.26 -38.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.87 -57.06 21.33 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.307 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.69 -26.08 67.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.283 0.633 . . . . 0.0 111.42 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 84.3 mm-40 -70.63 -40.63 72.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.166 0.587 . . . . 0.0 110.651 173.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 9.2 m-85 -71.73 -27.38 62.96 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.2 mp -68.21 -46.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.026 0.93 . . . . 0.0 110.493 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.79 -28.31 63.52 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 0.0 109.865 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.16 -42.31 80.25 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.481 0.712 . . . . 0.0 110.961 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 34.8 mm -67.72 -34.95 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.484 0.713 . . . . 0.0 109.913 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -64.94 -37.97 89.42 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.455 0.472 . . . . 0.0 111.036 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.28 -25.56 60.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.689 0.396 . . . . 0.0 111.501 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -78.44 -46.05 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.976 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.0 -52.95 5.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.28 0.632 . . . . 0.0 110.802 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.13 168.73 10.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.414 0.686 . . . . 0.0 109.778 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -66.1 -67.37 0.45 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.238 0.615 . . . . 0.0 110.692 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.41 -108.51 3.18 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.6 p -166.23 141.09 4.5 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 122.915 0.486 . . . . 0.0 111.661 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD11 ' HG2' ' A' ' 57' ' ' MET . 0.0 OUTLIER -89.08 147.78 24.05 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 163.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p -70.82 141.41 51.34 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -60.18 -34.22 73.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.53 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -53.66 -34.86 60.08 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.884 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -51.6 68.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.512 1.125 . . . . 0.0 112.092 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.432 HG13 HD21 ' A' ' 89' ' ' LEU . 34.6 m -77.86 -22.51 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.635 0.652 . . . . 0.0 111.215 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.7 m -67.64 -38.83 84.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.54 0.736 . . . . 0.0 111.13 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -76.49 -33.01 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.665 0.386 . . . . 0.0 110.868 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.47 -29.54 59.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 0.0 111.98 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -81.71 -29.18 33.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.829 0.452 . . . . 0.0 110.274 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.32 -38.86 71.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.619 0.768 . . . . 0.0 110.831 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.776 177.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.35 104.71 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.523 2.149 . . . . 0.0 111.717 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.42 99.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.138 0.971 . . . . 0.0 110.68 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 8.2 p-10 -71.07 139.32 50.35 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.024 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 23' ' ' THR . 45.2 tp -146.81 117.86 7.74 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.714 1.205 . . . . 0.0 108.833 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -154.13 52.59 0.8 Allowed Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.72 -31.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.929 1.753 . . . . 0.0 113.622 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.472 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.7 m-85 -131.29 17.21 4.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.707 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' HD21 ' A' ' 16' ' ' LEU . 28.9 mt -68.05 121.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -96.64 92.44 1.1 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.39 82.05 2.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.725 2.283 . . . . 0.0 111.298 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.97 -37.85 0.26 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.092 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 10' ' ' LEU . 6.4 m -82.71 159.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.889 0.476 . . . . 0.0 110.513 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -83.77 -0.21 50.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.318 0.647 . . . . 0.0 112.701 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' H ' HG23 ' A' ' 13' ' ' VAL . 40.3 p90 -131.15 -174.04 3.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.815 0.846 . . . . 0.0 111.354 -171.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 17' ' ' SER . 1.5 tm? -139.1 147.34 41.84 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.515 ' N ' HD13 ' A' ' 16' ' ' LEU . 25.3 t -63.62 -77.52 0.05 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.43 0.692 . . . . 0.0 111.011 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -145.44 94.63 2.54 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.802 0.441 . . . . 0.0 110.621 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.32 132.91 68.83 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 122.25 11.24 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.637 2.225 . . . . 0.0 111.927 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.462 ' HA ' HD23 ' A' ' 24' ' ' LEU . 13.5 pt20 -64.63 -22.78 67.06 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.027 0.931 . . . . 0.0 111.212 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -60.91 -39.28 88.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.16 0.984 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 5' ' ' LEU . 33.0 m -71.51 -37.15 71.24 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.16 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.3 mm? -63.44 -37.0 85.61 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.684 0.675 . . . . 0.0 110.789 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -63.91 -35.0 79.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.046 0.539 . . . . 0.0 110.519 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 10.5 tp10 -70.37 -36.72 74.31 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.764 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 38' ' ' ILE . 11.9 mm -63.36 -42.32 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 67.6 mtt180 -65.32 -25.29 67.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.451 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -71.78 -43.97 64.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.675 0.39 . . . . 0.0 111.101 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.7 mm-40 -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.23 0.612 . . . . 0.0 110.429 -177.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.0 p -67.18 -18.67 65.36 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.338 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 44.4 mm -66.67 -28.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -71.57 -15.79 62.29 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.382 0.673 . . . . 0.0 110.446 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.79 -22.19 19.57 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 123.547 0.594 . . . . 0.0 113.238 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 154.64 45.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.563 0.745 . . . . 0.0 110.043 173.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.9 147.0 34.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.074 . . . . 0.0 108.607 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -129.03 117.02 20.21 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 47' ' ' ILE . 1.6 mp -107.5 115.37 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 92.0 mtt180 -88.25 88.51 7.66 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 58.8 mt -71.47 77.49 0.78 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 -99.91 0.53 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -169.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -110.71 -4.37 15.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.308 1.043 . . . . 0.0 111.618 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 72' ' ' ILE . 13.0 mt -83.46 111.26 18.89 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.537 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.6 tpt -87.54 103.95 16.03 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.163 0.506 . . . . 0.0 110.409 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.99 152.28 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.081 0.952 . . . . 0.0 109.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.2 109.44 6.47 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.688 0.795 . . . . 0.0 109.704 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.58 HG22 ' HB2' ' A' ' 56' ' ' PHE . 34.6 mm -97.34 110.21 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.853 0.861 . . . . 0.0 109.163 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -128.05 116.74 20.46 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 122.744 0.417 . . . . 0.0 110.831 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 71.0 Cg_endo -84.17 -0.4 9.51 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 113.057 166.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.0 tpp -73.26 -45.84 53.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.108 0.563 . . . . 0.0 111.438 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -155.52 150.54 26.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.716 -173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t 68.88 110.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.048 1.339 . . . . 0.0 110.183 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 76.2 137.27 0.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.258 1.423 . . . . 0.0 110.629 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.31 -35.96 91.73 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.218 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -122.62 169.49 10.98 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 47' ' ' ILE . 50.2 p90 -86.76 129.0 35.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.087 0.47 . . . . 0.0 110.385 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.586 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -158.5 -176.4 5.87 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.389 1.075 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.35 114.02 3.9 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.811 0.695 . . . . 0.0 114.552 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.7 t -134.01 120.44 20.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.6 tp -89.04 144.15 26.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.457 . . . . 0.0 111.961 -174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -96.52 81.64 3.26 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.468 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -78.19 -14.09 59.59 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.436 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.19 106.79 0.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.431 1.092 . . . . 0.0 110.827 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.85 20.45 77.93 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.547 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -97.55 155.22 17.06 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.748 0.819 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 m -66.73 139.81 57.84 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.97 -34.44 74.76 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.203 0.601 . . . . 0.0 112.269 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.034 0.533 . . . . 0.0 109.736 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.47 -23.84 67.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.582 0.753 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.5 mt -72.87 -42.73 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 122.971 0.508 . . . . 0.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -65.27 -58.32 6.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 43' ' ' LEU . 3.2 mp -68.4 -26.66 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.354 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.6 24.22 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.269 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.06 -34.47 78.14 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.705 0.752 . . . . 0.0 112.167 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 72' ' ' ILE . 13.1 pt20 -73.05 -34.49 66.31 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.974 0.416 . . . . 0.0 110.808 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 80' ' ' ILE . 5.0 m-85 -69.9 -29.83 67.11 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.818 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.71 -45.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.296 0.638 . . . . 0.0 110.892 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.79 -26.98 64.53 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.559 0.537 . . . . 0.0 110.251 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.88 -43.96 82.12 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.46 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.5 mm -66.37 -29.23 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 110.983 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 51.8 mt-10 -64.36 -44.04 92.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.09 0.471 . . . . 0.0 110.232 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -66.35 -31.45 72.24 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.803 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -78.88 -35.59 43.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.504 0.722 . . . . 0.0 111.466 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.4 mt -99.46 7.72 45.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.818 0.847 . . . . 0.0 112.172 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.46 118.77 7.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -94.15 8.92 39.89 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.12 -148.69 20.61 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 121.775 -0.25 . . . . 0.0 113.055 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -63.21 93.67 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 111.241 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -144.01 137.42 27.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 15.4 m -103.58 145.59 29.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 t -54.86 -37.96 66.88 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.712 0.633 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -68.06 -38.87 82.94 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.58 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 47.6 mt-10 -61.18 -45.0 96.41 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.852 0.461 . . . . 0.0 111.564 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.57 -24.79 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.807 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.0 m -72.87 -52.05 16.33 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.05 0.54 . . . . 0.0 111.437 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.01 -27.44 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.736 0.815 . . . . 0.0 112.418 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.36 -48.32 80.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.877 0.871 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -83.04 -24.76 32.65 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.085 0.554 . . . . 0.0 111.272 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -75.68 -36.93 59.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.106 0.962 . . . . 0.0 111.325 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 CA--C 1.567 1.621 0 C-N-CA 122.731 0.412 . . . . 0.0 111.614 -178.05 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 CA--C 1.544 0.742 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 23.6 Cg_exo -63.64 119.35 6.38 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.268 2.646 . . . . 0.0 114.189 -170.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 38' ' ' ILE . 17.1 t -76.7 93.95 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.927 0.891 . . . . 0.0 108.713 169.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.48 102.2 1.1 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.5 100.3 7.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.564 0.746 . . . . 0.0 109.272 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.9 t -151.0 47.32 0.43 Allowed Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 123.263 0.625 . . . . 0.0 111.704 170.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 6' ' ' THR . 5.9 Cg_exo -80.75 -45.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.751 2.3 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 5.4 m-85 -126.89 20.5 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.962 0.905 . . . . 0.0 110.617 -170.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 16' ' ' LEU . 26.9 mt -65.77 131.24 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 117.893 0.315 . . . . 0.0 110.701 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -110.93 88.5 8.23 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.63 -2.62 12.12 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.464 2.109 . . . . 0.0 112.959 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.94 -21.56 57.17 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 123.17 0.414 . . . . 0.0 113.488 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.97 166.06 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 117.371 0.586 . . . . 0.0 111.05 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 t -67.93 -23.72 65.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.37 1.068 . . . . 0.0 112.27 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -112.32 175.53 5.39 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.818 0.818 . . . . 0.0 111.672 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 9' ' ' ILE . 3.1 tt -109.67 152.1 26.03 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 48.6 m -55.66 -55.45 32.01 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.45 0.568 . . . . 0.0 111.185 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -167.97 128.75 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.37 1.068 . . . . 0.0 108.273 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.3 mt -98.94 119.85 59.97 Favored Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 42.8 Cg_endo -67.51 142.61 59.86 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.26 1.974 . . . . 0.0 111.411 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.6 -27.01 67.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.69 0.796 . . . . 0.0 111.495 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 13.4 pt-20 -68.14 -31.45 71.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.628 0.771 . . . . 0.0 112.148 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.9 m -68.19 -52.21 36.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 95.5 mt -57.73 -42.52 84.03 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.27 0.981 . . . . 0.0 111.539 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.5 p -66.01 -33.55 76.06 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 124.049 0.843 . . . . 0.0 111.39 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 35.0 tt0 -70.22 -43.44 70.64 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 174.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.74 -35.86 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.5 0.72 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.8 mmt85 -63.97 -37.82 88.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.69 -40.46 84.38 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.089 0.556 . . . . 0.0 109.831 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 71.2 mm-40 -71.66 -33.95 69.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.523 0.729 . . . . 0.0 111.25 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 34.5 p -66.31 -26.23 67.21 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.719 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.5 mm -70.1 -27.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 120.604 0.24 . . . . 0.0 110.494 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -73.53 -14.57 61.23 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.396 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.81 15.64 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 123.849 0.738 . . . . 0.0 113.415 171.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.57 126.76 18.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.418 0.687 . . . . 0.0 109.734 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -110.01 102.14 10.9 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.486 1.115 . . . . 0.0 108.643 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 13.7 mp0 -82.43 120.27 25.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 3' ' ' VAL . 2.4 mp -118.76 127.44 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -98.38 95.31 7.26 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 90.5 mt -79.1 70.46 5.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.046 174.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -103.37 0.92 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.735 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.48 -18.3 28.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.615 0.766 . . . . 0.0 110.959 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 72' ' ' ILE . 12.4 mt -86.07 109.18 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.61 0.764 . . . . 0.0 109.459 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.1 tpt -86.61 101.83 13.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.46 152.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.191 0.997 . . . . 0.0 109.003 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 59' ' ' SER . 64.0 m -141.35 102.83 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.503 0.721 . . . . 0.0 109.621 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.611 HG22 ' HB2' ' A' ' 56' ' ' PHE . 22.1 mm -84.03 110.62 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.363 1.465 . . . . 0.0 110.874 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.63 131.14 23.53 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 41.8 Cg_endo -64.28 -32.7 61.57 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.927 2.418 . . . . 0.0 111.392 168.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.9 tpp 67.54 147.78 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.174 1.39 . . . . 0.0 111.377 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.26 178.54 8.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.879 0.472 . . . . 0.0 109.979 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.282 15.0 p 54.34 -70.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 126.624 1.97 . . . . 0.0 114.19 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -152.0 152.55 32.59 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.339 0.656 . . . . 0.0 109.658 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.14 -178.81 20.86 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -153.92 178.65 9.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.654 0.782 . . . . 0.0 109.786 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 47' ' ' ILE . 9.7 p90 -85.63 121.92 29.0 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 122.005 0.907 . . . . 0.0 111.388 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.6 ptp -146.37 -179.18 6.57 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 121.16 22.43 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.439 0.462 . . . . 0.0 112.485 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 46' ' ' SER . 42.8 t -130.5 97.8 4.49 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 172.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -76.09 120.7 21.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.985 0.914 . . . . 0.0 109.204 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.57 100.76 0.91 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HA ' HD22 ' A' ' 65' ' ' LEU . 10.1 pt20 -112.1 6.12 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -161.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.5 120.56 22.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.864 0.466 . . . . 0.0 111.016 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.47 18.57 75.65 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 113.673 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 62' ' ' GLN . 10.9 mp -92.4 -176.31 4.28 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.884 0.85 . . . . 0.0 111.62 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.8 t -119.76 151.19 39.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.356 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.02 -15.89 37.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.19 -57.57 6.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.58 0.752 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.08 -35.29 80.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.381 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mm -56.65 -46.72 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.565 0.746 . . . . 0.0 110.908 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.9 -53.02 36.32 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.477 0.486 . . . . 0.0 110.851 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 43' ' ' LEU . 49.5 mt -54.77 -41.88 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 123.827 0.705 . . . . 0.0 109.562 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.72 -58.07 16.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.629 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -65.75 -26.22 67.63 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.106 0.453 . . . . 0.0 111.919 -172.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.83 -46.58 84.43 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.601 0.761 . . . . 0.0 110.457 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 80' ' ' ILE . 48.9 m-85 -70.82 -33.22 70.47 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.433 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.03 -43.98 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.989 0.916 . . . . 0.0 111.194 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.47 -25.47 60.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.778 0.431 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.22 -42.17 72.65 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.774 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -67.22 -40.81 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.988 0.915 . . . . 0.0 111.65 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.4 -36.08 79.3 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.188 0.305 . . . . 0.0 111.226 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -71.31 -44.2 65.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.439 0.696 . . . . 0.0 110.097 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -61.8 -38.77 89.33 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.592 1.157 . . . . 0.0 112.234 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.94 -46.18 9.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.057 0.543 . . . . 0.0 111.818 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -145.96 93.45 2.34 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.256 0.55 . . . . 0.0 110.653 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -80.56 98.21 7.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.6 157.64 25.8 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.211 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 m -83.92 69.21 10.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.547 0.739 . . . . 0.0 109.792 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 89' ' ' LEU . 2.7 pt? -76.15 153.18 36.4 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.489 -176.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.593 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 58.2 m -85.3 144.17 28.25 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -59.4 -51.42 70.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.878 0.471 . . . . 0.0 111.674 -172.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -63.2 -19.5 64.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 0.0 112.612 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.593 ' HG2' ' HB ' ' A' ' 90' ' ' THR . 10.3 mm-40 -59.21 -52.72 64.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.253 0.621 . . . . 0.0 111.559 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.3 m -90.44 -27.37 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 122.992 0.517 . . . . 0.0 112.026 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -72.63 -33.28 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.811 0.444 . . . . 0.0 111.527 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.3 p -59.81 -27.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.722 0.409 . . . . 0.0 111.013 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 mp -54.25 -51.45 64.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.501 1.12 . . . . 0.0 111.239 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -81.67 -27.11 34.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 0.0 111.101 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.84 -27.91 36.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.769 0.828 . . . . 0.0 112.359 -166.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 96' ' ' VAL . 9.1 pt . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 119.139 -0.457 . . . . 0.0 110.503 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.17 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.391 2.787 0 CA-C-N 121.21 1.468 . . . . 0.0 112.454 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.429 HG22 HD11 ' A' ' 27' ' ' ILE . 30.7 m -93.3 128.76 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.061 0.544 . . . . 0.0 110.048 175.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.91 129.53 37.83 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.2 100.72 4.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.4 t -152.79 38.24 0.12 Allowed Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -79.79 -18.48 10.38 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 121.621 1.547 . . . . 0.0 111.978 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.33 -9.07 5.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.051 -171.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.451 HG13 ' HA ' ' A' ' 6' ' ' THR . 29.2 mt -47.9 116.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -164.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 17' ' ' SER . 44.8 mt -98.93 98.33 6.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.17 1.388 . . . . 0.0 108.438 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.85 42.12 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.686 2.257 . . . . 0.0 112.588 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.23 -6.17 0.57 Allowed Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.819 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.2 163.8 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.766 0.827 . . . . 0.0 110.254 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -77.56 -38.56 48.24 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.992 0.917 . . . . 0.0 111.621 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -82.29 -175.22 5.57 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.067 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 19' ' ' ILE . 12.1 tp -137.99 136.49 36.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.062 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' LEU . 22.0 t -58.63 -33.72 70.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.886 0.874 . . . . 0.0 111.813 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -162.4 148.04 12.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 108.599 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.661 HG12 HD23 ' A' ' 16' ' ' LEU . 64.6 mt -127.43 124.58 23.65 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 166.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.42 113.44 1.79 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.075 1.85 . . . . 0.0 110.555 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.46 ' HA ' HD23 ' A' ' 24' ' ' LEU . 24.0 tm0? -64.91 -22.73 67.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.835 0.854 . . . . 0.0 110.727 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.72 -38.32 69.61 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.223 0.609 . . . . 0.0 111.101 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 27' ' ' ILE . 26.3 m -71.91 -36.64 70.05 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.676 0.79 . . . . 0.0 110.751 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 21' ' ' GLN . 4.1 mm? -63.59 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.833 0.453 . . . . 0.0 110.517 173.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -68.66 -33.21 73.6 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.508 0.723 . . . . 0.0 110.864 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 12.6 tp10 -65.64 -45.9 81.25 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.731 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 3' ' ' VAL . 32.9 mm -60.49 -39.78 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' NH2' ' HB2' ' A' ' 88' ' ' SER . 55.9 mmm-85 -61.88 -38.46 88.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.378 0.671 . . . . 0.0 110.966 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 33.7 t30 -62.05 -41.31 98.0 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.814 0.846 . . . . 0.0 110.871 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 61.7 mt-30 -79.51 -32.08 42.32 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.008 0.923 . . . . 0.0 112.415 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 27' ' ' ILE . 42.5 p -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.1 -38.82 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.202 0.525 . . . . 0.0 110.024 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -72.17 -12.39 61.16 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.901 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -8.62 58.21 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.475 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -140.12 124.54 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.242 0.521 . . . . 0.0 111.041 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -145.56 143.39 29.9 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.232 1.013 . . . . 0.0 108.585 168.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -137.27 153.9 50.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.43 129.58 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -96.91 87.49 4.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 78.7 mt -70.79 74.89 0.61 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.422 0.689 . . . . 0.0 109.253 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.42 -101.47 0.76 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -100.77 -16.77 17.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.516 0.726 . . . . 0.0 111.282 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.6 mt -74.97 110.53 9.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.309 0.644 . . . . 0.0 109.361 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.1 tpt -85.57 129.23 34.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.67 117.33 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.648 0.779 . . . . 0.0 109.803 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.5 m -86.87 111.98 21.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.341 0.656 . . . . 0.0 110.227 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 mm -119.19 88.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -154.44 139.12 11.61 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.92 -0.488 . . . . 0.0 111.574 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.33 102.58 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.849 2.366 . . . . 0.0 111.907 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -81.29 150.34 28.56 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.729 1.212 . . . . 0.0 110.783 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.75 175.32 2.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.863 0.465 . . . . 0.0 111.992 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m 65.14 -58.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 127.524 2.33 . . . . 0.0 111.862 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -173.54 150.41 1.78 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 107.795 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.0 87.41 1.19 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HE1' HD21 ' A' ' 97' ' ' LEU . 11.5 m-85 -77.5 -176.4 4.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.265 1.026 . . . . 0.0 111.28 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.033 0.92 . . . . 0.0 108.928 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.625 ' HA ' HD23 ' A' ' 84' ' ' LEU . 14.7 ptp -158.17 172.4 18.46 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.658 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 110.15 1.56 Allowed Glycine 0 C--N 1.352 1.458 0 O-C-N 123.978 0.799 . . . . 0.0 113.199 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -134.35 119.07 18.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.712 0.805 . . . . 0.0 109.491 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.85 124.93 34.66 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.033 0.933 . . . . 0.0 109.525 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.69 107.1 16.71 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.521 0.729 . . . . 0.0 109.104 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -83.88 -14.92 49.9 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.083 0.953 . . . . 0.0 112.235 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.26 113.35 3.53 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.505 0.722 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.0 0.74 85.33 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.964 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.39 161.98 14.17 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.597 0.759 . . . . 0.0 110.815 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 70' ' ' ILE . 46.1 m -97.52 163.73 12.73 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.18 0.592 . . . . 0.0 110.379 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -61.18 -42.08 97.93 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.97 0.908 . . . . 0.0 112.641 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.74 -37.21 86.83 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.222 0.534 . . . . 0.0 109.978 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.4 -22.91 58.94 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.684 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 66' ' ' SER . 46.0 mm -65.79 -43.86 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -69.6 -45.92 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.269 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -66.82 -34.32 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 123.727 0.642 . . . . 0.0 109.481 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.32 -57.26 17.55 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.724 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.7 pp -67.96 -33.52 74.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.98 0.512 . . . . 0.0 111.854 -171.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.84 -38.33 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.059 0.456 . . . . 0.0 110.038 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 80' ' ' ILE . 6.2 m-85 -69.47 -29.86 67.62 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.816 173.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -68.56 -35.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 110.591 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 49.9 mt-10 -70.27 -32.6 70.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.886 0.741 . . . . 0.0 110.345 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -74.21 -41.59 61.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.997 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.8 mm -63.02 -37.61 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.698 0.799 . . . . 0.0 109.111 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.79 -48.5 81.06 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 123.797 0.686 . . . . 0.0 109.743 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -34.4 77.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.415 0.447 . . . . 0.0 111.308 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -79.26 -24.21 43.12 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 111.823 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 57' ' ' MET . 19.5 tp -110.15 -20.19 12.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.704 . . . . 0.0 111.884 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 90' ' ' THR . 64.2 t30 -72.11 150.07 44.2 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.095 0.558 . . . . 0.0 109.836 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.9 t60 76.81 -9.96 1.42 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.812 1.245 . . . . 0.0 110.71 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.31 86.52 1.56 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.447 ' HB2' ' NH2' ' A' ' 28' ' ' ARG . 32.3 t 79.94 -42.13 0.24 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.185 1.794 . . . . 0.0 111.693 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.23 162.18 26.8 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.226 0.61 . . . . 0.0 110.523 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 93' ' ' GLU . 14.8 t -140.68 -175.96 4.48 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.129 0.972 . . . . 0.0 109.175 174.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -54.28 -35.98 63.17 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.033 0.933 . . . . 0.0 111.995 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' H ' HG23 ' A' ' 90' ' ' THR . 57.8 ttt180 -66.83 -41.28 87.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.049 0.539 . . . . 0.0 111.219 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.634 ' HG2' HG22 ' A' ' 90' ' ' THR . 22.7 mm-40 -71.56 -22.15 61.79 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -170.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.02 -27.85 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 118.072 0.396 . . . . 0.0 111.19 168.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.4 m -79.35 -28.38 42.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.096 0.558 . . . . 0.0 112.136 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.77 -17.81 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.288 0.635 . . . . 0.0 112.266 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' HE1' ' A' ' 55' ' ' TYR . 3.8 mm? -66.41 -35.09 79.43 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.295 0.638 . . . . 0.0 110.099 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.64 -31.14 28.91 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.236 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.11 -38.54 78.95 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.563 0.745 . . . . 0.0 112.187 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 123.365 0.666 . . . . 0.0 111.856 -175.612 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.5 141.35 60.84 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.993 2.462 . . . . 0.0 114.45 -173.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.81 92.63 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.845 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.21 113.77 4.23 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD23 ' HD3' ' A' ' 7' ' ' PRO . 3.9 tt -125.71 95.12 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.496 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.2 t -154.46 52.92 0.81 Allowed Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.465 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 6' ' ' THR . 3.2 Cg_exo -80.59 -38.53 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.374 2.049 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.29 17.25 6.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.526 0.73 . . . . 0.0 111.866 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.463 ' HA ' HD21 ' A' ' 16' ' ' LEU . 22.7 mt -64.15 133.49 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.2 101.7 20.65 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.62 1.168 . . . . 0.0 107.911 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.33 92.84 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.567 2.844 . . . . 0.0 111.458 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -38.58 1.65 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.729 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 15' ' ' PHE . 7.3 t -80.92 142.37 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 122.852 0.461 . . . . 0.0 110.023 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 p -74.12 -23.7 59.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 111.681 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.402 ' H ' HG12 ' A' ' 13' ' ' VAL . 17.9 p90 -109.54 177.34 4.77 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.256 0.622 . . . . 0.0 111.619 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.55 149.31 47.11 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.995 -177.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -61.01 -57.92 10.58 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.606 0.762 . . . . 0.0 110.023 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -171.62 133.91 0.81 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.123 0.89 . . . . 0.0 109.307 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 83' ' ' THR . 58.6 mt -103.61 136.48 19.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.62 112.69 1.08 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.691 2.26 . . . . 0.0 111.644 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.513 ' HA ' HD23 ' A' ' 24' ' ' LEU . 93.1 mt-30 -63.89 -24.99 67.95 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.526 0.731 . . . . 0.0 111.699 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.3 -35.06 76.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.376 0.67 . . . . 0.0 110.957 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.8 m -74.23 -27.44 60.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.171 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.7 mm? -72.27 -34.09 67.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -62.95 -38.92 93.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.353 0.661 . . . . 0.0 111.571 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 11.3 pt-20 -71.08 -34.84 71.54 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.278 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD12 HD13 ' A' ' 24' ' ' LEU . 78.4 mt -63.05 -36.89 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.077 0.551 . . . . 0.0 110.206 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' ILE . 10.9 mmm180 -57.87 -38.4 75.65 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 110.284 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -68.61 -43.78 75.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.851 0.86 . . . . 0.0 111.375 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.5 mm-40 -65.44 -37.19 86.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.948 0.499 . . . . 0.0 110.644 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -69.57 -22.84 63.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.452 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.1 mm -69.13 -36.16 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HE ' ' HB3' ' A' ' 35' ' ' GLU . 39.9 ttp-105 -66.35 -34.46 78.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 169.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.05 5.4 47.01 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.637 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' HB3' ' HE ' ' A' ' 33' ' ' ARG . 1.9 tm-20 -133.93 107.83 8.05 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -134.56 95.54 3.39 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -98.27 104.77 16.83 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -104.64 128.22 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.306 0.643 . . . . 0.0 109.838 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -105.46 98.47 8.16 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.641 0.376 . . . . 0.0 109.987 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 97.3 mt -77.33 64.95 2.8 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.681 0.792 . . . . 0.0 110.093 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.54 -110.0 3.06 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.238 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 -20.82 37.69 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.389 0.675 . . . . 0.0 110.903 175.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -81.56 110.98 17.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.08 130.35 35.03 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.08 145.54 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.087 0.955 . . . . 0.0 108.992 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -135.96 97.69 3.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.83 0.452 . . . . 0.0 110.507 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 5.7 mm -72.3 102.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.887 0.875 . . . . 0.0 109.0 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -129.25 123.15 21.44 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 55.2 Cg_endo -67.25 151.63 80.65 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -78.25 132.44 37.53 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -58.8 -34.6 71.67 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.754 0.659 . . . . 0.0 112.263 -171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.33 115.67 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.012 0.925 . . . . 0.0 109.187 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.29 80.26 0.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.73 1.212 . . . . 0.0 112.522 171.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.03 130.9 1.31 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.375 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.19 147.7 42.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.112 0.965 . . . . 0.0 111.249 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HB2' HG22 ' A' ' 47' ' ' ILE . 21.5 p90 -87.77 114.0 23.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.745 0.783 . . . . 0.0 108.937 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtm -130.06 -174.74 3.41 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.708 1.203 . . . . 0.0 108.268 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.65 137.93 49.78 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.878 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -133.66 98.82 4.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.754 0.822 . . . . 0.0 108.847 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.54 104.21 3.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.221 0.609 . . . . 0.0 109.679 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.15 109.65 3.64 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 49.6 tt0 -83.94 -75.77 0.32 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 35.7 43.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.627 1.571 . . . . 0.0 114.105 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.84 -19.78 4.65 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.811 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 62' ' ' GLN . 4.1 mp -63.31 148.91 46.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.188 0.994 . . . . 0.0 110.654 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 m -149.61 -168.15 3.03 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.986 1.315 . . . . 0.0 108.005 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.53 -168.35 0.2 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.15 0.58 . . . . 0.0 111.257 165.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.64 -18.46 20.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.164 0.986 . . . . 0.0 112.759 169.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.12 -40.78 77.78 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.782 0.433 . . . . 0.0 110.869 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.3 mm -56.12 -49.28 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.998 0.519 . . . . 0.0 111.131 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.24 -54.82 40.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.737 0.815 . . . . 0.0 111.429 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.04 -37.87 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.929 0.892 . . . . 0.0 110.103 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -63.2 -59.71 8.59 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.581 177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -67.42 -27.92 67.46 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -172.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -67.26 -41.65 85.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.119 0.567 . . . . 0.0 110.189 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -73.47 -25.52 60.51 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.991 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -63.86 -43.27 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.4 -34.36 65.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.117 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.08 -39.73 93.62 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.814 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.531 HD11 HD11 ' A' ' 40' ' ' LEU . 68.2 mt -66.33 -34.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.591 0.756 . . . . 0.0 110.24 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.65 -47.07 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.046 0.539 . . . . 0.0 110.106 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -76.47 -30.44 57.29 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.491 1.116 . . . . 0.0 112.722 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 19' ' ' ILE . 31.3 m -86.65 -28.56 23.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.871 0.469 . . . . 0.0 111.659 -173.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -87.98 -38.58 15.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.216 1.006 . . . . 0.0 109.888 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -139.64 148.7 42.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.636 -1.166 . . . . 0.0 107.915 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -65.8 -34.86 79.14 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 119.045 0.839 . . . . 0.0 110.15 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.63 0.46 Allowed Glycine 0 C--N 1.348 1.241 0 CA-C-N 114.42 -1.263 . . . . 0.0 114.706 165.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 m 67.03 20.99 10.34 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.213 1.405 . . . . 0.0 111.756 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.603 ' H ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.46 165.71 24.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.082 0.553 . . . . 0.0 110.011 173.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 37.9 m -79.76 140.3 36.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.3 t -65.02 -45.55 85.03 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.385 0.428 . . . . 0.0 110.33 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.336 0.654 . . . . 0.0 111.492 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 4.7 tm-20 -58.68 -51.47 69.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 109.982 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.66 -23.52 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.249 0.62 . . . . 0.0 112.254 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 m -66.5 -48.53 69.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.593 0.357 . . . . 0.0 110.466 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.7 m -69.41 -24.41 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.269 0.628 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 89.6 mt -66.26 -47.35 73.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.99 0.424 . . . . 0.0 110.08 171.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -80.41 -24.14 39.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.682 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -75.65 -46.8 29.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.692 0.797 . . . . 0.0 111.841 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.952 -172.095 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.45 92.65 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.237 1.958 . . . . 0.0 111.077 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.61 99.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.75 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.11 146.21 53.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -146.25 93.5 2.32 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.913 -1.144 . . . . 0.0 107.913 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -139.02 33.7 0.21 Allowed Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.42 -33.57 0.96 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 CA-C-N 121.173 1.455 . . . . 0.0 112.731 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 39.9 m-85 -129.34 22.1 5.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.527 0.731 . . . . 0.0 111.651 -174.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -64.25 123.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' A' ' 17' ' ' SER . 25.3 mt -111.7 85.76 6.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.55 -12.8 34.08 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.407 2.071 . . . . 0.0 113.083 -167.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.83 -12.81 79.2 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.767 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -126.92 178.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 117.826 0.813 . . . . 0.0 111.128 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 p -84.13 -42.94 15.5 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.184 0.994 . . . . 0.0 111.983 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -81.97 -177.95 6.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.471 0.653 . . . . 0.0 112.207 -173.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -134.63 148.42 50.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.277 1.031 . . . . 0.0 108.336 -173.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 49.3 m -84.86 63.94 8.33 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.543 0.687 . . . . 0.0 111.223 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.5 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.197 1.399 . . . . 0.0 112.094 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 65.6 mt -68.85 136.32 89.95 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.213 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 17.2 Cg_endo -58.22 117.57 4.3 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.871 1.714 . . . . 0.0 110.504 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.442 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.0 pt20 -62.35 -18.24 60.98 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.665 0.786 . . . . 0.0 111.365 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.8 -46.55 77.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.787 1.235 . . . . 0.0 110.48 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.409 HG21 HD13 ' A' ' 5' ' ' LEU . 18.1 m -60.89 -47.34 86.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.274 0.629 . . . . 0.0 110.933 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.8 mm? -58.58 -42.36 87.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.668 0.605 . . . . 0.0 110.741 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -63.09 -32.62 74.04 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.913 0.758 . . . . 0.0 111.44 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.8 tp10 -71.66 -45.46 61.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.233 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.25 -35.6 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.935 0.894 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' O ' HG12 ' A' ' 32' ' ' ILE . 22.5 mmm180 -56.77 -42.67 79.81 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.786 0.834 . . . . 0.0 110.608 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -72.97 -40.52 65.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.666 0.786 . . . . 0.0 111.488 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 24.5 mm-40 -64.47 -40.62 96.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.491 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.9 p -69.96 -24.85 63.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.225 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.9 mm -68.46 -32.78 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 172.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.09 -12.33 58.28 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.981 0.419 . . . . 0.0 110.409 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.42 -16.94 29.04 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 114.491 0.557 . . . . 0.0 114.491 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -134.9 116.8 15.16 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.35 0.575 . . . . 0.0 111.223 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.59 138.09 54.69 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.71 105.03 5.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 47' ' ' ILE . 2.8 mp -101.81 114.81 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.713 0.805 . . . . 0.0 109.636 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 42.7 mtm180 -87.08 93.56 9.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 86.4 mt -75.89 71.54 2.71 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.119 0.485 . . . . 0.0 109.815 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.33 -101.99 0.56 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.594 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -99.61 -15.02 18.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.783 0.833 . . . . 0.0 111.251 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 18.3 mt -83.5 109.77 17.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.466 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.7 tpt -86.51 117.88 25.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.31 149.97 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 59' ' ' SER . 57.1 m -137.17 134.44 36.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.844 0.858 . . . . 0.0 108.902 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 84' ' ' LEU . 31.9 mm -112.85 104.03 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -127.91 107.6 20.22 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.102 0.561 . . . . 0.0 109.54 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.22 142.84 38.47 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.606 2.204 . . . . 0.0 111.738 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 mmt -128.1 154.68 45.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.151 0.98 . . . . 0.0 109.087 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -67.93 171.83 6.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.528 168.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.253 9.6 p 46.59 75.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.015 1.326 . . . . 0.0 113.284 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 97' ' ' LEU . 3.2 m-20 63.6 21.08 12.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.062 1.345 . . . . 0.0 113.689 170.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.68 76.1 1.25 Allowed Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' HG11 ' A' ' 94' ' ' VAL . 88.8 m-85 -74.55 136.11 42.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.264 0.625 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -88.1 110.2 20.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.784 0.433 . . . . 0.0 110.648 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 8.4 ptt? -170.26 108.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.551 0.74 . . . . 0.0 109.852 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.21 106.18 0.01 OUTLIER Glycine 0 CA--C 1.541 1.69 0 O-C-N 124.532 1.145 . . . . 0.0 115.765 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' SER . 28.7 t -134.98 99.78 4.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.81 113.92 12.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 109.428 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -68.7 109.08 3.64 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.757 0.661 . . . . 0.0 109.474 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.15 7.5 46.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.244 1.018 . . . . 0.0 112.004 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.61 95.35 0.48 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.067 0.547 . . . . 0.0 110.548 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.69 9.92 86.57 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.784 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 70' ' ' ILE . 12.8 tp -84.96 143.77 28.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.321 0.649 . . . . 0.0 110.56 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 70' ' ' ILE . 33.0 t -64.05 148.74 49.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.761 0.824 . . . . 0.0 111.674 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.35 -32.66 71.48 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 111.617 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.8 -38.92 73.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.35 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -69.2 -28.02 66.01 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.52 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD13 HD23 ' A' ' 65' ' ' LEU . 33.6 mm -64.63 -45.25 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 tt0 -61.86 -57.1 13.11 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.07 0.856 . . . . 0.0 111.281 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.27 -37.75 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.46 -52.6 52.17 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.115 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.99 -24.81 65.18 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.295 0.547 . . . . 0.0 111.537 -174.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 80.0 mm-40 -59.69 -50.74 72.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.497 0.665 . . . . 0.0 109.327 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -68.84 -26.66 65.27 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.993 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.91 -37.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.11 -38.76 75.69 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.856 0.863 . . . . 0.0 111.987 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -76.89 -48.12 19.22 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.029 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.65 -29.85 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.349 0.66 . . . . 0.0 110.646 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 4.6 tt0 -47.14 -66.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.401 1.08 . . . . 0.0 111.161 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -71.0 -24.43 62.38 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.083 -173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.0 m -72.72 -23.43 60.85 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.113 0.565 . . . . 0.0 111.448 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 47' ' ' ILE . 34.2 tp -113.3 -56.46 2.4 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -171.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.31 136.92 13.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.773 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -167.85 -47.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.609 0.764 . . . . 0.0 109.698 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.72 -86.06 0.12 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.388 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -145.1 22.57 1.55 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.1 163.57 33.88 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.293 0.637 . . . . 0.0 111.185 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 93' ' ' GLU . 5.3 t -93.41 166.89 12.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.801 0.841 . . . . 0.0 110.954 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.7 p -59.85 -36.55 77.07 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 0.0 110.632 172.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -62.38 -33.31 74.5 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.636 0.774 . . . . 0.0 111.339 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.569 ' H ' HG23 ' A' ' 90' ' ' THR . 7.1 tp10 -65.9 -48.7 70.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.072 0.549 . . . . 0.0 110.031 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 55' ' ' TYR . 15.7 m -73.66 -24.12 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 100.0 m -65.45 -46.46 79.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.866 0.466 . . . . 0.0 110.495 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 100' ' ' ILE . 25.0 m -75.24 -23.65 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.323 0.249 . . . . 0.0 111.393 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 93' ' ' GLU . 5.4 mp -62.47 -47.85 82.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.681 0.792 . . . . 0.0 110.261 169.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -74.0 -23.16 59.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -76.62 -35.93 57.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.134 0.974 . . . . 0.0 110.463 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 96' ' ' VAL . 38.4 pt . . . . . 0 CA--C 1.568 1.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.352 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.26 122.76 4.76 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.471 2.114 . . . . 0.0 111.137 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.21 103.7 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 0.0 109.172 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -70.35 136.46 49.73 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.17 0.51 . . . . 0.0 110.168 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 23' ' ' THR . 48.2 tp -136.29 100.59 4.43 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.547 1.139 . . . . 0.0 108.283 -175.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.412 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -143.31 42.17 0.39 Allowed Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 6' ' ' THR . 97.1 Cg_endo -82.34 -34.85 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 121.546 1.497 . . . . 0.0 112.803 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -129.66 25.11 5.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.053 0.941 . . . . 0.0 110.848 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.81 121.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' A' ' 13' ' ' VAL . 26.7 mt -111.07 91.56 13.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -16.99 47.46 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.736 2.291 . . . . 0.0 113.502 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.84 -27.78 64.11 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.46 0.475 . . . . 0.0 113.142 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 10' ' ' LEU . 16.3 m -112.19 170.37 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 0.0 110.77 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -90.37 -23.62 21.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.243 1.017 . . . . 0.0 112.18 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -95.57 168.01 10.95 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.372 0.606 . . . . 0.0 111.682 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.67 143.61 39.19 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -57.22 -64.84 0.75 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.43 0.692 . . . . 0.0 111.081 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -170.89 123.3 0.61 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.04 135.1 32.09 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.879 0.471 . . . . 0.0 109.859 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.79 123.13 12.66 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.86 2.374 . . . . 0.0 111.566 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.77 -22.79 67.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.154 0.581 . . . . 0.0 110.938 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.52 -34.89 74.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.804 0.841 . . . . 0.0 111.08 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 5' ' ' LEU . 31.3 m -65.26 -48.4 73.38 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 83' ' ' THR . 8.6 mp -61.92 -30.48 70.93 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.286 0.634 . . . . 0.0 111.64 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -68.86 -52.36 30.55 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.866 0.866 . . . . 0.0 110.279 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.6 pt-20 -65.09 -42.84 93.68 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.227 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 31' ' ' THR . 35.0 mm -63.8 -31.63 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.583 0.753 . . . . 0.0 111.031 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 32' ' ' ILE . 14.0 tpt180 -61.56 -34.8 76.21 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.697 0.399 . . . . 0.0 110.439 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -73.22 -43.08 61.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.805 0.842 . . . . 0.0 110.882 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.6 mm100 -61.69 -44.1 97.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.984 0.914 . . . . 0.0 111.812 -176.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 68.1 p -60.47 -38.67 85.0 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.595 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.4 mm -58.71 -37.74 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.005 0.522 . . . . 0.0 110.974 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.3 -7.66 59.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.256 1.022 . . . . 0.0 111.429 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.37 63.72 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.717 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 26.1 tt0 -137.63 105.82 5.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.168 0.587 . . . . 0.0 109.651 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.29 106.69 2.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.693 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 92.4 mt-30 -121.37 116.58 25.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.779 0.832 . . . . 0.0 109.12 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.38 116.63 49.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mtm105 -87.9 99.19 11.94 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.44 78.43 4.9 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.48 -100.95 0.52 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.73 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.87 -29.51 32.42 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.749 0.82 . . . . 0.0 110.728 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.24 160.44 15.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 111.129 -167.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.693 ' SD ' ' HB3' ' A' ' 37' ' ' GLN . 48.9 tpp -120.3 140.74 50.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.019 0.928 . . . . 0.0 108.903 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.28 110.12 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.779 0.832 . . . . 0.0 109.549 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -90.96 95.75 10.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 120.988 0.423 . . . . 0.0 110.219 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 56' ' ' PHE . 19.0 mm -88.36 84.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -135.26 126.28 17.33 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.24 85.95 1.74 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.878 2.385 . . . . 0.0 111.474 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.425 ' HG3' HG12 ' A' ' 52' ' ' VAL . 16.0 tpt -68.96 94.95 0.67 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -72.03 85.53 1.01 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 50' ' ' MET . 12.2 p -165.0 44.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' HB3' HD22 ' A' ' 97' ' ' LEU . 24.8 m-80 68.3 65.06 0.34 Allowed 'General case' 0 C--N 1.36 1.039 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.161 -166.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.5 138.67 5.56 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.799 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.89 166.77 11.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.309 1.044 . . . . 0.0 110.626 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.469 ' HB2' HG22 ' A' ' 47' ' ' ILE . 54.1 p90 -87.6 115.86 25.33 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.451 ' SD ' HG11 ' A' ' 94' ' ' VAL . 7.2 ptm -169.67 -178.17 2.93 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.97 110.23 1.42 Allowed Glycine 0 CA--C 1.537 1.436 0 O-C-N 123.796 0.685 . . . . 0.0 114.071 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 t -127.84 100.47 5.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.453 0.701 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.52 112.82 20.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.608 HD21 ' HB3' ' A' ' 44' ' ' MET . 2.4 p-10 -83.78 133.1 34.79 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.33 -1.25 42.15 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.534 1.134 . . . . 0.0 112.874 -168.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.26 107.92 2.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.92 -17.11 58.67 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.184 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.99 162.22 21.52 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.711 0.767 . . . . 0.0 111.786 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 70' ' ' ILE . 42.1 t -113.18 167.63 10.38 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.121 1.369 . . . . 0.0 108.756 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -52.33 -43.23 64.46 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.216 1.007 . . . . 0.0 112.789 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.44 -40.82 96.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.702 . . . . 0.0 110.975 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -66.18 -39.39 89.68 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.425 0.69 . . . . 0.0 110.673 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 66' ' ' SER . 50.0 mm -59.93 -43.68 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.573 0.749 . . . . 0.0 109.935 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.85 -51.74 65.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.894 0.746 . . . . 0.0 111.042 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.4 mt -53.18 -41.62 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.826 0.85 . . . . 0.0 110.192 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.31 -58.93 8.49 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.964 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.8 pp -64.72 -22.98 67.11 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.988 0.515 . . . . 0.0 112.17 -172.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -73.98 -47.76 35.03 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.111 0.564 . . . . 0.0 110.86 173.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -66.28 -26.79 67.5 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -70.44 -47.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.787 0.835 . . . . 0.0 109.929 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -24.89 60.25 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.687 0.617 . . . . 0.0 110.604 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -70.68 -49.25 49.23 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.375 0.67 . . . . 0.0 110.471 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.42 -35.4 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.564 0.745 . . . . 0.0 110.6 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 57' ' ' MET . 37.2 tt0 -59.14 -43.56 92.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.586 1.154 . . . . 0.0 110.667 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.4 -39.82 94.59 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.202 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 24' ' ' LEU . 17.9 m -72.03 -29.16 63.9 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.99 -6.84 56.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.879 0.872 . . . . 0.0 111.771 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -69.22 87.93 0.43 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.624 0.726 . . . . 0.0 110.003 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.409 ' HB3' HH22 ' A' ' 28' ' ' ARG . 84.4 t60 -102.99 128.83 49.65 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.42 1.088 . . . . 0.0 108.384 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.07 -115.37 4.01 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -140.83 115.28 9.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 110.327 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.21 139.29 11.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 92' ' ' ARG . 25.4 m -112.89 149.48 33.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 t -57.19 -39.47 75.44 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.022 0.529 . . . . 0.0 110.361 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.8 ttp180 -67.55 -28.99 68.26 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.635 0.774 . . . . 0.0 111.795 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -47.09 83.32 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.068 0.547 . . . . 0.0 109.565 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.451 HG11 ' SD ' ' A' ' 57' ' ' MET . 10.6 p -80.7 -23.25 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.954 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 92' ' ' ARG . 3.6 m -64.73 -46.51 81.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.505 0.722 . . . . 0.0 111.204 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.6 -33.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 53' ' ' ASN . 86.2 mt -68.4 -43.37 77.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.727 . . . . 0.0 111.753 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.1 -25.87 52.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.885 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -23.65 38.21 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.639 0.775 . . . . 0.0 112.6 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.005 178.062 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 CA--C 1.542 0.885 0 N-CA-C 110.836 -0.486 . . . . 0.0 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.23 103.66 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.397 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.13 132.46 45.08 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.842 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.94 85.69 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.406 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.4 t -141.06 35.13 0.21 Allowed Pre-proline 0 CA--C 1.57 1.712 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 -29.88 6.83 Favored 'Trans proline' 0 C--N 1.387 2.604 0 CA-C-N 121.002 1.394 . . . . 0.0 112.327 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.0 m-85 -130.87 29.77 4.69 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.336 0.654 . . . . 0.0 111.826 -175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 6' ' ' THR . 11.6 mt -76.6 128.75 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 118.162 0.437 . . . . 0.0 112.025 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -103.83 91.07 3.27 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 86.44 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 0.0 111.518 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.64 -13.5 0.17 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.405 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 10' ' ' LEU . 25.1 m -119.71 158.31 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.202 0.601 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -74.52 -37.81 62.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.079 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -80.61 162.65 24.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.427 0.632 . . . . 0.0 111.285 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 17' ' ' SER . 1.1 tm? -113.43 151.96 30.7 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 35.7 t -57.1 -59.31 5.28 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.673 0.789 . . . . 0.0 110.629 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -174.69 117.43 0.19 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.24 137.56 27.69 Favored Pre-proline 0 N--CA 1.485 1.32 0 CA-C-N 118.402 0.546 . . . . 0.0 110.359 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.87 116.66 3.39 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.272 1.982 . . . . 0.0 110.736 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.504 ' HA ' HD23 ' A' ' 24' ' ' LEU . 27.8 tt0 -65.31 -26.13 67.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.477 0.711 . . . . 0.0 111.129 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.77 -25.94 67.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.871 0.868 . . . . 0.0 111.438 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 20.5 m -71.28 -47.84 54.5 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.2 mm? -57.33 -33.2 67.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 117.847 0.294 . . . . 0.0 110.627 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.8 m -61.46 -51.09 70.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.458 0.703 . . . . 0.0 111.401 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 23' ' ' THR . 8.2 pt-20 -66.52 -35.73 80.97 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.623 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 15.5 mm -58.24 -51.52 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.855 0.862 . . . . 0.0 110.091 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 91.4 mtm180 -59.88 -28.26 67.4 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.98 -42.4 26.81 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.964 0.506 . . . . 0.0 111.553 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 5.4 pt20 -77.7 -23.64 49.43 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.392 0.677 . . . . 0.0 112.448 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 74.1 p -61.49 -28.19 69.12 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.328 0.513 . . . . 0.0 111.352 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.39 -24.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.985 0.914 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -67.19 -19.05 65.5 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.744 0.818 . . . . 0.0 110.316 173.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.24 -22.86 14.83 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.997 0.808 . . . . 0.0 113.25 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 43.7 tt0 -143.98 145.11 32.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.294 0.638 . . . . 0.0 110.366 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.07 106.44 5.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.022 0.929 . . . . 0.0 109.085 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.56 121.9 31.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.683 0.393 . . . . 0.0 110.105 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -111.92 129.08 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 33.1 mtm105 -103.29 106.08 16.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 95.4 mt -77.27 68.37 3.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.68 0.82 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.266 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.46 -16.73 22.04 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.021 0.928 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 11.7 mt -81.12 111.27 17.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.7 tpt -84.89 124.76 32.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.98 152.14 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.597 1.159 . . . . 0.0 108.487 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -139.18 99.93 3.88 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.523 0.729 . . . . 0.0 109.757 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.507 HG12 HD13 ' A' ' 38' ' ' ILE . 11.1 mm -88.46 120.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -161.95 137.76 5.77 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 118.189 0.45 . . . . 0.0 111.189 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 96.7 Cg_endo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 122.563 2.176 . . . . 0.0 111.311 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 9.7 p90 -87.06 114.7 23.9 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.429 0.633 . . . . 0.0 110.202 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.582 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -162.65 -176.57 5.07 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.0 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.7 110.29 2.04 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -125.66 106.47 9.76 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 118.85 19.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.019 0.927 . . . . 0.0 109.684 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.79 91.72 3.53 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.709 . . . . 0.0 109.132 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 125.092 1.357 . . . . 0.0 112.856 -177.172 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.549 0.92 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 15.1 m120 -56.79 -44.65 82.08 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.358 0.663 . . . . 0.0 111.82 -172.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.32 -35.35 80.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.123 0.569 . . . . 0.0 111.446 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -66.37 -32.96 74.67 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.964 0.505 . . . . 0.0 111.447 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mm -66.19 -45.01 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 76.3 mm-40 -71.61 -54.82 9.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.59 0.756 . . . . 0.0 112.079 -174.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.72 -30.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.35 0.595 . . . . 0.0 109.469 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.62 -57.66 17.8 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.654 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -71.27 -26.78 63.03 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.643 0.722 . . . . 0.0 112.737 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -74.05 -37.0 64.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.357 0.598 . . . . 0.0 110.096 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.93 -24.83 48.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.731 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 1.2 mp -71.54 -46.49 63.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.12 -30.51 71.57 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.608 0.568 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.06 -54.95 34.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.369 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.45 HG23 HD23 ' A' ' 84' ' ' LEU . 56.2 mt -61.24 -32.92 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.332 1.053 . . . . 0.0 112.364 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 49.7 mt-10 -63.1 -39.49 94.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.047 0.539 . . . . 0.0 110.84 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -77.36 -32.9 55.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.917 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -77.63 -26.19 50.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.299 0.64 . . . . 0.0 112.018 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.465 HD22 HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 C-N-CA 124.086 0.955 . . . . 0.0 109.956 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 93' ' ' GLU . 9.0 t . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.9 p -58.16 -53.46 58.03 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.359 1.063 . . . . 0.0 111.182 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -68.17 -27.88 66.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.094 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 90' ' ' THR . 15.0 tp10 -59.91 -33.34 71.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.822 0.849 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.79 -39.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.004 0.922 . . . . 0.0 110.947 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -61.54 -37.28 83.19 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.385 0.674 . . . . 0.0 111.734 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.68 -27.92 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.294 0.638 . . . . 0.0 111.859 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.5 -39.83 85.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.911 0.484 . . . . 0.0 110.031 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -83.22 -34.45 25.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.604 0.761 . . . . 0.0 111.901 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.03 -38.35 57.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.576 0.75 . . . . 0.0 112.38 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.642 0.777 . . . . 0.0 112.557 -176.141 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 CA--C 1.555 1.529 0 CA-C-O 121.373 0.489 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.96 112.89 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.045 0.938 . . . . 0.0 110.465 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.91 134.43 47.24 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.208 0.527 . . . . 0.0 110.275 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD21 HG23 ' A' ' 19' ' ' ILE . 4.5 tt -140.42 92.75 2.55 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -150.09 55.0 1.67 Allowed Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.66 -31.58 0.43 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.956 1.771 . . . . 0.0 113.099 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.439 ' HE1' ' HD3' ' A' ' 20' ' ' PRO . 48.4 m-85 -127.86 4.83 6.0 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.439 -171.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.28 122.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 mt -98.91 96.4 3.99 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.7 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.18 40.3 0.97 Allowed 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.078 2.518 . . . . 0.0 115.118 -161.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.12 23.23 0.15 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.103 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.36 178.18 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.277 0.631 . . . . 0.0 110.412 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 57.6 p -91.83 -48.96 6.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.748 0.819 . . . . 0.0 111.01 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -79.0 -175.93 4.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.342 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 19' ' ' ILE . 15.7 tp -141.78 169.64 17.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -55.39 -64.44 0.84 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.303 0.641 . . . . 0.0 109.722 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -176.41 105.6 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.167 0.917 . . . . 0.0 108.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.431 HG12 HD23 ' A' ' 16' ' ' LEU . 56.8 mt -63.3 129.47 93.54 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.702 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 14.8 Cg_endo -56.17 120.34 8.12 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.75 2.3 . . . . 0.0 112.038 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.6 pm0 -60.39 -26.05 66.36 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.453 0.701 . . . . 0.0 111.978 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.41 -36.44 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.762 0.825 . . . . 0.0 110.926 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' ILE . 16.5 m -72.78 -37.51 67.57 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.237 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.0 mm? -64.67 -29.78 70.79 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.6 0.636 . . . . 0.0 110.479 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.1 t -72.48 -35.38 68.19 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.372 0.669 . . . . 0.0 110.289 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 10.6 tp10 -61.33 -50.19 73.95 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.395 0.678 . . . . 0.0 110.229 173.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 23' ' ' THR . 13.9 mm -59.18 -37.17 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.171 0.989 . . . . 0.0 110.522 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.2 tpt180 -60.9 -33.42 73.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.69 -39.05 58.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.445 0.698 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 54.0 mt-30 -73.68 -29.85 62.54 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.25 0.62 . . . . 0.0 110.973 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.5 p -69.81 -27.92 65.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.947 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ARG . 43.3 mm -67.43 -35.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -67.75 -19.05 65.08 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.17 -21.86 21.62 Favored Glycine 0 C--N 1.346 1.126 0 C-N-CA 123.793 0.711 . . . . 0.0 112.759 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -141.89 119.32 11.58 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 122.974 0.51 . . . . 0.0 110.538 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.95 111.09 21.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -103.12 113.03 26.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.4 mp -101.23 149.08 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 108.588 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 42' ' ' GLU . 12.7 mmm-85 -126.03 88.25 2.82 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.187 0.995 . . . . 0.0 109.252 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.1 mt -71.32 77.43 0.74 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 -102.26 0.66 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.829 -166.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HA ' HH21 ' A' ' 39' ' ' ARG . 15.2 pt-20 -100.18 -18.63 16.81 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.811 0.844 . . . . 0.0 111.139 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.0 mt -69.08 110.95 4.76 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.4 ttt -88.8 108.71 19.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.088 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 19.2 t -98.5 154.13 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.641 1.177 . . . . 0.0 108.664 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.3 98.89 3.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.409 0.683 . . . . 0.0 109.8 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 38' ' ' ILE . 37.5 mm -89.63 104.84 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.041 0.936 . . . . 0.0 108.787 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -130.29 128.14 22.64 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.338 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.383 2.369 0 C-N-CA 123.148 2.566 . . . . 0.0 111.922 -178.729 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -86.35 130.25 34.57 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -153.06 179.13 8.98 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.515 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . -61.89 110.44 3.19 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.23 0.956 . . . . 0.0 113.19 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.2 t -122.43 98.58 5.99 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 121.6 23.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.36 85.8 0.59 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.478 0.969 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.282 -172.043 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 119.632 -0.223 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -57.52 -26.37 61.24 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.744 0.818 . . . . 0.0 111.879 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.22 -54.32 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.495 1.118 . . . . 0.0 110.644 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.57 -25.23 61.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.648 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.03 -39.86 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 50.9 tt0 -65.35 -58.3 6.24 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.445 0.466 . . . . 0.0 110.108 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 43' ' ' LEU . 59.8 mt -59.91 -34.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.556 0.743 . . . . 0.0 110.027 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.29 -54.89 26.81 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.37 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -66.93 -26.98 67.12 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.02 0.91 . . . . 0.0 111.467 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 24.4 mt-30 -64.69 -50.72 65.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.734 0.778 . . . . 0.0 109.44 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 80' ' ' ILE . 10.4 m-85 -69.64 -24.9 63.7 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.773 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -70.52 -42.42 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.404 0.682 . . . . 0.0 111.095 -178.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -68.87 -27.67 66.01 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -72.77 -36.01 67.55 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.279 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 76' ' ' TYR . 38.1 mm -73.59 -43.28 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.234 0.47 . . . . 0.0 110.605 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.544 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 12.7 pt-20 -65.5 -38.55 90.05 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.637 0.375 . . . . 0.0 111.489 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -70.39 -26.04 63.52 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.39 0.676 . . . . 0.0 110.555 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m -78.26 -31.87 49.31 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.722 0.809 . . . . 0.0 111.23 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 123.013 0.525 . . . . 0.0 112.178 -178.422 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 81.9 m . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.6 p -56.89 -48.57 77.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.956 0.902 . . . . 0.0 112.194 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' VAL . 42.4 ttp180 -69.0 -27.61 65.84 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 122.219 0.208 . . . . 0.0 111.097 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 1.5 tm-20 -61.69 -24.98 67.12 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 122.993 0.517 . . . . 0.0 110.174 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.17 -34.87 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.056 0.542 . . . . 0.0 111.368 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.0 m -62.97 -30.57 71.68 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 92' ' ' ARG . 26.8 m -65.92 -21.21 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.419 0.688 . . . . 0.0 111.558 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.08 -43.48 87.03 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.628 0.771 . . . . 0.0 110.102 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -79.81 -31.46 40.7 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.918 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -71.66 -44.51 64.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.64 0.776 . . . . 0.0 112.552 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 96' ' ' VAL . 27.5 pt . . . . . 0 CA--C 1.57 1.74 0 C-N-CA 122.971 0.508 . . . . 0.0 111.339 -172.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo . . . . . 0 CA--C 1.548 1.224 0 CA-C-O 121.391 0.496 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.97 116.17 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.761 1.225 . . . . 0.0 108.597 167.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 7.6 p-10 -69.98 142.23 52.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -145.4 89.05 1.9 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.1 t -147.05 41.46 0.27 Allowed Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.002 0.521 . . . . 0.0 112.377 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 6' ' ' THR . 1.7 Cg_endo -79.6 -39.06 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 121.535 1.49 . . . . 0.0 112.021 -174.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.463 ' HE2' ' HD3' ' A' ' 20' ' ' PRO . 1.1 m-85 -129.43 31.09 4.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.071 0.548 . . . . 0.0 111.03 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.6 mt -63.35 109.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 118.817 0.735 . . . . 0.0 111.258 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.02 98.58 2.04 Favored Pre-proline 0 C--N 1.356 0.879 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.99 -16.79 50.49 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.419 2.079 . . . . 0.0 112.851 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.56 83.17 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.648 0.593 . . . . 0.0 114.356 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 10' ' ' LEU . 33.9 m -129.08 171.1 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 117.248 0.524 . . . . 0.0 111.503 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p -82.73 -34.7 27.13 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.635 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -84.91 177.34 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 122.084 0.945 . . . . 0.0 111.95 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.68 142.03 49.85 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 171.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.1 m -52.76 -48.0 67.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.456 0.702 . . . . 0.0 111.606 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 t70 179.41 119.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.838 1.255 . . . . 0.0 108.015 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.14 134.89 37.83 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 19.8 Cg_endo -58.86 122.65 11.98 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.797 2.331 . . . . 0.0 111.38 170.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.38 -17.9 64.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.153 0.581 . . . . 0.0 111.102 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -56.19 -47.21 78.78 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.222 1.009 . . . . 0.0 110.295 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -65.87 -34.94 79.3 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.043 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.9 mm? -67.65 -32.7 73.58 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.125 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -62.88 -38.61 91.57 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.846 0.458 . . . . 0.0 111.769 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 15.3 pt-20 -73.39 -40.84 64.0 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.261 0.351 . . . . 0.0 110.103 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 24' ' ' LEU . 97.1 mt -55.67 -36.83 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.004 0.922 . . . . 0.0 110.84 176.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 32' ' ' ILE . 21.9 mmm180 -61.73 -45.08 95.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.812 0.845 . . . . 0.0 110.934 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.24 -37.67 83.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.032 0.533 . . . . 0.0 110.935 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 18.0 mm-40 -68.47 -38.38 81.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.842 0.857 . . . . 0.0 111.148 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -69.06 -27.79 65.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 28' ' ' ARG . 46.6 mm -71.45 -36.61 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -75.17 -12.17 60.24 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.914 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.94 -9.73 60.07 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.594 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -139.23 111.95 7.8 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.214 1.007 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -125.67 98.99 5.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.811 0.844 . . . . 0.0 109.041 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -99.17 105.96 18.08 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.76 110.25 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.594 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 41.5 mtm105 -88.22 90.23 8.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.629 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 93.5 mt -76.1 70.6 2.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.291 0.637 . . . . 0.0 109.905 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.02 0.55 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.807 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.06 -15.13 32.38 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.177 0.991 . . . . 0.0 111.449 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 22.3 mt -91.3 142.86 27.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.963 0.905 . . . . 0.0 109.765 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.594 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.2 tpt -120.24 106.02 11.51 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.42 103.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.114 0.966 . . . . 0.0 109.898 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 t -90.36 98.91 12.05 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -84.74 103.64 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.04 139.36 13.35 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.618 -0.229 . . . . 0.0 110.665 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo . . . . . 0 C--N 1.378 2.089 0 C-N-CA 122.728 2.285 . . . . 0.0 112.283 175.192 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -88.24 132.77 34.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.926 0.49 . . . . 0.0 110.422 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.9 ptp -160.01 -175.98 5.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.943 1.297 . . . . 0.0 108.628 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.29 110.69 1.89 Allowed Glycine 0 C--N 1.352 1.462 0 O-C-N 123.655 0.597 . . . . 0.0 113.168 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.9 t -128.72 97.73 4.77 Favored 'General case' 0 C--N 1.353 0.717 0 C-N-CA 123.196 0.599 . . . . 0.0 109.872 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.658 ' HG ' ' HA3' ' A' ' 73' ' ' GLY . 3.3 tm? -79.54 113.03 17.36 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -79.49 142.24 36.0 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.174 0.59 . . . . 0.0 112.167 -175.035 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -55.31 -31.92 62.05 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.457 1.103 . . . . 0.0 112.134 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -51.85 67.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.497 1.119 . . . . 0.0 110.216 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.23 -39.46 82.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.04 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 22.6 mm -59.12 -51.71 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.874 0.734 . . . . 0.0 110.65 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 47.5 mt-30 -57.61 -46.72 83.71 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.543 1.152 . . . . 0.0 111.487 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 43' ' ' LEU . 59.5 mt -58.13 -41.45 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 124.09 0.869 . . . . 0.0 110.158 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.658 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -60.37 -49.11 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.295 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 70' ' ' ILE . 50.7 mt -57.86 -36.98 73.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.991 0.917 . . . . 0.0 111.323 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 83.6 mm-40 -58.54 -51.39 70.08 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.429 174.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -68.81 -30.43 68.99 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.589 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 73' ' ' GLY . 1.2 mp -66.64 -42.72 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.385 1.074 . . . . 0.0 111.098 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.88 -30.13 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.431 0.457 . . . . 0.0 110.663 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -78.29 -26.75 47.18 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 40' ' ' LEU . 65.2 mt -71.03 -32.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 123.37 0.668 . . . . 0.0 109.638 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.64 -41.31 76.95 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.844 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -71.2 -38.83 72.06 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.638 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -66.83 -33.48 75.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.823 0.849 . . . . 0.0 111.38 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 N--CA 1.482 1.159 0 C-N-CA 124.528 1.131 . . . . 0.0 109.777 177.412 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 92' ' ' ARG . 21.8 m . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -66.61 -21.5 66.13 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.918 -0.489 . . . . 0.0 111.245 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 90' ' ' THR . 42.3 ttm180 -69.26 -33.5 73.34 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -69.03 -36.83 78.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.47 -20.45 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 120.99 0.424 . . . . 0.0 110.394 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.8 m -78.23 -38.96 41.76 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.406 0.683 . . . . 0.0 111.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 99' ' ' GLU . 30.0 m -76.38 -17.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.723 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 93.7 mt -51.01 -53.95 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.929 0.491 . . . . 0.0 111.988 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -84.11 -24.13 30.44 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.803 0.441 . . . . 0.0 111.949 176.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 34.8 tt0 -77.63 -31.57 52.87 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 112.655 -167.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 CA--C 1.561 1.373 0 C-N-CA 123.341 0.656 . . . . 0.0 112.329 -176.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 CA--C 1.549 1.232 0 CA-C-O 121.321 0.467 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.43 94.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 122.176 0.989 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.24 148.61 49.58 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.547 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.03 102.89 3.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -149.97 38.95 0.18 Allowed Pre-proline 0 CA--C 1.571 1.787 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.69 -26.82 1.9 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 CA-C-N 121.014 1.398 . . . . 0.0 112.507 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.546 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 41.8 m-85 -127.97 21.96 6.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.545 0.738 . . . . 0.0 111.225 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.56 126.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.024 0.375 . . . . 0.0 110.507 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.4 90.17 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.34 -16.28 47.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.503 2.135 . . . . 0.0 113.675 -168.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.41 -13.9 82.1 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.585 -0.564 . . . . 0.0 114.082 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.47 173.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 117.737 0.769 . . . . 0.0 110.802 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 p -88.3 9.02 24.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.461 1.104 . . . . 0.0 112.406 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -146.04 177.3 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.375 0.67 . . . . 0.0 111.334 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.49 149.53 45.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 22.7 t -57.45 -64.54 0.86 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.063 0.545 . . . . 0.0 110.868 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -163.34 144.82 9.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.27 130.29 27.45 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.383 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.99 141.31 86.58 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.103 2.535 . . . . 0.0 112.332 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.18 -24.56 67.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.184 0.593 . . . . 0.0 111.647 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.85 -39.86 87.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.03 0.532 . . . . 0.0 110.803 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 27' ' ' ILE . 37.1 m -72.69 -42.88 63.76 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.018 0.527 . . . . 0.0 110.411 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.57 -46.3 90.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.043 0.537 . . . . 0.0 110.775 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -64.85 -33.69 76.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.778 0.831 . . . . 0.0 111.12 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.1 tp10 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.669 0.606 . . . . 0.0 109.697 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 23' ' ' THR . 67.9 mt -54.03 -43.21 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.797 0.839 . . . . 0.0 110.696 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 28' ' ' ARG . 10.4 mmm180 -66.17 -31.39 72.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -73.28 -44.37 59.34 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.553 0.741 . . . . 0.0 111.11 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 15.2 mm-40 -77.73 -27.7 50.6 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.184 0.994 . . . . 0.0 112.054 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.6 p -63.51 -25.86 68.45 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.577 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.41 -26.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-O 121.279 0.561 . . . . 0.0 109.771 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -77.56 -26.36 50.84 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.057 168.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.78 4.85 60.21 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.469 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 24.0 tt0 -129.76 116.86 19.37 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.62 96.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.426 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.49 113.02 26.01 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.36 112.86 34.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 52.0 mtp180 -87.46 92.24 9.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 80' ' ' ILE . 90.5 mt -70.22 75.53 0.52 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.273 0.629 . . . . 0.0 109.709 175.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.45 -99.91 0.37 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -103.62 -7.68 20.56 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.237 1.015 . . . . 0.0 111.657 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 24.3 mt -88.35 109.95 20.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.506 0.722 . . . . 0.0 109.069 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.553 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.5 tpt -84.47 114.44 21.93 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.25 110.68 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.047 0.539 . . . . 0.0 110.561 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.3 m -88.16 113.77 24.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.149 0.58 . . . . 0.0 110.573 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 31.7 mm -104.08 85.03 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 36' ' ' ALA . 24.6 mtm180 -130.55 145.06 55.91 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo . . . . . 0 C--N 1.38 2.225 0 C-N-CA 122.455 2.103 . . . . 0.0 111.681 174.002 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -94.44 108.05 20.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.279 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 59.2 mtm -152.78 107.71 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.427 1.491 . . . . 0.0 108.055 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 108.34 0.01 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 m -131.4 96.98 4.13 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 165.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.7 117.75 20.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 0.0 108.977 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 27.7 t-20 -67.65 89.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.761 0.791 . . . . 0.0 109.102 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? . . . . . 0 N--CA 1.477 0.92 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.312 -175.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 119.817 -0.135 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -63.92 -26.69 68.71 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.5 -42.44 71.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.99 -20.66 60.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.416 0.686 . . . . 0.0 111.933 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.54 -50.17 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.88 -57.32 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.097 0.873 . . . . 0.0 110.59 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 43' ' ' LEU . 49.3 mt -61.42 -36.2 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.209 0.603 . . . . 0.0 109.882 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -57.92 -58.0 16.86 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.681 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -67.09 -27.24 67.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.057 0.543 . . . . 0.0 111.811 -175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -65.04 -43.33 92.73 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.524 0.678 . . . . 0.0 110.198 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.17 -22.62 59.34 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.848 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -67.24 -38.34 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.077 0.551 . . . . 0.0 109.735 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 -34.88 76.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.381 0.673 . . . . 0.0 110.23 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -62.6 -52.7 62.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.695 0.398 . . . . 0.0 110.675 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 40' ' ' LEU . 79.5 mt -64.58 -32.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.258 0.623 . . . . 0.0 110.633 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -53.01 -49.67 65.77 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.263 0.625 . . . . 0.0 110.212 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -75.75 -34.82 60.3 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.268 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.5 m -84.06 -31.78 25.18 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.788 0.835 . . . . 0.0 111.901 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 N--CA 1.485 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 109.328 -173.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.476 0.833 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.8 p -60.61 -39.85 89.68 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.626 171.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -61.42 -41.33 97.0 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.935 0.894 . . . . 0.0 111.971 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.87 -31.66 72.92 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.246 0.341 . . . . 0.0 111.699 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.414 ' HA ' HD23 ' A' ' 97' ' ' LEU . 7.7 p -90.99 -23.21 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 C-N-CA 122.761 0.424 . . . . 0.0 112.047 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.1 m -65.6 -34.95 79.42 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.982 0.513 . . . . 0.0 110.86 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.25 -20.41 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 94' ' ' VAL . 4.4 mm? -73.06 -48.78 33.0 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.82 0.448 . . . . 0.0 110.488 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -71.19 -24.19 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.736 0.303 . . . . 0.0 110.438 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -69.94 -53.97 15.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.276 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.715 -175.284 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.519 ' HB2' ' HG3' ' A' ' 39' ' ' ARG . 71.8 Cg_endo . . . . . 0 CA--C 1.557 1.656 0 CA-C-O 121.117 0.382 . . . . 0.0 112.644 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.75 99.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.809 0.844 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.4 89.59 0.35 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.312 1.053 . . . . 0.0 111.163 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.43 102.99 15.44 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.6 t -154.83 53.14 0.82 Allowed Pre-proline 0 CA--C 1.566 1.559 0 C-N-CA 122.833 0.453 . . . . 0.0 112.113 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -82.19 -36.56 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.251 1.967 . . . . 0.0 112.006 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -129.13 17.52 6.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.631 0.772 . . . . 0.0 111.814 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 HD21 ' A' ' 16' ' ' LEU . 30.0 mt -67.23 123.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 118.577 0.626 . . . . 0.0 111.28 -175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -101.29 86.55 0.76 Allowed Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.88 -5.45 17.04 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.381 2.054 . . . . 0.0 113.698 -163.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.81 -11.26 68.35 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.347 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 10' ' ' LEU . 19.7 m -122.07 169.38 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.203 0.601 . . . . 0.0 110.842 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 15.6 m -81.89 -34.99 29.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.351 1.06 . . . . 0.0 111.877 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -88.81 170.82 10.42 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.778 0.799 . . . . 0.0 112.175 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.527 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -125.83 133.02 52.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 m -55.47 -66.52 0.4 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.823 0.702 . . . . 0.0 110.406 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -146.72 134.18 20.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.59 126.3 37.78 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 169.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.78 121.72 9.55 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.585 2.19 . . . . 0.0 111.683 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 10.1 pt20 -62.1 -23.95 66.83 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.991 0.917 . . . . 0.0 112.059 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.63 -37.09 86.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.71 0.804 . . . . 0.0 110.999 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' ILE . 23.3 m -76.97 -29.83 55.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.468 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.6 mm? -61.0 -41.33 96.31 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -54.51 -43.27 71.69 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.935 0.894 . . . . 0.0 112.714 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.9 pt-20 -72.9 -40.72 65.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.234 0.334 . . . . 0.0 110.904 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 33.7 mm -61.97 -39.98 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.329 0.652 . . . . 0.0 110.084 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.4 mmm180 -60.88 -25.48 66.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.999 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -87.06 -41.86 13.51 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 0.0 112.073 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 45.2 mt-30 -63.92 -31.44 72.62 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.562 0.745 . . . . 0.0 111.982 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -55.63 -33.44 64.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.337 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.45 -37.73 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.245 0.618 . . . . 0.0 110.287 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -61.61 -24.24 66.56 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.787 0.835 . . . . 0.0 111.178 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.67 2.63 67.15 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.231 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 122.53 19.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.821 0.849 . . . . 0.0 110.269 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -164.9 96.33 0.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.611 1.164 . . . . 0.0 108.361 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -105.28 125.32 50.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.96 116.8 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.155 0.982 . . . . 0.0 108.409 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 40.5 mtm105 -86.17 101.34 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.734 HD11 HD11 ' A' ' 80' ' ' ILE . 48.1 mt -76.12 77.67 2.95 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.23 -101.29 0.66 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.284 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -25.93 17.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.143 0.977 . . . . 0.0 111.217 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 72' ' ' ILE . 61.4 mt -71.77 131.06 42.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.757 0.823 . . . . 0.0 111.143 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.9 tpt -98.14 99.94 11.22 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.48 152.9 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.957 0.903 . . . . 0.0 108.979 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 98.61 4.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.6 0.76 . . . . 0.0 109.52 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 84' ' ' LEU . 40.7 mm -93.19 84.13 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -129.45 117.14 18.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 C--N 1.383 2.388 0 C-N-CA 122.414 2.076 . . . . 0.0 112.305 -176.588 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.448 ' HB2' HG11 ' A' ' 94' ' ' VAL . 48.3 m-85 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -97.25 126.44 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 121.503 0.668 . . . . 0.0 110.763 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 14.0 ptt? -174.75 -174.38 0.8 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.71 2.004 . . . . 0.0 106.996 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.24 109.24 0.47 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -134.82 122.32 21.9 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.434 1.094 . . . . 0.0 108.203 170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.1 tm? -99.49 124.23 44.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.633 0.773 . . . . 0.0 109.545 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.68 105.75 3.28 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 123.913 0.885 . . . . 0.0 112.072 -178.949 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 70' ' ' ILE . 34.5 t . . . . . 0 N--CA 1.474 0.727 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.53 -26.02 68.51 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.129 0.572 . . . . 0.0 111.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.23 -48.96 76.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.32 0.648 . . . . 0.0 110.181 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.97 -35.93 81.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.881 0.873 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 66' ' ' SER . 37.5 mm -61.66 -40.27 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.933 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.48 -57.77 10.51 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.909 0.755 . . . . 0.0 112.008 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.0 mp -66.01 -34.85 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.55 -57.3 20.56 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.175 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 70' ' ' ILE . 3.7 pp -66.95 -30.65 70.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.954 0.501 . . . . 0.0 111.614 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 23.1 mm-40 -60.72 -54.63 42.93 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.531 0.519 . . . . 0.0 110.048 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' ILE . 12.9 m-85 -60.79 -35.91 77.65 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.679 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -62.64 -35.9 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.956 0.902 . . . . 0.0 111.561 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.75 -31.58 66.82 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.457 0.473 . . . . 0.0 110.5 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.78 -32.59 62.07 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.702 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 40' ' ' LEU . 95.5 mt -74.07 -29.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.863 0.865 . . . . 0.0 109.734 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 12.8 tt0 -58.01 -35.7 71.62 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.976 0.911 . . . . 0.0 110.551 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.87 -43.96 43.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.229 0.612 . . . . 0.0 110.692 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -65.93 -25.15 67.01 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.456 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 90.9 mt . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 124.825 1.25 . . . . 0.0 109.546 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 111.423 0.157 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -59.62 -40.39 87.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.943 0.897 . . . . 0.0 110.935 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -39.25 76.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.388 0.675 . . . . 0.0 110.843 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.6 -35.3 78.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 0.0 111.98 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 55' ' ' TYR . 28.0 m -79.39 -28.98 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 118.332 0.515 . . . . 0.0 111.102 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.5 m -68.9 -42.46 76.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.835 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -65.21 -27.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.614 0.571 . . . . 0.0 111.569 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -63.26 -39.7 95.34 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.586 0.707 . . . . 0.0 110.22 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -32.06 32.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.26 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.69 -15.55 56.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.033 0.933 . . . . 0.0 112.482 -167.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.568 1.643 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.523 176.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.556 1.593 0 N-CA-C 113.424 0.509 . . . . 0.0 113.424 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 38' ' ' ILE . 61.9 t -88.62 94.14 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.967 0.907 . . . . 0.0 109.442 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.73 99.31 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.169 0.988 . . . . 0.0 110.259 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 23' ' ' THR . 56.1 tp -117.83 98.73 6.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.728 . . . . 0.0 109.208 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 t -158.33 60.3 1.77 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.649 0.78 . . . . 0.0 110.97 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.7 -36.03 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.536 2.158 . . . . 0.0 112.286 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.43 -4.78 5.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.611 0.764 . . . . 0.0 111.552 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -48.07 124.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -161.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.1 mt -107.74 90.22 6.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.34 -19.41 38.18 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.458 2.105 . . . . 0.0 112.589 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.63 -2.41 80.55 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.983 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.92 173.43 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.51 0.655 . . . . 0.0 110.349 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 m -91.5 -13.39 32.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.269 1.027 . . . . 0.0 111.877 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -114.65 -172.86 2.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.838 . . . . 0.0 110.482 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 19' ' ' ILE . 16.0 tp -143.33 139.71 30.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -50.03 -41.99 48.57 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.76 1.224 . . . . 0.0 112.183 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -166.47 147.66 6.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.597 0.759 . . . . 0.0 110.029 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 16' ' ' LEU . 69.1 mt -121.24 130.47 24.81 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 168.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.99 116.63 2.9 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.964 2.442 . . . . 0.0 111.63 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HA ' HD23 ' A' ' 24' ' ' LEU . 25.6 mp0 -63.75 -27.24 69.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.619 1.168 . . . . 0.0 110.384 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.15 -36.13 83.28 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.077 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.555 HG21 HD13 ' A' ' 5' ' ' LEU . 48.3 m -66.77 -36.28 82.06 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.671 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 83' ' ' THR . 3.8 mm? -63.27 -42.75 99.16 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.156 0.435 . . . . 0.0 110.292 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.3 t -61.21 -39.47 90.38 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.563 0.745 . . . . 0.0 110.849 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 38.3 tt0 -65.62 -45.12 84.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.608 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 23' ' ' THR . 96.4 mt -60.3 -41.83 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.245 1.018 . . . . 0.0 110.184 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 20.4 mtp180 -63.52 -25.47 68.27 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.459 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.39 -34.88 25.45 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.613 0.765 . . . . 0.0 111.548 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 5.4 mm100 -73.21 -31.32 64.1 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.423 0.63 . . . . 0.0 110.239 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -68.27 -19.02 64.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.193 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.24 -33.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -70.47 -31.15 68.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.211 0.605 . . . . 0.0 110.11 168.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.5 3.09 50.39 Favored Glycine 0 N--CA 1.468 0.81 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.258 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.97 107.59 7.41 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.905 0.882 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -136.64 95.85 3.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -101.56 98.11 8.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG22 HD22 ' A' ' 40' ' ' LEU . 1.9 mp -94.22 117.79 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -172.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 -89.59 104.65 17.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 38' ' ' ILE . 3.9 mm? -76.68 74.88 3.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.35 -104.31 1.26 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.62 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.85 -20.55 23.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.123 0.969 . . . . 0.0 110.572 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 43.7 mt -78.13 146.52 35.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.471 0.708 . . . . 0.0 110.543 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.5 tpt -116.72 121.21 40.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.85 123.99 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.341 1.057 . . . . 0.0 109.435 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' SER . 66.9 m -98.58 97.68 8.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.212 0.605 . . . . 0.0 110.416 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -85.16 100.7 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.88 141.55 41.5 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.385 2.456 0 C-N-CA 123.166 2.578 . . . . 0.0 112.445 -177.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 121.359 0.6 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 38.5 p90 -84.67 125.75 32.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 111.162 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 23.8 ptt? -177.62 112.95 0.08 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.581 1.152 . . . . 0.0 109.002 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 43.29 103.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.182 1.372 . . . . 0.0 116.254 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 32.4 m -136.72 98.91 3.9 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.168 -0.607 . . . . 0.0 109.639 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.9 126.4 27.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.58 0.752 . . . . 0.0 109.35 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.93 93.11 6.44 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--N 1.35 0.592 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -176.257 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 119.436 -0.316 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -62.7 -23.36 67.11 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.615 0.766 . . . . 0.0 112.228 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -48.51 73.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.708 0.803 . . . . 0.0 109.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -71.2 -26.36 62.92 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.147 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.66 -43.85 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.481 0.712 . . . . 0.0 109.859 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 26.9 tt0 -59.75 -58.94 6.39 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.204 1.001 . . . . 0.0 111.591 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.26 -29.75 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -55.94 -57.66 17.93 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.592 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.74 -26.26 66.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.976 0.51 . . . . 0.0 111.802 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 16.1 mm-40 -65.3 -41.55 93.96 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.577 172.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 80' ' ' ILE . 11.7 m-85 -77.98 -23.09 48.53 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.737 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -65.52 -47.77 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.563 0.619 . . . . 0.0 110.086 175.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -71.6 -28.49 63.85 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.949 0.781 . . . . 0.0 110.912 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -68.08 -50.32 55.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.197 0.311 . . . . 0.0 110.173 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 76' ' ' TYR . 45.8 mm -61.53 -39.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.755 0.822 . . . . 0.0 109.757 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 43.4 tt0 -57.74 -42.69 84.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.101 0.96 . . . . 0.0 111.174 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -71.8 -27.51 62.98 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.559 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.475 HG22 ' HG ' ' A' ' 24' ' ' LEU . 10.5 m -97.13 -23.41 16.23 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.767 0.827 . . . . 0.0 112.091 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 57' ' ' MET . 41.9 tp . . . . . 0 N--CA 1.492 1.673 0 C-N-CA 124.175 0.99 . . . . 0.0 111.094 -170.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -63.04 -52.47 62.72 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.02 0.928 . . . . 0.0 112.071 -172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -57.74 -34.02 69.09 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.497 0.719 . . . . 0.0 112.189 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -33.08 72.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.941 0.897 . . . . 0.0 112.359 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.37 -36.21 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.992 0.517 . . . . 0.0 110.024 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -64.07 -39.61 94.46 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.552 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.01 -32.83 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 0.0 111.086 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.67 -35.61 79.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.213 0.605 . . . . 0.0 110.432 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -82.19 -25.47 34.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.087 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.14 -41.22 22.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.953 0.901 . . . . 0.0 111.42 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.288 0.635 . . . . 0.0 111.068 -178.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 CA--C 1.549 1.257 0 N-CA-C 113.815 0.66 . . . . 0.0 113.815 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 99.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.17 0.986 . . . . 0.0 109.127 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.55 110.42 3.66 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.2 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.81 113.3 15.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.333 1.053 . . . . 0.0 110.154 -168.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -154.75 40.65 0.14 Allowed Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.66 -31.97 0.98 Allowed 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 121.844 1.696 . . . . 0.0 112.998 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -128.09 21.99 6.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.665 0.786 . . . . 0.0 111.21 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.67 128.24 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 120.905 0.383 . . . . 0.0 110.07 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.1 mm? -98.55 95.65 3.19 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.4 95.92 0.95 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.975 2.45 . . . . 0.0 110.674 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.61 -35.2 0.75 Allowed Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.999 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.5 m -93.56 175.74 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.438 0.637 . . . . 0.0 111.535 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.7 p -85.03 -32.36 22.94 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.03 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -102.71 172.34 6.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.877 0.846 . . . . 0.0 112.91 -167.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.83 47.04 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.0 p -64.66 -62.76 1.38 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.591 0.757 . . . . 0.0 110.215 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -166.82 126.87 1.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.766 0.826 . . . . 0.0 109.137 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.0 mt -88.44 137.02 30.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.0 Cg_endo -55.22 129.62 36.23 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.513 2.142 . . . . 0.0 111.251 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -23.68 62.9 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.593 0.757 . . . . 0.0 112.822 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.0 pt-20 -63.52 -32.51 73.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.095 0.958 . . . . 0.0 111.326 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 m -70.9 -46.71 62.07 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.551 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.09 -27.46 68.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.55 0.159 . . . . 0.0 111.055 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -73.12 -44.2 60.57 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 111.045 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 -28.77 62.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.451 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.43 -42.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.641 0.776 . . . . 0.0 109.324 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 tpt85 -64.21 -24.66 67.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.542 0.737 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -75.66 -54.68 6.59 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.915 0.886 . . . . 0.0 111.002 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.7 pt20 -68.27 -25.02 64.96 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.36 0.664 . . . . 0.0 112.553 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 37.8 p -64.98 -33.42 76.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.414 0.285 . . . . 0.0 111.186 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.15 -32.57 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.849 0.46 . . . . 0.0 110.187 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -71.01 -26.56 63.18 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.083 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.23 11.94 57.97 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.958 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -138.34 105.96 5.59 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -147.09 126.29 12.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.957 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.448 HE21 ' NH2' ' A' ' 48' ' ' ARG . 26.9 mp0 -130.06 137.93 50.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.595 0.758 . . . . 0.0 108.963 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.49 112.17 30.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 21.2 mtm105 -87.52 95.46 10.04 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -80.77 69.51 7.33 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.559 0.695 . . . . 0.0 109.505 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -103.53 1.31 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.079 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.38 -19.14 21.6 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.966 0.906 . . . . 0.0 110.375 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -76.85 109.67 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.48 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 14.1 tpt -87.75 111.8 21.73 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -110.16 153.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 59' ' ' SER . 61.1 m -137.77 139.47 40.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.482 1.113 . . . . 0.0 108.337 172.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 28.3 mm -123.62 100.76 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' NH2' HE21 ' A' ' 37' ' ' GLN . 67.5 mtt85 -129.77 129.21 23.06 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--N 1.373 1.82 0 C-N-CA 122.366 2.044 . . . . 0.0 111.533 170.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.533 0.206 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -123.94 118.21 26.54 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.718 0.807 . . . . 0.0 110.041 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -167.51 107.24 0.57 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.885 0.874 . . . . 0.0 108.938 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' HA3' HG23 ' A' ' 77' ' ' ILE . . . 55.5 106.98 0.01 OUTLIER Glycine 0 CA--C 1.54 1.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 115.006 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' SER . 47.1 t -133.58 97.77 4.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.69 107.79 4.7 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.502 0.721 . . . . 0.0 109.464 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.1 96.93 1.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 . . . . . 0 N--CA 1.484 1.267 0 C-N-CA 123.884 0.874 . . . . 0.0 111.984 -176.522 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 70' ' ' ILE . 23.0 t . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.42 -40.13 64.9 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.229 1.011 . . . . 0.0 112.791 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -67.22 -40.75 86.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.542 0.737 . . . . 0.0 111.198 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -68.16 -29.6 68.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.486 0.714 . . . . 0.0 111.012 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' SER . 43.3 mm -65.51 -46.11 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.167 0.587 . . . . 0.0 109.963 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -58.09 -55.29 36.91 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.068 0.855 . . . . 0.0 110.879 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 43' ' ' LEU . 34.0 mt -60.8 -38.77 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 O-C-N 123.689 0.618 . . . . 0.0 110.06 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.452 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -59.52 -57.33 20.16 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.066 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 pp -64.96 -26.35 68.26 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.851 0.46 . . . . 0.0 111.634 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -64.56 -48.51 74.76 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.573 0.545 . . . . 0.0 110.379 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' HG12 ' A' ' 80' ' ' ILE . 26.1 m-85 -67.35 -29.12 68.58 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.279 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.3 -44.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.817 0.847 . . . . 0.0 111.158 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.74 -20.92 61.1 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.89 0.376 . . . . 0.0 111.026 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -81.9 -27.04 33.63 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.8 mm -69.89 -35.71 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.896 0.478 . . . . 0.0 110.683 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.5 -30.98 71.43 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 110.564 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -75.89 -32.82 59.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.697 0.799 . . . . 0.0 110.913 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.8 m -78.75 -38.39 38.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.482 0.713 . . . . 0.0 110.375 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 125.055 1.342 . . . . 0.0 108.634 171.103 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 19.6 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 p -49.03 -50.72 34.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.697 1.199 . . . . 0.0 112.291 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -63.69 -28.5 69.94 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 123.996 0.918 . . . . 0.0 112.431 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 43.5 mt-10 -59.51 -39.02 82.51 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.546 0.612 . . . . 0.0 112.544 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 122.8 0.44 . . . . 0.0 111.319 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -69.9 -27.61 64.94 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.092 0.557 . . . . 0.0 111.469 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.9 p -66.69 -22.85 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.439 0.695 . . . . 0.0 110.951 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.24 -35.15 76.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.183 0.516 . . . . 0.0 110.681 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -82.41 -31.29 29.66 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.836 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.96 -58.3 3.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.458 0.703 . . . . 0.0 111.39 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 96' ' ' VAL . 31.2 pt . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.528 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo . . . . . 0 CA--C 1.55 1.308 0 CA-C-O 121.07 0.363 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 38' ' ' ILE . 5.7 p -80.23 94.37 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 121.793 0.806 . . . . 0.0 109.643 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 9.4 p-10 -64.2 123.69 19.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.135 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -131.01 106.41 8.38 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.565 0.746 . . . . 0.0 109.681 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -150.07 71.0 9.38 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 121.498 0.666 . . . . 0.0 110.329 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.87 -40.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.827 2.352 . . . . 0.0 113.318 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 66.3 m-85 -129.18 20.45 5.81 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.092 0.957 . . . . 0.0 111.122 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.584 HG12 HD21 ' A' ' 16' ' ' LEU . 19.6 mt -72.5 129.83 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -107.34 87.45 3.27 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.48 -4.46 13.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.66 2.24 . . . . 0.0 114.284 -163.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.89 -8.59 72.53 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.218 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.9 m -126.52 175.99 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.594 0.758 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -88.22 -28.76 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.306 1.042 . . . . 0.0 112.4 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -91.95 166.38 12.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.417 0.627 . . . . 0.0 112.002 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.584 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -112.39 149.3 32.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.925 1.29 . . . . 0.0 107.708 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 55.0 m -67.58 -58.94 3.82 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -171.91 149.73 2.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.034 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.01 134.68 22.47 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.86 126.54 22.82 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.7 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.104 0.962 . . . . 0.0 110.994 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.35 -44.35 95.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.242 1.017 . . . . 0.0 110.782 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.646 HG21 HD13 ' A' ' 5' ' ' LEU . 13.7 m -72.19 -34.52 68.48 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.793 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.81 -40.94 97.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.786 0.266 . . . . 0.0 111.115 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 m -66.81 -36.83 83.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.489 0.716 . . . . 0.0 110.345 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.7 tp10 -60.4 -45.38 93.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.227 1.011 . . . . 0.0 110.294 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' THR . 97.5 mt -60.9 -48.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.447 1.099 . . . . 0.0 110.701 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.72 -24.73 64.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.515 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 8.8 p30 -85.13 -35.66 21.6 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.599 0.636 . . . . 0.0 111.879 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 3.8 pt20 -75.68 -23.39 56.2 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.148 0.579 . . . . 0.0 111.812 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' ILE . 35.0 p -56.82 -25.45 55.97 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.9 -19.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.246 1.018 . . . . 0.0 110.858 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 30' ' ' GLN . 2.9 mpt_? -75.16 -8.49 56.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.376 1.07 . . . . 0.0 111.159 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.43 -22.85 37.8 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 123.44 0.543 . . . . 0.0 112.927 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.1 134.64 33.17 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 108.865 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -145.3 97.63 3.03 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -100.09 122.87 43.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.046 0.538 . . . . 0.0 110.716 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.456 HG13 HG13 ' A' ' 3' ' ' VAL . 2.6 mp -109.31 113.43 44.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 71.3 mtt180 -85.0 92.1 8.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.62 76.7 1.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.242 0.544 . . . . 0.0 109.893 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -102.13 0.75 Allowed Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.423 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.01 -18.18 20.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 110.979 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt -84.52 113.58 21.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.167 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.722 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.4 tpt -85.1 111.64 19.94 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.85 148.46 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 t -134.02 110.12 9.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.193 0.52 . . . . 0.0 109.668 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 56' ' ' PHE . 31.9 mm -87.44 107.11 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 14.2 ptm180 -154.29 128.45 4.61 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 118.709 0.686 . . . . 0.0 111.176 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HD1' ' A' ' 56' ' ' PHE . 31.3 Cg_exo . . . . . 0 C--N 1.384 2.403 0 C-N-CA 123.256 2.637 . . . . 0.0 113.546 -178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.009 0.433 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' ILE . 35.9 p90 -101.42 116.46 32.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.357 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.705 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 55.6 mtm -145.37 -176.03 4.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.725 0.81 . . . . 0.0 109.535 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' HG2' ' A' ' 81' ' ' GLU . . . -54.37 113.52 3.46 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.324 1.015 . . . . 0.0 114.467 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -129.51 113.0 14.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 112.76 16.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.317 0.647 . . . . 0.0 109.834 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.85 115.59 18.64 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.894 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 . . . . . 0 CA--C 1.549 0.932 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.074 179.511 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 119.814 -0.136 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -59.5 -33.53 71.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.331 1.052 . . . . 0.0 112.895 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.5 p-10 -71.44 -42.35 68.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -34.95 78.99 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.868 0.867 . . . . 0.0 111.714 175.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.5 mm -58.01 -43.2 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.363 0.665 . . . . 0.0 109.461 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.24 -56.75 12.47 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.922 0.763 . . . . 0.0 110.95 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' ASP . 7.4 mm -57.08 -38.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.526 0.679 . . . . 0.0 109.352 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.25 -58.05 14.26 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.426 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.89 -22.93 66.55 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.669 0.735 . . . . 0.0 111.891 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 25.1 mm-40 -70.86 -46.45 62.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.632 0.773 . . . . 0.0 110.145 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' ILE . 13.8 m-85 -69.84 -27.2 64.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.201 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -61.98 -51.42 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.625 0.77 . . . . 0.0 109.893 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 75' ' ' GLN . 12.5 pt-20 -64.42 -34.66 78.69 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.475 0.484 . . . . 0.0 110.411 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.95 -31.5 66.38 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.873 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 76' ' ' TYR . 28.5 mm -69.77 -43.7 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.705 ' HG2' ' HB3' ' A' ' 57' ' ' MET . 44.9 mt-10 -60.75 -36.99 80.32 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.604 0.761 . . . . 0.0 111.377 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -73.28 -39.3 65.48 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.929 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -74.42 -22.93 58.9 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.672 0.789 . . . . 0.0 111.202 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.225 1.01 . . . . 0.0 110.08 -176.126 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 26.0 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.6 m -64.02 -47.1 81.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -62.17 -26.22 68.22 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.2 tp10 -57.34 -47.65 81.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.063 0.945 . . . . 0.0 111.306 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.11 -27.2 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.412 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 m -64.96 -45.24 86.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.156 0.582 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.31 -28.1 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 111.195 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 75.0 mt -69.74 -38.56 76.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -80.51 -26.97 37.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.768 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.721 0.808 . . . . 0.0 111.372 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.293 174.082 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 56.2 Cg_endo . . . . . 0 CA--C 1.553 1.435 0 CA-C-O 121.991 0.746 . . . . 0.0 112.742 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.37 116.32 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.473 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.84 137.42 43.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.907 0.483 . . . . 0.0 110.455 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 19' ' ' ILE . 5.4 tt -145.11 94.11 2.48 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -147.81 47.4 0.54 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 6' ' ' THR . 67.9 Cg_endo -85.18 -30.69 0.46 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 121.88 1.72 . . . . 0.0 113.642 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.47 18.82 6.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.961 0.505 . . . . 0.0 111.542 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 16' ' ' LEU . 20.6 mt -70.63 135.97 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.691 0.396 . . . . 0.0 111.307 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.584 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -117.31 85.59 19.94 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.7 22.12 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.017 2.478 . . . . 0.0 114.081 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.57 -39.2 90.88 Favored Glycine 0 C--N 1.346 1.127 0 O-C-N 123.425 0.453 . . . . 0.0 113.862 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.3 m -108.71 178.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.972 0.509 . . . . 0.0 111.666 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.5 p -91.29 -24.89 19.7 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.256 1.023 . . . . 0.0 112.026 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -94.15 162.08 14.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.306 0.574 . . . . 0.0 111.589 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -103.66 142.82 33.66 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 10' ' ' LEU . 23.6 t -74.59 -48.8 24.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.879 0.471 . . . . 0.0 110.026 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.19 142.56 10.13 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.47 HG23 HD21 ' A' ' 5' ' ' LEU . 76.0 mt -121.43 121.74 28.33 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 163.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.8 127.22 20.87 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.742 2.295 . . . . 0.0 111.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.58 -16.81 62.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 111.182 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.76 -38.26 88.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.056 0.542 . . . . 0.0 110.35 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 17.9 m -74.66 -35.63 62.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.9 0.48 . . . . 0.0 109.836 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.19 -25.1 65.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.772 0.429 . . . . 0.0 111.138 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -68.8 -40.74 79.43 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.652 0.781 . . . . 0.0 110.962 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 23' ' ' THR . 12.8 pt-20 -71.66 -30.7 66.01 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 23' ' ' THR . 12.0 mm -65.29 -43.07 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 121.427 0.632 . . . . 0.0 109.57 172.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -62.04 -31.08 71.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.959 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.37 -41.14 14.74 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 3.6 pt20 -70.58 -24.03 62.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -53.64 -36.31 61.93 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.014 0.526 . . . . 0.0 111.244 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.08 -36.45 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.621 0.768 . . . . 0.0 110.311 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.84 -16.62 63.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.595 0.758 . . . . 0.0 110.627 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.16 -19.17 25.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.41 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -138.2 131.03 29.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -143.28 101.57 3.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.313 1.045 . . . . 0.0 108.439 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 42.1 mt-30 -109.67 115.41 29.82 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 40' ' ' LEU . 3.0 mp -107.66 126.61 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.519 0.728 . . . . 0.0 109.747 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -91.6 96.98 10.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.151 0.58 . . . . 0.0 110.243 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 38' ' ' ILE . 8.1 mp -81.76 71.85 8.8 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 169.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.34 -102.88 1.07 Allowed Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 -19.03 18.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.611 0.764 . . . . 0.0 110.445 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.472 HD13 ' HA2' ' A' ' 73' ' ' GLY . 17.6 mt -74.64 108.76 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.2 tpt -93.13 113.63 25.93 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.78 151.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.798 0.839 . . . . 0.0 109.521 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 m -133.66 98.11 4.11 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.27 0.628 . . . . 0.0 109.921 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 49.5 mm -83.21 93.02 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.72 0.808 . . . . 0.0 109.0 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -127.04 126.39 24.32 Favored Pre-proline 0 N--CA 1.483 1.209 0 O-C-N 121.929 -0.482 . . . . 0.0 110.853 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 45.0 Cg_endo . . . . . 0 C--N 1.383 2.365 0 C-N-CA 124.18 3.253 . . . . 0.0 112.831 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.659 0.266 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 25.0 p90 -86.43 113.19 22.17 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.771 0.796 . . . . 0.0 111.373 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.1 -178.23 3.52 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.643 1.177 . . . . 0.0 108.2 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 77' ' ' ILE . . . -67.57 110.77 3.64 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.541 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.3 t -100.84 96.67 7.45 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.0 tm? -82.23 109.49 16.56 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -64.06 92.9 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.826 -178.003 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 120.62 0.248 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 37.55 -79.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.535 2.334 . . . . 0.0 116.32 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.1 p-10 -79.97 -42.76 23.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.12 0.568 . . . . 0.0 110.222 -170.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -67.8 -35.4 78.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.088 0.47 . . . . 0.0 110.066 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -55.94 -48.47 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.456 0.702 . . . . 0.0 110.876 169.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -59.9 -52.02 67.22 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.665 0.603 . . . . 0.0 111.044 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ASP . 33.8 mt -57.87 -39.24 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.263 0.625 . . . . 0.0 109.702 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -62.99 -59.08 9.6 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.161 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.1 pp -68.13 -23.11 64.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.449 0.625 . . . . 0.0 112.261 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -73.98 -37.08 64.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.073 0.549 . . . . 0.0 110.978 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -72.54 -31.19 65.1 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.409 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -67.46 -39.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.707 0.803 . . . . 0.0 110.64 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -22.46 57.69 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.773 0.32 . . . . 0.0 110.511 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.41 -40.43 57.83 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.417 0.687 . . . . 0.0 110.167 168.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.57 HG23 HD23 ' A' ' 84' ' ' LEU . 42.8 mt -73.98 -33.68 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 0.0 111.528 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -64.05 -33.05 74.86 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 120.928 0.394 . . . . 0.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -76.73 -37.1 56.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.008 0.923 . . . . 0.0 111.134 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -71.78 -42.78 66.74 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.037 0.535 . . . . 0.0 111.108 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.57 HD23 HG23 ' A' ' 80' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.484 1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 110.964 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -60.25 -49.46 77.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 0.0 110.364 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -50.67 -33.95 24.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.093 1.357 . . . . 0.0 112.399 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -61.26 -42.4 98.57 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.297 0.639 . . . . 0.0 111.19 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.84 -20.83 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 122.621 0.368 . . . . 0.0 111.442 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 96.1 m -75.37 -30.74 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.131 0.572 . . . . 0.0 111.759 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.38 -18.37 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 118.19 0.45 . . . . 0.0 112.136 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.86 -42.11 73.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.727 0.411 . . . . 0.0 110.116 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -81.84 -29.27 32.62 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.751 0.421 . . . . 0.0 110.884 177.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -71.45 -27.03 62.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.899 0.88 . . . . 0.0 111.609 -168.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.561 1.396 0 C-N-CA 123.166 0.586 . . . . 0.0 110.618 173.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.715 0 N-CA-C 113.209 0.427 . . . . 0.0 113.209 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -69.46 127.78 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.42 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.91 140.81 42.32 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -146.02 87.97 1.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 12.8 t -147.04 37.12 0.18 Allowed Pre-proline 0 CA--C 1.571 1.779 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.3 Cg_endo -79.69 -32.47 1.56 Allowed 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 121.609 1.54 . . . . 0.0 111.758 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 59.5 m-85 -129.23 24.89 5.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.882 0.873 . . . . 0.0 111.529 -173.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 6' ' ' THR . 17.7 mt -67.79 123.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.989 0.423 . . . . 0.0 110.524 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 13' ' ' VAL . 62.8 mt -107.32 91.61 7.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 86.47 1.58 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.513 2.142 . . . . 0.0 110.866 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.53 -37.44 0.27 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.598 -173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' LEU . 11.5 m -93.36 167.88 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.993 0.517 . . . . 0.0 110.392 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 45.3 m -78.82 -37.22 41.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.425 0.69 . . . . 0.0 111.499 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -91.85 177.85 6.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.44 0.696 . . . . 0.0 112.272 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 140.6 49.46 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 22.8 m -52.55 -58.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.303 0.641 . . . . 0.0 111.059 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -172.24 135.53 0.77 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.608 1.163 . . . . 0.0 108.018 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 83' ' ' THR . 65.3 mt -105.91 127.86 27.55 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.08 130.35 31.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.849 2.366 . . . . 0.0 112.517 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.53 -14.91 62.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.117 0.567 . . . . 0.0 111.409 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.97 -43.32 93.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.642 0.777 . . . . 0.0 110.252 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 m -65.82 -42.21 90.9 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.063 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 9.4 mp -58.6 -39.11 79.5 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.849 0.46 . . . . 0.0 110.52 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -39.16 69.49 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.711 0.804 . . . . 0.0 111.818 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -72.08 -27.11 62.45 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HA ' HE21 ' A' ' 30' ' ' GLN . 83.9 mt -68.53 -42.65 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 122.734 0.414 . . . . 0.0 109.997 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 20.1 mmt180 -63.5 -25.17 68.13 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.389 0.675 . . . . 0.0 110.883 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -76.42 -52.73 9.29 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.446 0.698 . . . . 0.0 110.696 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.456 HE21 ' HA ' ' A' ' 27' ' ' ILE . 25.7 pt20 -70.03 -27.57 64.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.855 0.462 . . . . 0.0 111.813 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' HG3' ' A' ' 49' ' ' PRO . 8.3 p -61.91 -24.11 66.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.052 0.541 . . . . 0.0 112.272 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.51 -23.35 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 122.944 0.498 . . . . 0.0 110.924 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.13 0.87 26.38 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.718 0.807 . . . . 0.0 111.029 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.23 -17.84 54.11 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.432 0.539 . . . . 0.0 112.698 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.37 131.48 30.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.914 0.885 . . . . 0.0 110.213 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -126.78 133.36 50.84 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.155 0.982 . . . . 0.0 108.935 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -112.03 115.82 29.54 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.75 144.38 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.467 1.107 . . . . 0.0 108.24 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -128.54 88.59 2.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.917 . . . . 0.0 110.392 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 76' ' ' TYR . 88.4 mt -76.68 80.16 3.32 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.75 -104.04 1.16 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -99.04 -11.78 21.17 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.525 0.73 . . . . 0.0 110.966 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD13 ' HA2' ' A' ' 73' ' ' GLY . 52.9 mt -83.3 132.0 35.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.296 1.038 . . . . 0.0 110.236 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.05 128.65 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.48 120.76 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.051 0.94 . . . . 0.0 109.603 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.6 m -100.84 110.32 22.38 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.774 0.83 . . . . 0.0 110.403 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 22.8 mm -101.84 115.08 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -133.59 103.49 12.27 Favored Pre-proline 0 N--CA 1.493 1.685 0 C-N-CA 122.754 0.422 . . . . 0.0 111.963 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 52.5 Cg_endo . . . . . 0 C--N 1.378 2.12 0 C-N-CA 123.185 2.59 . . . . 0.0 113.65 167.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.242 0.688 0 CA-C-O 121.363 0.601 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 47' ' ' ILE . 8.1 p90 -88.68 116.88 27.25 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.709 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.644 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 21.3 ptt? -172.89 -175.73 1.3 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.437 1.095 . . . . 0.0 109.379 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.8 110.29 0.22 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 124.397 1.061 . . . . 0.0 115.618 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.0 t -134.49 101.4 4.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.882 0.873 . . . . 0.0 108.79 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.71 111.72 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.843 0.857 . . . . 0.0 109.717 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.54 103.05 3.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.19 0.996 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 -174.159 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.2 p . . . . . 0 CA--C 1.546 0.826 0 N-CA-C 110.92 -0.03 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -57.9 -31.55 66.86 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.227 1.011 . . . . 0.0 113.363 -171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.3 p-10 -65.15 -44.28 89.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.461 HD22 HD12 ' A' ' 72' ' ' ILE . 15.1 m120 -75.44 -19.37 59.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 0.0 111.804 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 -44.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 35.2 tt0 -66.84 -55.81 13.16 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.804 0.69 . . . . 0.0 110.281 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 69' ' ' ASN . 28.8 mt -56.81 -37.02 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 123.725 0.81 . . . . 0.0 109.928 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -60.88 -56.86 21.77 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.901 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.18 -27.23 68.56 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.203 0.501 . . . . 0.0 111.945 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 22.5 mm-40 -66.5 -47.0 74.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 0.0 110.332 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 12.4 m-85 -73.55 -27.11 61.16 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.362 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.5 -43.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.737 0.815 . . . . 0.0 110.456 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.36 -21.35 62.04 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.61 0.569 . . . . 0.0 110.947 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -78.05 -40.42 38.78 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.242 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.4 mm -65.68 -29.59 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 123.219 0.608 . . . . 0.0 110.825 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.2 pt-20 -70.46 -39.5 74.27 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -24.5 42.97 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 19' ' ' ILE . 99.6 m -73.11 -55.68 6.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.611 0.765 . . . . 0.0 110.404 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 124.927 1.291 . . . . 0.0 108.367 178.596 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -63.47 -50.23 70.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.366 0.667 . . . . 0.0 111.45 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -62.07 -40.2 95.02 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.528 0.331 . . . . 0.0 110.227 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 14.5 tp10 -66.6 -34.06 77.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.004 0.522 . . . . 0.0 111.149 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.3 -23.01 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.4 m -77.65 -34.66 53.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.954 0.902 . . . . 0.0 110.78 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.87 -25.82 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 23.9 tp -67.79 -42.03 82.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.517 1.127 . . . . 0.0 111.039 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -79.66 -21.67 44.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.592 176.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.99 -40.96 68.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.099 0.56 . . . . 0.0 111.583 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 CA--C 1.568 1.657 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.516 -174.489 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.542 0.9 0 N-CA-C 110.5 -0.615 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.59 107.23 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.165 0.986 . . . . 0.0 111.879 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.4 136.09 37.58 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 HD21 HD13 ' A' ' 19' ' ' ILE . 61.3 tp -136.27 95.51 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.61 1.164 . . . . 0.0 108.079 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.423 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.3 t -144.54 31.05 0.1 Allowed Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.83 -29.71 8.25 Favored 'Trans proline' 0 C--N 1.391 2.811 0 CA-C-N 121.565 1.595 . . . . 0.0 112.949 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 59.1 m-85 -129.44 26.27 5.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.602 0.761 . . . . 0.0 111.484 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 6' ' ' THR . 21.8 mt -71.76 135.4 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 173.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -109.9 90.19 8.98 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.43 90.91 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.913 2.409 . . . . 0.0 109.77 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.72 -43.06 0.28 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.667 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 10' ' ' LEU . 34.2 m -99.69 -175.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 110.968 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -105.68 6.01 31.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.106 0.962 . . . . 0.0 112.755 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -126.91 165.76 18.77 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.435 0.636 . . . . 0.0 111.715 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.42 143.82 34.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' HD21 ' A' ' 10' ' ' LEU . 28.9 t -63.71 -60.68 3.0 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.545 0.738 . . . . 0.0 109.834 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.4 138.6 0.71 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.537 1.135 . . . . 0.0 108.548 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 83' ' ' THR . 76.4 mt -104.52 137.18 19.15 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 123.096 0.558 . . . . 0.0 109.616 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.5 Cg_endo -57.19 133.11 55.38 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.872 2.381 . . . . 0.0 111.94 170.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.369 1.068 . . . . 0.0 112.128 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.4 pt-20 -60.0 -31.85 70.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 0.0 111.557 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.488 HG21 HD13 ' A' ' 5' ' ' LEU . 6.3 m -67.89 -50.32 56.97 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD22 ' H ' ' A' ' 24' ' ' LEU . 2.5 mm? -62.8 -27.06 69.05 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.729 0.412 . . . . 0.0 110.659 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -69.92 -47.33 62.87 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.046 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.8 -32.38 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.191 0.197 . . . . 0.0 110.979 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.2 mt -62.72 -44.58 99.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.547 0.739 . . . . 0.0 109.333 171.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.441 HH12 HD11 ' A' ' 32' ' ' ILE . 46.8 tpt85 -60.0 -27.85 67.22 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.558 0.743 . . . . 0.0 111.606 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.09 -46.23 15.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.538 0.735 . . . . 0.0 111.621 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -75.29 -25.89 58.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.994 0.518 . . . . 0.0 111.867 -175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -62.12 -28.67 69.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.552 0.341 . . . . 0.0 111.281 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.441 HD11 HH12 ' A' ' 28' ' ' ARG . 49.2 mm -65.75 -30.54 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.987 0.515 . . . . 0.0 110.527 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -70.87 -13.06 61.89 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.419 0.688 . . . . 0.0 110.452 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.07 -21.88 21.83 Favored Glycine 0 C--N 1.348 1.207 0 C-N-CA 124.2 0.905 . . . . 0.0 112.919 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 48' ' ' ARG . 34.6 tt0 -140.32 128.46 22.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.996 0.518 . . . . 0.0 110.979 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.13 130.39 53.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.89 0.876 . . . . 0.0 108.72 169.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -120.99 99.44 6.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.36 0.664 . . . . 0.0 109.328 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.15 123.09 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.877 0.871 . . . . 0.0 109.077 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 15.0 mtm180 -99.2 92.74 5.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 94.6 mt -74.45 75.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 -103.72 1.21 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.19 -10.56 19.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.515 0.726 . . . . 0.0 110.71 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.9 mt -81.2 108.41 14.82 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 13.2 tpt -86.26 124.4 32.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.02 126.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.795 0.838 . . . . 0.0 109.651 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -107.57 99.76 9.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.596 0.758 . . . . 0.0 110.569 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 56' ' ' PHE . 18.3 mm -86.68 90.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 46.4 mtp180 -125.99 124.43 24.68 Favored Pre-proline 0 N--CA 1.484 1.255 0 O-C-N 121.914 -0.491 . . . . 0.0 111.986 -171.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo . . . . . 0 C--N 1.376 2.009 0 C-N-CA 122.412 2.075 . . . . 0.0 111.066 165.491 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.012 0.434 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB2' HG22 ' A' ' 47' ' ' ILE . 29.4 p90 -87.99 114.21 24.39 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.262 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 37.7 mtm -139.66 -174.84 4.01 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.493 1.117 . . . . 0.0 108.081 174.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.12 110.39 1.51 Allowed Glycine 0 C--N 1.351 1.399 0 O-C-N 123.497 0.498 . . . . 0.0 112.755 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 t -133.82 115.95 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.6 115.1 18.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.353 0.661 . . . . 0.0 109.26 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.93 96.6 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.418 1.087 . . . . 0.0 109.31 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 N--CA 1.487 1.4 0 C-N-CA 124.269 1.028 . . . . 0.0 112.825 -169.322 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 118.971 -0.537 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -91.4 -53.45 4.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.061 0.846 . . . . 0.0 112.68 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -57.04 -46.4 82.45 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.524 0.73 . . . . 0.0 112.232 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.21 -40.74 74.52 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.149 0.98 . . . . 0.0 112.707 175.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.2 mm -64.65 -46.29 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 122.47 0.308 . . . . 0.0 110.592 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 97.9 mt-30 -62.48 -57.4 11.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.035 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.81 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.864 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -52.05 55.06 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.852 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -66.87 -26.85 67.1 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.487 0.643 . . . . 0.0 111.437 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 13.9 mm-40 -60.76 -50.82 71.94 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.119 0.962 . . . . 0.0 110.24 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.51 ' O ' HG12 ' A' ' 80' ' ' ILE . 49.3 m-85 -72.46 -25.11 61.32 Favored 'General case' 0 C--O 1.202 -1.424 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.583 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.23 -45.7 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.619 0.768 . . . . 0.0 110.924 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.74 -22.37 61.62 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -73.69 -47.17 41.62 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.668 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -66.53 -35.79 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 124.337 1.055 . . . . 0.0 111.349 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.425 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.8 pt-20 -56.79 -43.39 80.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.288 0.367 . . . . 0.0 110.705 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -78.0 -32.73 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.763 0.825 . . . . 0.0 111.879 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.572 HG21 HD12 ' A' ' 19' ' ' ILE . 21.9 m -69.58 -37.02 76.8 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.049 0.54 . . . . 0.0 110.803 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 t -60.05 -34.36 73.31 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -65.68 -42.48 91.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.499 0.59 . . . . 0.0 110.77 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -27.13 69.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.798 -173.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.9 p -90.04 -35.91 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.161 0.505 . . . . 0.0 110.748 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.8 m -75.77 -27.88 58.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 100' ' ' ILE . 8.1 p -67.4 -20.69 26.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.201 0.6 . . . . 0.0 110.43 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 0.0 111.1 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -32.67 71.1 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.487 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.44 -35.11 58.69 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.596 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 96' ' ' VAL . 15.1 pt . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 CA--C 1.546 1.076 0 N-CA-C 113.054 0.367 . . . . 0.0 113.054 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -103.64 139.47 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -89.65 141.16 28.86 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 19' ' ' ILE . 38.5 tp -145.71 110.46 5.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -149.93 53.51 1.3 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 123.415 0.686 . . . . 0.0 111.2 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.99 -27.64 0.65 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.282 1.988 . . . . 0.0 113.443 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.86 4.55 6.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.99 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.84 116.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -165.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.564 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -104.6 90.95 3.7 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 172.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.5 -23.17 58.01 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.205 1.937 . . . . 0.0 113.925 -167.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.25 72.61 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.133 0.413 . . . . 0.0 114.133 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.9 m -104.82 158.66 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.907 0.483 . . . . 0.0 111.324 -174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -73.28 -20.28 60.86 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.465 1.106 . . . . 0.0 112.905 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -105.89 174.6 5.81 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.374 0.67 . . . . 0.0 111.525 -175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -123.03 147.57 46.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.476 ' OG ' HD21 ' A' ' 10' ' ' LEU . 12.8 m -53.09 -49.27 66.78 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.939 0.774 . . . . 0.0 110.098 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -176.2 166.9 2.9 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.021 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.521 HG23 HD21 ' A' ' 5' ' ' LEU . 83.0 mt -121.35 129.94 25.03 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 167.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 124.17 15.29 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.638 2.225 . . . . 0.0 111.897 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 24' ' ' LEU . 27.3 mp0 -71.08 -15.0 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.645 0.778 . . . . 0.0 111.577 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.47 -46.19 84.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.567 0.747 . . . . 0.0 110.102 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 5' ' ' LEU . 17.6 m -69.47 -37.41 77.27 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.248 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 83' ' ' THR . 95.8 mt -61.32 -37.23 82.5 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.564 0.54 . . . . 0.0 111.217 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -69.88 -30.86 68.41 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.727 0.642 . . . . 0.0 110.775 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.1 tp10 -66.6 -38.5 87.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.842 0.457 . . . . 0.0 109.917 172.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 23' ' ' THR . 18.0 mm -63.37 -44.64 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.952 0.501 . . . . 0.0 109.912 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 11.6 mmm180 -64.44 -29.34 70.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.975 0.91 . . . . 0.0 110.807 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.62 -48.13 34.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.798 0.839 . . . . 0.0 110.987 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.1 pt20 -76.96 -26.11 53.58 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.115 0.566 . . . . 0.0 112.207 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -61.01 -23.77 65.66 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.13 0.423 . . . . 0.0 111.68 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.89 -31.62 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 122.663 0.385 . . . . 0.0 110.137 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -73.44 -13.57 61.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.018 0.927 . . . . 0.0 111.144 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.39 -18.61 22.92 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-O 119.585 -0.564 . . . . 0.0 113.839 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.83 154.56 48.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.757 0.778 . . . . 0.0 112.105 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.466 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -153.15 138.96 17.98 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.708 1.203 . . . . 0.0 107.781 168.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -140.26 129.33 23.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 109.651 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.81 112.61 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -82.5 94.32 7.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 76.5 mt -76.31 65.2 2.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.236 0.615 . . . . 0.0 110.426 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.08 -99.96 0.26 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -71.67 -43.19 66.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.23 1.012 . . . . 0.0 110.984 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.56 160.87 25.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.729 0.812 . . . . 0.0 110.231 -174.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.4 ttt -140.47 129.41 23.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.862 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.78 153.8 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.007 1.323 . . . . 0.0 108.564 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -132.55 98.59 4.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.698 0.799 . . . . 0.0 109.777 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 56' ' ' PHE . 30.2 mm -89.32 84.19 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -116.38 125.47 28.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 121.976 -0.452 . . . . 0.0 110.467 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 92.5 Cg_endo . . . . . 0 C--N 1.378 2.126 0 C-N-CA 123.308 2.672 . . . . 0.0 112.427 169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 31.1 p90 -87.67 116.46 25.82 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.487 0.661 . . . . 0.0 111.42 -172.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.8 ptp -148.11 -176.09 5.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.997 1.319 . . . . 0.0 108.925 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.97 119.23 8.44 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 -172.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -135.33 118.13 16.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.932 . . . . 0.0 109.17 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.24 128.64 35.15 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.312 0.645 . . . . 0.0 109.316 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.3 78.32 1.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.447 0.699 . . . . 0.0 109.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 122.968 0.507 . . . . 0.0 111.804 -173.453 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 70' ' ' ILE . 30.7 t . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -37.19 74.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.05 -41.13 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -68.46 -17.33 64.17 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 66' ' ' SER . 47.3 mm -59.32 -43.63 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.919 0.487 . . . . 0.0 109.947 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -50.92 69.14 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.161 0.584 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -63.71 -34.54 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.508 0.671 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.44 -55.13 24.98 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.811 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.4 pp -67.12 -33.2 74.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.067 0.547 . . . . 0.0 111.685 -169.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -70.76 -36.46 73.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.791 0.436 . . . . 0.0 110.187 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -71.79 -25.9 62.2 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.729 172.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.58 -38.03 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.517 0.727 . . . . 0.0 109.985 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 73.4 mt-10 -68.05 -33.11 73.96 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.896 0.747 . . . . 0.0 110.533 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -66.37 -52.31 48.19 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.337 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 40' ' ' LEU . 75.2 mt -64.35 -29.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.3 -38.38 83.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.272 1.029 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -77.66 -47.05 20.18 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.834 0.854 . . . . 0.0 111.187 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 24' ' ' LEU . 31.5 m -78.47 -54.61 5.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.302 1.041 . . . . 0.0 112.782 -164.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 122.915 0.486 . . . . 0.0 110.686 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.686 0.279 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.7 t -61.75 -46.45 89.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.791 0.836 . . . . 0.0 112.268 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.26 -43.31 92.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.702 0.626 . . . . 0.0 110.604 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.51 -29.31 70.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.877 0.871 . . . . 0.0 113.219 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 8.1 p -89.1 -33.55 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 118.341 0.518 . . . . 0.0 110.771 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.5 m -66.49 -39.61 88.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.495 0.718 . . . . 0.0 110.978 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.1 -27.83 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.309 0.644 . . . . 0.0 111.48 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.76 -38.75 73.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.073 0.549 . . . . 0.0 110.882 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -79.93 -24.89 40.75 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.321 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.51 -49.17 64.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.274 1.03 . . . . 0.0 110.914 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.563 1.457 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.026 -177.072 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 CA--C 1.551 1.368 0 N-CA-C 114.502 0.924 . . . . 0.0 114.502 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 121.44 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.878 0.871 . . . . 0.0 109.058 168.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 4.8 p-10 -81.7 96.41 7.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.667 . . . . 0.0 109.665 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.404 ' HG ' HG21 ' A' ' 23' ' ' THR . 3.2 tm? -110.77 106.62 15.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.108 0.963 . . . . 0.0 109.108 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.2 t -153.98 57.71 1.94 Allowed Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 123.295 0.638 . . . . 0.0 111.819 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -89.25 -34.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.322 2.014 . . . . 0.0 113.282 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 55.7 m-85 -127.85 22.07 6.33 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.481 0.713 . . . . 0.0 110.499 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.51 117.49 12.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-O 121.251 0.548 . . . . 0.0 110.285 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 13' ' ' VAL . 65.5 mt -106.97 99.22 25.0 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.4 -20.99 66.79 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.739 2.292 . . . . 0.0 112.85 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.27 -3.3 81.78 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.891 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 10' ' ' LEU . 27.1 m -132.57 170.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.623 0.769 . . . . 0.0 109.889 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.6 p -89.31 -0.52 57.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.092 0.957 . . . . 0.0 112.455 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.444 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 40.1 p90 -129.01 159.01 37.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.646 0.736 . . . . 0.0 112.111 -173.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.04 142.54 47.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.873 166.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 34.3 t -67.04 -33.06 74.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 168.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -167.61 152.94 7.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.996 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -125.94 133.08 24.57 Favored Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.88 126.8 23.72 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.263 1.976 . . . . 0.0 111.061 168.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -65.31 -17.49 64.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 110.868 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.28 -43.88 83.51 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.944 0.898 . . . . 0.0 110.139 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 27' ' ' ILE . 25.7 m -65.46 -48.63 72.02 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.035 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.4 mm? -58.08 -39.56 78.85 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.299 0.5 . . . . 0.0 111.209 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -66.48 -43.45 85.36 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.073 0.549 . . . . 0.0 111.72 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.1 pt-20 -74.92 -27.5 60.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 119.442 -0.313 . . . . 0.0 111.062 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.665 ' HA ' HE21 ' A' ' 30' ' ' GLN . 95.4 mt -58.96 -39.9 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.328 0.651 . . . . 0.0 109.692 172.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' O ' HG12 ' A' ' 32' ' ' ILE . 17.9 mmt180 -62.02 -25.2 67.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.576 0.751 . . . . 0.0 111.893 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' N ' HD22 ' A' ' 29' ' ' ASN . 0.8 OUTLIER -80.22 -36.12 35.23 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.889 0.476 . . . . 0.0 109.908 176.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 27' ' ' ILE . 30.1 mt-30 -73.68 -30.54 62.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.275 0.63 . . . . 0.0 111.036 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.8 p -67.93 -32.24 72.56 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.74 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.3 mm -74.93 -28.54 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.555 0.742 . . . . 0.0 110.595 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -64.74 -33.34 75.74 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 168.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.65 39.98 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.253 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.02 106.2 5.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.203 0.601 . . . . 0.0 110.755 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -117.11 122.05 43.02 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -131.46 107.42 8.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.103 0.478 . . . . 0.0 109.919 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 47' ' ' ILE . 1.7 mp -98.41 110.29 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 61.4 mtt-85 -82.07 88.16 6.44 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.0 mt -78.62 78.54 5.07 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 -102.22 0.45 Allowed Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.981 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.95 -40.85 19.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.037 0.935 . . . . 0.0 109.751 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.82 110.65 14.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.68 1.192 . . . . 0.0 110.531 -166.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.462 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.1 tpt -82.28 105.51 13.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.47 155.39 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.677 0.791 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -140.25 127.73 21.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.841 0.857 . . . . 0.0 108.7 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 38' ' ' ILE . 16.0 mm -113.09 92.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -134.57 127.76 18.77 Favored Pre-proline 0 N--CA 1.484 1.234 0 O-C-N 122.235 -0.291 . . . . 0.0 110.499 -174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 59.1 Cg_endo . . . . . 0 C--N 1.385 2.491 0 C-N-CA 123.136 2.557 . . . . 0.0 112.242 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 . . . . . 0 C--O 1.242 0.699 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 27.6 p90 -102.42 139.76 37.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 0.0 110.737 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -159.94 -174.97 4.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 125.063 1.345 . . . . 0.0 108.2 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.29 115.54 6.32 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 123.338 0.399 . . . . 0.0 112.806 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 t -126.0 135.05 51.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.299 1.04 . . . . 0.0 108.395 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.0 tm? -101.82 112.14 24.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.902 0.481 . . . . 0.0 110.555 -171.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -73.64 97.02 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.873 1.269 . . . . 0.0 112.034 -177.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -53.72 -45.7 70.57 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.423 0.689 . . . . 0.0 111.337 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.55 -45.21 80.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.885 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -57.77 -24.94 59.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.596 0.759 . . . . 0.0 112.626 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.6 mm -62.89 -46.72 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 122.781 0.432 . . . . 0.0 110.064 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.426 ' NE2' HE21 ' A' ' 75' ' ' GLN . 56.0 tp60 -64.14 -54.82 27.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.718 0.807 . . . . 0.0 111.137 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.33 -33.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.943 0.497 . . . . 0.0 109.922 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.02 -58.19 13.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.011 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.36 -28.67 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.851 0.461 . . . . 0.0 111.909 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.426 HE21 ' NE2' ' A' ' 71' ' ' GLN . 88.0 mm-40 -63.09 -54.25 40.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.49 ' O ' HG12 ' A' ' 80' ' ' ILE . 17.4 m-85 -61.13 -37.81 84.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.075 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -60.09 -43.43 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.669 0.788 . . . . 0.0 112.19 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.32 -29.39 61.58 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.177 0.298 . . . . 0.0 110.811 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.444 ' ND1' ' HB3' ' A' ' 15' ' ' PHE . 58.9 m-70 -77.62 -27.38 51.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 76' ' ' TYR . 37.6 mm -71.91 -40.35 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.52 -45.04 77.16 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 124.224 1.009 . . . . 0.0 109.948 176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -50.46 -43.38 55.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 111.884 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -81.77 -33.63 30.82 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.921 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 0.0 110.522 -168.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.246 0.919 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.3 p -55.23 -39.7 70.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.614 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -63.07 -34.51 77.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.505 0.503 . . . . 0.0 111.359 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HD13 ' A' ' 97' ' ' LEU . 1.2 mp0 -62.09 -50.58 71.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.675 0.39 . . . . 0.0 111.951 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.99 -30.02 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 118.16 0.436 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.0 m -69.42 -46.19 67.4 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 124.238 1.015 . . . . 0.0 111.174 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 100' ' ' ILE . 34.0 m -75.22 -25.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.431 0.457 . . . . 0.0 111.084 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 93' ' ' GLU . 7.7 mp -68.05 -40.68 82.78 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.627 0.771 . . . . 0.0 110.078 170.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -78.29 -24.26 46.83 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.94 0.896 . . . . 0.0 110.255 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.03 -49.45 44.8 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.135 0.974 . . . . 0.0 109.918 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' VAL . 28.9 pt . . . . . 0 CA--C 1.569 1.681 0 O-C-N 123.47 0.481 . . . . 0.0 110.508 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 CA--C 1.55 1.299 0 CA-C-O 121.089 0.37 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.57 99.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-O 121.931 0.872 . . . . 0.0 110.401 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.62 124.58 24.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.073 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 19' ' ' ILE . 4.0 tt -133.78 94.2 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -152.52 60.38 3.38 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 121.512 0.673 . . . . 0.0 111.689 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.13 -34.59 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.146 1.897 . . . . 0.0 113.129 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.37 0.43 11.11 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.479 0.712 . . . . 0.0 112.143 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.5 mt -59.68 123.37 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -165.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.16 92.22 5.29 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 113.828 -1.533 . . . . 0.0 107.51 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.38 88.49 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.893 2.395 . . . . 0.0 110.761 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.25 -36.5 0.3 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.255 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -83.61 165.51 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 49.6 m -85.7 -20.09 29.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 111.848 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -113.56 -173.3 2.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 0.0 110.302 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.701 HD23 HG12 ' A' ' 19' ' ' ILE . 8.1 tp -133.38 133.26 42.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 m -51.55 -55.4 19.32 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.313 1.008 . . . . 0.0 111.106 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -141.6 144.45 34.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.858 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.701 HG12 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -127.8 127.58 23.95 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.76 117.33 4.04 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.815 2.343 . . . . 0.0 112.415 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -61.3 -23.05 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.242 1.017 . . . . 0.0 111.727 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.08 -47.74 82.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.295 1.038 . . . . 0.0 110.502 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.0 m -67.36 -36.81 82.14 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 27' ' ' ILE . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.47 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 m -62.39 -42.12 99.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.832 0.453 . . . . 0.0 110.112 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.8 tp10 -60.16 -56.96 15.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 109.894 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 24' ' ' LEU . 74.4 mt -54.85 -46.88 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.131 1.372 . . . . 0.0 111.331 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -72.58 -28.14 62.62 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.624 -171.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.09 -42.28 16.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.646 0.378 . . . . 0.0 111.948 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 5.1 pt20 -69.31 -23.62 63.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.079 0.552 . . . . 0.0 111.711 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -62.39 -25.98 68.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.47 -34.41 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.122 0.486 . . . . 0.0 109.769 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -73.19 -14.49 61.36 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.274 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 12.23 67.16 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 123.719 0.676 . . . . 0.0 113.047 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -138.35 107.34 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.293 0.637 . . . . 0.0 111.024 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -146.67 134.48 21.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.883 0.873 . . . . 0.0 108.685 173.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.67 122.27 5.26 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.48 141.97 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.132 1.373 . . . . 0.0 109.245 -174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -108.07 97.68 7.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 HG21 ' A' ' 45' ' ' VAL . 96.4 mt -77.9 69.14 4.09 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.56 0.695 . . . . 0.0 109.843 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.03 2.04 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.693 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.466 ' HG3' HD21 ' A' ' 69' ' ' ASN . 11.7 pt-20 -91.74 -21.88 20.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.293 0.637 . . . . 0.0 110.627 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' A' ' 73' ' ' GLY . 34.6 mt -74.71 108.18 7.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -88.96 131.82 34.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 40' ' ' LEU . 59.3 t -132.14 135.49 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.693 0.797 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 t -116.75 126.54 53.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.378 0.671 . . . . 0.0 109.774 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.21 84.35 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -116.49 108.14 45.78 Favored Pre-proline 0 N--CA 1.481 1.121 0 O-C-N 121.932 -0.48 . . . . 0.0 110.394 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 C--N 1.374 1.885 0 C-N-CA 122.516 2.144 . . . . 0.0 111.585 170.171 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 . . . . . 0 C--O 1.241 0.629 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -87.49 113.33 23.09 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-O 121.908 0.861 . . . . 0.0 109.898 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.03 -175.23 4.79 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.721 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 109.38 1.97 Allowed Glycine 0 CA--C 1.534 1.246 0 O-C-N 123.651 0.594 . . . . 0.0 113.608 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 t -102.92 97.82 7.89 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -73.66 109.18 6.97 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 36.2 t30 -64.28 109.95 2.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.813 0.845 . . . . 0.0 109.451 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 62' ' ' GLN . 4.2 pp0? . . . . . 0 N--CA 1.477 0.915 0 C-N-CA 124.066 0.946 . . . . 0.0 112.096 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' HG12 ' A' ' 70' ' ' ILE . 48.5 t . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -54.13 -33.54 58.07 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.61 -36.56 73.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.457 0.703 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.466 HD21 ' HG3' ' A' ' 42' ' ' GLU . 63.0 t30 -76.81 -35.96 57.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.221 0.608 . . . . 0.0 111.635 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 66' ' ' SER . 29.9 mm -50.42 -37.53 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.939 0.896 . . . . 0.0 110.553 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 56.1 tp60 -53.16 -53.18 54.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.177 0.991 . . . . 0.0 111.557 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -61.26 -38.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.87 -57.06 21.33 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.307 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.69 -26.08 67.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.283 0.633 . . . . 0.0 111.42 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 84.3 mm-40 -70.63 -40.63 72.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.166 0.587 . . . . 0.0 110.651 173.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 9.2 m-85 -71.73 -27.38 62.96 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.2 mp -68.21 -46.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.026 0.93 . . . . 0.0 110.493 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.79 -28.31 63.52 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 0.0 109.865 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.16 -42.31 80.25 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.481 0.712 . . . . 0.0 110.961 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 34.8 mm -67.72 -34.95 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.484 0.713 . . . . 0.0 109.913 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -64.94 -37.97 89.42 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.455 0.472 . . . . 0.0 111.036 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.28 -25.56 60.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.689 0.396 . . . . 0.0 111.501 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -78.44 -46.05 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.976 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.479 1.017 0 C-N-CA 123.28 0.632 . . . . 0.0 110.802 -176.873 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -60.18 -34.22 73.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.53 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -53.66 -34.86 60.08 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.884 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -51.6 68.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.512 1.125 . . . . 0.0 112.092 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -77.86 -22.51 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.635 0.652 . . . . 0.0 111.215 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.7 m -67.64 -38.83 84.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.54 0.736 . . . . 0.0 111.13 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -76.49 -33.01 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.665 0.386 . . . . 0.0 110.868 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.47 -29.54 59.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 0.0 111.98 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -81.71 -29.18 33.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.829 0.452 . . . . 0.0 110.274 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.32 -38.86 71.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.619 0.768 . . . . 0.0 110.831 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.776 177.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo . . . . . 0 CA--C 1.55 1.324 0 CA-C-O 121.216 0.423 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.42 99.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.138 0.971 . . . . 0.0 110.68 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 8.2 p-10 -71.07 139.32 50.35 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.024 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 23' ' ' THR . 45.2 tp -146.81 117.86 7.74 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.714 1.205 . . . . 0.0 108.833 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -154.13 52.59 0.8 Allowed Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.72 -31.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.929 1.753 . . . . 0.0 113.622 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.472 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.7 m-85 -131.29 17.21 4.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.707 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' HD21 ' A' ' 16' ' ' LEU . 28.9 mt -68.05 121.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -96.64 92.44 1.1 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.39 82.05 2.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.725 2.283 . . . . 0.0 111.298 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.97 -37.85 0.26 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.092 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 10' ' ' LEU . 6.4 m -82.71 159.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.889 0.476 . . . . 0.0 110.513 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -83.77 -0.21 50.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.318 0.647 . . . . 0.0 112.701 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' H ' HG23 ' A' ' 13' ' ' VAL . 40.3 p90 -131.15 -174.04 3.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.815 0.846 . . . . 0.0 111.354 -171.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 17' ' ' SER . 1.5 tm? -139.1 147.34 41.84 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.515 ' N ' HD13 ' A' ' 16' ' ' LEU . 25.3 t -63.62 -77.52 0.05 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.43 0.692 . . . . 0.0 111.011 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -145.44 94.63 2.54 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.802 0.441 . . . . 0.0 110.621 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.32 132.91 68.83 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 122.25 11.24 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.637 2.225 . . . . 0.0 111.927 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.462 ' HA ' HD23 ' A' ' 24' ' ' LEU . 13.5 pt20 -64.63 -22.78 67.06 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.027 0.931 . . . . 0.0 111.212 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -60.91 -39.28 88.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.16 0.984 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 5' ' ' LEU . 33.0 m -71.51 -37.15 71.24 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.16 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.3 mm? -63.44 -37.0 85.61 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.684 0.675 . . . . 0.0 110.789 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -63.91 -35.0 79.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.046 0.539 . . . . 0.0 110.519 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 10.5 tp10 -70.37 -36.72 74.31 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.764 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 38' ' ' ILE . 11.9 mm -63.36 -42.32 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 67.6 mtt180 -65.32 -25.29 67.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.451 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -71.78 -43.97 64.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.675 0.39 . . . . 0.0 111.101 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.23 0.612 . . . . 0.0 110.429 -177.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.0 p -67.18 -18.67 65.36 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.338 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 44.4 mm -66.67 -28.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -71.57 -15.79 62.29 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.382 0.673 . . . . 0.0 110.446 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.79 -22.19 19.57 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 123.547 0.594 . . . . 0.0 113.238 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 154.64 45.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.563 0.745 . . . . 0.0 110.043 173.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.9 147.0 34.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.074 . . . . 0.0 108.607 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -129.03 117.02 20.21 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 47' ' ' ILE . 1.6 mp -107.5 115.37 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 92.0 mtt180 -88.25 88.51 7.66 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 58.8 mt -71.47 77.49 0.78 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 -99.91 0.53 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -169.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -110.71 -4.37 15.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.308 1.043 . . . . 0.0 111.618 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 72' ' ' ILE . 13.0 mt -83.46 111.26 18.89 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.537 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.6 tpt -87.54 103.95 16.03 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.163 0.506 . . . . 0.0 110.409 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.99 152.28 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.081 0.952 . . . . 0.0 109.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.2 109.44 6.47 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.688 0.795 . . . . 0.0 109.704 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.58 HG22 ' HB2' ' A' ' 56' ' ' PHE . 34.6 mm -97.34 110.21 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.853 0.861 . . . . 0.0 109.163 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -128.05 116.74 20.46 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 122.744 0.417 . . . . 0.0 110.831 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 71.0 Cg_endo . . . . . 0 C--N 1.371 1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 113.057 166.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 p90 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 47' ' ' ILE . 50.2 p90 -86.76 129.0 35.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.087 0.47 . . . . 0.0 110.385 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.586 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -158.5 -176.4 5.87 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.389 1.075 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.35 114.02 3.9 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.811 0.695 . . . . 0.0 114.552 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.7 t -134.01 120.44 20.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.6 tp -89.04 144.15 26.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.457 . . . . 0.0 111.961 -174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -96.52 81.64 3.26 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.468 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 . . . . . 0 N--CA 1.484 1.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.436 175.199 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.97 -34.44 74.76 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.203 0.601 . . . . 0.0 112.269 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.034 0.533 . . . . 0.0 109.736 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.47 -23.84 67.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.582 0.753 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.5 mt -72.87 -42.73 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 122.971 0.508 . . . . 0.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -65.27 -58.32 6.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 43' ' ' LEU . 3.2 mp -68.4 -26.66 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.354 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.6 24.22 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.269 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.06 -34.47 78.14 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.705 0.752 . . . . 0.0 112.167 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 72' ' ' ILE . 13.1 pt20 -73.05 -34.49 66.31 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.974 0.416 . . . . 0.0 110.808 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 80' ' ' ILE . 5.0 m-85 -69.9 -29.83 67.11 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.818 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.71 -45.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.296 0.638 . . . . 0.0 110.892 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.79 -26.98 64.53 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.559 0.537 . . . . 0.0 110.251 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.88 -43.96 82.12 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.46 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.5 mm -66.37 -29.23 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 110.983 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 51.8 mt-10 -64.36 -44.04 92.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.09 0.471 . . . . 0.0 110.232 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -66.35 -31.45 72.24 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.803 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -78.88 -35.59 43.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.504 0.722 . . . . 0.0 111.466 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.4 mt . . . . . 0 N--CA 1.486 1.348 0 C-N-CA 123.818 0.847 . . . . 0.0 112.172 -177.584 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 15.4 m . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 t -54.86 -37.96 66.88 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.712 0.633 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -68.06 -38.87 82.94 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.58 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 47.6 mt-10 -61.18 -45.0 96.41 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.852 0.461 . . . . 0.0 111.564 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.57 -24.79 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.807 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.0 m -72.87 -52.05 16.33 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.05 0.54 . . . . 0.0 111.437 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.01 -27.44 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.736 0.815 . . . . 0.0 112.418 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.36 -48.32 80.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.877 0.871 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -83.04 -24.76 32.65 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.085 0.554 . . . . 0.0 111.272 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -75.68 -36.93 59.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.106 0.962 . . . . 0.0 111.325 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 CA--C 1.567 1.621 0 C-N-CA 122.731 0.412 . . . . 0.0 111.614 -178.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 23.6 Cg_exo . . . . . 0 CA--C 1.542 0.902 0 N-CA-C 114.189 0.804 . . . . 0.0 114.189 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 38' ' ' ILE . 17.1 t -76.7 93.95 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.927 0.891 . . . . 0.0 108.713 169.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.48 102.2 1.1 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.5 100.3 7.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.564 0.746 . . . . 0.0 109.272 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.9 t -151.0 47.32 0.43 Allowed Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 123.263 0.625 . . . . 0.0 111.704 170.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 6' ' ' THR . 5.9 Cg_exo -80.75 -45.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.751 2.3 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 5.4 m-85 -126.89 20.5 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.962 0.905 . . . . 0.0 110.617 -170.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 16' ' ' LEU . 26.9 mt -65.77 131.24 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 117.893 0.315 . . . . 0.0 110.701 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -110.93 88.5 8.23 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.63 -2.62 12.12 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.464 2.109 . . . . 0.0 112.959 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.94 -21.56 57.17 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 123.17 0.414 . . . . 0.0 113.488 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.97 166.06 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 117.371 0.586 . . . . 0.0 111.05 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 t -67.93 -23.72 65.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.37 1.068 . . . . 0.0 112.27 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -112.32 175.53 5.39 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.818 0.818 . . . . 0.0 111.672 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 9' ' ' ILE . 3.1 tt -109.67 152.1 26.03 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 48.6 m -55.66 -55.45 32.01 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.45 0.568 . . . . 0.0 111.185 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -167.97 128.75 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.37 1.068 . . . . 0.0 108.273 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.3 mt -98.94 119.85 59.97 Favored Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 42.8 Cg_endo -67.51 142.61 59.86 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.26 1.974 . . . . 0.0 111.411 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.6 -27.01 67.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.69 0.796 . . . . 0.0 111.495 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 13.4 pt-20 -68.14 -31.45 71.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.628 0.771 . . . . 0.0 112.148 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.9 m -68.19 -52.21 36.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.528 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 95.5 mt -57.73 -42.52 84.03 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.27 0.981 . . . . 0.0 111.539 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.5 p -66.01 -33.55 76.06 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 124.049 0.843 . . . . 0.0 111.39 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 35.0 tt0 -70.22 -43.44 70.64 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 174.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.74 -35.86 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.5 0.72 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.8 mmt85 -63.97 -37.82 88.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.69 -40.46 84.38 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.089 0.556 . . . . 0.0 109.831 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 71.2 mm-40 -71.66 -33.95 69.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.523 0.729 . . . . 0.0 111.25 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 34.5 p -66.31 -26.23 67.21 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.719 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.5 mm -70.1 -27.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 120.604 0.24 . . . . 0.0 110.494 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -73.53 -14.57 61.23 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.396 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.81 15.64 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 123.849 0.738 . . . . 0.0 113.415 171.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.57 126.76 18.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.418 0.687 . . . . 0.0 109.734 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -110.01 102.14 10.9 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.486 1.115 . . . . 0.0 108.643 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 13.7 mp0 -82.43 120.27 25.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 3' ' ' VAL . 2.4 mp -118.76 127.44 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -98.38 95.31 7.26 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 90.5 mt -79.1 70.46 5.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.046 174.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -103.37 0.92 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.735 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.48 -18.3 28.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.615 0.766 . . . . 0.0 110.959 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 72' ' ' ILE . 12.4 mt -86.07 109.18 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.61 0.764 . . . . 0.0 109.459 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.1 tpt -86.61 101.83 13.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.46 152.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.191 0.997 . . . . 0.0 109.003 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 59' ' ' SER . 64.0 m -141.35 102.83 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.503 0.721 . . . . 0.0 109.621 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.611 HG22 ' HB2' ' A' ' 56' ' ' PHE . 22.1 mm -84.03 110.62 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.363 1.465 . . . . 0.0 110.874 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.63 131.14 23.53 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 41.8 Cg_endo . . . . . 0 C--N 1.376 2.003 0 C-N-CA 122.927 2.418 . . . . 0.0 111.392 168.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 p90 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 47' ' ' ILE . 9.7 p90 -85.63 121.92 29.0 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 122.005 0.907 . . . . 0.0 111.388 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.6 ptp -146.37 -179.18 6.57 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 121.16 22.43 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.439 0.462 . . . . 0.0 112.485 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 46' ' ' SER . 42.8 t -130.5 97.8 4.49 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 172.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -76.09 120.7 21.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.985 0.914 . . . . 0.0 109.204 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.57 100.76 0.91 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -161.636 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.02 -15.89 37.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.19 -57.57 6.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.58 0.752 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.08 -35.29 80.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.381 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mm -56.65 -46.72 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.565 0.746 . . . . 0.0 110.908 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.9 -53.02 36.32 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.477 0.486 . . . . 0.0 110.851 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 43' ' ' LEU . 49.5 mt -54.77 -41.88 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 123.827 0.705 . . . . 0.0 109.562 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.72 -58.07 16.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.629 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -65.75 -26.22 67.63 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.106 0.453 . . . . 0.0 111.919 -172.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.83 -46.58 84.43 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.601 0.761 . . . . 0.0 110.457 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 80' ' ' ILE . 48.9 m-85 -70.82 -33.22 70.47 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.433 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.03 -43.98 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.989 0.916 . . . . 0.0 111.194 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.47 -25.47 60.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.778 0.431 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.22 -42.17 72.65 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.774 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -67.22 -40.81 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.988 0.915 . . . . 0.0 111.65 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.4 -36.08 79.3 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.188 0.305 . . . . 0.0 111.226 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -71.31 -44.2 65.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.439 0.696 . . . . 0.0 110.097 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -61.8 -38.77 89.33 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.592 1.157 . . . . 0.0 112.234 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 123.057 0.543 . . . . 0.0 111.818 -176.728 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.593 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 58.2 m . . . . . 0 CA--C 1.55 0.95 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -59.4 -51.42 70.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.878 0.471 . . . . 0.0 111.674 -172.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -63.2 -19.5 64.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 0.0 112.612 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.593 ' HG2' ' HB ' ' A' ' 90' ' ' THR . 10.3 mm-40 -59.21 -52.72 64.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.253 0.621 . . . . 0.0 111.559 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.3 m -90.44 -27.37 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 122.992 0.517 . . . . 0.0 112.026 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -72.63 -33.28 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.811 0.444 . . . . 0.0 111.527 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.3 p -59.81 -27.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.722 0.409 . . . . 0.0 111.013 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 mp -54.25 -51.45 64.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.501 1.12 . . . . 0.0 111.239 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -81.67 -27.11 34.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 0.0 111.101 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.84 -27.91 36.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.769 0.828 . . . . 0.0 112.359 -166.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 96' ' ' VAL . 9.1 pt . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 119.139 -0.457 . . . . 0.0 110.503 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.549 1.244 0 CA-C-O 120.9 0.292 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.429 HG22 HD11 ' A' ' 27' ' ' ILE . 30.7 m -93.3 128.76 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.061 0.544 . . . . 0.0 110.048 175.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.91 129.53 37.83 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.2 100.72 4.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.4 t -152.79 38.24 0.12 Allowed Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -79.79 -18.48 10.38 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 121.621 1.547 . . . . 0.0 111.978 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.33 -9.07 5.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.051 -171.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.451 HG13 ' HA ' ' A' ' 6' ' ' THR . 29.2 mt -47.9 116.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -164.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 17' ' ' SER . 44.8 mt -98.93 98.33 6.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.17 1.388 . . . . 0.0 108.438 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.85 42.12 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.686 2.257 . . . . 0.0 112.588 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.23 -6.17 0.57 Allowed Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.819 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.2 163.8 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.766 0.827 . . . . 0.0 110.254 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -77.56 -38.56 48.24 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.992 0.917 . . . . 0.0 111.621 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -82.29 -175.22 5.57 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.067 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 19' ' ' ILE . 12.1 tp -137.99 136.49 36.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.062 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' LEU . 22.0 t -58.63 -33.72 70.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.886 0.874 . . . . 0.0 111.813 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -162.4 148.04 12.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 108.599 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.661 HG12 HD23 ' A' ' 16' ' ' LEU . 64.6 mt -127.43 124.58 23.65 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 166.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.42 113.44 1.79 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.075 1.85 . . . . 0.0 110.555 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.46 ' HA ' HD23 ' A' ' 24' ' ' LEU . 24.0 tm0? -64.91 -22.73 67.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.835 0.854 . . . . 0.0 110.727 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.72 -38.32 69.61 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.223 0.609 . . . . 0.0 111.101 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 27' ' ' ILE . 26.3 m -71.91 -36.64 70.05 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.676 0.79 . . . . 0.0 110.751 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 21' ' ' GLN . 4.1 mm? -63.59 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.833 0.453 . . . . 0.0 110.517 173.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -68.66 -33.21 73.6 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.508 0.723 . . . . 0.0 110.864 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 12.6 tp10 -65.64 -45.9 81.25 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.731 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 3' ' ' VAL . 32.9 mm -60.49 -39.78 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 55.9 mmm-85 -61.88 -38.46 88.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.378 0.671 . . . . 0.0 110.966 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 33.7 t30 -62.05 -41.31 98.0 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.814 0.846 . . . . 0.0 110.871 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 61.7 mt-30 -79.51 -32.08 42.32 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.008 0.923 . . . . 0.0 112.415 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 27' ' ' ILE . 42.5 p -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.1 -38.82 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.202 0.525 . . . . 0.0 110.024 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -72.17 -12.39 61.16 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.901 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -8.62 58.21 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.475 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -140.12 124.54 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.242 0.521 . . . . 0.0 111.041 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -145.56 143.39 29.9 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.232 1.013 . . . . 0.0 108.585 168.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -137.27 153.9 50.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.43 129.58 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -96.91 87.49 4.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 78.7 mt -70.79 74.89 0.61 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.422 0.689 . . . . 0.0 109.253 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.42 -101.47 0.76 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -100.77 -16.77 17.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.516 0.726 . . . . 0.0 111.282 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.6 mt -74.97 110.53 9.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.309 0.644 . . . . 0.0 109.361 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.1 tpt -85.57 129.23 34.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.67 117.33 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.648 0.779 . . . . 0.0 109.803 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.5 m -86.87 111.98 21.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.341 0.656 . . . . 0.0 110.227 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 mm -119.19 88.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -154.44 139.12 11.61 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.92 -0.488 . . . . 0.0 111.574 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.379 2.162 0 C-N-CA 122.849 2.366 . . . . 0.0 111.907 176.528 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HE1' HD21 ' A' ' 97' ' ' LEU . 11.5 m-85 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 121.265 0.555 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.033 0.92 . . . . 0.0 108.928 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.625 ' HA ' HD23 ' A' ' 84' ' ' LEU . 14.7 ptp -158.17 172.4 18.46 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.658 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 110.15 1.56 Allowed Glycine 0 C--N 1.352 1.458 0 O-C-N 123.978 0.799 . . . . 0.0 113.199 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -134.35 119.07 18.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.712 0.805 . . . . 0.0 109.491 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.85 124.93 34.66 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.033 0.933 . . . . 0.0 109.525 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.69 107.1 16.71 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.521 0.729 . . . . 0.0 109.104 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.083 0.953 . . . . 0.0 112.235 -174.584 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 70' ' ' ILE . 46.1 m . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -61.18 -42.08 97.93 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.97 0.908 . . . . 0.0 112.641 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.74 -37.21 86.83 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.222 0.534 . . . . 0.0 109.978 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.4 -22.91 58.94 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.684 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 66' ' ' SER . 46.0 mm -65.79 -43.86 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -69.6 -45.92 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.269 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -66.82 -34.32 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 123.727 0.642 . . . . 0.0 109.481 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.32 -57.26 17.55 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.724 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.7 pp -67.96 -33.52 74.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.98 0.512 . . . . 0.0 111.854 -171.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.84 -38.33 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.059 0.456 . . . . 0.0 110.038 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 80' ' ' ILE . 6.2 m-85 -69.47 -29.86 67.62 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.816 173.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -68.56 -35.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 110.591 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 49.9 mt-10 -70.27 -32.6 70.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.886 0.741 . . . . 0.0 110.345 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -74.21 -41.59 61.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.997 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.8 mm -63.02 -37.61 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.698 0.799 . . . . 0.0 109.111 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.79 -48.5 81.06 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 123.797 0.686 . . . . 0.0 109.743 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -34.4 77.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.415 0.447 . . . . 0.0 111.308 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -79.26 -24.21 43.12 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 111.823 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 57' ' ' MET . 19.5 tp . . . . . 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.704 . . . . 0.0 111.884 -171.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 93' ' ' GLU . 14.8 t . . . . . 0 C--O 1.245 0.817 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -54.28 -35.98 63.17 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.033 0.933 . . . . 0.0 111.995 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.453 ' H ' HG23 ' A' ' 90' ' ' THR . 57.8 ttt180 -66.83 -41.28 87.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.049 0.539 . . . . 0.0 111.219 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.634 ' HG2' HG22 ' A' ' 90' ' ' THR . 22.7 mm-40 -71.56 -22.15 61.79 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -170.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.02 -27.85 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 118.072 0.396 . . . . 0.0 111.19 168.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.4 m -79.35 -28.38 42.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.096 0.558 . . . . 0.0 112.136 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.77 -17.81 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.288 0.635 . . . . 0.0 112.266 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' HE1' ' A' ' 55' ' ' TYR . 3.8 mm? -66.41 -35.09 79.43 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.295 0.638 . . . . 0.0 110.099 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.64 -31.14 28.91 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.236 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.11 -38.54 78.95 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.563 0.745 . . . . 0.0 112.187 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 123.365 0.666 . . . . 0.0 111.856 -175.612 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 CA--C 1.552 1.398 0 N-CA-C 114.45 0.904 . . . . 0.0 114.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.81 92.63 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.845 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.21 113.77 4.23 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.466 HD23 ' HD3' ' A' ' 7' ' ' PRO . 3.9 tt -125.71 95.12 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.496 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.2 t -154.46 52.92 0.81 Allowed Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.465 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 6' ' ' THR . 3.2 Cg_exo -80.59 -38.53 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.374 2.049 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.29 17.25 6.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.526 0.73 . . . . 0.0 111.866 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.463 ' HA ' HD21 ' A' ' 16' ' ' LEU . 22.7 mt -64.15 133.49 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.2 101.7 20.65 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.62 1.168 . . . . 0.0 107.911 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.33 92.84 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.567 2.844 . . . . 0.0 111.458 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -38.58 1.65 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.729 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 15' ' ' PHE . 7.3 t -80.92 142.37 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 122.852 0.461 . . . . 0.0 110.023 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 p -74.12 -23.7 59.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 111.681 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.402 ' H ' HG12 ' A' ' 13' ' ' VAL . 17.9 p90 -109.54 177.34 4.77 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.256 0.622 . . . . 0.0 111.619 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.55 149.31 47.11 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.995 -177.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -61.01 -57.92 10.58 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.606 0.762 . . . . 0.0 110.023 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -171.62 133.91 0.81 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.123 0.89 . . . . 0.0 109.307 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 83' ' ' THR . 58.6 mt -103.61 136.48 19.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.62 112.69 1.08 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.691 2.26 . . . . 0.0 111.644 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.513 ' HA ' HD23 ' A' ' 24' ' ' LEU . 93.1 mt-30 -63.89 -24.99 67.95 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.526 0.731 . . . . 0.0 111.699 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.3 -35.06 76.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.376 0.67 . . . . 0.0 110.957 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.8 m -74.23 -27.44 60.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.171 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.7 mm? -72.27 -34.09 67.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -62.95 -38.92 93.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.353 0.661 . . . . 0.0 111.571 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 11.3 pt-20 -71.08 -34.84 71.54 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.278 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD12 HD13 ' A' ' 24' ' ' LEU . 78.4 mt -63.05 -36.89 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.077 0.551 . . . . 0.0 110.206 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' ILE . 10.9 mmm180 -57.87 -38.4 75.65 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 110.284 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -68.61 -43.78 75.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.851 0.86 . . . . 0.0 111.375 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.5 mm-40 -65.44 -37.19 86.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.948 0.499 . . . . 0.0 110.644 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -69.57 -22.84 63.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.452 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.1 mm -69.13 -36.16 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HE ' ' HB3' ' A' ' 35' ' ' GLU . 39.9 ttp-105 -66.35 -34.46 78.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 169.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.05 5.4 47.01 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.637 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' HB3' ' HE ' ' A' ' 33' ' ' ARG . 1.9 tm-20 -133.93 107.83 8.05 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -134.56 95.54 3.39 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -98.27 104.77 16.83 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -104.64 128.22 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.306 0.643 . . . . 0.0 109.838 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -105.46 98.47 8.16 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.641 0.376 . . . . 0.0 109.987 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 97.3 mt -77.33 64.95 2.8 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.681 0.792 . . . . 0.0 110.093 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.54 -110.0 3.06 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.238 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 -20.82 37.69 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.389 0.675 . . . . 0.0 110.903 175.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -81.56 110.98 17.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.08 130.35 35.03 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.08 145.54 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.087 0.955 . . . . 0.0 108.992 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -135.96 97.69 3.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.83 0.452 . . . . 0.0 110.507 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 5.7 mm -72.3 102.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.887 0.875 . . . . 0.0 109.0 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -129.25 123.15 21.44 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 55.2 Cg_endo . . . . . 0 C--N 1.378 2.095 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 111.249 0.092 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HB2' HG22 ' A' ' 47' ' ' ILE . 21.5 p90 -87.77 114.0 23.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.745 0.783 . . . . 0.0 108.937 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtm -130.06 -174.74 3.41 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.708 1.203 . . . . 0.0 108.268 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.65 137.93 49.78 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.878 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -133.66 98.82 4.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.754 0.822 . . . . 0.0 108.847 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.54 104.21 3.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.221 0.609 . . . . 0.0 109.679 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.15 109.65 3.64 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.238 0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.245 0.842 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.53 -168.35 0.2 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.15 0.58 . . . . 0.0 111.257 165.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.64 -18.46 20.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.164 0.986 . . . . 0.0 112.759 169.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.12 -40.78 77.78 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.782 0.433 . . . . 0.0 110.869 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.3 mm -56.12 -49.28 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.998 0.519 . . . . 0.0 111.131 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.24 -54.82 40.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.737 0.815 . . . . 0.0 111.429 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.04 -37.87 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.929 0.892 . . . . 0.0 110.103 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -63.2 -59.71 8.59 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.581 177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -67.42 -27.92 67.46 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -172.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -67.26 -41.65 85.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.119 0.567 . . . . 0.0 110.189 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -73.47 -25.52 60.51 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.991 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -63.86 -43.27 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.4 -34.36 65.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.117 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.08 -39.73 93.62 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.814 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.531 HD11 HD11 ' A' ' 40' ' ' LEU . 68.2 mt -66.33 -34.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.591 0.756 . . . . 0.0 110.24 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.65 -47.07 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.046 0.539 . . . . 0.0 110.106 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -76.47 -30.44 57.29 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.491 1.116 . . . . 0.0 112.722 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 19' ' ' ILE . 31.3 m -86.65 -28.56 23.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.871 0.469 . . . . 0.0 111.659 -173.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 124.216 1.006 . . . . 0.0 109.888 -177.031 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 37.9 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.3 t -65.02 -45.55 85.03 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.385 0.428 . . . . 0.0 110.33 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.336 0.654 . . . . 0.0 111.492 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 4.7 tm-20 -58.68 -51.47 69.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 109.982 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.66 -23.52 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.249 0.62 . . . . 0.0 112.254 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 m -66.5 -48.53 69.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.593 0.357 . . . . 0.0 110.466 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.7 m -69.41 -24.41 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.269 0.628 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 89.6 mt -66.26 -47.35 73.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.99 0.424 . . . . 0.0 110.08 171.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -80.41 -24.14 39.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.682 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -75.65 -46.8 29.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.692 0.797 . . . . 0.0 111.841 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.952 -172.095 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 CA--C 1.545 1.051 0 CA-C-O 121.269 0.445 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.61 99.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.75 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.11 146.21 53.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -146.25 93.5 2.32 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.913 -1.144 . . . . 0.0 107.913 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -139.02 33.7 0.21 Allowed Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.42 -33.57 0.96 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 CA-C-N 121.173 1.455 . . . . 0.0 112.731 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 39.9 m-85 -129.34 22.1 5.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.527 0.731 . . . . 0.0 111.651 -174.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -64.25 123.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' A' ' 17' ' ' SER . 25.3 mt -111.7 85.76 6.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.55 -12.8 34.08 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.407 2.071 . . . . 0.0 113.083 -167.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.83 -12.81 79.2 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.767 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -126.92 178.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 117.826 0.813 . . . . 0.0 111.128 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 p -84.13 -42.94 15.5 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.184 0.994 . . . . 0.0 111.983 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -81.97 -177.95 6.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.471 0.653 . . . . 0.0 112.207 -173.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -134.63 148.42 50.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.277 1.031 . . . . 0.0 108.336 -173.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 49.3 m -84.86 63.94 8.33 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.543 0.687 . . . . 0.0 111.223 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.5 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.197 1.399 . . . . 0.0 112.094 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 65.6 mt -68.85 136.32 89.95 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.213 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 17.2 Cg_endo -58.22 117.57 4.3 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.871 1.714 . . . . 0.0 110.504 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.442 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.0 pt20 -62.35 -18.24 60.98 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.665 0.786 . . . . 0.0 111.365 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.8 -46.55 77.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.787 1.235 . . . . 0.0 110.48 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.409 HG21 HD13 ' A' ' 5' ' ' LEU . 18.1 m -60.89 -47.34 86.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.274 0.629 . . . . 0.0 110.933 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.8 mm? -58.58 -42.36 87.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.668 0.605 . . . . 0.0 110.741 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -63.09 -32.62 74.04 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.913 0.758 . . . . 0.0 111.44 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.8 tp10 -71.66 -45.46 61.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.233 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.25 -35.6 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.935 0.894 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' O ' HG12 ' A' ' 32' ' ' ILE . 22.5 mmm180 -56.77 -42.67 79.81 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.786 0.834 . . . . 0.0 110.608 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -72.97 -40.52 65.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.666 0.786 . . . . 0.0 111.488 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 24.5 mm-40 -64.47 -40.62 96.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.491 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.9 p -69.96 -24.85 63.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.225 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.9 mm -68.46 -32.78 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 172.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.09 -12.33 58.28 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.981 0.419 . . . . 0.0 110.409 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.42 -16.94 29.04 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 114.491 0.557 . . . . 0.0 114.491 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -134.9 116.8 15.16 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.35 0.575 . . . . 0.0 111.223 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.59 138.09 54.69 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.71 105.03 5.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 47' ' ' ILE . 2.8 mp -101.81 114.81 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.713 0.805 . . . . 0.0 109.636 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 42.7 mtm180 -87.08 93.56 9.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 86.4 mt -75.89 71.54 2.71 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.119 0.485 . . . . 0.0 109.815 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.33 -101.99 0.56 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.594 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -99.61 -15.02 18.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.783 0.833 . . . . 0.0 111.251 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 18.3 mt -83.5 109.77 17.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.466 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.7 tpt -86.51 117.88 25.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.31 149.97 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 59' ' ' SER . 57.1 m -137.17 134.44 36.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.844 0.858 . . . . 0.0 108.902 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 84' ' ' LEU . 31.9 mm -112.85 104.03 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -127.91 107.6 20.22 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.102 0.561 . . . . 0.0 109.54 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--N 1.377 2.053 0 C-N-CA 122.606 2.204 . . . . 0.0 111.738 173.344 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' HG11 ' A' ' 94' ' ' VAL . 88.8 m-85 . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -88.1 110.2 20.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.784 0.433 . . . . 0.0 110.648 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 8.4 ptt? -170.26 108.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.551 0.74 . . . . 0.0 109.852 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.21 106.18 0.01 OUTLIER Glycine 0 CA--C 1.541 1.69 0 O-C-N 124.532 1.145 . . . . 0.0 115.765 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' SER . 28.7 t -134.98 99.78 4.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.81 113.92 12.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 109.428 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -68.7 109.08 3.64 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.757 0.661 . . . . 0.0 109.474 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 124.244 1.018 . . . . 0.0 112.004 -176.432 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 70' ' ' ILE . 33.0 t . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 119.54 -0.266 . . . . 0.0 111.674 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.35 -32.66 71.48 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 111.617 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.8 -38.92 73.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.35 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -69.2 -28.02 66.01 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.52 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 66' ' ' SER . 33.6 mm -64.63 -45.25 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 tt0 -61.86 -57.1 13.11 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.07 0.856 . . . . 0.0 111.281 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.27 -37.75 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.46 -52.6 52.17 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.115 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.99 -24.81 65.18 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.295 0.547 . . . . 0.0 111.537 -174.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 80.0 mm-40 -59.69 -50.74 72.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.497 0.665 . . . . 0.0 109.327 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -68.84 -26.66 65.27 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.993 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.91 -37.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.11 -38.76 75.69 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.856 0.863 . . . . 0.0 111.987 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -76.89 -48.12 19.22 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.029 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.65 -29.85 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.349 0.66 . . . . 0.0 110.646 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 4.6 tt0 -47.14 -66.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.401 1.08 . . . . 0.0 111.161 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -71.0 -24.43 62.38 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.083 -173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.0 m -72.72 -23.43 60.85 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.113 0.565 . . . . 0.0 111.448 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 47' ' ' ILE . 34.2 tp . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 93' ' ' GLU . 5.3 t . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.849 0.357 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.7 p -59.85 -36.55 77.07 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 0.0 110.632 172.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -62.38 -33.31 74.5 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.636 0.774 . . . . 0.0 111.339 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.569 ' H ' HG23 ' A' ' 90' ' ' THR . 7.1 tp10 -65.9 -48.7 70.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.072 0.549 . . . . 0.0 110.031 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 55' ' ' TYR . 15.7 m -73.66 -24.12 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 100.0 m -65.45 -46.46 79.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.866 0.466 . . . . 0.0 110.495 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 100' ' ' ILE . 25.0 m -75.24 -23.65 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.323 0.249 . . . . 0.0 111.393 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 93' ' ' GLU . 5.4 mp -62.47 -47.85 82.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.681 0.792 . . . . 0.0 110.261 169.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -74.0 -23.16 59.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -76.62 -35.93 57.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.134 0.974 . . . . 0.0 110.463 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 96' ' ' VAL . 38.4 pt . . . . . 0 CA--C 1.568 1.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.352 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 CA--C 1.546 1.089 0 CA-C-O 121.171 0.405 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.21 103.7 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 0.0 109.172 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -70.35 136.46 49.73 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.17 0.51 . . . . 0.0 110.168 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 23' ' ' THR . 48.2 tp -136.29 100.59 4.43 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.547 1.139 . . . . 0.0 108.283 -175.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.412 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -143.31 42.17 0.39 Allowed Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 6' ' ' THR . 97.1 Cg_endo -82.34 -34.85 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 121.546 1.497 . . . . 0.0 112.803 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -129.66 25.11 5.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.053 0.941 . . . . 0.0 110.848 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.81 121.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' A' ' 13' ' ' VAL . 26.7 mt -111.07 91.56 13.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -16.99 47.46 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.736 2.291 . . . . 0.0 113.502 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.84 -27.78 64.11 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.46 0.475 . . . . 0.0 113.142 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 10' ' ' LEU . 16.3 m -112.19 170.37 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 0.0 110.77 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -90.37 -23.62 21.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.243 1.017 . . . . 0.0 112.18 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -95.57 168.01 10.95 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.372 0.606 . . . . 0.0 111.682 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.67 143.61 39.19 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -57.22 -64.84 0.75 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.43 0.692 . . . . 0.0 111.081 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -170.89 123.3 0.61 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.04 135.1 32.09 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.879 0.471 . . . . 0.0 109.859 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.79 123.13 12.66 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.86 2.374 . . . . 0.0 111.566 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.77 -22.79 67.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.154 0.581 . . . . 0.0 110.938 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.52 -34.89 74.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.804 0.841 . . . . 0.0 111.08 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 5' ' ' LEU . 31.3 m -65.26 -48.4 73.38 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 83' ' ' THR . 8.6 mp -61.92 -30.48 70.93 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.286 0.634 . . . . 0.0 111.64 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -68.86 -52.36 30.55 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.866 0.866 . . . . 0.0 110.279 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.6 pt-20 -65.09 -42.84 93.68 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.227 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 31' ' ' THR . 35.0 mm -63.8 -31.63 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.583 0.753 . . . . 0.0 111.031 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 32' ' ' ILE . 14.0 tpt180 -61.56 -34.8 76.21 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.697 0.399 . . . . 0.0 110.439 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -73.22 -43.08 61.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.805 0.842 . . . . 0.0 110.882 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.6 mm100 -61.69 -44.1 97.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.984 0.914 . . . . 0.0 111.812 -176.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 68.1 p -60.47 -38.67 85.0 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.595 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.4 mm -58.71 -37.74 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.005 0.522 . . . . 0.0 110.974 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.3 -7.66 59.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.256 1.022 . . . . 0.0 111.429 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.37 63.72 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.717 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 26.1 tt0 -137.63 105.82 5.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.168 0.587 . . . . 0.0 109.651 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.29 106.69 2.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.693 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 92.4 mt-30 -121.37 116.58 25.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.779 0.832 . . . . 0.0 109.12 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.38 116.63 49.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mtm105 -87.9 99.19 11.94 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.44 78.43 4.9 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.48 -100.95 0.52 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.73 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.87 -29.51 32.42 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.749 0.82 . . . . 0.0 110.728 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.24 160.44 15.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 111.129 -167.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.693 ' SD ' ' HB3' ' A' ' 37' ' ' GLN . 48.9 tpp -120.3 140.74 50.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.019 0.928 . . . . 0.0 108.903 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.28 110.12 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.779 0.832 . . . . 0.0 109.549 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -90.96 95.75 10.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 120.988 0.423 . . . . 0.0 110.219 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 56' ' ' PHE . 19.0 mm -88.36 84.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -135.26 126.28 17.33 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 C--N 1.378 2.087 0 C-N-CA 122.878 2.385 . . . . 0.0 111.474 -179.103 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.469 ' HB2' HG22 ' A' ' 47' ' ' ILE . 54.1 p90 -87.6 115.86 25.33 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.451 ' SD ' HG11 ' A' ' 94' ' ' VAL . 7.2 ptm -169.67 -178.17 2.93 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.97 110.23 1.42 Allowed Glycine 0 CA--C 1.537 1.436 0 O-C-N 123.796 0.685 . . . . 0.0 114.071 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 t -127.84 100.47 5.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.453 0.701 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.52 112.82 20.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.608 HD21 ' HB3' ' A' ' 44' ' ' MET . 2.4 p-10 -83.78 133.1 34.79 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 C-N-CA 124.534 1.134 . . . . 0.0 112.874 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 70' ' ' ILE . 42.1 t . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -52.33 -43.23 64.46 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.216 1.007 . . . . 0.0 112.789 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.44 -40.82 96.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.702 . . . . 0.0 110.975 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -66.18 -39.39 89.68 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.425 0.69 . . . . 0.0 110.673 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 66' ' ' SER . 50.0 mm -59.93 -43.68 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.573 0.749 . . . . 0.0 109.935 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.85 -51.74 65.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.894 0.746 . . . . 0.0 111.042 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.4 mt -53.18 -41.62 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.826 0.85 . . . . 0.0 110.192 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.31 -58.93 8.49 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.964 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.8 pp -64.72 -22.98 67.11 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.988 0.515 . . . . 0.0 112.17 -172.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -73.98 -47.76 35.03 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.111 0.564 . . . . 0.0 110.86 173.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -66.28 -26.79 67.5 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -70.44 -47.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.787 0.835 . . . . 0.0 109.929 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -24.89 60.25 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.687 0.617 . . . . 0.0 110.604 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -70.68 -49.25 49.23 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.375 0.67 . . . . 0.0 110.471 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.42 -35.4 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.564 0.745 . . . . 0.0 110.6 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 57' ' ' MET . 37.2 tt0 -59.14 -43.56 92.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.586 1.154 . . . . 0.0 110.667 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.4 -39.82 94.59 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.202 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 24' ' ' LEU . 17.9 m -72.03 -29.16 63.9 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 123.879 0.872 . . . . 0.0 111.771 179.794 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 92' ' ' ARG . 25.4 m . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 t -57.19 -39.47 75.44 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.022 0.529 . . . . 0.0 110.361 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.8 ttp180 -67.55 -28.99 68.26 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.635 0.774 . . . . 0.0 111.795 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -47.09 83.32 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.068 0.547 . . . . 0.0 109.565 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.451 HG11 ' SD ' ' A' ' 57' ' ' MET . 10.6 p -80.7 -23.25 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.954 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 92' ' ' ARG . 3.6 m -64.73 -46.51 81.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.505 0.722 . . . . 0.0 111.204 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.6 -33.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.2 mt -68.4 -43.37 77.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.727 . . . . 0.0 111.753 -176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.1 -25.87 52.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.885 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -23.65 38.21 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.639 0.775 . . . . 0.0 112.6 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.005 178.062 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 1.2 pmm? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.2 Cg_endo -79.01 90.61 1.26 Allowed 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.575 2.183 . . . . 0.0 110.836 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.23 103.66 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.397 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.13 132.46 45.08 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.842 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tt -125.94 85.69 2.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.406 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.4 t -141.06 35.13 0.21 Allowed Pre-proline 0 CA--C 1.57 1.712 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 176.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.64 -29.88 6.83 Favored 'Trans proline' 0 C--N 1.387 2.604 0 CA-C-N 121.002 1.394 . . . . 0.0 112.327 -176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.522 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 30.0 m-85 -130.87 29.77 4.69 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.336 0.654 . . . . 0.0 111.826 -175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 6' ' ' THR . 11.6 mt -76.6 128.75 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 118.162 0.437 . . . . 0.0 112.025 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -103.83 91.07 3.27 Favored Pre-proline 0 CA--C 1.556 1.179 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.3 86.44 0.98 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.675 2.25 . . . . 0.0 111.518 -167.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.64 -13.5 0.17 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.405 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 10' ' ' LEU . 25.1 m -119.71 158.31 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.202 0.601 . . . . 0.0 111.116 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.7 t -74.52 -37.81 62.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.079 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -80.61 162.65 24.14 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.427 0.632 . . . . 0.0 111.285 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 17' ' ' SER . 1.1 tm? -113.43 151.96 30.7 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.522 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 35.7 t -57.1 -59.31 5.28 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.673 0.789 . . . . 0.0 110.629 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -174.69 117.43 0.19 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 58.1 mt -90.24 137.56 27.69 Favored Pre-proline 0 N--CA 1.485 1.32 0 CA-C-N 118.402 0.546 . . . . 0.0 110.359 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.87 116.66 3.39 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.272 1.982 . . . . 0.0 110.736 164.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.504 ' HA ' HD23 ' A' ' 24' ' ' LEU . 27.8 tt0 -65.31 -26.13 67.92 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.477 0.711 . . . . 0.0 111.129 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.77 -25.94 67.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.871 0.868 . . . . 0.0 111.438 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 20.5 m -71.28 -47.84 54.5 Favored 'General case' 0 C--O 1.213 -0.831 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 173.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.2 mm? -57.33 -33.2 67.48 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 117.847 0.294 . . . . 0.0 110.627 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.8 m -61.46 -51.09 70.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.458 0.703 . . . . 0.0 111.401 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 23' ' ' THR . 8.2 pt-20 -66.52 -35.73 80.97 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.623 -177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 15.5 mm -58.24 -51.52 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.855 0.862 . . . . 0.0 110.091 176.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 91.4 mtm180 -59.88 -28.26 67.4 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -78.98 -42.4 26.81 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.964 0.506 . . . . 0.0 111.553 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 5.4 pt20 -77.7 -23.64 49.43 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.392 0.677 . . . . 0.0 112.448 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 74.1 p -61.49 -28.19 69.12 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.328 0.513 . . . . 0.0 111.352 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mm -68.39 -24.15 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.985 0.914 . . . . 0.0 110.809 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -67.19 -19.05 65.5 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.744 0.818 . . . . 0.0 110.316 173.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.24 -22.86 14.83 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 123.997 0.808 . . . . 0.0 113.25 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 43.7 tt0 -143.98 145.11 32.0 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.294 0.638 . . . . 0.0 110.366 169.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.07 106.44 5.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.022 0.929 . . . . 0.0 109.085 170.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.56 121.9 31.44 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.683 0.393 . . . . 0.0 110.105 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -111.92 129.08 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 33.1 mtm105 -103.29 106.08 16.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 95.4 mt -77.27 68.37 3.38 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 170.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.84 -101.68 0.82 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.266 -169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.46 -16.73 22.04 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.021 0.928 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 11.7 mt -81.12 111.27 17.41 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.46 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.7 tpt -84.89 124.76 32.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.7 t -124.98 152.14 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.597 1.159 . . . . 0.0 108.487 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.8 m -139.18 99.93 3.88 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.523 0.729 . . . . 0.0 109.757 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.507 HG12 HD13 ' A' ' 38' ' ' ILE . 11.1 mm -88.46 120.12 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -161.95 137.76 5.77 Favored Pre-proline 0 N--CA 1.486 1.335 0 CA-C-N 118.189 0.45 . . . . 0.0 111.189 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 96.7 Cg_endo -80.44 87.38 1.52 Allowed 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.563 2.176 . . . . 0.0 111.311 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.55 ' HG3' HG22 ' A' ' 52' ' ' VAL . 15.7 tpt -71.15 102.45 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.854 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.27 75.93 4.79 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.673 0.789 . . . . 0.0 110.944 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.55 HG22 ' HG3' ' A' ' 50' ' ' MET . 15.9 m -144.98 -43.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.824 1.649 . . . . 0.0 107.642 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' ' 98' ' ' ARG . 4.4 t30 179.51 104.41 0.03 OUTLIER 'General case' 0 C--N 1.354 0.786 0 C-N-CA 126.188 1.795 . . . . 0.0 106.987 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.26 134.09 3.22 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 122.871 0.107 . . . . 0.0 112.886 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -87.06 173.13 9.47 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.871 0.868 . . . . 0.0 110.157 175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 9.7 p90 -87.06 114.7 23.9 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.429 0.633 . . . . 0.0 110.202 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.582 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -162.65 -176.57 5.07 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.0 -176.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.7 110.29 2.04 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 114.682 0.633 . . . . 0.0 114.682 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -125.66 106.47 9.76 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 118.85 19.47 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.019 0.927 . . . . 0.0 109.684 -175.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -76.79 91.72 3.53 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.709 . . . . 0.0 109.132 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -71.62 -11.47 60.86 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.092 1.357 . . . . 0.0 112.856 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.86 118.49 7.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.521 0.728 . . . . 0.0 110.909 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.11 -4.3 85.76 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.573 0.545 . . . . 0.0 114.282 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.48 175.96 10.09 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.813 0.816 . . . . 0.0 112.685 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -113.84 171.03 7.83 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.686 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 15.1 m120 -56.79 -44.65 82.08 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.358 0.663 . . . . 0.0 111.82 -172.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.32 -35.35 80.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.123 0.569 . . . . 0.0 111.446 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -66.37 -32.96 74.67 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.964 0.505 . . . . 0.0 111.447 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.5 mm -66.19 -45.01 91.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.406 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 67' ' ' ASN . 76.3 mm-40 -71.61 -54.82 9.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.59 0.756 . . . . 0.0 112.079 -174.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.72 -30.25 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.35 0.595 . . . . 0.0 109.469 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.62 -57.66 17.8 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.654 172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -71.27 -26.78 63.03 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 117.643 0.722 . . . . 0.0 112.737 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -74.05 -37.0 64.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.357 0.598 . . . . 0.0 110.096 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.93 -24.83 48.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.731 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.481 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 1.2 mp -71.54 -46.49 63.0 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.12 -30.51 71.57 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.608 0.568 . . . . 0.0 110.693 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -62.06 -54.95 34.19 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.369 168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.45 HG23 HD23 ' A' ' 84' ' ' LEU . 56.2 mt -61.24 -32.92 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.332 1.053 . . . . 0.0 112.364 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 49.7 mt-10 -63.1 -39.49 94.87 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.047 0.539 . . . . 0.0 110.84 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -77.36 -32.9 55.35 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.917 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.9 m -77.63 -26.19 50.31 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.299 0.64 . . . . 0.0 112.018 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.465 HD22 HD12 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -75.94 -28.56 58.01 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.086 0.955 . . . . 0.0 109.956 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -138.02 87.83 2.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.12 0.968 . . . . 0.0 108.725 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -60.82 107.32 0.69 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.507 0.723 . . . . 0.0 112.386 -169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 10.56 76.96 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 114.222 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.9 t -80.45 -66.9 0.82 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.297 0.639 . . . . 0.0 110.479 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.9 162.24 40.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.034 0.534 . . . . 0.0 111.131 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.42 HG22 ' HB2' ' A' ' 93' ' ' GLU . 9.0 t -102.81 179.11 4.37 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.9 p -58.16 -53.46 58.03 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.359 1.063 . . . . 0.0 111.182 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -68.17 -27.88 66.8 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.094 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 90' ' ' THR . 15.0 tp10 -59.91 -33.34 71.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.822 0.849 . . . . 0.0 110.758 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.4 t -89.79 -39.37 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.004 0.922 . . . . 0.0 110.947 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -61.54 -37.28 83.19 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.385 0.674 . . . . 0.0 111.734 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.7 m -60.68 -27.92 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.294 0.638 . . . . 0.0 111.859 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -59.5 -39.83 85.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.911 0.484 . . . . 0.0 110.031 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.536 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 3.3 tpm_? -83.22 -34.45 25.88 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.604 0.761 . . . . 0.0 111.901 177.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -76.03 -38.35 57.34 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.576 0.75 . . . . 0.0 112.38 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.642 0.777 . . . . 0.0 112.557 -176.141 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.6 116.3 2.57 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.634 2.223 . . . . 0.0 112.856 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.5 p -74.96 112.89 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.045 0.938 . . . . 0.0 110.465 177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.91 134.43 47.24 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.208 0.527 . . . . 0.0 110.275 175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD21 HG23 ' A' ' 19' ' ' ILE . 4.5 tt -140.42 92.75 2.55 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.9 t -150.09 55.0 1.67 Allowed Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -84.66 -31.58 0.43 Allowed 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.956 1.771 . . . . 0.0 113.099 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.439 ' HE1' ' HD3' ' A' ' 20' ' ' PRO . 48.4 m-85 -127.86 4.83 6.0 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.439 -171.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.28 122.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -164.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.9 mt -98.91 96.4 3.99 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 113.687 -1.597 . . . . 0.0 106.7 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -81.18 40.3 0.97 Allowed 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.078 2.518 . . . . 0.0 115.118 -161.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.12 23.23 0.15 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.734 -0.481 . . . . 0.0 113.103 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 m -130.36 178.18 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.277 0.631 . . . . 0.0 110.412 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 57.6 p -91.83 -48.96 6.51 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.748 0.819 . . . . 0.0 111.01 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -79.0 -175.93 4.8 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.342 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 19' ' ' ILE . 15.7 tp -141.78 169.64 17.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 169.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.3 t -55.39 -64.44 0.84 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.303 0.641 . . . . 0.0 109.722 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -176.41 105.6 0.07 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.167 0.917 . . . . 0.0 108.671 175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.431 HG12 HD23 ' A' ' 16' ' ' LEU . 56.8 mt -63.3 129.47 93.54 Favored Pre-proline 0 N--CA 1.484 1.259 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.702 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.439 ' HD3' ' HE1' ' A' ' 8' ' ' TYR . 14.8 Cg_endo -56.17 120.34 8.12 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.75 2.3 . . . . 0.0 112.038 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.6 pm0 -60.39 -26.05 66.36 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.453 0.701 . . . . 0.0 111.978 -175.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.41 -36.44 80.31 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.762 0.825 . . . . 0.0 110.926 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 27' ' ' ILE . 16.5 m -72.78 -37.51 67.57 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.237 177.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.0 mm? -64.67 -29.78 70.79 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.6 0.636 . . . . 0.0 110.479 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.1 t -72.48 -35.38 68.19 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.372 0.669 . . . . 0.0 110.289 174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 10.6 tp10 -61.33 -50.19 73.95 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.395 0.678 . . . . 0.0 110.229 173.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 23' ' ' THR . 13.9 mm -59.18 -37.17 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.171 0.989 . . . . 0.0 110.522 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.2 tpt180 -60.9 -33.42 73.1 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.994 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.69 -39.05 58.12 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.445 0.698 . . . . 0.0 111.374 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 54.0 mt-30 -73.68 -29.85 62.54 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.25 0.62 . . . . 0.0 110.973 -175.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.5 p -69.81 -27.92 65.29 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.947 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ARG . 43.3 mm -67.43 -35.66 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -67.75 -19.05 65.08 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.17 -21.86 21.62 Favored Glycine 0 C--N 1.346 1.126 0 C-N-CA 123.793 0.711 . . . . 0.0 112.759 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -141.89 119.32 11.58 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 122.974 0.51 . . . . 0.0 110.538 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.95 111.09 21.79 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -103.12 113.03 26.18 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.584 ' HB ' ' HB ' ' A' ' 45' ' ' VAL . 2.4 mp -101.23 149.08 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.978 0.911 . . . . 0.0 108.588 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 42' ' ' GLU . 12.7 mmm-85 -126.03 88.25 2.82 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.187 0.995 . . . . 0.0 109.252 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.1 mt -71.32 77.43 0.74 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.46 -102.26 0.66 Allowed Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.829 -166.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HA ' HH21 ' A' ' 39' ' ' ARG . 15.2 pt-20 -100.18 -18.63 16.81 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.811 0.844 . . . . 0.0 111.139 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.0 mt -69.08 110.95 4.76 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.4 ttt -88.8 108.71 19.66 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.016 0.436 . . . . 0.0 110.088 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.584 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 19.2 t -98.5 154.13 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.641 1.177 . . . . 0.0 108.664 175.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.3 98.89 3.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.409 0.683 . . . . 0.0 109.8 175.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.514 HG12 HD13 ' A' ' 38' ' ' ILE . 37.5 mm -89.63 104.84 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.041 0.936 . . . . 0.0 108.787 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -130.29 128.14 22.64 Favored Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.338 -174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.6 110.76 1.71 Allowed 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.148 2.566 . . . . 0.0 111.922 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.3 tpt -71.45 105.12 3.45 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.309 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -63.06 -52.92 60.86 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.182 0.993 . . . . 0.0 112.275 -168.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 t -85.87 81.62 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 71.19 145.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.156 1.382 . . . . 0.0 111.761 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.7 -143.16 15.67 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.454 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.07 179.39 5.2 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.057 0.943 . . . . 0.0 110.224 -176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -86.35 130.25 34.57 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.0 ptt? -153.06 179.13 8.98 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.515 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 81' ' ' GLU . . . -61.89 110.44 3.19 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 124.23 0.956 . . . . 0.0 113.19 -176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.2 t -122.43 98.58 5.99 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 171.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -76.35 121.6 23.24 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.36 85.8 0.59 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -103.67 20.35 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.282 -172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -66.81 94.62 0.32 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.812 0.845 . . . . 0.0 109.85 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 68.59 16.32 69.6 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.173 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.0 tp -73.63 157.42 36.65 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.096 0.959 . . . . 0.0 110.416 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -60.73 132.92 55.42 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.549 0.34 . . . . 0.0 110.539 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -57.52 -26.37 61.24 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.744 0.818 . . . . 0.0 111.879 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.22 -54.32 48.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.495 1.118 . . . . 0.0 110.644 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -72.57 -25.23 61.27 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.648 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.03 -39.86 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 50.9 tt0 -65.35 -58.3 6.24 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.445 0.466 . . . . 0.0 110.108 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 43' ' ' LEU . 59.8 mt -59.91 -34.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.556 0.743 . . . . 0.0 110.027 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.29 -54.89 26.81 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 114.79 -1.096 . . . . 0.0 113.37 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -66.93 -26.98 67.12 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.02 0.91 . . . . 0.0 111.467 -174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 24.4 mt-30 -64.69 -50.72 65.86 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.734 0.778 . . . . 0.0 109.44 173.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 80' ' ' ILE . 10.4 m-85 -69.64 -24.9 63.7 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.773 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.486 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -70.52 -42.42 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.404 0.682 . . . . 0.0 111.095 -178.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 75' ' ' GLN . 0.2 OUTLIER -68.87 -27.67 66.01 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 176.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -72.77 -36.01 67.55 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.279 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 76' ' ' TYR . 38.1 mm -73.59 -43.28 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-N 118.234 0.47 . . . . 0.0 110.605 -178.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.544 ' HB3' ' H ' ' A' ' 58' ' ' GLY . 12.7 pt-20 -65.5 -38.55 90.05 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.637 0.375 . . . . 0.0 111.489 -174.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -70.39 -26.04 63.52 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.39 0.676 . . . . 0.0 110.555 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.7 m -78.26 -31.87 49.31 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.722 0.809 . . . . 0.0 111.23 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 82.8 mt -89.2 -22.63 22.68 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.013 0.525 . . . . 0.0 112.178 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -85.98 92.81 8.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.088 0.555 . . . . 0.0 110.109 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -119.82 14.29 12.48 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.513 0.725 . . . . 0.0 110.393 171.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.35 -177.27 44.55 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 116.741 -0.209 . . . . 0.0 112.595 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m -82.88 66.83 8.7 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.85 0.833 . . . . 0.0 108.967 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -157.58 146.19 19.41 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.016 -169.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 81.9 m -122.91 147.69 46.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.353 1.061 . . . . 0.0 109.051 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.6 p -56.89 -48.57 77.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.956 0.902 . . . . 0.0 112.194 -176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' VAL . 42.4 ttp180 -69.0 -27.61 65.84 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 122.219 0.208 . . . . 0.0 111.097 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 1.5 tm-20 -61.69 -24.98 67.12 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 122.993 0.517 . . . . 0.0 110.174 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.17 -34.87 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.056 0.542 . . . . 0.0 111.368 171.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.0 m -62.97 -30.57 71.68 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.282 0.633 . . . . 0.0 111.836 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 92' ' ' ARG . 26.8 m -65.92 -21.21 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 123.419 0.688 . . . . 0.0 111.558 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.08 -43.48 87.03 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.628 0.771 . . . . 0.0 110.102 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.8 ttp180 -79.81 -31.46 40.7 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.918 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -71.66 -44.51 64.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.64 0.776 . . . . 0.0 112.552 -171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 96' ' ' VAL . 27.5 pt . . . . . 0 CA--C 1.57 1.74 0 C-N-CA 122.971 0.508 . . . . 0.0 111.339 -172.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.54 155.63 24.56 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.118 1.879 . . . . 0.0 112.559 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.97 116.17 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.761 1.225 . . . . 0.0 108.597 167.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.439 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 7.6 p-10 -69.98 142.23 52.86 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.946 0.403 . . . . 0.0 110.49 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 tt -145.4 89.05 1.9 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.511 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.1 t -147.05 41.46 0.27 Allowed Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.002 0.521 . . . . 0.0 112.377 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 6' ' ' THR . 1.7 Cg_endo -79.6 -39.06 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 121.535 1.49 . . . . 0.0 112.021 -174.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' HE2' ' HD3' ' A' ' 20' ' ' PRO . 1.1 m-85 -129.43 31.09 4.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.071 0.548 . . . . 0.0 111.03 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.6 mt -63.35 109.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 118.817 0.735 . . . . 0.0 111.258 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -92.02 98.58 2.04 Favored Pre-proline 0 C--N 1.356 0.879 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 173.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -66.99 -16.79 50.49 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.419 2.079 . . . . 0.0 112.851 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.56 83.17 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.648 0.593 . . . . 0.0 114.356 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 10' ' ' LEU . 33.9 m -129.08 171.1 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 117.248 0.524 . . . . 0.0 111.503 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.0 p -82.73 -34.7 27.13 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.635 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -84.91 177.34 8.0 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 122.084 0.945 . . . . 0.0 111.95 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.68 142.03 49.85 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 171.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.1 m -52.76 -48.0 67.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.456 0.702 . . . . 0.0 111.606 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 t70 179.41 119.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.838 1.255 . . . . 0.0 108.015 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.14 134.89 37.83 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 19.8 Cg_endo -58.86 122.65 11.98 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.797 2.331 . . . . 0.0 111.38 170.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -65.38 -17.9 64.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.153 0.581 . . . . 0.0 111.102 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -56.19 -47.21 78.78 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.222 1.009 . . . . 0.0 110.295 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -65.87 -34.94 79.3 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.043 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.9 mm? -67.65 -32.7 73.58 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 119.558 -0.258 . . . . 0.0 111.125 175.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -62.88 -38.61 91.57 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.846 0.458 . . . . 0.0 111.769 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 15.3 pt-20 -73.39 -40.84 64.0 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 123.261 0.351 . . . . 0.0 110.103 176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 24' ' ' LEU . 97.1 mt -55.67 -36.83 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 124.004 0.922 . . . . 0.0 110.84 176.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' O ' HG12 ' A' ' 32' ' ' ILE . 21.9 mmm180 -61.73 -45.08 95.48 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.812 0.845 . . . . 0.0 110.934 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.24 -37.67 83.92 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.032 0.533 . . . . 0.0 110.935 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 18.0 mm-40 -68.47 -38.38 81.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.842 0.857 . . . . 0.0 111.148 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -69.06 -27.79 65.94 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 28' ' ' ARG . 46.6 mm -71.45 -36.61 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -75.17 -12.17 60.24 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.914 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.94 -9.73 60.07 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.594 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -139.23 111.95 7.8 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 118.214 1.007 . . . . 0.0 110.968 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -125.67 98.99 5.79 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.811 0.844 . . . . 0.0 109.041 169.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -99.17 105.96 18.08 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.76 110.25 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.594 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 41.5 mtm105 -88.22 90.23 8.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.629 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 93.5 mt -76.1 70.6 2.79 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.291 0.637 . . . . 0.0 109.905 175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.84 -101.02 0.55 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.807 -176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -90.06 -15.13 32.38 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.177 0.991 . . . . 0.0 111.449 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 22.3 mt -91.3 142.86 27.25 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.963 0.905 . . . . 0.0 109.765 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.594 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.2 tpt -120.24 106.02 11.51 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.4 t -111.42 103.41 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.114 0.966 . . . . 0.0 109.898 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.0 t -90.36 98.91 12.05 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -174.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 mm -84.74 103.64 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.04 139.36 13.35 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 119.618 -0.229 . . . . 0.0 110.665 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.44 153.26 23.78 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 122.728 2.285 . . . . 0.0 112.283 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.457 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 56.9 ttm -98.41 137.84 36.51 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.383 0.673 . . . . 0.0 110.188 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -59.92 -41.94 92.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.5 1.12 . . . . 0.0 112.432 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.4 m -87.57 46.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.571 0.748 . . . . 0.0 111.098 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.5 t30 65.83 99.48 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.528 1.531 . . . . 0.0 110.892 -176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -161.67 124.6 1.33 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -81.73 147.16 29.6 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.232 0.613 . . . . 0.0 110.439 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -88.24 132.77 34.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.926 0.49 . . . . 0.0 110.422 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.9 ptp -160.01 -175.98 5.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.943 1.297 . . . . 0.0 108.628 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.29 110.69 1.89 Allowed Glycine 0 C--N 1.352 1.462 0 O-C-N 123.655 0.597 . . . . 0.0 113.168 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.9 t -128.72 97.73 4.77 Favored 'General case' 0 C--N 1.353 0.717 0 C-N-CA 123.196 0.599 . . . . 0.0 109.872 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.658 ' HG ' ' HA3' ' A' ' 73' ' ' GLY . 3.3 tm? -79.54 113.03 17.36 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -79.49 142.24 36.0 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -107.49 1.7 23.65 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.174 0.59 . . . . 0.0 112.167 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -74.31 107.87 6.74 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.68 12.84 58.93 Favored Glycine 0 N--CA 1.471 1.019 0 CA-C-N 116.107 -0.497 . . . . 0.0 113.535 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 mp -117.0 162.62 17.49 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.863 0.865 . . . . 0.0 110.497 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.4 m -100.82 161.72 13.4 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.051 0.94 . . . . 0.0 109.637 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -55.31 -31.92 62.05 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 124.457 1.103 . . . . 0.0 112.134 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 -51.85 67.59 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.497 1.119 . . . . 0.0 110.216 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -59.23 -39.46 82.8 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.04 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 22.6 mm -59.12 -51.71 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 123.874 0.734 . . . . 0.0 110.65 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 47.5 mt-30 -57.61 -46.72 83.71 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 124.543 1.152 . . . . 0.0 111.487 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 43' ' ' LEU . 59.5 mt -58.13 -41.45 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 O-C-N 124.09 0.869 . . . . 0.0 110.158 176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.658 ' HA3' ' HG ' ' A' ' 60' ' ' LEU . . . -60.37 -49.11 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.295 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 70' ' ' ILE . 50.7 mt -57.86 -36.98 73.08 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.991 0.917 . . . . 0.0 111.323 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 83.6 mm-40 -58.54 -51.39 70.08 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.429 174.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -68.81 -30.43 68.99 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.589 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 73' ' ' GLY . 1.2 mp -66.64 -42.72 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.385 1.074 . . . . 0.0 111.098 -175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.88 -30.13 65.09 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.431 0.457 . . . . 0.0 110.663 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -78.29 -26.75 47.18 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 173.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 40' ' ' LEU . 65.2 mt -71.03 -32.32 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 123.37 0.668 . . . . 0.0 109.638 174.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -56.64 -41.31 76.95 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.915 0.886 . . . . 0.0 110.844 174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -71.2 -38.83 72.06 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.638 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.6 m -66.83 -33.48 75.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 123.823 0.849 . . . . 0.0 111.38 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.14 46.09 0.93 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.528 1.131 . . . . 0.0 109.777 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -54.68 115.65 2.27 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.22 1.008 . . . . 0.0 111.721 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -99.03 176.99 5.38 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.094 0.958 . . . . 0.0 109.542 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.57 -165.56 4.71 Favored Glycine 0 C--N 1.353 1.5 0 C-N-CA 122.883 0.277 . . . . 0.0 112.627 169.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.4 m -60.54 94.49 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.515 0.726 . . . . 0.0 112.796 -170.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 93' ' ' GLU . 2.7 pp -156.27 177.72 11.12 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.449 1.1 . . . . 0.0 109.75 169.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 92' ' ' ARG . 21.8 m -135.16 156.02 49.71 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.7 p -66.61 -21.5 66.13 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.918 -0.489 . . . . 0.0 111.245 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.454 ' H ' HG22 ' A' ' 90' ' ' THR . 42.3 ttm180 -69.26 -33.5 73.34 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.626 0.771 . . . . 0.0 111.223 172.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -69.03 -36.83 78.19 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.138 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.47 -20.45 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 120.99 0.424 . . . . 0.0 110.394 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 92.8 m -78.23 -38.96 41.76 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.406 0.683 . . . . 0.0 111.19 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 99' ' ' GLU . 30.0 m -76.38 -17.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.723 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 93.7 mt -51.01 -53.95 28.81 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.929 0.491 . . . . 0.0 111.988 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HD3' ' H ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -84.11 -24.13 30.44 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.803 0.441 . . . . 0.0 111.949 176.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 34.8 tt0 -77.63 -31.57 52.87 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.627 0.771 . . . . 0.0 112.655 -167.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 CA--C 1.561 1.373 0 C-N-CA 123.341 0.656 . . . . 0.0 112.329 -176.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.6 80.25 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.563 2.175 . . . . 0.0 111.941 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 p -61.43 94.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 CA-C-O 122.176 0.989 . . . . 0.0 110.84 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -69.24 148.61 49.58 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.547 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -146.03 102.89 3.69 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -149.97 38.95 0.18 Allowed Pre-proline 0 CA--C 1.571 1.787 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 173.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.69 -26.82 1.9 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 CA-C-N 121.014 1.398 . . . . 0.0 112.507 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.546 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 41.8 m-85 -127.97 21.96 6.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.545 0.738 . . . . 0.0 111.225 -175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.7 mt -74.56 126.94 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 118.024 0.375 . . . . 0.0 110.507 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.4 90.17 6.78 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -67.34 -16.28 47.67 Favored 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.503 2.135 . . . . 0.0 113.675 -168.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.41 -13.9 82.1 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-O 119.585 -0.564 . . . . 0.0 114.082 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.2 m -115.47 173.04 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 CA-C-N 117.737 0.769 . . . . 0.0 110.802 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.9 p -88.3 9.02 24.63 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.461 1.104 . . . . 0.0 112.406 -173.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -146.04 177.3 9.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.375 0.67 . . . . 0.0 111.334 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.49 149.53 45.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 22.7 t -57.45 -64.54 0.86 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.063 0.545 . . . . 0.0 110.868 -177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -163.34 144.82 9.55 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 81.8 mt -99.27 130.29 27.45 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.383 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.99 141.31 86.58 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.103 2.535 . . . . 0.0 112.332 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.18 -24.56 67.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.184 0.593 . . . . 0.0 111.647 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -66.85 -39.86 87.71 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.03 0.532 . . . . 0.0 110.803 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 27' ' ' ILE . 37.1 m -72.69 -42.88 63.76 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 123.018 0.527 . . . . 0.0 110.411 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.57 -46.3 90.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.043 0.537 . . . . 0.0 110.775 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -64.85 -33.69 76.61 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.778 0.831 . . . . 0.0 111.12 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.1 tp10 -62.06 -53.63 52.82 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 123.669 0.606 . . . . 0.0 109.697 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 23' ' ' THR . 67.9 mt -54.03 -43.21 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.797 0.839 . . . . 0.0 110.696 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 28' ' ' ARG . 10.4 mmm180 -66.17 -31.39 72.21 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -73.28 -44.37 59.34 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.553 0.741 . . . . 0.0 111.11 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.52 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 15.2 mm-40 -77.73 -27.7 50.6 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.184 0.994 . . . . 0.0 112.054 -171.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.6 p -63.51 -25.86 68.45 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.577 171.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.4 mm -77.41 -26.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-O 121.279 0.561 . . . . 0.0 109.771 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -77.56 -26.36 50.84 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.057 168.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.78 4.85 60.21 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.469 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 24.0 tt0 -129.76 116.86 19.37 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.137 0.975 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.62 96.26 1.75 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.261 0.624 . . . . 0.0 109.426 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.49 113.02 26.01 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.36 112.86 34.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 52.0 mtp180 -87.46 92.24 9.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.648 HD11 HD11 ' A' ' 80' ' ' ILE . 90.5 mt -70.22 75.53 0.52 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.273 0.629 . . . . 0.0 109.709 175.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.45 -99.91 0.37 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -103.62 -7.68 20.56 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.237 1.015 . . . . 0.0 111.657 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 24.3 mt -88.35 109.95 20.4 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.506 0.722 . . . . 0.0 109.069 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.553 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 11.5 tpt -84.47 114.44 21.93 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.25 110.68 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.047 0.539 . . . . 0.0 110.561 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.3 m -88.16 113.77 24.11 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.149 0.58 . . . . 0.0 110.573 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 31.7 mm -104.08 85.03 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 36' ' ' ALA . 24.6 mtm180 -130.55 145.06 55.91 Favored Pre-proline 0 N--CA 1.481 1.111 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.88 154.77 64.27 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.455 2.103 . . . . 0.0 111.681 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.742 ' HB2' ' HA3' ' A' ' 54' ' ' GLY . 22.4 mmt -101.61 -172.08 2.09 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.92 -60.34 2.58 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.1 0.56 . . . . 0.0 110.432 -174.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.71 145.0 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.342 0.657 . . . . 0.0 109.588 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.8 m120 61.67 21.63 12.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.578 1.151 . . . . 0.0 111.489 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.742 ' HA3' ' HB2' ' A' ' 50' ' ' MET . . . -113.4 79.1 0.26 Allowed Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.299 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.43 142.4 57.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.678 0.791 . . . . 0.0 109.232 168.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -94.44 108.05 20.0 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.279 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.5 ' SD ' ' HB3' ' A' ' 85' ' ' ASN . 59.2 mtm -152.78 107.71 3.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.427 1.491 . . . . 0.0 108.055 174.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 56.89 108.34 0.01 OUTLIER Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.013 1.165 . . . . 0.0 116.013 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.3 m -131.4 96.98 4.13 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 165.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.7 117.75 20.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.751 0.82 . . . . 0.0 108.977 -177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 27.7 t-20 -67.65 89.16 0.24 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.761 0.791 . . . . 0.0 109.102 174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -86.5 -8.3 57.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.312 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -65.02 100.82 0.45 Allowed 'General case' 0 CA--C 1.539 0.529 0 O-C-N 123.742 0.651 . . . . 0.0 110.596 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.99 9.66 86.64 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.615 -0.72 . . . . 0.0 113.602 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.0 tp -81.95 143.52 31.57 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.268 0.627 . . . . 0.0 109.349 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -72.18 150.19 43.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.308 0.643 . . . . 0.0 110.855 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -63.92 -26.69 68.71 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.5 -42.44 71.32 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.99 -20.66 60.27 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.416 0.686 . . . . 0.0 111.933 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.54 -50.17 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.88 -57.32 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.097 0.873 . . . . 0.0 110.59 -177.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.443 HG22 HD11 ' A' ' 43' ' ' LEU . 49.3 mt -61.42 -36.2 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.209 0.603 . . . . 0.0 109.882 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -57.92 -58.0 16.86 Favored Glycine 0 C--N 1.35 1.333 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.681 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.445 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.6 pp -67.09 -27.24 67.19 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.057 0.543 . . . . 0.0 111.811 -175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -65.04 -43.33 92.73 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.524 0.678 . . . . 0.0 110.198 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.17 -22.62 59.34 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.848 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -67.24 -38.34 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.077 0.551 . . . . 0.0 109.735 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.88 -34.88 76.16 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.381 0.673 . . . . 0.0 110.23 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -62.6 -52.7 62.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.695 0.398 . . . . 0.0 110.675 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.648 HD11 HD11 ' A' ' 40' ' ' LEU . 79.5 mt -64.58 -32.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.258 0.623 . . . . 0.0 110.633 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -53.01 -49.67 65.77 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.263 0.625 . . . . 0.0 110.212 174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -75.75 -34.82 60.3 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.268 -175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 61.5 m -84.06 -31.78 25.18 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.788 0.835 . . . . 0.0 111.901 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -92.13 -41.93 10.2 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.367 0.667 . . . . 0.0 109.328 -173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.5 ' HB3' ' SD ' ' A' ' 57' ' ' MET . 23.8 t-20 -128.12 156.42 42.87 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.563 0.745 . . . . 0.0 109.469 -174.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -142.25 19.08 2.08 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.175 0.59 . . . . 0.0 111.014 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.89 -174.95 34.57 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 123.469 0.557 . . . . 0.0 114.26 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.3 p -77.61 4.26 11.79 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.563 0.745 . . . . 0.0 112.974 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.48 139.13 43.81 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.259 0.624 . . . . 0.0 110.446 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 77.3 p -81.68 -179.21 7.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.094 0.958 . . . . 0.0 111.406 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 79.8 p -60.61 -39.85 89.68 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.626 171.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.0 ttt85 -61.42 -41.33 97.0 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.935 0.894 . . . . 0.0 111.971 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.87 -31.66 72.92 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.246 0.341 . . . . 0.0 111.699 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.414 ' HA ' HD23 ' A' ' 97' ' ' LEU . 7.7 p -90.99 -23.21 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.45 0 C-N-CA 122.761 0.424 . . . . 0.0 112.047 173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.1 m -65.6 -34.95 79.42 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.982 0.513 . . . . 0.0 110.86 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -68.25 -20.41 25.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 94' ' ' VAL . 4.4 mm? -73.06 -48.78 33.0 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.82 0.448 . . . . 0.0 110.488 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -71.19 -24.19 62.18 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.736 0.303 . . . . 0.0 110.438 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -69.94 -53.97 15.46 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.276 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.715 -175.284 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 tpp . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.519 ' HB2' ' HG3' ' A' ' 39' ' ' ARG . 71.8 Cg_endo -73.23 112.22 3.47 Favored 'Trans proline' 0 C--N 1.397 3.119 0 CA-C-N 121.157 1.449 . . . . 0.0 112.644 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -71.75 99.74 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.809 0.844 . . . . 0.0 110.492 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.4 89.59 0.35 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 122.312 1.053 . . . . 0.0 111.163 174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.43 102.99 15.44 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.6 t -154.83 53.14 0.82 Allowed Pre-proline 0 CA--C 1.566 1.559 0 C-N-CA 122.833 0.453 . . . . 0.0 112.113 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -82.19 -36.56 0.28 Allowed 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.251 1.967 . . . . 0.0 112.006 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -129.13 17.52 6.09 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.631 0.772 . . . . 0.0 111.814 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 HD21 ' A' ' 16' ' ' LEU . 30.0 mt -67.23 123.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 118.577 0.626 . . . . 0.0 111.28 -175.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -101.29 86.55 0.76 Allowed Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.88 -5.45 17.04 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.381 2.054 . . . . 0.0 113.698 -163.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.81 -11.26 68.35 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.246 -0.434 . . . . 0.0 113.347 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 10' ' ' LEU . 19.7 m -122.07 169.38 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.203 0.601 . . . . 0.0 110.842 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 15.6 m -81.89 -34.99 29.7 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.351 1.06 . . . . 0.0 111.877 -176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -88.81 170.82 10.42 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.778 0.799 . . . . 0.0 112.175 -175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.527 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -125.83 133.02 52.11 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 m -55.47 -66.52 0.4 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 123.823 0.702 . . . . 0.0 110.406 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -146.72 134.18 20.84 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.8 mt -99.59 126.3 37.78 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 169.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.78 121.72 9.55 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.585 2.19 . . . . 0.0 111.683 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.475 ' HA ' HD23 ' A' ' 24' ' ' LEU . 10.1 pt20 -62.1 -23.95 66.83 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.991 0.917 . . . . 0.0 112.059 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.63 -37.09 86.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.71 0.804 . . . . 0.0 110.999 172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 27' ' ' ILE . 23.3 m -76.97 -29.83 55.72 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.468 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.6 mm? -61.0 -41.33 96.31 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 171.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -54.51 -43.27 71.69 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.935 0.894 . . . . 0.0 112.714 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.9 pt-20 -72.9 -40.72 65.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 123.234 0.334 . . . . 0.0 110.904 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 23' ' ' THR . 33.7 mm -61.97 -39.98 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.329 0.652 . . . . 0.0 110.084 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.4 mmm180 -60.88 -25.48 66.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.999 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -87.06 -41.86 13.51 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.252 0.621 . . . . 0.0 112.073 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' GLU . 45.2 mt-30 -63.92 -31.44 72.62 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.562 0.745 . . . . 0.0 111.982 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -55.63 -33.44 64.03 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.337 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.45 -37.73 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.245 0.618 . . . . 0.0 110.287 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 mmt85 -61.61 -24.24 66.56 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.787 0.835 . . . . 0.0 111.178 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.67 2.63 67.15 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.231 -176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 122.53 19.08 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 123.821 0.849 . . . . 0.0 110.269 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -164.9 96.33 0.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.611 1.164 . . . . 0.0 108.361 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -105.28 125.32 50.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.96 116.8 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.155 0.982 . . . . 0.0 108.409 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 40.5 mtm105 -86.17 101.34 12.92 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.734 HD11 HD11 ' A' ' 80' ' ' ILE . 48.1 mt -76.12 77.67 2.95 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 170.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.23 -101.29 0.66 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.284 -171.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.51 -25.93 17.38 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.143 0.977 . . . . 0.0 111.217 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 72' ' ' ILE . 61.4 mt -71.77 131.06 42.56 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.757 0.823 . . . . 0.0 111.143 -177.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.429 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 9.9 tpt -98.14 99.94 11.22 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.48 152.9 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.957 0.903 . . . . 0.0 108.979 175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -134.34 98.61 4.14 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.6 0.76 . . . . 0.0 109.52 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 84' ' ' LEU . 40.7 mm -93.19 84.13 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 -129.45 117.14 18.64 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.05 -55.0 0.87 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.414 2.076 . . . . 0.0 112.305 -176.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.4 tpt 68.33 141.06 0.04 OUTLIER 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.613 1.196 . . . . 0.0 110.702 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -78.26 167.81 20.8 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.067 -0.396 . . . . 0.0 110.726 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.8 t 67.48 76.63 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 124.649 1.18 . . . . 0.0 110.009 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 60.6 t30 68.64 16.67 9.01 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.607 1.563 . . . . 0.0 112.987 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.59 137.08 13.52 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 122.217 -0.302 . . . . 0.0 112.926 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.448 ' HB2' HG11 ' A' ' 94' ' ' VAL . 48.3 m-85 -126.25 146.52 49.96 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.302 1.041 . . . . 0.0 109.564 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -97.25 126.44 42.46 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-O 121.503 0.668 . . . . 0.0 110.763 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 14.0 ptt? -174.75 -174.38 0.8 Allowed 'General case' 0 C--O 1.245 0.853 0 C-N-CA 126.71 2.004 . . . . 0.0 106.996 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.24 109.24 0.47 Allowed Glycine 0 CA--C 1.541 1.657 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 -175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -134.82 122.32 21.9 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.434 1.094 . . . . 0.0 108.203 170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.1 tm? -99.49 124.23 44.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.633 0.773 . . . . 0.0 109.545 -174.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -70.68 105.75 3.28 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 173.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -88.04 -8.73 55.13 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.913 0.885 . . . . 0.0 112.072 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -63.64 115.76 5.04 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.478 0.711 . . . . 0.0 111.21 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.95 -5.19 83.38 Favored Glycine 0 C--N 1.351 1.392 0 O-C-N 123.793 0.683 . . . . 0.0 113.843 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -89.03 169.26 11.67 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 122.018 0.913 . . . . 0.0 111.93 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 70' ' ' ILE . 34.5 t -101.75 158.88 15.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.422 172.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.53 -26.02 68.51 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.129 0.572 . . . . 0.0 111.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.23 -48.96 76.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.32 0.648 . . . . 0.0 110.181 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.97 -35.93 81.79 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.881 0.873 . . . . 0.0 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 66' ' ' SER . 37.5 mm -61.66 -40.27 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.933 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -55.48 -57.77 10.51 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.909 0.755 . . . . 0.0 112.008 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.0 mp -66.01 -34.85 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.55 -57.3 20.56 Favored Glycine 0 C--N 1.351 1.408 0 CA-C-N 114.69 -1.141 . . . . 0.0 113.175 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 70' ' ' ILE . 3.7 pp -66.95 -30.65 70.84 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.954 0.501 . . . . 0.0 111.614 -173.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 23.1 mm-40 -60.72 -54.63 42.93 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 123.531 0.519 . . . . 0.0 110.048 175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' ILE . 12.9 m-85 -60.79 -35.91 77.65 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.679 176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -62.64 -35.9 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.956 0.902 . . . . 0.0 111.561 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.75 -31.58 66.82 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.457 0.473 . . . . 0.0 110.5 177.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.78 -32.59 62.07 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.702 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.734 HD11 HD11 ' A' ' 40' ' ' LEU . 95.5 mt -74.07 -29.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 123.863 0.865 . . . . 0.0 109.734 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 12.8 tt0 -58.01 -35.7 71.62 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.976 0.911 . . . . 0.0 110.551 174.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -75.87 -43.96 43.0 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.229 0.612 . . . . 0.0 110.692 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.7 m -65.93 -25.15 67.01 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.456 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 90.9 mt -129.98 43.86 3.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.825 1.25 . . . . 0.0 109.546 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -68.29 97.08 0.7 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.717 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -137.46 108.41 6.71 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.699 0.8 . . . . 0.0 108.98 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.77 -134.88 7.69 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.984 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -163.47 41.2 0.1 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.639 0.776 . . . . 0.0 109.531 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.1 164.36 38.96 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.673 0.389 . . . . 0.0 111.959 -171.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.7 m -82.49 161.87 22.24 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.487 1.115 . . . . 0.0 111.423 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -59.62 -40.39 87.41 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.943 0.897 . . . . 0.0 110.935 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.54 -39.25 76.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.388 0.675 . . . . 0.0 110.843 173.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.6 -35.3 78.7 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.222 0.609 . . . . 0.0 111.98 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 55' ' ' TYR . 28.0 m -79.39 -28.98 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 118.332 0.515 . . . . 0.0 111.102 174.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.5 m -68.9 -42.46 76.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.835 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.3 m -65.21 -27.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 O-C-N 123.614 0.571 . . . . 0.0 111.569 -177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 mt -63.26 -39.7 95.34 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 121.586 0.707 . . . . 0.0 110.22 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -32.06 32.86 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.26 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.69 -15.55 56.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.033 0.933 . . . . 0.0 112.482 -167.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.568 1.643 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.523 176.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 CA--C 1.55 0.975 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.31 138.19 8.61 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.27 2.647 . . . . 0.0 113.424 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 38' ' ' ILE . 61.9 t -88.62 94.14 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 123.967 0.907 . . . . 0.0 109.442 174.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.73 99.31 0.45 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.169 0.988 . . . . 0.0 110.259 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.555 HD13 HG21 ' A' ' 23' ' ' THR . 56.1 tp -117.83 98.73 6.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.728 . . . . 0.0 109.208 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.0 t -158.33 60.3 1.77 Allowed Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.649 0.78 . . . . 0.0 110.97 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.7 -36.03 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.7 0 C-N-CA 122.536 2.158 . . . . 0.0 112.286 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -128.43 -4.78 5.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.611 0.764 . . . . 0.0 111.552 -173.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.8 mt -48.07 124.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -161.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.1 mt -107.74 90.22 6.04 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.437 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.34 -19.41 38.18 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.458 2.105 . . . . 0.0 112.589 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.63 -2.41 80.55 Favored Glycine 0 C--N 1.345 1.083 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.983 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.92 173.43 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.51 0.655 . . . . 0.0 110.349 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.9 m -91.5 -13.39 32.24 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.269 1.027 . . . . 0.0 111.877 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -114.65 -172.86 2.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.794 0.838 . . . . 0.0 110.482 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.583 HD23 HG12 ' A' ' 19' ' ' ILE . 16.0 tp -143.33 139.71 30.21 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 167.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -50.03 -41.99 48.57 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.76 1.224 . . . . 0.0 112.183 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -166.47 147.66 6.35 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.597 0.759 . . . . 0.0 110.029 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.583 HG12 HD23 ' A' ' 16' ' ' LEU . 69.1 mt -121.24 130.47 24.81 Favored Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 168.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -51.99 116.63 2.9 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 122.964 2.442 . . . . 0.0 111.63 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' HA ' HD23 ' A' ' 24' ' ' LEU . 25.6 mp0 -63.75 -27.24 69.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.619 1.168 . . . . 0.0 110.384 -175.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.15 -36.13 83.28 Favored 'General case' 0 C--N 1.348 0.509 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.077 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.555 HG21 HD13 ' A' ' 5' ' ' LEU . 48.3 m -66.77 -36.28 82.06 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.671 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 83' ' ' THR . 3.8 mm? -63.27 -42.75 99.16 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 118.156 0.435 . . . . 0.0 110.292 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.3 t -61.21 -39.47 90.38 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.563 0.745 . . . . 0.0 110.849 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 38.3 tt0 -65.62 -45.12 84.28 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.608 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 23' ' ' THR . 96.4 mt -60.3 -41.83 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.245 1.018 . . . . 0.0 110.184 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' HG2' ' HE1' ' A' ' 56' ' ' PHE . 20.4 mtp180 -63.52 -25.47 68.27 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.459 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.39 -34.88 25.45 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.613 0.765 . . . . 0.0 111.548 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.613 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 5.4 mm100 -73.21 -31.32 64.1 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.423 0.63 . . . . 0.0 110.239 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -68.27 -19.02 64.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.193 174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.24 -33.51 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.9 ttp-105 -70.47 -31.15 68.18 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.211 0.605 . . . . 0.0 110.11 168.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.5 3.09 50.39 Favored Glycine 0 N--CA 1.468 0.81 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.258 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -134.97 107.59 7.41 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.905 0.882 . . . . 0.0 109.333 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -136.64 95.85 3.23 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 168.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -101.56 98.11 8.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.556 HG22 HD22 ' A' ' 40' ' ' LEU . 1.9 mp -94.22 117.79 38.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -172.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.2 mtm105 -89.59 104.65 17.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD22 HG22 ' A' ' 38' ' ' ILE . 3.9 mm? -76.68 74.88 3.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.35 -104.31 1.26 Allowed Glycine 0 C--N 1.346 1.118 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.62 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.85 -20.55 23.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.123 0.969 . . . . 0.0 110.572 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 43.7 mt -78.13 146.52 35.08 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.471 0.708 . . . . 0.0 110.543 -177.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.5 tpt -116.72 121.21 40.97 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.1 t -129.85 123.99 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.341 1.057 . . . . 0.0 109.435 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' SER . 66.9 m -98.58 97.68 8.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.212 0.605 . . . . 0.0 110.416 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 mm -85.16 100.7 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 173.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -127.88 141.55 41.5 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.03 -26.05 66.1 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.166 2.578 . . . . 0.0 112.445 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 62.5 mtt 76.43 -21.99 0.29 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.843 1.657 . . . . 0.0 112.748 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 60.22 99.85 0.02 OUTLIER 'General case' 0 C--N 1.368 1.375 0 C-N-CA 125.227 1.411 . . . . 0.0 109.646 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.6 t 71.5 155.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 124.998 1.319 . . . . 0.0 109.363 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.35 72.29 0.13 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.883 1.273 . . . . 0.0 109.392 -177.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.34 -127.25 17.01 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.932 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -163.83 -178.78 5.9 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.794 0.838 . . . . 0.0 111.046 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HE1' ' HG2' ' A' ' 28' ' ' ARG . 38.5 p90 -84.67 125.75 32.77 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 111.162 -174.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.61 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 23.8 ptt? -177.62 112.95 0.08 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.581 1.152 . . . . 0.0 109.002 175.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 43.29 103.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.182 1.372 . . . . 0.0 116.254 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 46' ' ' SER . 32.4 m -136.72 98.91 3.9 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 122.168 -0.607 . . . . 0.0 109.639 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.9 126.4 27.19 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.58 0.752 . . . . 0.0 109.35 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -96.93 93.11 6.44 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -82.58 -56.0 4.13 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.409 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p30 41.72 33.72 0.35 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 125.506 1.522 . . . . 0.0 113.508 -175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.14 45.27 2.23 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.53 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' A' ' 69' ' ' ASN . 14.4 tp -91.11 156.46 17.87 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.236 1.014 . . . . 0.0 110.225 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.2 m -67.85 144.54 55.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.107 0.563 . . . . 0.0 110.623 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -62.7 -23.36 67.11 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.615 0.766 . . . . 0.0 112.228 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.1 -48.51 73.43 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.708 0.803 . . . . 0.0 109.759 171.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.496 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . 1.4 m-20 -71.2 -26.36 62.92 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.147 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.66 -43.85 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.481 0.712 . . . . 0.0 109.859 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 26.9 tt0 -59.75 -58.94 6.39 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.204 1.001 . . . . 0.0 111.591 -175.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -69.26 -29.75 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -55.94 -57.66 17.93 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.592 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.569 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.74 -26.26 66.05 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.976 0.51 . . . . 0.0 111.802 -175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 16.1 mm-40 -65.3 -41.55 93.96 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.526 0.679 . . . . 0.0 110.577 172.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.489 ' O ' HG12 ' A' ' 80' ' ' ILE . 11.7 m-85 -77.98 -23.09 48.53 Favored 'General case' 0 C--O 1.21 -1.005 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.737 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -65.52 -47.77 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 118.563 0.619 . . . . 0.0 110.086 175.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -71.6 -28.49 63.85 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 123.949 0.781 . . . . 0.0 110.912 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -68.08 -50.32 55.78 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.197 0.311 . . . . 0.0 110.173 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 76' ' ' TYR . 45.8 mm -61.53 -39.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.755 0.822 . . . . 0.0 109.757 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.61 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 43.4 tt0 -57.74 -42.69 84.42 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.101 0.96 . . . . 0.0 111.174 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -71.8 -27.51 62.98 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.559 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.475 HG22 ' HG ' ' A' ' 24' ' ' LEU . 10.5 m -97.13 -23.41 16.23 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 123.767 0.827 . . . . 0.0 112.091 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 57' ' ' MET . 41.9 tp -109.94 -5.82 15.37 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.175 0.99 . . . . 0.0 111.094 -170.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.1 OUTLIER -49.85 138.31 15.14 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.674 0.79 . . . . 0.0 112.246 176.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -79.0 -33.23 45.17 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.453 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.67 172.2 45.24 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 m 70.18 -61.1 0.47 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.209 1.404 . . . . 0.0 110.849 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.89 138.74 38.26 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 23.7 m -92.6 153.52 18.97 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.355 0.662 . . . . 0.0 109.902 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.1 p -63.04 -52.47 62.72 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 124.02 0.928 . . . . 0.0 112.071 -172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -57.74 -34.02 69.09 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.497 0.719 . . . . 0.0 112.189 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.71 -33.08 72.35 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.941 0.897 . . . . 0.0 112.359 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.37 -36.21 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.992 0.517 . . . . 0.0 110.024 176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -64.07 -39.61 94.46 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.552 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -66.01 -32.83 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 0.0 111.086 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 71.3 mt -67.67 -35.61 79.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.213 0.605 . . . . 0.0 110.432 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -82.19 -25.47 34.22 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.087 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.14 -41.22 22.79 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.953 0.901 . . . . 0.0 111.42 -174.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.288 0.635 . . . . 0.0 111.068 -178.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -87.91 100.72 0.45 Allowed 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.904 2.403 . . . . 0.0 113.815 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.74 99.72 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.17 0.986 . . . . 0.0 109.127 170.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.55 110.42 3.66 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.2 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.9 tp -127.81 113.3 15.77 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.333 1.053 . . . . 0.0 110.154 -168.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -154.75 40.65 0.14 Allowed Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -81.66 -31.97 0.98 Allowed 'Trans proline' 0 C--N 1.388 2.634 0 C-N-CA 121.844 1.696 . . . . 0.0 112.998 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -128.09 21.99 6.22 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.665 0.786 . . . . 0.0 111.21 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.7 mt -70.67 128.24 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 120.905 0.383 . . . . 0.0 110.07 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.1 mm? -98.55 95.65 3.19 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 173.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.4 95.92 0.95 Allowed 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.975 2.45 . . . . 0.0 110.674 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.61 -35.2 0.75 Allowed Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.999 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.5 m -93.56 175.74 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.438 0.637 . . . . 0.0 111.535 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.7 p -85.03 -32.36 22.94 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.03 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -102.71 172.34 6.9 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.877 0.846 . . . . 0.0 112.91 -167.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.83 47.04 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.0 p -64.66 -62.76 1.38 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.591 0.757 . . . . 0.0 110.215 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -166.82 126.87 1.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.766 0.826 . . . . 0.0 109.137 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 82.0 mt -88.44 137.02 30.83 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.0 Cg_endo -55.22 129.62 36.23 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.513 2.142 . . . . 0.0 111.251 176.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -23.68 62.9 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.593 0.757 . . . . 0.0 112.822 -174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.0 pt-20 -63.52 -32.51 73.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.095 0.958 . . . . 0.0 111.326 176.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 43.3 m -70.9 -46.71 62.07 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.551 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -65.09 -27.46 68.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.55 0.159 . . . . 0.0 111.055 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.5 m -73.12 -44.2 60.57 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 111.045 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.0 -28.77 62.57 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.451 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -68.43 -42.92 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.641 0.776 . . . . 0.0 109.324 170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.4 tpt85 -64.21 -24.66 67.75 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.542 0.737 . . . . 0.0 110.833 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -75.66 -54.68 6.59 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.915 0.886 . . . . 0.0 111.002 175.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.7 pt20 -68.27 -25.02 64.96 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.36 0.664 . . . . 0.0 112.553 -176.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 37.8 p -64.98 -33.42 76.01 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.414 0.285 . . . . 0.0 111.186 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -66.15 -32.57 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.849 0.46 . . . . 0.0 110.187 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -71.01 -26.56 63.18 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.083 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.23 11.94 57.97 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.958 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -138.34 105.96 5.59 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -147.09 126.29 12.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 0.0 109.957 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.448 HE21 ' NH2' ' A' ' 48' ' ' ARG . 26.9 mp0 -130.06 137.93 50.47 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.595 0.758 . . . . 0.0 108.963 175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.49 112.17 30.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 21.2 mtm105 -87.52 95.46 10.04 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 96.4 mt -80.77 69.51 7.33 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.559 0.695 . . . . 0.0 109.505 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.91 -103.53 1.31 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.079 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -93.38 -19.14 21.6 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.966 0.906 . . . . 0.0 110.375 176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -76.85 109.67 10.83 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.48 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 14.1 tpt -87.75 111.8 21.73 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.0 t -110.16 153.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 59' ' ' SER . 61.1 m -137.77 139.47 40.08 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.482 1.113 . . . . 0.0 108.337 172.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 28.3 mm -123.62 100.76 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' NH2' HE21 ' A' ' 37' ' ' GLN . 67.5 mtt85 -129.77 129.21 23.06 Favored Pre-proline 0 N--CA 1.478 0.947 0 CA-C-O 118.966 -0.54 . . . . 0.0 109.55 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.02 151.65 45.03 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.366 2.044 . . . . 0.0 111.533 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.484 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 12.6 tpt -89.19 149.89 22.92 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 171.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -56.94 -35.75 69.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.735 1.214 . . . . 0.0 112.372 -175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 p -163.62 149.3 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.627 0.771 . . . . 0.0 109.605 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.14 30.33 19.79 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.262 1.025 . . . . 0.0 111.59 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -164.49 146.73 11.69 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.121 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -123.64 -178.34 4.0 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.925 1.29 . . . . 0.0 111.099 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -123.94 118.21 26.54 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.718 0.807 . . . . 0.0 110.041 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -167.51 107.24 0.57 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.885 0.874 . . . . 0.0 108.938 167.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' HA3' HG23 ' A' ' 77' ' ' ILE . . . 55.5 106.98 0.01 OUTLIER Glycine 0 CA--C 1.54 1.653 0 CA-C-N 115.372 -0.831 . . . . 0.0 115.006 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 46' ' ' SER . 47.1 t -133.58 97.77 4.03 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.69 107.79 4.7 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.502 0.721 . . . . 0.0 109.464 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.1 96.93 1.83 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -74.27 -6.87 50.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.884 0.874 . . . . 0.0 111.984 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -67.19 115.36 6.78 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.414 0.685 . . . . 0.0 110.05 176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.78 -6.79 67.5 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.248 0.452 . . . . 0.0 113.197 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD11 ' H ' ' A' ' 44' ' ' MET . 10.9 mp -98.68 163.2 12.74 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 111.419 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 70' ' ' ILE . 23.0 t -115.1 172.23 7.19 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.984 173.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -53.42 -40.13 64.9 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 124.229 1.011 . . . . 0.0 112.791 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -67.22 -40.75 86.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.542 0.737 . . . . 0.0 111.198 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -68.16 -29.6 68.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.486 0.714 . . . . 0.0 111.012 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 66' ' ' SER . 43.3 mm -65.51 -46.11 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.167 0.587 . . . . 0.0 109.963 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -58.09 -55.29 36.91 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.068 0.855 . . . . 0.0 110.879 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 43' ' ' LEU . 34.0 mt -60.8 -38.77 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 O-C-N 123.689 0.618 . . . . 0.0 110.06 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.452 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -59.52 -57.33 20.16 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 114.684 -1.144 . . . . 0.0 113.066 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.1 pp -64.96 -26.35 68.26 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.851 0.46 . . . . 0.0 111.634 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -64.56 -48.51 74.76 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.573 0.545 . . . . 0.0 110.379 172.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' O ' HG12 ' A' ' 80' ' ' ILE . 26.1 m-85 -67.35 -29.12 68.58 Favored 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 119.312 -0.375 . . . . 0.0 111.279 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.3 -44.43 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 123.817 0.847 . . . . 0.0 111.158 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.74 -20.92 61.1 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 120.89 0.376 . . . . 0.0 111.026 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -81.9 -27.04 33.63 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.8 mm -69.89 -35.71 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 122.896 0.478 . . . . 0.0 110.683 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -66.5 -30.98 71.43 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 110.564 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -75.89 -32.82 59.83 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.697 0.799 . . . . 0.0 110.913 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.8 m -78.75 -38.39 38.85 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.482 0.713 . . . . 0.0 110.375 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.3 mt -95.95 47.42 1.1 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.055 1.342 . . . . 0.0 108.634 171.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -54.34 107.95 0.33 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.975 0.91 . . . . 0.0 111.73 -171.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -75.87 178.79 5.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.446 1.099 . . . . 0.0 111.851 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.97 -125.66 3.25 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.641 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.6 m -74.29 104.52 5.09 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.833 0.853 . . . . 0.0 109.826 177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tt -162.0 139.32 8.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 19.6 m -111.32 147.48 35.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.837 0.855 . . . . 0.0 109.242 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 p -49.03 -50.72 34.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.697 1.199 . . . . 0.0 112.291 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -63.69 -28.5 69.94 Favored 'General case' 0 C--O 1.212 -0.884 0 C-N-CA 123.996 0.918 . . . . 0.0 112.431 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 43.5 mt-10 -59.51 -39.02 82.51 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 118.546 0.612 . . . . 0.0 112.544 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.54 -32.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 122.8 0.44 . . . . 0.0 111.319 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -69.9 -27.61 64.94 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.092 0.557 . . . . 0.0 111.469 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.9 p -66.69 -22.85 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 123.439 0.695 . . . . 0.0 110.951 -175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.2 mt -61.24 -35.15 76.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 121.183 0.516 . . . . 0.0 110.681 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -82.41 -31.29 29.66 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.836 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -71.96 -58.3 3.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.458 0.703 . . . . 0.0 111.39 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 96' ' ' VAL . 31.2 pt . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.571 -0.728 . . . . 0.0 110.528 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.28 106.62 1.91 Allowed 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.426 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 HG13 ' A' ' 38' ' ' ILE . 5.7 p -80.23 94.37 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 CA-C-O 121.793 0.806 . . . . 0.0 109.643 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 9.4 p-10 -64.2 123.69 19.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.135 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -131.01 106.41 8.38 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.565 0.746 . . . . 0.0 109.681 -174.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -150.07 71.0 9.38 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 121.498 0.666 . . . . 0.0 110.329 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -91.87 -40.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.827 2.352 . . . . 0.0 113.318 175.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.524 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 66.3 m-85 -129.18 20.45 5.81 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.092 0.957 . . . . 0.0 111.122 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.584 HG12 HD21 ' A' ' 16' ' ' LEU . 19.6 mt -72.5 129.83 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.571 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -107.34 87.45 3.27 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -69.48 -4.46 13.88 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.66 2.24 . . . . 0.0 114.284 -163.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.89 -8.59 72.53 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.218 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 10' ' ' LEU . 20.9 m -126.52 175.99 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 123.594 0.758 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 p -88.22 -28.76 20.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.306 1.042 . . . . 0.0 112.4 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -91.95 166.38 12.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.417 0.627 . . . . 0.0 112.002 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.584 HD21 HG12 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -112.39 149.3 32.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.925 1.29 . . . . 0.0 107.708 177.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 55.0 m -67.58 -58.94 3.82 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -171.91 149.73 2.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.034 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 83.5 mt -115.01 134.68 22.47 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.86 126.54 22.82 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.498 2.132 . . . . 0.0 111.7 171.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.104 0.962 . . . . 0.0 110.994 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.35 -44.35 95.64 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.242 1.017 . . . . 0.0 110.782 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.646 HG21 HD13 ' A' ' 5' ' ' LEU . 13.7 m -72.19 -34.52 68.48 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.793 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.81 -40.94 97.02 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.786 0.266 . . . . 0.0 111.115 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 m -66.81 -36.83 83.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.489 0.716 . . . . 0.0 110.345 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 11.7 tp10 -60.4 -45.38 93.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.227 1.011 . . . . 0.0 110.294 175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' THR . 97.5 mt -60.9 -48.86 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.447 1.099 . . . . 0.0 110.701 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -68.72 -24.73 64.51 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 118.84 -0.6 . . . . 0.0 112.515 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.569 ' ND2' ' HA ' ' A' ' 26' ' ' GLU . 8.8 p30 -85.13 -35.66 21.6 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.599 0.636 . . . . 0.0 111.879 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.438 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 3.8 pt20 -75.68 -23.39 56.2 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.148 0.579 . . . . 0.0 111.812 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' ILE . 35.0 p -56.82 -25.45 55.97 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 mp -67.9 -19.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.246 1.018 . . . . 0.0 110.858 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 30' ' ' GLN . 2.9 mpt_? -75.16 -8.49 56.72 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.376 1.07 . . . . 0.0 111.159 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.43 -22.85 37.8 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 123.44 0.543 . . . . 0.0 112.927 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.1 134.64 33.17 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 108.865 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -145.3 97.63 3.03 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -100.09 122.87 43.62 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.046 0.538 . . . . 0.0 110.716 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.456 HG13 HG13 ' A' ' 3' ' ' VAL . 2.6 mp -109.31 113.43 44.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 71.3 mtt180 -85.0 92.1 8.25 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.62 76.7 1.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.242 0.544 . . . . 0.0 109.893 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -102.13 0.75 Allowed Glycine 0 C--N 1.35 1.343 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.423 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.01 -18.18 20.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.408 0.683 . . . . 0.0 110.979 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt -84.52 113.58 21.33 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.909 0.884 . . . . 0.0 110.167 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.722 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.4 tpt -85.1 111.64 19.94 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.85 148.46 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 t -134.02 110.12 9.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.193 0.52 . . . . 0.0 109.668 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' A' ' 56' ' ' PHE . 31.9 mm -87.44 107.11 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 51' ' ' GLN . 14.2 ptm180 -154.29 128.45 4.61 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-N 118.709 0.686 . . . . 0.0 111.176 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HG3' ' HD1' ' A' ' 56' ' ' PHE . 31.3 Cg_exo -59.5 -49.04 11.38 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.256 2.637 . . . . 0.0 113.546 -178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.8 tpt -86.12 64.6 8.66 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.712 0.768 . . . . 0.0 110.673 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.503 ' HB3' ' HG3' ' A' ' 48' ' ' ARG . 5.8 tp-100 -176.67 -52.98 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.065 1.346 . . . . 0.0 107.871 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 68.0 t -70.27 -35.39 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.971 175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 97' ' ' LEU . 56.2 t30 73.54 143.61 0.07 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 126.198 1.799 . . . . 0.0 110.966 -178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.79 -75.75 2.33 Favored Glycine 0 C--N 1.343 0.922 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -134.03 177.34 7.81 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.299 1.04 . . . . 0.0 110.327 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 47' ' ' ILE . 35.9 p90 -101.42 116.46 32.83 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.357 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.705 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 55.6 mtm -145.37 -176.03 4.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.725 0.81 . . . . 0.0 109.535 174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' HG2' ' A' ' 81' ' ' GLU . . . -54.37 113.52 3.46 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.324 1.015 . . . . 0.0 114.467 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.2 t -129.51 113.0 14.32 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.482 HD11 HD23 ' A' ' 65' ' ' LEU . 3.2 tm? -79.22 112.76 16.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.317 0.647 . . . . 0.0 109.834 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -78.85 115.59 18.64 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.894 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 10.2 pt20 -79.47 -64.96 1.07 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.074 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t70 59.86 19.05 7.97 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.8 0.81 . . . . 0.0 110.811 -173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.1 43.56 4.67 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD11 ' A' ' 60' ' ' LEU . 21.2 tp -80.46 146.14 31.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.922 0.889 . . . . 0.0 110.431 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.1 m -65.09 148.8 51.0 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.486 0.714 . . . . 0.0 111.285 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -59.5 -33.53 71.46 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.331 1.052 . . . . 0.0 112.895 -170.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.485 ' O ' HG12 ' A' ' 72' ' ' ILE . 6.5 p-10 -71.44 -42.35 68.35 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.67 -34.95 78.99 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.868 0.867 . . . . 0.0 111.714 175.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.5 mm -58.01 -43.2 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 123.363 0.665 . . . . 0.0 109.461 172.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -64.24 -56.75 12.47 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.922 0.763 . . . . 0.0 110.95 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' ASP . 7.4 mm -57.08 -38.1 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.526 0.679 . . . . 0.0 109.352 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.25 -58.05 14.26 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.426 178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.558 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.89 -22.93 66.55 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.669 0.735 . . . . 0.0 111.891 -175.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 78' ' ' GLU . 25.1 mm-40 -70.86 -46.45 62.65 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.632 0.773 . . . . 0.0 110.145 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.504 ' O ' HG12 ' A' ' 80' ' ' ILE . 13.8 m-85 -69.84 -27.2 64.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.201 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -61.98 -51.42 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.625 0.77 . . . . 0.0 109.893 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 75' ' ' GLN . 12.5 pt-20 -64.42 -34.66 78.69 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.475 0.484 . . . . 0.0 110.411 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -71.95 -31.5 66.38 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.873 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 76' ' ' TYR . 28.5 mm -69.77 -43.7 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.705 ' HG2' ' HB3' ' A' ' 57' ' ' MET . 44.9 mt-10 -60.75 -36.99 80.32 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.604 0.761 . . . . 0.0 111.377 -175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -73.28 -39.3 65.48 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.929 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -74.42 -22.93 58.9 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.672 0.789 . . . . 0.0 111.202 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.0 tp -109.43 10.0 25.42 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.225 1.01 . . . . 0.0 110.08 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -60.14 125.76 24.91 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.991 0.916 . . . . 0.0 109.858 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -73.38 -29.0 62.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.563 0.745 . . . . 0.0 111.503 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.72 -75.2 0.03 OUTLIER Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.3 m -136.77 19.69 3.06 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.12 0.968 . . . . 0.0 109.905 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.8 tp -62.59 140.48 58.66 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.005 1.322 . . . . 0.0 112.452 -173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 26.0 m -102.15 149.21 24.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.238 1.015 . . . . 0.0 109.545 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.6 m -64.02 -47.1 81.57 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.24 0.616 . . . . 0.0 110.408 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -62.17 -26.22 68.22 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 29.2 tp10 -57.34 -47.65 81.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.063 0.945 . . . . 0.0 111.306 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.5 m -84.11 -27.2 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.412 -178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.7 m -64.96 -45.24 86.56 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.156 0.582 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -68.31 -28.1 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 111.195 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . 75.0 mt -69.74 -38.56 76.86 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -80.51 -26.97 37.84 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.768 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.03 -34.92 69.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.721 0.808 . . . . 0.0 111.372 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt . . . . . 0 CA--C 1.553 1.062 0 C-N-CA 123.145 0.578 . . . . 0.0 110.293 174.082 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ptp . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 56.2 Cg_endo -68.97 91.79 0.44 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.572 2.181 . . . . 0.0 112.742 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.37 116.32 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.473 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -73.84 137.42 43.77 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.907 0.483 . . . . 0.0 110.455 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.47 HD21 HG23 ' A' ' 19' ' ' ILE . 5.4 tt -145.11 94.11 2.48 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.424 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -147.81 47.4 0.54 Allowed Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' A' ' 6' ' ' THR . 67.9 Cg_endo -85.18 -30.69 0.46 Allowed 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 121.88 1.72 . . . . 0.0 113.642 -176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -128.47 18.82 6.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.961 0.505 . . . . 0.0 111.542 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.623 HG12 HD21 ' A' ' 16' ' ' LEU . 20.6 mt -70.63 135.97 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 122.691 0.396 . . . . 0.0 111.307 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.584 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -117.31 85.59 19.94 Favored Pre-proline 0 CA--C 1.553 1.095 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.22 -19.7 22.12 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 123.017 2.478 . . . . 0.0 114.081 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.57 -39.2 90.88 Favored Glycine 0 C--N 1.346 1.127 0 O-C-N 123.425 0.453 . . . . 0.0 113.862 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.3 m -108.71 178.3 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 122.972 0.509 . . . . 0.0 111.666 -175.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.5 p -91.29 -24.89 19.7 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.256 1.023 . . . . 0.0 112.026 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -94.15 162.08 14.01 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.306 0.574 . . . . 0.0 111.589 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.623 HD21 HG12 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -103.66 142.82 33.66 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 10' ' ' LEU . 23.6 t -74.59 -48.8 24.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.879 0.471 . . . . 0.0 110.026 177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -162.19 142.56 10.13 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.47 HG23 HD21 ' A' ' 5' ' ' LEU . 76.0 mt -121.43 121.74 28.33 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 163.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.8 127.22 20.87 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.742 2.295 . . . . 0.0 111.118 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.58 -16.81 62.89 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.186 0.594 . . . . 0.0 111.182 -177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -65.76 -38.26 88.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.056 0.542 . . . . 0.0 110.35 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 17.9 m -74.66 -35.63 62.84 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.9 0.48 . . . . 0.0 109.836 175.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.19 -25.1 65.96 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.772 0.429 . . . . 0.0 111.138 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.9 t -68.8 -40.74 79.43 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.652 0.781 . . . . 0.0 110.962 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 23' ' ' THR . 12.8 pt-20 -71.66 -30.7 66.01 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 23' ' ' THR . 12.0 mm -65.29 -43.07 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 121.427 0.632 . . . . 0.0 109.57 172.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -62.04 -31.08 71.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.959 -174.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -86.37 -41.14 14.74 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 3.6 pt20 -70.58 -24.03 62.7 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.3 p -53.64 -36.31 61.93 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.014 0.526 . . . . 0.0 111.244 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.08 -36.45 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.621 0.768 . . . . 0.0 110.311 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -64.84 -16.62 63.38 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.595 0.758 . . . . 0.0 110.627 173.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.16 -19.17 25.2 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.671 -0.516 . . . . 0.0 113.41 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -138.2 131.03 29.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.109 0.48 . . . . 0.0 110.952 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -143.28 101.57 3.82 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.313 1.045 . . . . 0.0 108.439 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 42.1 mt-30 -109.67 115.41 29.82 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 40' ' ' LEU . 3.0 mp -107.66 126.61 64.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.519 0.728 . . . . 0.0 109.747 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -91.6 96.98 10.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.151 0.58 . . . . 0.0 110.243 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 38' ' ' ILE . 8.1 mp -81.76 71.85 8.8 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 169.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.34 -102.88 1.07 Allowed Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.26 -19.03 18.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.611 0.764 . . . . 0.0 110.445 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.48 ' HA ' HD11 ' A' ' 65' ' ' LEU . 17.6 mt -74.64 108.76 7.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.2 tpt -93.13 113.63 25.93 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -115.78 151.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.798 0.839 . . . . 0.0 109.521 -176.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.4 m -133.66 98.11 4.11 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.27 0.628 . . . . 0.0 109.921 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 49.5 mm -83.21 93.02 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.72 0.808 . . . . 0.0 109.0 177.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -127.04 126.39 24.32 Favored Pre-proline 0 N--CA 1.483 1.209 0 O-C-N 121.929 -0.482 . . . . 0.0 110.853 -174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 45.0 Cg_endo -78.79 -145.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 124.18 3.253 . . . . 0.0 112.831 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.4 tpp 80.73 162.05 0.16 Allowed 'General case' 0 C--N 1.371 1.505 0 C-N-CA 124.834 1.253 . . . . 0.0 110.352 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.57 -20.82 0.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.964 1.306 . . . . 0.0 114.371 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -65.85 112.67 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 C-N-CA 123.859 0.864 . . . . 0.0 110.217 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 61.53 18.63 9.63 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.592 1.157 . . . . 0.0 112.888 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.66 -76.89 2.05 Favored Glycine 0 C--N 1.349 1.303 0 C-N-CA 123.138 0.399 . . . . 0.0 113.583 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -131.45 178.09 6.99 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.932 0.893 . . . . 0.0 110.652 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 25.0 p90 -86.43 113.19 22.17 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 121.771 0.796 . . . . 0.0 111.373 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -119.1 -178.23 3.52 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.643 1.177 . . . . 0.0 108.2 167.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 77' ' ' ILE . . . -67.57 110.77 3.64 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.541 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.3 t -100.84 96.67 7.45 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.532 ' HB2' HG12 ' A' ' 77' ' ' ILE . 3.0 tm? -82.23 109.49 16.56 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -64.06 92.9 0.08 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.32 -17.88 57.93 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.826 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.23 101.8 4.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.14 -32.71 3.88 Favored Glycine 0 N--CA 1.471 1.031 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD11 ' HA ' ' A' ' 43' ' ' LEU . 69.5 mt -90.99 162.46 14.71 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.445 0.698 . . . . 0.0 110.554 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -148.07 145.82 28.59 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.121 0.568 . . . . 0.0 111.21 177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 37.55 -79.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 127.535 2.334 . . . . 0.0 116.32 172.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.1 p-10 -79.97 -42.76 23.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.12 0.568 . . . . 0.0 110.222 -170.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -67.8 -35.4 78.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.088 0.47 . . . . 0.0 110.066 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -55.94 -48.47 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.456 0.702 . . . . 0.0 110.876 169.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -59.9 -52.02 67.22 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.665 0.603 . . . . 0.0 111.044 -177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ASP . 33.8 mt -57.87 -39.24 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 123.263 0.625 . . . . 0.0 109.702 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -62.99 -59.08 9.6 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.161 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.545 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.1 pp -68.13 -23.11 64.86 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.449 0.625 . . . . 0.0 112.261 -175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -73.98 -37.08 64.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.073 0.549 . . . . 0.0 110.978 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -72.54 -31.19 65.1 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.409 171.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.545 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -67.46 -39.28 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.707 0.803 . . . . 0.0 110.64 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -22.46 57.69 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 120.773 0.32 . . . . 0.0 110.511 178.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -75.41 -40.43 57.83 Favored 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.417 0.687 . . . . 0.0 110.167 168.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.57 HG23 HD23 ' A' ' 84' ' ' LEU . 42.8 mt -73.98 -33.68 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 0.0 111.528 -173.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -64.05 -33.05 74.86 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 120.928 0.394 . . . . 0.0 110.372 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -76.73 -37.1 56.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.008 0.923 . . . . 0.0 111.134 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.6 m -71.78 -42.78 66.74 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.037 0.535 . . . . 0.0 111.108 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.57 HD23 HG23 ' A' ' 80' ' ' ILE . 3.9 mm? -100.55 21.69 12.93 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.273 1.029 . . . . 0.0 110.964 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -61.53 146.31 49.1 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.705 0.802 . . . . 0.0 109.117 172.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -64.82 -33.39 75.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.946 0.499 . . . . 0.0 111.091 -175.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.7 -44.14 0.6 Allowed Glycine 0 C--N 1.347 1.169 0 CA-C-N 116.529 -0.305 . . . . 0.0 112.674 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.6 m -148.06 73.92 1.28 Allowed 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.205 1.002 . . . . 0.0 108.731 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.52 140.23 27.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.367 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 52.3 m -91.35 144.31 25.72 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.565 0.746 . . . . 0.0 109.009 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 p -60.25 -49.46 77.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.403 0.681 . . . . 0.0 110.364 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -50.67 -33.95 24.58 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.093 1.357 . . . . 0.0 112.399 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -61.26 -42.4 98.57 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.297 0.639 . . . . 0.0 111.19 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.84 -20.83 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 C-N-CA 122.621 0.368 . . . . 0.0 111.442 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 98' ' ' ARG . 96.1 m -75.37 -30.74 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.131 0.572 . . . . 0.0 111.759 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.38 -18.37 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-N 118.19 0.45 . . . . 0.0 112.136 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 mp -69.86 -42.11 73.94 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.727 0.411 . . . . 0.0 110.116 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -81.84 -29.27 32.62 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.751 0.421 . . . . 0.0 110.884 177.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -71.45 -27.03 62.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.899 0.88 . . . . 0.0 111.609 -168.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 CA--C 1.561 1.396 0 C-N-CA 123.166 0.586 . . . . 0.0 110.618 173.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 tmm? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.43 102.56 1.57 Allowed 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.644 2.229 . . . . 0.0 113.209 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -69.46 127.78 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.42 175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.91 140.81 42.32 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -146.02 87.97 1.79 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 12.8 t -147.04 37.12 0.18 Allowed Pre-proline 0 CA--C 1.571 1.779 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.3 Cg_endo -79.69 -32.47 1.56 Allowed 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 121.609 1.54 . . . . 0.0 111.758 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 59.5 m-85 -129.23 24.89 5.53 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.882 0.873 . . . . 0.0 111.529 -173.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 6' ' ' THR . 17.7 mt -67.79 123.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 120.989 0.423 . . . . 0.0 110.524 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 13' ' ' VAL . 62.8 mt -107.32 91.61 7.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 175.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -76.62 86.47 1.58 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.513 2.142 . . . . 0.0 110.866 -171.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.53 -37.44 0.27 Allowed Glycine 0 C--N 1.338 0.657 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.598 -173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 10' ' ' LEU . 11.5 m -93.36 167.88 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 122.993 0.517 . . . . 0.0 110.392 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 45.3 m -78.82 -37.22 41.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.425 0.69 . . . . 0.0 111.499 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -91.85 177.85 6.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.44 0.696 . . . . 0.0 112.272 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 140.6 49.46 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 22.8 m -52.55 -58.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.303 0.641 . . . . 0.0 111.059 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -172.24 135.53 0.77 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.608 1.163 . . . . 0.0 108.018 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 83' ' ' THR . 65.3 mt -105.91 127.86 27.55 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.08 130.35 31.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.849 2.366 . . . . 0.0 112.517 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -65.53 -14.91 62.06 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.117 0.567 . . . . 0.0 111.409 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -64.97 -43.32 93.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.642 0.777 . . . . 0.0 110.252 171.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.3 m -65.82 -42.21 90.9 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.063 175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 9.4 mp -58.6 -39.11 79.5 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.849 0.46 . . . . 0.0 110.52 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -39.16 69.49 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.711 0.804 . . . . 0.0 111.818 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -72.08 -27.11 62.45 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HA ' HE21 ' A' ' 30' ' ' GLN . 83.9 mt -68.53 -42.65 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 122.734 0.414 . . . . 0.0 109.997 169.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 20.1 mmt180 -63.5 -25.17 68.13 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.389 0.675 . . . . 0.0 110.883 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -76.42 -52.73 9.29 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.446 0.698 . . . . 0.0 110.696 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.456 HE21 ' HA ' ' A' ' 27' ' ' ILE . 25.7 pt20 -70.03 -27.57 64.77 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.855 0.462 . . . . 0.0 111.813 -176.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' HG3' ' A' ' 49' ' ' PRO . 8.3 p -61.91 -24.11 66.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.052 0.541 . . . . 0.0 112.272 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.6 mm -65.51 -23.35 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 122.944 0.498 . . . . 0.0 110.924 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.13 0.87 26.38 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.718 0.807 . . . . 0.0 111.029 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.23 -17.84 54.11 Favored Glycine 0 C--N 1.349 1.304 0 C-N-CA 123.432 0.539 . . . . 0.0 112.698 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -138.37 131.48 30.0 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.914 0.885 . . . . 0.0 110.213 -175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -126.78 133.36 50.84 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.155 0.982 . . . . 0.0 108.935 171.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -112.03 115.82 29.54 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -115.75 144.38 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.467 1.107 . . . . 0.0 108.24 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -128.54 88.59 2.76 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.994 0.917 . . . . 0.0 110.392 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 76' ' ' TYR . 88.4 mt -76.68 80.16 3.32 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.29 0.636 . . . . 0.0 109.809 175.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.75 -104.04 1.16 Allowed Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -99.04 -11.78 21.17 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.525 0.73 . . . . 0.0 110.966 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD13 ' HA2' ' A' ' 73' ' ' GLY . 52.9 mt -83.3 132.0 35.05 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.296 1.038 . . . . 0.0 110.236 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.05 128.65 54.85 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -127.48 120.76 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.051 0.94 . . . . 0.0 109.603 -173.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.6 m -100.84 110.32 22.38 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.774 0.83 . . . . 0.0 110.403 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 22.8 mm -101.84 115.08 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -133.59 103.49 12.27 Favored Pre-proline 0 N--CA 1.493 1.685 0 C-N-CA 122.754 0.422 . . . . 0.0 111.963 -171.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HG3' ' HB ' ' A' ' 31' ' ' THR . 52.5 Cg_endo -91.57 145.83 3.27 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.185 2.59 . . . . 0.0 113.65 167.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.6 ttm 169.12 -54.19 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.415 1.886 . . . . 0.0 106.36 168.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -178.82 -24.73 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.397 -1.728 . . . . 0.0 107.758 175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.4 t -57.42 137.02 20.03 Favored 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.359 1.063 . . . . 0.0 110.319 169.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 98' ' ' ARG . 17.2 m120 64.09 14.73 8.76 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.645 1.178 . . . . 0.0 112.36 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.487 ' HA3' HD23 ' A' ' 97' ' ' LEU . . . 65.89 -98.15 0.34 Allowed Glycine 0 C--N 1.352 1.462 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -169.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -96.7 160.41 14.39 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.518 0.727 . . . . 0.0 110.742 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.483 ' HB2' HG22 ' A' ' 47' ' ' ILE . 8.1 p90 -88.68 116.88 27.25 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.709 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.644 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 21.3 ptt? -172.89 -175.73 1.3 Allowed 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.437 1.095 . . . . 0.0 109.379 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -41.8 110.29 0.22 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 124.397 1.061 . . . . 0.0 115.618 -170.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 42.0 t -134.49 101.4 4.96 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.882 0.873 . . . . 0.0 108.79 174.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.71 111.72 8.12 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.843 0.857 . . . . 0.0 109.717 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -72.54 103.05 3.4 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.19 0.996 . . . . 0.0 108.987 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 63' ' ' ASP . 8.6 pt20 -98.99 -71.18 0.7 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 -174.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' H ' ' HG3' ' A' ' 62' ' ' GLN . 4.9 m-20 56.2 26.26 10.13 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 124.546 1.139 . . . . 0.0 113.323 172.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.51 12.38 6.19 Favored Glycine 0 N--CA 1.477 1.413 0 C-N-CA 123.308 0.48 . . . . 0.0 113.265 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.1 tp -64.68 153.61 39.04 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.882 0.873 . . . . 0.0 111.669 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.2 p -66.93 139.94 57.73 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.267 1.027 . . . . 0.0 110.92 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -57.9 -31.55 66.86 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.227 1.011 . . . . 0.0 113.363 -171.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.3 p-10 -65.15 -44.28 89.09 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.461 HD22 HD12 ' A' ' 72' ' ' ILE . 15.1 m120 -75.44 -19.37 59.51 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.455 0.702 . . . . 0.0 111.804 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 49.7 mm -65.8 -44.24 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 35.2 tt0 -66.84 -55.81 13.16 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.804 0.69 . . . . 0.0 110.281 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 69' ' ' ASN . 28.8 mt -56.81 -37.02 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 123.725 0.81 . . . . 0.0 109.928 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.455 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -60.88 -56.86 21.77 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.901 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.18 -27.23 68.56 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.203 0.501 . . . . 0.0 111.945 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 22.5 mm-40 -66.5 -47.0 74.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 0.0 110.332 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 12.4 m-85 -73.55 -27.11 61.16 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.362 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -68.5 -43.62 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.737 0.815 . . . . 0.0 110.456 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -71.36 -21.35 62.04 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 123.61 0.569 . . . . 0.0 110.947 177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -78.05 -40.42 38.78 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 121.171 -0.212 . . . . 0.0 111.242 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 26.4 mm -65.68 -29.59 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 123.219 0.608 . . . . 0.0 110.825 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.644 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.2 pt-20 -70.46 -39.5 74.27 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.25 -24.5 42.97 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 175.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.489 HG21 HD12 ' A' ' 19' ' ' ILE . 99.6 m -73.11 -55.68 6.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.611 0.765 . . . . 0.0 110.404 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.62 47.65 1.25 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.927 1.291 . . . . 0.0 108.367 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -59.06 130.3 46.35 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.78 -166.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -80.9 -147.78 0.06 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 125.779 1.632 . . . . 0.0 110.061 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.85 -102.1 0.02 OUTLIER Glycine 0 C--N 1.354 1.544 0 N-CA-C 112.311 -0.316 . . . . 0.0 112.311 167.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.7 m -154.79 104.69 2.53 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.96 0.904 . . . . 0.0 109.782 176.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.478 HD22 ' HB ' ' A' ' 94' ' ' VAL . 4.0 tt -152.98 139.46 18.65 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.414 ' N ' HD23 ' A' ' 89' ' ' LEU . 32.2 m -70.55 149.38 47.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.365 1.066 . . . . 0.0 111.493 -176.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -63.47 -50.23 70.5 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.366 0.667 . . . . 0.0 111.45 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.8 ttt-85 -62.07 -40.2 95.02 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.528 0.331 . . . . 0.0 110.227 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' LEU . 14.5 tp10 -66.6 -34.06 77.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.004 0.522 . . . . 0.0 111.149 -176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.478 ' HB ' HD22 ' A' ' 89' ' ' LEU . 1.4 p -80.3 -23.01 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.4 m -77.65 -34.66 53.05 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.954 0.902 . . . . 0.0 110.78 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.6 m -79.87 -25.82 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 HD23 ' HA3' ' A' ' 54' ' ' GLY . 23.9 tp -67.79 -42.03 82.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.517 1.127 . . . . 0.0 111.039 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HB3' ' HA ' ' A' ' 53' ' ' ASN . 13.3 ptp180 -79.66 -21.67 44.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.592 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.99 -40.96 68.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.099 0.56 . . . . 0.0 111.583 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.7 pt . . . . . 0 CA--C 1.568 1.657 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.516 -174.489 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 23.8 mmt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 5.3 Cg_exo -75.11 99.74 1.29 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.538 2.158 . . . . 0.0 110.5 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -54.59 107.23 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.165 0.986 . . . . 0.0 111.879 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.4 136.09 37.58 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 HD21 HD13 ' A' ' 19' ' ' ILE . 61.3 tp -136.27 95.51 3.2 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.61 1.164 . . . . 0.0 108.079 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.423 ' HA ' HG13 ' A' ' 9' ' ' ILE . 15.3 t -144.54 31.05 0.1 Allowed Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.83 -29.71 8.25 Favored 'Trans proline' 0 C--N 1.391 2.811 0 CA-C-N 121.565 1.595 . . . . 0.0 112.949 -176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 59.1 m-85 -129.44 26.27 5.38 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.602 0.761 . . . . 0.0 111.484 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 6' ' ' THR . 21.8 mt -71.76 135.4 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 173.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.48 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -109.9 90.19 8.98 Favored Pre-proline 0 C--O 1.245 0.847 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -71.43 90.91 0.68 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.913 2.409 . . . . 0.0 109.77 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.72 -43.06 0.28 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.667 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 10' ' ' LEU . 34.2 m -99.69 -175.88 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.328 0.651 . . . . 0.0 110.968 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -105.68 6.01 31.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.106 0.962 . . . . 0.0 112.755 -176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -126.91 165.76 18.77 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-O 121.435 0.636 . . . . 0.0 111.715 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.42 143.82 34.0 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 173.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.461 ' HB2' HD21 ' A' ' 10' ' ' LEU . 28.9 t -63.71 -60.68 3.0 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.545 0.738 . . . . 0.0 109.834 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.4 138.6 0.71 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.537 1.135 . . . . 0.0 108.548 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 83' ' ' THR . 76.4 mt -104.52 137.18 19.15 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 123.096 0.558 . . . . 0.0 109.616 176.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 18.5 Cg_endo -57.19 133.11 55.38 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.872 2.381 . . . . 0.0 111.94 170.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -61.57 -29.03 69.76 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.369 1.068 . . . . 0.0 112.128 -175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 12.4 pt-20 -60.0 -31.85 70.31 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 0.0 111.557 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.488 HG21 HD13 ' A' ' 5' ' ' LEU . 6.3 m -67.89 -50.32 56.97 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD22 ' H ' ' A' ' 24' ' ' LEU . 2.5 mm? -62.8 -27.06 69.05 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.729 0.412 . . . . 0.0 110.659 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -69.92 -47.33 62.87 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.37 0.668 . . . . 0.0 111.046 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.8 -32.38 65.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.191 0.197 . . . . 0.0 110.979 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.2 mt -62.72 -44.58 99.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.547 0.739 . . . . 0.0 109.333 171.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 HH12 HD11 ' A' ' 32' ' ' ILE . 46.8 tpt85 -60.0 -27.85 67.22 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.558 0.743 . . . . 0.0 111.606 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.09 -46.23 15.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.538 0.735 . . . . 0.0 111.621 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -75.29 -25.89 58.28 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.994 0.518 . . . . 0.0 111.867 -175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -62.12 -28.67 69.79 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.552 0.341 . . . . 0.0 111.281 173.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.441 HD11 HH12 ' A' ' 28' ' ' ARG . 49.2 mm -65.75 -30.54 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 122.987 0.515 . . . . 0.0 110.527 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -70.87 -13.06 61.89 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.419 0.688 . . . . 0.0 110.452 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.07 -21.88 21.83 Favored Glycine 0 C--N 1.348 1.207 0 C-N-CA 124.2 0.905 . . . . 0.0 112.919 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.586 ' HA ' ' HG2' ' A' ' 48' ' ' ARG . 34.6 tt0 -140.32 128.46 22.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.996 0.518 . . . . 0.0 110.979 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.13 130.39 53.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.89 0.876 . . . . 0.0 108.72 169.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -120.99 99.44 6.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.36 0.664 . . . . 0.0 109.328 -177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.15 123.09 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.877 0.871 . . . . 0.0 109.077 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 15.0 mtm180 -99.2 92.74 5.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 94.6 mt -74.45 75.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 -103.72 1.21 Allowed Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 -174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.19 -10.56 19.49 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.515 0.726 . . . . 0.0 110.71 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 13.9 mt -81.2 108.41 14.82 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.419 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 13.2 tpt -86.26 124.4 32.59 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.02 126.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.795 0.838 . . . . 0.0 109.651 -172.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -107.57 99.76 9.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.596 0.758 . . . . 0.0 110.569 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 56' ' ' PHE . 18.3 mm -86.68 90.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 35' ' ' GLU . 46.4 mtp180 -125.99 124.43 24.68 Favored Pre-proline 0 N--CA 1.484 1.255 0 O-C-N 121.914 -0.491 . . . . 0.0 111.986 -171.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.27 -35.83 1.15 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.412 2.075 . . . . 0.0 111.066 165.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -80.4 82.21 6.48 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 172.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 176.38 178.9 0.2 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 125.7 1.6 . . . . 0.0 107.253 -174.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.7 m -61.81 168.3 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.454 0.701 . . . . 0.0 111.219 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 94' ' ' VAL . 28.6 m-80 73.95 158.8 0.21 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.289 1.436 . . . . 0.0 110.283 -169.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.57 -40.04 59.91 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 114.027 0.371 . . . . 0.0 114.027 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -130.91 168.69 16.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.861 0.865 . . . . 0.0 110.81 -174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HB2' HG22 ' A' ' 47' ' ' ILE . 29.4 p90 -87.99 114.21 24.39 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.262 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' A' ' 81' ' ' GLU . 37.7 mtm -139.66 -174.84 4.01 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.493 1.117 . . . . 0.0 108.081 174.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.12 110.39 1.51 Allowed Glycine 0 C--N 1.351 1.399 0 O-C-N 123.497 0.498 . . . . 0.0 112.755 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 t -133.82 115.95 15.11 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -78.6 115.1 18.07 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.353 0.661 . . . . 0.0 109.26 -175.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.93 96.6 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.418 1.087 . . . . 0.0 109.31 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.525 ' HA ' HD12 ' A' ' 65' ' ' LEU . 11.3 pt20 -93.41 12.79 23.66 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.269 1.028 . . . . 0.0 112.825 -169.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.52 106.75 1.21 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.133 0.973 . . . . 0.0 111.76 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 70.78 22.24 78.14 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 115.507 -0.769 . . . . 0.0 114.062 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.659 ' HB3' ' ND2' ' A' ' 69' ' ' ASN . 14.2 mt -88.33 174.59 8.08 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.34 0.656 . . . . 0.0 112.337 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.3 m -105.4 -151.08 0.44 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.658 1.183 . . . . 0.0 109.644 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -91.4 -53.45 4.33 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.061 0.846 . . . . 0.0 112.68 -175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -57.04 -46.4 82.45 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 123.524 0.73 . . . . 0.0 112.232 -171.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.659 ' ND2' ' HB3' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -56.21 -40.74 74.52 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.149 0.98 . . . . 0.0 112.707 175.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 51.2 mm -64.65 -46.29 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 122.47 0.308 . . . . 0.0 110.592 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 97.9 mt-30 -62.48 -57.4 11.32 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.094 0.958 . . . . 0.0 111.035 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.0 mt -64.81 -34.77 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.864 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.42 -52.05 55.06 Favored Glycine 0 C--N 1.347 1.175 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.852 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -66.87 -26.85 67.1 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.487 0.643 . . . . 0.0 111.437 -174.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 13.9 mm-40 -60.76 -50.82 71.94 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 122.119 0.962 . . . . 0.0 110.24 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.51 ' O ' HG12 ' A' ' 80' ' ' ILE . 49.3 m-85 -72.46 -25.11 61.32 Favored 'General case' 0 C--O 1.202 -1.424 0 CA-C-N 114.581 -1.191 . . . . 0.0 111.583 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -68.23 -45.7 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 123.619 0.768 . . . . 0.0 110.924 -178.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.74 -22.37 61.62 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.391 177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -73.69 -47.17 41.62 Favored 'General case' 0 CA--C 1.561 1.403 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.668 169.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -66.53 -35.79 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 124.337 1.055 . . . . 0.0 111.349 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' HB2' ' SD ' ' A' ' 57' ' ' MET . 12.8 pt-20 -56.79 -43.39 80.85 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.288 0.367 . . . . 0.0 110.705 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -78.0 -32.73 51.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.763 0.825 . . . . 0.0 111.879 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.572 HG21 HD12 ' A' ' 19' ' ' ILE . 21.9 m -69.58 -37.02 76.8 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.049 0.54 . . . . 0.0 110.803 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.9 -51.22 12.95 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -154.59 103.76 2.49 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.665 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -74.03 165.05 25.83 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.02 176.98 38.42 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.867 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 62.2 p -73.33 -11.76 60.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.961 0.904 . . . . 0.0 111.264 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.539 HD21 ' HB ' ' A' ' 94' ' ' VAL . 8.9 tt -65.34 138.34 58.1 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.38 0.672 . . . . 0.0 109.416 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.7 p -117.15 152.69 34.22 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.127 0.971 . . . . 0.0 109.706 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.7 t -60.05 -34.36 73.31 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -65.68 -42.48 91.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.499 0.59 . . . . 0.0 110.77 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -27.13 69.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.118 0.967 . . . . 0.0 112.798 -173.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' HB ' HD21 ' A' ' 89' ' ' LEU . 14.9 p -90.04 -35.91 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.161 0.505 . . . . 0.0 110.748 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 84.8 m -75.77 -27.88 58.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.273 1.029 . . . . 0.0 111.766 -175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 100' ' ' ILE . 8.1 p -67.4 -20.69 26.88 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.601 0 C-N-CA 123.201 0.6 . . . . 0.0 110.43 -172.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.71 -32.99 74.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.62 0.768 . . . . 0.0 111.1 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.91 -32.67 71.1 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.487 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.44 -35.11 58.69 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.596 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 96' ' ' VAL . 15.1 pt . . . . . 0 CA--C 1.565 1.531 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -86.13 147.23 9.02 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.692 2.261 . . . . 0.0 113.054 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -103.64 139.47 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -89.65 141.16 28.86 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.521 HD21 HG23 ' A' ' 19' ' ' ILE . 38.5 tp -145.71 110.46 5.14 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -149.93 53.51 1.3 Allowed Pre-proline 0 CA--C 1.567 1.631 0 C-N-CA 123.415 0.686 . . . . 0.0 111.2 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -86.99 -27.64 0.65 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.282 1.988 . . . . 0.0 113.443 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -127.86 4.55 6.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 118.566 -0.73 . . . . 0.0 111.99 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.8 mt -62.84 116.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -165.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.564 ' HB2' HG22 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -104.6 90.95 3.7 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 172.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.5 -23.17 58.01 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.205 1.937 . . . . 0.0 113.925 -167.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.83 -27.25 72.61 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 114.133 0.413 . . . . 0.0 114.133 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 10' ' ' LEU . 22.9 m -104.82 158.66 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.907 0.483 . . . . 0.0 111.324 -174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -73.28 -20.28 60.86 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.465 1.106 . . . . 0.0 112.905 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -105.89 174.6 5.81 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.374 0.67 . . . . 0.0 111.525 -175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -123.03 147.57 46.52 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.476 ' OG ' HD21 ' A' ' 10' ' ' LEU . 12.8 m -53.09 -49.27 66.78 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 123.939 0.774 . . . . 0.0 110.098 178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -176.2 166.9 2.9 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.021 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.521 HG23 HD21 ' A' ' 5' ' ' LEU . 83.0 mt -121.35 129.94 25.03 Favored Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 167.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 124.17 15.29 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.638 2.225 . . . . 0.0 111.897 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 24' ' ' LEU . 27.3 mp0 -71.08 -15.0 62.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.645 0.778 . . . . 0.0 111.577 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.47 -46.19 84.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.567 0.747 . . . . 0.0 110.102 170.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 5' ' ' LEU . 17.6 m -69.47 -37.41 77.27 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.248 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 HG22 ' A' ' 83' ' ' THR . 95.8 mt -61.32 -37.23 82.5 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 123.564 0.54 . . . . 0.0 111.217 175.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -69.88 -30.86 68.41 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.727 0.642 . . . . 0.0 110.775 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.1 tp10 -66.6 -38.5 87.13 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.842 0.457 . . . . 0.0 109.917 172.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 23' ' ' THR . 18.0 mm -63.37 -44.64 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.952 0.501 . . . . 0.0 109.912 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 11.6 mmm180 -64.44 -29.34 70.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.975 0.91 . . . . 0.0 110.807 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -73.62 -48.13 34.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.798 0.839 . . . . 0.0 110.987 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 4.1 pt20 -76.96 -26.11 53.58 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.115 0.566 . . . . 0.0 112.207 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.0 p -61.01 -23.77 65.66 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.13 0.423 . . . . 0.0 111.68 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.89 -31.62 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 122.663 0.385 . . . . 0.0 110.137 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 mtp180 -73.44 -13.57 61.09 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.018 0.927 . . . . 0.0 111.144 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.39 -18.61 22.92 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-O 119.585 -0.564 . . . . 0.0 113.839 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -138.83 154.56 48.46 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.757 0.778 . . . . 0.0 112.105 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.466 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -153.15 138.96 17.98 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.708 1.203 . . . . 0.0 107.781 168.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -140.26 129.33 23.55 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.092 0.557 . . . . 0.0 109.651 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.2 mp -112.81 112.61 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -82.5 94.32 7.44 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 174.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 76.5 mt -76.31 65.2 2.19 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.236 0.615 . . . . 0.0 110.426 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.08 -99.96 0.26 Allowed Glycine 0 C--N 1.35 1.307 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -71.67 -43.19 66.48 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.23 1.012 . . . . 0.0 110.984 176.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.5 OUTLIER -80.56 160.87 25.03 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.729 0.812 . . . . 0.0 110.231 -174.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 26.4 ttt -140.47 129.41 23.32 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.815 0.446 . . . . 0.0 109.862 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.78 153.8 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.007 1.323 . . . . 0.0 108.564 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -132.55 98.59 4.4 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.698 0.799 . . . . 0.0 109.777 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 56' ' ' PHE . 30.2 mm -89.32 84.19 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -116.38 125.47 28.46 Favored Pre-proline 0 N--CA 1.478 0.963 0 O-C-N 121.976 -0.452 . . . . 0.0 110.467 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 92.5 Cg_endo -78.41 1.91 8.58 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 123.308 2.672 . . . . 0.0 112.427 169.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 52.1 ttp -74.36 73.2 1.85 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.999 0.905 . . . . 0.0 109.392 177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -171.96 119.97 0.44 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.148 1.379 . . . . 0.0 107.428 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.0 m -69.93 133.98 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . 93.6 m-20 62.31 18.82 10.55 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.267 1.027 . . . . 0.0 111.702 -170.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.62 100.93 0.67 Allowed Glycine 0 C--N 1.351 1.387 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.843 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -74.79 152.75 38.98 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.767 0.827 . . . . 0.0 109.581 170.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 31.1 p90 -87.67 116.46 25.82 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.487 0.661 . . . . 0.0 111.42 -172.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.8 ptp -148.11 -176.09 5.15 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.997 1.319 . . . . 0.0 108.925 174.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.97 119.23 8.44 Favored Glycine 0 CA--C 1.54 1.604 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 -172.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.3 t -135.33 118.13 16.15 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.029 0.932 . . . . 0.0 109.17 173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.24 128.64 35.15 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.312 0.645 . . . . 0.0 109.316 -176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.3 78.32 1.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.447 0.699 . . . . 0.0 109.668 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -73.45 -23.92 60.16 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.968 0.507 . . . . 0.0 111.804 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -75.02 102.1 4.72 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.747 0.819 . . . . 0.0 109.482 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.76 3.43 55.02 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.517 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.18 161.03 14.58 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.83 0.852 . . . . 0.0 109.166 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.407 ' O ' HG12 ' A' ' 70' ' ' ILE . 30.7 t -85.99 146.52 26.63 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.897 0.479 . . . . 0.0 110.2 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.46 -37.19 74.97 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.392 1.077 . . . . 0.0 113.631 -170.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -75.05 -41.13 59.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -68.46 -17.33 64.17 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.958 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 66' ' ' SER . 47.3 mm -59.32 -43.63 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 122.919 0.487 . . . . 0.0 109.947 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -50.92 69.14 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.161 0.584 . . . . 0.0 111.143 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -63.71 -34.54 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.508 0.671 . . . . 0.0 109.832 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -64.44 -55.13 24.98 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.811 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.4 pp -67.12 -33.2 74.95 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.067 0.547 . . . . 0.0 111.685 -169.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -70.76 -36.46 73.1 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.791 0.436 . . . . 0.0 110.187 178.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -71.79 -25.9 62.2 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.729 172.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.58 -38.03 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.517 0.727 . . . . 0.0 109.985 176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 73.4 mt-10 -68.05 -33.11 73.96 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.896 0.747 . . . . 0.0 110.533 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -66.37 -52.31 48.19 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.337 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 HD11 ' A' ' 40' ' ' LEU . 75.2 mt -64.35 -29.65 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 124.234 1.014 . . . . 0.0 111.263 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.3 -38.38 83.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.272 1.029 . . . . 0.0 110.955 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -77.66 -47.05 20.18 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.834 0.854 . . . . 0.0 111.187 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 24' ' ' LEU . 31.5 m -78.47 -54.61 5.98 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.302 1.041 . . . . 0.0 112.782 -164.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.98 -41.96 81.57 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.915 0.486 . . . . 0.0 110.686 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -71.09 81.87 0.69 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.615 0.722 . . . . 0.0 110.903 -172.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -84.69 127.07 33.91 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 170.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.23 -2.58 3.56 Favored Glycine 0 N--CA 1.47 0.964 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.589 -175.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t 62.9 21.12 12.66 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.734 1.214 . . . . 0.0 111.943 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD11 ' HB ' ' A' ' 94' ' ' VAL . 3.2 tm? -73.94 135.68 43.24 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p -97.2 142.92 28.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.281 0.632 . . . . 0.0 110.44 -175.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.7 t -61.75 -46.45 89.55 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.791 0.836 . . . . 0.0 112.268 -174.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -59.26 -43.31 92.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 123.702 0.626 . . . . 0.0 110.604 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.51 -29.31 70.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.877 0.871 . . . . 0.0 113.219 -177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' A' ' 89' ' ' LEU . 8.1 p -89.1 -33.55 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 118.341 0.518 . . . . 0.0 110.771 174.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 54.5 m -66.49 -39.61 88.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.495 0.718 . . . . 0.0 110.978 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.7 m -69.1 -27.83 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.309 0.644 . . . . 0.0 111.48 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 53' ' ' ASN . 97.1 mt -70.76 -38.75 73.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.073 0.549 . . . . 0.0 110.882 177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -79.93 -24.89 40.75 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.321 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.51 -49.17 64.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.274 1.03 . . . . 0.0 110.914 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 CA--C 1.563 1.457 0 CA-C-O 118.565 -0.731 . . . . 0.0 111.026 -177.072 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.564 ' SD ' ' HG3' ' A' ' 33' ' ' ARG . 20.2 ptm . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -100.11 161.36 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.382 2.721 . . . . 0.0 114.502 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.3 121.44 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.878 0.871 . . . . 0.0 109.058 168.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.557 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 4.8 p-10 -81.7 96.41 7.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.366 0.667 . . . . 0.0 109.665 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' HG ' HG21 ' A' ' 23' ' ' THR . 3.2 tm? -110.77 106.62 15.87 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.108 0.963 . . . . 0.0 109.108 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.2 t -153.98 57.71 1.94 Allowed Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 123.295 0.638 . . . . 0.0 111.819 173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -89.25 -34.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.322 2.014 . . . . 0.0 113.282 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.521 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 55.7 m-85 -127.85 22.07 6.33 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.481 0.713 . . . . 0.0 110.499 -174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.7 mt -69.51 117.49 12.34 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-O 121.251 0.548 . . . . 0.0 110.285 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.445 ' HB2' HG22 ' A' ' 13' ' ' VAL . 65.5 mt -106.97 99.22 25.0 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -64.4 -20.99 66.79 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.739 2.292 . . . . 0.0 112.85 -173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.27 -3.3 81.78 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.891 178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 10' ' ' LEU . 27.1 m -132.57 170.95 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.623 0.769 . . . . 0.0 109.889 170.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.6 p -89.31 -0.52 57.53 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.092 0.957 . . . . 0.0 112.455 -175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.444 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 40.1 p90 -129.01 159.01 37.27 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.646 0.736 . . . . 0.0 112.111 -173.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.04 142.54 47.66 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.425 -1.262 . . . . 0.0 108.873 166.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 34.3 t -67.04 -33.06 74.71 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 168.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -167.61 152.94 7.16 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.996 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -125.94 133.08 24.57 Favored Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -54.88 126.8 23.72 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.263 1.976 . . . . 0.0 111.061 168.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -65.31 -17.49 64.55 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.424 0.69 . . . . 0.0 110.868 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -57.28 -43.88 83.51 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.944 0.898 . . . . 0.0 110.139 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.429 ' O ' HG13 ' A' ' 27' ' ' ILE . 25.7 m -65.46 -48.63 72.02 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.035 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.4 mm? -58.08 -39.56 78.85 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 118.299 0.5 . . . . 0.0 111.209 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.0 m -66.48 -43.45 85.36 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.073 0.549 . . . . 0.0 111.72 -179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 13.1 pt-20 -74.92 -27.5 60.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 119.442 -0.313 . . . . 0.0 111.062 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.665 ' HA ' HE21 ' A' ' 30' ' ' GLN . 95.4 mt -58.96 -39.9 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.328 0.651 . . . . 0.0 109.692 172.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' O ' HG12 ' A' ' 32' ' ' ILE . 17.9 mmt180 -62.02 -25.2 67.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.576 0.751 . . . . 0.0 111.893 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' N ' HD22 ' A' ' 29' ' ' ASN . 0.8 OUTLIER -80.22 -36.12 35.23 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.889 0.476 . . . . 0.0 109.908 176.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 27' ' ' ILE . 30.1 mt-30 -73.68 -30.54 62.95 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.275 0.63 . . . . 0.0 111.036 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.8 p -67.93 -32.24 72.56 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.74 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.3 mm -74.93 -28.54 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.555 0.742 . . . . 0.0 110.595 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.564 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 26.9 mmt180 -64.74 -33.34 75.74 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 168.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.29 -11.65 39.98 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.253 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -138.02 106.2 5.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.203 0.601 . . . . 0.0 110.755 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -117.11 122.05 43.02 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -131.46 107.42 8.88 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.103 0.478 . . . . 0.0 109.919 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.47 HD13 HG12 ' A' ' 47' ' ' ILE . 1.7 mp -98.41 110.29 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -172.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.557 ' HB2' ' HA ' ' A' ' 4' ' ' ASP . 61.4 mtt-85 -82.07 88.16 6.44 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.0 mt -78.62 78.54 5.07 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.15 -102.22 0.45 Allowed Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.981 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -82.95 -40.85 19.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.037 0.935 . . . . 0.0 109.751 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.548 ' H ' HD22 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -78.82 110.65 14.2 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.68 1.192 . . . . 0.0 110.531 -166.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.462 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 10.1 tpt -82.28 105.51 13.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.47 155.39 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.677 0.791 . . . . 0.0 109.361 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.1 m -140.25 127.73 21.45 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.841 0.857 . . . . 0.0 108.7 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 38' ' ' ILE . 16.0 mm -113.09 92.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -134.57 127.76 18.77 Favored Pre-proline 0 N--CA 1.484 1.234 0 O-C-N 122.235 -0.291 . . . . 0.0 110.499 -174.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 59.1 Cg_endo -71.32 125.9 11.77 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.136 2.557 . . . . 0.0 112.242 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.431 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 54.4 ttm -81.45 85.53 6.46 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.704 0.802 . . . . 0.0 110.78 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 47.72 -88.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 126.219 1.808 . . . . 0.0 114.351 170.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.98 133.28 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.069 0.948 . . . . 0.0 108.737 -174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 52.23 17.59 0.74 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 126.532 1.933 . . . . 0.0 113.574 -176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -114.21 94.54 0.69 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -73.08 169.1 17.71 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.48 0.712 . . . . 0.0 109.403 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.405 ' HD1' ' HB3' ' A' ' 49' ' ' PRO . 27.6 p90 -102.42 139.76 37.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 0.0 110.737 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -159.94 -174.97 4.84 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 125.063 1.345 . . . . 0.0 108.2 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.29 115.54 6.32 Favored Glycine 0 CA--C 1.54 1.609 0 O-C-N 123.338 0.399 . . . . 0.0 112.806 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 t -126.0 135.05 51.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.299 1.04 . . . . 0.0 108.395 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.0 tm? -101.82 112.14 24.64 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.902 0.481 . . . . 0.0 110.555 -171.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -73.64 97.02 2.57 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 65' ' ' LEU . 18.9 pt20 -82.32 -13.77 56.39 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.873 1.269 . . . . 0.0 112.034 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.6 103.59 4.26 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.434 0.694 . . . . 0.0 110.296 -177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.61 -9.63 23.86 Favored Glycine 0 N--CA 1.472 1.047 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.702 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 62' ' ' GLN . 36.3 mt -77.55 179.27 6.64 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.646 0.736 . . . . 0.0 111.916 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.4 t -104.81 166.95 10.04 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.268 172.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -53.72 -45.7 70.57 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.423 0.689 . . . . 0.0 111.337 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.55 -45.21 80.13 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.885 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' HB3' HD22 ' A' ' 65' ' ' LEU . 14.1 m120 -57.77 -24.94 59.6 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.596 0.759 . . . . 0.0 112.626 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 40.6 mm -62.89 -46.72 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 122.781 0.432 . . . . 0.0 110.064 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.426 ' NE2' HE21 ' A' ' 75' ' ' GLN . 56.0 tp60 -64.14 -54.82 27.78 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.718 0.807 . . . . 0.0 111.137 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.33 -33.86 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 C-N-CA 122.943 0.497 . . . . 0.0 109.922 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.02 -58.19 13.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.011 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.36 -28.67 70.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.851 0.461 . . . . 0.0 111.909 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.426 HE21 ' NE2' ' A' ' 71' ' ' GLN . 88.0 mm-40 -63.09 -54.25 40.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.669 0.787 . . . . 0.0 110.531 174.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.49 ' O ' HG12 ' A' ' 80' ' ' ILE . 17.4 m-85 -61.13 -37.81 84.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.075 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.3 mp -60.09 -43.43 92.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.669 0.788 . . . . 0.0 112.19 -176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -74.32 -29.39 61.58 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.177 0.298 . . . . 0.0 110.811 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.444 ' ND1' ' HB3' ' A' ' 15' ' ' PHE . 58.9 m-70 -77.62 -27.38 51.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 174.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 76' ' ' TYR . 37.6 mm -71.91 -40.35 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -55.52 -45.04 77.16 Favored 'General case' 0 C--O 1.212 -0.909 0 C-N-CA 124.224 1.009 . . . . 0.0 109.948 176.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -50.46 -43.38 55.2 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.36 0.664 . . . . 0.0 111.884 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -81.77 -33.63 30.82 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.921 -175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.38 -23.69 19.99 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 0.0 110.522 -168.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 7.8 t-20 -83.35 -174.55 5.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.538 0.735 . . . . 0.0 110.122 -174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 73.36 125.21 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.299 1.44 . . . . 0.0 111.493 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.26 -100.89 0.15 Allowed Glycine 0 C--N 1.343 0.934 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.9 m -69.19 -18.07 63.87 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.641 0.776 . . . . 0.0 111.671 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.51 173.65 14.88 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.38 1.072 . . . . 0.0 109.593 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.6 m -86.35 159.68 19.32 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.119 0.568 . . . . 0.0 109.664 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.3 p -55.23 -39.7 70.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.614 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -63.07 -34.51 77.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.505 0.503 . . . . 0.0 111.359 -176.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HD13 ' A' ' 97' ' ' LEU . 1.2 mp0 -62.09 -50.58 71.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.675 0.39 . . . . 0.0 111.951 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 m -63.99 -30.02 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-N 118.16 0.436 . . . . 0.0 110.501 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.0 m -69.42 -46.19 67.4 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 124.238 1.015 . . . . 0.0 111.174 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 100' ' ' ILE . 34.0 m -75.22 -25.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 O-C-N 123.431 0.457 . . . . 0.0 111.084 -177.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 93' ' ' GLU . 7.7 mp -68.05 -40.68 82.78 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.627 0.771 . . . . 0.0 110.078 170.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -78.29 -24.26 46.83 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.94 0.896 . . . . 0.0 110.255 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -71.03 -49.45 44.8 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.135 0.974 . . . . 0.0 109.918 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 96' ' ' VAL . 28.9 pt . . . . . 0 CA--C 1.569 1.681 0 O-C-N 123.47 0.481 . . . . 0.0 110.508 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.892 0.377 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -92.87 100.45 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 123.093 2.528 . . . . 0.0 111.558 176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.57 99.14 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 CA-C-O 121.931 0.872 . . . . 0.0 110.401 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -68.62 124.58 24.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.073 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 19' ' ' ILE . 4.0 tt -133.78 94.2 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -152.52 60.38 3.38 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 121.512 0.673 . . . . 0.0 111.689 172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.13 -34.59 0.12 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.146 1.897 . . . . 0.0 113.129 174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -119.37 0.43 11.11 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.479 0.712 . . . . 0.0 112.143 -171.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.5 mt -59.68 123.37 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -165.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 mt -105.16 92.22 5.29 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 113.828 -1.533 . . . . 0.0 107.51 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -73.38 88.49 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 122.893 2.395 . . . . 0.0 110.761 -173.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.25 -36.5 0.3 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.255 -175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -83.61 165.51 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.204 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.618 ' HA ' ' HB3' ' A' ' 75' ' ' GLN . 49.6 m -85.7 -20.09 29.88 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.48 0.712 . . . . 0.0 111.848 -177.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -113.56 -173.3 2.24 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 0.0 110.302 -174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.701 HD23 HG12 ' A' ' 19' ' ' ILE . 8.1 tp -133.38 133.26 42.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 162.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 m -51.55 -55.4 19.32 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.313 1.008 . . . . 0.0 111.106 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -141.6 144.45 34.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.858 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.701 HG12 HD23 ' A' ' 16' ' ' LEU . 31.6 mt -127.8 127.58 23.95 Favored Pre-proline 0 N--CA 1.477 0.898 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 167.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -58.76 117.33 4.04 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.815 2.343 . . . . 0.0 112.415 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -61.3 -23.05 65.43 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.242 1.017 . . . . 0.0 111.727 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.08 -47.74 82.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.295 1.038 . . . . 0.0 110.502 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.0 m -67.36 -36.81 82.14 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.98 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 27' ' ' ILE . 3.8 mm? -64.92 -32.03 73.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 119.514 -0.279 . . . . 0.0 111.47 176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 44.0 m -62.39 -42.12 99.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.832 0.453 . . . . 0.0 110.112 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.8 tp10 -60.16 -56.96 15.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.888 0.875 . . . . 0.0 109.894 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 24' ' ' LEU . 74.4 mt -54.85 -46.88 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 125.131 1.372 . . . . 0.0 111.331 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -72.58 -28.14 62.62 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.624 -171.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.09 -42.28 16.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.646 0.378 . . . . 0.0 111.948 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' A' ' 36' ' ' ALA . 5.1 pt20 -69.31 -23.62 63.83 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.079 0.552 . . . . 0.0 111.711 -176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 p -62.39 -25.98 68.23 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 122.685 0.394 . . . . 0.0 111.987 169.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.47 -34.41 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-O 121.122 0.486 . . . . 0.0 109.769 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -73.19 -14.49 61.36 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.274 172.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.63 12.23 67.16 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 123.719 0.676 . . . . 0.0 113.047 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -138.35 107.34 6.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.293 0.637 . . . . 0.0 111.024 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB2' ' HG3' ' A' ' 30' ' ' GLN . . . -146.67 134.48 21.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.883 0.873 . . . . 0.0 108.685 173.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -155.67 122.27 5.26 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.48 141.97 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.132 1.373 . . . . 0.0 109.245 -174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -108.07 97.68 7.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.431 HD12 HG21 ' A' ' 45' ' ' VAL . 96.4 mt -77.9 69.14 4.09 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.56 0.695 . . . . 0.0 109.843 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.03 2.04 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.693 -175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.466 ' HG3' HD21 ' A' ' 69' ' ' ASN . 11.7 pt-20 -91.74 -21.88 20.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.293 0.637 . . . . 0.0 110.627 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' A' ' 73' ' ' GLY . 34.6 mt -74.71 108.18 7.3 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.463 ' HB3' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -88.96 131.82 34.99 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 HD12 ' A' ' 40' ' ' LEU . 59.3 t -132.14 135.49 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.693 0.797 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 t -116.75 126.54 53.27 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.378 0.671 . . . . 0.0 109.774 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.21 84.35 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.0 mmm-85 -116.49 108.14 45.78 Favored Pre-proline 0 N--CA 1.481 1.121 0 O-C-N 121.932 -0.48 . . . . 0.0 110.394 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.14 137.69 26.67 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.516 2.144 . . . . 0.0 111.585 170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.655 ' HB3' ' HA3' ' A' ' 54' ' ' GLY . 51.4 ttm -130.86 115.22 16.28 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -66.32 -28.69 68.88 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.194 0.597 . . . . 0.0 111.811 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 t -86.15 60.7 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 59.73 101.94 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.543 1.537 . . . . 0.0 112.097 -178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.655 ' HA3' ' HB3' ' A' ' 50' ' ' MET . . . -176.1 96.13 0.1 Allowed Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -72.97 126.04 29.02 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.44 0.696 . . . . 0.0 109.788 -176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -87.49 113.33 23.09 Favored 'General case' 0 C--N 1.351 0.637 0 CA-C-O 121.908 0.861 . . . . 0.0 109.898 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.606 ' HG2' HD11 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -161.03 -175.23 4.79 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.721 176.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.67 109.38 1.97 Allowed Glycine 0 CA--C 1.534 1.246 0 O-C-N 123.651 0.594 . . . . 0.0 113.608 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.0 t -102.92 97.82 7.89 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HB2' HG12 ' A' ' 77' ' ' ILE . 2.9 tm? -73.66 109.18 6.97 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -176.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 44' ' ' MET . 36.2 t30 -64.28 109.95 2.06 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.813 0.845 . . . . 0.0 109.451 170.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.405 ' HG3' ' H ' ' A' ' 62' ' ' GLN . 4.2 pp0? -76.94 -19.42 57.4 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.066 0.946 . . . . 0.0 112.096 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.11 134.75 48.5 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.082 0.553 . . . . 0.0 110.317 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.6 -22.53 23.9 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.333 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.583 HD22 ' ND2' ' A' ' 69' ' ' ASN . 17.2 mt -91.03 -172.14 3.23 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.039 0.535 . . . . 0.0 110.944 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' O ' HG12 ' A' ' 70' ' ' ILE . 48.5 t -138.08 162.08 35.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.526 1.13 . . . . 0.0 107.979 170.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -54.13 -33.54 58.07 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -169.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -70.61 -36.56 73.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.457 0.703 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.583 ' ND2' HD22 ' A' ' 65' ' ' LEU . 63.0 t30 -76.81 -35.96 57.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.221 0.608 . . . . 0.0 111.635 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 66' ' ' SER . 29.9 mm -50.42 -37.53 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.939 0.896 . . . . 0.0 110.553 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 56.1 tp60 -53.16 -53.18 54.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.177 0.991 . . . . 0.0 111.557 176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -61.26 -38.14 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.87 -57.06 21.33 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.307 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.5 pp -65.69 -26.08 67.61 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.283 0.633 . . . . 0.0 111.42 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 14' ' ' SER . 84.3 mm-40 -70.63 -40.63 72.98 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.166 0.587 . . . . 0.0 110.651 173.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.493 ' O ' HG12 ' A' ' 80' ' ' ILE . 9.2 m-85 -71.73 -27.38 62.96 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.104 174.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 60' ' ' LEU . 1.2 mp -68.21 -46.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.026 0.93 . . . . 0.0 110.493 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.79 -28.31 63.52 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.691 0.619 . . . . 0.0 109.865 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -68.16 -42.31 80.25 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.481 0.712 . . . . 0.0 110.961 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 76' ' ' TYR . 34.8 mm -67.72 -34.95 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.484 0.713 . . . . 0.0 109.913 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -64.94 -37.97 89.42 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 123.455 0.472 . . . . 0.0 111.036 174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -73.28 -25.56 60.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.689 0.396 . . . . 0.0 111.501 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -78.44 -46.05 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.167 0.587 . . . . 0.0 110.976 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.0 -52.95 5.91 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.28 0.632 . . . . 0.0 110.802 -176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -96.13 168.73 10.42 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.414 0.686 . . . . 0.0 109.778 -176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -66.1 -67.37 0.45 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.238 0.615 . . . . 0.0 110.692 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.41 -108.51 3.18 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.6 p -166.23 141.09 4.5 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 122.915 0.486 . . . . 0.0 111.661 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.606 HD11 ' HG2' ' A' ' 57' ' ' MET . 0.0 OUTLIER -89.08 147.78 24.05 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 163.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 p -70.82 141.41 51.34 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.1 t -60.18 -34.22 73.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.763 0.825 . . . . 0.0 112.53 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -53.66 -34.86 60.08 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.884 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -51.6 68.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.512 1.125 . . . . 0.0 112.092 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.432 HG13 HD21 ' A' ' 89' ' ' LEU . 34.6 m -77.86 -22.51 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 118.635 0.652 . . . . 0.0 111.215 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.7 m -67.64 -38.83 84.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.54 0.736 . . . . 0.0 111.13 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -76.49 -33.01 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 122.665 0.386 . . . . 0.0 110.868 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -75.47 -29.54 59.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 0.0 111.98 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -81.71 -29.18 33.08 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.829 0.452 . . . . 0.0 110.274 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -71.32 -38.86 71.68 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.619 0.768 . . . . 0.0 110.831 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 27.6 pt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.776 177.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 ttm . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.35 104.71 0.44 Allowed 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 122.523 2.149 . . . . 0.0 111.717 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.42 99.06 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-O 122.138 0.971 . . . . 0.0 110.68 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 39' ' ' ARG . 8.2 p-10 -71.07 139.32 50.35 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.024 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 23' ' ' THR . 45.2 tp -146.81 117.86 7.74 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.714 1.205 . . . . 0.0 108.833 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -154.13 52.59 0.8 Allowed Pre-proline 0 CA--C 1.563 1.45 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.72 -31.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.929 1.753 . . . . 0.0 113.622 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.472 ' HB2' HD11 ' A' ' 16' ' ' LEU . 66.7 m-85 -131.29 17.21 4.96 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.5 0.72 . . . . 0.0 111.707 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' HA ' HD21 ' A' ' 16' ' ' LEU . 28.9 mt -68.05 121.21 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.562 ' HB2' HG22 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -96.64 92.44 1.1 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.39 82.05 2.16 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.725 2.283 . . . . 0.0 111.298 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.97 -37.85 0.26 Allowed Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.092 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 10' ' ' LEU . 6.4 m -82.71 159.76 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.889 0.476 . . . . 0.0 110.513 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -83.77 -0.21 50.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.318 0.647 . . . . 0.0 112.701 -175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' H ' HG23 ' A' ' 13' ' ' VAL . 40.3 p90 -131.15 -174.04 3.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.815 0.846 . . . . 0.0 111.354 -171.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 17' ' ' SER . 1.5 tm? -139.1 147.34 41.84 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 173.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.515 ' N ' HD13 ' A' ' 16' ' ' LEU . 25.3 t -63.62 -77.52 0.05 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.43 0.692 . . . . 0.0 111.011 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -145.44 94.63 2.54 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.802 0.441 . . . . 0.0 110.621 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 67.4 mt -77.32 132.91 68.83 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.3 122.25 11.24 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.637 2.225 . . . . 0.0 111.927 174.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.462 ' HA ' HD23 ' A' ' 24' ' ' LEU . 13.5 pt20 -64.63 -22.78 67.06 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.027 0.931 . . . . 0.0 111.212 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -60.91 -39.28 88.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.16 0.984 . . . . 0.0 110.187 173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.485 HG21 HD13 ' A' ' 5' ' ' LEU . 33.0 m -71.51 -37.15 71.24 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.16 177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.3 mm? -63.44 -37.0 85.61 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.684 0.675 . . . . 0.0 110.789 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.6 m -63.91 -35.0 79.22 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.046 0.539 . . . . 0.0 110.519 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 10.5 tp10 -70.37 -36.72 74.31 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.764 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.446 HG23 HD11 ' A' ' 38' ' ' ILE . 11.9 mm -63.36 -42.32 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG12 ' A' ' 32' ' ' ILE . 67.6 mtt180 -65.32 -25.29 67.55 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.451 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -71.78 -43.97 64.79 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.675 0.39 . . . . 0.0 111.101 173.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.23 0.612 . . . . 0.0 110.429 -177.008 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.0 p -67.18 -18.67 65.36 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.338 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 28' ' ' ARG . 44.4 mm -66.67 -28.9 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 174.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.9 tpt85 -71.57 -15.79 62.29 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.382 0.673 . . . . 0.0 110.446 173.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.79 -22.19 19.57 Favored Glycine 0 N--CA 1.472 1.089 0 C-N-CA 123.547 0.594 . . . . 0.0 113.238 171.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 154.64 45.73 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.563 0.745 . . . . 0.0 110.043 173.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.9 147.0 34.59 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.384 1.074 . . . . 0.0 108.607 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -129.03 117.02 20.21 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.525 HD13 HG12 ' A' ' 47' ' ' ILE . 1.6 mp -107.5 115.37 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 92.0 mtt180 -88.25 88.51 7.66 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 58.8 mt -71.47 77.49 0.78 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.05 -99.91 0.53 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -169.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -110.71 -4.37 15.39 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.308 1.043 . . . . 0.0 111.618 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 72' ' ' ILE . 13.0 mt -83.46 111.26 18.89 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.537 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.6 tpt -87.54 103.95 16.03 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.163 0.506 . . . . 0.0 110.409 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.99 152.28 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.081 0.952 . . . . 0.0 109.422 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.4 m -139.2 109.44 6.47 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.688 0.795 . . . . 0.0 109.704 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.58 HG22 ' HB2' ' A' ' 56' ' ' PHE . 34.6 mm -97.34 110.21 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.853 0.861 . . . . 0.0 109.163 -178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.3 mtt-85 -128.05 116.74 20.46 Favored Pre-proline 0 N--CA 1.488 1.426 0 C-N-CA 122.744 0.417 . . . . 0.0 110.831 -171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HB3' ' HD2' ' A' ' 56' ' ' PHE . 71.0 Cg_endo -84.17 -0.4 9.51 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.778 2.319 . . . . 0.0 113.057 166.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 54.0 tpp -73.26 -45.84 53.47 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.108 0.563 . . . . 0.0 111.438 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -155.52 150.54 26.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.716 -173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.0 t 68.88 110.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.048 1.339 . . . . 0.0 110.183 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 76.2 137.27 0.06 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.258 1.423 . . . . 0.0 110.629 -175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.31 -35.96 91.73 Favored Glycine 0 N--CA 1.476 1.342 0 CA-C-N 115.926 -0.579 . . . . 0.0 114.218 -175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -122.62 169.49 10.98 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.58 ' HB2' HG22 ' A' ' 47' ' ' ILE . 50.2 p90 -86.76 129.0 35.04 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.087 0.47 . . . . 0.0 110.385 -176.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.586 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 26.4 ptt? -158.5 -176.4 5.87 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.389 1.075 . . . . 0.0 109.351 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.35 114.02 3.9 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.811 0.695 . . . . 0.0 114.552 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.7 t -134.01 120.44 20.26 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.6 tp -89.04 144.15 26.35 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.844 0.457 . . . . 0.0 111.961 -174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -96.52 81.64 3.26 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.468 168.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -78.19 -14.09 59.59 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.436 175.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.19 106.79 0.92 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.431 1.092 . . . . 0.0 110.827 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 75.85 20.45 77.93 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.547 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.6 tp -97.55 155.22 17.06 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.748 0.819 . . . . 0.0 110.301 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.1 m -66.73 139.81 57.84 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -60.97 -34.44 74.76 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.203 0.601 . . . . 0.0 112.269 -171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.034 0.533 . . . . 0.0 109.736 173.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.47 -23.84 67.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.582 0.753 . . . . 0.0 111.439 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.5 mt -72.87 -42.73 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 122.971 0.508 . . . . 0.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -65.27 -58.32 6.25 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.865 0.466 . . . . 0.0 111.016 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 43' ' ' LEU . 3.2 mp -68.4 -26.66 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.354 -178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.6 24.22 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.424 -0.653 . . . . 0.0 113.269 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.06 -34.47 78.14 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 117.705 0.752 . . . . 0.0 112.167 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 72' ' ' ILE . 13.1 pt20 -73.05 -34.49 66.31 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 120.974 0.416 . . . . 0.0 110.808 177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 80' ' ' ILE . 5.0 m-85 -69.9 -29.83 67.11 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.818 171.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.71 -45.4 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.296 0.638 . . . . 0.0 110.892 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.79 -26.98 64.53 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.559 0.537 . . . . 0.0 110.251 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.88 -43.96 82.12 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.46 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.5 mm -66.37 -29.23 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 123.962 0.905 . . . . 0.0 110.983 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 51.8 mt-10 -64.36 -44.04 92.65 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.09 0.471 . . . . 0.0 110.232 173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -66.35 -31.45 72.24 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.803 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -78.88 -35.59 43.46 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.504 0.722 . . . . 0.0 111.466 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.4 mt -99.46 7.72 45.18 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.818 0.847 . . . . 0.0 112.172 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -62.46 118.77 7.99 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -94.15 8.92 39.89 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -170.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.12 -148.69 20.61 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 121.775 -0.25 . . . . 0.0 113.055 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -63.21 93.67 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.392 1.077 . . . . 0.0 111.241 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -144.01 137.42 27.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.58 ' HB ' ' HG3' ' A' ' 93' ' ' GLU . 15.4 m -103.58 145.59 29.82 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.2 t -54.86 -37.96 66.88 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.712 0.633 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -68.06 -38.87 82.94 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 122.632 0.373 . . . . 0.0 111.859 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.58 ' HG3' ' HB ' ' A' ' 90' ' ' THR . 47.6 mt-10 -61.18 -45.0 96.41 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 122.852 0.461 . . . . 0.0 111.564 -177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 p -76.57 -24.79 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.807 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 55.0 m -72.87 -52.05 16.33 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 123.05 0.54 . . . . 0.0 111.437 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -55.01 -27.44 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 123.736 0.815 . . . . 0.0 112.418 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.36 -48.32 80.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.877 0.871 . . . . 0.0 111.2 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -83.04 -24.76 32.65 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.085 0.554 . . . . 0.0 111.272 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -75.68 -36.93 59.93 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.106 0.962 . . . . 0.0 111.325 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 CA--C 1.567 1.621 0 C-N-CA 122.731 0.412 . . . . 0.0 111.614 -178.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.3 mtm . . . . . 0 CA--C 1.544 0.742 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 23.6 Cg_exo -63.64 119.35 6.38 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 123.268 2.646 . . . . 0.0 114.189 -170.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.547 ' HB ' HG13 ' A' ' 38' ' ' ILE . 17.1 t -76.7 93.95 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 C-N-CA 123.927 0.891 . . . . 0.0 108.713 169.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.48 102.2 1.1 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.5 100.3 7.98 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.564 0.746 . . . . 0.0 109.272 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.9 t -151.0 47.32 0.43 Allowed Pre-proline 0 CA--C 1.573 1.832 0 C-N-CA 123.263 0.625 . . . . 0.0 111.704 170.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 6' ' ' THR . 5.9 Cg_exo -80.75 -45.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.751 2.3 . . . . 0.0 111.268 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 5.4 m-85 -126.89 20.5 7.02 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.962 0.905 . . . . 0.0 110.617 -170.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 16' ' ' LEU . 26.9 mt -65.77 131.24 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-N 117.893 0.315 . . . . 0.0 110.701 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -110.93 88.5 8.23 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.63 -2.62 12.12 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 122.464 2.109 . . . . 0.0 112.959 -172.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.94 -21.56 57.17 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 123.17 0.414 . . . . 0.0 113.488 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.97 166.06 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 117.371 0.586 . . . . 0.0 111.05 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.7 t -67.93 -23.72 65.11 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.37 1.068 . . . . 0.0 112.27 -174.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -112.32 175.53 5.39 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.818 0.818 . . . . 0.0 111.672 -173.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 9' ' ' ILE . 3.1 tt -109.67 152.1 26.03 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 48.6 m -55.66 -55.45 32.01 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.45 0.568 . . . . 0.0 111.185 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -167.97 128.75 1.38 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.37 1.068 . . . . 0.0 108.273 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 84.3 mt -98.94 119.85 59.97 Favored Pre-proline 0 N--CA 1.47 0.561 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 42.8 Cg_endo -67.51 142.61 59.86 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.26 1.974 . . . . 0.0 111.411 -178.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.6 -27.01 67.4 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.69 0.796 . . . . 0.0 111.495 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 20' ' ' PRO . 13.4 pt-20 -68.14 -31.45 71.03 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.628 0.771 . . . . 0.0 112.148 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.9 m -68.19 -52.21 36.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 95.5 mt -57.73 -42.52 84.03 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.27 0.981 . . . . 0.0 111.539 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.5 p -66.01 -33.55 76.06 Favored 'General case' 0 C--O 1.242 0.673 0 O-C-N 124.049 0.843 . . . . 0.0 111.39 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 35.0 tt0 -70.22 -43.44 70.64 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 174.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.74 -35.86 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.5 0.72 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 12.8 mmt85 -63.97 -37.82 88.82 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.69 -40.46 84.38 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.089 0.556 . . . . 0.0 109.831 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 71.2 mm-40 -71.66 -33.95 69.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.523 0.729 . . . . 0.0 111.25 -176.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.474 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 34.5 p -66.31 -26.23 67.21 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.719 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.5 mm -70.1 -27.03 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 CA-C-O 120.604 0.24 . . . . 0.0 110.494 176.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 22.2 tpt180 -73.53 -14.57 61.23 Favored 'General case' 0 CA--C 1.56 1.336 0 CA-C-O 121.27 0.557 . . . . 0.0 110.396 172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.81 15.64 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 123.849 0.738 . . . . 0.0 113.415 171.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.57 126.76 18.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.418 0.687 . . . . 0.0 109.734 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -110.01 102.14 10.9 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.486 1.115 . . . . 0.0 108.643 176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 2' ' ' PRO . 13.7 mp0 -82.43 120.27 25.24 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.547 HG13 ' HB ' ' A' ' 3' ' ' VAL . 2.4 mp -118.76 127.44 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 175.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -98.38 95.31 7.26 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 90.5 mt -79.1 70.46 5.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.339 0.59 . . . . 0.0 110.046 174.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.17 -103.37 0.92 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.735 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.48 -18.3 28.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.615 0.766 . . . . 0.0 110.959 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 72' ' ' ILE . 12.4 mt -86.07 109.18 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.61 0.764 . . . . 0.0 109.459 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.1 tpt -86.61 101.83 13.6 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.46 152.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 124.191 0.997 . . . . 0.0 109.003 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 59' ' ' SER . 64.0 m -141.35 102.83 4.3 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.503 0.721 . . . . 0.0 109.621 177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.611 HG22 ' HB2' ' A' ' 56' ' ' PHE . 22.1 mm -84.03 110.62 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.363 1.465 . . . . 0.0 110.874 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -114.63 131.14 23.53 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.647 -0.658 . . . . 0.0 110.562 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 31' ' ' THR . 41.8 Cg_endo -64.28 -32.7 61.57 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.927 2.418 . . . . 0.0 111.392 168.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.9 tpp 67.54 147.78 0.05 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.174 1.39 . . . . 0.0 111.377 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.26 178.54 8.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 122.879 0.472 . . . . 0.0 109.979 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.282 15.0 p 54.34 -70.89 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 126.624 1.97 . . . . 0.0 114.19 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -152.0 152.55 32.59 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.339 0.656 . . . . 0.0 109.658 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.14 -178.81 20.86 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -170.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -153.92 178.65 9.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.654 0.782 . . . . 0.0 109.786 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.611 ' HB2' HG22 ' A' ' 47' ' ' ILE . 9.7 p90 -85.63 121.92 29.0 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-O 122.005 0.907 . . . . 0.0 111.388 -175.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 7.6 ptp -146.37 -179.18 6.57 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 121.16 22.43 Favored Glycine 0 C--N 1.343 0.956 0 O-C-N 123.439 0.462 . . . . 0.0 112.485 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 46' ' ' SER . 42.8 t -130.5 97.8 4.49 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 172.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -76.09 120.7 21.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.985 0.914 . . . . 0.0 109.204 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.57 100.76 0.91 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.545 ' HA ' HD22 ' A' ' 65' ' ' LEU . 10.1 pt20 -112.1 6.12 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -161.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.5 120.56 22.65 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.864 0.466 . . . . 0.0 111.016 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.47 18.57 75.65 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 116.468 -0.333 . . . . 0.0 113.673 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 62' ' ' GLN . 10.9 mp -92.4 -176.31 4.28 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.884 0.85 . . . . 0.0 111.62 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.8 t -119.76 151.19 39.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.356 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.02 -15.89 37.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.19 -57.57 6.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.58 0.752 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -65.08 -35.29 80.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.381 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mm -56.65 -46.72 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.565 0.746 . . . . 0.0 110.908 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.9 -53.02 36.32 Favored 'General case' 0 C--N 1.355 0.82 0 O-C-N 123.477 0.486 . . . . 0.0 110.851 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 43' ' ' LEU . 49.5 mt -54.77 -41.88 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 123.827 0.705 . . . . 0.0 109.562 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.493 ' HA2' HD13 ' A' ' 43' ' ' LEU . . . -58.72 -58.07 16.53 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 114.174 -1.375 . . . . 0.0 112.629 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.564 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.4 pp -65.75 -26.22 67.63 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 117.106 0.453 . . . . 0.0 111.919 -172.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -63.83 -46.58 84.43 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.601 0.761 . . . . 0.0 110.457 174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.469 ' O ' HG12 ' A' ' 80' ' ' ILE . 48.9 m-85 -70.82 -33.22 70.47 Favored 'General case' 0 C--O 1.214 -0.8 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.433 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.03 -43.98 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.989 0.916 . . . . 0.0 111.194 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.47 -25.47 60.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.778 0.431 . . . . 0.0 110.696 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -70.22 -42.17 72.65 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.774 169.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 76' ' ' TYR . 23.2 mm -67.22 -40.81 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.988 0.915 . . . . 0.0 111.65 -174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.4 -36.08 79.3 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 123.188 0.305 . . . . 0.0 111.226 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -71.31 -44.2 65.62 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.439 0.696 . . . . 0.0 110.097 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.3 m -61.8 -38.77 89.33 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.592 1.157 . . . . 0.0 112.234 -177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -88.94 -46.18 9.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.057 0.543 . . . . 0.0 111.818 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -145.96 93.45 2.34 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.256 0.55 . . . . 0.0 110.653 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -80.56 98.21 7.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.6 157.64 25.8 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.211 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 m -83.92 69.21 10.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.547 0.739 . . . . 0.0 109.792 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 89' ' ' LEU . 2.7 pt? -76.15 153.18 36.4 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.489 -176.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.593 ' HB ' ' HG2' ' A' ' 93' ' ' GLU . 58.2 m -85.3 144.17 28.25 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -59.4 -51.42 70.0 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.878 0.471 . . . . 0.0 111.674 -172.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 tmm_? -63.2 -19.5 64.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 0.0 112.612 -173.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.593 ' HG2' ' HB ' ' A' ' 90' ' ' THR . 10.3 mm-40 -59.21 -52.72 64.45 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.253 0.621 . . . . 0.0 111.559 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.3 m -90.44 -27.37 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 122.992 0.517 . . . . 0.0 112.026 178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.1 m -72.63 -33.28 66.53 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.811 0.444 . . . . 0.0 111.527 -176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 100' ' ' ILE . 9.3 p -59.81 -27.67 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.722 0.409 . . . . 0.0 111.013 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.8 mp -54.25 -51.45 64.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.501 1.12 . . . . 0.0 111.239 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -81.67 -27.11 34.19 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.338 0.655 . . . . 0.0 111.101 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -80.84 -27.91 36.31 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.769 0.828 . . . . 0.0 112.359 -166.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 96' ' ' VAL . 9.1 pt . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 119.139 -0.457 . . . . 0.0 110.503 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.17 99.76 1.29 Allowed 'Trans proline' 0 C--N 1.391 2.787 0 CA-C-N 121.21 1.468 . . . . 0.0 112.454 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.429 HG22 HD11 ' A' ' 27' ' ' ILE . 30.7 m -93.3 128.76 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.061 0.544 . . . . 0.0 110.048 175.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -74.91 129.53 37.83 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 175.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 tt -135.2 100.72 4.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.527 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 9.4 t -152.79 38.24 0.12 Allowed Pre-proline 0 CA--C 1.571 1.786 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 6' ' ' THR . 2.1 Cg_endo -79.79 -18.48 10.38 Favored 'Trans proline' 0 C--N 1.389 2.693 0 C-N-CA 121.621 1.547 . . . . 0.0 111.978 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -128.33 -9.07 5.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-O 117.775 -1.107 . . . . 0.0 113.051 -171.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.451 HG13 ' HA ' ' A' ' 6' ' ' THR . 29.2 mt -47.9 116.53 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -164.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 17' ' ' SER . 44.8 mt -98.93 98.33 6.16 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.17 1.388 . . . . 0.0 108.438 176.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.85 42.12 1.23 Allowed 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.686 2.257 . . . . 0.0 112.588 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.23 -6.17 0.57 Allowed Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.819 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.2 163.8 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.766 0.827 . . . . 0.0 110.254 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.0 p -77.56 -38.56 48.24 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.992 0.917 . . . . 0.0 111.621 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -82.29 -175.22 5.57 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.067 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 19' ' ' ILE . 12.1 tp -137.99 136.49 36.98 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.062 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 10' ' ' LEU . 22.0 t -58.63 -33.72 70.36 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.886 0.874 . . . . 0.0 111.813 -173.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -162.4 148.04 12.7 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.967 0.907 . . . . 0.0 108.599 173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.661 HG12 HD23 ' A' ' 16' ' ' LEU . 64.6 mt -127.43 124.58 23.65 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 166.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.42 113.44 1.79 Allowed 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.075 1.85 . . . . 0.0 110.555 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.46 ' HA ' HD23 ' A' ' 24' ' ' LEU . 24.0 tm0? -64.91 -22.73 67.05 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.835 0.854 . . . . 0.0 110.727 -177.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -55.72 -38.32 69.61 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.223 0.609 . . . . 0.0 111.101 170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 27' ' ' ILE . 26.3 m -71.91 -36.64 70.05 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.676 0.79 . . . . 0.0 110.751 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 21' ' ' GLN . 4.1 mm? -63.59 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 122.833 0.453 . . . . 0.0 110.517 173.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -68.66 -33.21 73.6 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.508 0.723 . . . . 0.0 110.864 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 30' ' ' GLN . 12.6 tp10 -65.64 -45.9 81.25 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.731 172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 3' ' ' VAL . 32.9 mm -60.49 -39.78 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.268 0.627 . . . . 0.0 110.909 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.447 ' NH2' ' HB2' ' A' ' 88' ' ' SER . 55.9 mmm-85 -61.88 -38.46 88.38 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.378 0.671 . . . . 0.0 110.966 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 33.7 t30 -62.05 -41.31 98.0 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 123.814 0.846 . . . . 0.0 110.871 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 61.7 mt-30 -79.51 -32.08 42.32 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.008 0.923 . . . . 0.0 112.415 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 27' ' ' ILE . 42.5 p -66.67 -22.35 66.09 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.7 mm -66.1 -38.82 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-O 121.202 0.525 . . . . 0.0 110.024 172.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -72.17 -12.39 61.16 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.901 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.72 -8.62 58.21 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 113.475 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -140.12 124.54 17.95 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.242 0.521 . . . . 0.0 111.041 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -145.56 143.39 29.9 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.232 1.013 . . . . 0.0 108.585 168.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -137.27 153.9 50.24 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.43 129.58 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 170.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.7 mtm180 -96.91 87.49 4.28 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 78.7 mt -70.79 74.89 0.61 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.422 0.689 . . . . 0.0 109.253 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.42 -101.47 0.76 Allowed Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -100.77 -16.77 17.21 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.516 0.726 . . . . 0.0 111.282 176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 23.6 mt -74.97 110.53 9.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.309 0.644 . . . . 0.0 109.361 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.1 tpt -85.57 129.23 34.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.67 117.33 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.648 0.779 . . . . 0.0 109.803 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.5 m -86.87 111.98 21.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.341 0.656 . . . . 0.0 110.227 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.8 mm -119.19 88.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -154.44 139.12 11.61 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.92 -0.488 . . . . 0.0 111.574 -175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.33 102.58 1.63 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.849 2.366 . . . . 0.0 111.907 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -81.29 150.34 28.56 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.729 1.212 . . . . 0.0 110.783 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.75 175.32 2.45 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.863 0.465 . . . . 0.0 111.992 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.269 3.0 m 65.14 -58.48 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 127.524 2.33 . . . . 0.0 111.862 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -173.54 150.41 1.78 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.297 1.439 . . . . 0.0 107.795 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.0 87.41 1.19 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.484 ' HE1' HD21 ' A' ' 97' ' ' LEU . 11.5 m-85 -77.5 -176.4 4.23 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.265 1.026 . . . . 0.0 111.28 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -81.32 112.35 18.54 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.033 0.92 . . . . 0.0 108.928 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.625 ' HA ' HD23 ' A' ' 84' ' ' LEU . 14.7 ptp -158.17 172.4 18.46 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.658 176.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 110.15 1.56 Allowed Glycine 0 C--N 1.352 1.458 0 O-C-N 123.978 0.799 . . . . 0.0 113.199 -174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -134.35 119.07 18.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.712 0.805 . . . . 0.0 109.491 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -88.85 124.93 34.66 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.033 0.933 . . . . 0.0 109.525 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -84.69 107.1 16.71 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.521 0.729 . . . . 0.0 109.104 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -83.88 -14.92 49.9 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.083 0.953 . . . . 0.0 112.235 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.26 113.35 3.53 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.505 0.722 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.0 0.74 85.33 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.964 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tp -93.39 161.98 14.17 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.597 0.759 . . . . 0.0 110.815 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 70' ' ' ILE . 46.1 m -97.52 163.73 12.73 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.18 0.592 . . . . 0.0 110.379 178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -61.18 -42.08 97.93 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.97 0.908 . . . . 0.0 112.641 -173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -64.74 -37.21 86.83 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.222 0.534 . . . . 0.0 109.978 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -74.4 -22.91 58.94 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.684 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 66' ' ' SER . 46.0 mm -65.79 -43.86 93.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 170.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -69.6 -45.92 67.48 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.269 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -66.82 -34.32 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 O-C-N 123.727 0.642 . . . . 0.0 109.481 175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.32 -57.26 17.55 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.724 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.442 ' O ' ' HG3' ' A' ' 78' ' ' GLU . 4.7 pp -67.96 -33.52 74.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.98 0.512 . . . . 0.0 111.854 -171.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.84 -38.33 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.059 0.456 . . . . 0.0 110.038 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' O ' HG12 ' A' ' 80' ' ' ILE . 6.2 m-85 -69.47 -29.86 67.62 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.816 173.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.3 mp -68.56 -35.75 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 110.591 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 74' ' ' LEU . 49.9 mt-10 -70.27 -32.6 70.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 123.886 0.741 . . . . 0.0 110.345 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -74.21 -41.59 61.14 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.997 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 76' ' ' TYR . 36.8 mm -63.02 -37.61 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.698 0.799 . . . . 0.0 109.111 176.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -58.79 -48.5 81.06 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 123.797 0.686 . . . . 0.0 109.743 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -62.87 -34.4 77.29 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 123.415 0.447 . . . . 0.0 111.308 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.7 m -79.26 -24.21 43.12 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.553 0.741 . . . . 0.0 111.823 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 57' ' ' MET . 19.5 tp -110.15 -20.19 12.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.704 . . . . 0.0 111.884 -171.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 90' ' ' THR . 64.2 t30 -72.11 150.07 44.2 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.095 0.558 . . . . 0.0 109.836 -177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.9 t60 76.81 -9.96 1.42 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.812 1.245 . . . . 0.0 110.71 -172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.31 86.52 1.56 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.447 ' HB2' ' NH2' ' A' ' 28' ' ' ARG . 32.3 t 79.94 -42.13 0.24 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.185 1.794 . . . . 0.0 111.693 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.23 162.18 26.8 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.226 0.61 . . . . 0.0 110.523 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 ' HG2' ' A' ' 93' ' ' GLU . 14.8 t -140.68 -175.96 4.48 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.129 0.972 . . . . 0.0 109.175 174.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.9 m -54.28 -35.98 63.17 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.033 0.933 . . . . 0.0 111.995 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' H ' HG23 ' A' ' 90' ' ' THR . 57.8 ttt180 -66.83 -41.28 87.72 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.049 0.539 . . . . 0.0 111.219 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.634 ' HG2' HG22 ' A' ' 90' ' ' THR . 22.7 mm-40 -71.56 -22.15 61.79 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -170.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -83.02 -27.85 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 118.072 0.396 . . . . 0.0 111.19 168.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 90.4 m -79.35 -28.38 42.01 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.096 0.558 . . . . 0.0 112.136 -177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -63.77 -17.81 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 123.288 0.635 . . . . 0.0 112.266 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.484 HD21 ' HE1' ' A' ' 55' ' ' TYR . 3.8 mm? -66.41 -35.09 79.43 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.295 0.638 . . . . 0.0 110.099 176.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.64 -31.14 28.91 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.236 175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.11 -38.54 78.95 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.563 0.745 . . . . 0.0 112.187 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 CA--C 1.557 1.224 0 C-N-CA 123.365 0.666 . . . . 0.0 111.856 -175.612 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -66.5 141.35 60.84 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.993 2.462 . . . . 0.0 114.45 -173.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -76.81 92.63 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 124.296 1.038 . . . . 0.0 109.845 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -65.21 113.77 4.23 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 173.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD23 ' HD3' ' A' ' 7' ' ' PRO . 3.9 tt -125.71 95.12 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -177.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.496 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 10.2 t -154.46 52.92 0.81 Allowed Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 121.154 0.502 . . . . 0.0 111.465 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 6' ' ' THR . 3.2 Cg_exo -80.59 -38.53 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.374 2.049 . . . . 0.0 111.962 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -128.29 17.25 6.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.526 0.73 . . . . 0.0 111.866 -169.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.463 ' HA ' HD21 ' A' ' 16' ' ' LEU . 22.7 mt -64.15 133.49 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -102.2 101.7 20.65 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.62 1.168 . . . . 0.0 107.911 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -72.33 92.84 0.74 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.567 2.844 . . . . 0.0 111.458 -169.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.95 -38.58 1.65 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.729 -177.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 15' ' ' PHE . 7.3 t -80.92 142.37 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 122.852 0.461 . . . . 0.0 110.023 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 p -74.12 -23.7 59.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.803 0.841 . . . . 0.0 111.681 -175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.402 ' H ' HG12 ' A' ' 13' ' ' VAL . 17.9 p90 -109.54 177.34 4.77 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.256 0.622 . . . . 0.0 111.619 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 9' ' ' ILE . 0.2 OUTLIER -124.55 149.31 47.11 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.995 -177.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -61.01 -57.92 10.58 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.606 0.762 . . . . 0.0 110.023 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -171.62 133.91 0.81 Allowed 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.123 0.89 . . . . 0.0 109.307 170.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.455 HD12 HG21 ' A' ' 83' ' ' THR . 58.6 mt -103.61 136.48 19.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 173.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.62 112.69 1.08 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.691 2.26 . . . . 0.0 111.644 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.513 ' HA ' HD23 ' A' ' 24' ' ' LEU . 93.1 mt-30 -63.89 -24.99 67.95 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.526 0.731 . . . . 0.0 111.699 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.3 -35.06 76.3 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.376 0.67 . . . . 0.0 110.957 173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.8 m -74.23 -27.44 60.78 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.171 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 21' ' ' GLN . 3.7 mm? -72.27 -34.09 67.96 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 171.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.4 t -62.95 -38.92 93.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.353 0.661 . . . . 0.0 111.571 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 11.3 pt-20 -71.08 -34.84 71.54 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 119.201 -0.428 . . . . 0.0 110.278 177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD12 HD13 ' A' ' 24' ' ' LEU . 78.4 mt -63.05 -36.89 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.077 0.551 . . . . 0.0 110.206 176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' ILE . 10.9 mmm180 -57.87 -38.4 75.65 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.525 0.73 . . . . 0.0 110.284 173.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -68.61 -43.78 75.68 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.851 0.86 . . . . 0.0 111.375 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 7.5 mm-40 -65.44 -37.19 86.16 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.948 0.499 . . . . 0.0 110.644 -176.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -69.57 -22.84 63.51 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.452 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.1 mm -69.13 -36.16 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 173.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.52 ' HE ' ' HB3' ' A' ' 35' ' ' GLU . 39.9 ttp-105 -66.35 -34.46 78.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.107 169.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.05 5.4 47.01 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.637 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' HB3' ' HE ' ' A' ' 33' ' ' ARG . 1.9 tm-20 -133.93 107.83 8.05 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' A' ' 30' ' ' GLN . . . -134.56 95.54 3.39 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -98.27 104.77 16.83 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD13 HG12 ' A' ' 47' ' ' ILE . 1.9 mp -104.64 128.22 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.306 0.643 . . . . 0.0 109.838 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -105.46 98.47 8.16 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.641 0.376 . . . . 0.0 109.987 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 97.3 mt -77.33 64.95 2.8 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.681 0.792 . . . . 0.0 110.093 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.54 -110.0 3.06 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.238 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 -20.82 37.69 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.389 0.675 . . . . 0.0 110.903 175.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 17.6 mt -81.56 110.98 17.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.08 130.35 35.03 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -132.08 145.54 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.087 0.955 . . . . 0.0 108.992 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -135.96 97.69 3.69 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.83 0.452 . . . . 0.0 110.507 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 36' ' ' ALA . 5.7 mm -72.3 102.69 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.887 0.875 . . . . 0.0 109.0 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.3 mtm-85 -129.25 123.15 21.44 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HB3' ' HD1' ' A' ' 56' ' ' PHE . 55.2 Cg_endo -67.25 151.63 80.65 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.559 2.173 . . . . 0.0 112.799 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.8 ttt -78.25 132.44 37.53 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 169.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -58.8 -34.6 71.67 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.754 0.659 . . . . 0.0 112.263 -171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.33 115.67 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.012 0.925 . . . . 0.0 109.187 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 62.29 80.26 0.23 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.73 1.212 . . . . 0.0 112.522 171.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 173.03 130.9 1.31 Allowed Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.375 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -74.19 147.7 42.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.112 0.965 . . . . 0.0 111.249 -175.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HB2' HG22 ' A' ' 47' ' ' ILE . 21.5 p90 -87.77 114.0 23.97 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.745 0.783 . . . . 0.0 108.937 170.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.4 mtm -130.06 -174.74 3.41 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.708 1.203 . . . . 0.0 108.268 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.65 137.93 49.78 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.878 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.3 t -133.66 98.82 4.3 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.754 0.822 . . . . 0.0 108.847 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.54 104.21 3.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.221 0.609 . . . . 0.0 109.679 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -68.15 109.65 3.64 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 65' ' ' LEU . 49.6 tt0 -83.94 -75.77 0.32 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 35.7 43.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.627 1.571 . . . . 0.0 114.105 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.84 -19.78 4.65 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.811 -177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 62' ' ' GLN . 4.1 mp -63.31 148.91 46.99 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.188 0.994 . . . . 0.0 110.654 174.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 m -149.61 -168.15 3.03 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.986 1.315 . . . . 0.0 108.005 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.53 -168.35 0.2 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.15 0.58 . . . . 0.0 111.257 165.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.64 -18.46 20.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.164 0.986 . . . . 0.0 112.759 169.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.12 -40.78 77.78 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.782 0.433 . . . . 0.0 110.869 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 29.3 mm -56.12 -49.28 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.998 0.519 . . . . 0.0 111.131 171.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.24 -54.82 40.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.737 0.815 . . . . 0.0 111.429 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.04 -37.87 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.929 0.892 . . . . 0.0 110.103 -178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -63.2 -59.71 8.59 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.581 177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.7 pp -67.42 -27.92 67.46 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -172.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -67.26 -41.65 85.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.119 0.567 . . . . 0.0 110.189 174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -73.47 -25.52 60.51 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.991 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.1 mp -63.86 -43.27 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.481 0.712 . . . . 0.0 109.942 176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -73.4 -34.36 65.47 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.117 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.08 -39.73 93.62 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.814 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.531 HD11 HD11 ' A' ' 40' ' ' LEU . 68.2 mt -66.33 -34.06 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 123.591 0.756 . . . . 0.0 110.24 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -53.65 -47.07 70.69 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.046 0.539 . . . . 0.0 110.106 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -76.47 -30.44 57.29 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.491 1.116 . . . . 0.0 112.722 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.455 HG21 HD12 ' A' ' 19' ' ' ILE . 31.3 m -86.65 -28.56 23.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.871 0.469 . . . . 0.0 111.659 -173.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.1 tp -87.98 -38.58 15.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.216 1.006 . . . . 0.0 109.888 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -139.64 148.7 42.8 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.636 -1.166 . . . . 0.0 107.915 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -65.8 -34.86 79.14 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 119.045 0.839 . . . . 0.0 110.15 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.86 -100.63 0.46 Allowed Glycine 0 C--N 1.348 1.241 0 CA-C-N 114.42 -1.263 . . . . 0.0 114.706 165.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 m 67.03 20.99 10.34 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.213 1.405 . . . . 0.0 111.756 -177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.603 ' H ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -77.46 165.71 24.03 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.082 0.553 . . . . 0.0 110.011 173.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 37.9 m -79.76 140.3 36.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 173.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.3 t -65.02 -45.55 85.03 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 123.385 0.428 . . . . 0.0 110.33 -177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -63.45 -36.18 82.9 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.336 0.654 . . . . 0.0 111.492 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 4.7 tm-20 -58.68 -51.47 69.82 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 109.982 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.7 m -78.66 -23.52 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.249 0.62 . . . . 0.0 112.254 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.2 m -66.5 -48.53 69.5 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.593 0.357 . . . . 0.0 110.466 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.7 m -69.41 -24.41 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.269 0.628 . . . . 0.0 111.305 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 89.6 mt -66.26 -47.35 73.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.99 0.424 . . . . 0.0 110.08 171.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -80.41 -24.14 39.88 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.682 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -75.65 -46.8 29.39 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.692 0.797 . . . . 0.0 111.841 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt . . . . . 0 CA--C 1.564 1.486 0 C-N-CA 124.279 1.032 . . . . 0.0 112.952 -172.095 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.45 92.65 0.66 Allowed 'Trans proline' 0 C--N 1.373 1.842 0 C-N-CA 122.237 1.958 . . . . 0.0 111.077 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 p -62.61 99.62 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.75 -177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.11 146.21 53.67 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.409 HD13 HG21 ' A' ' 23' ' ' THR . 58.9 tp -146.25 93.5 2.32 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.913 -1.144 . . . . 0.0 107.913 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -139.02 33.7 0.21 Allowed Pre-proline 0 CA--C 1.576 1.976 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.42 -33.57 0.96 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 CA-C-N 121.173 1.455 . . . . 0.0 112.731 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' SER . 39.9 m-85 -129.34 22.1 5.62 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.527 0.731 . . . . 0.0 111.651 -174.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -64.25 123.99 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.829 0.347 . . . . 0.0 110.454 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.486 HD11 ' OG ' ' A' ' 17' ' ' SER . 25.3 mt -111.7 85.76 6.45 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 175.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.55 -12.8 34.08 Favored 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 122.407 2.071 . . . . 0.0 113.083 -167.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.83 -12.81 79.2 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.501 -0.611 . . . . 0.0 113.767 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -126.92 178.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 117.826 0.813 . . . . 0.0 111.128 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.2 p -84.13 -42.94 15.5 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.184 0.994 . . . . 0.0 111.983 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -81.97 -177.95 6.8 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.471 0.653 . . . . 0.0 112.207 -173.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.441 HD13 ' N ' ' A' ' 17' ' ' SER . 1.0 OUTLIER -134.63 148.42 50.39 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.277 1.031 . . . . 0.0 108.336 -173.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.566 ' HB2' ' HB3' ' A' ' 8' ' ' TYR . 49.3 m -84.86 63.94 8.33 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.543 0.687 . . . . 0.0 111.223 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.5 99.44 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.197 1.399 . . . . 0.0 112.094 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 65.6 mt -68.85 136.32 89.95 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.636 -0.697 . . . . 0.0 109.213 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HD3' ' HE2' ' A' ' 8' ' ' TYR . 17.2 Cg_endo -58.22 117.57 4.3 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 121.871 1.714 . . . . 0.0 110.504 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.442 ' HA ' HD23 ' A' ' 24' ' ' LEU . 5.0 pt20 -62.35 -18.24 60.98 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.665 0.786 . . . . 0.0 111.365 177.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.8 -46.55 77.98 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.787 1.235 . . . . 0.0 110.48 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.409 HG21 HD13 ' A' ' 5' ' ' LEU . 18.1 m -60.89 -47.34 86.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.274 0.629 . . . . 0.0 110.933 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' O ' ' HG2' ' A' ' 28' ' ' ARG . 3.8 mm? -58.58 -42.36 87.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 123.668 0.605 . . . . 0.0 110.741 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.0 m -63.09 -32.62 74.04 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.913 0.758 . . . . 0.0 111.44 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.8 tp10 -71.66 -45.46 61.9 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.233 174.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.25 -35.6 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 123.935 0.894 . . . . 0.0 110.518 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' O ' HG12 ' A' ' 32' ' ' ILE . 22.5 mmm180 -56.77 -42.67 79.81 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.786 0.834 . . . . 0.0 110.608 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -72.97 -40.52 65.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.666 0.786 . . . . 0.0 111.488 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 24.5 mm-40 -64.47 -40.62 96.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.491 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.9 p -69.96 -24.85 63.41 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.225 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 28' ' ' ARG . 38.9 mm -68.46 -32.78 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 172.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -82.09 -12.33 58.28 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-O 120.981 0.419 . . . . 0.0 110.409 172.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.42 -16.94 29.04 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 114.491 0.557 . . . . 0.0 114.491 168.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -134.9 116.8 15.16 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.35 0.575 . . . . 0.0 111.223 -172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . . . -122.59 138.09 54.69 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 165.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -135.71 105.03 5.99 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 47' ' ' ILE . 2.8 mp -101.81 114.81 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.713 0.805 . . . . 0.0 109.636 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 42.7 mtm180 -87.08 93.56 9.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 43' ' ' LEU . 86.4 mt -75.89 71.54 2.71 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.119 0.485 . . . . 0.0 109.815 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.33 -101.99 0.56 Allowed Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.594 -173.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -99.61 -15.02 18.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.783 0.833 . . . . 0.0 111.251 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 18.3 mt -83.5 109.77 17.64 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.466 ' SD ' ' HG2' ' A' ' 39' ' ' ARG . 12.7 tpt -86.51 117.88 25.57 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -116.31 149.97 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 59' ' ' SER . 57.1 m -137.17 134.44 36.33 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.844 0.858 . . . . 0.0 108.902 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 84' ' ' LEU . 31.9 mm -112.85 104.03 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -127.91 107.6 20.22 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 123.102 0.561 . . . . 0.0 109.54 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.22 142.84 38.47 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.606 2.204 . . . . 0.0 111.738 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 mmt -128.1 154.68 45.45 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.151 0.98 . . . . 0.0 109.087 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -67.93 171.83 6.25 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.528 168.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.253 9.6 p 46.59 75.81 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.532 0 C-N-CA 125.015 1.326 . . . . 0.0 113.284 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB3' HD23 ' A' ' 97' ' ' LEU . 3.2 m-20 63.6 21.08 12.57 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.062 1.345 . . . . 0.0 113.689 170.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.68 76.1 1.25 Allowed Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.847 -0.501 . . . . 0.0 111.847 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.418 ' HB2' HG11 ' A' ' 94' ' ' VAL . 88.8 m-85 -74.55 136.11 42.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.264 0.625 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -88.1 110.2 20.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.784 0.433 . . . . 0.0 110.648 -175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.419 ' HB2' ' HA ' ' A' ' 81' ' ' GLU . 8.4 ptt? -170.26 108.99 0.37 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.551 0.74 . . . . 0.0 109.852 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 51.21 106.18 0.01 OUTLIER Glycine 0 CA--C 1.541 1.69 0 O-C-N 124.532 1.145 . . . . 0.0 115.765 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' SER . 28.7 t -134.98 99.78 4.39 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.81 113.92 12.66 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 109.428 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -68.7 109.08 3.64 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 123.757 0.661 . . . . 0.0 109.474 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.15 7.5 46.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.244 1.018 . . . . 0.0 112.004 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.61 95.35 0.48 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.067 0.547 . . . . 0.0 110.548 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.69 9.92 86.57 Favored Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.784 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.482 HD23 HD13 ' A' ' 70' ' ' ILE . 12.8 tp -84.96 143.77 28.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.321 0.649 . . . . 0.0 110.56 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 70' ' ' ILE . 33.0 t -64.05 148.74 49.06 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.761 0.824 . . . . 0.0 111.674 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -60.35 -32.66 71.48 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 111.617 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -70.8 -38.92 73.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.35 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -69.2 -28.02 66.01 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.52 175.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD13 HD23 ' A' ' 65' ' ' LEU . 33.6 mm -64.63 -45.25 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 75' ' ' GLN . 53.5 tt0 -61.86 -57.1 13.11 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.07 0.856 . . . . 0.0 111.281 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 57.7 mt -61.27 -37.75 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 77' ' ' ILE . . . -59.46 -52.6 52.17 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 114.501 -1.227 . . . . 0.0 112.115 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.562 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 4.3 pp -67.99 -24.81 65.18 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.295 0.547 . . . . 0.0 111.537 -174.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 80.0 mm-40 -59.69 -50.74 72.65 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.497 0.665 . . . . 0.0 109.327 172.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -68.84 -26.66 65.27 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.993 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.562 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.4 mp -64.91 -37.32 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -70.11 -38.76 75.69 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.856 0.863 . . . . 0.0 111.987 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -76.89 -48.12 19.22 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.029 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.65 -29.85 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.349 0.66 . . . . 0.0 110.646 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 57' ' ' MET . 4.6 tt0 -47.14 -66.04 0.47 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.401 1.08 . . . . 0.0 111.161 173.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -71.0 -24.43 62.38 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.083 -173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.0 m -72.72 -23.43 60.85 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.113 0.565 . . . . 0.0 111.448 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 47' ' ' ILE . 34.2 tp -113.3 -56.46 2.4 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -171.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -156.31 136.92 13.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.263 1.025 . . . . 0.0 109.773 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -167.85 -47.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.609 0.764 . . . . 0.0 109.698 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.72 -86.06 0.12 Allowed Glycine 0 C--N 1.351 1.391 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.388 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.0 m -145.1 22.57 1.55 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.96 0.904 . . . . 0.0 110.556 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.1 163.57 33.88 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.293 0.637 . . . . 0.0 111.185 176.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.569 HG23 ' H ' ' A' ' 93' ' ' GLU . 5.3 t -93.41 166.89 12.06 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.801 0.841 . . . . 0.0 110.954 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.7 p -59.85 -36.55 77.07 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 0.0 110.632 172.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -62.38 -33.31 74.5 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.636 0.774 . . . . 0.0 111.339 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.569 ' H ' HG23 ' A' ' 90' ' ' THR . 7.1 tp10 -65.9 -48.7 70.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.072 0.549 . . . . 0.0 110.031 -177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 55' ' ' TYR . 15.7 m -73.66 -24.12 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.09 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 100.0 m -65.45 -46.46 79.79 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.866 0.466 . . . . 0.0 110.495 173.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 100' ' ' ILE . 25.0 m -75.24 -23.65 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.323 0.249 . . . . 0.0 111.393 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 93' ' ' GLU . 5.4 mp -62.47 -47.85 82.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.681 0.792 . . . . 0.0 110.261 169.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -74.0 -23.16 59.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.928 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -76.62 -35.93 57.76 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.134 0.974 . . . . 0.0 110.463 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 96' ' ' VAL . 38.4 pt . . . . . 0 CA--C 1.568 1.648 0 CA-C-O 120.845 0.355 . . . . 0.0 110.352 177.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.26 122.76 4.76 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.471 2.114 . . . . 0.0 111.137 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.3 t -103.21 103.7 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 0.0 109.172 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -70.35 136.46 49.73 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.17 0.51 . . . . 0.0 110.168 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 23' ' ' THR . 48.2 tp -136.29 100.59 4.43 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.547 1.139 . . . . 0.0 108.283 -175.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.412 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 11.9 t -143.31 42.17 0.39 Allowed Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 6' ' ' THR . 97.1 Cg_endo -82.34 -34.85 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 121.546 1.497 . . . . 0.0 112.803 -174.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -129.66 25.11 5.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.053 0.941 . . . . 0.0 110.848 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.0 mt -66.81 121.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.487 ' HB2' HG22 ' A' ' 13' ' ' VAL . 26.7 mt -111.07 91.56 13.37 Favored Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.72 -16.99 47.46 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.736 2.291 . . . . 0.0 113.502 -169.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.84 -27.78 64.11 Favored Glycine 0 C--N 1.348 1.229 0 O-C-N 123.46 0.475 . . . . 0.0 113.142 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 10' ' ' LEU . 16.3 m -112.19 170.37 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.186 0.594 . . . . 0.0 110.77 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -90.37 -23.62 21.03 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.243 1.017 . . . . 0.0 112.18 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -95.57 168.01 10.95 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 121.372 0.606 . . . . 0.0 111.682 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.67 143.61 39.19 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 175.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -57.22 -64.84 0.75 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.43 0.692 . . . . 0.0 111.081 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -170.89 123.3 0.61 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.392 1.077 . . . . 0.0 108.633 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 75.5 mt -89.04 135.1 32.09 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.879 0.471 . . . . 0.0 109.859 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.79 123.13 12.66 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.86 2.374 . . . . 0.0 111.566 170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -64.77 -22.79 67.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.154 0.581 . . . . 0.0 110.938 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -60.52 -34.89 74.75 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.804 0.841 . . . . 0.0 111.08 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 5' ' ' LEU . 31.3 m -65.26 -48.4 73.38 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD21 HG22 ' A' ' 83' ' ' THR . 8.6 mp -61.92 -30.48 70.93 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.286 0.634 . . . . 0.0 111.64 177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.7 t -68.86 -52.36 30.55 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.866 0.866 . . . . 0.0 110.279 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 12.6 pt-20 -65.09 -42.84 93.68 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.227 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 31' ' ' THR . 35.0 mm -63.8 -31.63 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.583 0.753 . . . . 0.0 111.031 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' O ' HG12 ' A' ' 32' ' ' ILE . 14.0 tpt180 -61.56 -34.8 76.21 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.697 0.399 . . . . 0.0 110.439 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -73.22 -43.08 61.85 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.805 0.842 . . . . 0.0 110.882 175.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 12.6 mm100 -61.69 -44.1 97.6 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.984 0.914 . . . . 0.0 111.812 -176.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 47' ' ' ILE . 68.1 p -60.47 -38.67 85.0 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.595 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 28' ' ' ARG . 50.4 mm -58.71 -37.74 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.005 0.522 . . . . 0.0 110.974 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.3 -7.66 59.63 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.256 1.022 . . . . 0.0 111.429 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.37 63.72 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.717 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 30' ' ' GLN . 26.1 tt0 -137.63 105.82 5.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.168 0.587 . . . . 0.0 109.651 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 47' ' ' ILE . . . -155.29 106.69 2.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.693 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 92.4 mt-30 -121.37 116.58 25.05 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.779 0.832 . . . . 0.0 109.12 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.38 116.63 49.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 29.1 mtm105 -87.9 99.19 11.94 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.9 mt -78.44 78.43 4.9 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.48 -100.95 0.52 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.73 -175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.87 -29.51 32.42 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.749 0.82 . . . . 0.0 110.728 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.24 160.44 15.16 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.221 1.008 . . . . 0.0 111.129 -167.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.693 ' SD ' ' HB3' ' A' ' 37' ' ' GLN . 48.9 tpp -120.3 140.74 50.8 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.019 0.928 . . . . 0.0 108.903 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.28 110.12 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.779 0.832 . . . . 0.0 109.549 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 51.0 m -90.96 95.75 10.28 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 120.988 0.423 . . . . 0.0 110.219 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 56' ' ' PHE . 19.0 mm -88.36 84.59 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -135.26 126.28 17.33 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.24 85.95 1.74 Allowed 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.878 2.385 . . . . 0.0 111.474 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.425 ' HG3' HG12 ' A' ' 52' ' ' VAL . 16.0 tpt -68.96 94.95 0.67 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -72.03 85.53 1.01 Allowed 'General case' 0 C--N 1.353 0.759 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 50' ' ' MET . 12.2 p -165.0 44.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.427 ' HB3' HD22 ' A' ' 97' ' ' LEU . 24.8 m-80 68.3 65.06 0.34 Allowed 'General case' 0 C--N 1.36 1.039 0 CA-C-N 113.136 -1.847 . . . . 0.0 109.161 -166.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.5 138.67 5.56 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.799 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -113.89 166.77 11.25 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.309 1.044 . . . . 0.0 110.626 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.469 ' HB2' HG22 ' A' ' 47' ' ' ILE . 54.1 p90 -87.6 115.86 25.33 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.451 ' SD ' HG11 ' A' ' 94' ' ' VAL . 7.2 ptm -169.67 -178.17 2.93 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.478 -177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.97 110.23 1.42 Allowed Glycine 0 CA--C 1.537 1.436 0 O-C-N 123.796 0.685 . . . . 0.0 114.071 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.3 t -127.84 100.47 5.94 Favored 'General case' 0 C--N 1.352 0.674 0 C-N-CA 123.453 0.701 . . . . 0.0 109.303 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.52 112.82 20.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.608 HD21 ' HB3' ' A' ' 44' ' ' MET . 2.4 p-10 -83.78 133.1 34.79 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.33 -1.25 42.15 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.534 1.134 . . . . 0.0 112.874 -168.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -66.26 107.92 2.14 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.352 0.661 . . . . 0.0 110.729 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.92 -17.11 58.67 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 115.915 -0.584 . . . . 0.0 113.184 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 mp -82.99 162.22 21.52 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.711 0.767 . . . . 0.0 111.786 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 70' ' ' ILE . 42.1 t -113.18 167.63 10.38 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.121 1.369 . . . . 0.0 108.756 176.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -52.33 -43.23 64.46 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.216 1.007 . . . . 0.0 112.789 -173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -64.44 -40.82 96.46 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.454 0.702 . . . . 0.0 110.975 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -66.18 -39.39 89.68 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.425 0.69 . . . . 0.0 110.673 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 66' ' ' SER . 50.0 mm -59.93 -43.68 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.573 0.749 . . . . 0.0 109.935 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -62.85 -51.74 65.82 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 123.894 0.746 . . . . 0.0 111.042 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.4 mt -53.18 -41.62 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 123.826 0.85 . . . . 0.0 110.192 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.31 -58.93 8.49 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.964 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' HA ' ' HB ' ' A' ' 77' ' ' ILE . 3.8 pp -64.72 -22.98 67.11 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.988 0.515 . . . . 0.0 112.17 -172.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -73.98 -47.76 35.03 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.111 0.564 . . . . 0.0 110.86 173.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -66.28 -26.79 67.5 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' LEU . 1.2 mp -70.44 -47.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.787 0.835 . . . . 0.0 109.929 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -24.89 60.25 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.687 0.617 . . . . 0.0 110.604 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -70.68 -49.25 49.23 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.375 0.67 . . . . 0.0 110.471 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.42 -35.4 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.564 0.745 . . . . 0.0 110.6 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 57' ' ' MET . 37.2 tt0 -59.14 -43.56 92.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.586 1.154 . . . . 0.0 110.667 176.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.4 -39.82 94.59 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.202 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 24' ' ' LEU . 17.9 m -72.03 -29.16 63.9 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.58 0.752 . . . . 0.0 111.323 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.99 -6.84 56.94 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.879 0.872 . . . . 0.0 111.771 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -69.22 87.93 0.43 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.624 0.726 . . . . 0.0 110.003 176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.409 ' HB3' HH22 ' A' ' 28' ' ' ARG . 84.4 t60 -102.99 128.83 49.65 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.42 1.088 . . . . 0.0 108.384 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.07 -115.37 4.01 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.7 m -140.83 115.28 9.42 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 110.327 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.21 139.29 11.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 92' ' ' ARG . 25.4 m -112.89 149.48 33.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 t -57.19 -39.47 75.44 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.022 0.529 . . . . 0.0 110.361 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.509 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 16.8 ttp180 -67.55 -28.99 68.26 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.635 0.774 . . . . 0.0 111.795 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.44 -47.09 83.32 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.068 0.547 . . . . 0.0 109.565 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.451 HG11 ' SD ' ' A' ' 57' ' ' MET . 10.6 p -80.7 -23.25 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.222 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.954 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.509 ' HB ' ' HA ' ' A' ' 92' ' ' ARG . 3.6 m -64.73 -46.51 81.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.505 0.722 . . . . 0.0 111.204 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.6 -33.09 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 53' ' ' ASN . 86.2 mt -68.4 -43.37 77.41 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.519 0.727 . . . . 0.0 111.753 -176.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -77.1 -25.87 52.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.885 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.12 -23.65 38.21 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.639 0.775 . . . . 0.0 112.6 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.005 178.062 . . . . . . . . 0 0 . 1 stop_ save_